Citrus Sinensis ID: 024347
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 269 | 2.2.26 [Sep-21-2011] | |||||||
| Q2V452 | 441 | CBL-interacting serine/th | yes | no | 0.933 | 0.569 | 0.900 | 1e-138 | |
| Q2QY53 | 438 | CBL-interacting protein k | yes | no | 0.966 | 0.593 | 0.853 | 1e-135 | |
| Q2RAX3 | 454 | CBL-interacting protein k | yes | no | 0.966 | 0.572 | 0.85 | 1e-134 | |
| Q84VQ3 | 439 | CBL-interacting serine/th | no | no | 0.966 | 0.592 | 0.811 | 1e-126 | |
| Q93VD3 | 482 | CBL-interacting serine/th | no | no | 0.914 | 0.510 | 0.808 | 1e-122 | |
| Q6ZLP5 | 450 | CBL-interacting protein k | no | no | 0.947 | 0.566 | 0.776 | 1e-121 | |
| Q6X4A2 | 449 | CBL-interacting protein k | no | no | 0.936 | 0.561 | 0.785 | 1e-121 | |
| Q9MAM1 | 447 | CBL-interacting serine/th | no | no | 0.944 | 0.568 | 0.740 | 1e-117 | |
| Q8S9D1 | 831 | Pentatricopeptide repeat- | no | no | 0.966 | 0.312 | 0.742 | 1e-115 | |
| Q8LIG4 | 445 | CBL-interacting protein k | no | no | 0.933 | 0.564 | 0.749 | 1e-115 |
| >sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 491 bits (1263), Expect = e-138, Method: Compositional matrix adjust.
Identities = 226/251 (90%), Positives = 243/251 (96%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+RE+AT
Sbjct: 6 QVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIAT 65
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL+KHPNVV+LYEVM SKTKIFI+LE+VTGGELFDKIVN GRMKEDEARRYFQQLI+AV
Sbjct: 66 MKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAV 125
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLKPENLLLD+YGNLK+SDFGLSALSQQVRDDGLLHT+CGTPNYVAPEV
Sbjct: 126 DYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEV 185
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
LNDRGYDG+TAD+WSCGV+L+VLLAGYLPFDDSNLMNLYKKIS+ EF CPPWLS A KL
Sbjct: 186 LNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKL 245
Query: 245 IARILDPNPMT 255
I RILDPNPMT
Sbjct: 246 ITRILDPNPMT 256
|
Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 480 bits (1236), Expect = e-135, Method: Compositional matrix adjust.
Identities = 222/260 (85%), Positives = 244/260 (93%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS K+KRRVGKYE+GRTIGEGTFAKVKFAR++ETG+PVA+KILDKEKVLKHKM EQIKR
Sbjct: 1 MSTTKVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL+KHPNVVR+YEVMGSKTKI+IVLE+VTGGELFD IVNHGRM+EDEARRYFQQL
Sbjct: 61 EISTMKLIKHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD+YGNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D+GYDG+ ADLWSCGVILFVLLAGYLPF+DSNLM LYKKIS AEFT PPW SF
Sbjct: 181 APEVLEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFP 240
Query: 241 ARKLIARILDPNPMTVSIYP 260
A++L+ RILDPNPMT P
Sbjct: 241 AKRLLTRILDPNPMTRVTIP 260
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 477 bits (1228), Expect = e-134, Method: Compositional matrix adjust.
Identities = 221/260 (85%), Positives = 243/260 (93%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS K+KRRVGKYE+GRTIGEGTFAKVKFAR++ETG+PVA+KILDKEKVLKHKM EQIKR
Sbjct: 1 MSTTKVKRRVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL+KHPNVVR+YEVMGSKT I+IVLE+VTGGELFD IVNHGRM+EDEARRYFQQL
Sbjct: 61 EISTMKLIKHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD+YGNLKVSDFGLSALSQQ++DDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D+GYDG+ ADLWSCGVILFVLLAGYLPF+DSNLM LYKKIS AEFT PPW SF
Sbjct: 181 APEVLEDQGYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFP 240
Query: 241 ARKLIARILDPNPMTVSIYP 260
A++L+ RILDPNPMT P
Sbjct: 241 AKRLLTRILDPNPMTRITIP 260
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q84VQ3|CIPKQ_ARATH CBL-interacting serine/threonine-protein kinase 26 OS=Arabidopsis thaliana GN=CIPK26 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-126, Method: Compositional matrix adjust.
Identities = 211/260 (81%), Positives = 235/260 (90%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M++PK++RRVGKYEVG+T+G+GTFAKV+ A N+ETGE VALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MNRPKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+ HPNVVRLYEV+ SKTKI+IVLEF TGGELFDKIV+ GR+KE+ AR+YFQQL
Sbjct: 61 EICTMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALS+QVR DGLLHT CGTPNY
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVLLAGYLPF+DSNLM LYKKI A E+ CPPWLS
Sbjct: 181 APEVLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPG 240
Query: 241 ARKLIARILDPNPMTVSIYP 260
A+ LI RILDPNPMT P
Sbjct: 241 AKNLIVRILDPNPMTRITIP 260
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 437 bits (1123), Expect = e-122, Method: Compositional matrix adjust.
Identities = 199/246 (80%), Positives = 227/246 (92%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
VGKYE+GRT+GEGTFAKVKFARN E G+ VA+K++DKEKVLK+KM QIKRE++TMKL+K
Sbjct: 28 VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPNV+R++EVM SKTKI+ VLEFVTGGELFDKI ++GR+KEDEAR+YFQQLINAVDYCHS
Sbjct: 88 HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
RGVYHRDLKPENLLLDA G LKVSDFGLSAL QQVR+DGLLHTTCGTPNYVAPEV+N++G
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
YDG+ ADLWSCGVILFVL+AGYLPF+DSNL +LYKKI AEFTCPPW S +A+KLI RIL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267
Query: 250 DPNPMT 255
DPNP T
Sbjct: 268 DPNPAT 273
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1119), Expect = e-121, Method: Compositional matrix adjust.
Identities = 198/255 (77%), Positives = 233/255 (91%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS + RVG+YE+GRT+GEGTFAKVKFARN+++GE VA+KILDK+KVLKHKM QIKR
Sbjct: 1 MSVSGGRTRVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++TMKL++HPNV+R++EVM SKTKI+IV+E VTGGELFDKI + GR+KED+AR+YFQQL
Sbjct: 61 EISTMKLIRHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA G LKVSDFGLSALSQQVR+DGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEV+N++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNLM+LYKKI A+F+CP W S +
Sbjct: 181 APEVINNKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTS 240
Query: 241 ARKLIARILDPNPMT 255
A+KLI +ILDPNP T
Sbjct: 241 AKKLIKKILDPNPST 255
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6X4A2|CIPKV_ORYSJ CBL-interacting protein kinase 31 OS=Oryza sativa subsp. japonica GN=CIPK31 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1116), Expect = e-121, Method: Compositional matrix adjust.
Identities = 198/252 (78%), Positives = 229/252 (90%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
PK+KRRVGKYE+GRTIGEGTFAKV+FA+N+E EPVA+KILDKEKV KH++ EQI+RE+
Sbjct: 11 PKVKRRVGKYELGRTIGEGTFAKVRFAKNTENDEPVAIKILDKEKVQKHRLVEQIRREIC 70
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
TMKLVKHPNVVRL+EVMGSK +IFIVLE+VTGGELF+ I +GR+KE+EAR+YFQQLINA
Sbjct: 71 TMKLVKHPNVVRLFEVMGSKARIFIVLEYVTGGELFEIIATNGRLKEEEARKYFQQLINA 130
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
VDYCHSRGVYHRDLK ENLLLDA GNLKVSDFGLSAL++QV+ DGLLHTTCGTPNYVAPE
Sbjct: 131 VDYCHSRGVYHRDLKLENLLLDASGNLKVSDFGLSALTEQVKADGLLHTTCGTPNYVAPE 190
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V+ DRGYDG+ AD+WSCGVIL+VLLAG+LPF+D N++ LYKKIS A+FTCP W S A+K
Sbjct: 191 VIEDRGYDGAAADIWSCGVILYVLLAGFLPFEDDNIIALYKKISEAQFTCPSWFSTGAKK 250
Query: 244 LIARILDPNPMT 255
LI RILDPNP T
Sbjct: 251 LITRILDPNPTT 262
|
Involved in cold stress tolerance. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9MAM1|CIPK9_ARATH CBL-interacting serine/threonine-protein kinase 9 OS=Arabidopsis thaliana GN=CIPK9 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 421 bits (1081), Expect = e-117, Method: Compositional matrix adjust.
Identities = 188/254 (74%), Positives = 223/254 (87%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ P + RVG YE+GRT+GEG+FAKVK+A+N+ TG+ A+KILD+EKV +HKM EQ+KRE
Sbjct: 8 ATPASRTRVGNYEMGRTLGEGSFAKVKYAKNTVTGDQAAIKILDREKVFRHKMVEQLKRE 67
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++TMKL+KHPNVV + EVM SKTKI+IVLE V GGELFDKI GR+KEDEARRYFQQLI
Sbjct: 68 ISTMKLIKHPNVVEIIEVMASKTKIYIVLELVNGGELFDKIAQQGRLKEDEARRYFQQLI 127
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
NAVDYCHSRGVYHRDLKPENL+LDA G LKVSDFGLSA S+QVR+DGLLHT CGTPNYVA
Sbjct: 128 NAVDYCHSRGVYHRDLKPENLILDANGVLKVSDFGLSAFSRQVREDGLLHTACGTPNYVA 187
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEVL+D+GYDG+ AD+WSCGVILFVL+AGYLPFD+ NLM LYK+I AEF+CPPW S A
Sbjct: 188 PEVLSDKGYDGAAADVWSCGVILFVLMAGYLPFDEPNLMTLYKRICKAEFSCPPWFSQGA 247
Query: 242 RKLIARILDPNPMT 255
+++I RIL+PNP+T
Sbjct: 248 KRVIKRILEPNPIT 261
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8S9D1|PP395_ARATH Pentatricopeptide repeat-containing protein At5g21222 OS=Arabidopsis thaliana GN=ATC401 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1067), Expect = e-115, Method: Compositional matrix adjust.
Identities = 193/260 (74%), Positives = 223/260 (85%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS+PK++R VGKYEVGR IGE F K++ A ++ETG+PVAL ILDK+KVLKHKMAEQIKR
Sbjct: 1 MSEPKVRRWVGKYEVGRLIGECNFGKLRSAVDTETGDPVALMILDKDKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++ MKL+ HPNVV+LYEV+ SK KI+IVLEF++GG+LFDKI N GRM EDEA+RYFQQL
Sbjct: 61 EISIMKLINHPNVVQLYEVLASKAKIYIVLEFISGGKLFDKIKNDGRMNEDEAQRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA NLKV++FGL ALSQQ DGL HT CG P+Y
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQENLKVAEFGLIALSQQAGGDGLRHTACGNPDYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+ ADLWSCGVILFVLLAGYLPF+DS+L LYKKIS+A+F+CPPWLS
Sbjct: 181 APEVLNDQGYDGAKADLWSCGVILFVLLAGYLPFEDSSLTTLYKKISSADFSCPPWLSSG 240
Query: 241 ARKLIARILDPNPMTVSIYP 260
+ LI RILDPNPMT P
Sbjct: 241 VKNLIVRILDPNPMTRITIP 260
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q8LIG4|CIPK3_ORYSJ CBL-interacting protein kinase 3 OS=Oryza sativa subsp. japonica GN=CIPK3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1062), Expect = e-115, Method: Compositional matrix adjust.
Identities = 188/251 (74%), Positives = 222/251 (88%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K++R +GKYE+GR IG+GTFAKV+FA+N ETG+ VA+KILDK KV KH++ EQI+RE+ T
Sbjct: 11 KVRRCLGKYELGRAIGQGTFAKVRFAKNMETGDHVAIKILDKAKVQKHRLVEQIRREICT 70
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL++HPNVV L+EVMGSKT+IFIVLE+V GGEL D I GR+KEDEAR+YFQQLINAV
Sbjct: 71 MKLIQHPNVVHLHEVMGSKTRIFIVLEYVMGGELHDIIATSGRLKEDEARKYFQQLINAV 130
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLK ENLLLD GN+KVSDFGLSA+S+QV+ DGLLHTTCGTPNYVAPEV
Sbjct: 131 DYCHSRGVYHRDLKLENLLLDTAGNIKVSDFGLSAISEQVKADGLLHTTCGTPNYVAPEV 190
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
+ D+GYDG+ ADLWSCGVILFVLLAGYLPF+D N+++LY KIS A+FTCP W S A++L
Sbjct: 191 IEDKGYDGALADLWSCGVILFVLLAGYLPFEDENIVSLYNKISGAQFTCPSWFSAEAKRL 250
Query: 245 IARILDPNPMT 255
IARILDPNP T
Sbjct: 251 IARILDPNPAT 261
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 269 | ||||||
| 255583653 | 466 | CBL-interacting serine/threonine-protein | 0.966 | 0.557 | 0.957 | 1e-146 | |
| 224120590 | 440 | predicted protein [Populus trichocarpa] | 0.966 | 0.590 | 0.942 | 1e-144 | |
| 147815805 | 439 | hypothetical protein VITISV_010092 [Viti | 0.966 | 0.592 | 0.942 | 1e-143 | |
| 225435981 | 439 | PREDICTED: CBL-interacting serine/threon | 0.966 | 0.592 | 0.942 | 1e-143 | |
| 224106656 | 440 | predicted protein [Populus trichocarpa] | 0.947 | 0.579 | 0.952 | 1e-142 | |
| 154425355 | 441 | CBL-interacting protein kinase [Vigna un | 0.966 | 0.589 | 0.926 | 1e-142 | |
| 363807728 | 414 | uncharacterized protein LOC100794566 [Gl | 0.966 | 0.628 | 0.930 | 1e-142 | |
| 357493713 | 441 | CBL-interacting protein kinase [Medicago | 0.947 | 0.578 | 0.933 | 1e-141 | |
| 357493717 | 338 | CBL-interacting protein kinase [Medicago | 0.947 | 0.754 | 0.933 | 1e-140 | |
| 357493715 | 430 | CBL-interacting protein kinase [Medicago | 0.947 | 0.593 | 0.933 | 1e-140 |
| >gi|255583653|ref|XP_002532581.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223527690|gb|EEF29798.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 523 bits (1347), Expect = e-146, Method: Compositional matrix adjust.
Identities = 249/260 (95%), Positives = 252/260 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 28 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 87
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 88 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 147
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 148 INAVDYCHSRGVYHRDLKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 207
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF
Sbjct: 208 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFG 267
Query: 241 ARKLIARILDPNPMTVSIYP 260
A KLI RILDPNPMT P
Sbjct: 268 AMKLITRILDPNPMTRITIP 287
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224120590|ref|XP_002330980.1| predicted protein [Populus trichocarpa] gi|116265926|gb|ABJ91211.1| CBL-interacting protein kinase 3 [Populus trichocarpa] gi|118485622|gb|ABK94661.1| unknown [Populus trichocarpa] gi|222872772|gb|EEF09903.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 517 bits (1331), Expect = e-144, Method: Compositional matrix adjust.
Identities = 245/260 (94%), Positives = 251/260 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EIETMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGV+HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVFHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSN+MNLYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGTTADLWSCGVILFVLLAGYLPFDDSNVMNLYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTVSIYP 260
A KLI RILDPNPMT P
Sbjct: 241 AMKLITRILDPNPMTRITIP 260
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815805|emb|CAN70422.1| hypothetical protein VITISV_010092 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1322), Expect = e-143, Method: Compositional matrix adjust.
Identities = 245/260 (94%), Positives = 251/260 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ PK+KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVA+KILDKEKVLKHKMAEQIKR
Sbjct: 1 MNPPKVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVAIKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLM LYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMILYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTVSIYP 260
A KLI RILDPNPMT P
Sbjct: 241 AMKLITRILDPNPMTRITIP 260
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225435981|ref|XP_002271894.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 3 [Vitis vinifera] gi|229609837|gb|ACQ83534.1| CBL-interacting protein kinase 18 [Vitis vinifera] gi|296083952|emb|CBI24340.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1322), Expect = e-143, Method: Compositional matrix adjust.
Identities = 245/260 (94%), Positives = 251/260 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ PK+KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVA+KILDKEKVLKHKMAEQIKR
Sbjct: 1 MNPPKVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVAIKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVLLAGYLPFDDSNLM LYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLLAGYLPFDDSNLMILYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMTVSIYP 260
A KLI RILDPNPMT P
Sbjct: 241 AMKLITRILDPNPMTRITIP 260
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106656|ref|XP_002314239.1| predicted protein [Populus trichocarpa] gi|116265928|gb|ABJ91212.1| CBL-interacting protein kinase 4 [Populus trichocarpa] gi|222850647|gb|EEE88194.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 511 bits (1316), Expect = e-142, Method: Compositional matrix adjust.
Identities = 243/255 (95%), Positives = 248/255 (97%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYE+GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGKYEMGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMK +KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM+EDEAR YF QL
Sbjct: 61 EVATMKRIKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMREDEARGYFHQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGV+HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVFHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+ ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF
Sbjct: 181 APEVLNDRGYDGAPADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFG 240
Query: 241 ARKLIARILDPNPMT 255
A KLI RILDPNPMT
Sbjct: 241 AMKLITRILDPNPMT 255
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|154425355|dbj|BAF74756.1| CBL-interacting protein kinase [Vigna unguiculata] | Back alignment and taxonomy information |
|---|
Score = 511 bits (1316), Expect = e-142, Method: Compositional matrix adjust.
Identities = 241/260 (92%), Positives = 250/260 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKI++VLEFVTGGELFDKIVNHGRM E+EARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIYVVLEFVTGGELFDKIVNHGRMSENEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLMNLYKKISAAEFTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMNLYKKISAAEFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMTVSIYP 260
ARKLI RILDP+P T P
Sbjct: 241 ARKLITRILDPDPTTRITIP 260
|
Source: Vigna unguiculata Species: Vigna unguiculata Genus: Vigna Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807728|ref|NP_001242682.1| uncharacterized protein LOC100794566 [Glycine max] gi|255638908|gb|ACU19756.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1312), Expect = e-142, Method: Compositional matrix adjust.
Identities = 242/260 (93%), Positives = 249/260 (95%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVGKYEVGRTIGEGTFAKVK ARNSETGEPVALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKSARNSETGEPVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
EVATMKL+KHPNVVRLYEVMGSKTKI+IVLEFVTGGELFDKIVNHGRM E+EARRYFQQL
Sbjct: 61 EVATMKLIKHPNVVRLYEVMGSKTKIYIVLEFVTGGELFDKIVNHGRMSENEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRD KPENLLLD YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INAVDYCHSRGVYHRDPKPENLLLDTYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLMNLYKKISAAEFTCPPWLSFT
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMNLYKKISAAEFTCPPWLSFT 240
Query: 241 ARKLIARILDPNPMTVSIYP 260
ARKLI RILDP+P T P
Sbjct: 241 ARKLITRILDPDPTTRITIP 260
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493713|ref|XP_003617145.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518480|gb|AET00104.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1302), Expect = e-141, Method: Compositional matrix adjust.
Identities = 238/255 (93%), Positives = 247/255 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ATMKL+KHPNVVRLYEVMGS+TKI+IVLEFVTGGELFDKIVNHGRM E EARRYFQQL
Sbjct: 61 EIATMKLIKHPNVVRLYEVMGSRTKIYIVLEFVTGGELFDKIVNHGRMGEPEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKIS+A+FTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISSADFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMT 255
ARKLI RILDPNPMT
Sbjct: 241 ARKLITRILDPNPMT 255
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493717|ref|XP_003617147.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518482|gb|AET00106.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 503 bits (1295), Expect = e-140, Method: Compositional matrix adjust.
Identities = 238/255 (93%), Positives = 247/255 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ATMKL+KHPNVVRLYEVMGS+TKI+IVLEFVTGGELFDKIVNHGRM E EARRYFQQL
Sbjct: 61 EIATMKLIKHPNVVRLYEVMGSRTKIYIVLEFVTGGELFDKIVNHGRMGEPEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKIS+A+FTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISSADFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMT 255
ARKLI RILDPNPMT
Sbjct: 241 ARKLITRILDPNPMT 255
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357493715|ref|XP_003617146.1| CBL-interacting protein kinase [Medicago truncatula] gi|355518481|gb|AET00105.1| CBL-interacting protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 503 bits (1295), Expect = e-140, Method: Compositional matrix adjust.
Identities = 238/255 (93%), Positives = 247/255 (96%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MSQPKIKRRVG YEVGRTIGEGTFAKVKFARNSETGE VALKILDKEKVLKHKMAEQIKR
Sbjct: 1 MSQPKIKRRVGIYEVGRTIGEGTFAKVKFARNSETGEAVALKILDKEKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ATMKL+KHPNVVRLYEVMGS+TKI+IVLEFVTGGELFDKIVNHGRM E EARRYFQQL
Sbjct: 61 EIATMKLIKHPNVVRLYEVMGSRTKIYIVLEFVTGGELFDKIVNHGRMGEPEARRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
IN VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV
Sbjct: 121 INVVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLNDRGYDG+TADLWSCGVILFVL+AGYLPFDD NLM LYKKIS+A+FTCPPWLSF+
Sbjct: 181 APEVLNDRGYDGATADLWSCGVILFVLVAGYLPFDDPNLMELYKKISSADFTCPPWLSFS 240
Query: 241 ARKLIARILDPNPMT 255
ARKLI RILDPNPMT
Sbjct: 241 ARKLITRILDPNPMT 255
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 269 | ||||||
| TAIR|locus:2059279 | 451 | CIPK3 "CBL-interacting protein | 0.933 | 0.556 | 0.900 | 6.3e-124 | |
| TAIR|locus:1005716172 | 439 | CIPK26 "calcineurin B-like pro | 0.947 | 0.580 | 0.823 | 9.4e-114 | |
| TAIR|locus:2009812 | 482 | CIPK23 "CBL-interacting protei | 0.955 | 0.533 | 0.779 | 3.8e-110 | |
| TAIR|locus:1005716169 | 831 | AT5G21222 [Arabidopsis thalian | 0.947 | 0.306 | 0.752 | 4.1e-104 | |
| TAIR|locus:2155233 | 446 | SOS2 "SALT OVERLY SENSITIVE 2" | 0.925 | 0.558 | 0.705 | 7.6e-96 | |
| TAIR|locus:2135962 | 445 | CIPK8 "CBL-interacting protein | 0.921 | 0.557 | 0.684 | 6.1e-94 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.907 | 0.553 | 0.661 | 2.8e-89 | |
| TAIR|locus:2181047 | 421 | CIPK15 "CBL-interacting protei | 0.903 | 0.577 | 0.668 | 1.1e-87 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.895 | 0.548 | 0.648 | 4.7e-87 | |
| TAIR|locus:2169444 | 456 | CIPK2 "CBL-interacting protein | 0.903 | 0.532 | 0.618 | 8e-85 |
| TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1218 (433.8 bits), Expect = 6.3e-124, P = 6.3e-124
Identities = 226/251 (90%), Positives = 243/251 (96%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI+RE+AT
Sbjct: 16 QVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREIAT 75
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MKL+KHPNVV+LYEVM SKTKIFI+LE+VTGGELFDKIVN GRMKEDEARRYFQQLI+AV
Sbjct: 76 MKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIHAV 135
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
DYCHSRGVYHRDLKPENLLLD+YGNLK+SDFGLSALSQQVRDDGLLHT+CGTPNYVAPEV
Sbjct: 136 DYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAPEV 195
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
LNDRGYDG+TAD+WSCGV+L+VLLAGYLPFDDSNLMNLYKKIS+ EF CPPWLS A KL
Sbjct: 196 LNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAMKL 255
Query: 245 IARILDPNPMT 255
I RILDPNPMT
Sbjct: 256 ITRILDPNPMT 266
|
|
| TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1122 (400.0 bits), Expect = 9.4e-114, P = 9.4e-114
Identities = 210/255 (82%), Positives = 234/255 (91%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M++PK++RRVGKYEVG+T+G+GTFAKV+ A N+ETGE VALKILDKEKVLKHKMAEQI+R
Sbjct: 1 MNRPKVQRRVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ TMKL+ HPNVVRLYEV+ SKTKI+IVLEF TGGELFDKIV+ GR+KE+ AR+YFQQL
Sbjct: 61 EICTMKLINHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA GNLKVSDFGLSALS+QVR DGLLHT CGTPNY
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+TADLWSCGVILFVLLAGYLPF+DSNLM LYKKI A E+ CPPWLS
Sbjct: 181 APEVLNDQGYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPG 240
Query: 241 ARKLIARILDPNPMT 255
A+ LI RILDPNPMT
Sbjct: 241 AKNLIVRILDPNPMT 255
|
|
| TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1088 (388.1 bits), Expect = 3.8e-110, P = 3.8e-110
Identities = 202/259 (77%), Positives = 234/259 (90%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+ RVGKYE+GRT+GEGTFAKVKFARN E G+ VA+K++DKEKVLK+KM QIKRE++TMK
Sbjct: 25 RTRVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMK 84
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
L+KHPNV+R++EVM SKTKI+ VLEFVTGGELFDKI ++GR+KEDEAR+YFQQLINAVDY
Sbjct: 85 LIKHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDY 144
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
CHSRGVYHRDLKPENLLLDA G LKVSDFGLSAL QQVR+DGLLHTTCGTPNYVAPEV+N
Sbjct: 145 CHSRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVIN 204
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
++GYDG+ ADLWSCGVILFVL+AGYLPF+DSNL +LYKKI AEFTCPPW S +A+KLI
Sbjct: 205 NKGYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIK 264
Query: 247 RILDPNPMTVSIYPFADIL 265
RILDPNP T FA+++
Sbjct: 265 RILDPNPATR--ITFAEVI 281
|
|
| TAIR|locus:1005716169 AT5G21222 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1031 (368.0 bits), Expect = 4.1e-104, P = 4.1e-104
Identities = 192/255 (75%), Positives = 222/255 (87%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
MS+PK++R VGKYEVGR IGE F K++ A ++ETG+PVAL ILDK+KVLKHKMAEQIKR
Sbjct: 1 MSEPKVRRWVGKYEVGRLIGECNFGKLRSAVDTETGDPVALMILDKDKVLKHKMAEQIKR 60
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E++ MKL+ HPNVV+LYEV+ SK KI+IVLEF++GG+LFDKI N GRM EDEA+RYFQQL
Sbjct: 61 EISIMKLINHPNVVQLYEVLASKAKIYIVLEFISGGKLFDKIKNDGRMNEDEAQRYFQQL 120
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
INAVDYCHSRGVYHRDLKPENLLLDA NLKV++FGL ALSQQ DGL HT CG P+Y
Sbjct: 121 INAVDYCHSRGVYHRDLKPENLLLDAQENLKVAEFGLIALSQQAGGDGLRHTACGNPDYA 180
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVLND+GYDG+ ADLWSCGVILFVLLAGYLPF+DS+L LYKKIS+A+F+CPPWLS
Sbjct: 181 APEVLNDQGYDGAKADLWSCGVILFVLLAGYLPFEDSSLTTLYKKISSADFSCPPWLSSG 240
Query: 241 ARKLIARILDPNPMT 255
+ LI RILDPNPMT
Sbjct: 241 VKNLIVRILDPNPMT 255
|
|
| TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 953 (340.5 bits), Expect = 7.6e-96, P = 7.6e-96
Identities = 177/251 (70%), Positives = 217/251 (86%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K RRVGKYEVGRTIGEGTFAKVKFARN++TG+ VA+KI+ K +LK++M +QIKRE++
Sbjct: 3 KKMRRVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISI 62
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
MK+V+HPN+VRLYEV+ S +KI+IVLEFVTGGELFD+IV+ GR++E E+R+YFQQL++AV
Sbjct: 63 MKIVRHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAV 122
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+CH +GVYHRDLKPENLLLD GNLKVSDFGLSAL Q+ + LL TTCGTPNYVAPEV
Sbjct: 123 AHCHCKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEV 180
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
L+ +GYDGS AD+WSCGVILFV+LAGYLPF +++L LY+KI+AAEF+CPPW S + L
Sbjct: 181 LSGQGYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFL 240
Query: 245 IARILDPNPMT 255
I RILDPNP T
Sbjct: 241 IHRILDPNPKT 251
|
|
| TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 935 (334.2 bits), Expect = 6.1e-94, P = 6.1e-94
Identities = 171/250 (68%), Positives = 213/250 (85%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+ R+VGKYE+GRTIGEGTFAKVKFA+N+ETGE VA+KI+D+ ++K KM +QIKRE++ M
Sbjct: 2 VVRKVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIM 61
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
KLV+HP VVRLYEV+ S+TKI+I+LE++TGGELFDKIV +GR+ E EAR+YF QLI+ VD
Sbjct: 62 KLVRHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVD 121
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
YCHS+GVYHRDLKPENLLLD+ GNLK+SDFGLSAL +Q +L TTCGTPNYVAPEVL
Sbjct: 122 YCHSKGVYHRDLKPENLLLDSQGNLKISDFGLSALPEQ--GVTILKTTCGTPNYVAPEVL 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245
+ +GY+G+ AD+WSCGVIL+VL+AGYLPFD+ +L LY KI AEF+CP + + A+ LI
Sbjct: 180 SHKGYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLI 239
Query: 246 ARILDPNPMT 255
RILDPNP T
Sbjct: 240 NRILDPNPET 249
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 891 (318.7 bits), Expect = 2.8e-89, P = 2.8e-89
Identities = 162/245 (66%), Positives = 202/245 (82%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+YE+GR +G GTFAKV ARN +TG+ VA+K++ KEKV+K M +QIKRE++ M++VKH
Sbjct: 22 GRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMVKH 81
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN+V L+EVM SK+KI+ +E V GGELF K+ GR++ED AR YFQQLI+AVD+CHSR
Sbjct: 82 PNIVELHEVMASKSKIYFAMELVRGGELFAKVAK-GRLREDVARVYFQQLISAVDFCHSR 140
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GVYHRDLKPENLLLD GNLKV+DFGLSA ++ ++ DGLLHTTCGTP YVAPEV+ +GY
Sbjct: 141 GVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKGY 200
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
DG+ ADLWSCGVILFVLLAGYLPF D NL+N+Y+KI +F CP WLS AR+L+ ++LD
Sbjct: 201 DGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLLD 260
Query: 251 PNPMT 255
PNP T
Sbjct: 261 PNPNT 265
|
|
| TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 876 (313.4 bits), Expect = 1.1e-87, P = 1.1e-87
Identities = 163/244 (66%), Positives = 203/244 (83%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YEVG+ +G+GTFAKV AR+ +TG+ VA+K++DKE++LK M EQIKRE++ M+L++HP
Sbjct: 11 RYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKREISAMRLLRHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L+EVM +K+KI+ V+E V GGELF+K V+ G+++ED AR+YFQQL+ AVD+CHSRG
Sbjct: 71 NIVELHEVMATKSKIYFVMEHVKGGELFNK-VSTGKLREDVARKYFQQLVRAVDFCHSRG 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKPENLLLD +GNLK+SDFGLSALS R DGLLHTTCGTP YVAPEV++ GYD
Sbjct: 130 VCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVAPEVISRNGYD 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G AD+WSCGVILFVLLAGYLPF DSNLM LYKKI AE P WL+ A++L+ RILDP
Sbjct: 190 GFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGAKRLLKRILDP 249
Query: 252 NPMT 255
NP T
Sbjct: 250 NPNT 253
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 870 (311.3 bits), Expect = 4.7e-87, P = 4.7e-87
Identities = 157/242 (64%), Positives = 201/242 (83%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE+GR +G+GTFAKV ARN +TGE VA+K++DK+KV K + +QIKRE++ M+LV+HP
Sbjct: 11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+VV L+EVM SKTKI+ +E+V GGELFDK V+ G++KE+ AR+YFQQLI A+DYCHSRG
Sbjct: 71 HVVFLHEVMASKTKIYFAMEYVKGGELFDK-VSKGKLKENIARKYFQQLIGAIDYCHSRG 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
VYHRDLKPENLLLD G+LK+SDFGLSAL + + DGLLHTTCGTP YVAPEV+ +GYD
Sbjct: 130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G+ AD+WSCGV+L+VLLAG+LPF + NL+ +Y+KI+ EF CP W +KL++RILDP
Sbjct: 190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249
Query: 252 NP 253
NP
Sbjct: 250 NP 251
|
|
| TAIR|locus:2169444 CIPK2 "CBL-interacting protein kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 849 (303.9 bits), Expect = 8.0e-85, P = 8.0e-85
Identities = 151/244 (61%), Positives = 200/244 (81%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YEVGR +G+GTFAKV F R++ T E VA+K++DK+KV++ +++QIKRE++ M++ KHP
Sbjct: 11 RYEVGRLLGQGTFAKVYFGRSNHTNESVAIKMIDKDKVMRVGLSQQIKREISVMRIAKHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NVV LYEVM +K++I+ V+E+ GGELF+K+ G++KED A +YF QLI+AVD+CHSRG
Sbjct: 71 NVVELYEVMATKSRIYFVIEYCKGGELFNKVAK-GKLKEDVAWKYFYQLISAVDFCHSRG 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
VYHRD+KPENLLLD NLKVSDFGLSAL+ R DGLLHTTCGTP YVAPEV+N +GY+
Sbjct: 130 VYHRDIKPENLLLDDNDNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRKGYE 189
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
G+ AD+WSCGV+LFVLLAGYLPF D+NLM +Y+KI A+F CP W + ++L+ ++LDP
Sbjct: 190 GTKADIWSCGVVLFVLLAGYLPFHDTNLMEMYRKIGKADFKCPSWFAPEVKRLLCKMLDP 249
Query: 252 NPMT 255
N T
Sbjct: 250 NHET 253
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q2V452 | CIPK3_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9003 | 0.9330 | 0.5691 | yes | no |
| Q2QY53 | CIPKW_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8538 | 0.9665 | 0.5936 | yes | no |
| Q2RAX3 | CIPKX_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.85 | 0.9665 | 0.5726 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 269 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-102 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-87 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-80 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-76 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-69 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-66 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-63 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-62 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-62 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-60 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-58 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-55 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-52 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-51 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-49 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-49 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-49 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-48 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-48 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-48 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-48 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-47 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-47 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-47 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-47 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-47 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-46 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-46 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-45 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-45 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-45 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-44 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-44 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-44 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-44 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-44 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-43 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-42 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-42 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-42 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-41 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-41 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-41 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-40 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-40 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-40 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-40 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-39 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-39 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-39 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-39 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-39 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-39 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-38 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-38 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-38 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-38 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-38 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-38 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-38 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-37 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-37 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-37 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-37 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-37 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-37 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-36 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-36 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-36 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-36 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 8e-36 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-36 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-36 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-35 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-35 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-35 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-35 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-35 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-35 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-34 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-34 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-34 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-34 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-34 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-34 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-33 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-33 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-33 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-33 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-33 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-33 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-33 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-33 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-33 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-32 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-32 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-32 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 9e-32 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-31 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-31 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-31 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-31 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-31 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-31 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-31 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-30 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-30 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-30 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-30 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-30 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-30 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-30 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-29 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-29 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-29 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-28 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-28 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-28 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-28 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-28 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-28 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-28 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-28 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-28 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-27 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-27 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-27 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-27 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-27 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-27 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-26 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-26 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-26 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-26 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-26 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-26 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-25 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-25 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-25 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-24 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-24 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-24 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-24 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-24 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 9e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-23 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-23 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-23 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-22 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 6e-22 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-22 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 9e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-21 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-21 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-21 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-21 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-21 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 7e-20 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-19 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-19 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-19 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-18 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-18 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-17 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-17 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-17 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-16 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-15 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-14 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 1e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-13 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-12 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-12 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-11 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-10 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-07 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-05 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 9e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 297 bits (762), Expect = e-102
Identities = 111/245 (45%), Positives = 166/245 (67%), Gaps = 10/245 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ +GEG+F KV AR+ +TG+ VA+K++ K+K+ K + E+I RE+ +K +KHPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDR--ERILREIKILKKLKHPN 58
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VRLY+V + K+++V+E+ GG+LFD + GR+ EDEAR Y +Q+++A++Y HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRDLKPEN+LLD G++K++DFGL+ Q+ L T GTP Y+APEVL +GY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 193 STADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAAEFTCPPW---LSFTARKLIARI 248
+ D+WS GVIL+ LL G PF D L+ L+KKI + PP +S A+ LI ++
Sbjct: 176 A-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 249 LDPNP 253
L +P
Sbjct: 235 LVKDP 239
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 261 bits (668), Expect = 1e-87
Identities = 97/248 (39%), Positives = 146/248 (58%), Gaps = 10/248 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ R +G G+F V A++ TG+ VA+KIL K K K + +RE+ ++ + HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSE-KSKKDQTARREIRILRRLSHPN 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VRL + K +++V+E+ GG+LFD + G + EDEA++ Q++ ++Y HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRDLKPEN+LLD G +K++DFGL+ + ++ L T GTP Y+APEVL G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----EFTCPPWLSF--TARKLI 245
D+WS GVIL+ LL G PF N+++ + I EF P W S A+ LI
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 246 ARILDPNP 253
+ L+ +P
Sbjct: 238 KKCLNKDP 245
|
Length = 260 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 8e-80
Identities = 93/241 (38%), Positives = 146/241 (60%), Gaps = 6/241 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +T+G G+F +V R+ +G+ ALKIL K K++K K E + E ++ ++HP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V LY + +++V+E+V GGELF + GR E AR Y Q++ A++Y HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPENLLLD+ G +K++DFG + R G +T CGTP Y+APE++ +GY G
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFA-----KRVKGRTYTLCGTPEYLAPEIILSKGY-G 176
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D W+ G++++ +LAGY PF D N + +Y+KI + P + S A+ LI +L +
Sbjct: 177 KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 253 P 253
Sbjct: 237 L 237
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 232 bits (593), Expect = 2e-76
Identities = 94/236 (39%), Positives = 144/236 (61%), Gaps = 3/236 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G+F KV R +TG+ A+K+L K+K++K K E E + + HP +V+L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++ K+++VLE+ GGELF + GR E+ AR Y +++ A++Y HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PEN+LLDA G++K++DFGL+ + +T CGTP Y+APEVL +GY G D W
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPM 254
S GV+L+ +L G PF + +Y+KI P +LS AR LI+ +L +P
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPT 233
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-69
Identities = 85/191 (44%), Positives = 123/191 (64%), Gaps = 6/191 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+GEG F V AR+ +TG+ VA+KI+ KE + E++ RE+ +K + HPN+V+LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 79 VMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V + +++V+E+ GG L D + N G++ EDE R Q++ ++Y HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 138 KPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
KPEN+LLD+ G +K++DFGLS L D LL T GTP Y+APEVL +GY +D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLTS--DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 197 LWSCGVILFVL 207
+WS GVIL+ L
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 207 bits (529), Expect = 2e-66
Identities = 87/260 (33%), Positives = 145/260 (55%), Gaps = 20/260 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
++ G+ IGEG+F+ V A+ ET + A+KILDK +++K K + +K E + +L HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+++LY + ++ VLE+ GEL I +G + E R Y +++ A++Y HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS------ALSQQVRDDGLLHTT------------ 173
+ HRDLKPEN+LLD ++K++DFG + + + + D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233
GT YV+PE+LN+ G ++DLW+ G I++ +L G PF SN ++KI E++
Sbjct: 183 VGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 234 PPWLSFTARKLIARILDPNP 253
PP A+ LI ++L +P
Sbjct: 242 PPNFPPDAKDLIEKLLVLDP 261
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 3e-63
Identities = 93/245 (37%), Positives = 146/245 (59%), Gaps = 6/245 (2%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
++ +E+G T+G G+F +V+ A++ TGE A+K L K ++LK K + + +E + + +
Sbjct: 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
HP +V + + +++ +LEFV GGELF + GR D A+ Y +L+ A +Y H
Sbjct: 76 SHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
S+ + +RDLKPENLLLD G++KV+DFG +++V D T CGTP Y+APEV+ +
Sbjct: 136 SKDIIYRDLKPENLLLDNKGHVKVTDFG---FAKKVPDR--TFTLCGTPEYLAPEVIQSK 190
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248
G+ G D W+ GV+L+ +AGY PF D +Y+KI A P W AR L+ +
Sbjct: 191 GH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249
Query: 249 LDPNP 253
L +
Sbjct: 250 LQTDH 254
|
Length = 329 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-62
Identities = 82/243 (33%), Positives = 136/243 (55%), Gaps = 9/243 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
I +G + +V A+ TG+ A+K++ K +++ +Q+ E + + P VV+LY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K +++V+E++ GG+L + N G + ED AR Y +++ A++Y HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLL------HTTCGTPNYVAPEVLNDRGYDG 192
P+N+L+D+ G+LK++DFGLS + R L GTP+Y+APEV+ +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILD 250
T D WS G IL+ L G PF +++ I + P +S A LI+++L
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 251 PNP 253
P+P
Sbjct: 240 PDP 242
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 2e-62
Identities = 86/248 (34%), Positives = 133/248 (53%), Gaps = 11/248 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE+ + IG+G+F KV R G+ LK +D + K E EV +K + HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN-MSEKEREDALNEVKILKKLNHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYC 127
N+++ YE K K+ IV+E+ GG+L KI + E++ +F QL A+ Y
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HSR + HRD+KP+N+ L + G +K+ DFG+S LS L T GTP Y++PE+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS---TVDLAKTVVGTPYYLSPELCQ 176
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLI 245
++ Y+ +D+WS G +L+ L PF+ NL+ L KI ++ P S R L+
Sbjct: 177 NKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV 235
Query: 246 ARILDPNP 253
+ +L +P
Sbjct: 236 SSLLQKDP 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 1e-60
Identities = 86/242 (35%), Positives = 135/242 (55%), Gaps = 12/242 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G F +V+ + ALK + K +++ E I E ++ HP +V+LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K I++++E+ GGEL+ + + G E AR Y ++ A +Y H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PENLLLD+ G +K+ DFG +++++ T CGTP YVAPE++ ++GYD + D W
Sbjct: 121 PENLLLDSNGYVKLVDFG---FAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD-FSVDYW 176
Query: 199 SCGVILFVLLAGYLPF--DDSNLMNLYKKI----SAAEFTCPPWLSFTARKLIARILDPN 252
S G++L+ LL G PF DD + M +Y I EF P ++ A+ LI ++L N
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEF--PNYIDKAAKDLIKQLLRRN 234
Query: 253 PM 254
P
Sbjct: 235 PE 236
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 3e-58
Identities = 75/248 (30%), Positives = 129/248 (52%), Gaps = 9/248 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ G +G G+F V A + +TGE +A+K ++ + E ++RE+ + ++HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHP 59
Query: 72 NVVRLYEVMGSKTKIF--IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
N+VR Y + K I LE+V+GG L + G++ E R+Y +Q++ + Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ HRD+K N+L+D+ G +K++DFG + + + GTP ++APEV+
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPP---WLSFTARKLI 245
Y G AD+WS G + + G P+ + N M KI ++ P LS A+ +
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG-EPPEIPEHLSEEAKDFL 237
Query: 246 ARILDPNP 253
+ L +P
Sbjct: 238 RKCLRRDP 245
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 2e-55
Identities = 83/237 (35%), Positives = 140/237 (59%), Gaps = 6/237 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
E +T+G GTF +V R+ + ALK++ +V++ K + + E +K V HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++RL+ + +++++E+V GGELF + N GR Y +++ A++Y HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD G++K++DFG ++++RD T CGTP Y+APEV+ +G+
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFG---FAKKLRDR--TWTLCGTPEYLAPEVIQSKGH-N 176
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
D W+ G++++ +L GY PF D N +Y+KI A + P L A+ LI ++L
Sbjct: 177 KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLL 233
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 9e-52
Identities = 84/246 (34%), Positives = 134/246 (54%), Gaps = 11/246 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+ IG+G F +V AR+ TG+ VA+K++ K + + K E+I E+ +K KHP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVI-KLESKEKK--EKIINEIQILKKCKHP 57
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V+ Y K +++IV+EF +GG L D + + + E + ++L+ ++Y HS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
G+ HRD+K N+LL + G +K+ DFGLSA Q+ D +T GTP ++APEV+N + Y
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPY 174
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIAR 247
D AD+WS G+ L G P+ + M KI+ P S + + +
Sbjct: 175 DY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233
Query: 248 ILDPNP 253
L NP
Sbjct: 234 CLQKNP 239
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 170 bits (431), Expect = 8e-51
Identities = 92/266 (34%), Positives = 141/266 (53%), Gaps = 27/266 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + R +GEG+F +V AR+ + VALK+L K+ K K E+ RE+ + + HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 72 -NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
N+V+LY+ + +++V+E+V GG L D + GR + E EA Q+++A++Y
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 128 HSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSAL----SQQVRDDGLLHTTCGTPNYVAP 182
HS+G+ HRD+KPEN+LLD G +K+ DFGL+ L L T+ GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 183 EVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTC--- 233
EVL Y S++D+WS G+ L+ LL G PF+ + K I
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 234 ------PPWLSFTARKLIARILDPNP 253
P +S A L+ ++L +P
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDP 263
|
Length = 384 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 2e-49
Identities = 87/254 (34%), Positives = 131/254 (51%), Gaps = 16/254 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
YEV TIG+G+F V+ R G+ + K +D + K +Q+ EV ++ +KHP
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN-MTEKEKQQLVSEVNILRELKHP 59
Query: 72 NVVRLY--EVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVD 125
N+VR Y + S ++IV+E+ GG+L I ++E+ R QL+ A+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 126 YCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
CH+R V HRDLKP N+ LDA N+K+ DFGL+ + D T GTP Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYM 177
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSF 239
+PE LN YD + D+WS G +++ L A PF N + L KI +F P S
Sbjct: 178 SPEQLNHMSYDEKS-DIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236
Query: 240 TARKLIARILDPNP 253
++I +L+ +P
Sbjct: 237 ELNEVIKSMLNVDP 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 3e-49
Identities = 74/204 (36%), Positives = 112/204 (54%), Gaps = 12/204 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G + +V A+ +TGE VALK + K + K + E + K +V+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+++ +E+V GG+ + N G + ED AR Y ++ AVD H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLL---HTTCGTPNYVAPEVLNDRGYDGSTA 195
PEN L+DA G++K++DFGLS G++ ++ G+P+Y+APEVL +GYD T
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179
Query: 196 DLWSCGVILFVLLAGYLPFDDSNL 219
D WS G +L+ L G+ PF S
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 4e-49
Identities = 89/273 (32%), Positives = 139/273 (50%), Gaps = 42/273 (15%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMAEQIKREVATMKL 67
+EV + IG G F +V R+ +TG+ A+K+L K ++K H AE R++ +
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAE---RDI--LAD 57
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
P +V+LY + +++V+E++ GG+L + ++ E+ AR Y +L+ A+D
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---------------LSQQVRDDGLLH- 171
H G HRD+KP+N+L+DA G++K++DFGL + RD+ L+
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 172 -----------TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
+T GTP+Y+APEVL Y D WS GVIL+ +L G+ PF L
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQ 236
Query: 221 NLYKKISAAE--FTCPP--WLSFTARKLIARIL 249
Y KI + PP +S A LI R+L
Sbjct: 237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLL 269
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-48
Identities = 84/238 (35%), Positives = 136/238 (57%), Gaps = 4/238 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVR 75
R +G+G+F KV AR E+G A+K+L K+ +L+ E E + L + HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY + ++F V+EFV GG+L I R E AR Y ++ +A+ + H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMC--KEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
D W+ GV+L+ +L G+ PF+ N +L++ I E P WLS A ++ + NP
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 2e-48
Identities = 71/244 (29%), Positives = 133/244 (54%), Gaps = 7/244 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ R IG+G F KV + +T + A+K ++K+K ++ + E ++ + HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L+ + +++V++ + GG+L + + E++ + + +++ A++Y HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
HRD+KP+N+LLD G++ ++DF ++ +V D L +T GTP Y+APEVL +GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 193 STADLWSCGVILFVLLAGYLPFD--DSNLMNLYK-KISAAEFTCPPWLSFTARKLIARIL 249
D WS GV + L G P+ + + + K A+ P S A I ++L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 250 DPNP 253
+ +P
Sbjct: 238 ERDP 241
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 5e-48
Identities = 85/237 (35%), Positives = 130/237 (54%), Gaps = 3/237 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG+ A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + ED AR Y ++++A+ Y HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LK ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 9e-48
Identities = 83/238 (34%), Positives = 136/238 (57%), Gaps = 4/238 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T E A+K+L K+ +L+ E E + L KHP + +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +K ++F V+E+V GG+L I GR E AR Y +++ + + H RG+ +R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++DFG+ + + T CGTP+Y+APE+L+ + Y +
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPYGPA-V 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
D W+ GV+L+ +LAG PF+ + L++ I E P WLS A+ ++ L NP
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP 235
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-47
Identities = 85/241 (35%), Positives = 140/241 (58%), Gaps = 7/241 (2%)
Query: 17 RTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKH-KMAEQIKREVATMKLVKHPN 72
+ +G+G + KV R ++TG+ A+K+L K ++++ K K E ++ VKHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L + K++++LE+++GGELF + G ED A Y ++ A+++ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLDA G++K++DFGL + + + + HT CGT Y+APE+L G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLC--KESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D WS G +++ +L G PF N KI + PP+L+ AR L+ ++L N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 253 P 253
P
Sbjct: 239 P 239
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-47
Identities = 72/210 (34%), Positives = 110/210 (52%), Gaps = 39/210 (18%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATMK 66
YE +GEGT+ V AR+ +TGE VALK LD E+ E I RE++ +K
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE-------EGIPSTALREISLLK 53
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE-----LFDKIVNHGRMKEDEARRYFQQLI 121
+KHPN+V+L +V+ ++ K+++V E+ + DK G + + + QL+
Sbjct: 54 ELKHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDK--RPGPLSPNLIKSIMYQLL 108
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN-- 178
+ YCHS + HRDLKP+N+L++ G LK++DFGL+ A +R T
Sbjct: 109 RGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--------TYTHEVV 160
Query: 179 ---YVAPEVL-NDRGYDGSTADLWSCGVIL 204
Y APE+L + Y + D+WS G I
Sbjct: 161 TLWYRAPEILLGSKHYSTA-VDIWSVGCIF 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-47
Identities = 86/237 (36%), Positives = 132/237 (55%), Gaps = 4/237 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV A++ G+ A+K+L K+ +LK K + I E + K VKHP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL++V GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + T CGTP Y+APEVL + YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D W G +L+ +L G PF + +Y I P +S +AR L+ +L +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 2e-47
Identities = 84/237 (35%), Positives = 131/237 (55%), Gaps = 3/237 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + E+ AR Y ++++A++Y HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 3e-47
Identities = 81/240 (33%), Positives = 125/240 (52%), Gaps = 12/240 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLY 77
I +G F V A+ TG+ A+K+L K ++ +K E A M + P V +LY
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
SK +++V+E++ GG+ I G + ED A++Y +++ V+ H RG+ HRD+
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
KPENLL+D G+LK++DFGLS + + GTP+Y+APE + G D +D
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILGVG-DDKMSDW 176
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNP 253
WS G ++F L GY PF ++ I + P + S A LI R+L +P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 4e-47
Identities = 74/225 (32%), Positives = 116/225 (51%), Gaps = 8/225 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++G IG G F V N ETG+ VA+K + EK+ + + I +E+ +K +KHP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V+ + + ++I+LE+ G L I G E Y Q++ + Y H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K N+L G +K++DFG++ ++ + GTP ++APEV+ G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA--TKLNDVSKDDASVVGTPYWMAPEVIEMSGA- 176
Query: 192 GSTA-DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
STA D+WS G + LL G P+ D N M +I + PP
Sbjct: 177 -STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI--VQDDHPP 218
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 3e-46
Identities = 87/243 (35%), Positives = 143/243 (58%), Gaps = 13/243 (5%)
Query: 17 RTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G+F KV R + G+ A+K+L K+ LK + + K E + V HP +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+L+ ++ K++++L+F+ GG+LF ++ E++ + Y +L A+D+ HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
+RDLKPEN+LLD G++K++DFGLS + + + ++ CGT Y+APEV+N RG+ S
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 194 TADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
AD WS GV++F +L G LPF D M + I A+ P +LS A+ L+ +
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTM---ILKAKLGMPQFLSPEAQSLLRALFK 234
Query: 251 PNP 253
NP
Sbjct: 235 RNP 237
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 5e-46
Identities = 86/238 (36%), Positives = 133/238 (55%), Gaps = 5/238 (2%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R +G+ A+KIL KE ++ E +K +HP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+K ++ V+E+V GGELF + ED R Y ++++A+DY HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LK ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLC--KEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL--DPN 252
W GV+++ ++ G LPF + + L++ I + P LS A+ L++ +L DPN
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPN 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 4e-45
Identities = 85/235 (36%), Positives = 124/235 (52%), Gaps = 3/235 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F KV R +T ALK + K ++ E + V P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
S K+++VL F+ GGELF + GR AR Y +L+ A++ H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
PEN+LLD G++ + DFGL L+ ++DD +T CGTP Y+APE+L GY D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKLN--MKDDDKTNTFCGTPEYLAPELLLGHGYT-KAVDWW 177
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
+ GV+L+ +L G PF D N+ +Y+KI P A+ L+ +L +P
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDP 232
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 6e-45
Identities = 83/252 (32%), Positives = 134/252 (53%), Gaps = 13/252 (5%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV 68
+E+ R +G G + KV R + G+ A+K+L K ++ K K AE + E ++ V
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ + TK+ ++L++V GGELF + E E R Y +++ A+D+
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN- 186
H G+ +RD+K EN+LLD+ G++ ++DFGLS ++ ++ CGT Y+APEV+
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRG 180
Query: 187 -DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTA 241
G+D D WS GV+ F LL G PF N +IS P +S A
Sbjct: 181 GSGGHD-KAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239
Query: 242 RKLIARILDPNP 253
R I ++L+ +P
Sbjct: 240 RDFIQKLLEKDP 251
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 9e-45
Identities = 84/239 (35%), Positives = 132/239 (55%), Gaps = 4/239 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV + TG A+KIL KE ++ E ++ +HP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHR 135
+ ++ V+E+ GGELF + ED AR Y ++++A+DY HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK ENL+LD G++K++DFGL + ++D + T CGTP Y+APEVL D Y G
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPM 254
D W GV+++ ++ G LPF + + L++ I E P LS A+ L++ +L +P
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPK 236
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-44
Identities = 86/234 (36%), Positives = 133/234 (56%), Gaps = 4/234 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV-ATMKLVKHPNVVR 75
+ IG+G+F KV AR+ + A+K+L K+ +LK K + I E +K VKHP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL+++ GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + +G T CGTP Y+APEVL+ + YD T
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLC--KENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
D W G +L+ +L G PF N +Y I P ++ +AR L+ +L
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 2e-44
Identities = 75/207 (36%), Positives = 116/207 (56%), Gaps = 13/207 (6%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
G IG GTF KV A N +TGE +A+K + + K ++I E+ ++L+KHPN+V+
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA--RRYFQQLINAVDYCHSRGVY 133
Y V + K++I +E+ +GG L + ++ HGR+ DE R Y QL+ + Y HS G+
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEE-LLEHGRI-LDEHVIRVYTLQLLEGLAYLHSHGIV 121
Query: 134 HRDLKPENLLLDAYGNLKVSDFG----LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
HRD+KP N+ LD G +K+ DFG L + + + + GTP Y+APEV+
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--EEVQSLAGTPAYMAPEVITGGK 179
Query: 190 YDG--STADLWSCGVILFVLLAGYLPF 214
G AD+WS G ++ + G P+
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRPW 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 2e-44
Identities = 84/234 (35%), Positives = 126/234 (53%), Gaps = 4/234 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV A+ G A+K+L K+ +LK K I E + K +KHP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL++V GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + V + T CGTP Y+APEVL YD T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLC--KEGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
D W G +L+ +L G PF ++ +Y I P + A L+ +L
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLL 231
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 3e-44
Identities = 79/227 (34%), Positives = 116/227 (51%), Gaps = 26/227 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE----QIKREVATMKLV 68
YE IGEGT+ +V ARN +TGE VALK K+ E RE+ ++ +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK-----KIRMENEKEGFPITAIREIKLLQKL 55
Query: 69 KHPNVVRLYEVMGSKTK--IFIVLEFV----TGGELFDKIVNHGRMK--EDEARRYFQQL 120
+HPN+VRL E++ SK K I++V E++ TG +++ +K E + + Y +QL
Sbjct: 56 RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG------LLDSPEVKFTESQIKCYMKQL 109
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS G+ HRD+K N+L++ G LK++DFGL A R+ T Y
Sbjct: 110 LEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYR 168
Query: 181 APEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
PE+L Y D+WS G IL L G F S + +KI
Sbjct: 169 PPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEKI 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 5e-44
Identities = 90/241 (37%), Positives = 133/241 (55%), Gaps = 12/241 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHP 71
+ IG+G+F KV A+ G+ A+K+L K+ VL KH MAE R V +K VKHP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAE---RNV-LLKNVKHP 56
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V L+ + K++ VL+FV GGELF + E AR Y ++ +A+ Y HS
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ +RDLKPEN+LLD+ G++ ++DFGL D T CGTP Y+APEV+ + YD
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT--TFCGTPEYLAPEVIRKQPYD 174
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
+T D W G +L+ +L G PF ++ +Y I P S TA ++ +L+
Sbjct: 175 -NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEK 233
Query: 252 N 252
+
Sbjct: 234 D 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 9e-43
Identities = 77/250 (30%), Positives = 122/250 (48%), Gaps = 37/250 (14%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+K L K ++L+ + ++ E + +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+LY + +++++E++ GG++ ++ E+E R Y + I A+D H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-------------------------SALSQQVRDD 167
HRD+KP+NLLLDA G++K+SDFGL +S+ +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 168 GLLHT-----------TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
T T GTP+Y+APEV GY D WS GVI++ +L GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 217 SNLMNLYKKI 226
N Y+KI
Sbjct: 242 DNPQETYRKI 251
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-42
Identities = 87/251 (34%), Positives = 138/251 (54%), Gaps = 11/251 (4%)
Query: 3 QPKIKRRVGKYE---VGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQI 58
+PK K ++ KYE RT+G G+F +V A +E PVA+K +K K++K K + +
Sbjct: 20 EPKRKNKM-KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 59 KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + + HP V LY ++ +++VLEFV GGE F + + R D Y
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q++ +Y S + +RDLKPENLLLD G +K++DFG + + D +T CGTP
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPE 193
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE+L + G+ G AD W+ G+ ++ +L G PF + + +Y+KI P +L
Sbjct: 194 YIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLD 252
Query: 239 FTARKLIARIL 249
+ L+ ++L
Sbjct: 253 NNCKHLMKKLL 263
|
Length = 340 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 72/201 (35%), Positives = 109/201 (54%), Gaps = 6/201 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y++ IGEG V A++ ETGE VALK + + L+ + Q RE+ ++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR-LEGGIPNQALREIKALQACQHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSR 130
VV+L +V + +V+E++ L + + + R + E + + Y + L+ V Y H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL-NDRG 189
G+ HRDLKP NLL+ A G LK++DFGL+ L + L T Y APE+L R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARL-FSEEEPRLYSHQVATRWYRAPELLYGARK 177
Query: 190 YDGSTADLWSCGVILFVLLAG 210
YD DLW+ G I LL G
Sbjct: 178 YDPG-VDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-42
Identities = 79/238 (33%), Positives = 134/238 (56%), Gaps = 4/238 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T E A+K+L K+ +L+ + E + L KHP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +K ++F V+E+V GG+L +I + E +R Y ++ A+ + H GV +R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G +
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMC--KEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
D W+ GV+++ ++AG PF+ N +L++ I + P WLS A ++ + NP
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 1e-41
Identities = 81/240 (33%), Positives = 135/240 (56%), Gaps = 8/240 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE---VATMKLVKHPNVVR 75
IG+GTF +V R +T A+K+L K++++ K E + L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L + + +++V ++++GGELF + GR ED A+ Y +L+ A+++ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGST 194
DLKPEN+LLDA G++ + DFGLS + D+ +T CGT Y+APEV L+++GY
Sbjct: 121 DLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 195 ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-WLSFTARKLIARILDPNP 253
D WS GV++F + G+ PF + +Y+ I+ + P LS R+ + +L+ NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-41
Identities = 81/247 (32%), Positives = 138/247 (55%), Gaps = 13/247 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV +T A+K++ KE V + + ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+EFV+GG+L + ++ E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G++K++D+G+ + +R T CGTPNY+APE+L Y S
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMC--KEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSV- 177
Query: 196 DLWSCGVILFVLLAGYLPFD-----DSNLMN----LYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PFD D+ N L++ I + P LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 247 RILDPNP 253
L+ +P
Sbjct: 238 GFLNKDP 244
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-41
Identities = 70/242 (28%), Positives = 125/242 (51%), Gaps = 6/242 (2%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNV 73
G+ +G+G F +V + +TG +A+K + + K ++ E+ +K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+ Y + + I +E++ GG + D++ +G + E R+Y +Q++ V+Y HS +
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDG 192
HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++ GY G
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-G 185
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIARILD 250
AD+WS G + +L P+ + M KI+ P +S AR + R
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFV 245
Query: 251 PN 252
N
Sbjct: 246 EN 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 7e-41
Identities = 78/253 (30%), Positives = 136/253 (53%), Gaps = 13/253 (5%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+G +++ + IG+G F+ V A G VALK + +++ K + +E+ +K +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ ++ IVLE G+L I + + K E +YF QL +A++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEV 184
+ HS+ + HRD+KP N+ + A G +K+ D GL S + H+ GTP Y++PE
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA---AHSLVGTPYYMSPER 177
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA- 241
+++ GY+ + D+WS G +L+ + A PF D NL +L KKI ++ P ++
Sbjct: 178 IHENGYNFKS-DIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236
Query: 242 -RKLIARILDPNP 253
R L++R ++P+P
Sbjct: 237 LRDLVSRCINPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 2e-40
Identities = 80/241 (33%), Positives = 135/241 (56%), Gaps = 6/241 (2%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE--QIKREVATMKLVKHPNVV 74
+ +G+G+F KV A T E A+K L K+ VL+ E ++R V + +HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLT 59
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
L+ +K +F V+E++ GG+L I + GR E AR Y ++I + + H +G+ +
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLK +N+LLD G++K++DFG+ + + +G T CGTP+Y+APE+L + Y+ S
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYNESV 177
Query: 195 ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPM 254
D WS GV+L+ +L G PF + L+ I P W+S A+ ++++ + +P
Sbjct: 178 -DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT 236
Query: 255 T 255
Sbjct: 237 K 237
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 4e-40
Identities = 70/210 (33%), Positives = 118/210 (56%), Gaps = 10/210 (4%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK-------ILDKEKVLKHKMAEQIKREVATMKLV 68
G IG+GT+ +V A N TGE +A+K I + + M + ++ E+ T+K +
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
H N+V+ ++ + I LE+V GG + + +GR +E R + +Q++ + Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND- 187
S+G+ HRDLK +NLL+DA G K+SDFG+S S + D+ + G+ ++APEV++
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 188 -RGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+GY D+WS G ++ + AG P+ D
Sbjct: 186 SQGYSAKV-DIWSLGCVVLEMFAGRRPWSD 214
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 4e-40
Identities = 80/252 (31%), Positives = 139/252 (55%), Gaps = 14/252 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEK-VLKHKMAEQIKREVATMKLV 68
+E+ + +G G + KV R +TG+ A+K+L K V K K E + E ++ V
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ ++ K+ ++L++V+GGE+F + EDE R Y ++I A+++
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ +RD+K EN+LLD+ G++ ++DFGLS LS++ ++ CGT Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT---YSFCGTIEYMAPEII 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTA 241
+G G D WS G+++F LL G PF N ++S C P ++ A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238
Query: 242 RKLIARILDPNP 253
+ L+ ++L +P
Sbjct: 239 QDLLHKLLRKDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 8e-40
Identities = 77/227 (33%), Positives = 131/227 (57%), Gaps = 9/227 (3%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
K++ + Y+V + IG G F +V+ R+ + + A+K+L K +++K + E
Sbjct: 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
M P VV+L+ +++V+E++ GG+L + + N+ + E A+ Y +++ A+
Sbjct: 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLAL 155
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAP 182
D HS G+ HRD+KP+N+LLD +G+LK++DFG ++ + G++ T GTP+Y++P
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG---TCMKMDETGMVRCDTAVGTPDYISP 212
Query: 183 EVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
EVL + GY G D WS GV LF +L G PF +L+ Y KI
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 1e-39
Identities = 83/247 (33%), Positives = 133/247 (53%), Gaps = 10/247 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YE+ + IGEG+F K+ A+ E +K +D K + K E K+EV + +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRM-KEDEARRYFQQLINAVDYCHS 129
N+V + ++FIV+E+ GG+L +I G + ED+ +F Q+ + + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 130 RGVYHRDLKPENLLLDAYGNL-KVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVLND 187
R + HRD+K +N+ L G + K+ DFG +++Q+ D L TC GTP Y++PE+ +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFG---IARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIA 246
R Y+ T D+WS G +L+ L PF+ +NL L KI F P S R LI+
Sbjct: 177 RPYNNKT-DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS 235
Query: 247 RILDPNP 253
++ +P
Sbjct: 236 QLFKVSP 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 1e-39
Identities = 81/222 (36%), Positives = 117/222 (52%), Gaps = 17/222 (7%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKL 67
KYEV +GEG + V RN TGE VA+K + ++ +K + REV ++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK----KTALREVKVLRQ 56
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFV--TGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
++H N+V L E K ++++V E+V T EL + + G + D R Y QL+ A+
Sbjct: 57 LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGLPPDAVRSYIWQLLQAIA 114
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV 184
YCHS + HRD+KPEN+L+ G LK+ DFG + AL + L T Y APE+
Sbjct: 115 YCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP--LTDYVATRWYRAPEL 172
Query: 185 L-NDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYK 224
L D Y G D+W+ G I+ LL G F DS++ LY
Sbjct: 173 LVGDTNY-GKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 2e-39
Identities = 69/226 (30%), Positives = 116/226 (51%), Gaps = 12/226 (5%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKLVKH 70
E + +G+G+ V R+ TG+ ALK + E+ K Q+ RE+ T++ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRK-----QLLRELKTLRSCES 58
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS- 129
P VV+ Y + +I IVLE++ GG L D + G++ E +Q++ +DY H+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R + HRD+KP NLL+++ G +K++DFG+S + + D +T GT Y++PE +
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGE- 175
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
AD+WS G+ L G PF + ++ + A PP
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPP 221
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-39
Identities = 81/247 (32%), Positives = 139/247 (56%), Gaps = 13/247 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV R +T A+K++ KE V + + ++ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++Y H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 196 DLWSCGVILFVLLAGYLPFD--------DSNLMN-LYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PFD D N + L++ I + P LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 247 RILDPNP 253
L+ +P
Sbjct: 238 SFLNKDP 244
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-39
Identities = 82/265 (30%), Positives = 139/265 (52%), Gaps = 31/265 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + I G + V R+ ET + A+K ++K+ ++ +Q+ E + ++P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV ++ +K + +V+E+V GG+ + N G + D AR YF + + A++Y H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT------------------- 173
HRDLKP+NLL+ + G++K++DFGLS + GL+ T
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKI-------GLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 174 -CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 232
CGTP Y+APEV+ +GY G D W+ G+IL+ L G +PF L+ ++ + +
Sbjct: 176 VCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234
Query: 233 CPPW---LSFTARKLIARILDPNPM 254
P L A+ LI+R+L NP+
Sbjct: 235 WPEGDEALPADAQDLISRLLRQNPL 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 9e-39
Identities = 79/245 (32%), Positives = 139/245 (56%), Gaps = 11/245 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVR 75
R IG G++AKV R + + A+K++ KE V + + ++ E + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++F+V+E+V GG+L + ++ E+ AR Y ++ A+++ H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLDA G++K++D+G+ + + T CGTPNY+APE+L Y G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMC--KEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 196 DLWSCGVILFVLLAGYLPFD---DSNLMN----LYKKISAAEFTCPPWLSFTARKLIARI 248
D W+ GV++F ++AG PFD D+ MN L++ I P +LS A ++
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 249 LDPNP 253
L+ +P
Sbjct: 238 LNKDP 242
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 76/243 (31%), Positives = 111/243 (45%), Gaps = 42/243 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +TIG G F +V R +T A+K L K VL A +K E + +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+LY K ++ V++++ GG++ ++ G +ED AR Y +L A++ H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSA------------LSQQVRDDG------------ 168
HRD+KP+N+L+D G++K++DFGL R D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL GY D WS GVIL+ +L G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 241
Query: 212 LPF 214
PF
Sbjct: 242 PPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-38
Identities = 71/246 (28%), Positives = 124/246 (50%), Gaps = 7/246 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
++ G +G G+F V N + G+ A+K L + + +Q+++E+A + ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPN+V+ + ++I LE V GG L + +G E R Y +Q++ ++Y H
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R HRD+K N+L+D G +K++DFG +++QV + + G+P ++APEV+ +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFG---MAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPWLSFTARKLIAR 247
G AD+WS G + + G P+ + KI S P LS A+ I +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237
Query: 248 ILDPNP 253
L +P
Sbjct: 238 CLQRDP 243
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 76/236 (32%), Positives = 130/236 (55%), Gaps = 4/236 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLY 77
+G+G+F KV A T E A+KIL K+ +++ E E + L P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L I G+ KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LDA G++K++DFG+ + + T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDAEGHIKIADFGMC--KENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
W+ GV+L+ +LAG PFD + L++ I + P LS A + +L +P
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP 240
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 2e-38
Identities = 76/223 (34%), Positives = 114/223 (51%), Gaps = 34/223 (15%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-I-LDKEKVLKHKMAEQIKREVATMKLVK 69
+YE G+ +GEGT+A V AR+ ETG VA+K I L + K K + RE+ ++ +K
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
HPN++ L +V G K+ I +V EF+ + DK + + + + Y + ++Y
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIKSYMLMTLRGLEY 117
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------- 178
HS + HRDLKP NLL+ + G LK++DFGL+ + G+PN
Sbjct: 118 LHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQVV 164
Query: 179 ---YVAPEVLNDRGYDGSTADLWSCGVILFVLLAG--YLPFDD 216
Y APE+L + G D+WS G I LL +LP D
Sbjct: 165 TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 78/226 (34%), Positives = 128/226 (56%), Gaps = 9/226 (3%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
++ + YEV + IG G F +V+ R+ T + A+K+L K +++K + E M
Sbjct: 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
P VV+L+ +++V+E++ GG+L + + N+ + E AR Y +++ A+D
Sbjct: 98 AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALD 156
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAPE 183
HS G HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PE
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFG---TCMKMNKEGMVRCDTAVGTPDYISPE 213
Query: 184 VLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
VL + GY G D WS GV L+ +L G PF +L+ Y KI
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI 259
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-38
Identities = 67/246 (27%), Positives = 120/246 (48%), Gaps = 11/246 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V + +G+G++ V + + ALK +D + + + + + E+ + V HPN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVDYCH 128
++ E K+ IV+E+ G+L I + + E E R F QL+ + H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ + HRDLK N+LL A +K+ D G+S + ++ + T GTP+Y+APEV R
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGR 176
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIAR 247
Y +D+WS G +L+ + PF+ ++ +L K+ ++ PP S + I
Sbjct: 177 PYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 248 ILDPNP 253
+L P
Sbjct: 236 MLQVKP 241
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 7e-38
Identities = 77/247 (31%), Positives = 134/247 (54%), Gaps = 11/247 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + IGEG+F K ++ E G+ +K ++ K + K E+ ++EVA + +KHP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCH 128
N+V+ E ++IV+++ GG+L+ KI N R ED+ +F Q+ A+ + H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
R + HRD+K +N+ L G +K+ DFG++ L+ V L T GTP Y++PE+ +
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE---LARTCIGTPYYLSPEICEN 175
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246
R Y+ + +D+W+ G +L+ + F+ N+ NL KI + S+ R L++
Sbjct: 176 RPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVS 234
Query: 247 RILDPNP 253
++ NP
Sbjct: 235 QLFKRNP 241
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 8e-38
Identities = 76/238 (31%), Positives = 128/238 (53%), Gaps = 4/238 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A T + A+K L K+ VL E E + L +HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY +K +F V+E++ GG+L I + + A Y ++I + + HS+G+ +R
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G++K++DFG+ + + D T CGTP+Y+APE+L + Y ++
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMC--KENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSV 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
D WS GV+L+ +L G PF + L++ I P WL+ A+ ++ ++ P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 79/246 (32%), Positives = 134/246 (54%), Gaps = 13/246 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V + IG G F +V+ R+ + + A+K+L K +++K + E M
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V+L+ +++V+E++ GG+L + + N+ + E AR Y +++ A+D HS G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGF 163
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGTPNYVAPEVLNDRGY 190
HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PEVL +G
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 191 D---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPWLSFTARK 243
D G D WS GV L+ +L G PF +L+ Y KI ++ F +S A+
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKD 280
Query: 244 LIARIL 249
LI L
Sbjct: 281 LICAFL 286
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 2e-37
Identities = 83/268 (30%), Positives = 135/268 (50%), Gaps = 32/268 (11%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+G +V R TG+ ALK+LDK++++K +++ E + + HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
Y ++T + +V+++ GGELF + + E+ AR Y +++ A++Y H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALS----QQVRDDGL-----------LHTT------ 173
RDLKPEN+LL G++ +SDF LS S V T
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 174 ------CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
GT Y+APEV++ G+ GS D W+ G++L+ +L G PF SN + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 228 AAEFTCP--PWLSFTARKLIARILDPNP 253
E T P P +S +AR LI ++L +P
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDP 273
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 3e-37
Identities = 76/253 (30%), Positives = 129/253 (50%), Gaps = 25/253 (9%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ IGEG +V A + TG+ VA+K K ++ K E I E+ MK KHP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIK---KMRLRKQNK-ELIINEILIMKDCKHP 75
Query: 72 NVVRLYE---VMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYC 127
N+V Y+ V +++V+E++ GG L D I + RM E + ++++ ++Y
Sbjct: 76 NIVDYYDSYLVGDE---LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQV--RDDGLLHTTCGTPNYVAPEV 184
HS+ V HRD+K +N+LL G++K++DFG +A L+++ R ++ GTP ++APEV
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR-----NSVVGTPYWMAPEV 187
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAA---EFTCPPWLSFT 240
+ + Y D+WS G++ + G P + L L+ I+ P S
Sbjct: 188 IKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-LITTKGIPPLKNPEKWSPE 245
Query: 241 ARKLIARILDPNP 253
+ + + L +P
Sbjct: 246 FKDFLNKCLVKDP 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-37
Identities = 73/204 (35%), Positives = 122/204 (59%), Gaps = 12/204 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A + TG VA+K +D + K + E + EV M+ +HPN+V +Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ + H++GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQV-RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+++LL + G +K+SDFG A +S++V R L+ GTP ++APEV++ Y G+ D
Sbjct: 143 SDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPY-GTEVD 197
Query: 197 LWSCGVILFVLLAGYLP-FDDSNL 219
+WS G+++ ++ G P F++ L
Sbjct: 198 IWSLGIMVIEMVDGEPPYFNEPPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 6e-37
Identities = 76/236 (32%), Positives = 132/236 (55%), Gaps = 4/236 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77
+G+G+F KV A T E A+KIL K+ V++ E E + L K P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L +I GR KE A Y ++ + + HS+G+ +RDL
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 8e-37
Identities = 70/208 (33%), Positives = 109/208 (52%), Gaps = 9/208 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ IG G A V A E VA+K +D EK +++++EV M HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD---KIVNHGRMKEDEARRYFQQLINAVDYCHS 129
VV+ Y ++++V+ +++GG L D G + E ++++ ++Y HS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQV-RDDGLLHTTCGTPNYVAPEVLN- 186
G HRD+K N+LL G++K++DFG+SA L+ R + T GTP ++APEV+
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPF 214
GYD AD+WS G+ L G P+
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPY 207
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 8e-37
Identities = 77/238 (32%), Positives = 129/238 (54%), Gaps = 4/238 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+ +G+G+F KV A GE A+K L K+ VL E E + L ++P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
LY +K +F V+EF+ GG+L I + GR A Y +++ + + HS+G+ +R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD G++K++DFG+ + V D T CGTP+Y+APE+L Y S
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMC--KENVFGDNRASTFCGTPDYIAPEILQGLKYTFSV- 177
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
D WS GV+L+ +L G PF + L++ I P W++ ++ ++ ++ + +P
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDP 235
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-36
Identities = 81/272 (29%), Positives = 132/272 (48%), Gaps = 38/272 (13%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+KIL K +L+ + I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+++ K +++++EF+ GG++ ++ + E+ + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDD------------------------ 167
HRD+KP+NLLLDA G++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 168 --------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L ++T GTP+Y+APEV GY+ D WS GVI++ +L GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 220 MNLYKKIS--AAEFTCPPW--LSFTARKLIAR 247
Y+K+ PP +S A+ LI R
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 71/202 (35%), Positives = 111/202 (54%), Gaps = 11/202 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y+ IGEGT+ V AR+ TGE VA+K + K + + + RE+ +K + HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSR 130
+++L +V K +++V EF+ K++ + + E + Y QL+ + +CHS
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVL-NDR 188
G+ HRDLKPENLL++ G LK++DFG L++ +T T Y APE+L D+
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFG---LARSFGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 189 GYDGSTADLWSCGVILFVLLAG 210
GY + D+WS G I LL+
Sbjct: 175 GY-STPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-36
Identities = 68/197 (34%), Positives = 106/197 (53%), Gaps = 11/197 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REV-ATMKLVKH 70
Y+V + +G+GTF V ARN ETGE VA+K + K+K + E + REV + KL +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKF--YSWEECMNLREVKSLRKLNEH 57
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCH 128
PN+V+L EV +++ V E++ G L+ + + E R Q++ + + H
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
G +HRDLKPENLL+ +K++DFG L++++R T Y APE+L
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFG---LAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 189 GYDGSTADLWSCGVILF 205
S D+W+ G I+
Sbjct: 174 TSYSSPVDIWALGCIMA 190
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 5e-36
Identities = 81/257 (31%), Positives = 125/257 (48%), Gaps = 34/257 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL---DKEKVLKHKMAEQIKREVATMKLVKH 70
E IG G V + TG ALK++ ++ V + QI RE+ ++ V H
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR-----QICREIEILRDVNH 131
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PNVV+ +++ +I ++LEF+ GG L + + D AR Q+++ + Y H R
Sbjct: 132 PNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRR 187
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV----LN 186
+ HRD+KP NLL+++ N+K++DFG+S + Q D +++ GT Y++PE LN
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLN 245
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPF------DDSNLMNLYKKISAAEFTCPPWLSFT 240
YDG D+WS GV + G PF D ++LM A + PP T
Sbjct: 246 HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM------CAICMSQPPEAPAT 299
Query: 241 A----RKLIARILDPNP 253
A R I+ L P
Sbjct: 300 ASREFRHFISCCLQREP 316
|
Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-36
Identities = 82/272 (30%), Positives = 132/272 (48%), Gaps = 38/272 (13%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E + IG G F +V+ + +TG A+KIL K +L+ + I+ E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+++ K +++++EF+ GG++ ++ + E+E + Y + + A+D H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDD------------------------ 167
HRD+KP+NLLLD+ G++K+SDFGL + L + R +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 168 --------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L +T GTP+Y+APEV GY+ D WS GVI++ +L GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 220 MNLYKKIS--AAEFTCPPW--LSFTARKLIAR 247
YKK+ PP +S A+ LI R
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 8e-36
Identities = 72/249 (28%), Positives = 125/249 (50%), Gaps = 15/249 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
++V +G G F +V+ R TG+ A+K++ K +L + + E + + P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+ +L K +++V+E+ GG+L + + + ED A+ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVLND-R 188
HRD+KPEN+L+D G++K++DFG +A ++ + ++++ GTP+Y+APEVL
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 189 GYDGST----ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAAEFTCPPWLSFT 240
G T D WS GVI + ++ G PF + Y I +F P +S
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 241 ARKLIARIL 249
LI +L
Sbjct: 240 FLDLIQSLL 248
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 8e-36
Identities = 77/236 (32%), Positives = 132/236 (55%), Gaps = 4/236 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77
+G+G+F KV A T E A+KIL K+ V++ E E + L K P + +L+
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLH 67
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +++ V+E+V GG+L I G+ KE +A Y ++ + + H RG+ +RDL
Sbjct: 68 SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDL 127
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
K +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G + D
Sbjct: 128 KLDNVMLDSEGHIKIADFGMC--KEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
W+ GV+L+ +LAG PFD + L++ I + P LS A + ++ +P
Sbjct: 185 WAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 240
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-35
Identities = 76/252 (30%), Positives = 143/252 (56%), Gaps = 13/252 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARN---SETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV 68
+E+ + +G G + KV R ++G+ A+K+L K ++ K K E + E ++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 69 KH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ P +V L+ + TK+ ++L+++ GGELF + R KE E + Y +++ A+++
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL-- 185
H G+ +RD+K EN+LLD+ G++ ++DFGLS + + ++ CGT Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRG 180
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTA 241
D G+D D WS GV+++ LL G PF + ++ + ++I +E P +S A
Sbjct: 181 GDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239
Query: 242 RKLIARILDPNP 253
+ +I R+L +P
Sbjct: 240 KDIIQRLLMKDP 251
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 2e-35
Identities = 80/282 (28%), Positives = 126/282 (44%), Gaps = 50/282 (17%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ IG+G F +V+ + +TG+ A+K L K ++ K +K E + P VV L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y +++++EF+ GG+L ++ + ED R Y + + A++ H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDG---------------------------- 168
+KP+N+L+D G++K+SDFGLS + D
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
+ ++T GTP+Y+APE+ +GY G D WS G I+F L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 212 LPFDDSNLMNLYKKISAAE----FTCPPWLSFTARKLIARIL 249
PF N Y+KI F LS A LI R++
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-35
Identities = 70/224 (31%), Positives = 117/224 (52%), Gaps = 10/224 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE R +G G F V R + V +K + E++ K + E +KL+ HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
N++ YE + IV+E+ GG L + I + ED +F Q++ A+ + H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 130 RGVYHRDLKPENLLLDAYGN-LKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLND 187
+ + HRDLK +N+LLD + +K+ DFG+S LS + + +T GTP Y++PE+
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK----AYTVVGTPCYISPELCEG 175
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231
+ Y+ +D+W+ G +L+ L + F+ +NL L KI + F
Sbjct: 176 KPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-35
Identities = 84/249 (33%), Positives = 128/249 (51%), Gaps = 25/249 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G+G F KV A++ ETG A KI+ E+ L+ M E + + KHPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVE-----IDILSECKHPNIVGL 67
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
YE + K++I++EF GG L ++ R + E + R +Q++ A+++ HS V HR
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGY 190
DLK N+LL G++K++DFG+SA ++ T GTP ++APEV+ D Y
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNK--STLQKRDTFIGTPYWMAPEVVACETFKDNPY 185
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL------SFTARKL 244
D AD+WS G+ L L P + N M + KI +E PP L S +
Sbjct: 186 D-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE---PPTLDQPSKWSSSFNDF 241
Query: 245 IARILDPNP 253
+ L +P
Sbjct: 242 LKSCLVKDP 250
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 77/238 (32%), Positives = 117/238 (49%), Gaps = 7/238 (2%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHPNVVR 75
+G G F KV A +TGE A+K L K ++ E + KR T +HP +V
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ ++ + V+E+ GG+L I + E A Y ++ + Y H + +R
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +NLLLD G +K++DFGL D T CGTP ++APEVL + Y +
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAV- 182
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
D W GV+++ +L G PF + ++ I E P +LS A ++ R+L NP
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNP 240
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-35
Identities = 78/194 (40%), Positives = 107/194 (55%), Gaps = 20/194 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
IGEGT+ V AR+ TGE VALK + + E V + RE++ +K + HPN+V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAI-----REISLLKELNHPNIV 61
Query: 75 RLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RL +V+ S+ K+++V EF+ + D G + + Y QL+ + YCHS V
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSHRV 120
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGY 190
HRDLKP+NLL+D G LK++DFGL+ A VR H T Y APE+ L R Y
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSRQY 177
Query: 191 DGSTA-DLWSCGVI 203
ST D+WS G I
Sbjct: 178 --STPVDIWSIGCI 189
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 8e-35
Identities = 77/217 (35%), Positives = 115/217 (52%), Gaps = 20/217 (9%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+GEGT+A V RN TGE VALK LD E+ RE++ MK +KH N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEE----GTPSTAIREISLMKELKHENIVRL 63
Query: 77 YEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
++V+ ++ K+ +V E++ + D G + + + + QL+ + +CH V H
Sbjct: 64 HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLH 123
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG----TPNYVAPEVL-NDRG 189
RDLKP+NLL++ G LK++DFGL+ R G+ T T Y AP+VL R
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRT 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
Y S D+WS G I+ ++ G F +N + KI
Sbjct: 178 YSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKI 213
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 3e-34
Identities = 68/216 (31%), Positives = 116/216 (53%), Gaps = 11/216 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+++ +GEG++ V A + ETG+ VA+K++ E+ L ++I +E++ +K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-----QEIIKEISILKQCDSPY 59
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+V+ Y T ++IV+E+ G + D KI N + E+E Q + ++Y HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSN 118
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL+ G K++DFG+S Q +T GTP ++APEV+ + GY
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + AD+WS G+ + G P+ D + M I
Sbjct: 177 N-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-34
Identities = 79/252 (31%), Positives = 131/252 (51%), Gaps = 11/252 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ + + + IG G F++V A G PVALK + ++ K +E+ +K +
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ Y ++ IVLE G+L I + + K E +YF QL +A++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ HSR V HRD+KP N+ + A G +K+ D GL H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERI 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA-- 241
++ GY+ +D+WS G +L+ + A PF D NL +L KKI ++ P ++
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237
Query: 242 RKLIARILDPNP 253
R+L+ ++P+P
Sbjct: 238 RQLVNMCINPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-34
Identities = 75/251 (29%), Positives = 126/251 (50%), Gaps = 18/251 (7%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK--ILD----KEKVLKHKMAEQIKREVATMKLVK 69
G IG G+F V N+ +GE +A+K L K K M + + RE+A +K ++
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H N+V+ + I LE+V GG + + N+G +E R + +Q++ ++Y H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-------GTPNYVAP 182
RG+ HRD+K N+L+D G +K+SDFG +S+++ + L T G+ ++AP
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFG---ISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTA 241
EV+ Y AD+WS G ++ +L G PF D + KI A P +S A
Sbjct: 182 EVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEA 240
Query: 242 RKLIARILDPN 252
+ + + +
Sbjct: 241 IDFLEKTFEID 251
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 5e-34
Identities = 80/243 (32%), Positives = 113/243 (46%), Gaps = 46/243 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+T+G G F +V AR +T A+K L K+ VL +K E + + VVRL
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y K ++ V++++ GG++ ++ G ED AR Y +L AV+ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGL---------SALSQ---QVRDDG---------------- 168
+KP+N+L+D G++K++DFGL S Q VR D
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL GY D WS GVIL+ +L G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 212 LPF 214
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 6e-34
Identities = 77/252 (30%), Positives = 133/252 (52%), Gaps = 11/252 (4%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +++ + IG G F++V A +PVALK + +++ K + +E+ +K +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HPNV++ + ++ IVLE G+L I + K E +YF QL +AV+
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ HSR V HRD+KP N+ + A G +K+ D GL H+ GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCPPWLSFTA-- 241
++ GY+ +D+WS G +L+ + A PF D NL +L +KI ++ P ++
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237
Query: 242 RKLIARILDPNP 253
R+L++ + P+P
Sbjct: 238 RELVSMCIYPDP 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 8e-34
Identities = 67/200 (33%), Positives = 108/200 (54%), Gaps = 6/200 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + TG+ A K LDK+++ K K + E ++ V +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYHRD 136
+K + +V+ + GG+L I N G EAR F Q+I +++ H R + +RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
LKPEN+LLD +GN+++SD GL+ +++ + GTP Y+APEVL YD + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176
Query: 197 LWSCGVILFVLLAGYLPFDD 216
++ G L+ ++AG PF
Sbjct: 177 WFALGCTLYEMIAGRSPFRQ 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-33
Identities = 70/226 (30%), Positives = 114/226 (50%), Gaps = 10/226 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ IG+G+F V A+K +D K + + E+ E + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSY 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSR 130
++R YE K K+ IV+E+ G+L + + ED+ R+F Q++ + + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+K NL LDAY N+K+ D G++ LS +T GTP Y++PE+ D+
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN---TNFANTIVGTPYYLSPELCEDKP 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
Y+ +D+W+ GV+L+ G PFD +N L KI F PP
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVF--PP 220
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 1e-33
Identities = 71/189 (37%), Positives = 103/189 (54%), Gaps = 10/189 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
IGEGT+ V ARN TGE VALK LD E + RE++ +K + HPN+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTET---EGVPSTAIREISLLKELNHPNIVKL 64
Query: 77 YEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
+V+ ++ K+++V EF+ + F + + Y QL+ + +CHS V HR
Sbjct: 65 LDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHR 124
Query: 136 DLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
DLKP+NLL++ G +K++DFGL+ A VR H T Y APE+L Y +
Sbjct: 125 DLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYSTA 181
Query: 195 ADLWSCGVI 203
D+WS G I
Sbjct: 182 VDIWSLGCI 190
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 71/214 (33%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVAT 64
V KYE IG+GTF +V AR+ +T + VALK +++ EK A RE+
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA---LREIKI 64
Query: 65 MKLVKHPNVVRLYEVMGSKTK--------IFIVLEFVT---GGELFDKIVNHGRMKEDEA 113
++L+KH NVV L E+ +K ++V EF G L +K V + E
Sbjct: 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEI 121
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHT 172
++ + L+N + Y H + HRD+K N+L+ G LK++DFGL+ A S +T
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 173 T-CGTPNYVAPEV-LNDRGYDGSTADLWSCGVIL 204
T Y PE+ L +R Y G D+W G I+
Sbjct: 182 NRVVTLWYRPPELLLGERDY-GPPIDMWGAGCIM 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 68/249 (27%), Positives = 122/249 (48%), Gaps = 12/249 (4%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILD---KEKVLKHKMAEQIKREVATMKLVKHPN 72
G+ +G G F+ AR+ +TG +A+K + + ++ E +++E+ M + HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++R+ + + +E++ GG + + +G KE Y +QL+ + Y H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 133 YHRDLKPENLLLDAYGN-LKVSDFGLSA-LSQQVRDDGLLH-TTCGTPNYVAPEVLNDRG 189
HRD+K NLL+D+ G L+++DFG +A L+ + G GT ++APEVL
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAAEFT--CPPWLSFTARKL 244
Y G + D+WS G ++ + P++ N KI++A P LS R +
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 245 IARILDPNP 253
R L+ P
Sbjct: 244 TLRCLELQP 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 5e-33
Identities = 74/223 (33%), Positives = 114/223 (51%), Gaps = 23/223 (10%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLV 68
G +E+ IGEGT+ KV AR+ +TG+ VA+KI+D + E+IK E + K
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 69 KHPNVVRLYEV------MGSKTKIFIVLEFVTGG---ELFDKIVNHG-RMKEDEARRYFQ 118
HPN+ Y G+ ++++V+E GG +L + G R+KE+ +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + + Y H V HRD+K +N+LL +K+ DFG+SA Q G +T GTP
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPY 178
Query: 179 YVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
++APEV+ D YD + +D+WS G+ L G P D
Sbjct: 179 WMAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-33
Identities = 78/263 (29%), Positives = 134/263 (50%), Gaps = 17/263 (6%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKHPNV 73
G+ +G+G F +V + +TG +A K + D E K ++ E+ +K ++H +
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 74 VRLYEVM---GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
V+ Y + KT + I +E++ GG + D++ +G + E R+Y +Q++ + Y HS
Sbjct: 67 VQYYGCLRDRAEKT-LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLNDRG 189
+ HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++ G
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT---ARKLIA 246
Y G AD+WS G + +L P+ + M KI A + T P S AR +
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI-ATQPTNPQLPSHISEHARDFLG 243
Query: 247 RIL-----DPNPMTVSIYPFADI 264
I P+ + +PFA +
Sbjct: 244 CIFVEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 7e-33
Identities = 76/201 (37%), Positives = 107/201 (53%), Gaps = 19/201 (9%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKL 67
KYE IGEGT+ V A+N ET E VALK + D E V + RE+ +K
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSAL-----REICLLKE 55
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVD 125
+KH N+VRLY+V+ S K+ +V E+ + FD +G + + + + QL+ +
Sbjct: 56 LKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLA 113
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEV 184
+CHS V HRDLKP+NLL++ G LK++DFGL+ A VR T Y P+V
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAEVVTLWYRPPDV 170
Query: 185 L-NDRGYDGSTADLWSCGVIL 204
L + Y S D+WS G I
Sbjct: 171 LFGAKLYSTSI-DMWSAGCIF 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 8e-33
Identities = 75/243 (30%), Positives = 112/243 (46%), Gaps = 46/243 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+T+G G F +V A +T A+K L K+ VL +K E + + VV+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
Y K ++ V++++ GG++ ++ E AR Y +L A++ H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGL---------SALSQQ---VRDDG---------------- 168
+KP+N+L+D G++K++DFGL S Q+ +R D
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 169 -----------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
L H+ GTPNY+APEVL +GY D WS GVILF +L G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 212 LPF 214
PF
Sbjct: 246 PPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 8e-33
Identities = 76/260 (29%), Positives = 135/260 (51%), Gaps = 12/260 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKH 70
+ +G+ +G+G F +V +++TG +A+K + D E K ++ E+ +K + H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 71 PNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+V+ Y + + + I +E + GG + D++ ++G + E+ R+Y +Q++ V Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLND 187
S + HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT--CPPWLSFTARKLI 245
GY G AD+WS G + +L P+ + M KI+ PP +S R +
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 246 ARILDPNPMTVSIYPFADIL 265
RI + + P AD L
Sbjct: 243 KRIF----VEAKLRPSADEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 9e-33
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 26/210 (12%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKLV 68
YE IGEG + V AR+ TG VALK KV E I RE+A +K +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALK-----KVRVPLSEEGIPLSTLREIALLKQL 55
Query: 69 K---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQ 118
+ HPN+VRL +V + K+ +V E V K G + + + +
Sbjct: 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLMR 114
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP 177
QL+ VD+ HS + HRDLKP+N+L+ + G +K++DFGL+ ++ + T+ T
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA----RIYSFEMALTSVVVTL 170
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL 207
Y APEVL Y + D+WS G I L
Sbjct: 171 WYRAPEVLLQSSY-ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 3e-32
Identities = 70/248 (28%), Positives = 125/248 (50%), Gaps = 16/248 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ + IG+G+F +V A + T + VA+K++D E+ E I++E+ + + P
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE--IEDIQQEIQFLSQCRSP 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+ + Y +K++I++E+ GG D ++ G++ E ++++ ++Y H G
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL G++K++DFG+S Q+ +T GTP ++APEV+ GY
Sbjct: 119 KIHRDIKAANILLSEEGDVKLADFGVSG---QLTSTMSKRNTFVGTPFWMAPEVIKQSGY 175
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----SFTARKLI 245
D AD+WS G+ L G P D + M + I PP L S + +
Sbjct: 176 D-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN---PPSLEGNKFSKPFKDFV 231
Query: 246 ARILDPNP 253
+ L+ +P
Sbjct: 232 SLCLNKDP 239
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-32
Identities = 68/223 (30%), Positives = 112/223 (50%), Gaps = 8/223 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y R +G+G F + R +E V K ++ + L K E+ + L++HPN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSR 130
++ Y + I +E+ GG L+DKIV +E+ Y Q+++AV Y H
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVLNDRG 189
G+ HRD+K N+ L G +K+ DFG +S+ + + + T GTP Y++PE+
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFG---ISKILGSEYSMAETVVGTPYYMSPELCQGVK 177
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 232
Y+ +D+W+ G +L+ LL FD +N +NL KI +T
Sbjct: 178 YN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 5e-32
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 22/201 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL---DKEKVLKHKMAEQIKREVATMKLV 68
YE+ + IG GT+ V AR+ TGE VA+K++ + E I++E++ +K
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF------EIIQQEISMLKEC 57
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYC 127
+HPN+V + + K++IV+E+ GG L D V G + E + ++ + + Y
Sbjct: 58 RHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYL 117
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL---SQQVRDDGLLHTTCGTPNYVAPEV 184
H G HRD+K N+LL G++K++DFG+SA + R + GTP ++APEV
Sbjct: 118 HETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK-----SFIGTPYWMAPEV 172
Query: 185 LNDR---GYDGSTADLWSCGV 202
GYDG D+W+ G+
Sbjct: 173 AAVERKGGYDGK-CDIWALGI 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-32
Identities = 66/220 (30%), Positives = 120/220 (54%), Gaps = 6/220 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKIL--DKEKVLKHKMAEQIKREVATMKLVKH 70
+ +G+ +G G F +V +++TG +A+K + D + K ++ E+ +K ++H
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 71 PNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+V+ Y + K+ I +E++ GG + D++ +G + E+ RRY +Q++ V Y H
Sbjct: 64 DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTTCGTPNYVAPEVLND 187
S + HRD+K N+L D+ GN+K+ DFG S Q + G + + GTP +++PEV++
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
GY G AD+WS + +L P+ + M KI+
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 67/238 (28%), Positives = 111/238 (46%), Gaps = 20/238 (8%)
Query: 14 EVGRTIGEGTFAKVK----FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
E+G+ +GEG F +V T VA+K L + + + E+ E + MK +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEER--EEFLEEASIMKKLS 59
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+VRL V ++IV E++ GG+L D + HG + + + Q+ ++Y
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVL 185
S+ HRDL N L+ +K+SDFG LS+ + +D G ++APE L
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFG---LSRDIYEDDYYRKRGGGKLPIKWMAPESL 176
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-----AAEFTCPPWL 237
D + S +D+WS GV+L+ + G P+ + + + + CP L
Sbjct: 177 KDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL 233
|
Length = 258 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-31
Identities = 79/251 (31%), Positives = 135/251 (53%), Gaps = 23/251 (9%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A TG+ VA+K +D + K + E + EV M+ H NVV +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ Y H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
+++LL + G +K+SDFG A +S++V L GTP ++APEV++ Y G+ D+
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYWMAPEVISRLPY-GTEVDI 201
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVS 257
WS G+++ ++ G P+ + + ++I PP R+ D + ++
Sbjct: 202 WSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPP-----------RVKDSHKVSSV 247
Query: 258 IYPFADILYMR 268
+ F D++ +R
Sbjct: 248 LRGFLDLMLVR 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-31
Identities = 76/221 (34%), Positives = 119/221 (53%), Gaps = 18/221 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKI-LDKEKVLKHKMAEQIK-REVATMKLVK 69
KYE +GEG++ V ++ ETG+ VA+K L+ E KM ++I RE+ +K ++
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED---DKMVKKIAMREIRMLKQLR 58
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H N+V L EV K ++++V EFV L D + E R+Y Q++ +++CHS
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVL- 185
+ HRD+KPEN+L+ G +K+ DFG + A +V D + T Y APE+L
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELLV 173
Query: 186 NDRGYDGSTADLWSCGVILFVLLAG--YLPFDDSNLMNLYK 224
D Y G D+W+ G ++ +L G P DS++ LY
Sbjct: 174 GDTKY-GRAVDIWAVGCLVTEMLTGEPLFP-GDSDIDQLYH 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-31
Identities = 73/201 (36%), Positives = 114/201 (56%), Gaps = 11/201 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REVATMKLVKH---PNVV 74
IG G F +V R ++TG+ A+K LDK+++ K K E + E + LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ + K+ +L+ + GG+L + HG E E R Y ++I +++ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND-RGYDGS 193
RDLKP N+LLD +G++++SD GL+ + + H + GT Y+APEVL YD S
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-S 175
Query: 194 TADLWSCGVILFVLLAGYLPF 214
+AD +S G +LF LL G+ PF
Sbjct: 176 SADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-31
Identities = 81/256 (31%), Positives = 137/256 (53%), Gaps = 29/256 (11%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-----L 67
+E+ + IG G F +V + TG+ A+KIL+K ++LK + E A + L
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLK-------RAETACFREERDVL 55
Query: 68 VKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAV 124
V + L+ + +++V+++ GG+L + R+ ED AR Y +++ A+
Sbjct: 56 VNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI 115
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAP 182
D H G HRD+KP+N+LLD G+++++DFG S L ++ DG + + GTP+Y++P
Sbjct: 116 DSVHQLGYVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISP 172
Query: 183 EVL----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW 236
E+L + +G G D WS GV ++ +L G PF +L+ Y KI + F PP
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPD 232
Query: 237 ---LSFTARKLIARIL 249
+S A+ LI R++
Sbjct: 233 VTDVSEEAKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 7e-31
Identities = 71/200 (35%), Positives = 112/200 (56%), Gaps = 9/200 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-REVATMKLVKH---PNVV 74
IG G F +V R ++TG+ A+K LDK+++ K K E + E + LV P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-KMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ + K+ +L+ + GG+L + HG E E R Y ++I +++ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKP N+LLD +G++++SD GL+ + + H + GT Y+APEVL S+
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSS 176
Query: 195 ADLWSCGVILFVLLAGYLPF 214
AD +S G +LF LL G+ PF
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 7e-31
Identities = 71/200 (35%), Positives = 118/200 (59%), Gaps = 8/200 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V AR +G VA+K++D + K + E + EV M+ +H NVV +Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++++EF+ GG L D IV+ R+ E++ + ++ A+ Y HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIK 144
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198
+++LL G +K+SDFG A Q +D + GTP ++APEV++ Y G+ D+W
Sbjct: 145 SDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIW 201
Query: 199 SCGVILFVLLAGYLP-FDDS 217
S G+++ ++ G P F DS
Sbjct: 202 SLGIMVIEMVDGEPPYFSDS 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 9e-31
Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 32/217 (14%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+ + IG G + V A + TG VA+K I + L A++I RE+ ++ ++H
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLID--AKRILREIKLLRHLRH 58
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFD----KIVNHGRMKEDEARRYFQ-QL 120
N++ L +++ + ++IV E L + K++ + D+ +YF Q+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTE------LMETDLHKVIKSPQPLTDDHIQYFLYQI 112
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS V HRDLKP N+L+++ +LK+ DFGL A +D T YV
Sbjct: 113 LRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGL-ARGVDPDEDEKGFLT----EYV 167
Query: 181 ------APEV-LNDRGYDGSTADLWSCGVILFVLLAG 210
APE+ L+ Y + D+WS G I LL
Sbjct: 168 VTRWYRAPELLLSSSRYTKA-IDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-30
Identities = 81/257 (31%), Positives = 131/257 (50%), Gaps = 25/257 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKH 70
+E+ +G+G F KV A+N ETG A K+++ E+ L+ M E + + H
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVE-----IEILATCNH 68
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHS 129
P +V+L K++I++EF GG + ++ R + E + + +Q++ A+ Y HS
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQVRDDGLLHTTCGTPNYVAPEV-- 184
+ HRDLK N+LL G++K++DFG+SA + Q RD + GTP ++APEV
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVM 183
Query: 185 ---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLS 238
+ D YD AD+WS G+ L + P + N M + KI+ +E + P S
Sbjct: 184 CETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWS 242
Query: 239 FTARKLIARILDPNPMT 255
R + LD +P T
Sbjct: 243 MEFRDFLKTALDKHPET 259
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 74/245 (30%), Positives = 123/245 (50%), Gaps = 8/245 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y V R +GEG+F + ++ + + A+K + K E ++E + +KHP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHP 58
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRM-KEDEARRYFQQLINAVDYCHS 129
N+V E + ++IV+E+ GG+L KI + G++ ED ++F Q+ V + H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ V HRD+K +N+ L G +K+ DFG + L T GTP YV PE+ +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248
Y+ + +D+WS G IL+ L PF ++ NL K+ + P S+ R LI ++
Sbjct: 177 YN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 249 LDPNP 253
NP
Sbjct: 236 FKRNP 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-30
Identities = 73/249 (29%), Positives = 132/249 (53%), Gaps = 15/249 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + + A+KIL+K ++LK + E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ + +++V+++ GG+L + R+ ED AR Y +++ A+D H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL---- 185
HRD+KP+N+L+D G+++++DFG S L ++ +DG + ++ GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPW---LSFT 240
+ +G G D WS GV ++ +L G PF +L+ Y KI F P +S
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239
Query: 241 ARKLIARIL 249
A+ LI R++
Sbjct: 240 AKDLIRRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 31/211 (14%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-------R 60
R V +YE I EGT+ V AR+ +TGE VALK K KM ++ + R
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLR 53
Query: 61 EVATMKLVKHPNVVRLYE-VMGSK-TKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYF 117
E+ + ++HPN+V + E V+GS KI++V+E+V +L + + E +
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
QL++ V + H + HRDLK NLLL+ G LK+ DFGL+ T
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-------YTQ 165
Query: 178 N-----YVAPEVLNDRGYDGSTADLWSCGVI 203
Y APE+L + D+WS G I
Sbjct: 166 LVVTLWYRAPELLLGAKEYSTAIDMWSVGCI 196
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-30
Identities = 73/212 (34%), Positives = 119/212 (56%), Gaps = 12/212 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEGT+ V RN +TG+ VA+K + E + + I RE++ +K ++HPN+V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAI-REISLLKELQHPNIVCLQD 66
Query: 79 VMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
V+ +++++++ EF++ + D + M + + Y Q++ + +CHSR V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 137 LKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHT-TCGTPNYVAPEVLNDRGYDGST 194
LKP+NLL+D G +K++DFGL+ A VR ++T T Y APEVL +
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPEVLLGSPRYSTP 182
Query: 195 ADLWSCGVILFVLLAGYLPF--DDSNLMNLYK 224
D+WS G I F +A P DS + L++
Sbjct: 183 VDIWSIGTI-FAEMATKKPLFHGDSEIDQLFR 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 3e-30
Identities = 75/249 (30%), Positives = 129/249 (51%), Gaps = 15/249 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + T A+KIL+K ++LK + E +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ + +++V+++ GG+L + R+ ED AR Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVL---- 185
HRD+KP+N+LLD G+++++DFG S L ++ DG + ++ GTP+Y++PE+L
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCL--KMNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPWL---SFT 240
+ G G D WS GV ++ +L G PF +L+ Y KI E F P + S
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 241 ARKLIARIL 249
A+ LI R++
Sbjct: 240 AKDLIQRLI 248
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-30
Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 16/229 (6%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
G+ +GEG F +V + + VA+K L ++ + E+ RE M+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
NVV+L V + ++IV+E++ GG+L + + ++ + + Q+ ++Y S+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK 121
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL N L+ +K+SDFG LS+ + DD G P ++APE L +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFG---LSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 189 GYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCPP 235
+ ++ D+WS GV+L+ + G P+ + + + + P
Sbjct: 179 KF--TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQP 225
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-29
Identities = 62/235 (26%), Positives = 109/235 (46%), Gaps = 22/235 (9%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
G+ +GEG F +V VA+K L ++ + E+ RE M+ + HP
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQI--EEFLREARIMRKLDHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
N+V+L V + + IV+E++ GG+L D + + + + + Q+ ++Y S
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLND 187
+ HRDL N L+ +K+SDFG LS+ + DD G P ++APE L +
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFG---LSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 188 RGYDGSTA-DLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-----TCPP 235
+ ++ D+WS GV+L+ + G P+ + + + + CPP
Sbjct: 179 GKF--TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPP 231
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 74/247 (29%), Positives = 128/247 (51%), Gaps = 13/247 (5%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K++ ++E IG+G V A + TG+ VA+K ++ ++ K E I E+ M+
Sbjct: 18 KKKYTRFE---KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMR 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
KHPN+V + ++++V+E++ GG L D +V M E + ++ + A+++
Sbjct: 72 ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HS V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEFTCPPWLSFTARK 243
+ Y G D+WS G++ ++ G P+ + N + I+ E P LS R
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247
Query: 244 LIARILD 250
+ R L+
Sbjct: 248 FLNRCLE 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 81/259 (31%), Positives = 129/259 (49%), Gaps = 23/259 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR----EVATMKL 67
KY + R +G G V A+ GEP A+K++D E M+E K EV +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG-----MSEADKNRAQAEVCCLLN 87
Query: 68 VKHPNVVRLYEVMGSKTK--------IFIVLEFVTGGELFDKIVNHGR----MKEDEARR 115
++V+ +E K I +VL++ G+L +I + + +E EA
Sbjct: 88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL 147
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
F Q++ AV + HS+ + HRD+K N+LL + G +K+ DFG S + D + T CG
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCG 207
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CP 234
TP YVAPE+ + Y AD++S GV+L+ LL PFD N+ + K A + P
Sbjct: 208 TPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266
Query: 235 PWLSFTARKLIARILDPNP 253
P +S ++++ +L +P
Sbjct: 267 PSISPEMQEIVTALLSSDP 285
|
Length = 496 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-29
Identities = 75/255 (29%), Positives = 127/255 (49%), Gaps = 29/255 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKL 67
+ E+ IG G + V ++ TG VALKI+ + V I+REVA +
Sbjct: 5 RLEL---IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDV------SDIQREVALLSQ 55
Query: 68 VKH---PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
++ PN+ + Y +++I++E+ GG + ++ G + E ++++ A+
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL 114
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y H GV HRD+K N+L+ GN+K+ DFG++AL Q T GTP ++APEV
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEV 172
Query: 185 LND-RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----S 238
+ + + YD + AD+WS G+ ++ + G P+ D + I ++ PP L S
Sbjct: 173 ITEGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK---PPRLEDNGYS 228
Query: 239 FTARKLIARILDPNP 253
R+ +A LD P
Sbjct: 229 KLLREFVAACLDEEP 243
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-29
Identities = 78/240 (32%), Positives = 128/240 (53%), Gaps = 23/240 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKH 70
+E+ +G+G F KV A+N ETG A K++D E+ L+ M E + + H
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVE-----IDILASCDH 61
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHS 129
PN+V+L + + ++I++EF GG + ++ R + E + R +Q + A++Y H
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV--RDDGLLHTTCGTPNYVAPEVL-- 185
+ HRDLK N+L G++K++DFG+SA + + R D + GTP ++APEV+
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMC 177
Query: 186 ---NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
DR YD AD+WS G+ L + P + N M + KI+ +E PP L+ +R
Sbjct: 178 ETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSE---PPTLAQPSR 233
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 75/247 (30%), Positives = 130/247 (52%), Gaps = 13/247 (5%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K++ +YE IG+G V A + TG+ VA+K ++ +K K ++ I E+ MK
Sbjct: 18 KKKYTRYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMK 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+K+PN+V + ++F+V+E++ GG L D +V M E + ++ + A+++
Sbjct: 72 ELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEF 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H+ V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+
Sbjct: 131 LHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARK 243
+ Y G D+WS G++ ++ G P+ + N + I+ E P LS R
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRD 247
Query: 244 LIARILD 250
+ R L+
Sbjct: 248 FLNRCLE 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 74/242 (30%), Positives = 124/242 (51%), Gaps = 10/242 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA+K ++ ++ K E I E+ M+ K+P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNP 76
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+D+ HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIARI 248
G D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252
Query: 249 LD 250
L+
Sbjct: 253 LE 254
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +GEG F +V + VA+K L ++ + + + +E MK + HPNV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER--KDFLKEARVMKKLGHPNV 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLI-------NAV 124
VRL V + +++VLE++ GG+L D + + + + L+ +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---A 181
+Y S+ HRDL N L+ +K+SDFG LS+ V DD G + A
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFG---LSRDVYDDDYYRKKTGGKLPIRWMA 175
Query: 182 PEVLNDRGYDGSTA-DLWSCGVILF 205
PE L D + ++ D+WS GV+L+
Sbjct: 176 PESLKDGIF--TSKSDVWSFGVLLW 198
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-28
Identities = 71/213 (33%), Positives = 103/213 (48%), Gaps = 21/213 (9%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R V ++E IGEGT+ V AR++ +GE VALK + + + + RE+ +
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLN 62
Query: 68 VKHPNVVRLYEVMGSK--TKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
++HPN+V L EV+ K IF+V+E+ L D + E + + QL+
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQVKCLMLQLLRG 120
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----- 178
+ Y H + HRDLK NLLL G LK++DFGL+ L TP
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG-------LPAKPMTPKVVTLW 173
Query: 179 YVAPEVL-NDRGYDGSTADLWSCGVILFVLLAG 210
Y APE+L Y + D+W+ G IL LLA
Sbjct: 174 YRAPELLLGCTTYTTAI-DMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 71/214 (33%), Positives = 110/214 (51%), Gaps = 24/214 (11%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKI--LDKEKVLKHKMAEQIKREVAT 64
KR V K+++ IGEGT+ +V AR+ +TGE VALK LD EK RE+
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK---EGFPITAIREIKI 59
Query: 65 MKLVKHPNVVRLYEVMGSKTK----------IFIVLEFVTG---GELFDKIVNHGRMKED 111
++ + H N+V L E++ K ++V E++ G L +V+ ED
Sbjct: 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSED 116
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171
+ + +QL+ ++YCH + HRD+K N+LL+ G +K++DFGL+ L ++ +
Sbjct: 117 HIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN--SEESRPY 174
Query: 172 TT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVIL 204
T T Y PE+L G D+WSCG IL
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-28
Identities = 72/203 (35%), Positives = 107/203 (52%), Gaps = 11/203 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE IGEG++ V RN ETG+ VA+K + ++ + K+A RE+ +K +K
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA---LREIRMLKQLK 58
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
HPN+V L EV K K+ +V E+ L + N + E ++ Q + AV++CH
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTPNYVAPEVL-ND 187
HRD+KPEN+L+ G +K+ DFG + + DD +T T Y APE+L D
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVGD 175
Query: 188 RGYDGSTADLWSCGVILFVLLAG 210
Y G D+W+ G + LL G
Sbjct: 176 TQY-GPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 69/227 (30%), Positives = 113/227 (49%), Gaps = 9/227 (3%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLK-HKMAEQIKREVATMKLVKHPN 72
G +G+G + V + + G+ +A+K LD VL K E+++ EV +K +KH N
Sbjct: 5 GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V+ I I +EFV GG + + G + E +Y +Q+++ V Y H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 133 YHRDLKPENLLLDAYGNLKVSDFG----LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
HRD+K N++L G +K+ DFG L+ + +L + GTP ++APEV+N+
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
GY G +D+WS G +F + G P + + I A P
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR 229
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-28
Identities = 68/197 (34%), Positives = 113/197 (57%), Gaps = 9/197 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IGEG+ V A +G+ VA+K +D + K + E + EV M+ +H NVV +Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
++++V+EF+ GG L D IV H RM E++ ++ A+ H++GV HRD+K
Sbjct: 85 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
+++LL G +K+SDFG A +S++V L GTP ++APE+++ Y G D+
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPELISRLPY-GPEVDI 199
Query: 198 WSCGVILFVLLAGYLPF 214
WS G+++ ++ G P+
Sbjct: 200 WSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-28
Identities = 71/232 (30%), Positives = 116/232 (50%), Gaps = 39/232 (16%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK-LVK 69
Y++ IGEGTF++V A++ +TG+ A+K + K K EQ+ RE+ ++ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 70 HPNVVRLYEVM-----GSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINA 123
HPN++RL EV+ G +F +++ L++ I R + E + Y QL+ +
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELMD----MNLYELIKGRKRPLPEKRVKSYMYQLLKS 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV--- 180
+D+ H G++HRD+KPEN+L+ LK++DFG S P Y
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADFG-SC-----------RGIYSKPPYTEYI 159
Query: 181 ------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
APE L GY G D+W+ G + F +L+ + F +N ++ KI
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 66/205 (32%), Positives = 111/205 (54%), Gaps = 8/205 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T E VA+KI+D E+ E I++E+ + P + R Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G ++E ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADL 197
N+LL G++K++DFG++ Q+ D + T GTP ++APEV+ YD AD+
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNL 222
WS G+ L G P D + M +
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRV 209
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 8e-28
Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 15/216 (6%)
Query: 34 ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY-EVMGSKTKIFIVLEF 92
TG VA+K+L + + + +RE A + HPN+V L +F V E+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---N 149
V G L + + G + E R Q+++A+ H++G+ HRDLKP+N+++ G +
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 150 LKVSDFGLSALSQQVRDDGLLHTT-----CGTPNYVAPEVLNDRGYDGSTA--DLWSCGV 202
KV DFG+ L VRD + T GTP Y APE L RG + T DL++ G+
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL--RG-EPVTPNSDLYAWGL 177
Query: 203 ILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCPPWL 237
I L G +++ LY+++S + + PPW+
Sbjct: 178 IFLECLTGQRVVQGASVAEILYQQLSPVDVSLPPWI 213
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-28
Identities = 72/242 (29%), Positives = 125/242 (51%), Gaps = 10/242 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA++ ++ ++ K ++ I E+ M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---AAEFTCPPWLSFTARKLIARI 248
G D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 249 LD 250
LD
Sbjct: 254 LD 255
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 63/206 (30%), Positives = 112/206 (54%), Gaps = 10/206 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G + E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
N+LL +G +K++DFG++ Q++ + + GTP ++APEV+ YD S AD
Sbjct: 129 AANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQSAYD-SKAD 183
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNL 222
+WS G+ L G P + + M +
Sbjct: 184 IWSLGITAIELAKGEPPHSELHPMKV 209
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 66/205 (32%), Positives = 111/205 (54%), Gaps = 8/205 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P V + Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
TK++I++E++ GG D ++ G E + ++++ +DY HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADL 197
N+LL G++K++DFG++ Q+ D + T GTP ++APEV+ YD S AD+
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 184
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNL 222
WS G+ L G P D + M +
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRV 209
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-27
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G DE R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD YG++++SD GL+ ++ + + GT Y+APEV+ + Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-27
Identities = 75/266 (28%), Positives = 127/266 (47%), Gaps = 15/266 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVK 69
+Y + + +G+G+F V ++ + LK+L + V L Q +E + +
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVD 125
HP +V+ + + I+ E+ G +L K+ + E++ +F QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H R + HRDLK +N+ L LK+ DFG+S L D L T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEAL 177
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKL 244
+GYD S +D+WS G IL+ + F+ N +++ +I + P S +
Sbjct: 178 KHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 245 IARILDPNPMTVSIYPFA-DILYMRF 269
+ +L+ +P S+ P A +IL F
Sbjct: 237 MQSMLNKDP---SLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 5e-27
Identities = 74/237 (31%), Positives = 119/237 (50%), Gaps = 16/237 (6%)
Query: 31 RNSETGEPVALKILD-KEKVL-------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82
RN T VA + D KEKV+ + A + E+ + H +V+ ++ S
Sbjct: 77 RNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS 136
Query: 83 KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
K+ +++E+ +GG+L +I H +E E F Q++ A+D HSR + HRDLK
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK 196
Query: 139 PENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
N+ L G +K+ DFG S S V D + + CGTP Y+APE+ + Y AD+
Sbjct: 197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLD-VASSFCGTPYYLAPELWERKRYS-KKADM 254
Query: 198 WSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNP 253
WS GVIL+ LL + PF + + +++ ++ P +S + L+ +L NP
Sbjct: 255 WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNP 311
|
Length = 478 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-27
Identities = 78/223 (34%), Positives = 117/223 (52%), Gaps = 20/223 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+YE IGEGT+ V AR+ T E +ALK + E+ + + I RE++ +K ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQHG 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR------YFQQLINAVD 125
N+VRL +V+ S+ ++++V E+ L + H D A+ Y Q++ +
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 126 YCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPE 183
YCHS V HRDLKP+NLL+D N LK++DFGL+ A VR H T Y APE
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVV-TLWYRAPE 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYK 224
+L + + D+WS G I F + P DS + L+K
Sbjct: 174 ILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSEIDELFK 215
|
Length = 294 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-26
Identities = 63/200 (31%), Positives = 106/200 (53%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G +E+ A Y +++ ++ H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD YG++++SD GL+ ++ + + GT Y+APEVLN++ Y +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---KIPEGESIRGRVGTVGYMAPEVLNNQRY-TLS 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 51/170 (30%), Positives = 92/170 (54%), Gaps = 2/170 (1%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
I G F KV R + A+K++ K ++ M Q++ E + L K P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+ S +++V+E++ GG++ + +G E+ A +Y ++ A+DY H G+ HRDLK
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLK 131
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
P+N+L+ G++K++DFGLS ++ + + + TP+ P+ R
Sbjct: 132 PDNMLISNEGHIKLTDFGLSKVT--LNRELNMMDILTTPSMAKPKNDYSR 179
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 75/231 (32%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
YE IGEGT+ KV AR+ TG+ VALK K E I RE++ +++
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALK-----KTRLEMDEEGIPPTALREISLLQM 56
Query: 68 VKH-PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGR-----MKEDEARRY 116
+ +VRL +V + K +++V E++ +L + ++GR + + +
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLS-ALSQQVRDDGLLHTTC 174
QL+ V +CH GV HRDLKP+NLL+D LK++D GL A S V+ H
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS--YTHEIV 173
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYK 224
T Y APEVL + + D+WS G I + F DS L L
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH 223
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 78/238 (32%), Positives = 120/238 (50%), Gaps = 27/238 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMK-LVK 69
KYE+ + +G+G + V A + T E VALK I D + A++ RE+ ++ L
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD--AQRTFREIMFLQELGD 65
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFD----KIVNHGRMKEDEARRYFQQLINAVD 125
HPN+V+L V+ ++ I L F E + ++ +++ R QL+ A+
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKRYIMYQLLKALK 121
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTT--CGTPNYVAP 182
Y HS V HRDLKP N+LL++ +K++DFGL+ +LS+ + T T Y AP
Sbjct: 122 YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 183 EVLNDRGYDGSTA-----DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
E+L GST D+WS G IL +L G F ++ +N +KI E PP
Sbjct: 182 EILL-----GSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKI--IEVIGPP 232
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-26
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 8/201 (3%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR-EVATMKLVKHPNVVRLY 77
+G+G F +V + TG+ A K LDK++ LK K E++ E ++ V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKR-LKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRGVYHR 135
SKT + +V+ + GG+L I N G + R Y Q+ + + HS + +R
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYR 119
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
D+KPEN+LLD GN ++SD GL+ +++D + GT Y+APE+L + Y
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV- 175
Query: 196 DLWSCGVILFVLLAGYLPFDD 216
D ++ G ++ ++AG PF D
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-26
Identities = 71/227 (31%), Positives = 113/227 (49%), Gaps = 8/227 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG GT+ V ARN TGE A+K++ E + +Q E+ MK KH N
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHSN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V + + K++I +EF GG L D G + E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV--LNDRGY 190
HRD+K N+LL G++K++DFG+SA Q + GTP ++APEV + +G
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 237
D+W+ G+ L P D + M ++ + F PP L
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ-PPKL 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-26
Identities = 67/196 (34%), Positives = 103/196 (52%), Gaps = 9/196 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
K+EV +GEG + V R+ ET E VA+K K+ ++ E RE+ ++ +K
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
N+V L E + K+++V E+V EL +++ N + ++ R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHK 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRD+KPENLL+ LK+ DFG + LS+ + T Y +PE+L
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG--SNANYTEYVATRWYRSPELLLGA 176
Query: 189 GYDGSTADLWSCGVIL 204
Y G D+WS G IL
Sbjct: 177 PY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 73/257 (28%), Positives = 124/257 (48%), Gaps = 20/257 (7%)
Query: 13 YEVGRTIGEGTFAKV-KFARNSETGEPVALK-------ILDKEKVLKHKMAEQIKREVAT 64
Y V +G G F V K + + +ALK K+K + K I EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIV-NHGRMKEDEARRYFQQ 119
+K ++HPN+VR Y+ +++IV++ + G GE F+ + R E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 120 LINAVDYCH-SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ A+ Y H + + HRDL P N++L + ++DFG L++Q + + L + GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQPESKLTSVVGTIL 178
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y PE++ + Y G AD+W+ G IL+ + PF +N+++L KI A + P
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 239 FT--ARKLIARILDPNP 253
++ +I L P+
Sbjct: 238 YSEDVTDVITSCLTPDA 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 11/205 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G V + TG+ +A+K + E + + +QI RE+ + P +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEARRYFQQLINAVDYCHS-RGVY 133
Y + I I +E++ GG L DKI GR+ E + ++ + Y H +
Sbjct: 65 YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
HRD+KP N+L+++ G +K+ DFG+S Q V + L T GT +Y+APE + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS--GQLV--NSLAKTFVGTSSYMAPERIQGNDYSVK 179
Query: 194 TADLWSCGVILFVLLAGYLPFDDSN 218
+D+WS G+ L L G P+ N
Sbjct: 180 -SDIWSLGLSLIELATGRFPYPPEN 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 76/229 (33%), Positives = 114/229 (49%), Gaps = 22/229 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHP 71
+E+ TIG+GT+ KV N + G A+KILD H + E+I+ E +K L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP----IHDIDEEIEAEYNILKALSDHP 75
Query: 72 NVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKI---VNHG-RMKEDEARRYFQQLIN 122
NVV+ Y + K ++++VLE GG + D + + G RM+E + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALM 135
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ + H HRD+K N+LL G +K+ DFG+SA R +T+ GTP ++AP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAP 193
Query: 183 EVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
EV+ D YD + D+WS G+ L G P D + M KI
Sbjct: 194 EVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKI 241
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 75/242 (30%), Positives = 121/242 (50%), Gaps = 37/242 (15%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R+ +YEV + IG G F +V ++ T E K + + LK + Q+ EV M+ +
Sbjct: 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMREL 69
Query: 69 KHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLIN 122
KH N+VR + +K K++I++EF G+L I G+++E +QL++
Sbjct: 70 KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129
Query: 123 AVDYCHS-------RGVYHRDLKPENLLLDA-----------YGNL------KVSDFGLS 158
A+ YCH+ V HRDLKP+N+ L NL K+ DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+ + + + H+ GTP Y +PE+L + YD +D+W+ G I++ L +G PF
Sbjct: 190 ---KNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPFHK 245
Query: 217 SN 218
+N
Sbjct: 246 AN 247
|
Length = 1021 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-24
Identities = 67/200 (33%), Positives = 105/200 (52%), Gaps = 20/200 (10%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEG++A V R+ TG+ VALK E L+H+ RE + +K +KH N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALK----EIRLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ +K + +V E++ +L + + G + R + QL+ + YCH R V HR
Sbjct: 69 HDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL+ G LK++DFGL A ++ V + T Y P+VL GST
Sbjct: 128 DLKPQNLLISERGELKLADFGL-ARAKSVPSKTYSNEVV-TLWYRPPDVLL-----GSTE 180
Query: 196 -----DLWSCGVILFVLLAG 210
D+W G I + + G
Sbjct: 181 YSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 2e-24
Identities = 69/214 (32%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKMAEQIKREVATMKLVK 69
K +GEG V R TG ALK I K QI RE+ K K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK---QILRELEINKSCK 57
Query: 70 HPNVVRLYE--VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-------RYFQQL 120
P +V+ Y + S + I I +E+ GG L D I + ++K+ R + + +
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSI--YKKVKKRGGRIGEKVLGKIAESV 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HSR + HRD+KP N+LL G +K+ DFG+S + V + L T GT Y+
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELV--NSLAGTFTGTSFYM 170
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
APE + + Y T+D+WS G+ L + PF
Sbjct: 171 APERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 5e-24
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I + G +E R F ++ ++ H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD +G++++SD GL+ V + + GT Y+APEV+ + Y S
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W+ G +L+ ++AG PF
Sbjct: 182 PDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-24
Identities = 71/228 (31%), Positives = 116/228 (50%), Gaps = 10/228 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ + +G GT+ V ARN TGE A+KI+ E + I++E+ +K KH N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKHCN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V + S+ K++I +E+ GG L D G + E + ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL---NDRG 189
HRD+K N+LL G++K++DFG++A + + GTP ++APEV + G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEKNGG 185
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 237
Y+ D+W+ G+ L P D + M +S + F PP L
Sbjct: 186 YN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ-PPKL 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 6e-24
Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + TG+ A K L+K+++ K K E E + V +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+KT + +V+ + GG+L I N + E A Y Q+I+ +++ H R + +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
RDLKPEN+LLD GN+++SD GL+ Q + G GTP ++APE+L YD
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY----AGTPGFMAPELLQGEEYDF 176
Query: 193 STADLWSCGVILFVLLAGYLPF 214
S D ++ GV L+ ++A PF
Sbjct: 177 SV-DYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 7e-24
Identities = 67/224 (29%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK E+ +K
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71
Query: 70 HPNVVRLYEVM------GSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D + N +KED ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H+ V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 189
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
PEV+ D YD +D+WS G+ + G P D + M
Sbjct: 190 PEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 9e-24
Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 16/203 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKL 67
+Y+ IG G + V A ++ +G+ VA+K K+ +A++ RE+ ++
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFV---TGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
KH N++ + +++ F + V +L I + + E+ R + QL+ +
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGL 120
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL--SALSQQVRDDGLLHTTCGTPNYVAP 182
Y HS V HRDLKP NLL++ L++ DFG+ S + T Y AP
Sbjct: 121 KYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP 180
Query: 183 EVLNDRGYDGSTA-DLWSCGVIL 204
E+L + +TA D+WS G I
Sbjct: 181 ELLLSLP-EYTTAIDMWSVGCIF 202
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 1e-23
Identities = 64/222 (28%), Positives = 114/222 (51%), Gaps = 16/222 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + +V A +++TG VA+K L + + H A++ RE+ +K + H
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH--AKRTYRELRLLKHMDH 73
Query: 71 PNVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V + +++V + G +L + IV ++ +D + Q++ +
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHIQFLVYQILRGL 131
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y HS G+ HRDLKP N+ ++ LK+ DFGL+ + D + T Y APE+
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPEI 186
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + + T D+WS G I+ LL G F S+ ++ K+I
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 1e-23
Identities = 64/200 (32%), Positives = 102/200 (51%), Gaps = 6/200 (3%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R +G+G F +V + TG+ A K L+K+++ K K E ++ V VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLINAVDYCHSRGVYH 134
+K + +VL + GG+L I N G DE R F +L ++ + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
RDLKPEN+LLD G++++SD GL+ Q+ + + GT Y+APEV+N+ Y S
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKYTFS- 181
Query: 195 ADLWSCGVILFVLLAGYLPF 214
D W G +++ ++ G PF
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 66/207 (31%), Positives = 109/207 (52%), Gaps = 16/207 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKHP 71
Y+ IGEG + V A + TG VA+K K +H+ ++ RE+ ++ KH
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIK---KISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 72 NVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ + +++ + ++IV E + +L+ K++ + D + + Q++ + Y
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLY-KLIKTQHLSNDHIQYFLYQILRGLKY 121
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEV- 184
HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D G L T Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM 181
Query: 185 LNDRGYDGSTA-DLWSCGVILFVLLAG 210
LN +GY + A D+WS G IL +L+
Sbjct: 182 LNSKGY--TKAIDIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 3e-23
Identities = 75/232 (32%), Positives = 116/232 (50%), Gaps = 27/232 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+E+ TIG+GT+ KV N + G A+KILD + E+I+ E ++ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 70 HPNVVRLYEVMGSKTK-----IFIVLEFVTGG---ELFDKIVNHG-RMKEDEARRYFQQL 120
HPNVV+ Y + K +++VLE GG EL ++ G R+ E
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA--LSQQVRDDGLLHTTCGTPN 178
+ + + H+ + HRD+K N+LL G +K+ DFG+SA S ++R + T+ GTP
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN----TSVGTPF 193
Query: 179 YVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYK 224
++APEV+ D YD + D+WS G+ L G P FD + L+K
Sbjct: 194 WMAPEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK 244
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-23
Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQ----IKREVATMKLV 68
+ +GEG F KV+ R TGE VA+K L H EQ +RE+ ++ +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVK------SLNHSGEEQHRSDFEREIEILRTL 63
Query: 69 KHPNVVRL----YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLIN 122
H N+V+ + G ++ ++E++ G L D + H R + + R + Q+
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRL--IMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICK 120
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
+DY S+ HRDL N+L+++ +K+SDFGL+ + + +D + +P + A
Sbjct: 121 GMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA 180
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLL 208
PE L + S +D+WS GV L+ L
Sbjct: 181 PECLRTSKFS-SASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 4e-23
Identities = 66/227 (29%), Positives = 110/227 (48%), Gaps = 17/227 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ T E VA+K + ++ + I +EV ++ ++HPN +
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 77 YEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ ++V+E+ G ++ + V+ ++E E + + Y HS H
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLHSHERIH 138
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG-YD 191
RD+K N+LL G +K++DFG ++L ++ GTP ++APEV+ D G YD
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYD 192
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
G D+WS G+ L P + N M+ I+ + P LS
Sbjct: 193 GK-VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---SPTLS 235
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-23
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 30/234 (12%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLV 68
+Y R +G G+ V A +S+ + VA+K +L + +KH + RE+ ++ +
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-----REIKIIRRL 59
Query: 69 KHPNVVRLYEVMGSKTK--------------IFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
H N+V++YEV+G ++IV E++ ++ G + E+ AR
Sbjct: 60 DHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHAR 117
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS-ALSQQVRDDGLLHT 172
+ QL+ + Y HS V HRDLKP N+ ++ LK+ DFGL+ + G L
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177
Query: 173 TCGTPNYVAPE-VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNL 222
T Y +P +L+ Y D+W+ G I +L G F ++ M L
Sbjct: 178 GLVTKWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL 230
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 6e-23
Identities = 68/224 (30%), Positives = 113/224 (50%), Gaps = 21/224 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK+E+ +K
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 70 HPNVVRLYEVM------GSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D I N +KE+ ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 179
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
PEV+ D YD +DLWS G+ + G P D + M
Sbjct: 180 PEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 6e-23
Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 15/209 (7%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F +V R PVA+K + L + + +E +K HPN+VRL
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V K I+IV+E V GG+ + G R+K E + + ++Y S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YVAPEVLNDRGYDGS 193
N L+ LK+SDFG+S + +DG+ +T G + APE LN Y S
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEALNYGRYS-S 175
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMN 221
+D+WS G++L+ + G +P+ +NL N
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPY--ANLSN 202
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 63/224 (28%), Positives = 102/224 (45%), Gaps = 40/224 (17%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVAT 64
++ YE+ +GEGTF +V AR +TG VALK K+L H + RE+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKI 60
Query: 65 MKLVKHPNVVRLYEVMGSKTK--------IFIVLEFVT---GGELFDKIVNHGRMKEDEA 113
+K +KHPNVV L ++ + +++V ++ G L + V + E +
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQI 117
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173
+ Y QL+ ++Y H + HRD+K N+L+D G LK++DFG L++
Sbjct: 118 KCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG---LARPYDGPPPNPKG 174
Query: 174 CGTPN------------YVAPE-VLNDRGYDGSTADLWSCGVIL 204
G Y PE +L +R Y + D+W G +
Sbjct: 175 GGGGGTRKYTNLVVTRWYRPPELLLGERRY-TTAVDIWGIGCVF 217
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 5e-22
Identities = 66/220 (30%), Positives = 112/220 (50%), Gaps = 12/220 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + V A ++ + VA+K L + + L H A + RE+ +K +KH
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIH--ARRTYRELRLLKHMKH 73
Query: 71 PNVVRLYEVMGSKTKI--FIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
NV+ L +V T I F + VT G + IV ++ ++ + QL+ + Y
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKY 133
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HS G+ HRDLKP N+ ++ L++ DFG L++Q D+ + T Y APE++
Sbjct: 134 IHSAGIIHRDLKPSNVAVNEDCELRILDFG---LARQADDE--MTGYVATRWYRAPEIML 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + T D+WS G I+ LL G F ++ ++ K+I
Sbjct: 189 NWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-22
Identities = 65/195 (33%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ ++ + +V E++ +L + N G M + + QL+ + YCH R + HR
Sbjct: 69 HDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL++ G LK++DFGL A ++ V + T Y P+VL +
Sbjct: 128 DLKPQNLLINEKGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPI 185
Query: 196 DLWSCGVILFVLLAG 210
D+W G IL+ + G
Sbjct: 186 DMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-22
Identities = 73/205 (35%), Positives = 109/205 (53%), Gaps = 19/205 (9%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
+YE IGEG + KV AR+ + G VALK + + + + M REVA ++ ++
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 60
Query: 70 --HPNVVRLYEV-----MGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQL 120
HPNVVRL++V +TK+ +V E V DK+ G + + + QL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-VPTETIKDMMFQL 119
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-SQQVRDDGLLHTTCGTPNY 179
+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ + S Q+ L + T Y
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM----ALTSVVVTLWY 175
Query: 180 VAPEVLNDRGYDGSTADLWSCGVIL 204
APEVL Y + DLWS G I
Sbjct: 176 RAPEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 7e-22
Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 23/209 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
KY + IG G + V A+NSET E VA+K + +++ A++ RE+ ++ + H
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIAN--AFDNRIDAKRTLREIKLLRHLDH 63
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFD----KIVNHGRMKEDEARRYF-QQL 120
NV+ + ++M + ++IV E L D +I+ + D+ +YF QL
Sbjct: 64 ENVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSDDHCQYFLYQL 117
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + Y HS V HRDLKP NLLL+A +LK+ DFGL+ + + + T Y
Sbjct: 118 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRWYR 175
Query: 181 APEV-LNDRGYDGSTADLWSCGVILFVLL 208
APE+ LN Y + D+WS G I LL
Sbjct: 176 APELLLNCSEY-TTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 9e-22
Identities = 56/217 (25%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 48 KVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG 106
K++K K I+ V MK +PN ++LY + + ++++++ G+LFD + G
Sbjct: 47 KIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG 104
Query: 107 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSAL--SQQ 163
++ E E ++ +QL+ A++ H + H D+K EN+L D + + D+GL + +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----- 218
D GT +Y +PE + YD S D W+ GV+ + LL G PF +
Sbjct: 165 CYD--------GTLDYFSPEKIKGHNYDVSF-DWWAVGVLTYELLTGKHPFKEDEDEELD 215
Query: 219 ---LMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
L+ +K + +S A + +L N
Sbjct: 216 LESLLKRQQK----KLPFIKNVSKNANDFVQSMLKYN 248
|
Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-21
Identities = 63/207 (30%), Positives = 112/207 (54%), Gaps = 11/207 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-KMAEQIKREVATMKLVKH 70
+Y++ IG+G++ V A ++ TGE VA+K ++ V +H A +I RE+ ++L++H
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIND--VFEHVSDATRILREIKLLRLLRH 58
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
P++V + +M ++ I++V E + +L I + + + + + QL+ A+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEV 184
Y H+ V+HRDLKP+N+L +A LK+ DFGL+ ++ + T T Y APE+
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 185 LNDRGYDGSTA-DLWSCGVILFVLLAG 210
+ A D+WS G I +L G
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 1e-21
Identities = 63/211 (29%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ YE +GEG++A V ++ G+ VALK++ ++ + RE + +K +
Sbjct: 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGL 60
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
KH N+V L++++ +K + +V E+V + DK + G + + + + QL+ + Y
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSY 118
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG---TPNYVAPE 183
H R + HRDLKP+NLL+ G LK++DFGL A ++ V HT T Y P+
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGL-ARAKSVPS----HTYSNEVVTLWYRPPD 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
VL + D+W G I ++ G F
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-21
Identities = 68/243 (27%), Positives = 124/243 (51%), Gaps = 12/243 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNVV 74
R +G+G++ +V R+ G+ +K L+ + K AEQ E + +KHPN+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNIV 62
Query: 75 RLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRM-KEDEARRYFQQLINAVDYCHSRG 131
E G ++IV+ F GG+L+ K+ G++ E++ +F Q+ A+ Y H +
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLK +N+ L +KV D G++ + + D + T GTP Y++PE+ +++ Y+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYN 180
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNL-YKKISAAEFTCPPWLSFTARKLIARILD 250
+D+W+ G ++ + F+ ++ +L Y+ I P S +LIA +L
Sbjct: 181 -YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLS 239
Query: 251 PNP 253
P
Sbjct: 240 KRP 242
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 2e-21
Identities = 75/254 (29%), Positives = 119/254 (46%), Gaps = 33/254 (12%)
Query: 19 IGEGTFAKVKFARNSETGEPVALK---ILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+GT+ V AR+ T +A+K D V + + E+A +KH N+V+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV------QPLHEEIALHSYLKHRNIVQ 69
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEA--RRYFQQLINAVDYCHSRGV 132
I +E V GG L + + G +K++E Y +Q++ + Y H +
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQI 129
Query: 133 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RG 189
HRD+K +N+L++ Y G +K+SDFG S + + T GT Y+APEV++ RG
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTS--KRLAGINPCTETFTGTLQYMAPEVIDKGPRG 187
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC---------PPWLSFT 240
Y G+ AD+WS G + + G PF + + AA F P LS
Sbjct: 188 Y-GAPADIWSLGCTIVEMATGKPPFIE------LGEPQAAMFKVGMFKIHPEIPESLSAE 240
Query: 241 ARKLIARILDPNPM 254
A+ I R +P+P
Sbjct: 241 AKNFILRCFEPDPD 254
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-21
Identities = 66/237 (27%), Positives = 113/237 (47%), Gaps = 16/237 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G G + V A + TG VA+K L + A++ RE+ +K +KH
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHE 74
Query: 72 NVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V + ++V+ F+ G K++ H ++ ED + Q++ +
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
+ + T D+WS G I+ +L G F + ++ +I + T P F +
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEI--MKVTGTPSKEFVQK 242
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 3e-21
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 10/215 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G+F V FA NS T E VA+K + ++ + I +EV ++ +KHPN +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138
+ ++V+E+ G V+ ++E E + + Y HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG-YDGSTA 195
N+LL G +K++DFG ++ S ++ GTP ++APEV+ D G YDG
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDGKV- 201
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230
D+WS G+ L P + N M+ I+ +
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQND 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 69/238 (28%), Positives = 111/238 (46%), Gaps = 41/238 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSET--GEPVALK----ILDKEKVLKHKMAEQIKREVATMK 66
YE+ + +G+G + V ARN+ET E VA+K + K+ + K + RE+ ++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRAL-----RELKLLR 56
Query: 67 LVK-HPNVVRLYEVMGSKTKIFIVLEFVTGG---------ELFD----KIVNHGRMKEDE 112
+ H N+ LY+ ++ V G EL + +I+ G+ D
Sbjct: 57 HFRGHKNITCLYD-----------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDA 105
Query: 113 ARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ--QVRDDGL 169
+ F Q++ + Y HS V HRDLKP NLL++A LK+ DFGL+ + G
Sbjct: 106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF 165
Query: 170 LHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ T Y APE+ L+ + Y + D+WS G IL LL F + ++ +I
Sbjct: 166 MTEYVATRWYRAPEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKDYVDQLNQI 222
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-21
Identities = 66/222 (29%), Positives = 115/222 (51%), Gaps = 19/222 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKL 67
+Y + +G G F V AR+ TG+ VA+K K++K +A++ RE+ +K
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIK-----KIMKPFSTPVLAKRTYRELKLLKH 65
Query: 68 VKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
++H N++ L ++ S I+ V E + G +++ +++ + + Q++ + Y
Sbjct: 66 LRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-L 185
HS GV HRDLKP N+L++ +LK+ DFGL+ + Q + G + T Y APE+ L
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLKICDFGLARI-QDPQMTGYVSTR----YYRAPEIML 178
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
+ YD D+WS G I +L G F + +N + I+
Sbjct: 179 TWQKYD-VEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIIT 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-21
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 10/217 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ T E VA+K + ++ + I +EV ++ +KHPN +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++V+E+ G V+ ++E E + + Y HS + HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGS 193
+K N+LL G +K++DFG ++++ ++ GTP ++APEV +++ YDG
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGK 204
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230
D+WS G+ L P + N M+ I+ E
Sbjct: 205 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 240
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 5e-21
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 10/204 (4%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHR 135
++++ + + +V E++ +L + + G M + + Q++ + YCH R V HR
Sbjct: 70 HDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKP+NLL++ G LK++DFGL A ++ V + T Y P+VL +
Sbjct: 129 DLKPQNLLINERGELKLADFGL-ARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQI 186
Query: 196 DLWSCGVILFVLLAGYLPFDDSNL 219
D+W G I F + +G F S +
Sbjct: 187 DMWGVGCIFFEMASGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 9e-21
Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 34/240 (14%)
Query: 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81
G KV ++ T + LK L K + I V PN+V L++ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCV--------PNMVCLHKYIV 55
Query: 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141
S+ +F+VL+ GG+L+ I + E+ +R+ +++ A+D H G+ RDL P N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 142 LLLDAYGNLKVSDFG-LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA--DLW 198
+LLD G+++++ F S + + + + C APEV G T D W
Sbjct: 116 ILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEV---GGISEETEACDWW 166
Query: 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAA-----EFTCPPWLSFTARKLIARILDPNP 253
S G ILF LL G L + + P W+S AR L+ ++L NP
Sbjct: 167 SLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNP 217
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-20
Identities = 66/204 (32%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-- 69
+YE IG G + V AR+ +G VALK + + + + + REVA +K ++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSV-RVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 70 -HPNVVRLYEVMGS-----KTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLI 121
HPN+VRL +V + +TK+ +V E V DK+ G + + + +Q +
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFL 118
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-SQQVRDDGLLHTTCGTPNYV 180
+D+ H+ + HRDLKPEN+L+ + G +K++DFGL+ + S Q+ ++ T Y
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----YR 174
Query: 181 APEVLNDRGYDGSTADLWSCGVIL 204
APEVL Y + D+WS G I
Sbjct: 175 APEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-20
Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 26/199 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++G TIG+G F V G+ VA+K L + A+ E + M ++HPN+
Sbjct: 9 KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNL 62
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI-------NAVDY 126
V+L V+ ++IV E++ G L D + + GR A Q + ++Y
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEY 117
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVL 185
+ HRDL N+L+ KVSDFGL+ + Q +D G L P + APE L
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPEAL 171
Query: 186 NDRGYDGSTADLWSCGVIL 204
++ + + +D+WS G++L
Sbjct: 172 REKKFS-TKSDVWSFGILL 189
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-20
Identities = 57/232 (24%), Positives = 109/232 (46%), Gaps = 17/232 (7%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + R +G G F +V VA+KIL + +LK + ++EV +K ++H +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQD---FQKEVQALKRLRHKH 63
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQ-QLINAVDYCHSR 130
++ L+ V ++I+ E + G L + + G++ + Q+ + Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRG 189
HRDL N+L+ KV+DFGL+ L +++D L + P + APE +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA-----AEFTCPP 235
+ + +D+WS G++L+ + G +P+ N +Y +I+A CP
Sbjct: 181 FS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ 231
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-20
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
+GEGT+A V R+ T VALK E L+H+ REV+ +K +KH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 77 YEVMGSKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
++++ ++ + +V E++ + D N M + + QL+ ++YCH R V H
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHN--VKLFLFQLLRGLNYCHRRKVLH 127
Query: 135 RDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
RDLKP+NLL++ G LK++DFGL+ ++ + + ++ T Y P++L
Sbjct: 128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-----TLWYRPPDILLGSTDY 182
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNL 219
+ D+W G I + + G F S +
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTV 210
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 7e-20
Identities = 57/198 (28%), Positives = 93/198 (46%), Gaps = 22/198 (11%)
Query: 19 IGEGTFAKVKFAR-NSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+G+F V+ ++ G+ PVA+K L +K+ + + +E A M + H N++R
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--------RYFQQLINAVDYC 127
LY V+ + + +V E G L D R+++D Y Q+ N + Y
Sbjct: 61 LYGVVLTH-PLMMVTELAPLGSLLD------RLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLN 186
S+ HRDL N+LL + +K+ DFGL Q D ++ P + APE L
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173
Query: 187 DRGYDGSTADLWSCGVIL 204
R + +D+W GV L
Sbjct: 174 TRTFS-HASDVWMFGVTL 190
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-19
Identities = 69/249 (27%), Positives = 117/249 (46%), Gaps = 21/249 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE-KVLKHKMAEQIKREVATMKLVKH 70
+Y+ +G G + V A +++TG VA+K L + + + H A++ RE+ +K +KH
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH--AKRTYRELRLLKHMKH 75
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V +++V + G + IV ++ +D + Q++ +
Sbjct: 76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
Y HS + HRDLKP NL ++ LK+ DFGL+ D + T Y APE+
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEI 188
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-----SF 239
+ + + T D+WS G I+ LL G F ++ ++ K I T L S
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248
Query: 240 TARKLIARI 248
+AR I +
Sbjct: 249 SARNYIQSL 257
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-19
Identities = 58/196 (29%), Positives = 101/196 (51%), Gaps = 12/196 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+GEG++A V + G+ VALK++ + + + RE + +K +KH N+V L++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
++ +K + V E++ +L ++ H G + R + QL+ + Y H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129
Query: 138 KPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
KP+NLL+ G LK++DFGL+ ++ Q ++ T Y P+VL S
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-----TLWYRPPDVLLGATDYSSA 184
Query: 195 ADLWSCGVILFVLLAG 210
D+W G I +L G
Sbjct: 185 LDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-19
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 26/220 (11%)
Query: 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-----------REVA 63
G +GEGT+ KV+ A ++ TG+ VA+K + ++ ++ RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLIN 122
M +KH N++ L +V I +V++ + K+V+ R+ E + + Q++N
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILN 130
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPN- 178
++ H HRDL P N+ +++ G K++DFGL+ T
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 179 --------YVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 210
Y APE+L D+WS G I LL G
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-19
Identities = 68/278 (24%), Positives = 126/278 (45%), Gaps = 41/278 (14%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +Y++ R IG+G +V A + VALK + ++ + ++ RE +
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR------------RYF 117
HP +V +Y + ++ + ++ G L ++ KE ++ F
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTL-KSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD---------G 168
++ ++Y HS+GV HRDLKP+N+LL +G + + D+G + + +D
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 169 LLHTT-------CGTPNYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLPF---DDS 217
+ +++ GTP+Y+APE L G S + D+++ GVIL+ +L P+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237
Query: 218 NLMNLYKKISAAEFT----CPPWLSFTARKLIARILDP 251
+ +S E PP+LS A K +A +DP
Sbjct: 238 KISYRDVILSPIEVAPYREIPPFLSQIAMKALA--VDP 273
|
Length = 932 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-19
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 10/217 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG G+F V FAR+ E VA+K + ++ + I +EV ++ ++HPN ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++V+E+ G V+ ++E E + + Y HS + HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV---LNDRGYDGS 193
+K N+LL G +K+ DFG +++ + GTP ++APEV +++ YDG
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230
D+WS G+ L P + N M+ I+ E
Sbjct: 195 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE 230
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-19
Identities = 64/221 (28%), Positives = 108/221 (48%), Gaps = 15/221 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G G + V A + TGE VA+K L + A++ RE+ +K ++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSR-PFQSEIFAKRAYRELTLLKHMQHE 74
Query: 72 NVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V S ++V+ ++ KI+ H + ED+ + Q++ +
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGLK 131
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y HS G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA-----DAEMTGYVVTRWYRAPEVI 186
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
+ + T D+WS G I+ +L G F + ++ +I
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 227
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-18
Identities = 62/205 (30%), Positives = 93/205 (45%), Gaps = 35/205 (17%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKIL-------DKEKVLKHKMAEQIKREVATMKLVK 69
IG+G F V E VA+K K K L+ E +K
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE-VAVKTCRSTLPPDLKRKFLQ---------EAEILKQYD 50
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE--ARRYFQQLINA---V 124
HPN+V+L V K I+IV+E V GG L + R K++ ++ Q ++A +
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSL----LTFLRKKKNRLTVKKLLQMSLDAAAGM 106
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YV 180
+Y S+ HRDL N L+ LK+SDFG+S + + G+ + G +
Sbjct: 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWT 162
Query: 181 APEVLNDRGYDGSTADLWSCGVILF 205
APE LN Y S +D+WS G++L+
Sbjct: 163 APEALNYGRYT-SESDVWSYGILLW 186
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-18
Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 17/227 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
K +G IGEG F V + TG+ VA+K + + A+ E A M + H
Sbjct: 7 KLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHK 59
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHS 129
N+VRL V+ ++IV+E ++ G L + + GR + ++ + ++Y S
Sbjct: 60 NLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES 118
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ + HRDL N+L+ G KVSDFGL+ + D+ L + APE L +
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEALKHKK 173
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
+ S +D+WS GV+L+ V G P+ +L + + + PP
Sbjct: 174 FS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP 219
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-18
Identities = 63/239 (26%), Positives = 112/239 (46%), Gaps = 20/239 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ G VA+K L + A++ RE+ +K V H
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNHK 80
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + +++V+E + ++ ++H RM Q++
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMS-----YLLYQMLCG 135
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ + ++ T Y APE
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTACTNFMMTPYVVTRYYRAPE 192
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
V+ GY D+WS G I+ L+ G + F ++ ++ + K+ E P F R
Sbjct: 193 VILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV--IEQLGTPSAEFMNR 248
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 58/194 (29%), Positives = 88/194 (45%), Gaps = 12/194 (6%)
Query: 17 RTIGEGTFAKVK---FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G F V + S VA+K L +E + K ++ RE + M + HP +
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
VRL V + + +V+E G L + + + + Q+ + Y S+
Sbjct: 59 VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDRGY 190
HRDL N+LL K+SDFG+S AL D TT G P + APE +N +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALG--AGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 191 DGSTADLWSCGVIL 204
S +D+WS GV L
Sbjct: 176 S-SKSDVWSYGVTL 188
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 14/210 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-EQIKREVATMKLVKHPNVVR 75
R IG G F V + G+ VALK + V ++ ++ +++ RE+ + KH NV+
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALKKM--PNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 76 LYEVM-----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+++ +I++V E + +L IV+ + D + + Q++ + Y HS
Sbjct: 64 ALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA 122
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPNYVAPEVLNDR 188
G+ HRD+KP NLL+++ LK+ DFGL+ + + D H T T Y APE+L
Sbjct: 123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP---DESKHMTQEVVTQYYRAPEILMGS 179
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSN 218
+ S D+WS G I LL + F +
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRRILFQAQS 209
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-18
Identities = 62/198 (31%), Positives = 101/198 (51%), Gaps = 26/198 (13%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V F + PVA+K ++ L ++ + E +K HPN+V+L
Sbjct: 3 LGKGNFGEV-FKGTLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD------YCHSRG 131
V + I+IV+E V GG+ + R K+DE + +QL+ A+D Y S+
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAAGMAYLESKN 113
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN----YVAPEVLND 187
HRDL N L+ LK+SDFG+S ++D ++++ G + APE LN
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 188 RGYDGSTADLWSCGVILF 205
Y S +D+WS G++L+
Sbjct: 169 GRYS-SESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-18
Identities = 65/260 (25%), Positives = 114/260 (43%), Gaps = 19/260 (7%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
EV +G+G + V + TG +A+K + E L QI E+ + P +
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYI 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
V Y + +++ +E++ G +L+ V + ED RR ++ + +
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 131 -GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL---- 185
+ HRD+KP N+L++ G +K+ DFG+S V L T G +Y+APE +
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVSG--NLVAS--LAKTNIGCQSYMAPERIKSGG 177
Query: 186 -NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFT 240
N +D+WS G+ + + G P+ N++ ++SA PP L S
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDD 237
Query: 241 ARKLIARILDPNPMTVSIYP 260
A+ +A+ L+ P Y
Sbjct: 238 AQDFVAKCLNKIPNRRPTYA 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 7e-18
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 37/223 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE+ IG GT+ +V A+ N + G+ A+K +K +++ RE+A ++ +K
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 70 HPNVVRLYEVMGSKT--KIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQ------- 118
H NVV L EV ++++ ++ D +I+ R R
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQA---KRVSIPPSMVKSL 113
Query: 119 --QLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGL-----SALSQQVRDD 167
Q++N V Y HS V HRDLKP N+L+ G +K+ D GL + L D
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 168 GLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLA 209
++ T Y APE+ L R Y D+W+ G I LL
Sbjct: 174 PVVVTIW----YRAPELLLGARHYT-KAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 9e-18
Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 15/217 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G G F V + + VA+K +++ + + E+ K MKL HP +V+L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIK-VAIKAINEGAMSEEDFIEEAK---VMMKL-SHPKLVQL 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
Y V + ++IV EF+ G L + + G++ +D Q + ++Y HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYDG 192
DL N L+ + G +KVSDFG +++ V DD ++ G + PEV N Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFG---MTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 193 STADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
S +D+WS GV+++ V G +PF+ + + + IS
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR 216
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-17
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
R +GEG F KV+ R TGE VA+K L E H +K+E+ ++ + H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNH--IADLKKEIEILRNLYHEN 67
Query: 73 VVRLYEVM--GSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+V+ + I +++EF+ G E + N +K+ +Y Q+ +DY
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ--QLKYAVQICKGMDYL 125
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-VAPEVL- 185
SR HRDL N+L+++ +K+ DFGL+ + ++ + +P + APE L
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 186 NDRGYDGSTADLWSCGVILFVLL 208
+ Y S D+WS GV L+ LL
Sbjct: 186 QSKFYIAS--DVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-17
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 16 GRTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G F V R VA+K++ +E + + E M + HPN+
Sbjct: 9 LKELGSGQFGVVHLGKWRGKID---VAIKMI-REGAMSE---DDFIEEAKVMMKLSHPNL 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 132
V+LY V + IFIV E++ G L + + G++ + + A++Y S G
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL N L+ +KVSDFG L++ V DD + GT + PEV D
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFG---LARYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYS 176
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFD 215
S +D+WS GV+++ V G +P++
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 18/225 (8%)
Query: 13 YEVGRT-------IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+E+ RT +G G + +V + VA+K L KE ++ E+ +E A M
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTME---VEEFLKEAAVM 56
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ--QLINA 123
K +KHPN+V+L V + +I+ EF+T G L D + R + + + Q+ +A
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAP 182
++Y + HRDL N L+ +KV+DFGLS L D H P + AP
Sbjct: 117 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAP 174
Query: 183 EVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
E L + +D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 175 ESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 2e-17
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 25/206 (12%)
Query: 17 RTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
R +GEG F KV N TGE VA+K L +E ++ K+E+ +K + H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTLYHEN 67
Query: 73 VVRLY---EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+V+ G K + +++E+V G L D + H ++ + + QQ+ + Y HS
Sbjct: 68 IVKYKGCCSEQGGKG-LQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHS 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA------LSQQVRDDGLLHTTCGTPNY-VAP 182
+ HRDL N+LLD +K+ DFGL+ +VR+DG +P + A
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAV 179
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLL 208
E L + + ++ D+WS GV L+ LL
Sbjct: 180 ECLKENKFSYAS-DVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-17
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y V +T+ G+ +V A +PV LKI K L M ++ V HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM---------LLQNVNHPS 118
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
V+R+ + + S +VL + +L+ + + D+A +Q++ + Y H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+K EN+ ++ + + D G + GL GT APEVL Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233
Query: 191 DGSTADLWSCGVILFVLLA 209
+ S AD+WS G++LF +LA
Sbjct: 234 N-SKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-17
Identities = 65/217 (29%), Positives = 109/217 (50%), Gaps = 17/217 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE-QIKREVATMKLVKHPNVVR 75
+ +G G F VK+ + VA+K++ KE M+E + E M + H +V+
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMI-KEG----SMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYH 134
LY V + I+IV E+++ G L + + HG R + + + + + Y S+ H
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYD 191
RDL N L+D G +KVSDFG LS+ V DD ++ G+ + PEVL +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFG---LSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS 179
Query: 192 GSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
S +D+W+ GV+++ V G +P++ N +K+S
Sbjct: 180 -SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-17
Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 24/226 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDK--EKVLKHKMAEQIKREVATMKLVK 69
+Y+ + IG G V A ++ TG+ VA+K L + + V K A RE+ MKLV
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRA---YRELVLMKLVN 73
Query: 70 HPNVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYF-QQL 120
H N++ L V + +++V+E + ++ ++H RM Y Q+
Sbjct: 74 HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS------YLLYQM 127
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYR 184
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
APEV+ GY D+WS G I+ ++ G + F ++ ++ + KI
Sbjct: 185 APEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKI 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-17
Identities = 58/208 (27%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
E +G G V ++ TG +A K++ K + +QI RE+ M + P +
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYI 65
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR-G 131
V Y ++ I + +EF+ G L D+I G + + + ++ + Y ++
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S L + D T GT Y++PE + Y
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGKY 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSN 218
+D+WS G+ + L G PF SN
Sbjct: 180 T-VKSDVWSLGISIIELALGKFPFAFSN 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 24/212 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KH--PNVV 74
IG GT +V R +TG +A+K ++ + E+ KR + + +V H P +V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKSHDCPYIV 77
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSR-G 131
+ Y + + +FI +E + DK++ G + ED + ++ A+ Y + G
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TCGTPNYVAPEVLN---- 186
V HRD+KP N+LLDA GN+K+ DFG+S + V D T + G Y+APE ++
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG--RLV--DSKAKTRSAGCAAYMAPERIDPPDP 191
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSN 218
+ YD AD+WS G+ L L G P+ +
Sbjct: 192 NPKYD-IRADVWSLGISLVELATGQFPYKNCK 222
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 14/214 (6%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMK 66
+ E + +G G F V GE PVA+K+L +E K ++I E M
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
V HP+VVRL + S + ++ + + G L D + NH + + Q+ +
Sbjct: 65 SVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPE 183
Y + + HRDL N+L+ ++K++DFGL+ L D+ H G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIKWMALE 181
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216
+ R Y +D+WS GV ++ L+ G P++
Sbjct: 182 SILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G V ++ +G +A K++ E +K + QI RE+ + P +V Y
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG------- 131
S +I I +E + GG L D+++ EA+R ++++ V RG
Sbjct: 71 AFYSDGEISICMEHMDGGSL-DQVLK-------EAKRIPEEILGKVSIAVLRGLAYLREK 122
Query: 132 --VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTH 178
Query: 190 YDGSTADLWSCGVILFVLLAGYLP 213
Y +D+WS G+ L L G P
Sbjct: 179 YS-VQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 59/201 (29%), Positives = 104/201 (51%), Gaps = 20/201 (9%)
Query: 19 IGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQI---KREVATMKLVKHP 71
+G+G F V+ R TGE VA+K L+H AE + +RE+ +K ++H
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVK------KLQHSTAEHLRDFEREIEILKSLQHD 65
Query: 72 NVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYC 127
N+V+ V S + + +V+E++ G L D + H R + D + Y Q+ ++Y
Sbjct: 66 NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYL 124
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-VAPEVLN 186
S+ HRDL N+L+++ +K+ DFGL+ + Q ++ + +P + APE L
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 187 DRGYDGSTADLWSCGVILFVL 207
+ + +D+WS GV+L+ L
Sbjct: 185 ESKFS-VASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 4e-16
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 36/219 (16%)
Query: 17 RTIGEGTFAKVKFARNSETGEP---VALKIL-----DKEKVLKHKMAEQIKREVATMKLV 68
+ IG G F +V R G+ VA+K L DK+++ E + M
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-------DFLTEASIMGQF 62
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN------ 122
HPN++RL V+ + I+ E++ G L DK ++E++ + QL+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116
Query: 123 -AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--TP-N 178
+ Y HRDL N+L+++ KVSDFG LS+++ D +TT G P
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFG---LSRRLEDSEATYTTKGGKIPIR 173
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
+ APE + R + S +D+WS G++++ V+ G P+ D
Sbjct: 174 WTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-16
Identities = 62/228 (27%), Positives = 110/228 (48%), Gaps = 22/228 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+TIG+G F V G VA+K + + A+ E + M ++H N+V+L
Sbjct: 12 QTIGKGEFGDVMLG--DYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQL 64
Query: 77 YEVM-GSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVY 133
V+ K ++IV E++ G L D + + GR + D ++ + A++Y +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
HRDL N+L+ KVSDFGL+ + +D G L + APE L ++ + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFS-T 178
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-----AEFTCPP 235
+D+WS G++L+ + + G +P+ L ++ ++ A CPP
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 18/223 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 83
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + ++IV+E + ++ ++H RM Q++
Sbjct: 84 NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 138
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y APE
Sbjct: 139 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPE 195
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
V+ GY D+WS G I+ ++ G + F ++ ++ + K+
Sbjct: 196 VILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 7e-16
Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 35/204 (17%)
Query: 16 GRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
R +G G F +V N T VA+K L K + E +E MK ++H +V
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTT--KVAVKTL-KPGTMS---PEAFLQEAQIMKKLRHDKLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR-YFQQLI-------NAVDY 126
+LY V + I+IV E+++ G L D +K E ++ QL+ + Y
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP---NYVAP 182
SR HRDL N+L+ K++DFGL+ L + DD +T G + AP
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFPIKWTAP 173
Query: 183 EVLNDRGYDGST--ADLWSCGVIL 204
E N Y T +D+WS G++L
Sbjct: 174 EAAN---YGRFTIKSDVWSFGILL 194
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-16
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 14 EVGRTIGEGTFAKV-KFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+GR IGEG F V + S E VA+K + E+ +E M+ H
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDH 66
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHS 129
P++V+L V+ ++ ++IV+E GEL + VN + Y QL A+ Y S
Sbjct: 67 PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLND 187
+ HRD+ N+L+ + +K+ DFGLS + D+ + G P ++APE +N
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY---LEDESYYKASKGKLPIKWMAPESINF 182
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPF 214
R + S +D+W GV ++ +L+ G PF
Sbjct: 183 RRFT-SASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 1e-15
Identities = 64/269 (23%), Positives = 124/269 (46%), Gaps = 39/269 (14%)
Query: 1 MSQPKIKRR---VGKYEVGRTIGEGTFAKV---------------KFARNSETGEPVALK 42
++Q K+K + + V + G F K+ + ++ G+P +
Sbjct: 135 LAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCER 194
Query: 43 ILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV---LEFVTGGELF 99
++ K + A Q++ E+ + + H N++++ E++ S+ +++ +F ++
Sbjct: 195 LIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMY 254
Query: 100 DKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
D+ + R + R +QL+ AV+Y H + + HRD+K EN+ L+ G + + DFG +
Sbjct: 255 DEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 159 AL---SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214
++ D G + GT +PE+L GY T D+WSCG+IL +L+ + P
Sbjct: 315 MPFEKEREAFDYGWV----GTVATNSPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPI 369
Query: 215 DDS------NLMNLYKKISAA--EFTCPP 235
D L+ + +S EF PP
Sbjct: 370 GDGGGKPGKQLLKIIDSLSVCDEEFPDPP 398
|
Length = 501 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 32/216 (14%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V A+ GE VA+K +++ ++ ++ + E + MK
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--------RYFQ 118
+VVRL V+ + +V+E + G+L + + R + + ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQ 123
Query: 119 ---QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL---SQQVRDDG--LL 170
++ + + Y ++ HRDL N ++ +K+ DFG++ + R G LL
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 171 HTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILF 205
P ++APE L D G + +D+WS GV+L+
Sbjct: 184 ------PVRWMAPESLKD-GVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-15
Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY 77
+G G V A + T +A+K++ + ++ + +QI E+ + P ++ Y
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFY 65
Query: 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
+ +I I EF+ GG L D + ++ E R ++ + Y S + HRD+
Sbjct: 66 GAFFVENRISICTEFMDGGSL-DV---YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDV 121
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADL 197
KP N+L++ G +K+ DFG+S +Q V + + T GT Y+APE ++ Y G +D+
Sbjct: 122 KPSNMLVNTRGQVKLCDFGVS--TQLV--NSIAKTYVGTNAYMAPERISGEQY-GIHSDV 176
Query: 198 WSCGVILFVLLAGYLPF 214
WS G+ L G P+
Sbjct: 177 WSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 8/202 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 64
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-G 131
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L Y
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTHYS 180
Query: 192 GSTADLWSCGVILFVLLAGYLP 213
+D+WS G+ L + G P
Sbjct: 181 -VQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 5e-15
Identities = 50/223 (22%), Positives = 102/223 (45%), Gaps = 19/223 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+ + V A++ T VA+K ++ + + + +++E+ T + ++HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPN 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHS 129
++ +++++V + G D + H G + E + ++NA+DY HS
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHS 119
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-------NYVAP 182
+G HR +K ++LL G + +S GL ++ P +++P
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSP 177
Query: 183 EVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223
EVL N +GY+ +D++S G+ L G++PF D +
Sbjct: 178 EVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-15
Identities = 60/235 (25%), Positives = 109/235 (46%), Gaps = 19/235 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNHK 76
Query: 72 NVVRLYEVMGSKTK------IFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLINA 123
N++ L V + +++V+E + ++ ++H RM Q++
Sbjct: 77 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS-----YLLYQMLCG 131
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPE 188
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWL 237
V+ GY D+WS G I+ ++ + F + ++ + K+ T CP ++
Sbjct: 189 VILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-14
Identities = 64/231 (27%), Positives = 105/231 (45%), Gaps = 18/231 (7%)
Query: 17 RTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ IG G F +V R G+ PVA+K L K + E + M HPN+
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHPNI 67
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV 132
+ L V+ + IV E++ G L + H G+ + + + + + Y G
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY 127
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL N+L+++ KVSDFGLS + + D +TT G + APE + R
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS-----AAEFTCP 234
+ S +D+WS G++++ V+ G P+ + + ++ K I A CP
Sbjct: 186 FT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCP 235
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 17/211 (8%)
Query: 19 IGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
IG G V AR TGE V ++ ++ E ++M ++ E+ KL HPN+V
Sbjct: 6 IGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPY 64
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYH 134
+ ++++V F+ G D I H M E Q ++ A+DY H G H
Sbjct: 65 RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVH 124
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-------VAPEVL-- 185
R +K ++L+ G + +S GL + + L P Y ++PEVL
Sbjct: 125 RSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ 182
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216
N +GYD + +D++S G+ L G++PF D
Sbjct: 183 NLQGYD-AKSDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-14
Identities = 65/232 (28%), Positives = 104/232 (44%), Gaps = 26/232 (11%)
Query: 19 IGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKR----EVATMKLVKHP 71
IG G F +V R G+ VA+K LK E+ +R E + M HP
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIK------TLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHS 129
N++ L V+ + I+ EF+ G L D + N G+ + + + + Y
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLN 186
HRDL N+L+++ KVSDFGLS + D ++ G + APE +
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 187 DRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE--FTCPP 235
R + S +D+WS G++++ V+ G P+ D M+ I+A E + PP
Sbjct: 185 YRKFT-SASDVWSYGIVMWEVMSYGERPYWD---MSNQDVINAIEQDYRLPP 232
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-14
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 15/228 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F V E + VA+K + +E + E E M + HP +V+LY
Sbjct: 12 IGSGQFGLVWLGYWLEKRK-VAIKTI-REGAMSE---EDFIEEAQVMMKLSHPKLVQLYG 66
Query: 79 VMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL 137
V ++ I +V EF+ G L D + G+ ++ + + Y S V HRDL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 138 KPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGYDGST 194
N L+ +KVSDFG++ V DD +T GT + +PEV + Y S
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRF---VLDDQYTSST-GTKFPVKWSSPEVFSFSKYS-SK 181
Query: 195 ADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
+D+WS GV+++ V G P+++ + + + I+A P L+ +
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS 229
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-14
Identities = 60/222 (27%), Positives = 108/222 (48%), Gaps = 26/222 (11%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +GR +G+G F V+ A+ + + VA+K+L K + E+ RE A MK
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 70 HPNVVRLYEV-MGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI-- 121
HPNV++L V + S+ K ++L F+ G+L ++ R+ E+ Q L+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRF 118
Query: 122 -----NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
+ ++Y S+ HRDL N +L+ + V+DFG LS+++ C +
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFG---LSKKIYSGDYYRQGCAS 175
Query: 177 P---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++A E L D Y + +D+W+ GV ++ ++ G P+
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 5e-14
Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 31/219 (14%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI-----KREV----AT 64
EV +G G + V R+ TG +A+K ++ + KR + +
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVK----------RIRATVNSQEQKRLLMDLDIS 53
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG--ELFDKIVNHG-RMKEDEARRYFQQLI 121
M+ V P V Y + + ++I +E + + + K+ + G + ED + ++
Sbjct: 54 MRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIV 113
Query: 122 NAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
A++Y HS+ V HRD+KP N+L++ G +K+ DFG+S + D G Y+
Sbjct: 114 KALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYM 170
Query: 181 APE----VLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215
APE LN +GYD +D+WS G+ + L G P+D
Sbjct: 171 APERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 9e-14
Identities = 55/221 (24%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALK----ILDKEKVLKHKMAEQIKREV-ATMKLVKHPNV 73
IG G F V + +G +A+K +D+ K +++ ++ M+ P +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE------KEQKRLLMDLDVVMRSSDCPYI 65
Query: 74 VRLYEVMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG- 131
V+ Y + + +I +E + + F K V + +K ++++ + +
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYV-YEVLK----SVIPEEILGKIAVATVKAL 120
Query: 132 --------VYHRDLKPENLLLDAYGNLKVSDFGLSALSQ----QVRDDGLLHTTCGTPNY 179
+ HRD+KP N+LLD GN+K+ DFG+S + RD G C P Y
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG-----C-RP-Y 173
Query: 180 VAPEVLNDRGYDGS--TADLWSCGVILFVLLAGYLPFDDSN 218
+APE ++ DG +D+WS G+ L+ + G P+ N
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 39/223 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEP-----VALKILDKEKVLKHKMAEQIKREVATMK 66
+ +G+ +GEG F +V A P VA+K+L K+ + +++ + E+ MK
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVS-EMEMMK 70
Query: 67 LV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ------- 118
++ KH N++ L V + +++V+E+ G L D + R + A
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETL 129
Query: 119 ----------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-- 166
Q+ +++ S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIH 183
Query: 167 --DGLLHTTCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILF 205
D TT G P ++APE L DR Y + D+WS GV+L+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQS-DVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 24/204 (11%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G V + +G +A K++ E +K + QI RE+ + P +V Y
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYG 66
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG------- 131
S +I I +E + GG L D+++ +A R + ++ + RG
Sbjct: 67 AFYSDGEISICMEHMDGGSL-DQVLK-------KAGRIPENILGKISIAVLRGLTYLREK 118
Query: 132 --VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRD+KP N+L+++ G +K+ DFG+S Q + D + ++ GT +Y++PE L
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLI--DSMANSFVGTRSYMSPERLQGTH 174
Query: 190 YDGSTADLWSCGVILFVLLAGYLP 213
Y + D+WS G+ L + G P
Sbjct: 175 YTVQS-DIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-13
Identities = 60/222 (27%), Positives = 97/222 (43%), Gaps = 30/222 (13%)
Query: 15 VGRTIGEGTFAKVKFAR-NSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+G+ +GEG F V + + + G VA+K + K + + E+ E A MK HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHP 61
Query: 72 NVVRLYEV---MGSKTKI---FIVLEFVTGGELFDKIVNHGRMKEDEARRYF--QQLIN- 122
NV++L V S KI ++L F+ G+L ++ + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL---YSRLGGLPEKLPLQTLLKF 118
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
VD Y +R HRDL N +L + V+DFG LS+++
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFG---LSKKIYSGDYYRQGRIA 175
Query: 177 P---NYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++A E L DR Y S +D+W+ GV ++ + G P+
Sbjct: 176 KMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 1 MSQPKIKRRVGK-YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
M I R K Y++G IG G+F V A +T E VA+K KVL+ +
Sbjct: 55 MIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK-----KVLQDPQYKN-- 107
Query: 60 REVATMKLVKHPNVVRLYE------VMGSKTKIF--IVLEFVTGGELFDKIVNHGRMKED 111
RE+ MK + H N++ L + ++ IF +V+EF+ + K + H
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP--QTVHKYMKHYARNNH 165
Query: 112 E-----ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVR 165
+ Y QL A+ Y HS+ + HRDLKP+NLL+D + LK+ DFG + +
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLA 223
Query: 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+ C + Y APE++ + DLWS G I+ ++ GY F
Sbjct: 224 GQRSVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF 271
|
Length = 440 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-13
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 17 RTIGEGTFAKV--KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F +V + NS VA+K L + E E MK ++H +V
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTK---VAVKTLKPGTMSVQAFLE----EANLMKTLQHDKLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RLY V+ + I+I+ E++ G L D K G++ + + Q+ + Y +
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRG 189
HRDL+ N+L+ K++DFGL+ +V +D G + APE +N G
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAIN-FG 179
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPF 214
+D+WS G++L+ ++ G +P+
Sbjct: 180 SFTIKSDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 30/88 (34%), Positives = 52/88 (59%), Gaps = 1/88 (1%)
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
+QL++A+DY H G+ HRD+K EN+L++ ++ + DFG + ++ + GT
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILF 205
+ APEVL Y + D+WS G+++F
Sbjct: 327 DTNAPEVLAGDPYT-PSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-12
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
+YE G +G GT+ V A+ + + +KE LK I RE+A ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKD-------EKEYALKQIEGTGISMSACREIALLRE 54
Query: 68 VKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDE---------ARRY 116
+KHPNV+ L +V S + K++++ ++ +L+ I H K ++ +
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSL 113
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSAL-SQQVRDDGLLH 171
Q+++ + Y H+ V HRDLKP N+L+ G +K++D G + L + ++ L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208
T Y APE+L + D+W+ G I LL
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-12
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 17 RTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
R +G G F +V N+ T PVA+K L K + + E MK ++HP +++
Sbjct: 12 RKLGAGQFGEVWEGLWNNTT--PVAVKTL-KPGTMD---PKDFLAEAQIMKKLRHPKLIQ 65
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVY 133
LY V + I+IV E + G L + + +K + Q+ + + Y ++
Sbjct: 66 LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI 125
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLNDRGY 190
HRDL N+L+ KV+DFGL+ +V + + G + APE Y
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLA----RVIKEDIYEAREGAKFPIKWTAPEAAL---Y 178
Query: 191 DGST--ADLWSCGVILFVLLA-GYLPF 214
+ + +D+WS G++L ++ G +P+
Sbjct: 179 NRFSIKSDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 65/248 (26%), Positives = 101/248 (40%), Gaps = 40/248 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSE-TGEP----VALKILDKEKVLKHKMAEQIKREVATMK 66
+G+T+GEG F KV A G VA+K+L + + E +K
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRD--LLSEFNLLK 58
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL----------------FDKIVNHGRMKE 110
V HP+V++LY + +++E+ G L D N +
Sbjct: 59 QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 111 DEAR--------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ R + Q+ + Y + HRDL N+L+ +K+SDFGLS
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RD 176
Query: 163 QVRDDGLLHTTCG-TP-NYVAPEVLNDRGYDGSTADLWSCGVILF--VLLAG--YLPFDD 216
+D + + G P ++A E L D Y + +D+WS GV+L+ V L G Y
Sbjct: 177 VYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
Query: 217 SNLMNLYK 224
L NL K
Sbjct: 236 ERLFNLLK 243
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-12
Identities = 54/246 (21%), Positives = 101/246 (41%), Gaps = 30/246 (12%)
Query: 19 IGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+GEG F KV + VA+K L + K + ++ ++E M ++HPN+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQEAELMSDLQHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ--------------- 118
V L V + ++ E++ G+L + +V + + A +
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
Q+ ++Y S HRDL N L+ +K+SDFGLS + +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPV 190
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLYKK--ISAAEF 231
++ PE + G + +D+WS GV+L+ + L Y F + ++ + + +
Sbjct: 191 RWMPPEAIL-YGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPE 249
Query: 232 TCPPWL 237
CP +
Sbjct: 250 DCPARV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-12
Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 31/217 (14%)
Query: 15 VGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
+G+ +GEG F +V A + VA+K+L K+ +A+ I E+ MKL
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-KDNATDKDLADLIS-EMELMKL 73
Query: 68 V-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI---------VNHGRMKEDEARRYF 117
+ KH N++ L V + +++++E+ G L + + K E + F
Sbjct: 74 IGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSF 133
Query: 118 QQLINAV-------DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170
+ L++ +Y SR HRDL N+L+ +K++DFGL+ + D
Sbjct: 134 KDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI--DYYK 191
Query: 171 HTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
T+ G ++APE L DR Y +D+WS G++++
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 29/217 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKL 67
+YE G +G GT+ V A+ + + D++ LK I RE+A ++
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKRKDGKD-------DRDYALKQIEGTGISMSACREIALLRE 54
Query: 68 VKHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGRMKEDE---------ARRY 116
+KHPNV+ L +V S K++++ ++ +L+ I H K ++ +
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSAL-SQQVRDDGLLH 171
Q+++ + Y H+ V HRDLKP N+L+ G +K++D G + L + ++ L
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208
T Y APE+L + D+W+ G I LL
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 36/252 (14%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEP--VALKILDKEKVLKHKM 54
+ PK + + +G+ +GEG F +V A + +P VA+K+L + K
Sbjct: 3 ADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKD 60
Query: 55 AEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------FDKI 102
+ E+ MK++ KH N++ L +++++E+ + G L D
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 103 VNHGRMKEDEARRYFQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155
+ ++ E++ F+ L++ ++Y S+ HRDL N+L+ +K++DF
Sbjct: 121 FDTCKLPEEQLT--FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 156 GLSALSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYL 212
GL+ + D TT G ++APE L DR Y +D+WS GV+L+ + G
Sbjct: 179 GLARDVHNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGS 235
Query: 213 PFDDSNLMNLYK 224
P+ + L+K
Sbjct: 236 PYPGIPVEELFK 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 17 RTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+ +G G F +V A N T VA+K + + E E MK ++H +V+
Sbjct: 12 KKLGAGQFGEVWMATYNKHT--KVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVK 65
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR--------YFQQLINAVDYC 127
L+ V+ +K I+I+ EF+ G L D +K DE + + Q+ + +
Sbjct: 66 LHAVV-TKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMAFI 118
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLN 186
R HRDL+ N+L+ A K++DFGL+ + + ++ P + APE +N
Sbjct: 119 EQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAIN 176
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPF 214
G +D+WS G++L ++ G +P+
Sbjct: 177 -FGSFTIKSDVWSFGILLMEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+K L + K ++I E M V +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ----QLINAVDYCH 128
V RL + + T + ++ + + G L D + H K++ +Y Q+ ++Y
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLE 126
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLN 186
R + HRDL N+L+ ++K++DFGL+ L D+ H G P ++A E +
Sbjct: 127 ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKWMALESIL 184
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFD 215
R Y +D+WS GV ++ L+ G P+D
Sbjct: 185 HRIYT-HQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 2/155 (1%)
Query: 60 REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
RE+ +K + H ++ L K+ + +V+ +LF + G + ++A ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
L+ A+ Y H RG+ HRD+K EN+ LD N + DFG + D + GT
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+PE+L Y T D+WS G++LF + +
Sbjct: 254 NSPELLALDPYCAKT-DIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-11
Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V AR + G L++ K +K ++ R+ A KL HPN+
Sbjct: 3 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA----------------RRYF 117
+ L + +++ +E+ G L D + ++ D A +
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+ +DY + HRDL N+L+ K++DFGLS + + T G
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-----GQEVYVKKTMGRL 173
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 174 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-11
Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 24/234 (10%)
Query: 17 RTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ IG G F +V K E VA+K L K + + E + M H
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEV--AVAIKTLKPGYTEKQR--QDFLSEASIMGQFSHH 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHS 129
N++RL V+ I+ E++ G L DK + + G + + + + Y
Sbjct: 67 NIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP---NYVAPEVLN 186
HRDL N+L+++ KVSDFGLS + + D +TT G + APE +
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 187 DRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS-----AAEFTCP 234
R + S +D+WS G++++ V+ G P+ D + + K I+ A CP
Sbjct: 184 YRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCP 236
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 62/241 (25%), Positives = 112/241 (46%), Gaps = 40/241 (16%)
Query: 15 VGRTIGEGTFAKVKFAR--NSETGEP-----VALKILDKEKVLKHKMAEQIKREVATMKL 67
+G+ +GEG F +V A + +P VA+K+L K + +++ I E+ MK+
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEMMKM 79
Query: 68 V-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------- 116
+ KH N++ L +++++E+ + G L + + R + Y
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYCYNPTQVPEE 135
Query: 117 ---FQQLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
F+ L++ ++Y S+ HRDL N+L+ +K++DFGL+ +
Sbjct: 136 QLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-- 193
Query: 167 DGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLY 223
D TT G ++APE L DR Y +D+WS GV+L+ + G P+ + L+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
Query: 224 K 224
K
Sbjct: 253 K 253
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-11
Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 6/190 (3%)
Query: 19 IGEGTFAKVK--FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F VK + ++ + VA+KIL K + +++ RE M+ + +P +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ +++ +V+E G L + + + E Q+ + Y HRD
Sbjct: 62 IGICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGSTA 195
L N+LL K+SDFGLS + T P + APE +N + S +
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS-SKS 179
Query: 196 DLWSCGVILF 205
D+WS GV+++
Sbjct: 180 DVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-11
Identities = 60/248 (24%), Positives = 113/248 (45%), Gaps = 32/248 (12%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAE 56
P+ + K +G+ +GEG F +V A + VA+K+L K+ + +++
Sbjct: 8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSD 66
Query: 57 QIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI------------- 102
+ E+ MK++ KH N++ L +++++E+ + G L + +
Sbjct: 67 LVS-EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125
Query: 103 ---VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
V +M + Q+ ++Y S+ HRDL N+L+ +K++DFGL+
Sbjct: 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 160 LSQQVRDDGLLHTTCG--TPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
+ D TT G ++APE L DR Y +D+WS GV+++ + G P+
Sbjct: 186 DVNNI--DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPG 242
Query: 217 SNLMNLYK 224
+ L+K
Sbjct: 243 IPVEELFK 250
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-11
Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
E+GR G V AR++ TG V ++I D E + + + ++ EV +HPN+
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNI 61
Query: 74 VRLYEVMGSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
+ + V + + ++++ F+ G L G M E + ++Y H
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQN 120
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY-------VAPE 183
G HR++K ++L+ G + +S GLS L VR+ P + ++PE
Sbjct: 121 GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 184 VLND--RGYDGSTADLWSCGVILFVLLAGYLPFDD 216
+L GY+ +D++S G+ L G +PF D
Sbjct: 179 LLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 15 VGRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+T+GEG F V + ++ VA+K + + +M E E MK HPN
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPN 61
Query: 73 VVRLYEV--MGSKTKIF----IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI----- 121
V+RL V +++ + ++L F+ G+L ++ + R+ + Q L+
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTD 120
Query: 122 --NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA------LSQQVRDDGLLHTT 173
+ ++Y S+ HRDL N +L+ N+ V+DFGLS +Q R +
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM---- 176
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
++A E L DR Y + +D+WS GV ++
Sbjct: 177 --PVKWIAIESLADRVYT-TKSDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 59/232 (25%), Positives = 101/232 (43%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V A + G + I K+LK +E R+ A KL HPN+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAI----KMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA----------------RRYF 117
+ L ++ ++I +E+ G L D + ++ D A ++
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+ + Y + HRDL N+L+ K++DFGLS ++ + T G
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR-----GEEVYVKKTMGRL 180
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 3e-10
Identities = 64/257 (24%), Positives = 102/257 (39%), Gaps = 29/257 (11%)
Query: 18 TIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
T+G G F +V A+ E V +K L K K + +RE+ + + H N
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE--FRRELDMFRKLSHKN 69
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGEL--FDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
VVRL + +++LE+ G+L F + K +Q + A+ +
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV-ALCTQIAL 128
Query: 131 GV--------YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
G+ HRDL N L+ + +KVS LS + P ++A
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLRWLA 186
Query: 182 PEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF----DDSNLMNLYKKISAAEFTCPPW 236
PE + + + + D+WS GV+++ V G LPF D+ L L + E P
Sbjct: 187 PEAVQEDDFSTKS-DVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL--QAGKLELPVPEG 243
Query: 237 LSFTARKLIARILDPNP 253
KL+ R NP
Sbjct: 244 CPSRLYKLMTRCWAVNP 260
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-10
Identities = 53/204 (25%), Positives = 97/204 (47%), Gaps = 17/204 (8%)
Query: 17 RTIGEGTFAKV--KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F +V + VA+K L K+ + E E MK ++HP +V
Sbjct: 12 KKLGAGQFGEVWMGYYNGHTK---VAIKSL-KQGSMS---PEAFLAEANLMKQLQHPRLV 64
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
RLY V+ ++ I+I+ E++ G L D K ++ ++ Q+ + + +
Sbjct: 65 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYD 191
HRDL+ N+L+ K++DFGL+ L + ++ P + APE +N G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAIN-YGTF 180
Query: 192 GSTADLWSCGVILF-VLLAGYLPF 214
+D+WS G++L ++ G +P+
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 38/216 (17%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK----REVATMKLVKHPN 72
R +GEG F KV F EP K L K LK + + RE + +H N
Sbjct: 11 RELGEGAFGKV-FLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-------MKEDEAR-------RYFQ 118
+V+ Y V +V E++ G+L + +HG +
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT----- 173
Q+ + + Y S+ HRDL N L+ +K+ DFG+S RD ++TT
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTTDYYRV 180
Query: 174 CGTP----NYVAPEVLNDRGYDGSTADLWSCGVILF 205
G ++ PE + R + + +D+WS GV+L+
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-09
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 20/214 (9%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMKLVKHPNVVRL 76
IG G F KV + G A +++ KE EQ+ +EV + + HPNV++
Sbjct: 3 IGNGWFGKV-LLGEAHRGMSKA-RVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQL----INAVDYCHSRG 131
+VLEF G+L + + N G + + + Q++ + + + H
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC-GTP-NYVAPEVLNDRG 189
H DL N L A ++K+ D+GL AL Q +D + C P ++APE++ RG
Sbjct: 121 FIHSDLALRNCQLTADLSVKIGDYGL-ALE-QYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 190 YDGSTAD------LWSCGVILFVLL-AGYLPFDD 216
D D +WS GV ++ L A P+ D
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-09
Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 27/221 (12%)
Query: 14 EVGRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ R +G G F +V VA+K L + + E M
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIMSKF 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-FQQLIN-AVD- 125
H N+VRL V + FI+LE + GG+L + R + + + L+ A D
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDL-KSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 126 -----YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSA---LSQQVRDDGLLHTTC 174
Y HRD+ N LL G K++DFG++ + R G
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG---RAM 182
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++ PE D G S D+WS GV+L+ + GY+P+
Sbjct: 183 LPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+KIL++ K + + E M + HP+
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV--EFMDEALIMASMDHPH 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+VRL V S T I +V + + G L D + H + + Q+ + Y R
Sbjct: 71 LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP--NYVAPEVLNDRG 189
+ HRDL N+L+ + ++K++DFGL+ L + D+ + G ++A E ++ R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEG--DEKEYNADGGKMPIKWMALECIHYRK 187
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFD 215
+ +D+WS GV ++ L+ G P+D
Sbjct: 188 FT-HQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 63/232 (27%), Positives = 105/232 (45%), Gaps = 34/232 (14%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-----TMKLVKHPNV 73
IGEG F +V AR + G L++ K +K ++ R+ A KL HPN+
Sbjct: 15 IGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEA---------RRYFQQLIN-- 122
+ L + +++ +E+ G L D + ++ D A QQL++
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 123 -----AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-- 175
+DY + HRDL N+L+ K++DFGLS Q+V + T G
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR-GQEV----YVKKTMGRL 185
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 186 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 29/222 (13%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREV 62
IKRR + R +GEG F KV F P K+L K LK + +RE
Sbjct: 2 IKRR--DIVLKRELGEGAFGKV-FLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREA 58
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------------- 106
+ ++H ++V+ Y V G + +V E++ G+L + HG
Sbjct: 59 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 107 RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQ 163
+ + Q+ + + Y S+ HRDL N L+ A +K+ DFG+S +
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
R G HT ++ PE + R + + +D+WS GVIL+
Sbjct: 179 YRVGG--HTMLPI-RWMPPESIMYRKFT-TESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 44/242 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++++ +GEGTF KV A + + E A+KI+ V K+ +I E+ M+ V+
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIV--RNVPKYTRDAKI--EIQFMEKVRQ 184
Query: 71 PNVVRLYEVM-------GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI-- 121
+ + +M + IV+ G L D I+ HG R+ Q+I
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMP-KYGPCLLDWIMKHGPFSH----RHLAQIIFQ 239
Query: 122 --NAVDYCHSR-GVYHRDLKPENLLLDAYGN----------------LKVSDFGLSALSQ 162
A+DY H+ + H DLKPEN+L++ +++ D G +
Sbjct: 240 TGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER 299
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMN 221
R T +Y +PEV+ G+ ST D+WS G I++ L G L +D NL +
Sbjct: 300 HSRT-----AIVSTRHYRSPEVVLGLGWMYST-DMWSMGCIIYELYTGKLLYDTHDNLEH 353
Query: 222 LY 223
L+
Sbjct: 354 LH 355
|
Length = 467 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-09
Identities = 49/175 (28%), Positives = 70/175 (40%), Gaps = 29/175 (16%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSE--TGEP---VALKILDKEKVLKHKMAEQIKREVATM 65
E R IG+G F +V AR EP VA+K+L +E M +RE A M
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASAD--MQADFQREAALM 62
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-------KIVNHGRMKEDEARRYFQ 118
HPN+V+L V + ++ E++ G+L + + AR+
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 119 ---------QLINAVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
QL A Y R HRDL N L+ +K++DFGLS
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-09
Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 24/208 (11%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNV 73
R +GEG F KV A P KIL K LK + RE + ++H ++
Sbjct: 11 RELGEGAFGKVFLAECYNLC-PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------RMKEDEARRYFQQL 120
V+ Y V + +V E++ G+L + HG + + + QQ+
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQQVRDDGLLHTTCGTP 177
+ Y S+ HRDL N L+ +K+ DFG+S + R G HT
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPI- 186
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILF 205
++ PE + R + + +D+WS GV+L+
Sbjct: 187 RWMPPESIMYRKFT-TESDVWSLGVVLW 213
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-09
Identities = 54/235 (22%), Positives = 99/235 (42%), Gaps = 22/235 (9%)
Query: 17 RTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +G G F ++ K E PVA+ L K + E T+ H
Sbjct: 11 RILGTGRFGELCRGCLKLPSKREL--PVAIHTLRAGCSDKQRRG--FLAEALTLGQFDHS 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
N+VRL V+ + IV E+++ G L + H G++ + L + + Y
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN--YVAPEVLNDR 188
G H+ L +L+++ K+S F Q+ + + + T G + APE +
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEAIQ-Y 182
Query: 189 GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-----AAEFTCPPWL 237
+ S +D+WS G++++ +++ G P+ D + ++ K + A CP L
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLL 237
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-09
Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G+G F +V + T + VA+K L + M E +E MK ++H +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYA 68
Query: 79 VMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
V+ S+ I+IV EF+ G L D K + +K + Q+ + + Y HRD
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGSTA 195
L+ N+L+ K++DFGL+ L + ++ P + APE G +
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTIKS 184
Query: 196 DLWSCGVILFVLLA-GYLPF 214
D+WS G++L L+ G +P+
Sbjct: 185 DVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 14/207 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F V GE PVA+K+L + K ++I E M V P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPY 70
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
V RL + + T + +V + + G L D + + R+ + + Q+ + Y
Sbjct: 71 VCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLNDRG 189
+ HRDL N+L+ + ++K++DFGL+ L D+ H G P ++A E + R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILHRR 187
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFD 215
+ +D+WS GV ++ L+ G P+D
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 40/220 (18%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V AR+ GE VA+K +++ L+ ++ + E + MK
Sbjct: 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELF--------DKIVNHGRMKE--DEARRY 116
+VVRL V+ +V+E + G+L + N GR E +
Sbjct: 65 GFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
++ + + Y +++ HRDL N ++ +K+ DFG++ RD
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIYETDYYRKG 178
Query: 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
GLL ++APE L D G +++D+WS GV+L+
Sbjct: 179 GKGLLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 15/214 (7%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
+I R + EV +G+G F +V + T VA+K L + E +E
Sbjct: 2 EIPRESLRLEV--KLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTM----SPEAFLQEAQV 54
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLIN 122
MK ++H +V+LY V+ S+ I+IV E+++ G L D K ++ + Q+ +
Sbjct: 55 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVA 181
+ Y HRDL+ N+L+ KV+DFGL+ L + ++ P + A
Sbjct: 114 GMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTA 171
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214
PE G +D+WS G++L L G +P+
Sbjct: 172 PEAAL-YGRFTIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 40/249 (16%)
Query: 19 IGEGTFAKVK----FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+GE F K+ + + + VA+K L + + ++E + M + HPN+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ--WGEFQQEASLMAELHHPNIV 70
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIV-------------NHGRMKEDEARRYFQ--- 118
L V+ + + ++ E++ G+L + ++ G +K F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-----SALSQQVRDDGLLHT 172
Q+ ++Y S H+DL N+L+ ++K+SD GL SA +V+ LL
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLYKK--I 226
++ PE + G S +D+WS GV+L+ + L Y F + ++ + +K +
Sbjct: 191 -----RWMPPEAIM-YGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244
Query: 227 SAAEFTCPP 235
CPP
Sbjct: 245 LPCSEDCPP 253
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 55/198 (27%), Positives = 90/198 (45%), Gaps = 22/198 (11%)
Query: 19 IGEGTFAKVK--FARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F VK + + VA+K+L E + + +++ RE M + +P +VR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-----RYFQQLINAVDYCHSRG 131
V ++ + +V+E +GG L + K+DE Q+ + Y +
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSG----KKDEITVSNVVELMHQVSMGMKYLEGKN 115
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTP---NYVAPEVLND 187
HRDL N+LL K+SDFGLS AL DD + APE +N
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINF 172
Query: 188 RGYDGSTADLWSCGVILF 205
R + S +D+WS G+ ++
Sbjct: 173 RKFS-SRSDVWSYGITMW 189
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-08
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 14/223 (6%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G G F +V + + VA+K L + E E MK ++H +V+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTK-VAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQL 66
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVN-HGR-MKEDEARRYFQQLINAVDYCHSRGVYH 134
Y V+ S+ I+IV E+++ G L D + + GR +K Q+ + Y H
Sbjct: 67 YAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIH 125
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRGYDGS 193
RDL+ N+L+ K++DFGL+ L + ++ P + APE G
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAAL-YGRFTI 182
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCP 234
+D+WS G++L L+ G +P+ N + +++ CP
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCP 225
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 36/155 (23%), Positives = 73/155 (47%), Gaps = 11/155 (7%)
Query: 61 EVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY 116
E ++ + HP++++L G+ K I+ + T +L+ + + +
Sbjct: 133 EAHILRAINHPSIIQL---KGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAI 187
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
+ ++ A+ Y H + HRD+K EN+ ++ G++ + DFG + + + + GT
Sbjct: 188 ERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGT 246
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY 211
APE+L Y G D+WS G++LF + +
Sbjct: 247 IATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 34/223 (15%)
Query: 17 RTIGEGTFAKV------KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+G G F +V VA+K L K + K E +K E M H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLK-EAHLMSNFNH 58
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVDYCHS 129
PN+V+L V +I++E + GG+L + + + ++L++ +D
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 130 RGVY-------HRDLKPENLLLDAYGN-----LKVSDFGL-----SALSQQVRDDGLLHT 172
VY HRDL N L+ G +K+ DFGL + + +GLL
Sbjct: 119 -CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPF 214
++APE L D G + +D+WS GV+++ +L G P+
Sbjct: 178 -----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 35/219 (15%)
Query: 21 EGTFAKVKFAR-NSETG---EPVALKILDKEKVLKHKMAEQIKR---EVATMKLVKHPNV 73
EGTF ++ + E E V +K V H Q+ E + + H N+
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVK-----TVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 74 VRLYEVMGSKT-KIFIVLEFVTGGEL--FDKIVNHGRMKEDEARRYFQ------QLINAV 124
+ + V F++ ++ G L F + G +A Q Q+ +
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGM 130
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN------ 178
Y H RGV H+D+ N ++D +K++D +ALS RD + C N
Sbjct: 131 SYLHKRGVIHKDIAARNCVIDEELQVKITD---NALS---RDLFPMDYHCLGDNENRPVK 184
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDD 216
++A E L ++ Y S +D+WS GV+L+ L+ G P+ +
Sbjct: 185 WMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 61/223 (27%), Positives = 97/223 (43%), Gaps = 32/223 (14%)
Query: 6 IKRR--VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK---HKMAEQIKR 60
IKRR V K+E +GEG F KV A P K+L K LK + +R
Sbjct: 2 IKRRDIVLKWE----LGEGAFGKVFLAECHNL-LPEQDKMLVAVKALKEASESARQDFQR 56
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRY 116
E + +++H ++VR Y V + +V E++ G+L + +HG + E
Sbjct: 57 EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116
Query: 117 FQ-----------QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA---LSQ 162
Q Q+ + + Y S HRDL N L+ +K+ DFG+S +
Sbjct: 117 GQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
R G T ++ PE + R + + +D+WS GV+L+
Sbjct: 177 YYRVGG---RTMLPIRWMPPESILYRKFT-TESDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-07
Identities = 60/213 (28%), Positives = 99/213 (46%), Gaps = 17/213 (7%)
Query: 17 RTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
R IG+G F V + A+K L++ L+ EQ +E MK HPNV
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEE--VEQFLKEGIIMKDFSHPNV 58
Query: 74 VRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAVDYCHSRG 131
+ L + S+ +VL ++ G+L + I + + F Q+ ++Y S+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK 118
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL----HTTCGTP-NYVAPEVLN 186
HRDL N +LD +KV+DFG L++ + D HT P ++A E L
Sbjct: 119 FVHRDLAARNCMLDESFTVKVADFG---LARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218
+ + + +D+WS GV+L+ L+ G P+ D +
Sbjct: 176 TQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 32/168 (19%)
Query: 19 IGEGTFAKVKFAR------------NSETGEP--VALKIL--DKEKVLKHKMAEQIKREV 62
+GEG F +V G+P VA+K+L D K ++ ++IK
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK--- 69
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL------------FDKIVNHGRMKE 110
M +K+PN++RL V S + ++ E++ G+L F N +
Sbjct: 70 -IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSI 128
Query: 111 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
Q+ + + Y S HRDL N L+ + +K++DFG+S
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-07
Identities = 56/246 (22%), Positives = 109/246 (44%), Gaps = 30/246 (12%)
Query: 19 IGEGTFAKVKFAR--NSETGEP---VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+GE F KV + GE VA+K L K+K + + E+ K E ++HPN+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIV------NHGRMKED-------EARRYFQ-- 118
V L V+ + + ++ + + +L + +V + G +D E +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 119 -QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
Q+ +++ S V H+DL N+L+ N+K+SD GL L+ +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVL----LAGYLPFDDSNLMNLY--KKISAAEF 231
+++PE + G +D+WS GV+L+ + L Y + + +++ + +++
Sbjct: 191 RWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD 249
Query: 232 TCPPWL 237
CP W+
Sbjct: 250 DCPAWV 255
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 52/220 (23%), Positives = 99/220 (45%), Gaps = 40/220 (18%)
Query: 12 KYEVGRTIGEGTFAKV--KFARNSETGEP---VALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V A+ EP VA+K +++ ++ ++ + E + MK
Sbjct: 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 64
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-------KIVNHGRMKEDEARRYFQ- 118
+VVRL V+ +++E +T G+L ++ N+ ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQM 124
Query: 119 --QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
++ + + Y ++ HRDL N ++ +K+ DFG++ RD
Sbjct: 125 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKG 178
Query: 167 -DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
GLL +++PE L D G + +D+WS GV+L+
Sbjct: 179 GKGLLPV-----RWMSPESLKD-GVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 40/213 (18%)
Query: 17 RTIGEGTFAKVKFARNSETGE----------PVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+GTF + + V LK+L H+ + + M
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS----DHRDSLAFFETASLMS 56
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF----QQLIN 122
+ H ++V+LY V I +V E+V G L D ++ R K + + + +QL +
Sbjct: 57 QLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL-DVFLH--REKNNVSLHWKLDVAKQLAS 112
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGN-------LKVSDFG--LSALSQQVRDDGLLHTT 173
A+ Y + + H ++ +N+L+ YG +K+SD G ++ LS++ R + +
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI---- 168
Query: 174 CGTPNYVAPEVL-NDRGYDGSTADLWSCGVILF 205
P ++APE + N + AD WS G L
Sbjct: 169 ---P-WIAPECIRNGQASLTIAADKWSFGTTLL 197
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-07
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 54/243 (22%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KL 67
G+T+G G F KV A S+ VA+K+L + E + E+ M L
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSER--EALMSELKIMSHL 95
Query: 68 VKHPNVVRLYEVMGSKTK---IFIVLEFVTGGELFDKIVNHGRMKE------DEARRYFQ 118
H N+V L +G+ T I ++ E+ G+L +N R K ++ +
Sbjct: 96 GNHENIVNL---LGACTIGGPILVITEYCCYGDL----LNFLRRKRESFLTLEDLLSFSY 148
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ + + S+ HRDL N+LL +K+ DFGL+ RD +++ + N
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS----N 196
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMN 221
YV APE + + Y +D+WS G++L+ + + G P+ DS
Sbjct: 197 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYK 255
Query: 222 LYK 224
L K
Sbjct: 256 LIK 258
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 30/86 (34%), Positives = 43/86 (50%), Gaps = 12/86 (13%)
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 234
GTP+Y+APE+L + + G D W+ GV LF L G PF+D +++ I +
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDI--- 597
Query: 235 PW------LSFTARKLIARIL--DPN 252
PW LS A+ I +L DP
Sbjct: 598 PWPEGEEKLSVNAQNAIEILLTMDPT 623
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 39/175 (22%), Positives = 67/175 (38%), Gaps = 29/175 (16%)
Query: 11 GKYEVGRTIGEGTFAKV--------------KFARNSETGEP--VALKILDKEKVLKHKM 54
+GEG F +V FA N P VA+K+L + +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAR 63
Query: 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL---------FDKIVNH 105
+ +K EV + + PN+ RL V + +++E++ G+L +
Sbjct: 64 EDFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 106 G-RMKEDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
+ Y Q+ + + Y S HRDL N L+ +K++DFG+S
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-06
Identities = 32/102 (31%), Positives = 48/102 (47%), Gaps = 25/102 (24%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y Q+ +++ SR HRDL N+LL +K+ DFGL+ RD
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYK 225
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
P+YV APE + D+ Y + +D+WS GV+L+
Sbjct: 226 DPDYVRKGDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 266
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 44/201 (21%), Positives = 88/201 (43%), Gaps = 13/201 (6%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA----TMKLVKHP 71
+ +G G F V G+ ++KI K ++ + Q +E+ M + H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGD--SIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA 69
Query: 72 NVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
+VRL + G+ ++ V + G L D + H + + Q+ + Y
Sbjct: 70 YIVRLLGICPGASLQL--VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDR 188
+ HR+L N+LL + ++++DFG++ L D ++ TP ++A E +
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP-DDKKYFYSEHKTPIKWMALESILFG 186
Query: 189 GYDGSTADLWSCGVILFVLLA 209
Y +D+WS GV ++ +++
Sbjct: 187 RYT-HQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR---RYFQQLINAVDYCHSRGV 132
L ++M SK + V + L K+ + + E E + +Q++ A+D HS G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276
Query: 133 YHRDLKPENLLLD-AYGNLKVSDFGLSA 159
HRD+KP+N++ G+ K+ D G +A
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 13/96 (13%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLL 170
Y Q+ +++ SR HRDL N+LL +K+ DFGL+ RD D +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RDIYKDPDYVR 232
Query: 171 HTTCGTP-NYVAPEVLNDRGYDGSTADLWSCGVILF 205
+ P ++APE + D+ Y + +D+WS GV+L+
Sbjct: 233 KGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLW 267
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 34/112 (30%), Positives = 53/112 (47%), Gaps = 26/112 (23%)
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y Q+ +++ SR HRDL N+LL +K+ DFG L++ + D
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG---LARDIYKD-------- 232
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214
P+YV APE + DR Y +D+WS GV+L+ + + G P+
Sbjct: 233 -PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 29/167 (17%)
Query: 19 IGEGTFAKV---------KFARNSETGEP-------VALKILDKEKVLKHKMAEQIKREV 62
+GEG F +V KF + + VA+K+L +E K+ + +K E+
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML-REDANKNARNDFLK-EI 70
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQ 118
M +K PN++RL V + + ++ E++ G+L + H K D +
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 119 QLIN-------AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
LI + Y S HRDL N L+ +K++DFG+S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 42/176 (23%), Positives = 75/176 (42%), Gaps = 39/176 (22%)
Query: 19 IGEGTFAKV--------------KFARNSETGEP--VALKILDKEKVLKHKMAEQIKREV 62
+GEG F +V +F N G P VA+KIL + K+ + +K EV
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKIL-RPDANKNARNDFLK-EV 70
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR-------- 114
+ +K PN++RL V + + ++ E++ G+L ++ ++ + + E
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129
Query: 115 ------------RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
Q+ + + Y S HRDL N L+ +K++DFG+S
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 20/66 (30%), Positives = 35/66 (53%)
Query: 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150
EF+ G+ + + + + +Q++ + H G+ HRD+KPENLL+ G +
Sbjct: 289 EFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQV 348
Query: 151 KVSDFG 156
K+ DFG
Sbjct: 349 KIIDFG 354
|
Length = 507 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 53/195 (27%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 39 VALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGE 97
V LK+LD H+ E A+M + V H ++V LY V + +V EFV G
Sbjct: 35 VILKVLDP----SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGP 90
Query: 98 LFDKIVNHGRMKEDEARRYFQ---QLINAVDYCHSRGVYHRDLKPENLLLDAYG------ 148
L + H + F+ QL +A+ Y + + H ++ +N+LL G
Sbjct: 91 L--DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG 148
Query: 149 -NLKVSDFG--LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
+K+SD G ++ LS+Q + + ++APE + D AD WS G L+
Sbjct: 149 PFIKLSDPGIPITVLSRQECVERI--------PWIAPECVEDSKNLSIAADKWSFGTTLW 200
Query: 206 -VLLAGYLPFDDSNL 219
+ G +P D L
Sbjct: 201 EICYNGEIPLKDKTL 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 27/136 (19%), Positives = 49/136 (36%), Gaps = 23/136 (16%)
Query: 33 SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-----PNVVRLYEVMGSKTKIF 87
E LKI + +REVA ++L+ P V+ E S +
Sbjct: 18 GTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGE---SDGWSY 69
Query: 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY---HRDLKPENLLL 144
+++E++ G L + ++ +L H + H DL P N+L+
Sbjct: 70 LLMEWIEGETLDEVSEEEKEDIAEQLAELLAKL-------HQLPLLVLCHGDLHPGNILV 122
Query: 145 DAYGNLKVSDFGLSAL 160
D L + D+ +
Sbjct: 123 DDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 3e-04
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 23/178 (12%)
Query: 39 VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98
V LK+LD +A + M V H ++ ++ V ++ +V EFV G L
Sbjct: 47 VVLKVLDPSH---RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL 103
Query: 99 FDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-------N 149
D + GR+ QQL +A+ Y + + H ++ +N+LL G
Sbjct: 104 -DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPF 162
Query: 150 LKVSDFGLS--ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205
+K+SD G+S ALS++ R + + ++APE + + AD WS G L
Sbjct: 163 IKLSDPGVSFTALSREERVERI--------PWIAPECVPGGNSLSTAADKWSFGTTLL 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 9e-04
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 7/95 (7%)
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NV +Y V I V+E++ G L D ++N M+E E R +L+ + HS G
Sbjct: 62 NVPAVYFVDPENFII--VMEYIEGEPLKD-LINSNGMEELELSREIGRLVGKL---HSAG 115
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
+ H DL N++L G + + DFGL+ S+ + D
Sbjct: 116 IIHGDLTTSNMILSG-GKIYLIDFGLAEFSKDLED 149
|
Length = 211 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 30/123 (24%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ +++ S+ HRDL N+LL +K+ DFGL+ RD ++H + N
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA------RD--IMHDS----N 292
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD----DSNLMN 221
YV APE + D Y + +D+WS G++L+ + + G P+ DS N
Sbjct: 293 YVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351
Query: 222 LYK 224
K
Sbjct: 352 KIK 354
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 42/161 (26%), Positives = 75/161 (46%), Gaps = 20/161 (12%)
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+A M ++HPN+V+L + S+ +++ E++ G L + + N + + R+ +
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGI 789
Query: 121 INAVDYCH---SRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDGLLHTTCG 175
A+ + H S V +L PE +++D +L++S GL T C
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTD----------TKCF 839
Query: 176 TPN-YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215
+ YVAPE + +D++ G+IL LL G P D
Sbjct: 840 ISSAYVAPET-RETKDITEKSDIYGFGLILIELLTGKSPAD 879
|
Length = 968 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.003
Identities = 28/101 (27%), Positives = 54/101 (53%), Gaps = 6/101 (5%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH--TTCGT 176
Q+ N +++ S+ HRDL N+L+ +K+ DFGL+ +RD + +T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA--RDIMRDSNYISKGSTFLP 304
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDD 216
++APE + + Y + +D+WS G++L+ + G P+ +
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPE 344
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 269 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.89 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.87 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.75 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.75 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.69 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.65 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.65 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.61 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.6 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.59 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.58 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.51 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.4 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.36 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.36 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.35 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.35 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.31 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.25 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.09 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.06 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.01 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.94 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.88 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.85 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.62 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.54 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.54 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.48 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.44 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.38 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.37 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.36 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.36 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.33 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.31 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.25 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.17 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.11 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.11 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.04 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.91 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.91 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.88 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.8 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.69 | |
| PLN02236 | 344 | choline kinase | 97.58 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.55 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.48 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.4 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.39 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.32 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.23 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.23 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.23 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.18 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.92 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.56 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.35 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.26 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.2 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.53 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 95.51 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.47 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.38 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 94.92 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-58 Score=366.31 Aligned_cols=256 Identities=39% Similarity=0.678 Sum_probs=228.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHH----HHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK----MAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
..+.|.+.+.||+|+||.|-+|..+.+|+.||+|+++........ ....+.+|+++|++|+||||++++++|....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 556789999999999999999999999999999999876554422 2345789999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC---CCEEEeeCCCcccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALS 161 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~---~~~~l~df~~~~~~ 161 (269)
..|+||||++||.|.+++-.++.+.++.-+.++.|++.|+.|||+.||+||||||+|||++.+ -.+|++|||++...
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999876 45899999999876
Q ss_pred ccccCCCcccccccCccccCcccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhcCcccCCC---
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKKISAAEFTCPP--- 235 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~--- 235 (269)
+ ........+||+.|.|||++.+.. .++.+.|+||+||++|-+++|.+||+...... +.+++..+++.+.+
T Consensus 330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w 406 (475)
T KOG0615|consen 330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW 406 (475)
T ss_pred c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence 5 344555678999999999998765 33468899999999999999999998765555 99999999987764
Q ss_pred -CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 236 -WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 236 -~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++.+..+||++||..||++|||+ .++|.|+|
T Consensus 407 ~~Iseea~dlI~~mL~VdP~~R~s~--~eaL~hpW 439 (475)
T KOG0615|consen 407 DRISEEALDLINWMLVVDPENRPSA--DEALNHPW 439 (475)
T ss_pred hhhhHHHHHHHHHhhEeCcccCcCH--HHHhcChh
Confidence 379999999999999999999999 99999999
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-56 Score=370.35 Aligned_cols=254 Identities=37% Similarity=0.677 Sum_probs=238.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
.+|...+.||.|+|..+|.+++..+|+.||+|++...........+.+.+|+++.+.|+||||++++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 45999999999999999999999999999999999888888888899999999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
|.|..++|..++..++++++.++..+++||+.||.|||+.+|+|||||..|+|++++.+||++|||+|.... ......
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le--~~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE--YDGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec--Cccccc
Confidence 999999999999988999999999999999999999999999999999999999999999999999987544 233556
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcC
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (269)
...+|||-|.|||++....+. ..+||||+||++|.|+.|++||...+..+.+..+...+...|..++.+.++||++||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 677899999999999987775 9999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCcCCCCccccccccC
Q 024347 251 PNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 251 ~dP~~Rps~~~~~~l~~~~ 269 (269)
+||.+|||+ .++|-|+|
T Consensus 255 ~~P~~Rpsl--~~vL~h~F 271 (592)
T KOG0575|consen 255 PNPSERPSL--DEVLDHPF 271 (592)
T ss_pred CCcccCCCH--HHHhcCHh
Confidence 999999999 66666665
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=349.13 Aligned_cols=252 Identities=27% Similarity=0.470 Sum_probs=225.6
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe-EE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-IF 87 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~ 87 (269)
..++.+.++.||.|..|+||+++++.+++-+|+|++.... ++...+++.+|+++++..+||+|+.+|+.|..... +.
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 3457888899999999999999999999999999995433 45567899999999999999999999999999994 99
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||+||+|...+...+.+++..+..++.++++||.|||+ .+|+||||||+|||++..|.|||+|||.+......
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999999888899999999999999999999996 89999999999999999999999999988754432
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCcccC-CCC-CCH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-----NLMNLYKKISAAEFTC-PPW-LSF 239 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~-~~~-~~~ 239 (269)
......||..|||||.+.+..+. .++||||||..++|+.+|+.||... +..++...++.+..+. |.. +++
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred --hcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 44556789999999999998775 9999999999999999999999874 6778888888876655 444 999
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++++||..||++||.+|||+ .+++.|+|
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~--~qLl~Hpf 337 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSA--KQLLQHPF 337 (364)
T ss_pred HHHHHHHHHhcCCcccCCCH--HHHhcCHH
Confidence 99999999999999999999 77888887
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-53 Score=334.68 Aligned_cols=247 Identities=38% Similarity=0.725 Sum_probs=229.1
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...+.|++.+.||.|+||.|++++.+.+++.+|+|+++..........+..++|..+|..++||.|+++...|++.+.++
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 55789999999999999999999999999999999999888877777899999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+|++|+.||.|...+++.+.++++.+.-++..|+.||.|||+.||+|||+||+|||++.+|+++|+|||+|+... ...
T Consensus 102 lVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~~ 179 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KDG 179 (357)
T ss_pred EEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cCC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999997432 233
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC-CCCHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-WLSFTARKLIA 246 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~ 246 (269)
......+||+.|+|||++.+..++ .++|.||||+++|+|++|..||.+.+..+..+.+..++...++ .++.+.+++++
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~ 258 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLK 258 (357)
T ss_pred CccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHH
Confidence 344456899999999999999875 9999999999999999999999999999999999999955554 49999999999
Q ss_pred HhcCCCCCCcC
Q 024347 247 RILDPNPMTVS 257 (269)
Q Consensus 247 ~~l~~dP~~Rp 257 (269)
.+|+.||++|.
T Consensus 259 ~LL~rdp~~RL 269 (357)
T KOG0598|consen 259 KLLKRDPRQRL 269 (357)
T ss_pred HHhccCHHHhc
Confidence 99999999997
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=335.84 Aligned_cols=257 Identities=38% Similarity=0.655 Sum_probs=226.3
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
......++|.+.+.||.|+|++||+|+++.++..||+|.+..... .....+.+..|+.+|+.++||||+.++++..+.+
T Consensus 4 ~~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~ 82 (429)
T KOG0595|consen 4 GSMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD 82 (429)
T ss_pred CcccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence 345678899999999999999999999999999999999977654 4566788999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC------CCEEEeeCCCc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY------GNLKVSDFGLS 158 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~------~~~~l~df~~~ 158 (269)
.+++|||||+||+|..++.+++.+++.++..+..|++.||++||+++|+|+||||.|||++.. ..+|++|||++
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 999999999999999999999999999999999999999999999999999999999999864 35899999999
Q ss_pred cccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCC
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPP 235 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~ 235 (269)
+... ........+|++.|||||++....++ .|+|+||+|+++|++++|..||+..+..++...+..+.. ..+.
T Consensus 163 R~L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 163 RFLQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred hhCC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 8665 34455667899999999999887776 999999999999999999999999999999888876653 3334
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCcccccccc
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
..+..+.+++...|+.+|..|.++ .+.+.|+
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~--~~~~~~~ 269 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISF--EDFFDHP 269 (429)
T ss_pred hccCchhhhhhHHHhcCccccCch--HHhhhhh
Confidence 577778888888888888888887 5544443
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-52 Score=347.23 Aligned_cols=258 Identities=59% Similarity=1.018 Sum_probs=235.6
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh--HHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCC
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 84 (269)
...++|.+.+.||.|+||.|+.|.+..+++.||+|++....... ....+.+.+|+.+++.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 56779999999999999999999999999999999776542211 134567778999999999 999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC-CCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~-~~~~l~df~~~~~~~~ 163 (269)
.+++||||+.||.|.+++.+.+++++.....+++|+++|++|+|+.||+||||||+||+++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 999999999999999999998899999999999999999999999999999999999999999 999999999988654
Q ss_pred ccCCCcccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCC-CHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL-SFTA 241 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~l 241 (269)
..........|++.|+|||++.+.. +.+.++||||+|+++|.|++|..||...+...++..+..+++.+|..+ ++++
T Consensus 173 -~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~ 251 (370)
T KOG0583|consen 173 -GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEA 251 (370)
T ss_pred -CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHHH
Confidence 3345566678999999999999988 878999999999999999999999999999999999999999999999 9999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++|++.||..||.+|+++ .+++.|+|
T Consensus 252 ~~Li~~mL~~~P~~R~t~--~~i~~h~w 277 (370)
T KOG0583|consen 252 RSLIEKMLVPDPSTRITL--LEILEHPW 277 (370)
T ss_pred HHHHHHHcCCCcccCCCH--HHHhhChh
Confidence 999999999999999999 66668887
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-54 Score=328.33 Aligned_cols=245 Identities=32% Similarity=0.555 Sum_probs=218.6
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeE-EE-eeCCeEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE-VM-GSKTKIFI 88 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~-~~~~~~~~ 88 (269)
..|++.+.||+|+||.||++++..+|..+|.|.++-... +....+++..|+.+|++|+||||++.++ .| .+...+++
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 459999999999999999999999999999999985544 4555788999999999999999999998 34 34445899
Q ss_pred EEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--cEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 89 VLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHS--RG--VYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~--~~--i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
+||+|.+|+|.+.+.. ++.+++.+++.++.|++.||...|+ .. |.|+||||.|||++.+|.|||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999888754 4579999999999999999999999 44 99999999999999999999999999986
Q ss_pred cccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc-CC-CCCC
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CP-PWLS 238 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~-~~~~ 238 (269)
.. ..........|||.||+||.+.+.++. ++|||||+||++|+|+.-+.||.+.+-.++.++|..++++ .| ..+|
T Consensus 178 l~--s~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS 254 (375)
T KOG0591|consen 178 LS--SKTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYS 254 (375)
T ss_pred hc--chhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhh
Confidence 54 344456677899999999999998886 9999999999999999999999999999999999999886 45 4589
Q ss_pred HHHHHHHHHhcCCCCCCcCCC
Q 024347 239 FTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~ 259 (269)
..+..+|+.|+..||+.||+.
T Consensus 255 ~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 255 TDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hHHHHHHHHHccCCcccCCCc
Confidence 999999999999999999983
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=340.74 Aligned_cols=260 Identities=34% Similarity=0.627 Sum_probs=236.2
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 85 (269)
.....+|.+++.||.|+|++|++|..+.+++.||+|++...-...+.-.+-+..|-.+|.+| .||+|++++-.|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45678999999999999999999999999999999999877776666667788899999999 79999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+|+|++|+++|.|.+++.+.+.|++.-....+.+|+.||.|||++|||||||||+|||++.+++++|+|||.+.......
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998876543
Q ss_pred CCC-----------cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC
Q 024347 166 DDG-----------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP 234 (269)
Q Consensus 166 ~~~-----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (269)
... ......||-.|.+||++...... ..+|+|+|||++|+|+.|.+||.+.+.-..++++....+.++
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~-~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAG-PSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCC-cccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 331 11335688899999999988775 999999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+++..++||+.+|..||.+|++++++ -.|+|
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qI--k~HpF 340 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQI--KAHPF 340 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHH--hhCcc
Confidence 9999999999999999999999999544 44544
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=346.74 Aligned_cols=256 Identities=45% Similarity=0.853 Sum_probs=240.2
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
-.+-|++++.||.|+-|.|-+|++..+|+..|||++.............+.+|+-+|+.+.|||++++|+++++...+|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 35679999999999999999999999999999999987654455556778999999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|.||.+||.|.+++..++++++.+.++++.||+.|+.|.|..+|||+|++|+|++++..+++|++|||+|.+- ..+.
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~~gk 166 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---VPGK 166 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---cCCc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999988643 3355
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHh
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (269)
.....+|++.|.|||++.+.++.+.++||||.|+++|+|++|+.||++.+...++.+++.|.+..|..++++.++||+.|
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~m 246 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRM 246 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHH
Confidence 56677899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|..||++|.+. .+++.|+|
T Consensus 247 l~VDp~~RiT~--~eI~kHP~ 265 (786)
T KOG0588|consen 247 LDVDPSTRITT--EEILKHPF 265 (786)
T ss_pred hccCccccccH--HHHhhCch
Confidence 99999999999 89999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=311.35 Aligned_cols=256 Identities=37% Similarity=0.695 Sum_probs=238.6
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
-..++|+..+.||.|+||.|.+++.+.+|..+|+|++...........+...+|-++|+.+.||.++++.+.+.+.+.++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 56788999999999999999999999999999999999888888888899999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+||||.+||.|..++.+.+++++....-++.+|+.||.|||+++|++||+||+|||++.+|.++++|||++... .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----~ 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----S 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----c
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998743 3
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 247 (269)
+.+...+|+|.|+|||++.+.++. .++|.||||+++|+|+.|.+||...++..++++|+.++..+|+.+++++++||+.
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 446777899999999999999886 9999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCcCCCC---ccccccccC
Q 024347 248 ILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
+|+.|-.+|-.-. -+++-.|+|
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~w 299 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPW 299 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCcc
Confidence 9999999994321 256666766
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=331.05 Aligned_cols=253 Identities=33% Similarity=0.615 Sum_probs=225.7
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.+..+++.+|+|.+...........+.+.+|+.+++.++||||+++++++.+....+++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997655444445677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||+++++|.+++...+.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998864322 12
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcC
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (269)
....+++.|+|||++.+... +.++||||||+++|+|++|..||.........+.+..+....+...+..+++||+.||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 23457889999999987766 48999999999999999999999999988999999888888888899999999999999
Q ss_pred CCCCCcCCCC---ccccccccC
Q 024347 251 PNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 251 ~dP~~Rps~~---~~~~l~~~~ 269 (269)
.||.+||+.. ..+++.|+|
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~ 256 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRW 256 (291)
T ss_pred CCHHHccCCccCCHHHHhcCcc
Confidence 9999999621 267778877
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=334.51 Aligned_cols=256 Identities=36% Similarity=0.690 Sum_probs=229.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||.|++|.||++.++.+++.+|+|.+...........+.+.+|+.++++++||||+++++.+.+.+..+
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34689999999999999999999999999999999998765555555678899999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
++|||+.|++|.+.+...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~---- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC----
Confidence 9999999999999998888899999999999999999999999999999999999999999999999998875422
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 247 (269)
......+++.|+|||++.+... +.++|+||||+++|+|++|..||.+.......+.+..+....+..++..+++||+.
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 171 -RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred -CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 1223457889999999987776 48999999999999999999999998888889999888888888899999999999
Q ss_pred hcCCCCCCcCCC---CccccccccC
Q 024347 248 ILDPNPMTVSIY---PFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~---~~~~~l~~~~ 269 (269)
||+.||.+||+. ...+++.|+|
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 999999999983 2366777876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=324.67 Aligned_cols=255 Identities=30% Similarity=0.543 Sum_probs=216.6
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC--eEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--KIF 87 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~~~ 87 (269)
..+|...+.||+|+||.||++.++.+|+..|+|.+..... .. .+.+.+|+.+|.+++||||++.+|...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--PT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--hh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 3468899999999999999999998899999999876522 12 688999999999999999999999744433 699
Q ss_pred EEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-CCCEEEeeCCCcccccc-c
Q 024347 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQ-V 164 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-~~~~~l~df~~~~~~~~-~ 164 (269)
+.|||+++|+|.+++...+ .+++..+....+|+++||.|||++|++|+||||+|||++. ++.+||+|||.+..... .
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998876 7999999999999999999999999999999999999999 79999999998875543 1
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC--cccCCCCCCHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAA--EFTCPPWLSFTA 241 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~--~~~~~~~~~~~l 241 (269)
..........|++.|+|||++........++|||||||++.+|+||..||.. .......-.+... .+.+|..++.+.
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 2223344567899999999998643333599999999999999999999987 4444444444433 357788899999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++|+..|+..||++|||+ .+.|.|+|
T Consensus 253 ~~Fl~~C~~~~p~~Rpta--~eLL~hpf 278 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTA--EELLEHPF 278 (313)
T ss_pred HHHHHHHhhcCcccCcCH--HHHhhChh
Confidence 999999999999999999 88888886
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=318.71 Aligned_cols=263 Identities=30% Similarity=0.454 Sum_probs=228.0
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
.-+.+...+.|++.+.||.|..++||+|+....++.||+|.++.+..++. .+.+.+|+..++.++||||+..+..|..
T Consensus 18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv 95 (516)
T KOG0582|consen 18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVV 95 (516)
T ss_pred cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEe
Confidence 44567788899999999999999999999999999999999998876655 7889999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
+..+++||+++.+||+.+.+... ..+.+..+..+++++++||.|||.+|.+|||||+.|||++.+|.|+|+|||.+..
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~ 175 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSAS 175 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeee
Confidence 99999999999999999999774 3589999999999999999999999999999999999999999999999997654
Q ss_pred ccccc-CCC-cccccccCccccCccc-ccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCC-
Q 024347 161 SQQVR-DDG-LLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW- 236 (269)
Q Consensus 161 ~~~~~-~~~-~~~~~~~~~~~~aPE~-~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~- 236 (269)
+...- ... ......++++|+|||+ ......|..|+||||||+++.|+.+|+.||...++++..-.-..+.++.+..
T Consensus 176 l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~ 255 (516)
T KOG0582|consen 176 LFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTS 255 (516)
T ss_pred ecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccc
Confidence 33211 110 1133468999999999 5555566799999999999999999999999999998776666666653321
Q ss_pred ---------CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 237 ---------LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 237 ---------~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++..++++|..||+.||++|||+ .+.|.|.|
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptA--skLlkh~F 295 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTA--SKLLKHAF 295 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCH--HHHhccHH
Confidence 67789999999999999999999 77887766
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=327.79 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=218.7
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCe-EEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEP-VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~-~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
++....++...+.+.+|.|+||+||.|.+. |+. +|+|.+......... .+.+.+|+.++.+++||||++++|++..
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 445566777788888999999999999986 556 999999876655555 7899999999999999999999999988
Q ss_pred CC-eEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeecCCCCceEecCCC-CEEEeeCCC
Q 024347 83 KT-KIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRG-VYHRDLKPENLLLDAYG-NLKVSDFGL 157 (269)
Q Consensus 83 ~~-~~~~v~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~-i~h~di~~~nIl~~~~~-~~~l~df~~ 157 (269)
.. ..++||||+++|+|.++++. .+.++...+..++.+|+.|+.|||+++ |+|+||||+|||++.++ ++||+|||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 77 79999999999999999988 578999999999999999999999999 99999999999999997 999999999
Q ss_pred ccccccccCCCcccccccCccccCcccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCcccCC
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS--AAEFTCP 234 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~ 234 (269)
++...... .......||+.|+|||++.+. ..++.++||||||+++|+++||..||.+.........+. ..++..+
T Consensus 191 sr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p 268 (362)
T KOG0192|consen 191 SREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP 268 (362)
T ss_pred ceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 97654422 222225689999999999952 334699999999999999999999999988876666664 3345666
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+++.+..++..||+.||.+||++.++
T Consensus 269 ~~~~~~l~~l~~~CW~~dp~~RP~f~ei 296 (362)
T KOG0192|consen 269 KECPPHLSSLMERCWLVDPSRRPSFLEI 296 (362)
T ss_pred ccCCHHHHHHHHHhCCCCCCcCCCHHHH
Confidence 7799999999999999999999998554
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=335.64 Aligned_cols=253 Identities=33% Similarity=0.590 Sum_probs=235.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+... .+...+.+.+|+++++.++||||+.++++|++....++|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 3689999999999999999999999999999999876554 455578999999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
.||+.| +|..++...+.++++.+..++.++.+||.|||+++|.|+|+||.||+++.++.+|++|||+++.+.. ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999987 9999999999999999999999999999999999999999999999999999999999999987654 4445
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhc
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (269)
.....|+|.|||||...+.+++ ..+|+|||||++|+++.|++||-......+.+.|.......|+..+..+.+|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 5566799999999999988876 999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCCCCccccccccC
Q 024347 250 DPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 250 ~~dP~~Rps~~~~~~l~~~~ 269 (269)
++||.+|.+. .+.+.|+|
T Consensus 236 ~kdP~~RltW--~~Ll~HpF 253 (808)
T KOG0597|consen 236 IKDPAQRLTW--TDLLGHPF 253 (808)
T ss_pred hcChhhcccH--HHHhcChH
Confidence 9999999998 88899886
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=327.45 Aligned_cols=250 Identities=35% Similarity=0.590 Sum_probs=219.7
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 96 (269)
+.||+|+||.||++.+..+|+.+|+|++.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544555667888999999999999999999999999999999999999
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccC
Q 024347 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (269)
Q Consensus 97 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 176 (269)
+|...+...+.+++.++..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++.... .........++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 9999998888899999999999999999999999999999999999999999999999998764221 11222334588
Q ss_pred ccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCc
Q 024347 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTV 256 (269)
Q Consensus 177 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 256 (269)
+.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..+....+..+++++.+||+.||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999877664 8999999999999999999999998888888888888888888899999999999999999999
Q ss_pred CCC---CccccccccC
Q 024347 257 SIY---PFADILYMRF 269 (269)
Q Consensus 257 ps~---~~~~~l~~~~ 269 (269)
|+. ...+++.|+|
T Consensus 238 ~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 238 LGGGPEDAKEIMEHRF 253 (323)
T ss_pred CCCCCCCHHHHHcCCC
Confidence 942 1266677776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=325.90 Aligned_cols=256 Identities=31% Similarity=0.572 Sum_probs=226.5
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCC-CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.....++|++.+.||.|++|.||+|.+..++ ..+|+|.+...........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 3456788999999999999999999876554 689999997765545555677889999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..+++|||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~- 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT- 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC-
Confidence 9999999999999999998888899999999999999999999999999999999999999999999999998865322
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 244 (269)
......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+....+..+++.+.++
T Consensus 184 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l 258 (340)
T PTZ00426 184 ----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHL 258 (340)
T ss_pred ----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 1223457889999999987666 48999999999999999999999999988889999888888888899999999
Q ss_pred HHHhcCCCCCCcC-----CCCccccccccC
Q 024347 245 IARILDPNPMTVS-----IYPFADILYMRF 269 (269)
Q Consensus 245 i~~~l~~dP~~Rp-----s~~~~~~l~~~~ 269 (269)
|+.||+.||++|+ ++ .+++.|+|
T Consensus 259 i~~~l~~dp~~R~~~~~~~~--~~~~~hp~ 286 (340)
T PTZ00426 259 MKKLLSHDLTKRYGNLKKGA--QNVKEHPW 286 (340)
T ss_pred HHHHcccCHHHcCCCCCCCH--HHHHcCCC
Confidence 9999999999996 55 56667776
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=322.57 Aligned_cols=248 Identities=35% Similarity=0.603 Sum_probs=219.7
Q ss_pred eeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCch
Q 024347 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (269)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l 98 (269)
||+|+||.||++.+..+++.+|+|.+.............+.+|+.++++++||||+++++.+...+..+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999765544455567788999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCcc
Q 024347 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (269)
Q Consensus 99 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 178 (269)
.+.+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........+++.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 99998888899999999999999999999999999999999999999999999999998864321 1222233457899
Q ss_pred ccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCC
Q 024347 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVSI 258 (269)
Q Consensus 179 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 258 (269)
|+|||++.+..+ +.++||||||+++|+|++|..||......+....+.......+..+++.+.+||..||+.||++||+
T Consensus 159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 999999987766 4899999999999999999999999888888888888888888889999999999999999999998
Q ss_pred CC-ccccccccC
Q 024347 259 YP-FADILYMRF 269 (269)
Q Consensus 259 ~~-~~~~l~~~~ 269 (269)
+. ..+++.|+|
T Consensus 238 ~~~~~e~l~hp~ 249 (312)
T cd05585 238 YNGAQEIKNHPF 249 (312)
T ss_pred CCCHHHHHcCCC
Confidence 63 356778876
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=330.03 Aligned_cols=254 Identities=28% Similarity=0.489 Sum_probs=225.8
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+.....|...+.||+|+.|.||.+....+++.||+|.+....... .+-+.+|+.+++..+|+||+.+++.+-..+.+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 445568889999999999999999999999999999998766443 46789999999999999999999999888999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||++||+|.+.+... .+++.+++.+++.+++||+|||..||+|+|||.+||+++.+|.+||+|||+|........
T Consensus 346 WVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred EEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 9999999999988866554 599999999999999999999999999999999999999999999999999986654332
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-c--ccCCCCCCHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-E--FTCPPWLSFTARK 243 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l~~ 243 (269)
......|+++|+|||+.....+. .+.||||||++++||+.|.+||-+.++......+... . +..+..+++.+++
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG-~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd 501 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD 501 (550)
T ss_pred --ccccccCCCCccchhhhhhcccC-ccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence 44556799999999999988875 9999999999999999999999988888877777543 3 3456679999999
Q ss_pred HHHHhcCCCCCCcCCCCccccccccC
Q 024347 244 LIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.+||+.||++|+++ .+.|.|+|
T Consensus 502 FL~~cL~~dv~~RasA--~eLL~HpF 525 (550)
T KOG0578|consen 502 FLDRCLVVDVEQRASA--KELLEHPF 525 (550)
T ss_pred HHHHHhhcchhcCCCH--HHHhcChh
Confidence 9999999999999999 88899987
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=323.00 Aligned_cols=250 Identities=34% Similarity=0.605 Sum_probs=218.7
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 96 (269)
+.||+|+||.||++.+..+|+.||+|.+.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765544555677788999999999999999999999999999999999999
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccC
Q 024347 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (269)
Q Consensus 97 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 176 (269)
+|...+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........++
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 9998888888899999999999999999999999999999999999999999999999998763211 11122234578
Q ss_pred ccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCc
Q 024347 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTV 256 (269)
Q Consensus 177 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 256 (269)
+.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+.......+..+++++.++|+.||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 99999999987766 48999999999999999999999998888888888888888888899999999999999999999
Q ss_pred CCC---CccccccccC
Q 024347 257 SIY---PFADILYMRF 269 (269)
Q Consensus 257 ps~---~~~~~l~~~~ 269 (269)
|+. ...+++.|+|
T Consensus 238 ~~~~~~~~~~~l~h~~ 253 (323)
T cd05595 238 LGGGPSDAKEVMEHRF 253 (323)
T ss_pred CCCCCCCHHHHHcCCC
Confidence 832 2267777776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-48 Score=322.97 Aligned_cols=264 Identities=35% Similarity=0.607 Sum_probs=230.3
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
.+.....++|++++.||+|+||.||+|+.+.+|+.+|+|+++............+..|=++|....+|.|++++-.|++.
T Consensus 134 ~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~ 213 (550)
T KOG0605|consen 134 RRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDK 213 (550)
T ss_pred ccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC
Confidence 34466789999999999999999999999999999999999998888888889999999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
.++|+||||.+||++..++.+.+.|+++.....+.+++-||..+|+.|++|+||||+|+||+..|++||+|||+|.....
T Consensus 214 ~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 214 EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999843211
Q ss_pred cc------------------C-CCcc--------------------------cccccCccccCcccccCCCCCCCchhHH
Q 024347 164 VR------------------D-DGLL--------------------------HTTCGTPNYVAPEVLNDRGYDGSTADLW 198 (269)
Q Consensus 164 ~~------------------~-~~~~--------------------------~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 198 (269)
.. . .... ....|+|.|+|||++.+..+. ..+|.|
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwW 372 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWW 372 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHH
Confidence 00 0 0000 111389999999999999864 999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--ccCC--CCCCHHHHHHHHHhcCCCCCCcCCCCc-cccccccC
Q 024347 199 SCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP--PWLSFTARKLIARILDPNPMTVSIYPF-ADILYMRF 269 (269)
Q Consensus 199 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~-~~~l~~~~ 269 (269)
||||++|||+.|.+||.+.++.+.+.++.+-+ +.+| ..++++.+|||..||. ||++|.-..= .++-.|+|
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPf 447 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPF 447 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCc
Confidence 99999999999999999999999999997655 3444 4588999999999999 9999987322 33335655
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=321.61 Aligned_cols=248 Identities=35% Similarity=0.610 Sum_probs=218.9
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 96 (269)
+.||.|+||.||++.+..+++.+|+|++.............+.+|+.+++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999998765555555678889999999999999999999999999999999999999
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccC
Q 024347 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (269)
Q Consensus 97 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 176 (269)
+|...+...+.+++.++..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..... .........++
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 9998888878899999999999999999999999999999999999999999999999998764221 11222334578
Q ss_pred ccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCc
Q 024347 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTV 256 (269)
Q Consensus 177 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 256 (269)
+.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+..+++++.+||+.||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 99999999987766 48999999999999999999999988888888888888888888899999999999999999999
Q ss_pred C-----CCCccccccccC
Q 024347 257 S-----IYPFADILYMRF 269 (269)
Q Consensus 257 p-----s~~~~~~l~~~~ 269 (269)
+ ++ .+++.|+|
T Consensus 238 ~~~~~~~~--~~il~h~~ 253 (328)
T cd05593 238 LGGGPDDA--KEIMRHSF 253 (328)
T ss_pred CCCCCCCH--HHHhcCCC
Confidence 8 45 66777776
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=319.21 Aligned_cols=250 Identities=35% Similarity=0.615 Sum_probs=218.5
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||+|++|.||++.++.+++.||+|++...........+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999866544444566777888888776 699999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 99999888888899999999999999999999999999999999999999999999999998764221 1122233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...+.......+.......+..++.++.++|+.||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 899999999987666 4899999999999999999999999999999999988888888889999999999999999999
Q ss_pred cCCCCc----cccccccC
Q 024347 256 VSIYPF----ADILYMRF 269 (269)
Q Consensus 256 Rps~~~----~~~l~~~~ 269 (269)
||++.. .+++.|+|
T Consensus 238 R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 238 RLGSLTLGGEEAILRHPF 255 (320)
T ss_pred CCCCCCCCCHHHHHcCCC
Confidence 999833 45667776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=317.83 Aligned_cols=255 Identities=31% Similarity=0.520 Sum_probs=221.7
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCC-CceeeeEEEeeCCeEEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~ 90 (269)
+|++.+.||.|++|.||+|.+..+++.+|+|++...........+.+..|..++..+.|+ +++++++.+...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544445567788899999999764 5888999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++|++|...+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 9999999999988888899999999999999999999999999999999999999999999999998763221 11222
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcC
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (269)
....+++.|+|||++.+..+. .++|+||+|+++|+|++|..||...+.......+.......+..+++++.++++.||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 334578999999999877764 8999999999999999999999999988999999888888888899999999999999
Q ss_pred CCCCCcCCCC---ccccccccC
Q 024347 251 PNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 251 ~dP~~Rps~~---~~~~l~~~~ 269 (269)
.||.+|++.. +.+++.|+|
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~ 259 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAF 259 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCC
Confidence 9999999862 245666665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=306.92 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=214.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|+....+|.|+||+|++++++.+|+.||+|.|.... +++...+-..+|+++|++++|+|++.++++|......++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 367889999999999999999999999999999996543 4456667889999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
+|||+. ++.+.++.. ..++.+.+..++.|++.|+.|.|+++++|+||||+||+++.+|.+||||||+++.... .+.
T Consensus 80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd 156 (396)
T KOG0593|consen 80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD 156 (396)
T ss_pred eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence 999976 666666654 5689999999999999999999999999999999999999999999999999987654 455
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-------------------- 228 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 228 (269)
....+..|.-|+|||.+.+...++...||||+||++.+|++|.+.|.+....+....|..
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 566667788899999999977778999999999999999999999988776665555421
Q ss_pred -CcccCCC----------CCCHHHHHHHHHhcCCCCCCcCCCCcccccccc
Q 024347 229 -AEFTCPP----------WLSFTARKLIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 229 -~~~~~~~----------~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
..++.++ .++..+.+|++.||+.||.+|++. .+.+.|.
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc--~qll~H~ 285 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSC--EQLLHHP 285 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccH--HHHhcCh
Confidence 0112111 156678999999999999999998 6666665
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=320.24 Aligned_cols=251 Identities=32% Similarity=0.564 Sum_probs=219.4
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||+|.+..+++.||+|++...........+.+.+|+.+++.++||||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544455677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++|++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998864432 22
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--ccCCC------CCCHHHH
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP------WLSFTAR 242 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~------~~~~~l~ 242 (269)
....+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+....+.... ...+. .++.++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 33457899999999988765 489999999999999999999999888877777665422 11111 4589999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||..||+.+|++||++ .+++.|+|
T Consensus 235 ~li~~~l~~~~~rr~s~--~~ll~h~~ 259 (333)
T cd05600 235 DLITKLINDPSRRFGSL--EDIKNHPF 259 (333)
T ss_pred HHHHHHhhChhhhcCCH--HHHHhCcc
Confidence 99999999999999998 77777776
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=312.51 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=213.4
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
.|++.+.||.|+||.||++.+..+++.+|+|.+.............+.+|+++++.++|++++++++.+.+.+..++++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 47899999999999999999999999999999876654444444567889999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|+++++|...+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 99999998777543 3689999999999999999999999999999999999999999999999998865322 112
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCcccCCCCCCHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li 245 (269)
.....++..|+|||++.+..+. .++||||||+++|+|++|+.||...... .....+.......+..+++.+.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 2334578999999999877764 8999999999999999999999875442 2333344445566677899999999
Q ss_pred HHhcCCCCCCcCCCC---ccccccccC
Q 024347 246 ARILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
+.||+.||++||++. ..+++.|+|
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 999999999999842 367778776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-48 Score=317.07 Aligned_cols=259 Identities=36% Similarity=0.646 Sum_probs=221.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH-----------HHHHHHHHHHHHhhhCCCCCceee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-----------KMAEQIKREVATMKLVKHPNVVRL 76 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-----------~~~~~~~~e~~~l~~l~~~~i~~~ 76 (269)
+-.+.|++.+.||.|.||.|-+|++..+++.||+|++........ .-.+.+.+|+.++++++|+||+++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 456899999999999999999999999999999999965433221 113588999999999999999999
Q ss_pred eEEEee--CCeEEEEEeccCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEe
Q 024347 77 YEVMGS--KTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (269)
Q Consensus 77 ~~~~~~--~~~~~~v~~~~~~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~ 153 (269)
+++..+ .+.+|+|+|||..|.+.. .-..++ +++.+...++++++.||.|||..||+||||||+|+|++.+|+|||+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w-~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKW-CPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEeecCcccCceEEEEEeccCCcccc-CCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 999865 467999999999887743 333344 9999999999999999999999999999999999999999999999
Q ss_pred eCCCccccccccC---CCcccccccCccccCcccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Q 024347 154 DFGLSALSQQVRD---DGLLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227 (269)
Q Consensus 154 df~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 227 (269)
|||.+........ ........|||.|+|||...+ ..+.+.+.||||+|+++|.|+.|..||-++...+++.+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 9998875433211 122334679999999999877 3455789999999999999999999999999999999999
Q ss_pred cCcccCCCC--CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 228 AAEFTCPPW--LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 228 ~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+....+|.. +.+.+++||+.||.+||++|.+. .++..|+|
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l--~~ik~Hpw 374 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITL--PDIKLHPW 374 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeeh--hhheecce
Confidence 988777654 79999999999999999999999 77777877
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-49 Score=314.76 Aligned_cols=251 Identities=41% Similarity=0.746 Sum_probs=233.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
-+|++.+.||.|.||.|-+|.....|+.||+|.+..+...+++..-.+.+|++++..|+||||+.+|.+|...+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 37899999999999999999998899999999999999988888899999999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||..+|.|.+++.+++.+++.+...+++||.+|+.|.|.++++|+|++.+||++++++++|++|||++..+. .....
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~~kfL 209 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---DKKFL 209 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---cccHH
Confidence 999999999999999999999999999999999999999999999999999999999999999999887544 34556
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcC
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (269)
...+|++.|.+||+.++.++.++..|-||||+++|.++-|..||++.+...+..++..+.+.-|+ -|....-||++||.
T Consensus 210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLm 288 (668)
T KOG0611|consen 210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWMLM 288 (668)
T ss_pred HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHHh
Confidence 66789999999999999999999999999999999999999999999999999999999876554 56678899999999
Q ss_pred CCCCCcCCCCccccccc
Q 024347 251 PNPMTVSIYPFADILYM 267 (269)
Q Consensus 251 ~dP~~Rps~~~~~~l~~ 267 (269)
.||++|.|+ .++.-|
T Consensus 289 VNP~RRATi--eDiAsH 303 (668)
T KOG0611|consen 289 VNPERRATI--EDIASH 303 (668)
T ss_pred cCcccchhH--HHHhhh
Confidence 999999998 555444
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=318.02 Aligned_cols=250 Identities=32% Similarity=0.554 Sum_probs=218.0
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||+|+||.||+|.+..+++.+|+|++...........+.+..|.+++..+ +||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876554555566777888888866 799999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 99998888888899999999999999999999999999999999999999999999999998764321 1222233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+. .++|+||||+++|+|++|..||...+.....+.+.......+..+++++.++++.||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 8899999999877664 899999999999999999999999999999999998888888889999999999999999999
Q ss_pred cCCCC-----ccccccccC
Q 024347 256 VSIYP-----FADILYMRF 269 (269)
Q Consensus 256 Rps~~-----~~~~l~~~~ 269 (269)
||+.. ..+++.|+|
T Consensus 238 R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred cCCCCCCCCCHHHHhcCCc
Confidence 99532 156667776
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=315.13 Aligned_cols=249 Identities=33% Similarity=0.608 Sum_probs=213.6
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhh-CCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||.|+||.||+|.+..+++.||+|.+...........+....|..++.. .+||||+++++.+......++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999987654444445556666777665 4799999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...... ........+
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--EGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC--CCccccccC
Confidence 999998888888999999999999999999999999999999999999999999999999988643221 122233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+ +.++|+||||+++|+|++|..||.+.+..+....+.......+..++.++.+|++.||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 899999999987765 4899999999999999999999999988888888888877888889999999999999999999
Q ss_pred cCCCCccccccccC
Q 024347 256 VSIYPFADILYMRF 269 (269)
Q Consensus 256 Rps~~~~~~l~~~~ 269 (269)
||++. .+.+.|+|
T Consensus 238 R~~~~-~~l~~h~~ 250 (316)
T cd05592 238 RLGVD-GDIRQHPF 250 (316)
T ss_pred cCCCh-HHHHcCcc
Confidence 99972 13445554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=316.06 Aligned_cols=253 Identities=30% Similarity=0.505 Sum_probs=216.3
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHh---hhCCCCCceeeeEEEeeCCeEEEE
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM---KLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l---~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
|++.+.||+|++|.||++.+..+++.||+|.+...........+.+.+|.+++ +.++||||+++++++.+....++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999866544444456677776654 566799999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||++|++|...+.. +.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..... ....
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~ 157 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR 157 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence 999999999876654 5799999999999999999999999999999999999999999999999998764221 1122
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhc
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (269)
.....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+..+....+.......+..+++.+.++|++||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L 236 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL 236 (324)
T ss_pred ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence 233457899999999987766 4899999999999999999999999998888888888888888889999999999999
Q ss_pred CCCCCCcCCCCc---cccccccC
Q 024347 250 DPNPMTVSIYPF---ADILYMRF 269 (269)
Q Consensus 250 ~~dP~~Rps~~~---~~~l~~~~ 269 (269)
+.||.+||+..+ .+++.|+|
T Consensus 237 ~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 237 RRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred hcCHhHcCCCCCCCHHHHhhCCC
Confidence 999999997532 45566665
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=322.63 Aligned_cols=255 Identities=34% Similarity=0.633 Sum_probs=221.4
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||+|.+..+++.||+|++.............+.+|+.++..++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc-----
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR----- 165 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~----- 165 (269)
||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987544322
Q ss_pred ----------------------CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 024347 166 ----------------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223 (269)
Q Consensus 166 ----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 223 (269)
.........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 0011223457899999999988766 48999999999999999999999988888777
Q ss_pred HHHhc--CcccCC--CCCCHHHHHHHHHhcCCCCCCcCC-CCccccccccC
Q 024347 224 KKISA--AEFTCP--PWLSFTARKLIARILDPNPMTVSI-YPFADILYMRF 269 (269)
Q Consensus 224 ~~~~~--~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps-~~~~~~l~~~~ 269 (269)
..+.. .....+ ..+++++.+||+.||. ||.+||+ + .+++.|+|
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~--~~ll~hp~ 287 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSF--EEIKSHPF 287 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCH--HHHhcCCC
Confidence 77766 333333 3469999999999998 9999999 8 77788876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=319.64 Aligned_cols=248 Identities=35% Similarity=0.614 Sum_probs=218.3
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 96 (269)
+.||.|+||.||++.+..+++.+|+|.+.............+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555555667788999999999999999999999999999999999999
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 97 ~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
+|...+...+.+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 999888887889999999999999999999997 7999999999999999999999999998764221 1112223457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+..+++++.+||+.||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 899999999987766 4899999999999999999999999888888888888888888889999999999999999999
Q ss_pred cC-----CCCccccccccC
Q 024347 256 VS-----IYPFADILYMRF 269 (269)
Q Consensus 256 Rp-----s~~~~~~l~~~~ 269 (269)
|+ ++ .+++.|+|
T Consensus 238 R~~~~~~~~--~~il~h~~ 254 (325)
T cd05594 238 RLGGGPDDA--KEIMQHKF 254 (325)
T ss_pred hCCCCCCCH--HHHhcCCC
Confidence 97 55 67778876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=321.49 Aligned_cols=255 Identities=33% Similarity=0.594 Sum_probs=218.6
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|+||.||++.+..+++.||+|++.............+.+|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544555677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC--
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-- 168 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~-- 168 (269)
||++|++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999876432211100
Q ss_pred ----------------------------------cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 024347 169 ----------------------------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (269)
Q Consensus 169 ----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 214 (269)
......|++.|+|||++.+..+. .++|||||||++|+|++|..||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 01123478999999999877664 8999999999999999999999
Q ss_pred CCCCHHHHHHHHhcCc--ccCCC--CCCHHHHHHHHHhcCCCCCCcCC---CCccccccccC
Q 024347 215 DDSNLMNLYKKISAAE--FTCPP--WLSFTARKLIARILDPNPMTVSI---YPFADILYMRF 269 (269)
Q Consensus 215 ~~~~~~~~~~~~~~~~--~~~~~--~~~~~l~~li~~~l~~dP~~Rps---~~~~~~l~~~~ 269 (269)
...........+.... ...+. .+++.+++||+.||. +|.+|++ + .+++.|+|
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~--~~ll~h~~ 298 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGV--NEIKSHPF 298 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCH--HHHhcCCC
Confidence 9988887777775533 23332 478999999999997 9999998 6 77778876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=314.38 Aligned_cols=249 Identities=31% Similarity=0.577 Sum_probs=214.0
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||+|+||.||++.++.+|+.+|+|.+................|..++... +||+|+++++.+.+.+..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999865543333455667777777654 899999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 99999888878899999999999999999999999999999999999999999999999998763211 1122233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+. .++|+||||+++|+|++|..||...+.....+.+.......+..++.+++++|+.||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 8999999999877664 899999999999999999999999888888888888877788889999999999999999999
Q ss_pred cCCCCccccccccC
Q 024347 256 VSIYPFADILYMRF 269 (269)
Q Consensus 256 Rps~~~~~~l~~~~ 269 (269)
||++. .+++.|+|
T Consensus 238 R~~~~-~~~~~h~~ 250 (316)
T cd05620 238 RLGVV-GNIRGHPF 250 (316)
T ss_pred cCCCh-HHHHcCCC
Confidence 99972 13445665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-47 Score=314.51 Aligned_cols=255 Identities=31% Similarity=0.522 Sum_probs=220.7
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+|++.+.||+|+||.||++.+..+++.+|+|.+...........+....|..++..+ +|++++++++.+.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 588999999999999999999999999999999876544444456677788888777 4789999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||+++++|...+...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 9999999999988888899999999999999999999999999999999999999999999999998864221 11122
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcC
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (269)
....+++.|+|||++.+..+. .++|+||||+++|+|++|..||...+.......+.......+..++.++.++++.||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 334578999999999887764 8999999999999999999999999999999999888888888899999999999999
Q ss_pred CCCCCcCCCC---ccccccccC
Q 024347 251 PNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 251 ~dP~~Rps~~---~~~~l~~~~ 269 (269)
.||++|++.. ..+.+.|+|
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAF 259 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCC
Confidence 9999999963 234556654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=316.10 Aligned_cols=250 Identities=35% Similarity=0.592 Sum_probs=215.5
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHH-HhhhCCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||.|++|.||++.+..+|+.+|+|.+.............+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999998665444444455555554 56889999999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 99999888888899999999999999999999999999999999999999999999999998764221 1222233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+..+.+.......++.+++.+.++|+.||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 899999999987766 4899999999999999999999999988888898888888888889999999999999999999
Q ss_pred cCCCC--ccccccccC
Q 024347 256 VSIYP--FADILYMRF 269 (269)
Q Consensus 256 Rps~~--~~~~l~~~~ 269 (269)
||++. ..+++.|+|
T Consensus 238 R~~~~~~~~~il~~~~ 253 (323)
T cd05575 238 RLGAKDDFLEIKNHVF 253 (323)
T ss_pred CCCCCCCHHHHHcCCC
Confidence 99974 246667766
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=320.97 Aligned_cols=246 Identities=25% Similarity=0.403 Sum_probs=213.7
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
.-+.++.++.||.|-||.||.|.++. ...|++|.+...... .+++.+|++++++|+|++|+++++++..+..+++
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 33456677899999999999999975 346999998765433 3567799999999999999999999999889999
Q ss_pred EEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 89 VLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
||||++.|+|.+++.. ++.+...+++.++.||++|++||+++++|||||...||||+++..+|++|||+++.......
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y 358 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY 358 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence 9999999999999987 45799999999999999999999999999999999999999999999999999984322111
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 244 (269)
. ......-+..|+|||.+....++ .+|||||||+++||++| |+.||.+....+..+.+..| +.+.|..||+++.++
T Consensus 359 ~-~~~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~l 436 (468)
T KOG0197|consen 359 T-ASEGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYEL 436 (468)
T ss_pred e-ecCCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHH
Confidence 1 11122235689999999888875 99999999999999998 99999999999999999775 578899999999999
Q ss_pred HHHhcCCCCCCcCCCCc
Q 024347 245 IARILDPNPMTVSIYPF 261 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~ 261 (269)
+..||+.+|++|||++.
T Consensus 437 M~~CW~~~P~~RPtF~~ 453 (468)
T KOG0197|consen 437 MKSCWHEDPEDRPTFET 453 (468)
T ss_pred HHHHhhCCcccCCCHHH
Confidence 99999999999999953
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=323.27 Aligned_cols=259 Identities=32% Similarity=0.561 Sum_probs=234.2
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 85 (269)
....++|.+.+.||+|.||.|+++..+.+++.+|+|++++......+..+..+.|-+++.... ||.++.++..|++.++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345689999999999999999999999999999999999988888888899999999998885 9999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+++||||..||++.. +...+.+++..+.-++..++.||+|||++||++||||.+||+++.+|.+||+|||+|+- ...
T Consensus 444 l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe--~m~ 520 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE--GMG 520 (694)
T ss_pred EEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc--cCC
Confidence 999999999999643 33446899999999999999999999999999999999999999999999999999973 223
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 245 (269)
....+....|||.|+|||++.+..++ .++|.||||+++|+|+.|..||.+++..+.++.|...+...|.+++.+..+++
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il 599 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM 599 (694)
T ss_pred CCCccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence 34466677899999999999998885 99999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCcCCCCc---cccccccC
Q 024347 246 ARILDPNPMTVSIYPF---ADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~---~~~l~~~~ 269 (269)
+++|..||++|.-+-+ .++-.|+|
T Consensus 600 ~~ll~k~p~kRLG~~e~d~~~i~~hpF 626 (694)
T KOG0694|consen 600 RRLLRKNPEKRLGSGERDAEDIKKHPF 626 (694)
T ss_pred HHHhccCcccccCCCCCCchhhhhCCc
Confidence 9999999999998743 33445554
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-47 Score=313.89 Aligned_cols=249 Identities=35% Similarity=0.609 Sum_probs=215.1
Q ss_pred eeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 16 GRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
++.||+|+||.||++++. .+++.+|+|++...... .......+.+|+.+++.++||||+++++.+...+..+++||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 46889999999765432 22334567889999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
|+++++|.+.+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 999999999998888899999999999999999999999999999999999999999999999998763221 122223
Q ss_pred ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCC
Q 024347 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (269)
...+++.|+|||++.+.... .++||||||+++|+|++|..||...+.......+..+....++.+++.+.+||+.||+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 34578999999999877664 89999999999999999999999988888888888888888889999999999999999
Q ss_pred CCCCcC-----CCCccccccccC
Q 024347 252 NPMTVS-----IYPFADILYMRF 269 (269)
Q Consensus 252 dP~~Rp-----s~~~~~~l~~~~ 269 (269)
||++|| ++ .+++.|+|
T Consensus 238 ~p~~R~~~~~~~~--~~l~~h~~ 258 (323)
T cd05584 238 NPSSRLGAGPGDA--AEVQSHPF 258 (323)
T ss_pred CHhHcCCCCCCCH--HHHhcCCC
Confidence 999999 44 55666665
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=314.94 Aligned_cols=250 Identities=33% Similarity=0.572 Sum_probs=213.9
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||+|++|.||++.+..+++.||+|++...........+.+..|..+++.+ +||||+++++++.+....+++|||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4689999999999999999999999999876655555567788999999888 699999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.... ..........+
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccC
Confidence 9999888887889999999999999999999999999999999999999999999999999876321 11222233467
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------NLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
++.|+|||++.+..+. .++|+||||+++|+|++|..||... ......+.+.......+..++..+.++|+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 8999999999877664 8999999999999999999999631 22234555666777778889999999999
Q ss_pred HhcCCCCCCcCCCC----ccccccccC
Q 024347 247 RILDPNPMTVSIYP----FADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~----~~~~l~~~~ 269 (269)
.||+.||.+|++.+ ..+++.|+|
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 99999999999853 367778877
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=309.99 Aligned_cols=254 Identities=29% Similarity=0.428 Sum_probs=208.6
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||+|++|.||+++++.+++.+++|.+..... .....+.+.+|+.+++.++|+||+++++.+...+..++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 579999999999999999999999999999999875432 2333567788999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++++.+.........+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccc
Confidence 9999876655444456789999999999999999999999999999999999999999999999999875432111 112
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------------
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------------- 229 (269)
....+++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...+..+....+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 23457889999999987765 48999999999999999999999876554433322110
Q ss_pred ccc-----------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EFT-----------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~~-----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+ ....++.++.+||++||++||++|||+ .+++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~--~~~l~hp~ 286 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT--EQCLNHPA 286 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH--HHHhcCCC
Confidence 000 011267889999999999999999999 88899998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=318.21 Aligned_cols=255 Identities=31% Similarity=0.492 Sum_probs=216.0
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCC-
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT- 84 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~- 84 (269)
....+||++.+.||.|.||.||+|+.+.+|+.||+|.++.....-++ -.-.+|+..|++++ ||||+++.+++.+..
T Consensus 6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee--~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE--CMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH--HHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 45568999999999999999999999999999999998654433222 23457999999998 999999999998877
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
.+++||||++ .+|.+++..+ +.+++..+..|+.||++||+++|.+|++|||+||+|||+.....+||+|||+|+....
T Consensus 84 ~L~fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 84 ILYFVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred eEeeeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccccc
Confidence 8999999995 5999988765 5799999999999999999999999999999999999999989999999999985433
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------------
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--------------- 228 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--------------- 228 (269)
......+..|.=|+|||++....+++.+.|+|++||+++|+.+-++.|.+.+..+...+++.
T Consensus 163 ---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 ---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred ---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 33344556677899999999998889999999999999999999999998888777766641
Q ss_pred ----CcccCC-----------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 ----AEFTCP-----------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 ----~~~~~~-----------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
-.+.+| +.++.+..++|..||.|||.+||++ .++|+|+|
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA--~~al~~pf 293 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA--SQALQHPF 293 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH--HHHhcCcc
Confidence 111111 1268899999999999999999999 66777765
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=312.43 Aligned_cols=250 Identities=34% Similarity=0.603 Sum_probs=216.7
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||.|+||.||++.+..+++.+|+|.+.............+..|..+++.+ +||||+++++++.+.+..++||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876555555567778888988888 699999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 99998888888899999999999999999999999999999999999999999999999998763211 1122223457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+. .++|+||||+++|+|++|..||...+.......+.......+..++..+.+||+.||+.||.+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 8899999999887764 899999999999999999999999888888888888888888889999999999999999999
Q ss_pred cCCCCc---cccccccC
Q 024347 256 VSIYPF---ADILYMRF 269 (269)
Q Consensus 256 Rps~~~---~~~l~~~~ 269 (269)
||++.. .+++.|+|
T Consensus 238 R~s~~~~~~~~ll~~~~ 254 (318)
T cd05570 238 RLGCLPTGEQDIKGHPF 254 (318)
T ss_pred cCCCCCCCHHHHhcCCC
Confidence 999722 33445544
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=311.93 Aligned_cols=255 Identities=31% Similarity=0.530 Sum_probs=220.8
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+|++.+.||.|++|.||++.++.+|+.||+|.+...........+.+..|..++..+. |++++++++.+.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999998765444455667788888888886 577888999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++|++|..++...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 9999999999988878899999999999999999999999999999999999999999999999998764221 11122
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcC
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (269)
....+++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...........+.......+..++.++.++++.||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 23457899999999987766 48999999999999999999999999888888888888888888899999999999999
Q ss_pred CCCCCcCCCCc---cccccccC
Q 024347 251 PNPMTVSIYPF---ADILYMRF 269 (269)
Q Consensus 251 ~dP~~Rps~~~---~~~l~~~~ 269 (269)
.||.+|++..+ .+++.|+|
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~ 259 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAF 259 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcc
Confidence 99999999642 34556655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=311.31 Aligned_cols=249 Identities=32% Similarity=0.568 Sum_probs=213.4
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhh-CCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||+|+||.||+|.+..+++.+|+|.+................|..++.. ++||||+++++++.+.+..+++|||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987654333344566677777775 4899999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+.....+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 99999988877899999999999999999999999999999999999999999999999998763221 1112233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+ +.++|+||+|+++|+|++|..||...+..+....+.......+..++.+++++|..||+.||++
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 889999999987766 4899999999999999999999999888888888887777777889999999999999999999
Q ss_pred cCCCCccccccccC
Q 024347 256 VSIYPFADILYMRF 269 (269)
Q Consensus 256 Rps~~~~~~l~~~~ 269 (269)
||++. .+++.|+|
T Consensus 238 R~~~~-~~l~~h~~ 250 (316)
T cd05619 238 RLGVK-GDIRQHPF 250 (316)
T ss_pred cCCCh-HHHHcCcc
Confidence 99983 14556665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=320.70 Aligned_cols=255 Identities=33% Similarity=0.583 Sum_probs=216.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++++.||.|+||.||++.+..+++.||+|++...........+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999997765555556678899999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC---
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~--- 167 (269)
||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999988532110000
Q ss_pred -------C-----------------------------------cccccccCccccCcccccCCCCCCCchhHHHHHHHHH
Q 024347 168 -------G-----------------------------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205 (269)
Q Consensus 168 -------~-----------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~ 205 (269)
. ......+++.|+|||++.+..+ +.++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence 0 0011357889999999987766 48999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhcC--cccCC--CCCCHHHHHHHHHhcCCCCCCcC---CCCccccccccC
Q 024347 206 VLLAGYLPFDDSNLMNLYKKISAA--EFTCP--PWLSFTARKLIARILDPNPMTVS---IYPFADILYMRF 269 (269)
Q Consensus 206 ~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~~~l~~li~~~l~~dP~~Rp---s~~~~~~l~~~~ 269 (269)
+|++|..||......+....+... ....+ ..++.++++||+.||+ +|.+|+ ++ .+++.|+|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~--~~~l~hp~ 307 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA--HEIKSHPF 307 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH--HHHhcCCC
Confidence 999999999988877777776542 23333 3478999999999998 777765 66 77888877
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=315.75 Aligned_cols=255 Identities=32% Similarity=0.580 Sum_probs=217.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||+|++|+||++.++.+++.+|+|++.............+.+|+.++..++|++|+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765555555678889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC---
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~--- 167 (269)
||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998643221100
Q ss_pred ------------------------------CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 024347 168 ------------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (269)
Q Consensus 168 ------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (269)
.......|++.|+|||++.+..+. .++|+||||+++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 001223588999999999877764 8999999999999999999999998
Q ss_pred CHHHHHHHHhcC--cccCCC--CCCHHHHHHHHHhcCCCCCC---cCCCCccccccccC
Q 024347 218 NLMNLYKKISAA--EFTCPP--WLSFTARKLIARILDPNPMT---VSIYPFADILYMRF 269 (269)
Q Consensus 218 ~~~~~~~~~~~~--~~~~~~--~~~~~l~~li~~~l~~dP~~---Rps~~~~~~l~~~~ 269 (269)
...+...++... ...+++ .++++++++|..|+. +|.+ ||++ .+++.|+|
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~--~ei~~hp~ 295 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGV--EEIKTNPF 295 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCH--HHHhCCCC
Confidence 888888887653 233443 378999999999775 4554 5777 77788887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=307.68 Aligned_cols=253 Identities=28% Similarity=0.417 Sum_probs=208.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+.++++++||||+++++++.+.+..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5789999999999999999999999999999999864332 12234667899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+.+ +|.+.+...+ .++...+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++....... .
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--K 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--c
Confidence 999975 8888776543 57899999999999999999999999999999999999999999999999886433211 1
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc------------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------ 230 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------ 230 (269)
......+++.|+|||++.+....+.++|+||+|+++|+|++|..||.+....+....+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 22234568899999998765545689999999999999999999998776655444332100
Q ss_pred ---c---------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ---F---------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ---~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+ ...+.++.+..+||++||++||.+|||+ .+++.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~--~~~l~hp~ 287 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISA--EAALRHSY 287 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCH--HHHhcCCC
Confidence 0 0112367889999999999999999999 88899988
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-48 Score=289.20 Aligned_cols=254 Identities=37% Similarity=0.686 Sum_probs=236.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|.+++.||.|.||.||+|+.+.++-.+|+|++...........+.+.+|+++-..|+||||+++|++|.+...+|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 46789999999999999999999999999999999988777777778899999999999999999999999999999999
Q ss_pred EEeccCCCchhHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 89 VLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 89 v~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||...|++...+. ..+.+++...+.++.|++.||.|+|..+++|+||+|+|++++..+.++++|||.+...+
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---- 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---- 175 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC----
Confidence 999999999999998 45679999999999999999999999999999999999999999999999999875422
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
.+......|+..|.|||...+..++ ...|+|++|++.|+++.|..||......+.++.+...+..+|+.++...+|+|.
T Consensus 176 ~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI~ 254 (281)
T KOG0580|consen 176 SNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLIS 254 (281)
T ss_pred CCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHHH
Confidence 4445566799999999999998886 999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.||..+|.+|.+. .+.+.|+|
T Consensus 255 ~ll~~~p~~r~~l--~~v~~hpw 275 (281)
T KOG0580|consen 255 RLLVKNPIERLAL--TEVMDHPW 275 (281)
T ss_pred HHhccCccccccH--HHHhhhHH
Confidence 9999999999998 77788877
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=312.74 Aligned_cols=257 Identities=30% Similarity=0.543 Sum_probs=214.9
Q ss_pred CeEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 86 (269)
+|++.+.||+|++|.||++++. .+++.+|+|++...... .....+.+.+|+.+++.++ |++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999998864 46899999998764432 2334567888999999995 89999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+++|||+++++|.+.+...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999998888899999999999999999999999999999999999999999999999998865332111
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHhcCcccCCCCCCHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD----SNLMNLYKKISAAEFTCPPWLSFTAR 242 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (269)
.......+++.|+|||++.+....+.++||||||+++|+|++|..||.. .........+.......+..+++.+.
T Consensus 161 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 161 -ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred -CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 1222345789999999998765446899999999999999999999964 23345555666666777778999999
Q ss_pred HHHHHhcCCCCCCcCCCC---ccccccccC
Q 024347 243 KLIARILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
++++.||+.||++||++. ..+++.|+|
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 999999999999999652 256777776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=313.13 Aligned_cols=250 Identities=33% Similarity=0.575 Sum_probs=213.0
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||+|+||.||++.+..+++.+|+|.+...........+.+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876555555567788898888776 799999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 99988888878899999999999999999999999999999999999999999999999998864221 1122233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---------SNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
++.|+|||++.+..+. .++|+||||+++|+|++|..||.. .......+.+.......+..++..+.++|+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 8999999999887764 899999999999999999999952 122334555666777778889999999999
Q ss_pred HhcCCCCCCcCCCC----ccccccccC
Q 024347 247 RILDPNPMTVSIYP----FADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~----~~~~l~~~~ 269 (269)
.||+.||++||++. ..+++.|+|
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPF 264 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCC
Confidence 99999999999963 357778876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=315.76 Aligned_cols=255 Identities=29% Similarity=0.513 Sum_probs=218.3
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.++.+++.+|+|.+...........+.+.+|+.+++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766545555677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||+++++|.+++... ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||++........ ..
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc-ee
Confidence 999999999998776 6799999999999999999999999999999999999999999999999999875432111 11
Q ss_pred ccccccCccccCcccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc----ccCCCCCCHH
Q 024347 170 LHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----FTCPPWLSFT 240 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 240 (269)
.....+++.|+|||++.. ....+.++||||||+++|+|++|..||..........++.... ++..+.+++.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 223357889999999863 2233588999999999999999999999888777777765432 2333458999
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+||+.||+ ||.+||++ .+++.|+|
T Consensus 240 ~~~li~~ll~-~p~~R~t~--~~l~~h~~ 265 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGY--EGLCCHPF 265 (330)
T ss_pred HHHHHHHHcc-ChhhCCCH--HHHhCCCC
Confidence 9999999998 99999999 77788876
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=297.80 Aligned_cols=255 Identities=37% Similarity=0.673 Sum_probs=227.7
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...+.|++.+.||+|+||.|+++.+..+|+.+++|.++...+... ..+.+.+|+++-+.|+||||+++.+.....+..+
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 345789999999999999999999999999999999987665544 5689999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC---CCCEEEeeCCCccccccc
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~---~~~~~l~df~~~~~~~~~ 164 (269)
+|+|++.|+.|..-+-.+..+++..+-...+||+++|.|.|++||||+|++|+|+++-. .-.+||+|||++...+
T Consensus 87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 99999999998766666667888888899999999999999999999999999999953 3349999999886544
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC----CCCHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFT 240 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 240 (269)
.........|+|+|+|||+....++. ..+|||+.|+++|-++.|.+||.+.+...+++++..+....++ .++++
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~ 242 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPE 242 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHH
Confidence 44555667899999999999888775 8899999999999999999999999999999999998876664 48999
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++|++.||..||.+|.|+ -++|.|+|
T Consensus 243 Ak~LvrrML~~dP~kRIta--~EAL~HpW 269 (355)
T KOG0033|consen 243 AKSLIRRMLTVNPKKRITA--DEALKHPW 269 (355)
T ss_pred HHHHHHHHhccChhhhccH--HHHhCCch
Confidence 9999999999999999999 88899998
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=311.13 Aligned_cols=250 Identities=34% Similarity=0.572 Sum_probs=213.9
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHH-HhhhCCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||+|++|.||+|++..+++.+++|.+.............+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997665444444455555554 67889999999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 99988888777899999999999999999999999999999999999999999999999998764221 1222233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+. .++|+||||+++|+|++|..||...+.....+.+.......+...+..+.++|..||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 8899999999876664 899999999999999999999999988888888888888888889999999999999999999
Q ss_pred cCCCC--ccccccccC
Q 024347 256 VSIYP--FADILYMRF 269 (269)
Q Consensus 256 Rps~~--~~~~l~~~~ 269 (269)
||+.. ..+++.|+|
T Consensus 238 R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 238 RLGAKADFLEIKNHVF 253 (321)
T ss_pred cCCCCCCHHHHhCCCC
Confidence 99863 235555554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=312.83 Aligned_cols=250 Identities=35% Similarity=0.566 Sum_probs=215.4
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHH-HhhhCCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||.|+||.||++.+..+|+.+|+|++.............+..|.. +++.++||||+++++.+...+..+++|||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999999999999999997655444444455555554 56789999999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 99998888888899999999999999999999999999999999999999999999999998764221 1222233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+. .++||||||+++|+|++|..||...+..+....+.......++..+..+.++|+.||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 8999999999887764 899999999999999999999999988888888888887777889999999999999999999
Q ss_pred cCCCCc--cccccccC
Q 024347 256 VSIYPF--ADILYMRF 269 (269)
Q Consensus 256 Rps~~~--~~~l~~~~ 269 (269)
||++.. .+++.|+|
T Consensus 238 R~~~~~~~~~i~~h~~ 253 (325)
T cd05604 238 RLGAKEDFLEIQEHPF 253 (325)
T ss_pred cCCCCCCHHHHhcCCC
Confidence 999743 46677766
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=318.30 Aligned_cols=256 Identities=29% Similarity=0.457 Sum_probs=225.8
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
...-..|+..+.||+|+||.||+|.+..+++.||+|++..+.. +..++++++|+.+|.+++++||.+.|+.+..+..+
T Consensus 9 ~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L 86 (467)
T KOG0201|consen 9 IDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL 86 (467)
T ss_pred CCcccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence 3445578888999999999999999999999999999987764 44478999999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+++|||+.||++.+.+..+..+.+..+.-+++.++.|+.|||..+.+|+||++.||++..+|.|+|+|||.+........
T Consensus 87 wiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999999999998887789999999999999999999999999999999999999999999999998876554332
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC-CCCCHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-PWLSFTARKLI 245 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li 245 (269)
. .....|++.|||||++.+..+. .++||||||+++++|.+|.+|+....++.....|-...+|.. ..+++.+++|+
T Consensus 167 r--r~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV 243 (467)
T KOG0201|consen 167 R--RKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFV 243 (467)
T ss_pred c--cccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHH
Confidence 2 2556799999999999976665 999999999999999999999999888766666655444433 45899999999
Q ss_pred HHhcCCCCCCcCCCCccccccccC
Q 024347 246 ARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..||++||+.|||+ .++|.|+|
T Consensus 244 ~~CL~k~P~~RpsA--~~LLKh~F 265 (467)
T KOG0201|consen 244 EACLDKNPEFRPSA--KELLKHKF 265 (467)
T ss_pred HHHhhcCcccCcCH--HHHhhhHH
Confidence 99999999999999 88888876
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=316.57 Aligned_cols=260 Identities=31% Similarity=0.520 Sum_probs=220.2
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
.....++|++.+.||.|++|.||++++..+++.+|+|.+.............+.+|+.+++.++||||+++++.+.+...
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 44567899999999999999999999999999999999976544444445667889999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999999987765 468899999999999999999999999999999999999999999999999886543211
Q ss_pred CCCcccccccCccccCcccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--ccCC--CCCC
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP--PWLS 238 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~--~~~~ 238 (269)
........+++.|+|||++.+.. ..+.++|+||||+++|+|++|..||........+.++.... ...+ ..++
T Consensus 197 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (370)
T cd05596 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEIS 275 (370)
T ss_pred -cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCC
Confidence 11122345889999999986543 24589999999999999999999999988888888876543 3333 3579
Q ss_pred HHHHHHHHHhcCCCCCC--cCCCCccccccccC
Q 024347 239 FTARKLIARILDPNPMT--VSIYPFADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~--Rps~~~~~~l~~~~ 269 (269)
.++++||+.||+.+|.+ |+++ .+++.|+|
T Consensus 276 ~~~~~li~~~L~~~p~r~~R~s~--~ell~h~~ 306 (370)
T cd05596 276 KQAKDLICAFLTDREVRLGRNGV--DEIKSHPF 306 (370)
T ss_pred HHHHHHHHHHccChhhccCCCCH--HHHhcCcc
Confidence 99999999999999988 9998 78888887
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=313.17 Aligned_cols=260 Identities=31% Similarity=0.485 Sum_probs=220.6
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK- 83 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 83 (269)
+.+...+.|+-+++||+|.||.||+|++..+|+.||+|.+..+.. .+.+..-..+|+.+|++|.||||+++.++....
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 456677889999999999999999999999999999999976553 234456778999999999999999999998765
Q ss_pred -CeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 84 -TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 84 -~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
+.+|+|+||++. +|..++... -.|++.+++-+.+|++.||.|+|++||+|+|||.+|||++.+|.+||+|||+++++
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 789999999976 887777764 36999999999999999999999999999999999999999999999999999977
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--Ccc-----c--
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEF-----T-- 232 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~-----~-- 232 (269)
....... .....-|.=|+|||.+.+...++.+.|+||.|||+.||+.|++.|.+.+..+....|.. |.+ +
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 6533322 33444577899999999999889999999999999999999999999988887777631 111 0
Q ss_pred -CC-------------------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 -CP-------------------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 -~~-------------------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.| ..+++...+|+..||..||.+|.|+ ..+|.++|
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA--~~aL~sey 402 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTA--SSALQSEY 402 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccH--HHHhcCcc
Confidence 01 0168888999999999999999999 77777665
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=317.72 Aligned_cols=257 Identities=33% Similarity=0.524 Sum_probs=215.4
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++++.||+|+||.||+|++..+++.+|+|.+.............+.+|+++++.++|+||+++++.+.+....++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765545555678899999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC----
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~---- 166 (269)
||+++++|.+.+.+.+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999999988878899999999999999999999999999999999999999999999999998743210000
Q ss_pred -----------------------------------------CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHH
Q 024347 167 -----------------------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205 (269)
Q Consensus 167 -----------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~ 205 (269)
........+++.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 0001123578899999999877764 8999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhcCc--c--cCCCCCCHHHHHHHHHhcCCCCCCcCCCC-ccccccccC
Q 024347 206 VLLAGYLPFDDSNLMNLYKKISAAE--F--TCPPWLSFTARKLIARILDPNPMTVSIYP-FADILYMRF 269 (269)
Q Consensus 206 ~l~~g~~p~~~~~~~~~~~~~~~~~--~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~-~~~~l~~~~ 269 (269)
+|++|+.||...+..+....+.... . +....+++++.++|..|+ .||++|++.. ..+++.|+|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~ 307 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPF 307 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCC
Confidence 9999999999887777666665422 2 223457999999999987 5999999822 256677776
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=310.94 Aligned_cols=250 Identities=35% Similarity=0.585 Sum_probs=212.4
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHH-HHhhhCCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV-ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~-~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||+|+||.||++++..+++.+|+|++.............+..|. .+++.++|+||+++++.+...+..+++|||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999765443333334444444 457889999999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 99999998888899999999999999999999999999999999999999999999999998864221 1222334458
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
++.|+|||++.+..+. .++||||||+++|+|++|..||...+..+....+.......++.++..+.++|+.||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 8999999999887664 899999999999999999999999888888888888777777889999999999999999999
Q ss_pred cCCCCc--cccccccC
Q 024347 256 VSIYPF--ADILYMRF 269 (269)
Q Consensus 256 Rps~~~--~~~l~~~~ 269 (269)
||++.+ .+++.|.|
T Consensus 238 R~~~~~~~~~i~~~~~ 253 (325)
T cd05602 238 RLGAKDDFMEIKNHIF 253 (325)
T ss_pred CCCCCCCHHHHhcCcc
Confidence 999853 24445543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-46 Score=309.21 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=212.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
-++|++.+.||+|++|.||++++..++..+++|.+.... .....+.+.+|++++++++||||+++++++...+..+++
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999987542 234457899999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+++++|.+++.....+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----c
Confidence 99999999999998888899999999999999999999986 699999999999999999999999998864422 1
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-------------------- 228 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 228 (269)
......+++.|+|||++.+... +.++|+||||+++|+|++|+.||...+..++...+..
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 2223457889999999987765 4899999999999999999999987665544332211
Q ss_pred --------------------------Ccc-cC-CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 --------------------------AEF-TC-PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 --------------------------~~~-~~-~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
... .. ...+++++++||++||++||++|||+ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~--~ell~h~~ 303 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL--KMLMNHTF 303 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCH--HHHhcChH
Confidence 100 11 12367899999999999999999999 77788876
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=316.04 Aligned_cols=256 Identities=32% Similarity=0.510 Sum_probs=215.0
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+.|++++.||+|+||+||+|.+..+++.+|+|.+.............+.+|+.+++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999998766555555678999999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC----
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~---- 166 (269)
||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998753211000
Q ss_pred -----------------------------------------CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHH
Q 024347 167 -----------------------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILF 205 (269)
Q Consensus 167 -----------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~ 205 (269)
........|++.|+|||++.+..+. .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHH
Confidence 0001123588999999999877664 8999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhc--CcccCC--CCCCHHHHHHHHHhc--CCCCCCcCCCCccccccccC
Q 024347 206 VLLAGYLPFDDSNLMNLYKKISA--AEFTCP--PWLSFTARKLIARIL--DPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 206 ~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~--~~~~~~l~~li~~~l--~~dP~~Rps~~~~~~l~~~~ 269 (269)
+|++|..||...........+.. .....+ ..+++++.+||++|+ ..+|..||++ .+++.|+|
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~--~~~l~hp~ 307 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA--DDIKAHPF 307 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCH--HHHhcCcc
Confidence 99999999988777666665543 223333 357999999999955 4556669998 78888887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=313.38 Aligned_cols=249 Identities=34% Similarity=0.581 Sum_probs=215.1
Q ss_pred eeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEecc
Q 024347 17 RTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 93 (269)
+.||+|++|.||++++. .+|+.+|+|++...... ......+.+|++++++++||||+++++.+.+.+..++||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999998763 57899999999765432 223456778999999999999999999999999999999999
Q ss_pred CCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccc
Q 024347 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173 (269)
Q Consensus 94 ~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 173 (269)
++++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CCceecc
Confidence 99999999888778999999999999999999999999999999999999999999999999987643221 1222334
Q ss_pred ccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCC
Q 024347 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253 (269)
Q Consensus 174 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 253 (269)
.+++.|+|||.+.+... +.++|+||||+++|+|++|..||...........+.......+..+++.+.+||+.||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 57889999999987666 48999999999999999999999998888888888888888888899999999999999999
Q ss_pred CCcCCCCc---cccccccC
Q 024347 254 MTVSIYPF---ADILYMRF 269 (269)
Q Consensus 254 ~~Rps~~~---~~~l~~~~ 269 (269)
++||++.+ .+++.|+|
T Consensus 238 ~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred hHcCCCCCCCHHHHhCCCC
Confidence 99999754 34556655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=303.37 Aligned_cols=253 Identities=37% Similarity=0.676 Sum_probs=223.9
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.+..+++.+++|.+...........+.+.+|+++++++.||||+++++.+......+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999997665555555678899999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||+++++|.+++...+.++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999988888999999999999999999999999999999999999999999999999988654322 2
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcC
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (269)
....+++.|+|||.+.+... +.++|+||||+++|+|++|..||...........+..+....+..++..++++|+.||+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 23356789999999877665 48899999999999999999999988888888888888888888899999999999999
Q ss_pred CCCCCcCCC---CccccccccC
Q 024347 251 PNPMTVSIY---PFADILYMRF 269 (269)
Q Consensus 251 ~dP~~Rps~---~~~~~l~~~~ 269 (269)
.||.+|++. ...+.+.|+|
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcc
Confidence 999999943 1256677776
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=299.90 Aligned_cols=256 Identities=27% Similarity=0.430 Sum_probs=216.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-----CC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-----KT 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~ 84 (269)
..+|...+.||.|++|.|..+.++.+|+.||+|++.. .+.+...+++..+|+.+|+.++|+||+.+.+++.. -.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3466668999999999999999999999999999853 34455667889999999999999999999999865 34
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++|+|++ +.+|.+.+..+..++.+.+.-++.|++.||+|+|+.+++|+|+||+|++++.+..+|++|||+++.....
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 689999999 5588888888777999999999999999999999999999999999999999999999999999977654
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------- 229 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 229 (269)
........+..|.-|+|||++.....++.+.||||+||++.+|++|+..|.+.+.....+.+..-
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 33444455667888999999988888889999999999999999999999876665444443110
Q ss_pred --------cccC--------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 --------EFTC--------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 --------~~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
-... -+..++...+|+.+||..||.+|+|+ .++|.|+|
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita--~eAL~hPY 312 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITA--EEALAHPY 312 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCH--HHHhcChh
Confidence 0011 12378899999999999999999999 88888875
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=316.91 Aligned_cols=255 Identities=33% Similarity=0.525 Sum_probs=215.0
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.+..+++.+|+|.+.............+.+|+++++.++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999987655444445677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC----
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~---- 166 (269)
||+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++........
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 9999999999998888899999999999999999999999999999999999999999999999998742210000
Q ss_pred -------------------------------------CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc
Q 024347 167 -------------------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA 209 (269)
Q Consensus 167 -------------------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 209 (269)
........|++.|+|||++.+..+. .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 0000123578899999999877764 89999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCc--cc--CCCCCCHHHHHHHHHhcCCCCCCcC---CCCccccccccC
Q 024347 210 GYLPFDDSNLMNLYKKISAAE--FT--CPPWLSFTARKLIARILDPNPMTVS---IYPFADILYMRF 269 (269)
Q Consensus 210 g~~p~~~~~~~~~~~~~~~~~--~~--~~~~~~~~l~~li~~~l~~dP~~Rp---s~~~~~~l~~~~ 269 (269)
|..||......+....+.... .. ....+++++.++|..|+ .+|++|+ ++ .+++.|+|
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~--~ell~h~~ 303 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGA--DEIKAHPF 303 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCH--HHHhCCCC
Confidence 999999888777666654432 22 23358899999999987 5999999 66 77888887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=306.93 Aligned_cols=253 Identities=27% Similarity=0.429 Sum_probs=202.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||+|.++.+++.+|+|.+...... .....+.+|+.+++.++||||+++++++.+....++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 47899999999999999999999999999999998643321 1234567899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+. +++.+.+... +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP--SH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC--Cc
Confidence 99996 4777766554 56899999999999999999999999999999999999999999999999988643221 11
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhc--Cc---------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISA--AE--------------- 230 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~--~~--------------- 230 (269)
......+++.|+|||++.+....+.++|+||||+++|+|++|..||.+... ....+.+.. +.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 223345688999999987655456889999999999999999999976432 222222110 00
Q ss_pred ----cc--CC---------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ----FT--CP---------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ----~~--~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. .+ ...+..+.+|++.||+.||.+|||+ .+++.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~--~~~l~h~~ 290 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA--QAALSHEY 290 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH--HHHhcCcc
Confidence 00 00 0135678999999999999999999 78888887
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=314.83 Aligned_cols=253 Identities=29% Similarity=0.487 Sum_probs=229.6
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe-EE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-IF 87 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~ 87 (269)
..++|.+++.+|+|+||.+++++++.+++.+++|++........ ..+...+|+.++++++||||+.+.+.|..++. .+
T Consensus 2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence 35789999999999999999999999999999999987765443 35688999999999999999999999988887 99
Q ss_pred EEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+||+|++||++.+.+.+.+ .++++.+..|+.|++.|+.|||++.|+|+||++.|||++.++.|+|+|||+++......
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999999997754 68999999999999999999999999999999999999999999999999998766533
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 244 (269)
.......|++.|++||++.+.++. .|+|||||||++|+|++-+.+|+..+-..+..++..+. .+.+..++.+++.+
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l 237 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL 237 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence 344566799999999999999986 99999999999999999999999999999999998887 67788899999999
Q ss_pred HHHhcCCCCCCcCCCCccccccc
Q 024347 245 IARILDPNPMTVSIYPFADILYM 267 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~ 267 (269)
|+.||+.+|+.||++ .+.|.+
T Consensus 238 v~~~l~~~P~~RPsa--~~LL~~ 258 (426)
T KOG0589|consen 238 VKSMLRKNPEHRPSA--LELLRR 258 (426)
T ss_pred HHHHhhcCCccCCCH--HHHhhC
Confidence 999999999999998 555543
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=309.09 Aligned_cols=253 Identities=40% Similarity=0.688 Sum_probs=229.1
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 88 (269)
...|++.+.||+|.||.||.++.+.+|+.+|+|.+.............+.+|+.+|++++ ||||+.+++.|.+...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 457999999999999999999999999999999998877666556789999999999998 9999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC----CCEEEeeCCCccccccc
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY----GNLKVSDFGLSALSQQV 164 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~----~~~~l~df~~~~~~~~~ 164 (269)
|||++.||.|.+.+... .+++.....+++|+++++.|+|+.|++|+|++|+|+++... +.++++|||++.....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~- 191 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP- 191 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence 99999999999998876 49999999999999999999999999999999999999633 4799999999876544
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC----CCCHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFT 240 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 240 (269)
........|++.|+|||++....+. ..+|+||+|+++|.|++|..||.+.........+..+++.+.. .++..
T Consensus 192 --~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~ 268 (382)
T KOG0032|consen 192 --GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES 268 (382)
T ss_pred --CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence 4456667899999999999887764 9999999999999999999999999999999999888775543 37999
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++||+.||..||.+|+++ .++|.|+|
T Consensus 269 akd~i~~ll~~dp~~R~ta--~~~L~HpW 295 (382)
T KOG0032|consen 269 AKDFIRKLLEFDPRKRLTA--AQALQHPW 295 (382)
T ss_pred HHHHHHHhcccCcccCCCH--HHHhcCcc
Confidence 9999999999999999999 88899998
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=301.78 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=211.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
.|++.+.||.|++|.||++.+..+++.||+|.+.............+.+|+.+++.++|+||+++++.+...+..+++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999998999999999876554444444567789999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|+++++|...+... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 99999998777543 3589999999999999999999999999999999999999999999999998865332 111
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHhcCcccCCCCCCHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY----KKISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li 245 (269)
.....+++.|+|||++.+... +.++|+||+|+++|++++|..||.+....... ..+.......+..++..+.+|+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 223357889999999987665 48899999999999999999999876554332 3333444455667899999999
Q ss_pred HHhcCCCCCCcCCCC---ccccccccC
Q 024347 246 ARILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
+.||+.||.+||++. ..+++.|+|
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 999999999999432 146667776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=313.65 Aligned_cols=257 Identities=32% Similarity=0.582 Sum_probs=219.0
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||+|++|.||++.++.+++.+|+|++.............+.+|+.++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998655545555678889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC---
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--- 167 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~--- 167 (269)
||++|++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999987643211100
Q ss_pred ------------------------------CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 024347 168 ------------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (269)
Q Consensus 168 ------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (269)
.......|++.|+|||++.+..+. .++|+|||||++|+|++|..||...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 001123578999999999877764 8999999999999999999999998
Q ss_pred CHHHHHHHHhcC--cccCCC--CCCHHHHHHHHHhcCCCCCCcCCCC-ccccccccC
Q 024347 218 NLMNLYKKISAA--EFTCPP--WLSFTARKLIARILDPNPMTVSIYP-FADILYMRF 269 (269)
Q Consensus 218 ~~~~~~~~~~~~--~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~-~~~~l~~~~ 269 (269)
........+... ...+++ .++++++++|.+|+. ||.+|++.. ..+++.|+|
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~ 295 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCC
Confidence 888887777653 233333 378999999999875 999999753 367778887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=308.17 Aligned_cols=250 Identities=32% Similarity=0.584 Sum_probs=213.1
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||+|++|.||++.+..+++.+|+|.+...........+.+.+|..++.++ +|++|+++++.+......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876655556677888999999888 599999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 99998888878899999999999999999999999999999999999999999999999998763221 1122233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHHhcCcccCCCCCCHHHHHHHHHh
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-------SNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (269)
++.|+|||++.+..+ +.++|+||||+++|+|++|..||.. .........+.......+..++..+.+++++|
T Consensus 159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 899999999987766 4899999999999999999999953 22334555556666777888999999999999
Q ss_pred cCCCCCCcCCCC----ccccccccC
Q 024347 249 LDPNPMTVSIYP----FADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~----~~~~l~~~~ 269 (269)
|+.||.+|++++ ..+++.|+|
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~ 262 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTF 262 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCC
Confidence 999999999964 346666665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=308.99 Aligned_cols=254 Identities=27% Similarity=0.449 Sum_probs=203.8
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----CeE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----TKI 86 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~ 86 (269)
+|++.+.||.|++|.||+|.++.+++.||+|.+..... .......+.+|+.+++.++||||+++++++... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999864322 222345688999999999999999999987543 347
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+++|||+. ++|.+.+.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 58888888877899999999999999999999999999999999999999999999999999875432221
Q ss_pred C-CcccccccCccccCcccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----------------
Q 024347 167 D-GLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------------- 228 (269)
Q Consensus 167 ~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------- 228 (269)
. .......+++.|+|||++.+. ...+.++||||||+++|+|++|+.||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 238 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 1 112334578899999998752 2335899999999999999999999976654332211100
Q ss_pred ----------CcccC-----CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 ----------AEFTC-----PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 ----------~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+. .+.+++.+.+++..||+.||++||++ .+++.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--~e~l~hp~ 292 (338)
T cd07859 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTA--EEALADPY 292 (338)
T ss_pred hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCH--HHHhcCch
Confidence 00000 12367889999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=295.34 Aligned_cols=256 Identities=28% Similarity=0.523 Sum_probs=217.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh--hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
+.|++.+.||.|++|.||.+.+..+++.+++|.+...... .....+.+.+|++++++++||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999889999999998654322 22235678899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
++||+++++|.+.+...+.++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999998887889999999999999999999999999999999999999999999999999886543322111
Q ss_pred c-ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cccCCCCCCHHHHHHH
Q 024347 169 L-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLI 245 (269)
Q Consensus 169 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li 245 (269)
. .....++..|+|||.+.+... +.++|+||||+++|++++|+.||............... ....+..++..+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 1 123346778999999988765 48999999999999999999999876666555554433 3445667899999999
Q ss_pred HHhcCCCCCCcCCCCccccccccC
Q 024347 246 ARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.||+.||++||++ .+++.|+|
T Consensus 241 ~~~l~~~p~~Rpt~--~~ll~~~~ 262 (263)
T cd06625 241 RRTFVENAKKRPSA--EELLRHFF 262 (263)
T ss_pred HHHhhcCcccCCCH--HHHhhCCC
Confidence 99999999999999 88888887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=311.33 Aligned_cols=260 Identities=32% Similarity=0.556 Sum_probs=218.0
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+....++|++.+.||+|+||.||++.+..+++.+|+|.+.............+.+|+.+++.++||||+++++.+.+...
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 44566899999999999999999999999999999999976544444445678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||++|++|.+++... .+++..+..++.|++.||.+||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 99999999999999888654 68899999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCccccCcccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--ccCCC--CCC
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPP--WLS 238 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~--~~~ 238 (269)
........+++.|+|||++.+.. ..+.++|+||||+++|+|++|..||...........+.... ...+. .++
T Consensus 197 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 275 (370)
T cd05621 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEIS 275 (370)
T ss_pred -ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCC
Confidence 11123345899999999987643 23589999999999999999999999888877777776532 33333 479
Q ss_pred HHHHHHHHHhcCCCCCC--cCCCCccccccccC
Q 024347 239 FTARKLIARILDPNPMT--VSIYPFADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~--Rps~~~~~~l~~~~ 269 (269)
..+++++..||+.+|.+ |+++ .+++.|+|
T Consensus 276 ~~~~~li~~~L~~~~~r~~R~~~--~e~l~hp~ 306 (370)
T cd05621 276 KHAKNLICAFLTDREVRLGRNGV--EEIKQHPF 306 (370)
T ss_pred HHHHHHHHHHccCchhccCCCCH--HHHhcCcc
Confidence 99999999999865544 7888 77888887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=320.00 Aligned_cols=260 Identities=31% Similarity=0.512 Sum_probs=220.1
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
......++|++.+.||.|+||+||++.+..+++.||+|.+...... ......+.+|+..+..++|+|++++++.+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 4456678999999999999999999999999999999998765432 344567889999999999999999987764322
Q ss_pred --------eEEEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEE
Q 024347 85 --------KIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (269)
Q Consensus 85 --------~~~~v~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l 152 (269)
.+++||||+++++|.+.+... ..+++..+..++.|++.+|.|||+.||+|+||+|+||+++.++.++|
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEE
Confidence 368999999999999888652 46899999999999999999999999999999999999999999999
Q ss_pred eeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-
Q 024347 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231 (269)
Q Consensus 153 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~- 231 (269)
+|||+++...............+++.|+|||++.+..+. .++||||||+++|+|++|..||...+.......+..+..
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~ 263 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD 263 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 999998765443333333445688999999999887664 899999999999999999999998888777777766544
Q ss_pred cCCCCCCHHHHHHHHHhcCCCCCCcCCCCcccccccc
Q 024347 232 TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 232 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
+.++.+++++.++++.||+.||.+||++ .+++.|+
T Consensus 264 ~~~~~~~~~l~~li~~~L~~dP~~RPs~--~ell~~p 298 (496)
T PTZ00283 264 PLPPSISPEMQEIVTALLSSDPKRRPSS--SKLLNMP 298 (496)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCcCH--HHHHhCH
Confidence 4567799999999999999999999999 5666554
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=299.72 Aligned_cols=248 Identities=29% Similarity=0.419 Sum_probs=206.6
Q ss_pred eeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCch
Q 024347 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (269)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l 98 (269)
||+|+||+||++.+..+++.+++|.+...........+.+..|+++++.++|+||+++.+++......+++|||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998765554444456778899999999999999999999999999999999999999
Q ss_pred hHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccc
Q 024347 99 FDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (269)
Q Consensus 99 ~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 174 (269)
...+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--ccccccC
Confidence 876643 3468999999999999999999999999999999999999999999999999886443211 1122345
Q ss_pred cCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCcccCCCCCCHHHHHHHHHhcC
Q 024347 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILD 250 (269)
Q Consensus 175 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (269)
+++.|+|||++.+..+. .++|+||||+++|+|++|+.||..... ......+.......+..+++.+.+++..||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 78899999999887764 899999999999999999999976433 2333444445555667789999999999999
Q ss_pred CCCCCcCCCCc---cccccccC
Q 024347 251 PNPMTVSIYPF---ADILYMRF 269 (269)
Q Consensus 251 ~dP~~Rps~~~---~~~l~~~~ 269 (269)
.||++||+++. .+++.|+|
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChh
Confidence 99999997632 56677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=299.52 Aligned_cols=252 Identities=34% Similarity=0.616 Sum_probs=210.4
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEec
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
|++++.||.|++|+||++.+..+++.+|+|.+......... .....+|+.+++.++|+||+++++++.+....+++|++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999876544333 33445699999999999999999999999999999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccc
Q 024347 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (269)
Q Consensus 93 ~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 172 (269)
+.+++|.+++...+.++..++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 999999999987788999999999999999999999999999999999999999999999999988653 122333444
Q ss_pred cccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCcccCCC----CCCHHHHHHH
Q 024347 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCPP----WLSFTARKLI 245 (269)
Q Consensus 173 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~----~~~~~l~~li 245 (269)
..++..|.|||++......+.++|+||||+++++|++|..||..... ................ ..++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 56788999999998333335999999999999999999999998733 3333333222221111 1248999999
Q ss_pred HHhcCCCCCCcCCCCccccccccC
Q 024347 246 ARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.||+.||++||++ .+++.|+|
T Consensus 238 ~~~l~~~p~~R~~~--~~l~~~~~ 259 (260)
T PF00069_consen 238 KKMLSKDPEQRPSA--EELLKHPW 259 (260)
T ss_dssp HHHSSSSGGGSTTH--HHHHTSGG
T ss_pred HHHccCChhHCcCH--HHHhcCCC
Confidence 99999999999998 88899987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=310.01 Aligned_cols=249 Identities=32% Similarity=0.546 Sum_probs=210.9
Q ss_pred eeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC---CCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
||+|+||.||+|+++.+++.+|+|++................|..++... .||+|+++++.+......+++|||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999999765544444445555666666655 699999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|...+...+.+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++|+|||++..... .........+
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 99999888888899999999999999999999999999999999999999999999999998764221 1222233457
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC-CCCHHHHHHHHHhcCCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-WLSFTARKLIARILDPNPM 254 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~ 254 (269)
+..|+|||++.+....+.++||||||+++|+|++|..||......+....+..+....+. .++.++.+||+.||+.||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 899999999876554468999999999999999999999998888888888877666654 4799999999999999999
Q ss_pred CcCCC--CccccccccC
Q 024347 255 TVSIY--PFADILYMRF 269 (269)
Q Consensus 255 ~Rps~--~~~~~l~~~~ 269 (269)
+||+. ...+++.|+|
T Consensus 239 ~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 239 HRLGAHRDAVELKEHPF 255 (330)
T ss_pred HCCCCCCCHHHHhcCcc
Confidence 99964 2356677776
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=317.92 Aligned_cols=253 Identities=27% Similarity=0.445 Sum_probs=213.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCC-CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
...|.+.+.||+|++|.||.|.+..+ ++.+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 44599999999999999999998877 7888888764332 3334567789999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 89 VLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
||||++|++|.+.+.. ..++++..+..++.|++.||.++|+.||+||||||+||+++.++.++|+|||++......
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999877643 346899999999999999999999999999999999999999999999999998754432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARK 243 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~ 243 (269)
..........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+..+.. +.+..++..+.+
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 301 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA 301 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence 22222334458899999999987665 4899999999999999999999998888887777766554 455678999999
Q ss_pred HHHHhcCCCCCCcCCCCcccccccc
Q 024347 244 LIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
+|..||+.||++||++ .+.+.++
T Consensus 302 li~~~L~~dP~~Rps~--~~~l~~~ 324 (478)
T PTZ00267 302 LLDPLLSKNPALRPTT--QQLLHTE 324 (478)
T ss_pred HHHHHhccChhhCcCH--HHHHhCH
Confidence 9999999999999998 5555443
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=308.94 Aligned_cols=259 Identities=32% Similarity=0.539 Sum_probs=216.0
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+....++|++.+.||+|++|.||++.++.+++.+|+|.+.............+.+|..+++.++||||+++++.+.+...
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34566899999999999999999999999999999999876544444445678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||++|++|.+++... .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.......
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~ 196 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 196 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence 99999999999998887654 58899999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCccccCcccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--c--cCCCCCC
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F--TCPPWLS 238 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~--~~~~~~~ 238 (269)
........+++.|+|||++.+.. ..+.++||||||+++|+|++|..||...+....+..+.... . +....++
T Consensus 197 -~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 275 (371)
T cd05622 197 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275 (371)
T ss_pred -cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCC
Confidence 11122345889999999987543 24589999999999999999999999988888888876543 2 3334589
Q ss_pred HHHHHHHHHhcCCCCCC---cCCCCccccccccC
Q 024347 239 FTARKLIARILDPNPMT---VSIYPFADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~---Rps~~~~~~l~~~~ 269 (269)
..++++|..||+ +|.. |+++ .+++.|+|
T Consensus 276 ~~~~~li~~~L~-~~~~r~~r~~~--~ei~~h~~ 306 (371)
T cd05622 276 KEAKNLICAFLT-DREVRLGRNGV--EEIKRHLF 306 (371)
T ss_pred HHHHHHHHHHcC-ChhhhcCCCCH--HHHhcCcc
Confidence 999999999998 5554 5666 66667765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=296.23 Aligned_cols=261 Identities=29% Similarity=0.466 Sum_probs=226.5
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
.-++.|++++.||.|.-|+||++....++..+|+|++.........-..+++.|-++|+.+.||.++.+|..|+.....|
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c 153 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC 153 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence 34567889999999999999999999999999999999888877777888999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++||||+||+|...++++ +.+++..+.-++..++-||.|||..|||++|+||+||||.++|++.|+||.++......+
T Consensus 154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999998888764 579999999999999999999999999999999999999999999999999864321100
Q ss_pred -------------------------------CCC-----------------------cccccccCccccCcccccCCCCC
Q 024347 166 -------------------------------DDG-----------------------LLHTTCGTPNYVAPEVLNDRGYD 191 (269)
Q Consensus 166 -------------------------------~~~-----------------------~~~~~~~~~~~~aPE~~~~~~~~ 191 (269)
... ......||-.|.|||++.+..+.
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 000 01112367789999999999986
Q ss_pred CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC--CCCCHHHHHHHHHhcCCCCCCcCCCC--ccccccc
Q 024347 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTVSIYP--FADILYM 267 (269)
Q Consensus 192 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~--~~~~l~~ 267 (269)
.++|.|+||+.+|||+.|..||.+.+..+...++......++ +.++..++|||+.+|.+||++|.-.. .+++-+|
T Consensus 314 -sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 314 -SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred -chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 999999999999999999999999999999999988776665 46889999999999999999999821 1666666
Q ss_pred cC
Q 024347 268 RF 269 (269)
Q Consensus 268 ~~ 269 (269)
+|
T Consensus 393 pF 394 (459)
T KOG0610|consen 393 PF 394 (459)
T ss_pred cc
Confidence 65
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=316.70 Aligned_cols=255 Identities=21% Similarity=0.354 Sum_probs=220.7
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
..++.+..+...+.+.||+|.||+||+|.+.++ ||||+++......+ ..+.|++|+.++++-+|.||+-++|++..
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 356678888999999999999999999999876 99999987665444 68999999999999999999999999987
Q ss_pred CCeEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
... .+|..+|+|.+|..+++-.. .|...+...|++|+++|+.|||.++|+|+|++..|||+.++++|+|+|||++...
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeee
Confidence 776 99999999999999887643 5888999999999999999999999999999999999999999999999999877
Q ss_pred ccccCCCcccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-----cCC
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-----TCP 234 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~ 234 (269)
............-+...|+|||++.. ...+++.+||||||+++|||++|..||.......+.-.+..|.. ...
T Consensus 539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~ 618 (678)
T KOG0193|consen 539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIR 618 (678)
T ss_pred eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhh
Confidence 66655555555667889999999863 33457999999999999999999999998777777776666632 223
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+++++++|+..||..+|++||.+.++
T Consensus 619 s~~pk~mk~Ll~~C~~~~~~eRP~F~~i 646 (678)
T KOG0193|consen 619 SNCPKAMKRLLSDCWKFDREERPLFPQL 646 (678)
T ss_pred ccCHHHHHHHHHHHHhcCcccCccHHHH
Confidence 4588999999999999999999998543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=307.38 Aligned_cols=253 Identities=21% Similarity=0.362 Sum_probs=201.3
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 80 (269)
....++|++.+.||.|+||.||+|.+. .+++.||+|.+.... .....+.+.+|+.++..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 445679999999999999999999752 345689999986432 233356788999999999 899999999988
Q ss_pred ee-CCeEEEEEeccCCCchhHHHHhc------------------------------------------------------
Q 024347 81 GS-KTKIFIVLEFVTGGELFDKIVNH------------------------------------------------------ 105 (269)
Q Consensus 81 ~~-~~~~~~v~~~~~~~~l~~~~~~~------------------------------------------------------ 105 (269)
.. ...++++|||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 65 44689999999999998888642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCc
Q 024347 106 --------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177 (269)
Q Consensus 106 --------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 177 (269)
.+++...+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++...............++.
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 236778889999999999999999999999999999999999999999999987543222111122233457
Q ss_pred cccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCCC
Q 024347 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAAE-FTCPPWLSFTARKLIARILDPNPM 254 (269)
Q Consensus 178 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~-~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~ 254 (269)
.|+|||++.+..+ +.++||||||+++|+|++ |..||...... .....+..+. ...+..+++.+.+++..||+.||+
T Consensus 241 ~y~aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~ 319 (338)
T cd05102 241 KWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPK 319 (338)
T ss_pred cccCcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChh
Confidence 8999999987666 489999999999999997 99999875433 3333333332 344566899999999999999999
Q ss_pred CcCCCCcc
Q 024347 255 TVSIYPFA 262 (269)
Q Consensus 255 ~Rps~~~~ 262 (269)
+|||+.++
T Consensus 320 ~RPs~~el 327 (338)
T cd05102 320 ERPTFSAL 327 (338)
T ss_pred hCcCHHHH
Confidence 99998544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=297.12 Aligned_cols=254 Identities=26% Similarity=0.391 Sum_probs=210.2
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|+||+||++.+..+++.+++|.+.............+.+|+.++++++|++++++++.+.+.+..+++||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876554444445667789999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|++|++|.+.+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG---QT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC---cc
Confidence 99999998887543 35889999999999999999999999999999999999999999999999987643221 11
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHH-HhcCcccCCCCCCHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKK-ISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~-~~~~~~~~~~~~~~~l~~li 245 (269)
.....++..|+|||++.+..+ +.++|+||+|+++|+|++|..||...... ..... ........+..+++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 123457889999999987766 48999999999999999999999864332 11121 12223344566899999999
Q ss_pred HHhcCCCCCCcCCCC---ccccccccC
Q 024347 246 ARILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
+.||+.||++|||++ ..+++.|+|
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChh
Confidence 999999999999954 367778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=301.53 Aligned_cols=256 Identities=29% Similarity=0.516 Sum_probs=212.7
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|+||.||++.+..+++.+|+|++...........+.+.+|..+++.++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999997655444455677889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||++|++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC-cc
Confidence 99999999998876 45789999999999999999999999999999999999999999999999998764332111 11
Q ss_pred ccccccCccccCcccccC----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--ccCC---CCCCHH
Q 024347 170 LHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP---PWLSFT 240 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---~~~~~~ 240 (269)
.....+++.|+|||++.. ....+.++|+||+|+++|+|++|..||......+....+.... ...+ ..++..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 122357899999999863 2333578999999999999999999999887777777765432 2222 347899
Q ss_pred HHHHHHHhcCCCCCC--cCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMT--VSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~--Rps~~~~~~l~~~~ 269 (269)
++++|++||..++++ |+++ .+++.|+|
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~--~~~l~hp~ 268 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGL--QDFKDHPF 268 (331)
T ss_pred HHHHHHHHccCcccccCCCCH--HHHhcCCC
Confidence 999999999764443 6676 77888887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-45 Score=309.91 Aligned_cols=253 Identities=27% Similarity=0.423 Sum_probs=208.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC-----eE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 86 (269)
+|++.+.||.|++|.||++.+..+++.||+|.+.... ......+.+.+|+.+++.++|+||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4789999999999999999999899999999985432 22334567889999999999999999999997766 78
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++++||+. +++...+...+.++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 99999996 5788888777789999999999999999999999999999999999999999999999999887543221
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc------------------
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------------ 228 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------ 228 (269)
........+++.|+|||.+.+....+.++||||+|+++|+|++|+.||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 11122334678899999998766556899999999999999999999988766554443321
Q ss_pred -----Ccc---------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 -----AEF---------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 -----~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
... ......++++.+||.+||+.||++|||+ .+++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~--~e~l~hp~ 290 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA--ADALAHPY 290 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH--HHHhcCHh
Confidence 000 1223457889999999999999999999 77788876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=294.56 Aligned_cols=247 Identities=27% Similarity=0.397 Sum_probs=201.8
Q ss_pred eeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCch
Q 024347 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (269)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l 98 (269)
||.|+||.||++....+|+.+++|.+.............+..|+++++.++||||+++++.+......+++|||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998754443333344566799999999999999999999999999999999999999
Q ss_pred hHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccC
Q 024347 99 FDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (269)
Q Consensus 99 ~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 176 (269)
...+.... .++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||.+...... .......++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceeeccCCC
Confidence 88775533 5888899999999999999999999999999999999999999999999987654321 112234578
Q ss_pred ccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCcccCC-CCCCHHHHHHHHHhcCC
Q 024347 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCP-PWLSFTARKLIARILDP 251 (269)
Q Consensus 177 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~ 251 (269)
..|+|||++.+..+ +.++|+||||+++|+|++|..||..... ............... ..++++++++++.||+.
T Consensus 158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 89999999987775 5899999999999999999999975432 233333333333322 35799999999999999
Q ss_pred CCCCcCCCCc--cccccccC
Q 024347 252 NPMTVSIYPF--ADILYMRF 269 (269)
Q Consensus 252 dP~~Rps~~~--~~~l~~~~ 269 (269)
||++||++++ .+.+.|+|
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~ 256 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEF 256 (277)
T ss_pred CHhhCCCCccchhhhhcChh
Confidence 9999999965 44667766
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=294.39 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=212.2
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
.|+..+.||.|+||+||.+.+..+++.+|+|.+.............+.+|+++++.++|++++++.+.+...+..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47888999999999999999999999999999876554444445667889999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|+++++|...+... ..++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~---~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG---ES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC---Cc
Confidence 99999998777543 36899999999999999999999999999999999999999999999999988643321 11
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHhcCcccCCCCCCHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK----KISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li 245 (269)
.....++..|+|||.+.+..+ +.++|+||||+++|++++|..||.........+ .+.......+..++.++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 223457899999999987665 489999999999999999999998766543333 333344455667889999999
Q ss_pred HHhcCCCCCCcCCCC---ccccccccC
Q 024347 246 ARILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
..||+.||++||+.+ ..+++.|+|
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChh
Confidence 999999999999965 356677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=307.09 Aligned_cols=253 Identities=29% Similarity=0.462 Sum_probs=206.7
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
...+++|+..+.||.|++|.||++.+..+++.|++|++.... .......+.+|+++++.++|+||+++++++...+..
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeE
Confidence 345678999999999999999999999999999999985432 234457788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++++||+++++|... ...++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 148 ~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 148 QVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred EEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 999999999988542 345677888999999999999999999999999999999999999999999887543211
Q ss_pred CCcccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHh-cCcccCCCCCC
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKIS-AAEFTCPPWLS 238 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~-~~~~~~~~~~~ 238 (269)
.......++..|+|||++... .+.+.++||||||+++|+|++|+.||....... ....+. ......+..++
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATAS 301 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccC
Confidence 112234578899999987532 233468999999999999999999997433222 222222 22334456689
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 239 FTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++.+||..||+.||++||++ .+++.|+|
T Consensus 302 ~~l~~li~~~l~~~P~~Rpt~--~ell~hp~ 330 (353)
T PLN00034 302 REFRHFISCCLQREPAKRWSA--MQLLQHPF 330 (353)
T ss_pred HHHHHHHHHHccCChhhCcCH--HHHhcCcc
Confidence 999999999999999999999 88888987
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=301.92 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=208.5
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
-++|++.+.||.|++|.||++.+..+++.+++|.+.... .......+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 478999999999999999999999999999999886542 233456788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+.+++|.+++...+.+++..+..++.+++.+|.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~---- 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----
Confidence 99999999999998878899999999999999999999985 7999999999999999999999999987644221
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----------------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI---------------------- 226 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---------------------- 226 (269)
......++..|+|||.+.+... +.++|+||||+++|++++|..||...........+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred ccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 1122357889999999987665 48999999999999999999999765443332111
Q ss_pred ----------------------hcCc-ccCC-CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 227 ----------------------SAAE-FTCP-PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 227 ----------------------~~~~-~~~~-~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.... ...+ ...+.++++|+.+||+.||++|||+ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~--~ell~h~~ 301 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADL--KQLMVHAF 301 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCH--HHHhhCHH
Confidence 1111 1111 1257889999999999999999999 77777776
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=280.13 Aligned_cols=253 Identities=30% Similarity=0.470 Sum_probs=211.7
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
.+|...+.||+|.||.||+|+++.+|+.||+|.+...... +.......+|+..|+.++|+||+.++++|.+.+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 5788899999999999999999999999999999765432 222356778999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||++. +|...+... ..++..+++.+..+++.|++|+|++.|+|+||||.|++++.+|.+|++|||+++..........
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99964 787777654 4799999999999999999999999999999999999999999999999999998765443332
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--C------------------
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--A------------------ 229 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~------------------ 229 (269)
. ..-+.=|+|||.+.+...++...|+||.||++.||+.+.+-|.+....+....+.. |
T Consensus 160 ~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 160 H--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred c--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 2 24566799999999988888999999999999999999988888776665555421 0
Q ss_pred --cccCC------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 --EFTCP------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 --~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++.+ +.++.+..+|+..||..||.+|+++ -++|.|+|
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita--~qaL~~~y 283 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITA--SQALKHPY 283 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccH--HHHhcchh
Confidence 01111 1157778999999999999999999 66677664
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=299.51 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=206.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+.+++.++|+||+++++++...+..+++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 57899999999999999999999989999999998654322 2234567899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+++ ++.+.+... ..++...+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+....... .
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--K 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--c
Confidence 999975 777777654 458899999999999999999999999999999999999999999999999886433211 1
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------- 229 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------- 229 (269)
......+++.|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 1222346788999999876554568999999999999999999999876655443333110
Q ss_pred --cc---------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 --EF---------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 --~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ...+.+++++.+||++||+.||.+|||+ .+++.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~--~e~l~h~~ 288 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA--EEAMKHAY 288 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH--HHHhcChh
Confidence 00 1112468899999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=295.75 Aligned_cols=258 Identities=32% Similarity=0.599 Sum_probs=218.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.+..+++.|++|.+...........+.+.+|+++++.++|+||+++++.+...+..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987665444455678889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC--
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-- 168 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~-- 168 (269)
||++|++|.+++...+.+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.++.........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999999887889999999999999999999999999999999999999999999999999876321110000
Q ss_pred -----------cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC--
Q 024347 169 -----------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-- 235 (269)
Q Consensus 169 -----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 235 (269)
......++..|+|||.+.+... +.++|+||||+++|++++|..||.+....+.......+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0111235678999999877665 48999999999999999999999988888877777666543332
Q ss_pred -CCCHHHHHHHHHhcCCCCCCcCCCC-ccccccccC
Q 024347 236 -WLSFTARKLIARILDPNPMTVSIYP-FADILYMRF 269 (269)
Q Consensus 236 -~~~~~l~~li~~~l~~dP~~Rps~~-~~~~l~~~~ 269 (269)
.++.++.++|++||+.||++||++. ..+++.|+|
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 4789999999999999999999963 356667765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=288.63 Aligned_cols=252 Identities=29% Similarity=0.460 Sum_probs=217.2
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|+.+++.++|||++++++.+...+..++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488899999999999999999999999999998765433 3446778899999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|+++++|.+++... ..++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~--~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc--ch
Confidence 99999999988764 578899999999999999999999999999999999999999999999999876543321 11
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc-CCCCCCHHHHHHHHHh
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARI 248 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~ 248 (269)
.....+++.|+|||++.+.... .++|+||||++++++++|..||...+.......+..+..+ .+..++..+.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 1223467889999999877764 8999999999999999999999988877777776665543 3446889999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.+|++||++ .+.+.++|
T Consensus 237 l~~~p~~Rp~~--~~ll~~~~ 255 (256)
T cd08529 237 LTKDYRQRPDT--FQLLRNPS 255 (256)
T ss_pred ccCCcccCcCH--HHHhhCCC
Confidence 99999999999 88888876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=292.19 Aligned_cols=254 Identities=28% Similarity=0.529 Sum_probs=218.9
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||++.+..+++.+++|.+...........+.+.+|+..+++++||||+++++.+......++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999998999999999987665555567889999999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
|+.|++|...+.....+++.++..++.+++++|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc---ccc
Confidence 99999999998877789999999999999999999999999999999999999999999999999876543221 223
Q ss_pred ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCcccCCCCCCHHHHHHHHHh
Q 024347 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (269)
...++..|+|||.+.+... +.++|+||||+++|++++|..||.... ...............+..++..+.++|++|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 3456788999999987665 489999999999999999999998766 344444444456667778899999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||.+||++...+.+.|+|
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~ 257 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPY 257 (258)
T ss_pred ccCChhHcCCccHHHHhcCCC
Confidence 999999999984345556666
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=295.61 Aligned_cols=239 Identities=14% Similarity=0.192 Sum_probs=204.3
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee----CCeEEEEEec
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTKIFIVLEF 92 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~v~~~ 92 (269)
..||+|+++.||+|.. +|+.||+|.+...........+.+.+|+.++++++||||+++++++.+ ....+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999998 588999999976655455556788899999999999999999999866 4578999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 93 ~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
+++|+|.+++...+.++......++.+++.+|.+||+. +++|+||+|+||+++.++.++++|||++....... .
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----F 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----c
Confidence 99999999998888899999999999999999999984 99999999999999999999999999887543211 2
Q ss_pred ccccCccccCcccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CcccCCCCCCHHHHHHHHHh
Q 024347 172 TTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIARI 248 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~ 248 (269)
...++..|+|||++.+. ...+.++||||||+++|+|++|..||...+..+....+.. .+++.+..+++.+++++.+|
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~c 258 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258 (283)
T ss_pred cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHH
Confidence 23467889999998762 2346899999999999999999999998888887777743 34455557899999999999
Q ss_pred cCCCCCCcCCCCcc
Q 024347 249 LDPNPMTVSIYPFA 262 (269)
Q Consensus 249 l~~dP~~Rps~~~~ 262 (269)
|+.||++|||++++
T Consensus 259 l~~dp~~Rps~~el 272 (283)
T PHA02988 259 TSHDSIKRPNIKEI 272 (283)
T ss_pred hcCCcccCcCHHHH
Confidence 99999999998543
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=297.90 Aligned_cols=256 Identities=32% Similarity=0.531 Sum_probs=218.3
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.+..+++.+++|.+...........+.+.+|++.++.++|+||+++++.+.+....++++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999889999999998765554455678899999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC-
Q 024347 91 EFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD- 167 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~- 167 (269)
||+.|++|.+++... ..+++..+..++.|++.+|+|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999988753 46899999999999999999999999999999999999999999999999987654321110
Q ss_pred --------------------------CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 024347 168 --------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (269)
Q Consensus 168 --------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 221 (269)
.......++..|+|||++.+... +.++||||||+++|++++|..||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 00112246778999999987766 489999999999999999999999888777
Q ss_pred HHHHHhcCcccCCCC--CCHHHHHHHHHhcCCCCCCcCC----CCccccccccC
Q 024347 222 LYKKISAAEFTCPPW--LSFTARKLIARILDPNPMTVSI----YPFADILYMRF 269 (269)
Q Consensus 222 ~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dP~~Rps----~~~~~~l~~~~ 269 (269)
...++.......+.. .+..+.++|++||+.||++||+ + .+++.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~--~~ll~~~~ 291 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGA--AEIKQHPF 291 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhH--HHHHcCch
Confidence 777766555544443 6899999999999999999999 7 77777876
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=287.17 Aligned_cols=252 Identities=25% Similarity=0.487 Sum_probs=213.9
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-CCeEEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVL 90 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~ 90 (269)
+|++.+.||.|++|.||.+.+..+++.+++|.+...... ....+.+.+|+.+++.++|+|++++++.+.. ....++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 589999999999999999999988999999998754432 3335678899999999999999999988754 44689999
Q ss_pred eccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 91 EFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
||++++++.+.+... ..+++.++..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CC
Confidence 999999998888653 46899999999999999999999999999999999999999999999999988654321 11
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIAR 247 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 247 (269)
......+++.|+|||++.+.... .++|+||||++++++++|..||...+.......+..+.. ..+...++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 22233467899999999887764 889999999999999999999988777666666655544 4456689999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+.||++||++ .+++.|+|
T Consensus 237 ~l~~~p~~Rp~~--~~~l~~~~ 256 (257)
T cd08223 237 MLSKRPEKRPSV--KSILRQPY 256 (257)
T ss_pred HhccCcccCCCH--HHHhcCCC
Confidence 999999999998 88889887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=312.02 Aligned_cols=248 Identities=27% Similarity=0.350 Sum_probs=198.7
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 83 (269)
...+|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++|+||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~ 136 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN 136 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence 3468999999999999999999999899999999875432 2234699999999999999998887432
Q ss_pred ---CeEEEEEeccCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-CEEEeeC
Q 024347 84 ---TKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDF 155 (269)
Q Consensus 84 ---~~~~~v~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-~~~l~df 155 (269)
..++++|||+++ ++.+.+. ....+++..+..++.|++.||.|||+.||+||||+|+||+++.++ .++|+||
T Consensus 137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 6655554 245789999999999999999999999999999999999999665 6999999
Q ss_pred CCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------ 229 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------ 229 (269)
|+++..... .......+++.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+...
T Consensus 216 Gla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 216 GSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred ccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 998754321 12223456889999999877655568999999999999999999999887655444333210
Q ss_pred -------------c----------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 -------------E----------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 -------------~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ..++...++++.+||++||+.||.+|||+ .+++.|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta--~e~l~hp~ 353 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNP--IEALADPF 353 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCH--HHHhCChh
Confidence 0 01223467899999999999999999999 88889887
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=291.08 Aligned_cols=255 Identities=30% Similarity=0.508 Sum_probs=214.8
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh------hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+|.+...||.|++|.||.|.+..+++.+++|.+...... .....+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588899999999999999999888999999988643222 22345678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++++||+++++|..++...+.++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999887554211
Q ss_pred CC----CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-cccCCCCCCHH
Q 024347 166 DD----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (269)
Q Consensus 166 ~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (269)
.. .......++..|+|||.+.+... +.++|+||||+++|++++|+.||...+......++... ....+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 11 11112346788999999987665 48899999999999999999999876665554444333 34455668999
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.++|++||+.||++||++ .+++.|+|
T Consensus 240 ~~~li~~~l~~~p~~Rp~~--~~il~~~~ 266 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTA--AELLKHPF 266 (267)
T ss_pred HHHHHHHHccCCchhCcCH--HHHhhCCC
Confidence 9999999999999999999 88888887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=302.59 Aligned_cols=251 Identities=25% Similarity=0.416 Sum_probs=201.9
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 84 (269)
..++|++.+.||.|+||.||++.+..+|+.+|+|.+..... .......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 46899999999999999999999999999999999865432 2333567778999999999999999999986543
Q ss_pred --eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 85 --~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
..+++|||+++ ++.+.+. ..++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 47999999976 5655553 348889999999999999999999999999999999999999999999999886432
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-------------- 228 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------- 228 (269)
. ........+++.|+|||++.+..+. .++||||||+++|+|++|..||.+.+.......+..
T Consensus 175 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 T---NFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred c---CccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 2 2222334578899999999887764 899999999999999999999987654432221110
Q ss_pred --------Cccc--------------------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 --------AEFT--------------------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 --------~~~~--------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.... .....++.+++||.+||+.||++|||+ .++|.|+|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~--~e~l~hp~ 317 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV--DEALRHPY 317 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCH--HHHhcCch
Confidence 0000 011246789999999999999999999 88889887
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=305.09 Aligned_cols=249 Identities=18% Similarity=0.280 Sum_probs=200.9
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+...++|++.+.||.|++|.||++.+..+++.||+|... ...+.+|++++++++||||+++++++......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 345578999999999999999999999999999999742 23467899999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+++++++. ++|..++.....++...+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 159 ~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 159 CLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred EEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 99999985 5888888777789999999999999999999999999999999999999999999999999886432211
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHH---------------
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYK--------------- 224 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~--------------- 224 (269)
........+++.|+|||++.+..+ +.++||||||+++|+|++|..||-... ......
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 122233468999999999987766 489999999999999999987764221 000000
Q ss_pred -----------HHhcCccc----CC-----CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 225 -----------KISAAEFT----CP-----PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 225 -----------~~~~~~~~----~~-----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
........ .+ ..++.++.+||++||++||++|||+ .++|.|+|
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta--~elL~hp~ 378 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSA--EALLDFAA 378 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCH--HHHhcChh
Confidence 00000000 00 1246789999999999999999999 77888876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=294.13 Aligned_cols=252 Identities=21% Similarity=0.354 Sum_probs=211.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCC-----CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETG-----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
..++|++.+.||.|++|.||+|.....+ ..+++|.+.... .......+.+|+..++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 3568999999999999999999876555 679999886432 233456788999999999999999999999988
Q ss_pred CeEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC
Q 024347 84 TKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~ 147 (269)
...++++||+++++|.+++... ..++..++..++.|++.||.+||+.|++|+||+|+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 8999999999999999988654 347888999999999999999999999999999999999999
Q ss_pred CCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 024347 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (269)
Q Consensus 148 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~ 226 (269)
+.++|+|||++................+++.|+|||.+.+... +.++|+||||+++|+|++ |..||.+....+....+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999998865432222122223345678999999877665 489999999999999998 99999988888888777
Q ss_pred hcCcc-cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 227 SAAEF-TCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 227 ~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
..+.. ..+..++.++.+|++.||+.||.+||+++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~ 277 (283)
T cd05048 240 RSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIH 277 (283)
T ss_pred HcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 66543 44567899999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=290.44 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=209.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
..++|++.+.||.|+||.||+|.++ ..+..+++|.+.... .......+.+|+..+++++|||++++++++.....
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 4568999999999999999999865 346789999986543 23335678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++||||+++++|.+++... ..+++.++..++.|++.||++||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999888764 47899999999999999999999999999999999999999999999999976542211
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 242 (269)
.. .......++..|+|||.+.+..+ +.++||||||+++|++++ |..||.........+.+..+ ..+.+..++..+.
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (266)
T cd05064 161 AI-YTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH 238 (266)
T ss_pred ch-hcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 11 11111223567999999987666 489999999999999875 99999988877777776654 3456677899999
Q ss_pred HHHHHhcCCCCCCcCCCCcccc
Q 024347 243 KLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~ 264 (269)
+++..||+.+|++||+++++..
T Consensus 239 ~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 239 QLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHHcCCCchhCCCHHHHHH
Confidence 9999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=296.51 Aligned_cols=252 Identities=19% Similarity=0.284 Sum_probs=201.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcC----------------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSE----------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 73 (269)
.++|++.+.||+|+||.||++.+.. ++..+|+|.+.... .......+.+|+.++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999997532 34479999986543 23345778899999999999999
Q ss_pred eeeeEEEeeCCeEEEEEeccCCCchhHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 024347 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------------------RMKEDEARRYFQQLINAVDYCHSRGVYH 134 (269)
Q Consensus 74 ~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~-------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h 134 (269)
+++++++.+.+..+++|||+++++|.+++.... .++..++..++.|++.||.+||+.|++|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999988875431 3567788999999999999999999999
Q ss_pred ecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc--CCC
Q 024347 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYL 212 (269)
Q Consensus 135 ~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~ 212 (269)
+||+|+||+++.++.++|+|||+++...............++..|+|||++.+..+ +.++||||||+++|+|++ +..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccCCC
Confidence 99999999999999999999998865432221111222334678999999877665 489999999999999986 667
Q ss_pred CCCCCCHHHHHHHHhc--------CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcccc
Q 024347 213 PFDDSNLMNLYKKISA--------AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 213 p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
||.............. .....++.++..+.+|+.+||+.||++|||++++..
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 8877665555444321 112334568899999999999999999999966643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=295.08 Aligned_cols=251 Identities=31% Similarity=0.431 Sum_probs=199.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcC-CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC---CCCCceeeeEEEe-----
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMG----- 81 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~----- 81 (269)
.+|++.+.||+|++|.||+|.+.. .++.+|+|.+....... .......+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 46889999986543222 1123444566666555 6999999999885
Q ss_pred eCCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
.....++++||+. ++|.+++... ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 2456899999996 4888887653 358999999999999999999999999999999999999999999999999886
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-c-------
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-F------- 231 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~------- 231 (269)
..... .......+++.|+|||.+.+..+. .++||||||+++|+|++|..||.+....+....+.... .
T Consensus 159 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSFQ---MALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccCC---cccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 54322 222334578899999999776654 89999999999999999999999877666555543210 0
Q ss_pred -------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 -------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.+++.+++|+.+||+.||++|||+ .+++.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~--~~~l~hp~ 289 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA--YSALSHPY 289 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH--HHHhcCCC
Confidence 0112467889999999999999999999 88889987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=297.07 Aligned_cols=256 Identities=28% Similarity=0.499 Sum_probs=213.9
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||+|+||.||++.++.+++.+++|.+.............+.+|..++..++|++|+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999987654444444566888999999999999999999999999999999
Q ss_pred eccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999876 457899999999999999999999999999999999999999999999999987643211 1111
Q ss_pred ccccccCccccCcccccC----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--ccCC---CCCCHH
Q 024347 170 LHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP---PWLSFT 240 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---~~~~~~ 240 (269)
.....+++.|+|||++.+ ....+.++|+||||+++|+|++|+.||......+....+.... ...+ ..++++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 223457899999999863 2334589999999999999999999999988888888776543 2233 347999
Q ss_pred HHHHHHHhcCCCCCC--cCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMT--VSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~--Rps~~~~~~l~~~~ 269 (269)
+++|++.||..+|.+ |+++ .+++.|+|
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~--~~~~~h~~ 268 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGI--EDFKQHPF 268 (332)
T ss_pred HHHHHHHHccChhhhcCCCCH--HHHhCCCC
Confidence 999999999765555 4566 78888876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=294.25 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=208.2
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||.|++|.||++.+..+++.|++|.+...... .....+.+|+.+++.++|+||+++++++......++
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 467899999999999999999999989999999998654321 123456789999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
++||+.+ +|...+... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 9999974 888877653 468899999999999999999999999999999999999999999999999886433211
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------------
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------ 229 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------ 229 (269)
.......+++.|+|||.+.+....+.++||||||+++|+|++|+.||...+..+....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 11222345788999999876554568999999999999999999999877665444332110
Q ss_pred -ccc-----------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 -EFT-----------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 -~~~-----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
... ..+.+++.+++||.+||+.||.+|||+ .+++.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~--~eil~h~~ 288 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISA--EEAMKHPY 288 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCH--HHHhcCcc
Confidence 000 112468889999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=306.58 Aligned_cols=245 Identities=31% Similarity=0.477 Sum_probs=207.2
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-C-----CCceeeeEEEeeCCe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-H-----PNVVRLYEVMGSKTK 85 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~-----~~i~~~~~~~~~~~~ 85 (269)
+|.|.+.||.|+||+|-+|++..+++.||||+++.. ..+.+....|+.+|..|+ | -|+++++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 899999999999999999999999999999998654 345677788999999997 3 379999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC--CEEEeeCCCcccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALS 161 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~--~~~l~df~~~~~~ 161 (269)
.|+|+|.+ +.+|.+++..++ .++...+..++.||+.+|.+||+.||||+||||+|||+.+.+ .+|++|||.++..
T Consensus 263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 99999999 569999998764 689999999999999999999999999999999999997554 5999999998753
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--------------
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS-------------- 227 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------------- 227 (269)
.. ....+..+..|+|||++.+.++. .+.|+|||||++.||++|.+.|.+.+..+....+.
T Consensus 342 ~q-----~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 SQ-----RVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred CC-----cceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 32 22366788999999999999986 99999999999999999999998776665555431
Q ss_pred --------c------------------------------CcccCCC-----------CCCHHHHHHHHHhcCCCCCCcCC
Q 024347 228 --------A------------------------------AEFTCPP-----------WLSFTARKLIARILDPNPMTVSI 258 (269)
Q Consensus 228 --------~------------------------------~~~~~~~-----------~~~~~l~~li~~~l~~dP~~Rps 258 (269)
. .+...|+ .-...+.+||+.||++||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 0 0000110 02346899999999999999999
Q ss_pred CCccccccccC
Q 024347 259 YPFADILYMRF 269 (269)
Q Consensus 259 ~~~~~~l~~~~ 269 (269)
. .++|.|+|
T Consensus 496 p--~qal~Hpf 504 (586)
T KOG0667|consen 496 P--AQALNHPF 504 (586)
T ss_pred H--HHHhcCcc
Confidence 9 89999988
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=289.85 Aligned_cols=253 Identities=29% Similarity=0.405 Sum_probs=208.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.++++++|+|++++++.+......+++
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 3579999999999999999999998999999999864432 2235678899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
+||+++++|.+.+...+.+++..+..++.|++.+|.+||+.|++|+|++|+||+++.++.++|+|||.+....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 162 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AK 162 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--cc
Confidence 9999999999988877789999999999999999999999999999999999999999999999999887543211 11
Q ss_pred ccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc-----CCCCCCHHHH
Q 024347 170 LHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-----CPPWLSFTAR 242 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~ 242 (269)
.....++..|+|||.+.. ....+.++|+||+|+++|+|++|..||...........+....+. ....++..+.
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHH
Confidence 223346788999998753 222357899999999999999999999765544333332222221 1234688999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+|++.||+.||++||++ .+++.|.|
T Consensus 243 ~li~~~l~~~P~~Rp~~--~~il~~l~ 267 (267)
T cd06646 243 NFVKISLTKNPKKRPTA--ERLLTHLF 267 (267)
T ss_pred HHHHHHhhCChhhCcCH--HHHhcCCC
Confidence 99999999999999999 67888876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=296.43 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=212.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||+|+||.||++++..+++.+|+|.+.............+.+|..++..++|++|+++++.+.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999987654444444567888999999999999999999999999999999
Q ss_pred eccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||++|++|.+++.. ...+++..+..++.|++.||.+||+.||+|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999877 4678999999999999999999999999999999999999999999999999886543211 111
Q ss_pred ccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--ccCC---CCCCHH
Q 024347 170 LHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP---PWLSFT 240 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~---~~~~~~ 240 (269)
.....+++.|+|||++.+. ...+.++|+||||+++|+|++|+.||...+..+....+.... .+.+ ..++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2234578999999998752 223588999999999999999999999888877777775533 3333 336899
Q ss_pred HHHHHHHhcCCCCCC--cCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMT--VSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~--Rps~~~~~~l~~~~ 269 (269)
++++|..||..+|.+ |+++ .+.+.|+|
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~--~~~~~h~~ 268 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGI--EDFKKHAF 268 (331)
T ss_pred HHHHHHHHccCchhhcCCCCH--HHHhcCCC
Confidence 999999999976654 2344 66667765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=291.32 Aligned_cols=245 Identities=29% Similarity=0.490 Sum_probs=202.1
Q ss_pred EEeeeeeccCCcEEEEEEEc----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 14 EVGRTIGEGTFAKVKFARNS----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.+.+.||.|.||.||+|.+. ..+..|+||.+... ...+..+.+.+|++.+++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999987 45778999998542 2344478899999999999999999999999988889999
Q ss_pred EeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 90 LEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+||+++++|.+++... ..++..++..++.|++.||.|||+++++|++|+++||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 67999999999999999999999999999999999999999999999999988765222222
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLI 245 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li 245 (269)
...........|+|||.+.+... +.++||||||+++|++++ |..||......+....+..+.. +.+..++..+.+++
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 22233345678999999877665 599999999999999999 7899999888888888766554 44566899999999
Q ss_pred HHhcCCCCCCcCCCCc
Q 024347 246 ARILDPNPMTVSIYPF 261 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~ 261 (269)
..||+.||++|||+++
T Consensus 239 ~~C~~~~p~~RPs~~~ 254 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQE 254 (259)
T ss_dssp HHHT-SSGGGS--HHH
T ss_pred HHHcCCChhhCcCHHH
Confidence 9999999999999844
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=286.95 Aligned_cols=247 Identities=34% Similarity=0.628 Sum_probs=212.6
Q ss_pred eeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCch
Q 024347 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (269)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l 98 (269)
||.|++|.||++.+..+++.+++|++...........+.+.+|+.+++.++|+||+++++.+.+....++++||.++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999988999999999766555455567899999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCcc
Q 024347 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (269)
Q Consensus 99 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 178 (269)
.+++.....++...+..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 9999887789999999999999999999999999999999999999999999999999886543321 2223356788
Q ss_pred ccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHh--cCcccCCCCCCHHHHHHHHHhcCCCCC
Q 024347 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKIS--AAEFTCPPWLSFTARKLIARILDPNPM 254 (269)
Q Consensus 179 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~ 254 (269)
|+|||.+.+... +.++|+||+|+++|++++|..||.... .......+. ......+...++.+.++|++||+.||+
T Consensus 158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 999999876665 488999999999999999999998766 666666665 445566666789999999999999999
Q ss_pred CcCC---CCccccccccC
Q 024347 255 TVSI---YPFADILYMRF 269 (269)
Q Consensus 255 ~Rps---~~~~~~l~~~~ 269 (269)
+||+ ....+++.|+|
T Consensus 237 ~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred hCcCCcccCHHHHhcChh
Confidence 9999 12277778876
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=303.72 Aligned_cols=254 Identities=20% Similarity=0.332 Sum_probs=202.6
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCC-----CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVM 80 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~ 80 (269)
....++|++.+.||+|+||.||++++... ++.||+|.+..... ....+.+.+|+.+++.+ +|+||+++++.+
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 34556899999999999999999986433 35799999865432 23356788999999999 899999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHHhc-------------------------------------------------------
Q 024347 81 GSKTKIFIVLEFVTGGELFDKIVNH------------------------------------------------------- 105 (269)
Q Consensus 81 ~~~~~~~~v~~~~~~~~l~~~~~~~------------------------------------------------------- 105 (269)
......+++|||+++++|.+++...
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 9999999999999999998887432
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 106 ---------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 106 ---------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
.+++..++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 13677889999999999999999999999999999999999999999999988654321111111
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC--cccCCCCCCHHHHHHHHH
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~ 247 (269)
....++..|+|||++.+..+ +.++||||||+++|+|++ |..||............... ....+...++++.+++..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 350 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKM 350 (374)
T ss_pred cCCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHH
Confidence 11223567999999977665 489999999999999997 99999876544433333222 334455678999999999
Q ss_pred hcCCCCCCcCCCCccc
Q 024347 248 ILDPNPMTVSIYPFAD 263 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~ 263 (269)
||+.||++|||++++-
T Consensus 351 cl~~dp~~RPs~~~l~ 366 (374)
T cd05106 351 CWNLEPTERPTFSQIS 366 (374)
T ss_pred HcCCChhhCcCHHHHH
Confidence 9999999999985543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=287.13 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=212.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh-------hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-------KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
+|.+.+.||.|++|.||+|.+..+++.+++|.+...... .....+.+.+|+.+++.++|+|++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 688999999999999999999888999999988643221 1123457888999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..++++||+++++|.+.+...+.++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999888788999999999999999999999999999999999999999999999999988754332
Q ss_pred cCCCcccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cccCC----CCC
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP----PWL 237 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~----~~~ 237 (269)
..........++..|+|||.+.... ..+.++|+||||++++++++|..||...........+... ....+ ..+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222223344678899999987654 2358999999999999999999999876655444443222 12222 246
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 238 SFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.++.+++..||+.||++||++ .+++.|+|
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~--~~il~~~~ 271 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTA--RELLQHPF 271 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCH--HHHhhCCC
Confidence 8899999999999999999998 88999988
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=303.34 Aligned_cols=252 Identities=21% Similarity=0.361 Sum_probs=201.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEE-----cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEe
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 81 (269)
...++|++.+.||.|+||.||+|.+ ..++..||+|++..... ....+.+.+|+++++.+ +||||+++++++.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 3455899999999999999999974 34567899999864332 23356788999999999 8999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcC-------------------------------------------------------
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHG------------------------------------------------------- 106 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~------------------------------------------------------- 106 (269)
..+..+++|||+++|+|.+++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 9999999999999999988885421
Q ss_pred --------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 107 --------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 107 --------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
.++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 367788899999999999999999999999999999999999999999999865432211
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhcC-cccCCCCCCHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAA-EFTCPPWLSFTARK 243 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~l~~ 243 (269)
........++..|+|||++.+..+ +.++|+||||+++|+|++ |..||...... .....+..+ ....+...+.++.+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD 348 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence 111111223567999999987766 489999999999999997 89999775543 333434333 23344567889999
Q ss_pred HHHHhcCCCCCCcCCCCcc
Q 024347 244 LIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~ 262 (269)
|+..||+.||++|||+.++
T Consensus 349 li~~cl~~dP~~RPs~~ei 367 (375)
T cd05104 349 IMKSCWDADPLKRPTFKQI 367 (375)
T ss_pred HHHHHccCChhHCcCHHHH
Confidence 9999999999999998544
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=285.02 Aligned_cols=245 Identities=30% Similarity=0.536 Sum_probs=210.1
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||.+.+..+++.+++|.+..... ....+.+.+|+.+++.++|+|++++++.+.+.+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999865432 2335778889999999999999999999999999999999
Q ss_pred ccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 92 FVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|++++++.+++.. ...+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++++|||.+...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 9999999888764 345889999999999999999999999999999999999999999999999987644321 111
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHHHh
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~ 248 (269)
.....++..|+|||++.+... +.++|+||||+++|+|++|..||...+.......+..+.. +.+..++..+.++|++|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 122346788999999987765 4899999999999999999999998887777777766554 34566889999999999
Q ss_pred cCCCCCCcCCCCc
Q 024347 249 LDPNPMTVSIYPF 261 (269)
Q Consensus 249 l~~dP~~Rps~~~ 261 (269)
|+.||++||++.+
T Consensus 236 l~~~P~~Rp~~~~ 248 (255)
T cd08219 236 FKRNPRSRPSATT 248 (255)
T ss_pred HhCCcccCCCHHH
Confidence 9999999999843
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=289.29 Aligned_cols=258 Identities=18% Similarity=0.312 Sum_probs=210.3
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEc----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNS----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.+++|++.+.||+|+||.||+|... ..++.+++|.+.... .......+.+|+.+++.++|+|++++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 356789999986432 2333567889999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~ 147 (269)
..+++|||+++++|.+++... ..++..++..++.+++.||.|||++|++|+||+|+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999887532 236788899999999999999999999999999999999999
Q ss_pred CCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 024347 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (269)
Q Consensus 148 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~ 226 (269)
+.++|+|||++................++..|+|||.+.+... +.++|+||||+++|+|++ |..||.........+.+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999998865433222222222334567999999987665 489999999999999998 99999877766666666
Q ss_pred hcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 227 SAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 227 ~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.... .+.+..+++.+.+++.+||+.||++||+++++......|
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 240 RKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 5443 455667899999999999999999999996655444433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=286.49 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=211.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
....+|++.+.||.|++|.||+|.+..+++.+++|.+.... .....+.+|++.++.++|+|++++++++......+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 45668999999999999999999999889999999986432 22467888999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++|||+++++|.+++... ..++...+..++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999988653 358889999999999999999999999999999999999999999999999886543321
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 243 (269)
... ......+..|+|||.+.+...+ .++|+||||+++|+|++ |..||...+..+....+... ....+..++..+.+
T Consensus 159 ~~~-~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (263)
T cd05052 159 YTA-HAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE 236 (263)
T ss_pred eec-cCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 111 1111234579999998776664 88999999999999998 99999988887777777654 45556678999999
Q ss_pred HHHHhcCCCCCCcCCCCccc
Q 024347 244 LIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~ 263 (269)
++++||+.||++||+++++.
T Consensus 237 li~~cl~~~p~~Rp~~~~l~ 256 (263)
T cd05052 237 LMRACWQWNPSDRPSFAEIH 256 (263)
T ss_pred HHHHHccCCcccCCCHHHHH
Confidence 99999999999999986553
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=299.78 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=202.5
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 83 (269)
..++|++.+.||.|+||.||++.+..+++.+++|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 56899999999999999999999998999999999865432 233356778899999999999999999988543
Q ss_pred -CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 84 -~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
...+++|||+++ ++.+.+.. .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 347999999976 56565543 48889999999999999999999999999999999999999999999999987433
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------- 229 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------- 229 (269)
. ........++..|+|||++.+..+. .++|+||||+++|+|++|..||.+.+...........
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 1122334578899999999877664 8999999999999999999999876654433322110
Q ss_pred ---------c----------------c----cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ---------E----------------F----TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ---------~----------------~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. . ..+...+..+++||.+||+.||++|||+ .+++.|+|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~--~ell~hp~ 313 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV--DEALQHPY 313 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCH--HHHhcCcc
Confidence 0 0 0111235678999999999999999999 88889887
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=284.61 Aligned_cols=243 Identities=27% Similarity=0.433 Sum_probs=201.3
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 96 (269)
+.||.|++|.||+|.+..+++.+++|.+.... ..+....+.+|+++++.++|+||+++++++......++|+||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999999899999999875332 2344577889999999999999999999999999999999999999
Q ss_pred chhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 97 ELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 97 ~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
+|.+++... ..+++.++..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||.+.................
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 999888654 3689999999999999999999999999999999999999999999999998764332111111111122
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHHHHHHhcCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNP 253 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP 253 (269)
+..|+|||.+.+... +.++|+||||+++|++++ |..||...........+... ....+..++..+.+++++||+.||
T Consensus 159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 456999999987765 489999999999999997 99999877666655555443 445566789999999999999999
Q ss_pred CCcCCCCcc
Q 024347 254 MTVSIYPFA 262 (269)
Q Consensus 254 ~~Rps~~~~ 262 (269)
++|||++++
T Consensus 238 ~~Rps~~~~ 246 (252)
T cd05084 238 GQRPSFSTV 246 (252)
T ss_pred hhCcCHHHH
Confidence 999998554
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=289.21 Aligned_cols=254 Identities=29% Similarity=0.425 Sum_probs=208.3
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.+..+++.+++|.+..... .....+.+.+|+.++++++|+|++++++++......++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999998899999999864332 2223456788999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++++++.........+++.++..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence 9999988877666666799999999999999999999999999999999999999999999999998875433221 12
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------------
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------------- 229 (269)
....++..|+|||.+.+....+.++|+||||+++|+|++|..||.+....+....+...
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 22345778999999876554568999999999999999999999876654433322110
Q ss_pred cccC----------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EFTC----------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+. .+.++..+.+|+.+||+.||++||++ .+++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~--~eil~~~~ 285 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC--EELLEHPY 285 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCH--HHHhcCCC
Confidence 0000 12357889999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=283.60 Aligned_cols=252 Identities=30% Similarity=0.579 Sum_probs=217.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||+|++|.+|.+.+..+|+.+++|.+...... ......+.+|+.+++.++|+|++++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 689999999999999999999999999999998764432 3345678899999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|+.+++|.+.+.... .+++.++..++.|++.+|.+||++|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--L 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--h
Confidence 999999988886543 578999999999999999999999999999999999999999999999998865433211 1
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHHHh
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARI 248 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~ 248 (269)
.....++..|+|||++.+... +.++|+||||++++++++|..||......+....+..+.. +.+..++.++.++|++|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 112346778999999987665 4899999999999999999999998888777777766554 34566899999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.+|.+||++ .+.+.|+|
T Consensus 237 l~~~p~~Rp~~--~~vl~~~~ 255 (256)
T cd08218 237 FKRNPRDRPSV--NSILEKNF 255 (256)
T ss_pred hhCChhhCcCH--HHHhhCcC
Confidence 99999999999 88888887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=284.00 Aligned_cols=252 Identities=30% Similarity=0.454 Sum_probs=213.5
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||++.+..+++.+++|.+..... ...+.+.+|+.++++++|||++++++.+......+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 4689999999999999999999988899999999875432 2467889999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+++++|..++... ..+++.++..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence 9999999999888765 68999999999999999999999999999999999999999999999999987653321 11
Q ss_pred cccccccCccccCcccccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc-----CCCCCCHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDR---GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-----CPPWLSFT 240 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~---~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 240 (269)
......++..|+|||.+.+. .. +.++|+||||+++|+|++|..||................+. .+..++.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 11223467789999998765 44 48899999999999999999999887766655555444222 12335788
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+++++||+.||.+||++ .+++.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~--~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTA--TKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCH--HHHhcCCC
Confidence 9999999999999999999 88888887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=284.76 Aligned_cols=254 Identities=27% Similarity=0.451 Sum_probs=212.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhh---hhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV---LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
+|++.+.||.|++|.||+|.. .+++.+++|.+..... ........+.+|+++++.++|+|++++++++.+....++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 588999999999999999986 4788899998864322 123335678899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC--
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-- 166 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~-- 166 (269)
++||+++++|.+++.+...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999998877889999999999999999999999999999999999999999999999998765432111
Q ss_pred --CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---cccCCCCCCHHH
Q 024347 167 --DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTA 241 (269)
Q Consensus 167 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 241 (269)
........++..|+|||.+.+.... .++|+||||++++++++|..||...+.......+... ....+..++.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 1112233467889999999877664 8999999999999999999999876655544443332 223455689999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++|+.||+.||++||++ .+.+.|+|
T Consensus 239 ~~~i~~~l~~~p~~Rp~~--~~~l~~~~ 264 (265)
T cd06631 239 IDFVTSCLTRDQHERPSA--LQLLRHDF 264 (265)
T ss_pred HHHHHHHhcCCcccCCCH--HHHhcCCC
Confidence 999999999999999999 88888887
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=289.57 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=215.2
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
+++....+|++.+.||.|++|.||++.+..+++.+++|.+..... ...+.+.+|+.+++.++|+|++++++.+....
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 89 (296)
T cd06655 13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGD 89 (296)
T ss_pred hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence 445566789999999999999999999999999999999865432 22467788999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..++++||+++++|...+.. ..+++.++..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 90 ELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred eEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 99999999999999887754 46899999999999999999999999999999999999999999999999987654322
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc---ccCCCCCCHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTA 241 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 241 (269)
.. ......++..|+|||.+.+... +.++|+||||+++|++++|..||...........+.... ...+..+++.+
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06655 169 QS--KRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIF 245 (296)
T ss_pred cc--cCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHH
Confidence 11 1222346788999999887665 489999999999999999999998877665544443332 23345688999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++|++||..||++||++ .+++.|+|
T Consensus 246 ~~li~~~l~~dp~~Rpt~--~~il~~~~ 271 (296)
T cd06655 246 RDFLNRCLEMDVEKRGSA--KELLQHPF 271 (296)
T ss_pred HHHHHHHhhcChhhCCCH--HHHhhChH
Confidence 999999999999999999 78888876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=289.36 Aligned_cols=258 Identities=33% Similarity=0.624 Sum_probs=223.8
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v 89 (269)
++|++.+.||.|++|.||++....+++.+++|++.............+.+|+.+++++. |+||+++++.+.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999997755555555677889999999998 99999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC--
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-- 167 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~-- 167 (269)
||++++++|.+.+...+.++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999988654432211
Q ss_pred ----------------CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc
Q 024347 168 ----------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (269)
Q Consensus 168 ----------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 231 (269)
.......++..|+|||...+... +.++|+||||++++++++|..||...........+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 11222345788999999887665 4899999999999999999999998887777777777777
Q ss_pred cCCCCCCHHHHHHHHHhcCCCCCCcCCCC--ccccccccC
Q 024347 232 TCPPWLSFTARKLIARILDPNPMTVSIYP--FADILYMRF 269 (269)
Q Consensus 232 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~--~~~~l~~~~ 269 (269)
..+..+++.+.+||+.||+.||++||++. -.+++.|+|
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 78888999999999999999999999982 126677776
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=282.06 Aligned_cols=252 Identities=29% Similarity=0.515 Sum_probs=217.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||.++...+++.+++|.+...... ....+.+.+|++++++++|+||+++++++.+.+..++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 689999999999999999999999999999998754433 2335678899999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|+++++|.+.+... ..++..++..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||.+........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--M 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--c
Confidence 99999999988764 4689999999999999999999999999999999999999999999999998865433221 2
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC-CCCCCHHHHHHHHHh
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSFTARKLIARI 248 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~ 248 (269)
.....+++.|.|||...+... +.++|+||||+++++|++|..||......+....+..+..+. +..++.++.+++..|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 223457889999999887665 488999999999999999999999888888777776655433 355789999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||.+||++ .+++.++|
T Consensus 237 l~~~p~~R~s~--~~ll~~~~ 255 (256)
T cd08221 237 LQQDPEKRPTA--DEVLDQPL 255 (256)
T ss_pred cccCcccCCCH--HHHhhCcC
Confidence 99999999998 67777665
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=288.67 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=210.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||.|++|.||.|.+..+++.+++|.+..... .....+.+|+.+++.++|||++++++.+......++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEE
Confidence 34589999999999999999999999999999999865432 224567889999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
++||+++++|.+++...+.+++.++..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~ 161 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA 161 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence 9999999999999888888999999999999999999999999999999999999999999999999987644321 11
Q ss_pred cccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC-----CCCCCHHH
Q 024347 169 LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-----PPWLSFTA 241 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l 241 (269)
......++..|+|||.+.. ....+.++|+||||+++|++++|..||................... ...++..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 2233457889999999742 2223589999999999999999999997655444333332222211 12367889
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++|++||+.||++||++ .+.+.|+|
T Consensus 242 ~~li~~~l~~~P~~R~~~--~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTA--EKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCH--HHHhcCCC
Confidence 999999999999999999 88889987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=290.28 Aligned_cols=253 Identities=32% Similarity=0.456 Sum_probs=214.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||++.+..+++.+++|.+... .....+.+.+|+.++++++|+|++++++.+......+++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 56899999999999999999999888999999998643 233457788899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+++++|..++... ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 9999999998888764 569999999999999999999999999999999999999999999999999875433211 1
Q ss_pred cccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTA 241 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 241 (269)
......++..|+|||.+... ...+.++|+||||+++|++++|..||...........+..... ..+..++.++
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF 238 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence 12233467889999997532 2234789999999999999999999988877776666655533 2345688999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++|..||+.||.+||++ .+++.|+|
T Consensus 239 ~~li~~~l~~~p~~Rps~--~~il~~~~ 264 (280)
T cd06611 239 NDFLKSCLVKDPDDRPTA--AELLKHPF 264 (280)
T ss_pred HHHHHHHhccChhhCcCH--HHHhcChh
Confidence 999999999999999999 78888887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=290.64 Aligned_cols=250 Identities=24% Similarity=0.397 Sum_probs=207.8
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .....+.+.+|++++++++||||+++++.+.+.+..++++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999886432 2334567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||+++++|.+++...+.+++..+..++.|++++|.|||+ .+++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----M 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc----c
Confidence 999999999999888889999999999999999999998 59999999999999999999999999987643221 1
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------------
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------- 229 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------- 229 (269)
.....++..|+|||.+.+... +.++|+||||++++++++|..||...+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 223356789999999876655 48999999999999999999999765443333222111
Q ss_pred ----------------cccC-C-CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ----------------EFTC-P-PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ----------------~~~~-~-~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+. + ..++.++.+|+.+||+.||++||++ .+++.|+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--~~ll~~~~ 289 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL--KELTKHPF 289 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH--HHHhcChh
Confidence 0011 1 1267789999999999999999999 78888877
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=291.18 Aligned_cols=250 Identities=30% Similarity=0.434 Sum_probs=198.2
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC---CCCCceeeeEEEee-----C
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGS-----K 83 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-----~ 83 (269)
+|++.+.||+|++|.||+|.++.+++.+++|.+....... .......+|+.+++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 6899999999999999999999999999999986532211 1122344566655554 79999999998754 3
Q ss_pred CeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
...++++||+.+ ++..++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999975 787777653 34899999999999999999999999999999999999999999999999988754
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------ 229 (269)
... .......++..|+|||++.+..+ +.++||||||+++|+|++|..||...........+...
T Consensus 159 ~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SCQ---MALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cCc---ccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 321 11223346788999999987665 48999999999999999999999877665544443210
Q ss_pred ------cc---------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ------EF---------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ------~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+ ...+.++..+.++|.+||++||++|||+ .+++.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~~~l~hp~ 287 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA--FRALQHPF 287 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH--HHHhcCCC
Confidence 00 1113467889999999999999999999 88889988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=289.19 Aligned_cols=256 Identities=28% Similarity=0.472 Sum_probs=213.4
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.++....+|++.+.||+|++|.||++.+..+++.+++|.+...... ..+.+.+|+.+++.+.|+|++++++.+....
T Consensus 14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~ 90 (296)
T cd06654 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD 90 (296)
T ss_pred ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence 4566678999999999999999999999989999999998654322 2467888999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..++|+||+++++|..++.. ..++..++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999999999988754 46889999999999999999999999999999999999999999999999987653321
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc---ccCCCCCCHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTA 241 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l 241 (269)
. .......+++.|+|||.+.+... +.++|+||||+++|++++|..||................ ...+..++..+
T Consensus 170 ~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (296)
T cd06654 170 Q--SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (296)
T ss_pred c--cccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence 1 11223356789999999887665 489999999999999999999998776644333333222 22345588999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+++++||..||++||++ .+++.|+|
T Consensus 247 ~~li~~~l~~~p~~Rpt~--~eil~~~~ 272 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSA--KELLQHQF 272 (296)
T ss_pred HHHHHHHCcCCcccCcCH--HHHhhChh
Confidence 999999999999999998 77777765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=285.17 Aligned_cols=255 Identities=29% Similarity=0.471 Sum_probs=215.0
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|+||++....++..+++|.+....... ..+.+.+|+..++.++|+|++++++.+......++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998889999999986544322 4678899999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 91 EFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+++++++|.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999988764 35899999999999999999999999999999999999999999999999988655443222
Q ss_pred C--cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC------CCCCH
Q 024347 168 G--LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP------PWLSF 239 (269)
Q Consensus 168 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~ 239 (269)
. ......++..|+|||.+......+.++|+||||+++++|++|..||.................+.. ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 1 122334678899999987764446899999999999999999999988776665655544432211 24678
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.++++.||+.||++||++ .+++.|+|
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~--~~ll~~p~ 266 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTA--EELLKHKF 266 (267)
T ss_pred HHHHHHHHHcCCChhhCcCH--HHHhhCCC
Confidence 99999999999999999998 88888987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=290.95 Aligned_cols=254 Identities=28% Similarity=0.440 Sum_probs=208.4
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||+|++|.||++.+..+++.+++|.+...... ....+.+.+|+++++.++|+|++++++++......++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 5799999999999999999999888999999987653322 234567888999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++++++.........++..++..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--ccc
Confidence 999998887766655678999999999999999999999999999999999999999999999999876543221 122
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------------
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------------- 229 (269)
....++..|+|||++.+....+.++|+||||++++++++|+.||......+....+...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 22346788999999876554568899999999999999999999766544333222110
Q ss_pred cc----------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EF----------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ...+.++..+.+|++.||+.||++||++ .+++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~--~~il~~~~ 285 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS--SQLLHHEF 285 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhH--HHHhcCCC
Confidence 00 0123468889999999999999999999 78999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=299.36 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=203.2
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 83 (269)
..++|++.+.||+|++|.||.+.+..+++.+|+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 46899999999999999999999999999999999865432 233356778899999999999999999987543
Q ss_pred -CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 84 -~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
...++||||+++ ++...+.. .++...+..++.|++.||.+||++||+|+||+|+||+++.++.++|+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 357999999965 66666643 47889999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------- 229 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------- 229 (269)
. ........++..|+|||++.+..+. .++||||||+++|+|++|..||.+.+.......+...
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 1122234578899999999887664 8999999999999999999999877665544443210
Q ss_pred ---------ccc--------------------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ---------EFT--------------------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ---------~~~--------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
... .....+..+++||.+||+.||.+|||+ .++|.|+|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~--~e~L~hp~ 320 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV--DEALQHPY 320 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCH--HHHhcCcc
Confidence 000 001134678999999999999999999 78889887
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=298.72 Aligned_cols=251 Identities=24% Similarity=0.382 Sum_probs=202.7
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 83 (269)
..++|++.+.||.|+||.||++.+..+++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45789999999999999999999999999999999865432 223345677899999999999999999887543
Q ss_pred -CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 84 -~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
...+++++++ +++|...+. ...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 3468899987 678876654 4579999999999999999999999999999999999999999999999999887533
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc------------
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 230 (269)
. ......+++.|+|||++.+....+.++||||||+++|+|++|+.||...+.......+....
T Consensus 170 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07878 170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS 244 (343)
T ss_pred C-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 2 12234578899999999775545689999999999999999999998766544333321100
Q ss_pred ----------cc---------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ----------FT---------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ----------~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+ .....++.+.+||++||+.||.+|||+ .+++.|+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~--~ell~hp~ 300 (343)
T cd07878 245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA--SEALAHPY 300 (343)
T ss_pred hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH--HHHhcCcc
Confidence 00 011256678999999999999999999 78888887
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=282.97 Aligned_cols=253 Identities=28% Similarity=0.480 Sum_probs=214.1
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhh--hhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
+|+..+.||+|++|.||+|....+++.+++|.+..... ...+..+.+.+|+.+++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 57888999999999999999988899999999865332 1234467889999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
+||+++++|.+++.....++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 9999999999998887789999999999999999999999999999999999999999999999999876543322 1
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CcccCCCCCCHHHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~ 247 (269)
.....++..|+|||.+......+.++|+||||+++|++++|+.||.............. .....+..+++.+.+++++
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 22344678899999987665235899999999999999999999987665544444433 2234456689999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+.+|.+||++ .+++.|+|
T Consensus 238 ~l~~~p~~Rp~~--~~~l~~~~ 257 (258)
T cd06632 238 CLQRDPSLRPTA--AELLEHPF 257 (258)
T ss_pred HhhcCcccCcCH--HHHhcCCC
Confidence 999999999998 88888887
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=284.63 Aligned_cols=251 Identities=30% Similarity=0.531 Sum_probs=207.5
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||+|.+..+++.+++|.+.............+.+|+.+++.++|||++++++.+...+..+++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999988654444455567788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+||+++++|...+.. ...++..++..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999877753 3458899999999999999999999999999999999999999999999999876543211
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHhcCccc-CC-CCCCHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEFT-CP-PWLSFTA 241 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-~~-~~~~~~l 241 (269)
.......++..|+|||.+.+.... .++|+||+|+++|++++|..||.... .......+.....+ .+ ...+..+
T Consensus 161 --~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 161 --TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred --HHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 111223467789999999876664 89999999999999999999996543 23444444443332 22 3477889
Q ss_pred HHHHHHhcCCCCCCcCCCCccc
Q 024347 242 RKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.+++++||+.+|++||++.++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl 259 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVH 259 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHH
Confidence 9999999999999999995543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=287.33 Aligned_cols=251 Identities=26% Similarity=0.472 Sum_probs=213.9
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.+..+++.+++|.+..... ......+.+|+++++.++|+|++++++.+.+....++++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 478999999999999999999999999999999865432 233466788999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||+++++|.+.+... .++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~ 155 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR 155 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence 999999999888765 78999999999999999999999999999999999999999999999999887654322 122
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc-CCCC-CCHHHHHHHHHh
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPW-LSFTARKLIARI 248 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-~~~~l~~li~~~ 248 (269)
....++..|+|||.+.+... +.++|+||||+++|++++|..||...+.......+.....+ .+.. ++.++.+++..|
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 234 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC 234 (274)
T ss_pred ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence 23346778999999987775 59999999999999999999999877766666555544332 2333 788999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|..||++||++ .+.+.|+|
T Consensus 235 l~~~p~~Rpt~--~~il~~~~ 253 (274)
T cd06609 235 LNKDPKERPSA--KELLKHKF 253 (274)
T ss_pred hhCChhhCcCH--HHHhhChh
Confidence 99999999998 77788876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=289.04 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=209.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.++|.+.+.||+|++|.||+|.+. .+++.+++|.+..... .+..+.+.+|+++++.++|+|++++++++....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 467999999999999999999874 3367899999865432 334578899999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCE
Q 024347 85 KIFIVLEFVTGGELFDKIVNHG--------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~--------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~ 150 (269)
..+++|||+++++|.+++...+ .++..++..++.+++.++++||+.|++|+||+|+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999886542 37788999999999999999999999999999999999999999
Q ss_pred EEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 024347 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 229 (269)
+|+|||.+.................+..|+|||++.+... +.++||||||+++|+|++ |..||......+....+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 9999998864322211111222234678999999987776 489999999999999998 99999888888888887766
Q ss_pred cccC-CCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 230 EFTC-PPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 230 ~~~~-~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.... +..++..+.+++++||+.||++||+++++.
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 275 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIH 275 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 5533 456899999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=287.12 Aligned_cols=253 Identities=30% Similarity=0.449 Sum_probs=211.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.+.|++.+.||.|++|.||+|.+..+++.+++|.+... .....+.+.+|+.+++.++|+|++++++.+..+...+++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 36799999999999999999999999999999998643 334467788899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||++++++...+.. ...++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~ 165 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQ 165 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc--cc
Confidence 999999999877654 456899999999999999999999999999999999999999999999999987643221 11
Q ss_pred cccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTA 241 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l 241 (269)
......+++.|+|||.+.+. ...+.++|+||||+++|+|++|..||..........++..... ..+..++.++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHH
Confidence 12233467889999998532 2234789999999999999999999987776665555544432 2345578899
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++|+.||+.||++||++ .+++.|+|
T Consensus 246 ~~li~~~l~~~p~~Rp~~--~~il~~~~ 271 (292)
T cd06644 246 RDFLKTALDKHPETRPSA--AQLLEHPF 271 (292)
T ss_pred HHHHHHHhcCCcccCcCH--HHHhcCcc
Confidence 999999999999999999 77788876
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=284.47 Aligned_cols=255 Identities=19% Similarity=0.344 Sum_probs=211.6
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
....++|++.+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|+.+++.++|+|++++++.+......
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 345689999999999999999999975 467799998754322 246788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
++++||+++++|.+++... ..++...+..++.+++.+|.|||+.+++|+||+|+||+++.++.++|+|||.+......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999999988653 46888999999999999999999999999999999999999999999999998754321
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 242 (269)
... ......++..|+|||.+.+... +.++|+||||+++|+|++ |..||...........+... ..+....++.++.
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05072 157 EYT-AREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELY 234 (261)
T ss_pred cee-ccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence 111 1112224567999999877665 489999999999999998 99999888777777776654 3344456889999
Q ss_pred HHHHHhcCCCCCCcCCCCcccccccc
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
+++++||+.||++||+++++..+...
T Consensus 235 ~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 235 DIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHHHccCCcccCcCHHHHHHHHhc
Confidence 99999999999999999777665543
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=287.42 Aligned_cols=252 Identities=28% Similarity=0.419 Sum_probs=203.6
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.+++.++|||++++++++.+....++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999989999999998654322 2224567889999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 92 FVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 92 ~~~~~~l~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|++ +++.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence 997 4777777542 46899999999999999999999999999999999999999999999999988644322 11
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-------------------- 228 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------------- 228 (269)
......+++.|+|||++.+....+.++|+||||++++++++|+.||..............
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 122234578899999987655446899999999999999999999986554322211100
Q ss_pred --------Cc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 --------AE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 --------~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ......+++++.++|++||+.||.+|||+ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~--~~ll~~~~ 284 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISA--KKALNHPY 284 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCH--HHHhcCCC
Confidence 00 01122378899999999999999999999 78888887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=287.68 Aligned_cols=251 Identities=22% Similarity=0.320 Sum_probs=208.9
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
...+|.+.+.||.|++|.||++... .++..+++|.+.... ....+.+.+|+.++++++|+|++++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3467999999999999999999852 345668889875432 33457789999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCE
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG-------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~ 150 (269)
+..++++||+++++|.+++...+ .+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999998886543 38999999999999999999999999999999999999999999
Q ss_pred EEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 024347 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 229 (269)
+|+|||.+................++..|+|||.+.+... +.++|+||||+++|+|++ |..||...........+..+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 9999998875432221111222334568999999987665 489999999999999998 99999888877777777776
Q ss_pred cc-cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 230 EF-TCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 230 ~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.. ..+..++.++.+|+.+||+.||.+|||++++.
T Consensus 239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~ 273 (288)
T cd05093 239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH 273 (288)
T ss_pred CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 53 44556889999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=306.08 Aligned_cols=249 Identities=23% Similarity=0.337 Sum_probs=195.1
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC------CCCceeeeEEEe
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK------HPNVVRLYEVMG 81 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~------~~~i~~~~~~~~ 81 (269)
...++|++.+.||.|+||.||+|.+..+++.||+|++..... .......|+.+++.+. |.+++.+++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 345789999999999999999999998999999999864221 1234445666665554 456888888886
Q ss_pred eC-CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCC-----------
Q 024347 82 SK-TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYG----------- 148 (269)
Q Consensus 82 ~~-~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~----------- 148 (269)
.. ...++||+++ |++|.+++...+.++...+..++.|++.||.|||+ .||+|+||||+||+++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 54 5688999988 67888888888889999999999999999999998 5999999999999998765
Q ss_pred -----CEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 024347 149 -----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY 223 (269)
Q Consensus 149 -----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 223 (269)
.++|+|||.+.... .......+++.|+|||++.+..+. .++|||||||++|+|++|+.||...+..+..
T Consensus 281 ~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred CCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 49999999765321 122345678999999999887764 8999999999999999999999876654433
Q ss_pred HHHhcC--cc-------------------------cC---------------CCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 224 KKISAA--EF-------------------------TC---------------PPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 224 ~~~~~~--~~-------------------------~~---------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
..+... .+ .. ....++.+.+||+.||++||++|||+
T Consensus 355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta-- 432 (467)
T PTZ00284 355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA-- 432 (467)
T ss_pred HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH--
Confidence 322110 00 00 00124567899999999999999999
Q ss_pred cccccccC
Q 024347 262 ADILYMRF 269 (269)
Q Consensus 262 ~~~l~~~~ 269 (269)
.++|.|+|
T Consensus 433 ~e~L~Hp~ 440 (467)
T PTZ00284 433 RQMTTHPY 440 (467)
T ss_pred HHHhcCcc
Confidence 88889988
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=285.49 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=211.1
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCC
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 84 (269)
++...++|++.+.||.|++|.||+|.+..+++.+++|.+..... ..+.+.+|+.+++++ .|+|++++++.+....
T Consensus 1 ~~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 76 (275)
T cd06608 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN 76 (275)
T ss_pred CCCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence 35677999999999999999999999988899999999865432 246788999999999 6999999999996544
Q ss_pred ------eEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEee
Q 024347 85 ------KIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSD 154 (269)
Q Consensus 85 ------~~~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~d 154 (269)
..++++||+++++|.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|
T Consensus 77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECC
Confidence 48999999999999887764 34789999999999999999999999999999999999999999999999
Q ss_pred CCCccccccccCCCcccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc
Q 024347 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (269)
Q Consensus 155 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (269)
||.+...... ........++..|+|||++... ...+.++|+||||+++|++++|+.||..........++....
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 234 (275)
T cd06608 157 FGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP 234 (275)
T ss_pred Cccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC
Confidence 9987653321 1222234467889999987542 223578999999999999999999998766665555554443
Q ss_pred c---cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 F---TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ..+..+++.+.+||++||..||++|||+ .+.+.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~--~~ll~~~~ 274 (275)
T cd06608 235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFM--EELLEHPF 274 (275)
T ss_pred CCCCCchhhcCHHHHHHHHHHhhcChhhCcCH--HHHhcCCC
Confidence 2 2223377899999999999999999999 88888988
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=273.99 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=206.3
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-- 83 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 83 (269)
+-+.-+||++.+.||.|||+-||+++...++..||+|.+...+ .+..+...+|++..++++|||+++++++...+
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 4456689999999999999999999999999999999997765 34468889999999999999999998876433
Q ss_pred ---CeEEEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEecCCCCEEEee
Q 024347 84 ---TKIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSD 154 (269)
Q Consensus 84 ---~~~~~v~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~~~~~~~l~d 154 (269)
...+++++|...|++.+.+... ..+++.+++.|+.++++||++||+.. +.|+||||.||++++.+.+++.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 3489999999999999988763 36899999999999999999999998 99999999999999999999999
Q ss_pred CCCccccccccCCCcc-------cccccCccccCcccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCH--HHHH
Q 024347 155 FGLSALSQQVRDDGLL-------HTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDSNL--MNLY 223 (269)
Q Consensus 155 f~~~~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~ 223 (269)
||.+........+... .....+..|+|||.+.-+.+ .+.++|||||||++|+||.|..||+..-. ..+.
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla 252 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA 252 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence 9998776543333221 11235788999999875543 36899999999999999999999963211 0111
Q ss_pred HHHhcCcccC--CCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 224 KKISAAEFTC--PPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 224 ~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
-.+.++...+ .+.++..+.++|++||+.||.+||++.+.
T Consensus 253 LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~l 293 (302)
T KOG2345|consen 253 LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPEL 293 (302)
T ss_pred EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHH
Confidence 1123333333 34489999999999999999999998543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=278.83 Aligned_cols=258 Identities=35% Similarity=0.616 Sum_probs=226.0
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhh-----hhHHHHHHHHHHHHHhhhCC-CCCceeeeEEE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLVK-HPNVVRLYEVM 80 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-----~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~ 80 (269)
...+++|..-+.||+|..++|-++.++.+|+.+++|++..... ...+..+.-.+|+++|+++. ||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 4567889999999999999999999999999999999863221 12344566778999999985 99999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 81 GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 81 ~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
+.+...++|++.++.|.|.+++.+.-.+++.....+.+|+++++.|||.++|||+|+||+||+++++-+++++|||++..
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQ 172 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeec
Confidence 99999999999999999999999988899999999999999999999999999999999999999999999999999875
Q ss_pred cccccCCCcccccccCccccCcccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC-
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP- 234 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~- 234 (269)
... .......+|+|+|.|||.+.. .+.++...|+|++|+++|.++.|.+||-....+-+...+..|++.+.
T Consensus 173 l~~---GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~s 249 (411)
T KOG0599|consen 173 LEP---GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRS 249 (411)
T ss_pred cCC---chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCC
Confidence 543 334445679999999999753 34456889999999999999999999998888899999998887654
Q ss_pred -CC--CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 -PW--LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 -~~--~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.| ++...++||++||+.||++|.|+ -+.|.|+|
T Consensus 250 peWadis~~~KdLIsrlLqVdp~~Rita--ke~LaHpf 285 (411)
T KOG0599|consen 250 PEWADISATVKDLISRLLQVDPTKRITA--KEALAHPF 285 (411)
T ss_pred cchhhccccHHHHHHHHHeeCchhcccH--HHHhcChH
Confidence 33 78899999999999999999999 67788876
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=285.90 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=209.3
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEec
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
|++.+.||.|++|.||++.+..++..+++|.+.... ....+.+.+|+.+++.++|+|++++++.+......++++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 688899999999999999999999999999985432 33356788899999999999999999999999999999999
Q ss_pred cCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 93 VTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 93 ~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
++++++...+.. ...+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++++|||++...... .....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~ 161 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRD 161 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--ccccc
Confidence 999999887754 457899999999999999999999999999999999999999999999999987643321 11223
Q ss_pred ccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHHHHHH
Q 024347 172 TTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKL 244 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~l 244 (269)
...+++.|+|||++... ...+.++|+||+|+++|+|++|..||..........++..... ..+..++.++.+|
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (282)
T cd06643 162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF 241 (282)
T ss_pred cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence 34578899999998421 2224789999999999999999999988776666555544332 3345588999999
Q ss_pred HHHhcCCCCCCcCCCCccccccccC
Q 024347 245 IARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||+.||++||++ .+.+.|+|
T Consensus 242 i~~~l~~~p~~Rp~~--~~il~~~~ 264 (282)
T cd06643 242 LKKCLEKNVDARWTT--TQLLQHPF 264 (282)
T ss_pred HHHHccCChhhCcCH--HHHhcCCC
Confidence 999999999999999 78888887
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=285.62 Aligned_cols=252 Identities=18% Similarity=0.251 Sum_probs=205.7
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
...++|++.+.||+|++|.||.|.+.. ++..+++|.+..... ......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998642 356799998754321 2234668899999999999999999999998
Q ss_pred CCeEEEEEeccCCCchhHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEE
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l 152 (269)
....+++|||+++++|.+++...+ .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 899999999999999998886522 3567788999999999999999999999999999999999999999
Q ss_pred eeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-
Q 024347 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE- 230 (269)
Q Consensus 153 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~- 230 (269)
+|||.+................++..|+|||++.+... +.++|+||||+++|++++ |..||...........+....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc
Confidence 99998764432221111112234678999999987665 489999999999999998 789998887777776665544
Q ss_pred ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 231 FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
...+..++..+.+++.+||+.||++|||+.++
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 271 (277)
T cd05062 240 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 34556689999999999999999999998443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=281.60 Aligned_cols=255 Identities=30% Similarity=0.374 Sum_probs=211.8
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--CCeE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKI 86 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 86 (269)
+.+.|+.+..|+.|.||.||+|+++.+++.||+|.++.+. ..+.+--.-.+|+.+|.+.+||||+.+-.+... -+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 5678999999999999999999999999999999987654 122222345689999999999999999888744 4679
Q ss_pred EEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
|+||||++. +|...+++-+ +++..+++-+..|+++|++|||.+.|+|+|+||+|++++..|.+|++|||+++.++...
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 999999976 8888887754 89999999999999999999999999999999999999999999999999999877642
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------------
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---------------- 229 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------- 229 (269)
. ......-|.-|+|||.+.+...++.+.|+||+||++.+++++.+.|.+....+..+.+...
T Consensus 232 k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 232 K--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred c--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 2 2223334677999999999988889999999999999999999999998887777665310
Q ss_pred ---cccCCC------------C-CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ---EFTCPP------------W-LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ---~~~~~~------------~-~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...++. . ++..-.+|++.+|..||.+|.|+ -+.|.|.|
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA--~~~L~h~~ 363 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITA--EDGLKHEY 363 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccH--HHhhcccc
Confidence 000110 0 35777899999999999999999 77788876
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=290.95 Aligned_cols=249 Identities=21% Similarity=0.338 Sum_probs=204.7
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCe----EEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEP----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
-.+|++.+.||+|+||.||+|.+..+++. +++|.+.... .....+.+.+|+.+++.++|+||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 35799999999999999999998766654 8999986432 233457788999999999999999999998764 4
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++++|+++++|.+.+... ..++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 67899999999999988764 46888999999999999999999999999999999999999999999999998765432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 242 (269)
...........+..|+|||.+.+..+. .++||||||+++|++++ |..||.+....+....+..+ ..+.++.++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 222111222335679999999877664 89999999999999997 99999887776665554433 3455677899999
Q ss_pred HHHHHhcCCCCCCcCCCCcc
Q 024347 243 KLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~ 262 (269)
+++..||+.||.+||++.++
T Consensus 242 ~li~~cl~~~p~~Rps~~~l 261 (316)
T cd05108 242 MIMVKCWMIDADSRPKFREL 261 (316)
T ss_pred HHHHHHccCChhhCcCHHHH
Confidence 99999999999999998544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=281.90 Aligned_cols=250 Identities=21% Similarity=0.359 Sum_probs=208.3
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||+|++|.||+|.+.. ++.+++|.+..... ..+.+.+|+.++++++|+|++++++++...+..+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 345789999999999999999999754 57799999865432 1456788999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+++||+++++|.+++.... .++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999886643 68999999999999999999999999999999999999999999999999887654211
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 243 (269)
.. .......+..|+|||++.+... +.++|+||||++++++++ |+.||.+.........+... ..+.+..++..+.+
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD 235 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 11 1111122357999999877665 489999999999999999 99999988877777766544 34556678999999
Q ss_pred HHHHhcCCCCCCcCCCCcccc
Q 024347 244 LIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~ 264 (269)
++.+||+.||++||+++++..
T Consensus 236 li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 236 IMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHHHhhcCcccCCCHHHHHH
Confidence 999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=285.58 Aligned_cols=253 Identities=31% Similarity=0.471 Sum_probs=209.9
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||+|.+..+|+.+++|.+...... ......+.+|+.++++++|+|++++++++......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 689999999999999999999989999999998764432 2335678899999999999999999999999999999999
Q ss_pred ccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 92 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
|+ +++|.+.+.. ...+++.++..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence 99 9999988765 45789999999999999999999999999999999999999999999999998875443221 112
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------------
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------------- 229 (269)
....++..|+|||.+.+....+.++||||+|++++++++|..||...........+...
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 23456788999999876555568999999999999999999888776655444333210
Q ss_pred cc---------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EF---------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+ ...+..+..+.++|++||+.||++||++ .+++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~--~~~l~h~~ 284 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA--AEALRHPY 284 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCH--HHHhhCcC
Confidence 00 0112467899999999999999999999 88889987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=283.85 Aligned_cols=250 Identities=33% Similarity=0.610 Sum_probs=215.3
Q ss_pred eeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCch
Q 024347 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (269)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l 98 (269)
||.|++|.||++.+..+|+.+++|.+...........+.+.+|++++++++|+|++++++.+......++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999988999999998766554455678899999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC------CCcccc
Q 024347 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------DGLLHT 172 (269)
Q Consensus 99 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~------~~~~~~ 172 (269)
.+++...+.+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99888877899999999999999999999999999999999999999999999999998765433211 112223
Q ss_pred cccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCC--CHHHHHHHHHhcC
Q 024347 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL--SFTARKLIARILD 250 (269)
Q Consensus 173 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~l~~li~~~l~ 250 (269)
..++..|+|||...+... +.++|+||||++++++++|..||...........+..+....+... +..+.+++++||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 346778999999887665 4899999999999999999999999888888888877666666555 9999999999999
Q ss_pred CCCCCcCCCCcc-ccccccC
Q 024347 251 PNPMTVSIYPFA-DILYMRF 269 (269)
Q Consensus 251 ~dP~~Rps~~~~-~~l~~~~ 269 (269)
.+|.+||++..+ +++.|+|
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred CCHhhcCCCccHHHHhcCcc
Confidence 999999998444 4556665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=292.97 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=199.8
Q ss_pred Eeeeeecc--CCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEec
Q 024347 15 VGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 15 ~~~~lg~g--~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
+.+.||+| ++++||++.++.+|+.||+|.+...... ....+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 6789999999999999999998765432 33456788899999999999999999999999999999999
Q ss_pred cCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC----
Q 024347 93 VTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---- 166 (269)
Q Consensus 93 ~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~---- 166 (269)
++++++.+++..+ +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++++||+..........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999888653 4589999999999999999999999999999999999999999999999975432211100
Q ss_pred -CCcccccccCccccCcccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc------------
Q 024347 167 -DGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------------ 232 (269)
Q Consensus 167 -~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------ 232 (269)
........++..|+|||++.+. ..++.++||||||+++|++++|..||..............+..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE 240 (327)
T ss_pred cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence 0111222356679999998764 23458999999999999999999999765443322222211110
Q ss_pred ----------------------------------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 ----------------------------------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 ----------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+++.+.+|++.||+.||++|||+ .+++.|+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~--~ell~~p~ 309 (327)
T cd08227 241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSA--STLLNHSF 309 (327)
T ss_pred cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCH--HHHhcChh
Confidence 111256789999999999999999999 78888887
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=290.16 Aligned_cols=248 Identities=21% Similarity=0.359 Sum_probs=203.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeE--EEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCC
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPV--ALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~--~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 84 (269)
..+++|++.+.||.|+||.||+|.+..++..+ ++|.+.. .........+.+|+.++.++ +|+|++++++++...+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 35679999999999999999999987777654 6665532 22334457788899999999 8999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC
Q 024347 85 KIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~ 148 (269)
..++++||+++++|.+++...+ .++..++..++.|++.||++||++|++|+||+|+||+++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999886532 478889999999999999999999999999999999999999
Q ss_pred CEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 024347 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (269)
Q Consensus 149 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 227 (269)
.++|+|||++........ ......+..|+|||.+.+... +.++||||||+++|++++ |..||......+..+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~ 237 (303)
T cd05088 162 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 237 (303)
T ss_pred cEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 999999998753221111 111123557999999877665 489999999999999998 999998877777776665
Q ss_pred cC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 228 AA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 228 ~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
.. ....+..+++.+.+|+.+||+.+|++||++++
T Consensus 238 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 272 (303)
T cd05088 238 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 272 (303)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 44 23344557899999999999999999999844
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=284.85 Aligned_cols=255 Identities=26% Similarity=0.469 Sum_probs=210.8
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhh---hhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK---VLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
+|+..+.||+|++|.||.+.+..+++.+++|++.... .......+.+.+|+..++.++|+|++++++++.+....++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4888999999999999999999999999999986432 1223346788999999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-CEEEeeCCCccccccccCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-~~~l~df~~~~~~~~~~~~ 167 (269)
+++|+++++|.+.+...+++++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999988878899999999999999999999999999999999999998776 5999999988655432111
Q ss_pred --CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHh--cCcccCCCCCCHH
Q 024347 168 --GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KIS--AAEFTCPPWLSFT 240 (269)
Q Consensus 168 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~--~~~~~~~~~~~~~ 240 (269)
.......++..|+|||.+.+..+ +.++|+||||++++++++|..||.......... ... ......+...+++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 11122346788999999877665 489999999999999999999997544322222 221 2233445568899
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+++.+||+.||.+||++ .+.+.|+|
T Consensus 240 ~~~~i~~~l~~~p~~R~~~--~~ll~~~~ 266 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPS--RELLKHPV 266 (268)
T ss_pred HHHHHHHHcCCCcccCcCH--HHHhcCcc
Confidence 9999999999999999999 88888887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=288.16 Aligned_cols=256 Identities=23% Similarity=0.402 Sum_probs=212.5
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCC-----CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceee
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRL 76 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~ 76 (269)
++++....++|++.+.||+|++|.||++.+... ...+++|.+.... .......+.+|+++++.+ +|+||+++
T Consensus 4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 81 (293)
T cd05053 4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 81 (293)
T ss_pred CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence 456777888999999999999999999987643 3678999886532 233356788999999999 79999999
Q ss_pred eEEEeeCCeEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCC
Q 024347 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (269)
Q Consensus 77 ~~~~~~~~~~~~v~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~ 140 (269)
++++...+..+++|||+++++|..++... +.++...+..++.|++.||.|||+.|++|+||+|+
T Consensus 82 ~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 82 LGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred EEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 99999999999999999999999888542 35788999999999999999999999999999999
Q ss_pred ceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 024347 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL 219 (269)
Q Consensus 141 nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~ 219 (269)
||+++.++.++|+|||.++...............++..|+|||++.+.... .++||||||+++|++++ |..||.....
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999999988765432221222222345679999998776664 89999999999999997 9999998887
Q ss_pred HHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 220 MNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 220 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
.+....+.... ...+..++..+.+|+..||+.||++|||+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 283 (293)
T cd05053 241 EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283 (293)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 77777765554 3455678899999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=290.26 Aligned_cols=252 Identities=32% Similarity=0.494 Sum_probs=203.4
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||++.+..+|+.+++|.+..... .......+.+|+.+++.++|+|++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 68999999999999999999999999999999865432 22223567789999999999999999999999999999999
Q ss_pred ccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 92 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
|+++ ++...+.. .+.+++..+..++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV--RCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC--CCc
Confidence 9975 77777654 4678999999999999999999999999999999999999999999999999886543211 112
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcC----------------c---
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA----------------E--- 230 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~----------------~--- 230 (269)
....++..|+|||.+.+....+.++|+||||+++|+|++|..|+ ...+..+..+.+... .
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 22345788999999877665568999999999999999998885 444433333322110 0
Q ss_pred c----------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 F----------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ...+.++++++++|++||+.||.+|||+ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~--~~il~h~~ 283 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISA--EEALQHPY 283 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCH--HHHhcCCC
Confidence 0 1112367899999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=284.13 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=202.6
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+.+|+++++++.|||++++++.+......++++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999986542 2334567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++++++..+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~ 150 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IA 150 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cc
Confidence 99999988543 35788899999999999999999999999999999999999999999999988644321 22
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCcccC--CCCCCHHH
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-------MNLYKKISAAEFTC--PPWLSFTA 241 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~--~~~~~~~l 241 (269)
....++..|+|||.+.+... +.++|+||||+++|+|++|..||..... ......+.....+. ....++++
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF 229 (279)
T ss_pred cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence 23457889999999987766 4899999999999999999999964221 12222222222221 23478899
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+++.+||+.||++||++ .+++.|+|
T Consensus 230 ~~li~~~l~~~P~~Rp~~--~eil~~~~ 255 (279)
T cd06619 230 VHFITQCMRKQPKERPAP--ENLMDHPF 255 (279)
T ss_pred HHHHHHHhhCChhhCCCH--HHHhcCcc
Confidence 999999999999999998 77778876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=281.85 Aligned_cols=250 Identities=22% Similarity=0.326 Sum_probs=208.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
.++|++.+.||.|+||.||+|.+... ...+++|.+.... .......+.+|+..++.++|+||+++++.+...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 46899999999999999999988644 4578999876433 233456788899999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+++|||+++++|.+++... +.++..++..++.|++.||.+||+++++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence 9999999999999988664 468999999999999999999999999999999999999999999999999987654212
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 243 (269)
..........+..|+|||.+.+... +.++|+||||+++|++++ |..||...........+... ..+.+..+++.+.+
T Consensus 161 ~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 239 (266)
T cd05033 161 ATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ 239 (266)
T ss_pred cceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1111112223567999999887665 489999999999999998 99999887777777776654 34555678999999
Q ss_pred HHHHhcCCCCCCcCCCCcc
Q 024347 244 LIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~ 262 (269)
++..||+.||++||+++++
T Consensus 240 li~~cl~~~p~~Rp~~~ei 258 (266)
T cd05033 240 LMLDCWQKDRNERPTFSQI 258 (266)
T ss_pred HHHHHcCCCcccCcCHHHH
Confidence 9999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=279.79 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=214.5
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ....+.+.+|+.+++.++|+|++++++.+......++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 689999999999999999999999999999998765433 3346788999999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-CEEEeeCCCccccccccCCC
Q 024347 92 FVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 92 ~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-~~~l~df~~~~~~~~~~~~~ 168 (269)
|+++++|.+++... ..+++..+..++.+++.+|.+||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS--- 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---
Confidence 99999999988763 3588999999999999999999999999999999999998655 57999999887543321
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~ 247 (269)
......++..|+|||.+.+... +.++|+||||+++|++++|..||...+.......+.... .+.+..+++.+.+++..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 1122346788999999987665 489999999999999999999998877776666665543 34556689999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+.||++|||+ .+++.|+|
T Consensus 236 ~l~~~p~~Rpt~--~~ll~~p~ 255 (256)
T cd08220 236 MLNLDPSKRPQL--SQIMAQPI 255 (256)
T ss_pred HccCChhhCCCH--HHHhhCCC
Confidence 999999999999 88888876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=280.93 Aligned_cols=245 Identities=24% Similarity=0.417 Sum_probs=205.1
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||++.++. +..+++|.+...... ...+.+|+.+++.++|||++++++++...+..+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 4679999999999999999998864 567999987643321 35678899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+++++|.+.+... +.++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++++|||.+.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 9999999999888653 46899999999999999999999999999999999999999999999999987643221111
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~ 246 (269)
......++..|+|||.+.+..+ +.++|+||||+++|++++ |+.||...+..+....+..+. ...+...+..+.++++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMY 235 (256)
T ss_pred ccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 1111223557999999987665 489999999999999999 999999888888877777654 3345567889999999
Q ss_pred HhcCCCCCCcCCCCc
Q 024347 247 RILDPNPMTVSIYPF 261 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~ 261 (269)
+||+.||++||++++
T Consensus 236 ~c~~~~p~~Rps~~~ 250 (256)
T cd05114 236 SCWHEKPEGRPTFAE 250 (256)
T ss_pred HHccCCcccCcCHHH
Confidence 999999999999844
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=284.73 Aligned_cols=250 Identities=20% Similarity=0.310 Sum_probs=205.8
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
..++|++.+.||+|++|.||+|.+.. .+..+++|.+.... .......+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45789999999999999999999876 67889999875432 233346788899999999999999999999888
Q ss_pred CeEEEEEeccCCCchhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC---CEEEe
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVS 153 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~---~~~l~ 153 (269)
...+++|||++|++|.+++...+ .+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++ .++|+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999999887643 478899999999999999999999999999999999998654 58999
Q ss_pred eCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cc
Q 024347 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EF 231 (269)
Q Consensus 154 df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~ 231 (269)
|||.+.................+..|+|||++.+..+ +.++||||||+++|+|++ |..||...........+... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL 240 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 9998875422111111112223467999999987766 489999999999999996 99999987777766665443 44
Q ss_pred cCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 232 TCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 232 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
..+..++..+.+++.+||+.||++||++++
T Consensus 241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~ 270 (277)
T cd05036 241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFAT 270 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 556778999999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=288.18 Aligned_cols=256 Identities=22% Similarity=0.385 Sum_probs=210.1
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCC-------CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCcee
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 75 (269)
+++....++|.+.+.||+|+||.||.+.+... ...+++|.+.... .......+.+|+.+++.+ +|+|+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34555668999999999999999999986432 3469999986542 233356788899999999 7999999
Q ss_pred eeEEEeeCCeEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 024347 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (269)
Q Consensus 76 ~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~ 139 (269)
+++.+...+..++++||+++++|.+++...+ .++..++..++.|++.||++||+.|++|+||+|
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 89 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 9999999999999999999999999987542 378889999999999999999999999999999
Q ss_pred CceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 024347 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (269)
Q Consensus 140 ~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 218 (269)
+||+++.++.++|+|||.+.................+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...+
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 999999999999999998765432211111112223467999999987665 489999999999999998 899998888
Q ss_pred HHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 219 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 219 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+....+.... ...+..++.++.+++..||+.+|++||+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ev 292 (307)
T cd05098 248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 292 (307)
T ss_pred HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 777777766554 35566789999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=279.84 Aligned_cols=255 Identities=31% Similarity=0.550 Sum_probs=213.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ....+.+.+|+.+++.++|+||+++++.+...+..++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 689999999999999999999888999999998765443 3457889999999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc--
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-- 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~-- 169 (269)
|+++++|.+.+.....++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999988877789999999999999999999999999999999999999999999999998875443222111
Q ss_pred ccccccCccccCcccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcC-cccCCCC--CCHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAA-EFTCPPW--LSFTARK 243 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~-~~~~~~~--~~~~l~~ 243 (269)
.....++..|+|||.+.+.. ..+.++|+||||++++++++|+.||... ........+..+ ....+.. +++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 11234678999999987655 2358999999999999999999999754 233333333332 2233333 4899999
Q ss_pred HHHHhcCCCCCCcCCCCccccccccC
Q 024347 244 LIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+|+.||+.||++||++ .+.+.|+|
T Consensus 240 li~~~l~~~p~~R~~~--~~i~~~~~ 263 (264)
T cd06626 240 FLDRCLESDPKKRPTA--SELLQHPF 263 (264)
T ss_pred HHHHHccCCcccCCCH--HHHhcCCC
Confidence 9999999999999999 78888887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=285.37 Aligned_cols=247 Identities=29% Similarity=0.427 Sum_probs=204.8
Q ss_pred eeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCch
Q 024347 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (269)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l 98 (269)
||.|++|+||++.+..+|+.+++|.+.............+.+|+.+++.++|||++++++.+...+..++++||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999998765444344455667899999999999999999999999999999999999999
Q ss_pred hHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccC
Q 024347 99 FDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (269)
Q Consensus 99 ~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 176 (269)
.+++...+ .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+..... ........++
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 98887655 689999999999999999999999999999999999999999999999998765432 1112223467
Q ss_pred ccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCC
Q 024347 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252 (269)
Q Consensus 177 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 252 (269)
..|+|||.+.+..+ +.++|+||||++++++++|+.||..... ..+...........+..+++.+.++|++||+.|
T Consensus 158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 78999999877665 4899999999999999999999976544 233333344445556678999999999999999
Q ss_pred CCCcCCCCc---cccccccC
Q 024347 253 PMTVSIYPF---ADILYMRF 269 (269)
Q Consensus 253 P~~Rps~~~---~~~l~~~~ 269 (269)
|++||++++ .+++.|+|
T Consensus 237 p~~R~~~~~~~~~~ll~h~~ 256 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPL 256 (277)
T ss_pred hhHccCCCcccHHHHHhChh
Confidence 999996533 34566665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=288.12 Aligned_cols=258 Identities=19% Similarity=0.311 Sum_probs=211.8
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
..++|++.+.||.|++|.||+|.+.. .++.+++|++.... .....+.+.+|+.++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 34678899999999999999998754 35789999986443 223456788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC
Q 024347 84 TKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~ 147 (269)
+..+++++|+.+++|..++... ..++...+..++.|++.||.++|+.|++|+||+|+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999998887531 247788899999999999999999999999999999999999
Q ss_pred CCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 024347 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (269)
Q Consensus 148 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~ 226 (269)
+.++|+|||+++...............+++.|+|||.+.+... +.++||||||+++|+|++ |..||.+....+..+.+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999998775433222222222334678999999877665 489999999999999998 88999988888888887
Q ss_pred hcCcc-cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 227 SAAEF-TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 227 ~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..... +.+..++..+.+|+..||+.||.+||+++++-.....|
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 240 RNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 76653 45677999999999999999999999996654443333
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=280.30 Aligned_cols=255 Identities=28% Similarity=0.517 Sum_probs=210.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhh--hhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--CeE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 86 (269)
.+|++.+.||+|++|.||.+.+..+++.+++|.+..... ......+.+.+|+.+++.+.|+||+++++.+.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998864321 1233457889999999999999999999988653 467
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++++||+++++|.+++...+.++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 89999999999999988777889999999999999999999999999999999999999999999999998875432211
Q ss_pred C-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cccCCCCCCHHHHH
Q 024347 167 D-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARK 243 (269)
Q Consensus 167 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 243 (269)
. .......++..|+|||.+.+... +.++|+||||+++|++++|+.||...........+... ....+...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 1 11222346788999999977665 48999999999999999999999876555544444332 23344557888999
Q ss_pred HHHHhcCCCCCCcCCCCccccccccC
Q 024347 244 LIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+|+.||. +|++||++ .+.+.|+|
T Consensus 241 ~i~~~l~-~p~~Rp~~--~~il~~~~ 263 (265)
T cd06652 241 FLKRIFV-EAKLRPSA--DELLRHTF 263 (265)
T ss_pred HHHHHhc-ChhhCCCH--HHHhcCcc
Confidence 9999995 99999998 88888887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=314.93 Aligned_cols=249 Identities=22% Similarity=0.390 Sum_probs=204.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||+|.+..+++.||+|.+..+........+.+.+|+++++.++|||++++++++.+.+..+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 47899999999999999999999999999999998765444455567889999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCc
Q 024347 90 LEFVTGGELFDKIVNH-----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~ 158 (269)
|||++|++|.+.+... ...+...+..++.|++.||++||+.|++||||||+||+++.++.++++|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999998887541 23456678899999999999999999999999999999999999999999998
Q ss_pred cccccccC----------------CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 024347 159 ALSQQVRD----------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 222 (269)
Q Consensus 159 ~~~~~~~~----------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~ 222 (269)
........ ........|++.|+|||.+.+... +.++||||||+++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 75521110 001112357899999999987776 4899999999999999999999987554443
Q ss_pred HHHHhcCc-ccC--CCCCCHHHHHHHHHhcCCCCCCcCCC
Q 024347 223 YKKISAAE-FTC--PPWLSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 223 ~~~~~~~~-~~~--~~~~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
........ ... ...+++.+.+++.+||+.||++||+.
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS 279 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCH
Confidence 33221111 111 13578999999999999999999886
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=315.66 Aligned_cols=258 Identities=29% Similarity=0.453 Sum_probs=208.0
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--C
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--K 83 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 83 (269)
-+...++|++++.||.|+||+||++.+..+++.+++|.+...... ......+..|+.+++.++||||++++++|.. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 356678999999999999999999999999999999998754432 3345778899999999999999999998854 4
Q ss_pred CeEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CcEeecCCCCceEecC------
Q 024347 84 TKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR-------GVYHRDLKPENLLLDA------ 146 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~-------~i~h~di~~~nIl~~~------ 146 (269)
..+++||||+++++|..++.. ...+++..++.++.||+.||.|||+. +|+|+||+|+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 568999999999999988865 25699999999999999999999985 4999999999999964
Q ss_pred -----------CCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCC
Q 024347 147 -----------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPF 214 (269)
Q Consensus 147 -----------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~ 214 (269)
.+.++|+|||++...... .......+++.|+|||++.+.. ..+.++|||||||++|+|++|..||
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 234899999988754321 1222345789999999986432 3358999999999999999999999
Q ss_pred CCCCHH-HHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 215 DDSNLM-NLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 215 ~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...... .....+...........+.++.+||..||+.+|.+||++ .++|.|+|
T Consensus 244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa--~QlL~h~~ 297 (1021)
T PTZ00266 244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSA--LQCLGYQI 297 (1021)
T ss_pred CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCH--HHHhccHH
Confidence 765443 344444433322234578999999999999999999999 66676654
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=283.36 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=205.4
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
.++|++.+.||.|++|+||+|.+..+++ .|++|.+.... .......+.+|+.+++.++|+|++++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 4689999999999999999999877776 47899876433 233456788999999999999999999998654 4
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++++|++++++.+.+... +.++..++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++.....
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 67899999999999988764 46899999999999999999999999999999999999999999999999998765432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 242 (269)
...........+..|+|||.+.+.... .++||||||+++|++++ |..||...........+..+. .+.+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 221111222345689999999776654 89999999999999998 999998877777766665543 455567899999
Q ss_pred HHHHHhcCCCCCCcCCCCc
Q 024347 243 KLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~ 261 (269)
+++..||+.||++||++.+
T Consensus 242 ~li~~~l~~dp~~Rp~~~~ 260 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRE 260 (279)
T ss_pred HHHHHHcCCChhhCcCHHH
Confidence 9999999999999999844
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=283.82 Aligned_cols=253 Identities=19% Similarity=0.255 Sum_probs=209.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCC-----CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
...++|++.+.||.|++|.||++.++.. +..+++|.+.... .......+.+|+.+++.++|+|++++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4457899999999999999999988643 3789999975433 22334677889999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEE
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHG----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l 152 (269)
....+++|||+++++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 999999999999999998886432 3677889999999999999999999999999999999999999999
Q ss_pred eeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-
Q 024347 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE- 230 (269)
Q Consensus 153 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~- 230 (269)
+|||+++...............++..|+|||.+.+... +.++|+||||+++|++++ |..||......+..+.+..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~ 239 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH 239 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence 99998865433221112222335678999999876665 489999999999999998 999998888877777776543
Q ss_pred ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 231 FTCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
...+..++..+.+++..||+.+|++|||++++.
T Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 455667899999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=287.95 Aligned_cols=255 Identities=28% Similarity=0.472 Sum_probs=212.2
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
++....+|++.+.||.|++|.||++.+..+++.+++|.+...... ..+.+.+|+.+++.++|+|++++++.+.....
T Consensus 14 ~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 90 (297)
T cd06656 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDE 90 (297)
T ss_pred cCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence 355568999999999999999999999889999999998654322 24567889999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++++||+++++|.+++.+ ..++..++..++.+++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 91 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred EEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 9999999999999888754 468899999999999999999999999999999999999999999999999876433211
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-Cc--ccCCCCCCHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-AE--FTCPPWLSFTAR 242 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~--~~~~~~~~~~l~ 242 (269)
.......+++.|+|||.+.+... +.++|+||||+++|++++|..||...+.......... +. ...+..++..+.
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06656 170 --SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFR 246 (297)
T ss_pred --cCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHH
Confidence 11223356788999999987666 4899999999999999999999977654333222222 21 123455788999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+++.+||+.||++||++ .+++.|+|
T Consensus 247 ~li~~~l~~~p~~Rps~--~~il~~~~ 271 (297)
T cd06656 247 DFLNRCLEMDVDRRGSA--KELLQHPF 271 (297)
T ss_pred HHHHHHccCChhhCcCH--HHHhcCch
Confidence 99999999999999999 88888887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=287.66 Aligned_cols=253 Identities=32% Similarity=0.440 Sum_probs=208.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh--hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
+|++.+.||.|++|.||+|.+..+++.+++|.+...... .......+.+|+++++.++|+|++++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999988999999998765433 122345677899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+ +++|.+++.... .+++..+..++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN--R 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--c
Confidence 9999 889999887765 79999999999999999999999999999999999999999999999999887544321 1
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-c----------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-F---------------- 231 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~---------------- 231 (269)
......++..|+|||.+.+....+.++|+||||++++++++|..||......+....+.... .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 12222356789999998665555689999999999999999988887766555444432110 0
Q ss_pred -----------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 -----------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 -----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
......+..+.++|..||++||++|||+ .+++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~--~e~l~~~~ 284 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITA--RQALEHPY 284 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCH--HHHhhCcc
Confidence 0012357889999999999999999999 88888877
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=285.93 Aligned_cols=247 Identities=21% Similarity=0.347 Sum_probs=203.5
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCC--eEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 86 (269)
+++|++.+.||.|++|.||+|....++. .+++|.+.... .....+.+.+|+.++.++ +||||+++++.+...+..
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 4789999999999999999999876665 46777765321 233356788999999999 699999999999988999
Q ss_pred EEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCE
Q 024347 87 FIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~ 150 (269)
++++||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence 99999999999999886532 47888999999999999999999999999999999999999999
Q ss_pred EEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 024347 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 229 (269)
+|+|||++........ ......+..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+..+
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~ 234 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 9999998753221111 111122457999999987665 489999999999999997 99999988887777776654
Q ss_pred c-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 230 E-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 230 ~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
. ...+..++..+.+|+..||+.||.+||+++++
T Consensus 235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 3 34456689999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=280.68 Aligned_cols=255 Identities=27% Similarity=0.485 Sum_probs=210.3
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh--hHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--CCeE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKI 86 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 86 (269)
..|++.+.||.|++|.||++.+..++..+++|.+...... .......+.+|+.+++.++|+|++++++.+.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999999989999999988643321 22345678899999999999999999998865 3578
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++++||+++++|.+.+...+.++...+..++.|++.+|.+||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 89999999999999988877899999999999999999999999999999999999999999999999998865433221
Q ss_pred C-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cccCCCCCCHHHHH
Q 024347 167 D-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARK 243 (269)
Q Consensus 167 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 243 (269)
. .......++..|+|||.+.+..+ +.++|+||+|+++|++++|..||............... ....+..+++.+++
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARD 240 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHH
Confidence 1 11122346788999999987665 48999999999999999999999876655544444332 23445567889999
Q ss_pred HHHHhcCCCCCCcCCCCccccccccC
Q 024347 244 LIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++ .||..+|++||++ .+++.|+|
T Consensus 241 li-~~~~~~p~~Rp~~--~eil~hp~ 263 (266)
T cd06651 241 FL-GCIFVEARHRPSA--EELLRHPF 263 (266)
T ss_pred HH-HHhcCChhhCcCH--HHHhcCcc
Confidence 99 6777899999999 88888887
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=284.34 Aligned_cols=245 Identities=32% Similarity=0.458 Sum_probs=201.9
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC-----eE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 86 (269)
+|...+.+|.|+||.||+|....+++.+|+|.+-.+.. --.+|+.+|+.+.||||+++.-+|.... ..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 68888999999999999999999999999999754432 2235999999999999999998885432 45
Q ss_pred EEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC-CCEEEeeCCCcccc
Q 024347 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALS 161 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~-~~~~l~df~~~~~~ 161 (269)
.+||||++ .+|.+.+.. +..++.-.++-+..|++.||.|||+.|||||||||.|++++.+ |.+||||||.|+..
T Consensus 98 nlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 78999996 488777763 4578888889999999999999999999999999999999976 88999999999865
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------ 229 (269)
..... ...+..+..|+|||.+.+...++.+.||||.||++.||+.|++.|.+....+....+...
T Consensus 177 ~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 54322 245556889999999999988889999999999999999999999987776655554210
Q ss_pred -----ccc------------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 -----EFT------------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 -----~~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.. .....+++..+|+.++|+.+|.+|.++ .+++.|+|
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~--~~~l~h~f 308 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSA--LEALAHPF 308 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCH--HHHhcchh
Confidence 111 112368999999999999999999999 77777765
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=280.18 Aligned_cols=250 Identities=28% Similarity=0.467 Sum_probs=212.5
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
-++|++.+.||.|++|.||++.+..+++.+++|.+..... .+.+.+|+++++.++|+|++++++.+......+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3689999999999999999999988899999999865432 57889999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
+||+++++|.+.+.. ...+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~ 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence 999999999998865 4578999999999999999999999999999999999999999999999999887544321 1
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc---ccCCCCCCHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLI 245 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li 245 (269)
......++..|+|||.+.+... +.++|+||||+++|+|++|..||...........+.... ...+..++..+.++|
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 233 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV 233 (256)
T ss_pred ccccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence 2223346778999999887765 489999999999999999999998766655444443322 223345788999999
Q ss_pred HHhcCCCCCCcCCCCccccccccC
Q 024347 246 ARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..||+.||++|||+ .+++.|+|
T Consensus 234 ~~~l~~~P~~Rps~--~~il~~~~ 255 (256)
T cd06612 234 KKCLVKDPEERPSA--IQLLQHPF 255 (256)
T ss_pred HHHHhcChhhCcCH--HHHhcCCC
Confidence 99999999999999 78888887
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=283.22 Aligned_cols=249 Identities=31% Similarity=0.550 Sum_probs=206.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
+++|++.+.||.|++|.||++.+..+++.+++|.+.............+.+|+.+++.++|+|++++++.+...+..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 36799999999999999999999989999999988765444455567888999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+||+++++|.+++.. ...+++.++..++.+++.+|.+||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999887753 3468999999999999999999999999999999999999999999999999876543221
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHhcCccc-CC-CCCCHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL--MNLYKKISAAEFT-CP-PWLSFTA 241 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~-~~-~~~~~~l 241 (269)
.......++..|+|||.+.+.... .++|+||||+++|++++|..||..... ......+.....+ .+ ...++.+
T Consensus 161 --~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08229 161 --TAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 237 (267)
T ss_pred --cccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence 112233467889999999776654 899999999999999999999975433 3344444333322 22 3478899
Q ss_pred HHHHHHhcCCCCCCcCCCCc
Q 024347 242 RKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~ 261 (269)
.+++.+||+.||++|||+++
T Consensus 238 ~~li~~~l~~~p~~Rpt~~~ 257 (267)
T cd08229 238 RQLVNMCINPDPEKRPDITY 257 (267)
T ss_pred HHHHHHhcCCCcccCCCHHH
Confidence 99999999999999999843
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=297.68 Aligned_cols=256 Identities=21% Similarity=0.343 Sum_probs=204.7
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCC-----CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeE
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYE 78 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~ 78 (269)
.+...-++|++.+.||.|+||.||+|.+... +..||+|.+.... .....+.+.+|+++++++. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4455667999999999999999999986432 3469999986433 2333577899999999996 999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhHHHHhc-----------------------------------------------------
Q 024347 79 VMGSKTKIFIVLEFVTGGELFDKIVNH----------------------------------------------------- 105 (269)
Q Consensus 79 ~~~~~~~~~~v~~~~~~~~l~~~~~~~----------------------------------------------------- 105 (269)
++...+..++||||+++++|.+++...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999998877542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCce
Q 024347 106 -------------------------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (269)
Q Consensus 106 -------------------------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nI 142 (269)
..++..++..++.|++.||.|||+.|++|+||+|+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 1367778889999999999999999999999999999
Q ss_pred EecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH-
Q 024347 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM- 220 (269)
Q Consensus 143 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~- 220 (269)
+++.++.++|+|||++................++..|+|||.+.+..+ +.++||||||+++|+|++ |..||......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 999999999999998875433222112222345678999999987666 489999999999999996 99999765433
Q ss_pred HHHHHHhcC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 221 NLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 221 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.....+..+ ..+.+..++..+.+++..||+.||++||++.++.
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~ 391 (400)
T cd05105 348 TFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391 (400)
T ss_pred HHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHH
Confidence 333333333 3445567899999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=283.60 Aligned_cols=250 Identities=22% Similarity=0.387 Sum_probs=210.9
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+..-.+|++.+.||.|++|.||+|.+.. ++.+++|.+.... ....+.+.+|+.+++.++|+|++++++++......
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV 77 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence 3456689999999999999999999987 8889999986543 22356788899999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
+++|||+++++|.+++... ..++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999999988753 46889999999999999999999999999999999999999999999999988654321
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 242 (269)
. .......++..|+|||.+.+..+ +.++|+||||+++|++++ |..||......+....+..+ ..+.+..+++.+.
T Consensus 158 ~--~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (261)
T cd05148 158 V--YLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIY 234 (261)
T ss_pred c--ccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHH
Confidence 1 11112234567999999877665 488999999999999998 89999888777777766654 3455677899999
Q ss_pred HHHHHhcCCCCCCcCCCCccc
Q 024347 243 KLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~ 263 (269)
+++.+||+.||++|||++++.
T Consensus 235 ~~i~~~l~~~p~~Rpt~~~l~ 255 (261)
T cd05148 235 KIMLECWAAEPEDRPSFKALR 255 (261)
T ss_pred HHHHHHcCCCchhCcCHHHHH
Confidence 999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=277.18 Aligned_cols=254 Identities=30% Similarity=0.537 Sum_probs=216.8
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--CeEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIV 89 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v 89 (269)
+|++.+.||+|++|.||+|.+..+++.+++|.+...... ....+.+.+|+..+++++|+|++++++.+... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999989999999998765432 34467889999999999999999999999888 889999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
+||+++++|.+++.....++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999988877899999999999999999999999999999999999999999999999998875544322112
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhc--CcccCCCCCCHHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISA--AEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~--~~~~~~~~~~~~l~~li~ 246 (269)
.....++..|.|||.+.+... +.++|+||||++++++++|..||.... .......+.. .....+..++..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 334457789999999987765 489999999999999999999998765 3333333332 334556668999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||+.||++||++ .+.+.|+|
T Consensus 239 ~~l~~~p~~Rp~~--~~ll~~~~ 259 (260)
T cd06606 239 KCLRRDPKKRPTA--DELLQHPF 259 (260)
T ss_pred HhCcCChhhCCCH--HHHhhCCC
Confidence 9999999999999 88899887
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=282.32 Aligned_cols=258 Identities=27% Similarity=0.394 Sum_probs=210.9
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEee
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 82 (269)
..++...++|++.+.||.|++|.||++....+++.+++|.+..... ....+.+|+.+++++ +|||++++++++..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 4566778999999999999999999999999999999999854321 134567788899988 79999999999864
Q ss_pred C-----CeEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEe
Q 024347 83 K-----TKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (269)
Q Consensus 83 ~-----~~~~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~ 153 (269)
. ...++++||+++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 358999999999999887753 3568999999999999999999999999999999999999999999999
Q ss_pred eCCCccccccccCCCcccccccCccccCcccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Q 024347 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY----DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 154 df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (269)
|||.+........ ......++..|+|||.+..... .+.++|+||||+++|+|++|+.||...........+...
T Consensus 171 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 248 (291)
T cd06639 171 DFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN 248 (291)
T ss_pred ecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence 9998765432211 1122346788999999764331 258899999999999999999999887665555555433
Q ss_pred cc---cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EF---TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ..+..++..+.++|..||+.||++||++ .+++.|+|
T Consensus 249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~~il~~~~ 289 (291)
T cd06639 249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV--THLLEHPF 289 (291)
T ss_pred CCCCCCcccccCHHHHHHHHHHhhcChhhCcCH--HHHhcCcc
Confidence 22 2244577889999999999999999999 88888887
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=280.02 Aligned_cols=243 Identities=25% Similarity=0.389 Sum_probs=209.3
Q ss_pred eeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEecc
Q 024347 17 RTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 93 (269)
+.||.|++|.||++.+... +..+++|.+....... ..+.+.+|++.++.++|+|++++++++.+....++++||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999866 8899999987654322 4678899999999999999999999999999999999999
Q ss_pred CCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 94 TGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 94 ~~~~l~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
++++|.+++... ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999998875 67999999999999999999999999999999999999999999999999998765543
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 242 (269)
..........++..|+|||.+.+... +.++|+||||+++|++++ |..||......+..+.+..+ ....+..++..+.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 22222333446778999999887654 589999999999999998 69999998888888887754 3455677899999
Q ss_pred HHHHHhcCCCCCCcCCCCcc
Q 024347 243 KLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~ 262 (269)
++++.||+.||++|||++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l 257 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSEL 257 (262)
T ss_pred HHHHHHccCCcccCcCHHHH
Confidence 99999999999999998443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=284.62 Aligned_cols=255 Identities=31% Similarity=0.478 Sum_probs=209.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||+|.+..+++.+++|.+..... .....+.+.+|+++++.++|+|++++++.+...+..++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 479999999999999999999998999999998865332 2334578899999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++++.+.........++..++..++.+++.+|.+||+.|++|+|++|+||+++.++.++|+|||.+........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 9998866665555556799999999999999999999999999999999999999999999999998765443322 122
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------------
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------------- 229 (269)
....++..|+|||++.+....+.++|+||||+++|++++|+.||......+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 23446788999999987744468999999999999999999999876554433322110
Q ss_pred cc-----------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EF-----------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ..+..++.++.+||++||+.||++||++ .+.+.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~~il~~~~ 287 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC--DELLQHPY 287 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH--HHHhcCCC
Confidence 00 1122358889999999999999999999 78888887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=279.15 Aligned_cols=246 Identities=33% Similarity=0.565 Sum_probs=204.7
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHH-hhhCCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
+.||.|++|.||+|.+..+++.+++|.+.............+..|..+ ....+|+|++++++.+...+..++++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 679999999999999998999999999865443333333344445444 4555899999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|..++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..... .....+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 99999998878899999999999999999999999999999999999999999999999998764322 122346
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC----CCCCCHHHHHHHHHhcCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLSFTARKLIARILDP 251 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~ 251 (269)
+..|+|||.+.+... +.++|+||||+++|++++|..||...+.......+....... ...+++.+.+++++||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 788999999887664 589999999999999999999999888888777776554332 234789999999999999
Q ss_pred CCCCcCCC-CccccccccC
Q 024347 252 NPMTVSIY-PFADILYMRF 269 (269)
Q Consensus 252 dP~~Rps~-~~~~~l~~~~ 269 (269)
||++||++ ...+++.|+|
T Consensus 235 ~p~~R~~~~~~~~~l~~~~ 253 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPF 253 (260)
T ss_pred CHHHccCCCcHHHHHcChH
Confidence 99999987 3356677776
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=283.40 Aligned_cols=251 Identities=28% Similarity=0.495 Sum_probs=209.1
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC---CCCceeeeEEEeeCCeEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~ 88 (269)
.|++.+.||.|++|.||+|.+..+++.+++|.+.... .......+.+|+.+++.++ |||++++++.+......++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788899999999999999999899999999986432 2233567788999998886 9999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
+|||+++++|.+++.. +.+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S 156 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence 9999999999888765 478999999999999999999999999999999999999999999999999886544322 2
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC-CC-CCCHHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PP-WLSFTARKLIA 246 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~-~~~~~l~~li~ 246 (269)
......++..|+|||.+.+....+.++|+||||+++|+|++|..||...........+.....+. +. .++.++.++++
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (277)
T cd06917 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA 236 (277)
T ss_pred ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence 22233577889999998765544689999999999999999999998877666555444433222 22 27889999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.||+.||++||++ .+++.|+|
T Consensus 237 ~~l~~~p~~R~~~--~~il~~~~ 257 (277)
T cd06917 237 ACLDEEPKERLSA--EELLKSKW 257 (277)
T ss_pred HHcCCCcccCcCH--HHHhhChH
Confidence 9999999999998 67777766
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=284.87 Aligned_cols=251 Identities=24% Similarity=0.420 Sum_probs=208.4
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.+..+++.+++|.+.... .......+.+|+.++++++|+||+++++.+...+..++++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47899999999999999999999899999999886432 2333467889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 91 EFVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
||+++++|..++... ..+++..+..++.+++.+|.|||+ .|++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999998877653 378999999999999999999997 59999999999999999999999999987643221
Q ss_pred CCcccccccCccccCcccccCCCC-----CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---hcC-cccCCCCC
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI---SAA-EFTCPPWL 237 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~-~~~~~~~~ 237 (269)
......++..|+|||.+.+... .+.++|+||||+++|++++|..||...........+ ... ....++.+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 1222346778999999865432 257899999999999999999999766554444332 222 23455668
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 238 SFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.++.+||++||+.||++||++ .+.+.|+|
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~--~~l~~~~~ 264 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTY--AQLLEHPW 264 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCH--HHHhcChh
Confidence 9999999999999999999999 67777776
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=279.51 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=210.8
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
..-++|++.+.||.|++|.||++... +++.+++|.+...... .+.+.+|+.+++.++|+|++++++.+......+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 45678999999999999999999975 4577999998654322 356888999999999999999999999888999
Q ss_pred EEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+++||+++++|.+++... ..++..++..++.+++.|+.+||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 999999999999988764 368999999999999999999999999999999999999999999999999876543211
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 243 (269)
.. .......+..|+|||.+.+... +.++|+||+|++++++++ |+.||...........+..+ ..+.+...+.++.+
T Consensus 158 ~~-~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (261)
T cd05034 158 YT-AREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD 235 (261)
T ss_pred hh-hhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11 1111123467999999987665 489999999999999998 99999888877777777654 34556668999999
Q ss_pred HHHHhcCCCCCCcCCCCccccccc
Q 024347 244 LIARILDPNPMTVSIYPFADILYM 267 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~ 267 (269)
++.+||+.||++||++++...+..
T Consensus 236 ~i~~~l~~~p~~Rp~~~~l~~~l~ 259 (261)
T cd05034 236 LMLQCWDKDPEERPTFEYLQSFLE 259 (261)
T ss_pred HHHHHcccCcccCCCHHHHHHHHh
Confidence 999999999999999876655443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=310.67 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=220.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
...-++.+.||+|+||.||+|+-.+ ..+.||||.++... +.+..++|++|++++..++||||++++|++...+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 4456778999999999999998543 45789999987554 3446799999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcC----------C----CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCE
Q 024347 85 KIFIVLEFVTGGELFDKIVNHG----------R----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~----------~----l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~ 150 (269)
..++|+||+..|+|.+++..+. + ++..+.+.|+.||+.|+.||-++.+||+||.+.|++|+++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 9999999999999999996431 2 7888999999999999999999999999999999999999999
Q ss_pred EEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 024347 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 229 (269)
|++|||+++-.-..+.-......+-+.+|||||.+....++ .+|||||+|+++||+++ |..||.+....+..+.+..+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999754433333333333446799999999998885 99999999999999998 99999999999999999887
Q ss_pred c-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccc
Q 024347 230 E-FTCPPWLSFTARKLIARILDPNPMTVSIYPFADIL 265 (269)
Q Consensus 230 ~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l 265 (269)
+ .+.|..+|.++.+|+..||+.+|++||++.++...
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~ 758 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSR 758 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 7 57788899999999999999999999999776543
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=286.39 Aligned_cols=254 Identities=31% Similarity=0.394 Sum_probs=208.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--CeEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIF 87 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 87 (269)
.++|++.+.||.|++|.||+|.+..+++.+++|.+...... ......+.+|+.++++++|||++++++++... ...+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999989999999998754432 22334567899999999999999999998777 8899
Q ss_pred EEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+++||+.+ +|.+.+.... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~- 160 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL- 160 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc-
Confidence 99999975 8888776643 58999999999999999999999999999999999999999999999999887544321
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------------
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----------------- 229 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 229 (269)
.......+++.|+|||.+.+....+.++|+||||+++++|++|..||...........+...
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 11222345778999999876655468999999999999999999999877665544433210
Q ss_pred --------------cccCCCC-CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 --------------EFTCPPW-LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 --------------~~~~~~~-~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...++.. +++.+.++|++||+.||++|||+ .+++.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~--~ell~~~~ 292 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA--EDALKHPY 292 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH--HHHhcCCC
Confidence 0011111 47889999999999999999999 88899887
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=283.71 Aligned_cols=250 Identities=22% Similarity=0.325 Sum_probs=206.9
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
...+|.+.+.||.|++|.||++.+.. ++..+++|.+.... ....+.+.+|+..+++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 35679999999999999999998542 45568888875433 23346788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY 147 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~ 147 (269)
...+++|||+++++|.+++..+. .++...+..++.+++.||++||++|++|+||+|+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999886532 37889999999999999999999999999999999999999
Q ss_pred CCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 024347 148 GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226 (269)
Q Consensus 148 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~ 226 (269)
+.++|+|||.+................++..|+|||.+.+... +.++||||||+++|+|++ |..||.........+.+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999998865433222222223345678999999887665 489999999999999998 99999887777777776
Q ss_pred hcCccc-CCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 227 SAAEFT-CPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 227 ~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+... .+..++..+.+++.+||+.||++||+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v 275 (291)
T cd05094 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEI 275 (291)
T ss_pred hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 665543 345578999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=277.85 Aligned_cols=252 Identities=33% Similarity=0.573 Sum_probs=215.2
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--CCeEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIV 89 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v 89 (269)
+|++.+.||.|++|.||++.+..+++.+++|.+..... .....+.+.+|+.+++.++|+|++++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999865433 23345778899999999999999999997753 4568999
Q ss_pred EeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCH-----SRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh-----~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
+||+++++|.+.+.. ...++...+..++.+++.+|.+|| +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999888865 357899999999999999999999 89999999999999999999999999998875
Q ss_pred cccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCH
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSF 239 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 239 (269)
...... ......++..|+|||.+.+... +.++|+||||++++++++|..||.........+.+..+.. ..+...+.
T Consensus 160 ~~~~~~--~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDSS--FAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCcc--cccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 443221 1223357889999999987665 4889999999999999999999998887777777776654 34567899
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.++++.||+.+|.+||++ .+.+.|+|
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~--~~il~~~~ 264 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPST--EELLQLPL 264 (265)
T ss_pred HHHHHHHHHccCCcccCCCH--HHHhhCCC
Confidence 99999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=278.00 Aligned_cols=249 Identities=30% Similarity=0.541 Sum_probs=207.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||+|.+..+|+.+++|.+...........+.+.+|+.++++++|++++++++.+...+..+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 36899999999999999999999989999999998754444444567888999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+||+++++|..++.. ...++..++..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~- 159 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC-
Confidence 999999999888754 245889999999999999999999999999999999999999999999999987643321
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHhcCcc-cCCC-CCCHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN--LMNLYKKISAAEF-TCPP-WLSFTA 241 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~-~~~~~l 241 (269)
........++..|.|||.+.+..+ +.++|+||||+++|++++|..||.... .....+.+..+.. +.+. .++..+
T Consensus 160 -~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08224 160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237 (267)
T ss_pred -CcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence 111223346788999999877666 489999999999999999999996543 2344444444333 2333 578899
Q ss_pred HHHHHHhcCCCCCCcCCCCc
Q 024347 242 RKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~ 261 (269)
.++|.+||+.+|++||++.+
T Consensus 238 ~~~i~~cl~~~p~~Rp~~~~ 257 (267)
T cd08224 238 RDLVSRCINPDPEKRPDISY 257 (267)
T ss_pred HHHHHHHcCCCcccCCCHHH
Confidence 99999999999999999844
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=284.25 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=209.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
....+|++.+.||+|++|.||+|.+..+++.+++|.+...........+.+.+|+.+++.++|||++++.+++.+....+
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~ 91 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAW 91 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEE
Confidence 34467999999999999999999999899999999987554444455677889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+|+||+.| ++.+.+.. .+.+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 92 lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-- 168 (307)
T cd06607 92 LVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-- 168 (307)
T ss_pred EEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--
Confidence 99999975 66666654 457899999999999999999999999999999999999999999999999987643321
Q ss_pred CCcccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC--CCCCCHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--PPWLSFTAR 242 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~ 242 (269)
....++..|+|||++.+ ....+.++||||||+++|++++|..||.+.+.......+.....+. +..++..+.
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFR 244 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHH
Confidence 12346778999999853 2333589999999999999999999998877666655554433222 234788999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++|..||+.||++||++ .+.+.|+|
T Consensus 245 ~li~~~l~~~p~~Rp~~--~~il~~~~ 269 (307)
T cd06607 245 NFVDSCLQKIPQDRPSS--EELLKHRF 269 (307)
T ss_pred HHHHHHhcCChhhCcCH--HHHhcChh
Confidence 99999999999999998 66677765
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=282.35 Aligned_cols=258 Identities=29% Similarity=0.429 Sum_probs=208.4
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEe-
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG- 81 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~- 81 (269)
..++...++|++.+.||+|++|.||++.+..+++.+++|.+.... .....+.+|+.+++.+ +|+|++++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 355678899999999999999999999999999999999875422 1135677899999999 6999999999873
Q ss_pred ----eCCeEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEe
Q 024347 82 ----SKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (269)
Q Consensus 82 ----~~~~~~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~ 153 (269)
.....+++|||+++++|.+.+.. ...+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEc
Confidence 34568999999999999887643 3468889999999999999999999999999999999999999999999
Q ss_pred eCCCccccccccCCCcccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Q 024347 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 154 df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (269)
|||.+...... ........++..|+|||++... ...+.++|+||+|+++|++++|..||...............
T Consensus 167 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 167 DFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred cCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 99988654321 1122233578899999998532 22358999999999999999999999876655444443332
Q ss_pred c---ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 E---FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ...+..++..+.+++.+||+.||++|||+ .+++.|+|
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~ell~~~~ 285 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTV--SDLLQHVF 285 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCH--HHHhhccc
Confidence 2 12334468899999999999999999999 88888876
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=286.02 Aligned_cols=256 Identities=23% Similarity=0.397 Sum_probs=209.5
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEc-------CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCcee
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 75 (269)
+++....++|.+.+.||+|++|.||++.+. ..+..+++|.+.... .......+.+|+.+++.+ .||||++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIIN 82 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeee
Confidence 455667789999999999999999999753 234568999876432 233356788899999999 5999999
Q ss_pred eeEEEeeCCeEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 024347 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (269)
Q Consensus 76 ~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~ 139 (269)
+++++...+..++++||+++++|.+++... ..++..++..++.|++.||.|||++|++|+||+|
T Consensus 83 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 83 LLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 999999889999999999999999988653 2478888999999999999999999999999999
Q ss_pred CceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 024347 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (269)
Q Consensus 140 ~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 218 (269)
+||+++.++.++|+|||.++...............++..|+|||.+.+..+ +.++|+||||+++|++++ |..||....
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999998875432221111111223457999999987665 489999999999999998 899999888
Q ss_pred HHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 219 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 219 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+....+.... ...+..++.++.+++.+||+.||++||+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l 286 (314)
T cd05099 242 VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQL 286 (314)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 887777776654 34456788999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=277.50 Aligned_cols=244 Identities=24% Similarity=0.448 Sum_probs=208.3
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||.|++|.||.+... |+.+++|.+..... ..+.+.+|+.+++.++|+|++++++++.+....+
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 35678999999999999999999874 78899999865432 3577889999999999999999999999899999
Q ss_pred EEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++|||+++++|.+++.... .+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999887655 68999999999999999999999999999999999999999999999999887542211
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 243 (269)
. ....+..|+|||.+.+... +.++|+||||++++++++ |..||...+.......+..+ ....+..+++.+.+
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK 230 (256)
T ss_pred c-----cCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHH
Confidence 1 2223567999999877665 489999999999999997 99999988877777666554 33445668899999
Q ss_pred HHHHhcCCCCCCcCCCCccc
Q 024347 244 LIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~ 263 (269)
+|++||+.+|++||+++++.
T Consensus 231 li~~~l~~~p~~Rp~~~~l~ 250 (256)
T cd05039 231 VMKDCWELDPAKRPTFKQLR 250 (256)
T ss_pred HHHHHhccChhhCcCHHHHH
Confidence 99999999999999985543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=295.83 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=199.9
Q ss_pred CCeEEeeeeeccCCcEEEEEEEc--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
.+|++.+.||.|++|.||++... .+++.+++|.+... ....+|++++++++|+||+++++.+......++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 47999999999999999999754 34678999987432 234579999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
+|+++. +++..++.....+++.++..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus 164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 999985 5888888777789999999999999999999999999999999999999999999999999987554433333
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHh----cC------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---NLYKKIS----AA------------ 229 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~----~~------------ 229 (269)
......+++.|+|||++.+..+. .++||||||+++|+|++|..||.+.... .....+. ..
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence 33345688999999999877664 8999999999999999999999653321 1111110 00
Q ss_pred -------------cccCC-----CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 -------------EFTCP-----PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 -------------~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+ ...+.++.++|+.||+.||++||++ .++|.|+|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa--~e~l~~p~ 377 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSA--QDILSLPL 377 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCH--HHHhhCch
Confidence 00111 1246788999999999999999999 88888887
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=284.63 Aligned_cols=257 Identities=22% Similarity=0.395 Sum_probs=212.3
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEc-------CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCce
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVV 74 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~ 74 (269)
.+++....++|++.+.||+|++|.||.+.+. ..+..+++|.+.... .....+.+.+|+.+++.+ +||||+
T Consensus 7 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~ 84 (304)
T cd05101 7 DPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNII 84 (304)
T ss_pred CCcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCch
Confidence 4567788899999999999999999999753 234578999876432 233457788999999999 799999
Q ss_pred eeeEEEeeCCeEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 024347 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138 (269)
Q Consensus 75 ~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~ 138 (269)
++++.+......+++|||+++++|.+++... ..++..++..++.|++.||.|||+.|++|+||+
T Consensus 85 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlk 164 (304)
T cd05101 85 NLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLA 164 (304)
T ss_pred heeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 9999999999999999999999999988753 236778899999999999999999999999999
Q ss_pred CCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 024347 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDS 217 (269)
Q Consensus 139 ~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 217 (269)
|+||+++.++.++|+|||.+................++..|+|||++.+..+ +.++||||||+++|++++ |..||...
T Consensus 165 p~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 165 ARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred cceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 9999999999999999999875543222222222334567999999977665 488999999999999998 88999988
Q ss_pred CHHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 218 NLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 218 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+..+..+.+.... ...+..++..+.+++..||+.+|++||+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~ 289 (304)
T cd05101 244 PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQL 289 (304)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 8888888776543 34456689999999999999999999998443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=277.72 Aligned_cols=252 Identities=30% Similarity=0.506 Sum_probs=215.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+.|++.+.||.|++|.||++.+..+++.+++|.+...... ...+.+.+|+..+..++|+|++++++.+......++++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4689999999999999999999999999999998654422 44678899999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||+++++|.+++.....+++..+..++.|++.++.+||+ .|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 999999999999887889999999999999999999999 99999999999999999999999999987654322211
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCc-ccCCCC-CCHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAE-FTCPPW-LSFTARKL 244 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~~-~~~~~~-~~~~l~~l 244 (269)
.....++..|+|||.+.+... +.++|+||||+++|++++|..||... ...+....+.... ...+.. ++..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 123346788999999887755 48999999999999999999999776 4455555555433 333444 78999999
Q ss_pred HHHhcCCCCCCcCCCCccccccccC
Q 024347 245 IARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||+.+|++||++ .+++.|+|
T Consensus 236 i~~~l~~~p~~R~~~--~~ll~~~~ 258 (264)
T cd06623 236 ISACLQKDPKKRPSA--AELLQHPF 258 (264)
T ss_pred HHHHccCChhhCCCH--HHHHhCHH
Confidence 999999999999999 88888776
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=280.63 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=201.8
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCC--eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC------C
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------T 84 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 84 (269)
|.+.+.||+|++|.||+|++..+++ .+++|.+..... .....+.+.+|+.+++.++|+||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999877665 589998765322 234467888999999999999999999976321 2
Q ss_pred eEEEEEeccCCCchhHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCc
Q 024347 85 KIFIVLEFVTGGELFDKIVN------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~ 158 (269)
..+++++|+.+++|..++.. ...++...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 46899999999999887742 134789999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPW 236 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 236 (269)
.................++.|+|||.+.+... +.++|+||||+++|++++ |..||.........+.+..+. ...++.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 76543221111222335678999999987766 489999999999999998 899998888877777776654 355667
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
++..+.++|..||+.||++|||++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l 264 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETL 264 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 88999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=284.11 Aligned_cols=251 Identities=19% Similarity=0.270 Sum_probs=205.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCC----------------CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETG----------------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~----------------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~ 72 (269)
..++|++.+.||+|+||.||++.+...+ ..+++|.+..... ....+.+.+|++++++++|+|
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 4568999999999999999998876533 4579998865432 244678889999999999999
Q ss_pred ceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 024347 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (269)
Q Consensus 73 i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~n 141 (269)
++++++++...+..++++|++.+++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999899999999999999999887654 68999999999999999999999999999999999
Q ss_pred eEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCH
Q 024347 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNL 219 (269)
Q Consensus 142 Il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~ 219 (269)
|+++.++.++|+|||.+................++..|+|||.+.+... +.++||||||+++|++++ +..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 9999999999999998865432221122222334668999999877665 489999999999999987 7889987666
Q ss_pred HHHHHHHhcC--------cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 220 MNLYKKISAA--------EFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 220 ~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.......... ..+.+..++.++.+++..||+.||++|||++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 240 QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 6665555322 123345578999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=280.47 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=208.8
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeC--
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK-- 83 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-- 83 (269)
....+.|++.+.||.|++|.||+|.+..+++.+++|.+..... ....+.+|+.+++.+ +|+|++++++.+...
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 77 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC
Confidence 3456789999999999999999999999999999999865331 235677899999988 699999999998642
Q ss_pred ----CeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 84 ----TKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 84 ----~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
...++++||+.+++|.+++... ..+++..+..++.|++.+|.|||+.+++|+||+|+||+++.++.++|+|||+
T Consensus 78 ~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 78 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999988763 3688999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCCcccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc--
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-- 231 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 231 (269)
+...... ........++..|+|||++.+. ...+.++|+||+|+++|+|++|..||...........+.....
T Consensus 158 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (272)
T cd06637 158 SAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR 235 (272)
T ss_pred ceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCC
Confidence 8654321 1222334578889999998632 2235789999999999999999999987666555554433322
Q ss_pred cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.....++..+.+|+.+||+.||.+|||+ .+++.|+|
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~--~~il~~~~ 271 (272)
T cd06637 236 LKSKKWSKKFQSFIESCLVKNHSQRPTT--EQLMKHPF 271 (272)
T ss_pred CCCCCcCHHHHHHHHHHcCCChhhCCCH--HHHhhCCC
Confidence 1223478899999999999999999999 88899988
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=279.57 Aligned_cols=251 Identities=22% Similarity=0.376 Sum_probs=206.7
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||.|++|.||++.+. .+..+++|.+...... .+.+.+|+.++++++|++++++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 44578999999999999999999876 4667999998654332 246888999999999999999999875 45678
Q ss_pred EEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++|||+++++|.+++... ..++..++..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999988653 358999999999999999999999999999999999999999999999999886543211
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 243 (269)
.. ......++..|+|||.+.+... +.++|+||||+++|++++ |..||...+..+....+... ..+.+...+..+.+
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE 234 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 11 1111223457999999876665 489999999999999998 99999888877777777654 44556668899999
Q ss_pred HHHHhcCCCCCCcCCCCcccccc
Q 024347 244 LIARILDPNPMTVSIYPFADILY 266 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~ 266 (269)
|+.+||+.||++|||+++...+.
T Consensus 235 li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 235 LMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHHH
Confidence 99999999999999987665443
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=278.03 Aligned_cols=254 Identities=28% Similarity=0.412 Sum_probs=208.6
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC-ceeeeEEEeeCC----
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKT---- 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~---- 84 (269)
...|+.+++||.|+||+||+|+.+.+|+.||+|.+..+... +..-....+|+.+++.++|+| |+.+++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 45688889999999999999999999999999999765432 122345678999999999999 999999998877
Q ss_pred --eEEEEEeccCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCc
Q 024347 85 --KIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (269)
Q Consensus 85 --~~~~v~~~~~~~~l~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~ 158 (269)
..++|+||.+ .+|.+++.... .++...++.+..|++.||+|+|+++|+|+||||.||+++..|.+||+|||++
T Consensus 89 ~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 7899999995 48888887754 4777899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--C-------
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--A------- 229 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~------- 229 (269)
+..... .........+.-|+|||++.+...++...||||+||++.+|+++...|.+....+....+.. +
T Consensus 168 ra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 854432 22234445677799999999987788999999999999999999999998777655555421 0
Q ss_pred ---------cccCCC------------CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ---------EFTCPP------------WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ---------~~~~~~------------~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...++. ..++...+++.+||+.+|.+|.|+ ..+|.|+|
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa--~~al~h~y 304 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISA--KGALTHPY 304 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCH--HHHhcChh
Confidence 001111 134578899999999999999999 77887764
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=281.70 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=210.0
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||.|++|.||++.++.+++.+++|.+..... ......+.+|+++++.++|||++++++.+......++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468889999999999999999999999999999876432 244567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
||+.+++|.+++... ..+++..+..++.|++.+|.+||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-- 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence 999999999988776 788999999999999999999999 9999999999999999999999999998765432111
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCcc-cCCCC-CCHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-----NLMNLYKKISAAEF-TCPPW-LSFTA 241 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~-~~~~~-~~~~l 241 (269)
....++..|+|||.+.+... +.++|+||||++++++++|..||... ......+.+..... ..+.. ++..+
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred --hcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 11456788999999977755 48999999999999999999999654 22333343333332 22333 78899
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++|..||..||++||++ .+++.|+|
T Consensus 234 ~~li~~~l~~~p~~Rpt~--~~ll~~~~ 259 (265)
T cd06605 234 QDFVNLCLIKDPRERPSY--KELLEHPF 259 (265)
T ss_pred HHHHHHHcCCCchhCcCH--HHHhhCch
Confidence 999999999999999999 77888877
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=300.91 Aligned_cols=245 Identities=22% Similarity=0.392 Sum_probs=214.4
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
-+.+.|+...-++-||.|+.|-||+|+.. ++.||||+++. .-..++.-|++|+|+||+.+.|+|....
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~e----------lkETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVRE----------LKETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhh----------hhhhhHHHHHhccCcceeeEeeeecCCc
Confidence 35677777888899999999999999974 67899998632 2234788899999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+|+|||||..|.|...+.....++...+..|..+|+.++.|||.+.|+|+|+|.-||||..+..||++|||.++-..
T Consensus 186 cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~-- 263 (904)
T KOG4721|consen 186 CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS-- 263 (904)
T ss_pred eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999876332
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~ 242 (269)
.........|++.|||||++...+.. .|+||||||+++|+|+||..||.+-+.+-++..+... .++.|+.+|.-++
T Consensus 264 -~~STkMSFaGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfk 341 (904)
T KOG4721|consen 264 -DKSTKMSFAGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFK 341 (904)
T ss_pred -hhhhhhhhhhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHH
Confidence 23556677899999999999998885 9999999999999999999999987766666555443 4577889999999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccc
Q 024347 243 KLIARILDPNPMTVSIYPFADILYM 267 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~ 267 (269)
=|+++||+-.|..|||+ .++|.|
T Consensus 342 lL~Kqcw~sKpRNRPSF--rqil~H 364 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSF--RQILLH 364 (904)
T ss_pred HHHHHHHhcCCCCCccH--HHHHHH
Confidence 99999999999999999 555544
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=281.33 Aligned_cols=251 Identities=21% Similarity=0.322 Sum_probs=206.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
...+|++.+.||.|++|.||++... .++..+++|.+... .....+.+.+|++.++.++|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 3568899999999999999999642 34667888887543 234457889999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG---------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~---------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~ 148 (269)
+..++++||+++++|.+++...+ .++...+..++.|++.||+|||+.|++|+||+|+||++++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999998886543 378899999999999999999999999999999999999999
Q ss_pred CEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 024347 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (269)
Q Consensus 149 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 227 (269)
.++|+|||++................+++.|+|||.+.+... +.++|+||||+++|+|++ |..||......+....+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 999999998864432111111122234578999999887765 489999999999999998 999998777766666665
Q ss_pred cCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 228 AAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 228 ~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.+. ...+..+++.+.+++.+||+.||++||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~ 275 (280)
T cd05092 239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIH 275 (280)
T ss_pred cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 543 445567899999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=283.01 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=203.7
Q ss_pred CeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+|++.+.||+|+||.||+|.... ....+++|.+..... ....+.+.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998753 235688888754332 23356788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCce
Q 024347 87 FIVLEFVTGGELFDKIVNH------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nI 142 (269)
++++||+.+++|.+++... ..++..++..++.|++.+|.+||+.|++|+||+|+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999998887542 2477889999999999999999999999999999999
Q ss_pred EecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 024347 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (269)
Q Consensus 143 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 221 (269)
++++++.++|+|||+++................+..|+|||.+.+... +.++||||||+++++|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999998865432221111222234568999999877665 489999999999999998 999999888777
Q ss_pred HHHHHhcC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 222 LYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 222 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
..+.+... ..+.+..++.++.+++..||+.||++||+++++-
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~ 280 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 77666543 3444566899999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=307.84 Aligned_cols=245 Identities=30% Similarity=0.464 Sum_probs=202.2
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEE-Eee---
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEV-MGS--- 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~--- 82 (269)
+---+++|.+.|.+|||+.||+|++...|..+|+|.+-.. ++...+.+++|++++++|+ |+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3345788999999999999999999987799999987543 5667899999999999997 9999999993 211
Q ss_pred ---CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEecCCCCEEEeeC
Q 024347 83 ---KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 83 ---~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~~~~~~~l~df 155 (269)
.-.++++||||.|+.|.++++.+ ..|++.++++|+.++++|++.||..+ |+|||||-+|||++.+++.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 12478999999999999999863 46999999999999999999999997 999999999999999999999999
Q ss_pred CCccccccccCCCc-------ccccccCccccCccccc--CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 024347 156 GLSALSQQVRDDGL-------LHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226 (269)
Q Consensus 156 ~~~~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 226 (269)
|.+.-......... ......|+.|+|||.+. ++...+.|+|||+|||++|.|+....||+.... -.|
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laI 266 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAI 266 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeE
Confidence 98754332221111 12234789999999875 222335999999999999999999999986422 345
Q ss_pred hcCcccCCC--CCCHHHHHHHHHhcCCCCCCcCCC
Q 024347 227 SAAEFTCPP--WLSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 227 ~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
.++++.+|+ .++..+++||+.||+.||.+||++
T Consensus 267 lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI 301 (738)
T KOG1989|consen 267 LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNI 301 (738)
T ss_pred EeccccCCCCccHHHHHHHHHHHHhccCcccCCCH
Confidence 666766664 699999999999999999999998
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=278.65 Aligned_cols=250 Identities=22% Similarity=0.379 Sum_probs=205.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||.|++|.||+|.+..+ ..+++|.+...... .+.+.+|+++++.++|+||+++++.+. ....+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence 3457899999999999999999988755 45999998643321 246788999999999999999999874 45578
Q ss_pred EEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++|||+++++|.+++... ..++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999988753 357889999999999999999999999999999999999999999999999886543322
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 243 (269)
.. ......++..|+|||...+... +.++|+||||+++|++++ |..||...........+... ..+.+..++..+.+
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 234 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 234 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHH
Confidence 11 1112234567999999877666 489999999999999999 89999887777776666554 34455678999999
Q ss_pred HHHHhcCCCCCCcCCCCccccc
Q 024347 244 LIARILDPNPMTVSIYPFADIL 265 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l 265 (269)
++..||+.||++||++++...+
T Consensus 235 li~~~l~~~p~~Rp~~~~~~~~ 256 (262)
T cd05071 235 LMCQCWRKEPEERPTFEYLQAF 256 (262)
T ss_pred HHHHHccCCcccCCCHHHHHHH
Confidence 9999999999999998665544
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=281.63 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=205.9
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 81 (269)
.+..++|++.+.||.|++|.||+|..+. .+..+++|.+..... ......+.+|+..++.++|+|++++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567899999999999999999997542 355799998754332 222456788999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEE
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~ 151 (269)
.....+++|||+++++|.+++... ..++...+..++.|++.||.|||++|++|+||+|+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 889999999999999999998652 1345678889999999999999999999999999999999999999
Q ss_pred EeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc
Q 024347 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE 230 (269)
Q Consensus 152 l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 230 (269)
|+|||+++...............++..|+|||.+.+... +.++|+||||+++|++++ |..||......+..+.+..+.
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 238 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGG 238 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 999998875433222111122234567999999887665 489999999999999998 789998887777777665543
Q ss_pred -ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 231 -FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 231 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
...+...++.+.+++..||+.||++|||++++
T Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l 271 (288)
T cd05061 239 YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 271 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 34556678999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=279.54 Aligned_cols=250 Identities=33% Similarity=0.587 Sum_probs=229.1
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
.+-.++|..++.||.|.||.|.+++.+.+++.+|+|+++.+..-..+....-..|-++|+..+||.+..+-..|+..+++
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRL 243 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceE
Confidence 34578899999999999999999999999999999999887766666666777899999999999999998899999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
|+||||.+||.|.-.+.+.+.++++...-....|.+||.|||+++||++|+|.+|.+++.+|++|+.|||+|.- ....
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I~~ 321 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EIKY 321 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--cccc
Confidence 99999999999988888888899999888999999999999999999999999999999999999999999873 2234
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
.......+|+|.|.|||++....+. .+.|.|.+|+++|+|++|+.||.+.+...+++.+......+|..++++.+.|+.
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLs 400 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLS 400 (516)
T ss_pred cceeccccCChhhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHHHH
Confidence 4455667899999999999998875 999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCcCCC
Q 024347 247 RILDPNPMTVSIY 259 (269)
Q Consensus 247 ~~l~~dP~~Rps~ 259 (269)
.+|.+||.+|.--
T Consensus 401 GLL~kdP~kRLGg 413 (516)
T KOG0690|consen 401 GLLKKDPKKRLGG 413 (516)
T ss_pred HHhhcChHhhcCC
Confidence 9999999999753
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=277.51 Aligned_cols=242 Identities=22% Similarity=0.347 Sum_probs=200.7
Q ss_pred eeeccCCcEEEEEEE--cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 18 TIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 18 ~lg~g~~~~v~~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
.||+|++|.||+|.+ +.+++.+++|++.... ......+.+.+|+.+++.+.|+||+++++++. ....+++|||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999964 4567889999876443 23445678899999999999999999999875 4467899999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC-cccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTC 174 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~ 174 (269)
++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 9999998877789999999999999999999999999999999999999999999999999887543322111 111222
Q ss_pred cCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCC
Q 024347 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPN 252 (269)
Q Consensus 175 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~d 252 (269)
++..|+|||.+..... +.++|+||||+++|++++ |..||.........+.+..+. .+.+..+++++.++|+.||+.|
T Consensus 160 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 3568999999876555 489999999999999998 999999888877777776654 4556779999999999999999
Q ss_pred CCCcCCCCcc
Q 024347 253 PMTVSIYPFA 262 (269)
Q Consensus 253 P~~Rps~~~~ 262 (269)
|++||+++.+
T Consensus 239 p~~Rp~~~~i 248 (257)
T cd05116 239 VDERPGFAVV 248 (257)
T ss_pred chhCcCHHHH
Confidence 9999998443
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=273.99 Aligned_cols=249 Identities=33% Similarity=0.552 Sum_probs=211.8
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
.|++.+.||.|++|.||++.+..+++.+++|.+..... ...+.+.+|+.+++.++|++++++++.+......+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48899999999999999999988899999999865443 345788899999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 92 FVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 92 ~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
|+++++|.+.+... ..++...+..++.+++.+|.+||+.|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 99999999888775 5789999999999999999999999999999999999999999999999998865443221 2
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHHHHHHHHH
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIAR 247 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~ 247 (269)
....++..|+|||.+.+... +.++|+||||++++++++|..||...+............. ..+..++..+.++|++
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 33456788999999877664 5899999999999999999999987755444433332221 2223348999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+.||++|||+ .+++.|+|
T Consensus 234 ~l~~~p~~R~t~--~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTA--EQLLKHPF 253 (253)
T ss_pred HccCChhhCCCH--HHHhcCCC
Confidence 999999999999 99999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=280.17 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=203.6
Q ss_pred eEEeeeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe----
Q 024347 13 YEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK---- 85 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 85 (269)
|++.+.||+|+||.||.|....+ +..+++|.+..... .......+.+|+..++.++|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987643 47899999875433 23345678899999999999999999998755443
Q ss_pred --EEEEEeccCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 86 --IFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 86 --~~~v~~~~~~~~l~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
.++++||+++++|...+... ..++...+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 78999999999998887442 2588999999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCC
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 235 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~ 235 (269)
++................+..|+|||.+.+... +.++||||||+++|++++ |..||......+..+.+..+ ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 875433222111222234567999999876665 489999999999999998 99999888777777776654 345567
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.++..+.+++.+||+.||++||++.++.
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~ 266 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLR 266 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 7899999999999999999999985544
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=277.80 Aligned_cols=252 Identities=21% Similarity=0.355 Sum_probs=207.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
+.-++|++.+.||+|++|.||+|..+ +++.+++|.+...... ...+.+|+.+++.++|+|++++++++. .+..+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999865 5788999998654432 356788999999999999999999874 45689
Q ss_pred EEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+++||+.+++|.+.+... ..++..++..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999887653 368899999999999999999999999999999999999999999999999886543211
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 243 (269)
.. ......++..|+|||.+.+... +.++|+||||+++|++++ |+.||...........+..+ ..+.+...+.++.+
T Consensus 157 ~~-~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05067 157 YT-AREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYE 234 (260)
T ss_pred cc-cccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 11 1112224567999999987665 489999999999999998 99999887777777766554 34555668899999
Q ss_pred HHHHhcCCCCCCcCCCCccccccc
Q 024347 244 LIARILDPNPMTVSIYPFADILYM 267 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~ 267 (269)
++++||+.||++||+++++..+..
T Consensus 235 li~~~l~~~p~~Rp~~~~l~~~l~ 258 (260)
T cd05067 235 LMRLCWKEKPEERPTFEYLRSVLE 258 (260)
T ss_pred HHHHHccCChhhCCCHHHHHHHhh
Confidence 999999999999999877655543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=279.50 Aligned_cols=249 Identities=18% Similarity=0.307 Sum_probs=203.5
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
.++|++.+.||.|++|+||+|.+..+++ .+++|.+.... .......+.+|+..++.+.||||+++++++. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 3689999999999999999999877776 46777764322 2233467778888999999999999999875 445
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++++|+++++|.+++... +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.++.....
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 67889999999999998764 57899999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 242 (269)
..........++..|+|||.+.+..+ +.++|+||||+++|++++ |..||.........+.+..+. .+.+..++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 22222223345678999999987665 489999999999999998 999998887777666665544 344556788999
Q ss_pred HHHHHhcCCCCCCcCCCCcc
Q 024347 243 KLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~ 262 (269)
+++..||..||++|||++++
T Consensus 242 ~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred HHHHHHcCCCcccCcCHHHH
Confidence 99999999999999998554
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=277.15 Aligned_cols=244 Identities=23% Similarity=0.333 Sum_probs=201.8
Q ss_pred eeeeccCCcEEEEEEEcCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEecc
Q 024347 17 RTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 93 (269)
+.||+|++|.||+|.+...+ ..+++|.+...... ...+.+.+|+.+++.+.|+|++++++++. ....+++++|+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999876554 78999998765543 34567889999999999999999999875 44679999999
Q ss_pred CCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc-ccc
Q 024347 94 TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHT 172 (269)
Q Consensus 94 ~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~-~~~ 172 (269)
++++|.+++.....+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.++.......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 9999999998877899999999999999999999999999999999999999999999999998875433211110 011
Q ss_pred cccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcC
Q 024347 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILD 250 (269)
Q Consensus 173 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~ 250 (269)
..++..|+|||.+.+... +.++|+||||+++|++++ |..||...+..+....+.... .+.+..++..+.+++.+||+
T Consensus 158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 112357999999977665 489999999999999998 999998887777777765554 35566789999999999999
Q ss_pred CCCCCcCCCCcccc
Q 024347 251 PNPMTVSIYPFADI 264 (269)
Q Consensus 251 ~dP~~Rps~~~~~~ 264 (269)
.||++||++.++..
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999865543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=277.95 Aligned_cols=246 Identities=23% Similarity=0.403 Sum_probs=204.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
..+|++.+.||.|++|.||++.+. .+..+++|.+...... ...+.+|++++++++|+|++++++++...+..+++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 457899999999999999999886 4667999997543321 24577899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
+||+++++|.+++... ..+++..+..++.|++.+|++||+.|++|+||+|+||+++.++.++++|||.++........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccc-
Confidence 9999999999988654 46899999999999999999999999999999999999999999999999988654321111
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 246 (269)
.......+..|+|||.+.+..+. .++|+||||+++|++++ |..||......+....+... ....+..++..+.+++.
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY 235 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence 11111123479999999876664 89999999999999998 89999888777777777655 34556668999999999
Q ss_pred HhcCCCCCCcCCCCcc
Q 024347 247 RILDPNPMTVSIYPFA 262 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~ 262 (269)
+||+.+|++|||++++
T Consensus 236 ~cl~~~p~~Rpt~~~~ 251 (256)
T cd05059 236 SCWHEKPEDRPAFKKL 251 (256)
T ss_pred HHhcCChhhCcCHHHH
Confidence 9999999999998443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=281.53 Aligned_cols=251 Identities=28% Similarity=0.468 Sum_probs=211.8
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
..|+..+.||.|++|.||.|.+..+++.+++|.+..... ....+.+.+|+.+++.+.|+|++++++.+.+....++++
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468888999999999999999998899999999865432 233578889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++|++|.+++.. +.++..++..++.+++.+|.++|+.+++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 99999999887764 578999999999999999999999999999999999999999999999999886543211 112
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhc
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARIL 249 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l 249 (269)
....++..|+|||.+.+... +.++|+||||+++|++++|..||...........+.... ...+..++..+.++++.||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 22346778999999877665 489999999999999999999998877766665554432 2334457889999999999
Q ss_pred CCCCCCcCCCCccccccccC
Q 024347 250 DPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 250 ~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+|++||++ .+.+.|+|
T Consensus 238 ~~~p~~Rp~~--~~il~~~~ 255 (277)
T cd06640 238 NKDPSFRPTA--KELLKHKF 255 (277)
T ss_pred ccCcccCcCH--HHHHhChH
Confidence 9999999999 77777765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=297.02 Aligned_cols=247 Identities=21% Similarity=0.312 Sum_probs=197.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
-.+|.+.+.||.|++|.||++.+...++.|++|.... ..+.+|++++++++|+||+++++++...+..+++
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 3479999999999999999999999999999996321 2346799999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
++++. ++|..++... +.++..++..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++.........
T Consensus 239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 99995 5787777653 469999999999999999999999999999999999999999999999999987543322222
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHhcCccc---C----
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD--------SNLMNLYKKISAAEFT---C---- 233 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--------~~~~~~~~~~~~~~~~---~---- 233 (269)
......++..|+|||++.+..+ +.++||||||+++|+|++|..|+-. .....+...+...... +
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~ 396 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA 396 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence 2223458899999999988776 4899999999999999987655421 1112222222211100 0
Q ss_pred ----------------------C-----CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 234 ----------------------P-----PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 234 ----------------------~-----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+ ...+..+.+||+.||+.||.+|||+ .++|.|+|
T Consensus 397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa--~elL~hp~ 457 (461)
T PHA03211 397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSA--AELLRLPL 457 (461)
T ss_pred chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCH--HHHhhCcc
Confidence 0 0245689999999999999999999 99999987
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=282.25 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=207.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
...++|++.+.||.|++|.||++.+.. ++..+++|.+.... .....+.+.+|+.+++.++|||++++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 346789999999999999999998753 57889999886432 23345678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCC
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHG----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~----------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~ 140 (269)
....++++||+++++|.+++.... .++...+..++.+++.||.+||+.|++|+||+|+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 889999999999999998886431 3677888999999999999999999999999999
Q ss_pred ceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 024347 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL 219 (269)
Q Consensus 141 nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~ 219 (269)
||+++.++.++|+|||.+.................+..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+...
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999998765432221111222233567999999877665 489999999999999997 8889988777
Q ss_pred HHHHHHHhcCcc-cCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 220 MNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 220 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+....+..+.. +.+..++..+.+|+.+||+.||++|||++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el 282 (288)
T cd05050 239 EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282 (288)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 777777766554 3456688999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=290.62 Aligned_cols=254 Identities=21% Similarity=0.360 Sum_probs=200.8
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEE
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV 79 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 79 (269)
+....++|++.+.||.|+||.||+|.... +++.|++|.+..... ....+.+.+|+.+++++ +|+||++++++
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 44556799999999999999999997543 357899999864332 23346778899999999 79999999998
Q ss_pred Eee-CCeEEEEEeccCCCchhHHHHhc-----------------------------------------------------
Q 024347 80 MGS-KTKIFIVLEFVTGGELFDKIVNH----------------------------------------------------- 105 (269)
Q Consensus 80 ~~~-~~~~~~v~~~~~~~~l~~~~~~~----------------------------------------------------- 105 (269)
+.. ....+++++|+++++|.+.+...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 754 45688999999999998887532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCc
Q 024347 106 --------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177 (269)
Q Consensus 106 --------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 177 (269)
..++...+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++................++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 257888999999999999999999999999999999999999999999999987543322111122233456
Q ss_pred cccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHhcC-cccCCCCCCHHHHHHHHHhcCCCCC
Q 024347 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN-LYKKISAA-EFTCPPWLSFTARKLIARILDPNPM 254 (269)
Q Consensus 178 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~-~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~ 254 (269)
.|+|||++.+..++ .++||||||+++|++++ |..||......+ ....+..+ ....+...++++.+++..||+.+|+
T Consensus 240 ~y~aPE~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~ 318 (337)
T cd05054 240 KWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPE 318 (337)
T ss_pred cccCcHHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChh
Confidence 79999999887764 89999999999999997 999997644333 23333332 2334456789999999999999999
Q ss_pred CcCCCCcc
Q 024347 255 TVSIYPFA 262 (269)
Q Consensus 255 ~Rps~~~~ 262 (269)
+||+++++
T Consensus 319 ~RPs~~el 326 (337)
T cd05054 319 DRPTFSEL 326 (337)
T ss_pred hCcCHHHH
Confidence 99998543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=285.13 Aligned_cols=255 Identities=31% Similarity=0.439 Sum_probs=206.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--CeE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 86 (269)
..++|++.+.||.|++|.||+|.+..+|+.|++|.+....... .......+|+.++++++|+|++++++++... +..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 5678999999999999999999999999999999986543221 1123456799999999999999999998654 568
Q ss_pred EEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++|+||+.+ +|...+.. ...+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999965 77777765 3578999999999999999999999999999999999999999999999999887554322
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------------
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---------------- 229 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------------- 229 (269)
. .......+..|+|||.+.+....+.++|+||||+++|+|++|..||...+.......+...
T Consensus 163 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 K--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred C--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 1 1122234677999999876554568999999999999999999999887776665554321
Q ss_pred ---cccCC-----------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ---EFTCP-----------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ---~~~~~-----------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+..+ ...++.+.++|+.||++||++|||+ .+++.|+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~--~~il~h~~ 292 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATA--EEALESSY 292 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCH--HHHhcChh
Confidence 00000 1257889999999999999999999 67888887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=276.88 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=205.1
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
+..++|++.+.||.|++|.||++.+... ..+++|.+..... ..+.+.+|+++++.++|+|++++++++. ....+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 3456899999999999999999988654 4599998754332 2356788999999999999999999875 45678
Q ss_pred EEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++|||+.+++|.+++... ..++...+..++.+++.||.+||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999988653 347889999999999999999999999999999999999999999999999886543221
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 243 (269)
.. ......++..|+|||...+... +.++|+||||+++|++++ |..||......+....+... ..+.+...+..+.+
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE 234 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 11 1112234567999999877665 489999999999999999 99999988777777766554 33445668899999
Q ss_pred HHHHhcCCCCCCcCCCCcccccc
Q 024347 244 LIARILDPNPMTVSIYPFADILY 266 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~ 266 (269)
++++||+.||++||+++++..+.
T Consensus 235 li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 235 LMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HHHHHccCCcccCcCHHHHHHHH
Confidence 99999999999999997665543
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=273.38 Aligned_cols=252 Identities=29% Similarity=0.498 Sum_probs=216.8
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ....+.+.+|+++++++.|+|++++++++.+....+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 588999999999999999999988999999998765432 3446789999999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
|+++++|.+.+.....+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 999999999988878899999999999999999999999999999999999999999999999998875543222 122
Q ss_pred ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCcccCCCCCCHHHHHHHHHhcC
Q 024347 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS-AAEFTCPPWLSFTARKLIARILD 250 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~ 250 (269)
...++..|+|||...+... +.++|+|++|++++++++|..||............. ......+..++..+.+++.+||+
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 3346788999999877664 589999999999999999999998766554444443 34445566789999999999999
Q ss_pred CCCCCcCCCCccccccccC
Q 024347 251 PNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 251 ~dP~~Rps~~~~~~l~~~~ 269 (269)
.+|++||++ .+.+.++|
T Consensus 237 ~~p~~R~~~--~~~l~~~~ 253 (254)
T cd06627 237 KDPNLRPTA--KQLLKHPW 253 (254)
T ss_pred CChhhCcCH--HHHhcCCC
Confidence 999999999 88888876
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=280.35 Aligned_cols=246 Identities=29% Similarity=0.424 Sum_probs=196.5
Q ss_pred eeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHH---HhhhCCCCCceeeeEEEeeCCeEEEEEeccC
Q 024347 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA---TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~---~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
.||.|+||.||++.+..+++.+++|.+...............++.. ++....|++++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999899999999987544332222223334433 3344579999999999998899999999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccc
Q 024347 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (269)
Q Consensus 95 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 174 (269)
+++|..++..++.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcC
Confidence 9999988888888999999999999999999999999999999999999999999999999987643221 112235
Q ss_pred cCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCC
Q 024347 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (269)
Q Consensus 175 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (269)
++..|+|||.+.+....+.++|+||+|+++|++++|..||.... ...............+..++.++.++|+.||+.
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 78899999998654434589999999999999999999996532 222222223334455667899999999999999
Q ss_pred CCCCcCC-----CCccccccccC
Q 024347 252 NPMTVSI-----YPFADILYMRF 269 (269)
Q Consensus 252 dP~~Rps-----~~~~~~l~~~~ 269 (269)
||.+||+ + .+.+.|+|
T Consensus 237 ~p~~R~~~~~~~~--~~~~~h~~ 257 (279)
T cd05633 237 DVSKRLGCLGRGA--QEVKEHVF 257 (279)
T ss_pred CHHHhcCCCCCCH--HHHHhCcc
Confidence 9999995 6 66677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=284.53 Aligned_cols=263 Identities=27% Similarity=0.368 Sum_probs=206.8
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
...+....++|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|+.++++++||||+++++++..
T Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 82 (310)
T cd07865 4 EFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRT 82 (310)
T ss_pred cCcccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEec
Confidence 345667788999999999999999999999999999999998643321 1223455679999999999999999998865
Q ss_pred CC--------eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEe
Q 024347 83 KT--------KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (269)
Q Consensus 83 ~~--------~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~ 153 (269)
.. ..++++||+.+ ++.+.+... ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~ 161 (310)
T cd07865 83 KATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLA 161 (310)
T ss_pred ccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEEC
Confidence 43 45999999965 777766654 368999999999999999999999999999999999999999999999
Q ss_pred eCCCccccccccCC--CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--
Q 024347 154 DFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-- 229 (269)
Q Consensus 154 df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-- 229 (269)
|||.+......... .......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...........+...
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~ 241 (310)
T cd07865 162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241 (310)
T ss_pred cCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99988755432221 11122345778999999876554458899999999999999999999877655433332210
Q ss_pred cc-----------------cC-------------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EF-----------------TC-------------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~-----------------~~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. .. ....+..+.+||.+||+.||++|||+ .+++.|+|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~--~e~l~h~~ 309 (310)
T cd07865 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA--DTALNHDF 309 (310)
T ss_pred CCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCH--HHHhcCCC
Confidence 00 00 01135678899999999999999999 88999988
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=276.47 Aligned_cols=245 Identities=23% Similarity=0.373 Sum_probs=203.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||.+.+.. +..+++|.+...... .+.+.+|+.++++++||||+++++++......+++
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 4679999999999999999998754 456999987644322 35678899999999999999999999888889999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+.+++|.+++... ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 9999999999988764 46899999999999999999999999999999999999999999999999987644321111
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 246 (269)
......++..|+|||.+.+... +.++|+||||+++|+|++ |..||...+.......+..+.. ..+...+..+.+++.
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 235 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMY 235 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 1111234567999999987665 489999999999999998 9999988777777777766543 345567899999999
Q ss_pred HhcCCCCCCcCCCCc
Q 024347 247 RILDPNPMTVSIYPF 261 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~ 261 (269)
.||+.||++||++.+
T Consensus 236 ~cl~~~p~~Rp~~~~ 250 (256)
T cd05113 236 SCWHEKAEERPTFQQ 250 (256)
T ss_pred HHcCCCcccCCCHHH
Confidence 999999999999833
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=283.07 Aligned_cols=255 Identities=21% Similarity=0.334 Sum_probs=205.3
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeE
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 78 (269)
+.....++|.+.+.||.|++|.||++.+. ..+..+++|.+.... .....+.+.+|+.+++++ +|+||+++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 106 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLG 106 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence 34556678999999999999999999752 345579999876432 233357789999999999 7999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCC
Q 024347 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (269)
Q Consensus 79 ~~~~~~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~ 156 (269)
.+...+..++++||+.+++|.+++.... .++..++..++.+++.+|.|||+.|++|+||+|+||+++.++.++++|||
T Consensus 107 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 107 ACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999999887543 38999999999999999999999999999999999999999999999999
Q ss_pred CccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh-cC-cccC
Q 024347 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-AA-EFTC 233 (269)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~-~~-~~~~ 233 (269)
.+................++..|+|||.+.+... +.++||||+|+++|++++ |..||............. .+ ....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~ 265 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQ 265 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCC
Confidence 8864432211111112234578999999887766 489999999999999998 999998766554443333 22 2233
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 234 PPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+...++.+.+++.+||+++|++||+++++
T Consensus 266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~el 294 (302)
T cd05055 266 PEHAPAEIYDIMKTCWDADPLKRPTFKQI 294 (302)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 45678999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=274.66 Aligned_cols=248 Identities=39% Similarity=0.678 Sum_probs=215.5
Q ss_pred eeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCch
Q 024347 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (269)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l 98 (269)
||.|++|.||.+.+..+++.+++|.+.............+.+|+.+++.++|+|++++++.+......+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999888999999998876655555567889999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCcc
Q 024347 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178 (269)
Q Consensus 99 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 178 (269)
.+++.....+++..+..++.|++.+|.++|+.+++|+||+|+||+++.++.++|+|||.+....... .......++..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 9999887789999999999999999999999999999999999999999999999999876543221 12233456778
Q ss_pred ccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCC
Q 024347 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVSI 258 (269)
Q Consensus 179 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 258 (269)
|+|||...+... +.++|+||||+++|++++|..||...+.......+.....+.+...+..+.+++++||..||++||+
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999877665 4889999999999999999999998887777777777778888888999999999999999999999
Q ss_pred CCc-cccccccC
Q 024347 259 YPF-ADILYMRF 269 (269)
Q Consensus 259 ~~~-~~~l~~~~ 269 (269)
+.. .+++.|+|
T Consensus 238 ~~~~~~l~~~~~ 249 (250)
T cd05123 238 SGGAEEIKAHPF 249 (250)
T ss_pred cccHHHHHhCCC
Confidence 722 14445655
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=276.69 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=209.4
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
++.-+++.+.....||+|++|.||+|.+..++..+++|.+.... ....+.+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 78 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCC
Confidence 45556667777789999999999999998889999999876443 233567889999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-CCCEEEeeCCCccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRM--KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSAL 160 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l--~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-~~~~~l~df~~~~~ 160 (269)
..++++||+++++|.+.+... ..+ +...+..++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999999988764 445 78888999999999999999999999999999999976 67899999998764
Q ss_pred cccccCCCcccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HhcCcccCCCC
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMN--LYKK-ISAAEFTCPPW 236 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~-~~~~~~~~~~~ 236 (269)
.... ........+++.|+|||.+.+.. ..+.++|+||+|+++|++++|..||....... .... ........+..
T Consensus 159 ~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (268)
T cd06624 159 LAGI--NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPES 236 (268)
T ss_pred cccC--CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcc
Confidence 4321 11122234678999999986543 23589999999999999999999997543221 1111 12233445667
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+++++.+++++||+.+|++||++ .+.+.|+|
T Consensus 237 ~~~~~~~li~~~l~~~p~~Rpt~--~~ll~~~~ 267 (268)
T cd06624 237 LSAEAKNFILRCFEPDPDKRASA--HDLLQDPF 267 (268)
T ss_pred cCHHHHHHHHHHcCCCchhCCCH--HHHHhCCC
Confidence 89999999999999999999999 88889888
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=290.28 Aligned_cols=254 Identities=41% Similarity=0.745 Sum_probs=228.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
-+-|.+.+.||+|-|.+|-+|++.-+|+.||||++...+.+... .-.+.+|++-++.++||||+++|++..++..+|+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi 95 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI 95 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence 34688999999999999999999999999999999887765543 46788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe-cCCCCEEEeeCCCccccccccCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-DAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~-~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
.|.-++|+|.+++.++ ..+.++...+++.||+.|+.|.|+..+||+|+||+||.+ ..-|-|||.|||++....+ .
T Consensus 96 LELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P---G 172 (864)
T KOG4717|consen 96 LELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP---G 172 (864)
T ss_pred EEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCC---c
Confidence 9999999999999876 469999999999999999999999999999999999875 5678899999998764443 3
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 247 (269)
......+|+..|.|||++.+..+.-++.||||||+++|.+++|+.||...+..+-...|..-++..|..++.+.++||..
T Consensus 173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~s 252 (864)
T KOG4717|consen 173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQS 252 (864)
T ss_pred chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHHH
Confidence 44455678999999999999999989999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||..||.+|.|. .++.-+.|
T Consensus 253 MLvRdPkkRAsl--EeI~s~~W 272 (864)
T KOG4717|consen 253 MLVRDPKKRASL--EEIVSTSW 272 (864)
T ss_pred HHhcCchhhccH--HHHhcccc
Confidence 999999999998 45555544
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=299.75 Aligned_cols=248 Identities=27% Similarity=0.406 Sum_probs=220.6
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEec
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
|+-+..||.|+||-||.+++..+.+.||+|.+........+-.+++..|++.|+++.|||++..-|++-.....++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55667899999999999999999999999999877777777789999999999999999999999999999999999999
Q ss_pred cCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 93 ~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
|-| |..+++.-+ +++-+.+++.|+.+.+.||+|||+.+.+|+|||..||++++.|.|||+|||.+....+ ..
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------An 180 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------AN 180 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------hh
Confidence 965 777777654 5899999999999999999999999999999999999999999999999998875443 23
Q ss_pred ccccCccccCccccc--CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC--CCCCHHHHHHHHH
Q 024347 172 TTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--PWLSFTARKLIAR 247 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~ 247 (269)
...|+|+|||||++. +...+.-++||||||++..++...++|+-+.+.+....-|...+.|.. +.++..+++|+..
T Consensus 181 sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~ 260 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS 260 (948)
T ss_pred cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence 456899999999985 334456899999999999999999999999999999999887776554 4589999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||++-|++|||. ++.|.|+|
T Consensus 261 CLqKipqeRpts--e~ll~H~f 280 (948)
T KOG0577|consen 261 CLQKIPQERPTS--EELLKHRF 280 (948)
T ss_pred HHhhCcccCCcH--HHHhhcch
Confidence 999999999999 77888876
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=286.24 Aligned_cols=256 Identities=22% Similarity=0.396 Sum_probs=210.2
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCC-------CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCce
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVV 74 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~ 74 (269)
.+++...-.+|++.+.||+|+||.||.+.+... +..+++|.+.... .....+.+.+|+.+++++ +|+||+
T Consensus 4 ~~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv 81 (334)
T cd05100 4 DPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNII 81 (334)
T ss_pred CcccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 466677777999999999999999999986432 2368999876432 233467888999999999 799999
Q ss_pred eeeEEEeeCCeEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 024347 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138 (269)
Q Consensus 75 ~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~ 138 (269)
++++.+......++++||+++++|.+++.... .++..++..++.|++.||.|||++|++|+||+
T Consensus 82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk 161 (334)
T cd05100 82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161 (334)
T ss_pred eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 99999999999999999999999999886532 36778889999999999999999999999999
Q ss_pred CCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCC
Q 024347 139 PENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDS 217 (269)
Q Consensus 139 ~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~ 217 (269)
|+||+++.++.++|+|||.++...............++..|+|||++.+..+. .++|+||||+++|+|++ |..||...
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999988654332211112222234579999999877664 88999999999999998 89999988
Q ss_pred CHHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 218 NLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 218 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
+..+....+.... ...+..++..+.+++..||+.+|++||++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 285 (334)
T cd05100 241 PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQ 285 (334)
T ss_pred CHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 8888877776543 3455668899999999999999999999844
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=283.29 Aligned_cols=251 Identities=19% Similarity=0.273 Sum_probs=200.6
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCC--------------CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCcee
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSET--------------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~--------------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 75 (269)
.++|++.+.||+|++|.||++.+... ...+++|.+.... .....+.+.+|++++++++|+|+++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 45899999999999999999987542 2358999986542 2334567899999999999999999
Q ss_pred eeEEEeeCCeEEEEEeccCCCchhHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceE
Q 024347 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (269)
Q Consensus 76 ~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl 143 (269)
+++++......+++|||+.+++|.+++.... .++...+..++.+++.||+|||+.|++|+||+|+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999988885431 3678889999999999999999999999999999999
Q ss_pred ecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 024347 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNLMN 221 (269)
Q Consensus 144 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~ 221 (269)
++.++.++|+|||++................++..|+|||.+.+... +.++|+||||+++++|++ +..||......+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999998865432211111122233568999999887665 589999999999999987 678888766655
Q ss_pred HHHHHhc--------CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 222 LYKKISA--------AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 222 ~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
....... .....++..++.+.+|++.||+.||++|||++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~ 290 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH 290 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 5444321 11233455789999999999999999999985543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=280.23 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=208.3
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEee-
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS- 82 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~- 82 (269)
......+.|++.+.||.|++|.||+|.+..+++.+++|.+.... .....+..|+.+++.+ +|+|++++++.+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44567789999999999999999999999999999999986532 2245678899999888 69999999999843
Q ss_pred -----CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeC
Q 024347 83 -----KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 83 -----~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
....+++|||+.+++|.+++... ..+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~df 165 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeC
Confidence 45789999999999998888653 35888889999999999999999999999999999999999999999999
Q ss_pred CCccccccccCCCcccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 231 (269)
|.+...... ........+++.|+|||.+... ...+.++|+||||+++|+|++|..||...........+.....
T Consensus 166 g~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 243 (282)
T cd06636 166 GVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP 243 (282)
T ss_pred cchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC
Confidence 987643321 1122334578889999997531 2235789999999999999999999977655444443333222
Q ss_pred c--CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 T--CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ....++..+.+||+.||+.||.+||++ .+++.|+|
T Consensus 244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~--~ell~~~~ 281 (282)
T cd06636 244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPST--EQLLKHPF 281 (282)
T ss_pred CCCcccccCHHHHHHHHHHhCCChhhCcCH--HHHhcCCC
Confidence 1 123478999999999999999999999 88899987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=274.33 Aligned_cols=255 Identities=27% Similarity=0.491 Sum_probs=212.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhh--hhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--CeE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK--VLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKI 86 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~ 86 (269)
.+|++.+.||+|++|.||++.+..+++.+++|.+.... .........+.+|+.++++++|+|++++++.+.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875321 12334467889999999999999999999998653 468
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++++||+++++|.+.+...+.++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 89999999999999888777889999999999999999999999999999999999999999999999998875432211
Q ss_pred C-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cccCCCCCCHHHHH
Q 024347 167 D-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPWLSFTARK 243 (269)
Q Consensus 167 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 243 (269)
. .......++..|+|||.+.+... +.++|+||||++++++++|+.||..........++... ....+..+++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1 11122346788999999987665 48999999999999999999999877666555555433 23456778999999
Q ss_pred HHHHhcCCCCCCcCCCCccccccccC
Q 024347 244 LIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++.+||+ +|.+||+. .+.+.|+|
T Consensus 241 ~i~~~l~-~~~~r~~~--~~~~~~~~ 263 (264)
T cd06653 241 FLKQIFV-EEKRRPTA--EFLLRHPF 263 (264)
T ss_pred HHHHHhc-CcccCccH--HHHhcCCC
Confidence 9999999 57999999 67888876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=273.76 Aligned_cols=252 Identities=35% Similarity=0.612 Sum_probs=217.4
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|++.++.++|+|++++.+.+......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999988999999998764432 3446778899999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 92 FVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 92 ~~~~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
|+++++|...+... ..++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 99999999888763 679999999999999999999999999999999999999999999999999876543322
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIA 246 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~ 246 (269)
.......+++.|+|||...+... +.++|+||+|++++++++|..||................. +.+..++..+.++++
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 12223456788999999877665 4889999999999999999999988877777776655543 444568899999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||+.+|++||++ .+.+.|+|
T Consensus 237 ~~l~~~p~~Rp~~--~~ll~~~~ 257 (258)
T cd08215 237 SLLQKDPEERPSI--AQILQSPF 257 (258)
T ss_pred HHcCCChhhCcCH--HHHhcCCC
Confidence 9999999999999 88888887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=278.54 Aligned_cols=249 Identities=30% Similarity=0.501 Sum_probs=210.7
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
.|...+.||.|++|.||++.+..+++.+++|.+.... ....+.+.+|+.+++.++|+|++++++.+...+..+++++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 5666789999999999999998899999999885432 2234668899999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
|+.+++|.+.+.. +.++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~ 173 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRK 173 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccc
Confidence 9999999888776 578999999999999999999999999999999999999999999999999776433211 1122
Q ss_pred ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC---CCCCCHHHHHHHHHh
Q 024347 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC---PPWLSFTARKLIARI 248 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~ 248 (269)
...+++.|+|||.+.+... +.++|+||+|+++|++++|..||...+.......+.....+. +..++..+.+++++|
T Consensus 174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 252 (285)
T cd06648 174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM 252 (285)
T ss_pred cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence 3457889999999877665 489999999999999999999998887777777766554322 233788999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||++||++ .+++.|+|
T Consensus 253 l~~~p~~Rpt~--~~il~~~~ 271 (285)
T cd06648 253 LVRDPAQRATA--AELLNHPF 271 (285)
T ss_pred cccChhhCcCH--HHHccCcc
Confidence 99999999999 77777776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=278.98 Aligned_cols=255 Identities=18% Similarity=0.253 Sum_probs=208.6
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcC----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSE----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
.+..++|++.+.||+|++|.||+|.+.. .+..+++|.+... ......+.+.+|+.+++.++|+|++++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE 79 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 4567899999999999999999999875 2578899987532 234446778899999999999999999998755
Q ss_pred -CCeEEEEEeccCCCchhHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEe
Q 024347 83 -KTKIFIVLEFVTGGELFDKIVNH--------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (269)
Q Consensus 83 -~~~~~~v~~~~~~~~l~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~ 153 (269)
....+++++|+.+++|..++... ..++..++..++.+++.||.|||+.+++|+||+|+||+++.++.++++
T Consensus 80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~ 159 (280)
T cd05043 80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKIT 159 (280)
T ss_pred CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEEC
Confidence 56788999999999999888653 358899999999999999999999999999999999999999999999
Q ss_pred eCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-c
Q 024347 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-F 231 (269)
Q Consensus 154 df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~ 231 (269)
|||+++...............++..|+|||.+.+..+ +.++||||||+++|++++ |..||...+..+....+..+. .
T Consensus 160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 238 (280)
T cd05043 160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL 238 (280)
T ss_pred CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCC
Confidence 9999875432211111112234567999999977665 489999999999999998 999999888777776665543 3
Q ss_pred cCCCCCCHHHHHHHHHhcCCCCCCcCCCCcccc
Q 024347 232 TCPPWLSFTARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 232 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
..+..+++.+.+++.+||+.||++|||+.++..
T Consensus 239 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 445567899999999999999999999865543
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=286.00 Aligned_cols=246 Identities=25% Similarity=0.388 Sum_probs=188.1
Q ss_pred eeeeeccCCcEEEEEEEc--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--CCeEEEEEe
Q 024347 16 GRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLE 91 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~~ 91 (269)
...||+|+||.||+|.++ .+++.+++|.+..... ...+.+|+.+++.++||||+++++.+.. ....+++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999965 3678899999864322 2446789999999999999999998854 456899999
Q ss_pred ccCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----cCCCCEEEeeCCCc
Q 024347 92 FVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (269)
Q Consensus 92 ~~~~~~l~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~----~~~~~~~l~df~~~ 158 (269)
|+.+ ++...+... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ +..+.++|+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9854 777766432 248899999999999999999999999999999999999 45568999999998
Q ss_pred cccccccC-CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHhc
Q 024347 159 ALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------NLYKKISA 228 (269)
Q Consensus 159 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~~~~ 228 (269)
+....... ........+++.|+|||++.+...++.++|+||+|+++|+|++|..||...... .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 76443211 112223457889999999987665568999999999999999999999643211 11111100
Q ss_pred ----------------------------CcccC----------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 ----------------------------AEFTC----------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 ----------------------------~~~~~----------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..... ....+..+.+||+.||++||++|||+ .++|.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~--~e~l~hp~ 316 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS--EQAMQDPY 316 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCH--HHHhcCCC
Confidence 00000 01134568899999999999999999 88999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=276.64 Aligned_cols=250 Identities=23% Similarity=0.352 Sum_probs=206.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
.+.|++.+.||.|++|.||+|....+++ .+++|.+.... .......+..|+.+++.++|||++++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4579999999999999999999876654 59999976432 344467889999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++++||+++++|.+++... +.++..++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999998888653 568999999999999999999999999999999999999999999999999876543322
Q ss_pred CCCcccccc---cCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHH
Q 024347 166 DDGLLHTTC---GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (269)
Q Consensus 166 ~~~~~~~~~---~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (269)
......... .+..|+|||.+.+... +.++|+||||+++|++++ |..||......+....+... ..+.+..++..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111111 1347999999987666 489999999999999886 99999887777766666443 34555678999
Q ss_pred HHHHHHHhcCCCCCCcCCCCcc
Q 024347 241 ARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.+++..||+.+|.+||+++++
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i 261 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQI 261 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHH
Confidence 9999999999999999998544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=275.01 Aligned_cols=252 Identities=32% Similarity=0.568 Sum_probs=212.9
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||++.++.+|..+++|.+...... ....+.+.+|+.+++.++|+|++++++.+......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 589999999999999999999999999999998765432 2334677889999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC-EEEeeCCCccccccccCCC
Q 024347 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~-~~l~df~~~~~~~~~~~~~ 168 (269)
|+++++|.+++.... .+++..+..++.+++++|.+||+.+++|+||+|+||++++++. ++++|||.+...... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence 999999999886643 4789999999999999999999999999999999999998764 699999988654321 11
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIAR 247 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 247 (269)
......++..|+|||.+.+... +.++|+||||++++++++|..||................. +..+..+..+.+++++
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 1222346788999999877665 4899999999999999999999988777666666555443 3445678999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+.+|++|||+ .+++.|+|
T Consensus 237 ~l~~~p~~Rpt~--~~ll~~~~ 256 (257)
T cd08225 237 LFKVSPRDRPSI--TSILKRPF 256 (257)
T ss_pred HhccChhhCcCH--HHHhhCCC
Confidence 999999999999 88888887
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=277.34 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=207.7
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
.++|++.+.||+|++|.||+|.+..+|+ .+++|....... ......+.+|+..++.++|+|++++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4689999999999999999999876654 588888765432 3345778899999999999999999999877 78
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++++||+++++|.+.+... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.++.....
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 89999999999999988764 46899999999999999999999999999999999999999999999999988765432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 242 (269)
...........+..|+|||.+....+. .++|+||||+++|++++ |..||......+....+..+. .+.+...+..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 211111112234679999998766654 89999999999999998 999999888887777776554 455666889999
Q ss_pred HHHHHhcCCCCCCcCCCCcc
Q 024347 243 KLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~ 262 (269)
+++.+||..||.+||++.++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l 261 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKEL 261 (279)
T ss_pred HHHHHHcCCChhhCCCHHHH
Confidence 99999999999999998544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=280.37 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=204.5
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
.|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|++++++++|||++++++++.+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48899999999999999999998999999998865432 22233578889999999999999999999999999999999
Q ss_pred ccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 92 FVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|+. +++..++.. ...++...+..++.+++.||+|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~--~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc--cc
Confidence 996 578777755 3468999999999999999999999999999999999999999999999999876543221 11
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-c------------------
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-E------------------ 230 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~------------------ 230 (269)
.....++..|+|||.+.+....+.++|+||||+++|++++|..||..........++... .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 222335778999999876655468899999999999999999999776554333222110 0
Q ss_pred ----------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ----------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+.++++++++|.+||+.||.+||++ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--~~~l~~~~ 283 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISA--KAALAHPF 283 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCH--HHHhcCCC
Confidence 01122367889999999999999999999 88899988
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=278.79 Aligned_cols=254 Identities=27% Similarity=0.404 Sum_probs=200.5
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||.|++|.||.|.+..+++.+++|.+...... .....+.+|+.+++.++|+||+++++++......++
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence 457899999999999999999999989999999998654321 122356789999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
++||+. +++...+.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 81 VFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred EEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC-
Confidence 999996 566666654 34678888999999999999999999999999999999999999999999998865332211
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhc--C---------------
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISA--A--------------- 229 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~--~--------------- 229 (269)
......+++.|+|||.+.+....+.++|+||||+++|++++|..||...... +....... +
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 -TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred -CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1222345788999999876544458899999999999999999999764432 11111100 0
Q ss_pred ---c-c--cCC---------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ---E-F--TCP---------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ---~-~--~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. . ..+ ...+..+.+++++||+.||.+|||+ .+++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~--~~~l~h~~ 290 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA--QDALLHPY 290 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH--HHHhcCCC
Confidence 0 0 000 0135689999999999999999999 88889987
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=278.44 Aligned_cols=248 Identities=29% Similarity=0.480 Sum_probs=199.9
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeC--CeEEEE
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK--TKIFIV 89 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~~~~v 89 (269)
|++.+.||.|++|.||++.+..+++.+++|.+....... . .....+|+..++++. |+|++++++++.+. +..+++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 678999999999999999999999999999986533221 1 223456888888885 99999999999887 889999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
+||+++ ++.+.+... ..+++.++..++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+.......
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~--- 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP--- 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCC---
Confidence 999975 777777653 57899999999999999999999999999999999999999 999999999886543221
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------------c
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------E 230 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------~ 230 (269)
......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 1122346788999998765555568999999999999999999999877665544433210 0
Q ss_pred ccC-----------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 FTC-----------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ~~~-----------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
... .+.++..+.++|++||++||++||++ .+++.|+|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~--~~~l~~~~ 281 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA--KQALRHPY 281 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH--HHHhhCCC
Confidence 111 12467899999999999999999999 88899987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-42 Score=279.75 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=201.5
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|++|.||++.++.+++.|++|.+....... ....+.+|++++++++|+||+++++++.+....++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 578999999999999999999999889999999986543211 123456799999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
+||+.+ +|.+++... ..++...+..++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||+++.......
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-- 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-- 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence 999975 888877654 4689999999999999999999999999999999999999999999999998864332111
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcC------------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA------------------ 229 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~------------------ 229 (269)
......++..|+|||.+.+....+.++|+||+|+++|+|++|..||.... ..+....+...
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 11122356789999998765544689999999999999999999997654 22222111100
Q ss_pred ---cc---------cCCCCCC--HHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ---EF---------TCPPWLS--FTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ---~~---------~~~~~~~--~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ...+.++ ..+.+++..||++||++|||+ .+.+.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~--~e~l~~~~ 290 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA--AEAMKHPY 290 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH--HHHhcCCC
Confidence 00 0001233 788999999999999999999 78888887
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=278.64 Aligned_cols=246 Identities=29% Similarity=0.427 Sum_probs=199.9
Q ss_pred eeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHH---HHHhhhCCCCCceeeeEEEeeCCeEEEEEeccC
Q 024347 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE---VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e---~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
.||+|++|.||++.+..+++.|++|.+...............+| +..++...|++++.+++.+...+..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999998999999999875433322211222233 344555679999999999999999999999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccc
Q 024347 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (269)
Q Consensus 95 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 174 (269)
|++|..++...+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+...... ......
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcCcC
Confidence 9999988887788999999999999999999999999999999999999999999999999987643221 112335
Q ss_pred cCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCC
Q 024347 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (269)
Q Consensus 175 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (269)
++..|+|||.+.+....+.++|+||+|+++|+|++|..||... ................+..++..+.+++++||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 7889999999976543458899999999999999999999765 3344444444455666667899999999999999
Q ss_pred CCCCcC-----CCCccccccccC
Q 024347 252 NPMTVS-----IYPFADILYMRF 269 (269)
Q Consensus 252 dP~~Rp-----s~~~~~~l~~~~ 269 (269)
||.+|| ++ .+++.|+|
T Consensus 237 ~p~~R~~~~~~~~--~~ll~~~~ 257 (278)
T cd05606 237 DVNRRLGCLGRGA--QEVKEHPF 257 (278)
T ss_pred CHHhccCCCCCCH--HHHHhCcc
Confidence 999999 66 66677776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=276.20 Aligned_cols=250 Identities=23% Similarity=0.378 Sum_probs=206.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
..+|++.+.||.|++|.||+|.++.++. .+++|.+.... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999998764443 68999876433 233357889999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+++|||+++++|.+++... +.++..++..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999988764 468999999999999999999999999999999999999999999999999887544321
Q ss_pred CCCc-ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHH
Q 024347 166 DDGL-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (269)
Q Consensus 166 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 242 (269)
.... ......+..|+|||.+.+... +.++|+||||+++|++++ |..||......+....+..+ +.+.+..+++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 1111 111122457999999987665 489999999999999886 99999887777666666554 3445556889999
Q ss_pred HHHHHhcCCCCCCcCCCCcc
Q 024347 243 KLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~ 262 (269)
+++.+||+.+|++||+++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i 259 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQI 259 (267)
T ss_pred HHHHHHcccCchhCCCHHHH
Confidence 99999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=274.67 Aligned_cols=243 Identities=23% Similarity=0.430 Sum_probs=202.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEE-eeCCeE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM-GSKTKI 86 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~ 86 (269)
....+|++.+.||.|++|.||++... |..+++|.+.... ..+.+.+|+.++++++|+|++++++++ ...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999864 7789999875432 246788899999999999999999876 455678
Q ss_pred EEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
++++||+++++|.+++...+ .+++..+..++.+++.+|++||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999887643 4788999999999999999999999999999999999999999999999987643321
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 242 (269)
. .....+..|+|||++.+... +.++|+||||+++|+|++ |..||...........+..+. ...++.+++.+.
T Consensus 156 ~-----~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd05082 156 Q-----DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY 229 (256)
T ss_pred C-----CCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 1 12223567999999877665 489999999999999997 999998877777777665543 344566899999
Q ss_pred HHHHHhcCCCCCCcCCCCccc
Q 024347 243 KLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~ 263 (269)
+++.+||+.||++|||++++.
T Consensus 230 ~li~~~l~~~p~~Rpt~~~l~ 250 (256)
T cd05082 230 DVMKQCWHLDAATRPSFLQLR 250 (256)
T ss_pred HHHHHHhcCChhhCcCHHHHH
Confidence 999999999999999985553
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=281.08 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=207.1
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||+|++|+||++.+..+++.+++|.+.... .....+.+.+|+++++.++|+||+++++.+......+++
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 468999999999999999999999899999999876432 233457888999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
+||+++++|...+...+.++...+..++.+++.+|.|||+ .+++|+||+|+||+++.++.++|+|||++..... .
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----S 157 (284)
T ss_pred EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----h
Confidence 9999999999888877789999999999999999999997 5999999999999999999999999998754321 1
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHhcCc-ccCCC-
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-----------NLYKKISAAE-FTCPP- 235 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----------~~~~~~~~~~-~~~~~- 235 (269)
......++..|+|||++.+... +.++|+||||+++|++++|..||...... +....+.... ...+.
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence 1123457889999999877655 48999999999999999999999864431 2222332222 22222
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++.++.+|++.||+.||++||++ .+++.++|
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~--~e~~~~~~ 268 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTP--QQLCAMPP 268 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCH--HHHhcCcc
Confidence 278899999999999999999999 55555543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=273.64 Aligned_cols=250 Identities=28% Similarity=0.471 Sum_probs=215.8
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|+..++.++|+||+++.+.+.+....++++|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 589999999999999999999989999999998765433 2335677889999999999999999999999999999999
Q ss_pred ccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 92 FVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 92 ~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
|+++++|..++.. ...++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999888765 356899999999999999999999999999999999999999999999999988765442
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc-CCCCCCHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIA 246 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~ 246 (269)
......++..|+|||...+... +.++|+||||++++++++|+.||...+.......+.....+ .+..++.++.++++
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 2222346788999999977665 48999999999999999999999988887777776665543 44568899999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||+.+|++||++ .+.++|++
T Consensus 235 ~~l~~~p~~Rp~~--~~~l~~p~ 255 (256)
T cd08530 235 SMLQVKPKLRPNC--DKILASPA 255 (256)
T ss_pred HHcCCCcccCCCH--HHHhcCCC
Confidence 9999999999999 88888875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=292.46 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=216.5
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCC---e-EEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEE
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGE---P-VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~-~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 80 (269)
.+.-.-++-.+.+.||+|+||.||+|..+..+. . ||+|....+.......+..+.+|++++++++||||++++|+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 334444555667999999999999998775422 3 899998765555667789999999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 81 GSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 81 ~~~~~~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
.....+++|||+|+||+|.+++...+ .++..+...++.+.+.||+|||+.+++||||-..|+|++.++.+|++|||+++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999999999876 59999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC--cccCCCC
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA--EFTCPPW 236 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~--~~~~~~~ 236 (269)
......... ....-+..|+|||.+....+ +.++||||+|+++||+++ |..||.+....+....+... +.+.+..
T Consensus 311 ~~~~~~~~~--~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~ 387 (474)
T KOG0194|consen 311 AGSQYVMKK--FLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSK 387 (474)
T ss_pred CCcceeecc--ccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCC
Confidence 543211111 11123578999999998855 599999999999999998 88899999999999999443 3455667
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.|.++..++.+||..||+.||++..+
T Consensus 388 ~p~~~~~~~~~c~~~~p~~R~tm~~i 413 (474)
T KOG0194|consen 388 TPKELAKVMKQCWKKDPEDRPTMSTI 413 (474)
T ss_pred CHHHHHHHHHHhccCChhhccCHHHH
Confidence 88899999999999999999998554
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=280.67 Aligned_cols=249 Identities=19% Similarity=0.292 Sum_probs=199.7
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcC----------------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCce
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSE----------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~----------------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 74 (269)
++|++.+.||.|++|.||++.+.. ++..+++|.+.... .....+.+.+|+.+++.++|+||+
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence 579999999999999999986432 34468999886442 233457888999999999999999
Q ss_pred eeeEEEeeCCeEEEEEeccCCCchhHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceE
Q 024347 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-----------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (269)
Q Consensus 75 ~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl 143 (269)
++++++...+..+++|||+++++|..++.... .++..++..++.|++.||++||+.|++|+||+|+||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 99999999999999999999999998886532 3667789999999999999999999999999999999
Q ss_pred ecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 024347 144 LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNLMN 221 (269)
Q Consensus 144 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~ 221 (269)
++.++.++|+|||.+.................+..|+|||...+..+ +.++|+||||+++|+|++ |..||......+
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 99999999999998865432211111112223567999998877665 489999999999999998 789997766555
Q ss_pred HHHHHh--------cCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 222 LYKKIS--------AAEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 222 ~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
...... ....+.+..+++.+.+|+.+||+.||.+||+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i 290 (296)
T cd05095 242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290 (296)
T ss_pred HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 443321 12234456688999999999999999999998655
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=276.82 Aligned_cols=251 Identities=28% Similarity=0.478 Sum_probs=211.0
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+-|++.+.||.|++|.||++.+..+++.+++|.+..... ......+.+|+..++.++|+|++++++.+......++|+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence 357888999999999999999988899999998754332 233567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++++++..++.. ..++...+..++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 82 e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06641 82 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhh
Confidence 99999999887764 468999999999999999999999999999999999999999999999999876443211 111
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHHHhc
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARIL 249 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l 249 (269)
....++..|+|||.+.+.... .++|+||||+++|++++|..||...........+..... ..+..++.++.+++..||
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 237 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL 237 (277)
T ss_pred ccccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHc
Confidence 223467789999998776654 889999999999999999999988777666666544433 344568899999999999
Q ss_pred CCCCCCcCCCCccccccccC
Q 024347 250 DPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 250 ~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+|++||++ .+++.|+|
T Consensus 238 ~~~p~~Rp~~--~~~l~~~~ 255 (277)
T cd06641 238 NKEPSFRPTA--KELLKHKF 255 (277)
T ss_pred cCChhhCcCH--HHHHhCHH
Confidence 9999999998 77777765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=292.16 Aligned_cols=257 Identities=44% Similarity=0.800 Sum_probs=235.6
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
...++.|.+.+.||.|.|+.|.++.+.-++..||+|.++....+... .+.+.+|+++++.+.||||++++.+...+..+
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeeccee
Confidence 45678899999999999999999999999999999999876655444 45589999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||..+|.+.+++.+++...+......+.|+.+|++|+|+.+|||+||+.+||+++.+-+++|+|||++.... .
T Consensus 131 ylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---~ 207 (596)
T KOG0586|consen 131 YLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---Y 207 (596)
T ss_pred EEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999876544 4
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
.......+|++.|.|||++.+..+.++++|+||+|+++|.++.|..||++....++-.....+++..+...+-+..++|+
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLr 287 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLR 287 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHHH
Confidence 55666778999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+|-.+|.+|++.+ ++-.++|
T Consensus 288 k~lvl~Pskr~~~d--qim~~~W 308 (596)
T KOG0586|consen 288 KFLVLNPSKRGPCD--QIMKDRW 308 (596)
T ss_pred HhhccCccccCCHH--Hhhhhcc
Confidence 99999999999984 4445555
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=282.65 Aligned_cols=251 Identities=28% Similarity=0.465 Sum_probs=209.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+.|+..+.||.|++|.||+|.+..+++.+++|.+..... ....+.+.+|+.+++.++|+|++++++.+......++|+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence 457788999999999999999988899999999864432 234578899999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||+++++|.+.+.. +.+++..+..++.+++.++.+||+.|++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06642 82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hhh
Confidence 99999999887754 568999999999999999999999999999999999999999999999999876543211 111
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHHHhc
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIARIL 249 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l 249 (269)
....++..|+|||.+.+... +.++|+||||+++|++++|..||...........+..... ..+..++..+.++|..||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 22346778999999987765 4899999999999999999999987665555554443332 233457889999999999
Q ss_pred CCCCCCcCCCCccccccccC
Q 024347 250 DPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 250 ~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+|++||++ .+.+.|+|
T Consensus 238 ~~~p~~Rp~~--~~il~~~~ 255 (277)
T cd06642 238 NKDPRFRPTA--KELLKHKF 255 (277)
T ss_pred cCCcccCcCH--HHHHHhHH
Confidence 9999999999 77777765
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=279.65 Aligned_cols=251 Identities=31% Similarity=0.443 Sum_probs=204.7
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEec
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
|++.+.||.|++|.||+|.++.+|+.+++|.+...... ......+.+|++.++.++|+|++++++++.+.+..++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67889999999999999999989999999998754322 22235677899999999999999999999999999999999
Q ss_pred cCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 93 VTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 93 ~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
++ +++..++.... .+++..+..++.|++.+|++||+.+++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV--RTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc--ccc
Confidence 95 58888887655 68999999999999999999999999999999999999999999999999886443221 111
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------------
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------- 229 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------------- 229 (269)
....++..|+|||++.+....+.++|+||||+++|++++|..||...+......++...
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 22345778999998876544458899999999999999999999876554333222110
Q ss_pred ----c----ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ----E----FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ----~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ....+.++..+.++|.+||+.||.+||++ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--~~il~~~~ 282 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISA--KAALQHPY 282 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCH--HHHhcCCC
Confidence 0 01123467899999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=279.19 Aligned_cols=253 Identities=29% Similarity=0.404 Sum_probs=202.6
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCe----
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK---- 85 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~---- 85 (269)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.+. |+|++++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999765432 2223456788999999995 6999999999877655
Q ss_pred -EEEEEeccCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-CCCEEEeeCCCc
Q 024347 86 -IFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLS 158 (269)
Q Consensus 86 -~~~v~~~~~~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-~~~~~l~df~~~ 158 (269)
.+++|||+++ ++.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||.+
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 787777542 35799999999999999999999999999999999999998 889999999988
Q ss_pred cccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--------
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------- 230 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------- 230 (269)
....... .......+++.|+|||++.+....+.++|+||||+++|+|++|..||...........+....
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 6443211 111223457789999998765544689999999999999999999998765554433321100
Q ss_pred -----------c---------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 -----------F---------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 -----------~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ...+.++..+.+||..||+.||.+||++ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~--~eil~~~~ 293 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA--KAALTHPY 293 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH--HHHhcCCC
Confidence 0 0013478889999999999999999999 89999988
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=279.07 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=203.4
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
+++|++.+.||.|++|.||+|.++.+++.+++|.+..... .....+.+.+|++++++++|+|++++++++.+....++|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3689999999999999999999998999999999855432 222345678899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-CCCEEEeeCCCccccccccC
Q 024347 90 LEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-~~~~~l~df~~~~~~~~~~~ 166 (269)
+||+++ ++...+.... .+++..+..++.|++.||.+||++|++|+||+|+||+++. ++.++++|||.+.......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~- 157 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV- 157 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-
Confidence 999964 7777775543 3578888899999999999999999999999999999985 4569999999886543221
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-----------------
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----------------- 229 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 229 (269)
.......+++.|+|||.+.+....+.++|+||||+++|++++|..||......+...++...
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 11122345778999999876554468999999999999999999999876665444432110
Q ss_pred ------cc------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ------EF------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ------~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ...+..++++.+++.+||+.||++||++ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~--~~~l~~~~ 286 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITA--RAALEHEY 286 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCH--HHHhcCch
Confidence 00 0123468889999999999999999998 77777776
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=277.98 Aligned_cols=252 Identities=31% Similarity=0.475 Sum_probs=206.5
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--CeEEEEE
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIFIVL 90 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~~v~ 90 (269)
|++.+.||.|++|.||+|.+..+++.+++|.+.... ........+.+|+.+++.++|+|++++++++... +..++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 688999999999999999999889999999997653 2333456788899999999999999999999887 8899999
Q ss_pred eccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
+|+++ ++...+... ..+++..+..++.+++.||++||+.|++|+||+|+||+++.++.++++|||.+........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 887777654 5789999999999999999999999999999999999999999999999998875544321 11
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-------cc----------
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------FT---------- 232 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~---------- 232 (269)
.....++..|+|||.+.+....+.++|+||||++++++++|..||...+.......+...- .+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 2223456789999988765545689999999999999999999998777655444432210 00
Q ss_pred --------------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 --------------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 --------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+++.+.+++++||+.||++||++ .+++.++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~--~~~l~~~~ 286 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA--DQALQHEY 286 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCH--HHHhhCcC
Confidence 001138889999999999999999999 78888887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=277.62 Aligned_cols=254 Identities=29% Similarity=0.480 Sum_probs=215.1
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
....+.|++.+.||.|++|.||.+.+..+++.+++|.+..... ....+.+|++.++.++|+|++++++.+......
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 4567789999999999999999999998899999999865432 356788899999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++++||+++++|.+++.... .++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 99999999999999998876 89999999999999999999999999999999999999999999999999875433221
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-c--CCCCCCHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-T--CPPWLSFTAR 242 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~ 242 (269)
. ......++..|+|||.+.+... +.++|+||||+++|++++|..||...........+..... . .+..++..+.
T Consensus 171 ~--~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 171 S--KRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred h--hhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 1 1122346778999999887665 4899999999999999999999988777665555544332 2 2233789999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++|+.||+.+|.+||++ .+++.|+|
T Consensus 248 ~li~~~l~~~p~~Rpt~--~~il~~~~ 272 (286)
T cd06614 248 DFLNKCLVKDPEKRPSA--EELLQHPF 272 (286)
T ss_pred HHHHHHhccChhhCcCH--HHHhhChH
Confidence 99999999999999999 77777765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=271.94 Aligned_cols=242 Identities=24% Similarity=0.358 Sum_probs=201.8
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 96 (269)
+.||.|++|.||++.+.. ++.+++|.+...... .....+.+|+++++++.|+||+++++++.+....++++||++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 468999999999999877 899999998654432 34567889999999999999999999999999999999999999
Q ss_pred chhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 97 ELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 97 ~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
+|.+++.. ...++...+..++.+++.+|.+||+++++|+||+|+||+++.++.++|+|||.+.................
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99988865 34688999999999999999999999999999999999999999999999998865432111111111223
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHHHHHHhcCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNP 253 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP 253 (269)
+..|+|||.+.+..+ +.++|+||||+++|++++ |..||...........+... ..+.+...+..+.+++.+||+.+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 457999999877665 489999999999999998 89999888777777666554 344556789999999999999999
Q ss_pred CCcCCCCcc
Q 024347 254 MTVSIYPFA 262 (269)
Q Consensus 254 ~~Rps~~~~ 262 (269)
++||+++++
T Consensus 237 ~~Rp~~~el 245 (251)
T cd05041 237 ENRPSFSEI 245 (251)
T ss_pred hhCcCHHHH
Confidence 999998544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=279.57 Aligned_cols=256 Identities=28% Similarity=0.479 Sum_probs=211.5
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.++...++|.+.+.||.|++|.||++.+..+++.+++|.+.... ....+.+.+|+.+++.++|||++++++.+....
T Consensus 13 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~ 89 (293)
T cd06647 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGD 89 (293)
T ss_pred eccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCC
Confidence 34667789999999999999999999998889999999985432 222467788999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..++|+||+++++|.+++.+. .++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 999999999999998887653 5788999999999999999999999999999999999999999999999987644322
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-c--ccCCCCCCHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-E--FTCPPWLSFTA 241 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~--~~~~~~~~~~l 241 (269)
. .......+++.|+|||.+..... +.++|+||||+++|++++|..||...........+... . ...+..++..+
T Consensus 169 ~--~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (293)
T cd06647 169 Q--SKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 245 (293)
T ss_pred c--cccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHH
Confidence 1 12222346778999999877665 48999999999999999999999876554433333222 1 12233467889
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++|++||+.+|++||++ .+++.|+|
T Consensus 246 ~~li~~~l~~~p~~Rp~~--~~il~h~~ 271 (293)
T cd06647 246 RDFLNRCLEMDVEKRGSA--KELLQHPF 271 (293)
T ss_pred HHHHHHHccCChhhCcCH--HHHhcCHH
Confidence 999999999999999998 78888876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=272.66 Aligned_cols=245 Identities=25% Similarity=0.389 Sum_probs=206.8
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCC----CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
+++.+.||.|++|.||++.+...+ ..+++|.+..... ....+.+.+|++.++.++|+|++++++.+.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467899999999999999998766 8999999865432 2245788899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 89 VLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~--l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+|+|+++++|.+.+..... +++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999998876544 89999999999999999999999999999999999999999999999999875543311
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKL 244 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 244 (269)
.... ...+++.|+|||.+.+... +.++|+||||++++++++ |..||...+.....+.+..... ..+...+..+.++
T Consensus 159 ~~~~-~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKKK-GGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred cccc-cCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 1111 1225678999999866555 589999999999999998 8999988887777777765543 4455689999999
Q ss_pred HHHhcCCCCCCcCCCCc
Q 024347 245 IARILDPNPMTVSIYPF 261 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~ 261 (269)
+.+||+.||++|||+++
T Consensus 237 i~~~l~~~p~~Rpt~~~ 253 (258)
T smart00219 237 MLQCWAEDPEDRPTFSE 253 (258)
T ss_pred HHHHCcCChhhCcCHHH
Confidence 99999999999999844
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=284.51 Aligned_cols=254 Identities=27% Similarity=0.444 Sum_probs=200.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----C
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 84 (269)
.++|++.+.||.|++|.||+|.+..+|+.|++|.+.... .......+.+|+.+++.++|+|++++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 368999999999999999999999999999999985322 223456678899999999999999999887543 3
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..+++++|+.+ ++.+.+. .+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~-~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 57999999965 7766654 457899999999999999999999999999999999999999999999999988654332
Q ss_pred cC-CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh---------------c
Q 024347 165 RD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS---------------A 228 (269)
Q Consensus 165 ~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---------------~ 228 (269)
.. ........++..|+|||.+.+....+.++|+||+|+++|+|++|+.||...+.......+. .
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 21 1122234568889999987665444689999999999999999999997654432221110 0
Q ss_pred ---------Cc--c-----cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 ---------AE--F-----TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 ---------~~--~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. . ...+..+.++.+++++||+.||++||++ .+++.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~--~e~l~hp~ 294 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITV--EEALAHPY 294 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCH--HHHhcCcc
Confidence 00 0 0113467889999999999999999999 78888876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=282.55 Aligned_cols=255 Identities=27% Similarity=0.389 Sum_probs=200.9
Q ss_pred CeEEeeeeeccCCcEEEEEEEcC--CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--CeEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TKIF 87 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~~~ 87 (269)
+|++.+.||+|++|.||+|.+.. +++.+|+|.+...........+.+.+|+.+++.++|||++++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 68999999999999999999988 8999999998764322233346678899999999999999999999887 7899
Q ss_pred EEEeccCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC----CCCEEEeeCCCc
Q 024347 88 IVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA----YGNLKVSDFGLS 158 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~----~~~~~l~df~~~ 158 (269)
+|+||+++ ++.+.+... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++. ++.++|+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 666655432 26889999999999999999999999999999999999998 889999999988
Q ss_pred cccccccC-CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHH--
Q 024347 159 ALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---------LYKKI-- 226 (269)
Q Consensus 159 ~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~-- 226 (269)
........ ........++..|+|||++.+....+.++|+||||+++++|++|+.||....... ....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 75433222 1112223457789999998765544589999999999999999999997543321 00000
Q ss_pred ------------------------hcCcccCC-----------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 227 ------------------------SAAEFTCP-----------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 227 ------------------------~~~~~~~~-----------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.......+ ...+..+.+++.+||++||++|||+ .+++.|+|
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~--~eil~~~~ 315 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITA--EEALEHPY 315 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCH--HHHhcCCC
Confidence 00000111 1456789999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=275.06 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=203.7
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--CCeEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKIFI 88 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~ 88 (269)
++|...+.||.|++|.||++.+..+++.+++|.+..... ......+.+|++++++++|+||+++++++.. ....++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999998999999999865432 2345778899999999999999999998855 346899
Q ss_pred EEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 89 VLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
+|||+++++|.+++.. ...++...+..++.+++.+|.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999877643 345889999999999999999999999999999999999999999999999987643321
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCcccC-C----
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-----NLMNLYKKISAAEFTC-P---- 234 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~~~~~~~~~~~~~~~~-~---- 234 (269)
. .....++..|+|||.+.+..++ .++|+||||+++|+|++|..||... ...+....+.....+. +
T Consensus 159 ~----~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 159 L----AGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred c----cccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 1 1123457789999998877664 8999999999999999999999765 2234444433322111 1
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 --PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 --~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+++.+.+|+.+||+.||.+|||+ .+++.|+|
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~--~eil~~~~ 268 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTP--WDMLEHPW 268 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCH--HHHHhCcc
Confidence 1246789999999999999999999 78888877
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=286.70 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=205.4
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee----CCeE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTKI 86 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 86 (269)
++|++.+.||.|++|.||++.++.+|+.|++|.+..... .......+.+|+.+++.++|+||+++++++.. ....
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999865332 22345677889999999999999999988753 3568
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++++||+. ++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 58888887777899999999999999999999999999999999999999999999999998865433221
Q ss_pred C--CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----------------
Q 024347 167 D--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------------- 228 (269)
Q Consensus 167 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------- 228 (269)
. .......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...+.......+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1 1112335678899999987654456899999999999999999999976554322211100
Q ss_pred ----------CcccC-----CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 ----------AEFTC-----PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 ----------~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+. .+..+.++.++|++||+.||++||++ .+++.|+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--~~~l~~~~ 296 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV--EQALQHPF 296 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH--HHHHhChh
Confidence 00011 13368899999999999999999999 78888887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=272.84 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=206.6
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
..++|+..+.||.|++|.||+|....+++ .+++|.+.... .....+.+.+|+.+++.++|+|++++.+++.+.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 34588999999999999999999876554 68999875432 22335678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++|||+++++|..++... +.++..++..++.+++.||++||+.|++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999998888654 57899999999999999999999999999999999999999999999999988654332
Q ss_pred cCCCcc-cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHH
Q 024347 165 RDDGLL-HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (269)
Q Consensus 165 ~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 241 (269)
...... .....+..|+|||.+..... +.++|+||||+++|++++ |..||...........+... ..+.+..++..+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 239 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV 239 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence 211111 11112457999999877665 489999999999999997 99999887777777776554 334455688999
Q ss_pred HHHHHHhcCCCCCCcCCCCcc
Q 024347 242 RKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+++.+||+.||++||+++++
T Consensus 240 ~~li~~c~~~~p~~Rp~~~~i 260 (268)
T cd05063 240 YQLMLQCWQQDRARRPRFVDI 260 (268)
T ss_pred HHHHHHHcCCCcccCcCHHHH
Confidence 999999999999999998544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=272.05 Aligned_cols=241 Identities=22% Similarity=0.342 Sum_probs=197.5
Q ss_pred eeeccCCcEEEEEEEc--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 18 TIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 18 ~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
.||.|++|.||+|.+. ..+..+++|.+.... .....+.+.+|+.++++++|+||+++++++. ....+++|||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999765 335568999886542 2344577899999999999999999999875 4568999999999
Q ss_pred CchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc-cccc
Q 024347 96 GELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL-LHTT 173 (269)
Q Consensus 96 ~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~ 173 (269)
++|.+++.. ...+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........... ....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999988865 45789999999999999999999999999999999999999999999999998864432211111 1111
Q ss_pred ccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCC
Q 024347 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDP 251 (269)
Q Consensus 174 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~ 251 (269)
.++..|+|||.+..... +.++|+||||+++|++++ |..||...........+..+. ...++.+++++.+++..||+.
T Consensus 159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 23467999999877665 489999999999999996 999999888777777766543 556677899999999999999
Q ss_pred CCCCcCCCCcc
Q 024347 252 NPMTVSIYPFA 262 (269)
Q Consensus 252 dP~~Rps~~~~ 262 (269)
||++||+++++
T Consensus 238 ~~~~Rp~~~~i 248 (257)
T cd05115 238 KWEDRPNFAKV 248 (257)
T ss_pred ChhhCcCHHHH
Confidence 99999998554
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=276.49 Aligned_cols=251 Identities=31% Similarity=0.474 Sum_probs=204.8
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|++.+.||.|++|.||+|.+..+|+.+++|.+...... .....+.+|+.++++++|+|++++++.+.+.+..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999998654321 223566789999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 92 FVTGGELFDKIVNH---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 92 ~~~~~~l~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|+++ ++.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--N 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc--c
Confidence 9975 787777653 358999999999999999999999999999999999999999999999999886433211 1
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------------- 229 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------------- 229 (269)
......++..|+|||.+.+....+.++|+||||+++|++++|..||...+..+....+...
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1122345778999999876555568999999999999999999999876655444432210
Q ss_pred -cc---------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 -EF---------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 -~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ...+.+++.+.+++..||+.||.+||++ .+++.|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~--~~~l~~~~ 283 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISA--HDALQHPW 283 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCH--HHHhcCCC
Confidence 00 0112357889999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=285.47 Aligned_cols=254 Identities=29% Similarity=0.425 Sum_probs=204.7
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----C
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 84 (269)
.++|++.+.||.|++|.||.+.+..+++.|++|.+..... .......+.+|+.+++.++|+||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 3589999999999999999999999999999999865322 222345677899999999999999999987544 3
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..++++||+. ++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 4799999995 588888887788999999999999999999999999999999999999999999999999988754332
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc----------------
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---------------- 228 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---------------- 228 (269)
. .......++..|+|||.+.+....+.++|+||||+++|++++|..||.+.+.......+..
T Consensus 162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd07858 162 G--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE 239 (337)
T ss_pred c--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence 1 1122234677899999987644356899999999999999999999976554332221110
Q ss_pred -----------C-c---ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 -----------A-E---FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 -----------~-~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. . ....+.+++++.++|++||+.||++|||+ .+++.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~--~ell~h~~ 293 (337)
T cd07858 240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV--EEALAHPY 293 (337)
T ss_pred hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH--HHHHcCcc
Confidence 0 0 01123578899999999999999999998 88888887
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=269.98 Aligned_cols=241 Identities=24% Similarity=0.412 Sum_probs=199.0
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 96 (269)
+.||+|++|.||++... +++.+++|.+.... .......+.+|+++++.++|||++++++++...+..+++|||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 46899999999999864 68889999976543 2333457889999999999999999999999999999999999999
Q ss_pred chhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 97 ELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 97 ~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
+|.+++... ..++..++..++.+++.+|.++|+.|++|+||+|+||+++.++.++|+|||.+......... .......
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCC
Confidence 999888653 46789999999999999999999999999999999999999999999999987643221111 1111223
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNP 253 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP 253 (269)
+..|+|||++.+... +.++|+||||+++|++++ |..||...........+..+. ...+..++..+.+++.+||+.+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 567999999977665 489999999999999998 999998877776666665543 34456689999999999999999
Q ss_pred CCcCCCCcc
Q 024347 254 MTVSIYPFA 262 (269)
Q Consensus 254 ~~Rps~~~~ 262 (269)
++||+++++
T Consensus 236 ~~Rp~~~~l 244 (250)
T cd05085 236 ENRPKFSEL 244 (250)
T ss_pred ccCCCHHHH
Confidence 999998543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=287.13 Aligned_cols=244 Identities=27% Similarity=0.403 Sum_probs=193.1
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
..+|++.+.||.|++|.||+|.+..+++.+|+|..... ....|+.++++++|+||+++++++......+++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 34799999999999999999999999999999985322 224588999999999999999999999999999
Q ss_pred EeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
++++.+ ++..++.. ...++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+..... ..
T Consensus 136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 999964 77777754 45789999999999999999999999999999999999999999999999998864222 11
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCHH----------HHHHHHhcC-----ccc
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLM----------NLYKKISAA-----EFT 232 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~----------~~~~~~~~~-----~~~ 232 (269)
......++..|+|||++.+..+ +.++|+||||+++|+|+++..| |...... .+...+... .++
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 1223457889999999988776 4899999999999999985444 3321110 111111100 000
Q ss_pred ---------------------C-------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 ---------------------C-------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 ---------------------~-------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ...++..+.+||++||+.||.+|||+ .++|.|+|
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta--~e~l~hp~ 353 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSA--EEILNYPM 353 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCH--HHHhcCch
Confidence 0 01246677889999999999999999 88999988
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=272.19 Aligned_cols=242 Identities=26% Similarity=0.435 Sum_probs=200.7
Q ss_pred eeeeccCCcEEEEEEEcC-CCC--eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEecc
Q 024347 17 RTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFV 93 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~-~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 93 (269)
+.||+|++|.||+|.+.. .++ .+++|.+...... ...+.+.+|+..+++++|+|++++++.+.. ...++++||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999998765 333 6899998765543 556889999999999999999999999988 8899999999
Q ss_pred CCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC-cc
Q 024347 94 TGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LL 170 (269)
Q Consensus 94 ~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~-~~ 170 (269)
++++|.+.+.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 9999999887654 68899999999999999999999999999999999999999999999999887654322111 11
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc--CcccCCCCCCHHHHHHHHH
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA--AEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~ 247 (269)
....++..|+|||.+.+... +.++|+||||+++++|++ |..||......+....+.. .....+...+..+.+++..
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 12345678999999877665 488999999999999998 9999987777776666553 2234445678999999999
Q ss_pred hcCCCCCCcCCCCcc
Q 024347 248 ILDPNPMTVSIYPFA 262 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~ 262 (269)
||+.+|++||+++++
T Consensus 237 ~l~~~p~~Rps~~~~ 251 (257)
T cd05040 237 CWAHNPADRPTFAAL 251 (257)
T ss_pred HCCCCcccCCCHHHH
Confidence 999999999998443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=284.78 Aligned_cols=251 Identities=27% Similarity=0.440 Sum_probs=201.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 83 (269)
-.++|++.+.||.|++|.||++.+..+++.+++|.+..... .......+.+|+.+++.++|+|++++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45789999999999999999999999999999999854322 223345677899999999999999999988543
Q ss_pred -CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 84 -~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
...++|+||+.+ ++.+.+... ++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 347999999965 777776544 8899999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------- 229 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------- 229 (269)
... ......++..|+|||.+.+..+. .++|+||||+++|+|++|+.||...+.......+...
T Consensus 170 ~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 TSF---MMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCC---CCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 311 12223467889999999887764 8999999999999999999999876554333332110
Q ss_pred ---------ccc--------------C-------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ---------EFT--------------C-------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ---------~~~--------------~-------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
... . +...+..+.++|+.||+.||++|||+ .++|.|+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~eiL~~~~ 313 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISV--DDALQHPY 313 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCH--HHHhcChh
Confidence 000 0 11245678999999999999999999 78888876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=280.44 Aligned_cols=250 Identities=29% Similarity=0.485 Sum_probs=207.9
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+.|.....||.|++|.||++.+..+++.+++|.+.... ....+.+.+|+..++.++|+|++++++.+...+..++++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 45566688999999999999998899999999986433 233567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||++++++..++.. +.++..++..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~ 175 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKR 175 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccC
Confidence 99999999887644 468999999999999999999999999999999999999999999999999876433211 112
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc---ccCCCCCCHHHHHHHHH
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIAR 247 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~ 247 (269)
....++..|+|||.+.+... +.++|+||||+++|++++|..||...........+.... .......+..+.+++..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL 254 (292)
T ss_pred ceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence 23346788999999977665 489999999999999999999998877665555543322 22233478899999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||..||++|||+ .+++.|+|
T Consensus 255 ~l~~~P~~Rpt~--~~il~~~~ 274 (292)
T cd06658 255 MLVREPSQRATA--QELLQHPF 274 (292)
T ss_pred HccCChhHCcCH--HHHhhChh
Confidence 999999999999 77777776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=288.54 Aligned_cols=255 Identities=21% Similarity=0.323 Sum_probs=204.9
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeE
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYE 78 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~ 78 (269)
.+....++|.+.+.||.|+||.||+|.+. .+++.||+|.+..... ....+.+.+|++++.++. ||||+++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR--SSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCC--hhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 45667788999999999999999999864 3456899999865432 233457889999999997 999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhHHHHhcC----------------------------------------------------
Q 024347 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG---------------------------------------------------- 106 (269)
Q Consensus 79 ~~~~~~~~~~v~~~~~~~~l~~~~~~~~---------------------------------------------------- 106 (269)
.+...+..++|+||+.+++|.+++...+
T Consensus 109 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 109 ACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 9999899999999999999998885431
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCC
Q 024347 107 ----------------------------------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (269)
Q Consensus 107 ----------------------------------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~ 140 (269)
.++...+..++.|++.||.|||+.+++|+||+|+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2556678889999999999999999999999999
Q ss_pred ceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 024347 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL 219 (269)
Q Consensus 141 nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~ 219 (269)
||+++.++.++|+|||+++...............++..|+|||.+.+..+ +.++|+||||+++|++++ |..||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 99999999999999999875432211111122345678999999987665 489999999999999998 8999987554
Q ss_pred HHHH-HHHhcC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 220 MNLY-KKISAA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 220 ~~~~-~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+.. ..+..+ ....+..++.++.++++.||+.||++||+++++
T Consensus 348 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~el 392 (401)
T cd05107 348 NEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQL 392 (401)
T ss_pred hHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 4433 333333 344566789999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=278.53 Aligned_cols=250 Identities=26% Similarity=0.394 Sum_probs=208.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
..|...+.||+|++|.||++.+..+++.+++|.+........+....+.+|+++++.++|+|++++++++......++++
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888899999999999999999899999999987654445555678889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||+.| ++.+.+.. ...++..++..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------ 177 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------ 177 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence 99975 66666644 45689999999999999999999999999999999999999999999999998764322
Q ss_pred ccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC--CCCCCHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--PPWLSFTARKLI 245 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 245 (269)
.....++..|+|||.+.. ....+.++|+||||+++|+|++|..||...........+.....+. ...+++.+.+++
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 257 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 257 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence 122346778999999742 2233589999999999999999999998877666666655443322 345788999999
Q ss_pred HHhcCCCCCCcCCCCccccccccC
Q 024347 246 ARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+||+.+|++||++ .+.+.|.|
T Consensus 258 ~~~l~~~p~~Rpt~--~~il~~~~ 279 (317)
T cd06635 258 DSCLQKIPQDRPTS--EELLKHMF 279 (317)
T ss_pred HHHccCCcccCcCH--HHHHhChh
Confidence 99999999999998 66666654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=271.01 Aligned_cols=250 Identities=20% Similarity=0.356 Sum_probs=204.8
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
..-++|++.+.||+|++|.||++.+. .+..+++|.+.... ...+.+.+|+.+++.++|+|++++++.+.. ...+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 44578999999999999999999865 45669999876432 234678889999999999999999999877 7789
Q ss_pred EEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+++||+++++|.+++... ..++..++..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999988753 357888999999999999999999999999999999999999999999999876433211
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 243 (269)
. .......++..|+|||.+..... +.++|+||||+++|++++ |+.||...+.......+..+. .+.+...+..+.+
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 1 11111234567999999977665 489999999999999998 999999877776666665543 3445668899999
Q ss_pred HHHHhcCCCCCCcCCCCccccc
Q 024347 244 LIARILDPNPMTVSIYPFADIL 265 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l 265 (269)
++.+||+.||++||++.++..+
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~~ 256 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQSV 256 (260)
T ss_pred HHHHHcccCcccCcCHHHHHHH
Confidence 9999999999999998665443
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=276.57 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=207.1
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
.|...+.||.|++|.||+|.+..+++.+++|.+.............+.+|+++++.++|+|++++++++.+....++++|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 36667889999999999999998999999999876554444556778899999999999999999999999999999999
Q ss_pred ccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 92 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
|+.+ ++.+.+.. ...++..++..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+..... .
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~ 174 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------A 174 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC------C
Confidence 9965 66666654 45689999999999999999999999999999999999999999999999998753221 1
Q ss_pred cccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC--CCCCCHHHHHHHH
Q 024347 171 HTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--PPWLSFTARKLIA 246 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~ 246 (269)
....++..|+|||.+.. ....+.++|+||||+++|+|++|..||...+.......+.....+. ...++..+.+|+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (313)
T cd06633 175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVD 254 (313)
T ss_pred CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHH
Confidence 23356788999999853 2333588999999999999999999998877666555554443322 2347788999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||+.+|++||++ .+++.|+|
T Consensus 255 ~~l~~~P~~Rp~~--~~~l~~~~ 275 (313)
T cd06633 255 YCLQKIPQERPAS--AELLRHDF 275 (313)
T ss_pred HHccCChhhCcCH--HHHhcCcc
Confidence 9999999999999 78888876
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=274.25 Aligned_cols=248 Identities=24% Similarity=0.441 Sum_probs=201.2
Q ss_pred ccccccCCeEEeeee--eccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEe
Q 024347 5 KIKRRVGKYEVGRTI--GEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (269)
Q Consensus 5 ~~~~~~~~~~~~~~l--g~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 81 (269)
++....++|.+.+.+ |.|+||.||.+.++.++..+++|.+........ |......+ +|+|++++++.+.
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEEe
Confidence 344556778888887 999999999999999999999999865432211 12222222 6999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-CEEEeeCCCccc
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSAL 160 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-~~~l~df~~~~~ 160 (269)
..+..++||||+++++|.+++.....+++.++..++.|++.||.+||+.|++|+||+|+||+++.++ .++++|||.+..
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999999999998877899999999999999999999999999999999999999988 999999998764
Q ss_pred cccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCcccCCCC
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFTCPPW 236 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~ 236 (269)
.... ....++..|+|||++.+... +.++|+||+|+++|++++|..||........ .........+.++.
T Consensus 160 ~~~~------~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (267)
T PHA03390 160 IGTP------SCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKN 232 (267)
T ss_pred cCCC------ccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccc
Confidence 4321 12346788999999987766 4899999999999999999999975433221 11112333455556
Q ss_pred CCHHHHHHHHHhcCCCCCCcCC-CCccccccccC
Q 024347 237 LSFTARKLIARILDPNPMTVSI-YPFADILYMRF 269 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps-~~~~~~l~~~~ 269 (269)
.++.+.+||..||+.||.+||+ + .+++.|+|
T Consensus 233 ~~~~~~~li~~~l~~~p~~R~~~~--~~~l~h~~ 264 (267)
T PHA03390 233 VSKNANDFVQSMLKYNINYRLTNY--NEIIKHPF 264 (267)
T ss_pred cCHHHHHHHHHHhccChhhCCchH--HHHhcCCc
Confidence 8999999999999999999995 6 67778887
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=272.41 Aligned_cols=249 Identities=25% Similarity=0.363 Sum_probs=204.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
....+|++.+.||.|++|.||+|.+... ...+++|.+.... .....+.+.+|+.+++.++|+|++++++++.+ .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3456799999999999999999987543 3468889875433 13345788999999999999999999998865 4
Q ss_pred eEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..+++|||+++++|.+++.... .++..++..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 5679999999999999987643 589999999999999999999999999999999999999999999999998765433
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 241 (269)
... .......++..|+|||.+....+ +.++|+||||++++++++ |..||......+....+..+ ..+.+..++..+
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (270)
T cd05056 160 ESY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 237 (270)
T ss_pred ccc-eecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence 211 11112223467999999876665 489999999999999885 99999888777766666554 345667789999
Q ss_pred HHHHHHhcCCCCCCcCCCCc
Q 024347 242 RKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~ 261 (269)
.+++.+||..+|.+|||+.+
T Consensus 238 ~~li~~~l~~~P~~Rpt~~~ 257 (270)
T cd05056 238 YSLMTKCWAYDPSKRPRFTE 257 (270)
T ss_pred HHHHHHHcCCChhhCcCHHH
Confidence 99999999999999999844
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=273.35 Aligned_cols=240 Identities=22% Similarity=0.368 Sum_probs=195.8
Q ss_pred eeeeccCCcEEEEEEEcCCCC--eEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEEEEEecc
Q 024347 17 RTIGEGTFAKVKFARNSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFV 93 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v~~~~ 93 (269)
+.||.|++|.||+|....++. .+++|.+... ......+.+.+|+.+++++ +|||++++++++...+..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999887765 4577776532 1233456788999999999 7999999999999999999999999
Q ss_pred CCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 94 TGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 94 ~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
++++|.+++...+ .++..++..++.+++.||++||+.|++|+||+|+||+++.++.++++|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999886532 378889999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCC
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPP 235 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~ 235 (269)
+....... .......+..|+|||++..... +.++|+||||+++|+|++ |..||...+..+....+..+ ....+.
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 75322111 1111223557999999877665 489999999999999997 99999887777777666554 334455
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.++.++.+++.+||+.||.+|||++++
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQI 261 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHH
Confidence 688999999999999999999998443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=269.79 Aligned_cols=246 Identities=24% Similarity=0.393 Sum_probs=205.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||.|++|.||++.+. ++..+++|.+...... ...+.+|++++++++||+++++++.+......++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 3568999999999999999999885 4678999987644332 2467889999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
++||+++++|.+++... +.++.+.+..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence 99999999998888654 4688999999999999999999999999999999999999999999999998764432111
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 245 (269)
........+..|+|||.+.+..+ +.++|+||||+++|++++ |..||.........+.+..+ ....+...+..+.+|+
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELM 234 (256)
T ss_pred cccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHH
Confidence 11111223568999999877665 489999999999999998 99999988888878777654 3334555789999999
Q ss_pred HHhcCCCCCCcCCCCc
Q 024347 246 ARILDPNPMTVSIYPF 261 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~ 261 (269)
++||+.+|++||++++
T Consensus 235 ~~~l~~~p~~Rp~~~~ 250 (256)
T cd05112 235 QHCWKERPEDRPSFSL 250 (256)
T ss_pred HHHcccChhhCCCHHH
Confidence 9999999999999844
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=281.76 Aligned_cols=254 Identities=27% Similarity=0.397 Sum_probs=205.8
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC-
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT- 84 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~- 84 (269)
+....++|++.+.||.|++|.||++.+..+++.||+|.+.... ........+.+|+++++.++|+||+++++++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 4445678999999999999999999999999999999985432 23334567889999999999999999999886543
Q ss_pred -----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 85 -----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 85 -----~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
.++++++|+ |+++...+. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 458999998 678877665 4578999999999999999999999999999999999999999999999999886
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc--------
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-------- 231 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 231 (269)
.... ......+++.|+|||.+.+....+.++|+||||+++|++++|..||...+.......+.....
T Consensus 167 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 167 QTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred cccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 4332 112234577899999987644446899999999999999999999987665444333221110
Q ss_pred -----------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 -----------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 -----------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.+++.+.++|.+||+.||++|||+ .+.+.|+|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~--~~~l~~~~ 300 (343)
T cd07880 242 KLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITA--AEALAHPY 300 (343)
T ss_pred hhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCH--HHHhcCcc
Confidence 1123478889999999999999999999 77788877
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=274.07 Aligned_cols=249 Identities=22% Similarity=0.346 Sum_probs=206.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.++|++.+.||.|+||.||+|..+. ..+.+++|.+.... .....+.+.+|++++++++|+|++++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3689999999999999999999653 35678999875432 2334577899999999999999999999999989
Q ss_pred eEEEEEeccCCCchhHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeC
Q 024347 85 KIFIVLEFVTGGELFDKIVNHG---------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
..+++|||+++++|.+++.... .++...+..++.|++.+|+|||++|++|+||+|+||+++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999987655 6899999999999999999999999999999999999999999999999
Q ss_pred CCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcc--c
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF--T 232 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~--~ 232 (269)
|.+....... ........++..|+|||.+.+.... .++|+||||+++|++++ |..||..............+.. +
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 239 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP 239 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCC
Confidence 9875332211 1111222345679999998776654 88999999999999998 8899987777777776665543 3
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 233 CPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+..++..+.+++.+||+.||++||+++++
T Consensus 240 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~ 269 (275)
T cd05046 240 VPEGCPSRLYKLMTRCWAVNPKDRPSFSEL 269 (275)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 355689999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=279.18 Aligned_cols=249 Identities=29% Similarity=0.501 Sum_probs=207.5
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
.|.....||.|++|.||.+.+..+++.+++|.+..... ...+.+.+|+.+++.+.|||++++++.+......++++|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 45556789999999999999988899999999865332 224668889999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
|+++++|...+.. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++...... .....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~ 175 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK 175 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--ccccc
Confidence 9999999876544 56899999999999999999999999999999999999999999999999987643221 11122
Q ss_pred ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHHHHHHHHHh
Q 024347 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIARI 248 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~ 248 (269)
...++..|+|||.+.+... +.++|+||||+++++|++|..||......+....+..... .....++..+.++|+.|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 3457789999999987665 4899999999999999999999987776666665544332 22335788999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||++||++ .+.+.|+|
T Consensus 255 l~~~P~~Rps~--~~ll~~~~ 273 (297)
T cd06659 255 LTREPQERATA--QELLDHPF 273 (297)
T ss_pred hcCCcccCcCH--HHHhhChh
Confidence 99999999998 67777765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=305.60 Aligned_cols=253 Identities=22% Similarity=0.364 Sum_probs=215.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCC-----eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
.....-+....||.|.||.||.|......- .|++|.+.. ..+.+...+|.+|+.+++.+.||||++++|++-+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 446677888999999999999998775433 377777654 3355667899999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeC
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH-------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
....++++||++||+|..++.+. ..++...++.++.+|+.++.||+++++||+||..+|+|++....||++||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999775 35899999999999999999999999999999999999999999999999
Q ss_pred CCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH-HHhcCcccC
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYK-KISAAEFTC 233 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~-~~~~~~~~~ 233 (269)
|+|+-..............-...|||||.+.+..+ +.++||||||+++||+++ |..||.+.+..+... -...++.+.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~ 925 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP 925 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC
Confidence 99983322222222222334578999999998776 499999999999999998 999999988888777 556678899
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcCCCCccccc
Q 024347 234 PPWLSFTARKLIARILDPNPMTVSIYPFADIL 265 (269)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l 265 (269)
|+.||..+.+++.+||+.+|++||++ +.++
T Consensus 926 P~~CP~~ly~lM~~CW~~~pe~RP~F--~~i~ 955 (1025)
T KOG1095|consen 926 PSYCPEKLYQLMLQCWKHDPEDRPSF--RTIV 955 (1025)
T ss_pred CCCCChHHHHHHHHHccCChhhCccH--HHHH
Confidence 99999999999999999999999998 5444
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=279.30 Aligned_cols=252 Identities=26% Similarity=0.377 Sum_probs=207.8
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
....|+..+.||.|++|.||+|.+..+++.+++|.+...........+.+.+|+++++.++|+|++++.+++......++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 44568888999999999999999998999999999875443344455778899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
|+||+.+ ++.+.+.. ...++..++..++.+++.++.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 93 v~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 93 VMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred EEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 9999964 77666644 456899999999999999999999999999999999999999999999999987643321
Q ss_pred CcccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC--CCCCCHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--PPWLSFTARK 243 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~ 243 (269)
....++..|+|||.+.+ ....+.++||||||+++|++++|..||...........+.....+. ...++..+.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN 245 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHH
Confidence 12346778999999753 2223578999999999999999999998766655555554443322 3458889999
Q ss_pred HHHHhcCCCCCCcCCCCccccccccC
Q 024347 244 LIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||++||+.+|++||++ .+.+.|+|
T Consensus 246 li~~cl~~~P~~Rp~~--~~ll~~~~ 269 (308)
T cd06634 246 FVDSCLQKIPQDRPTS--EVLLKHRF 269 (308)
T ss_pred HHHHHhhCCcccCCCH--HHHhhCcc
Confidence 9999999999999998 77777766
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=279.58 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=186.9
Q ss_pred eeeeccCCcEEEEEEEcC--CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe--eCCeEEEEEec
Q 024347 17 RTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEF 92 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~~~~~~~v~~~ 92 (269)
..||.|+||.||+|.+.. ++..+++|.+..... ...+.+|+.+++.++||||+++++++. .....++++||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999653 567899998754321 245678999999999999999999884 35678999999
Q ss_pred cCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----cCCCCEEEeeCCCcc
Q 024347 93 VTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSA 159 (269)
Q Consensus 93 ~~~~~l~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~----~~~~~~~l~df~~~~ 159 (269)
+.+ ++.+.+... ..+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 865 676665421 247889999999999999999999999999999999999 456789999999987
Q ss_pred ccccccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHh--
Q 024347 160 LSQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---------LYKKIS-- 227 (269)
Q Consensus 160 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---------~~~~~~-- 227 (269)
........ .......+++.|+|||++.+....+.++||||||+++|+|++|..||....... ....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV 240 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence 54432211 112233568899999999776555689999999999999999999996432210 000000
Q ss_pred --------------------------cCcc----------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 228 --------------------------AAEF----------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 228 --------------------------~~~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.... ......+..+.+|+..||+.||.+|||+ .++|.|+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~--~e~l~hp~ 316 (317)
T cd07867 241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS--EQALQDPY 316 (317)
T ss_pred cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCH--HHHhcCCC
Confidence 0000 0011235678899999999999999999 89999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=296.68 Aligned_cols=250 Identities=29% Similarity=0.453 Sum_probs=220.2
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
-|.+++.||.|+||.||+|..+.++-..|.|++.- ..++..+++.-|+++|....||+|+++++.|...+.++++.|
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 47788999999999999999998888888888743 346668999999999999999999999999999999999999
Q ss_pred ccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 92 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||.||.....+.. ...++++++.-++.+++.||.|||+.+|+|+|++..||++..+|.++|+|||.+..... .....
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkR 187 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKR 187 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhhh
Confidence 9999988877765 56899999999999999999999999999999999999999999999999998754222 22233
Q ss_pred cccccCccccCcccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC---CCCCCHHHH
Q 024347 171 HTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC---PPWLSFTAR 242 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~ 242 (269)
....|+|+|||||+... .++ ..++||||||+++.+|..+.+|-...+++...-++...+++. |+.++..+.
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PY-DykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~ 266 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS 266 (1187)
T ss_pred ccccCCcccccchheeeccccCCCc-hhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence 45679999999999653 344 489999999999999999999999999999998888877655 466999999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||++.||.+||..||++ +++|+|+|
T Consensus 267 DfLk~cL~Knp~~Rp~a--aqll~Hpf 291 (1187)
T KOG0579|consen 267 DFLKRCLVKNPRNRPPA--AQLLKHPF 291 (1187)
T ss_pred HHHHHHHhcCCccCCCH--HHHhhCcc
Confidence 99999999999999999 99999998
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=282.80 Aligned_cols=249 Identities=26% Similarity=0.424 Sum_probs=217.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+-|.+++.||.|+||.||++.++.+|+.+|+|.+..+. ..+.+..|+.++++...+++++.||.+.....+++||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 34788999999999999999999999999999986543 3688899999999999999999999998889999999
Q ss_pred eccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||..|++.+.+.. +++++++++..+++..+.+|+|||...-+|+||+..||+++.+|..+|.|||.+......- ..
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AK 185 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AK 185 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH--Hh
Confidence 99999999998854 5789999999999999999999999999999999999999999999999999886543321 22
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIA 246 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~ 246 (269)
.....|++-|+|||++..-.+. -++||||||++..+|..|++||....++...--+-...+ ..|..++.++.+|++
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~ 264 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIR 264 (502)
T ss_pred hCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHH
Confidence 2345689999999999988876 889999999999999999999998888776655544432 335668999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||-++|++|.++ .+.++|.|
T Consensus 265 ~CLiK~PE~R~TA--~~L~~H~F 285 (502)
T KOG0574|consen 265 SCLIKKPEERKTA--LRLCEHTF 285 (502)
T ss_pred HHhcCCHHHHHHH--HHHhhhhh
Confidence 9999999999998 77778876
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=273.78 Aligned_cols=257 Identities=32% Similarity=0.532 Sum_probs=210.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 86 (269)
+|++.+.||.|++|.||++.+. .+++.+++|.+...... .....+.+.+|+.++.++ +|++++++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 35788999998754332 233456788999999999 599999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++|+||+++++|...+.....+++..+..++.|++++|.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE- 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc-
Confidence 9999999999999988877789999999999999999999999999999999999999999999999999876533221
Q ss_pred CCcccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCcccCCCCCCHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLSFTA 241 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~l 241 (269)
........++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... .......+.....+.+..++..+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11122234678999999987654 23588999999999999999999996432 23444555556666777789999
Q ss_pred HHHHHHhcCCCCCCcCCCCcc-ccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFA-DILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~-~~l~~~~ 269 (269)
.+++.+||+.||++|||+..+ +.+.|+|
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 999999999999999997644 4566665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=282.66 Aligned_cols=254 Identities=27% Similarity=0.419 Sum_probs=209.7
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC-----eE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----KI 86 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~~ 86 (269)
+|++.+.||.|++|.||+|.+..+++.+++|.+.... ......+.+.+|+.+++.++|+|++++.+++.... ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6899999999999999999998889999999986533 12344577889999999999999999999987765 78
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+++++|+.+ ++.+.+.....+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999974 8888887777899999999999999999999999999999999999999999999999998876544321
Q ss_pred C-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc--------------
Q 024347 167 D-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-------------- 231 (269)
Q Consensus 167 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------------- 231 (269)
. .......++..|+|||.+.+....+.++|+||||+++|+|++|..||...+..+....+....-
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 0 1122334677899999998874446899999999999999999999988776655444432100
Q ss_pred -----------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 -----------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 -----------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.++..+.++|..||++||++||++ .+++.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--~~ll~~~~ 291 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA--DEALAHPY 291 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH--HHHHhCcc
Confidence 0112367889999999999999999999 77888877
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=278.19 Aligned_cols=258 Identities=29% Similarity=0.482 Sum_probs=206.3
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC--
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-- 84 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-- 84 (269)
.+..++|++.+.||.|++|.||+|.++.+++.+++|.+..... .......+.+|+.+++.++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchh
Confidence 4567899999999999999999999998999999999865432 1222356778999999999999999999886544
Q ss_pred --------eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeC
Q 024347 85 --------KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 85 --------~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
..++++||+++ ++...+... ..++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 78999999976 666666653 46899999999999999999999999999999999999999999999999
Q ss_pred CCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---Ccc-
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEF- 231 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~- 231 (269)
|.+........ ........+..|+|||.+.+....+.++|+||||++++++++|+.||...........+.. ...
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 98875433221 1111223466799999887655446899999999999999999999987665544433322 100
Q ss_pred --------------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 --------------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 --------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.....++..+.+++..||+.||.+||++ .+++.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~--~~il~~~~ 301 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA--EEALNSPW 301 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCH--HHHhcCCC
Confidence 0112368899999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=272.65 Aligned_cols=257 Identities=29% Similarity=0.521 Sum_probs=208.5
Q ss_pred CeEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 86 (269)
.|++.+.||.|++|.||.+.+. .+|+.+++|.+...... .....+.+.+|+++++.+ +|++|+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 46899999998754332 223346678899999999 589999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++++||+++++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999886543211
Q ss_pred CCcccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhcCcccCCCCCCHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLSFTA 241 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~l 241 (269)
........++..|+|||.+.+.. ..+.++|+||||+++|++++|..||... ........+.....+.+..+++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 11122334678899999987543 2357899999999999999999999643 234455555555666677789999
Q ss_pred HHHHHHhcCCCCCCcCCC---CccccccccC
Q 024347 242 RKLIARILDPNPMTVSIY---PFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~---~~~~~l~~~~ 269 (269)
.+++++||+.||++||+. ...+++.|+|
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~ 270 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence 999999999999999843 2244555554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=271.98 Aligned_cols=251 Identities=24% Similarity=0.388 Sum_probs=197.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHH-hhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
++|++.+.||.|+||.||++.++.+|+.||+|.+....... . ...+..|+.. ++.++|+|++++++++......+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-E-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-H-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 47999999999999999999999999999999986543221 2 2344445554 6777899999999999999999999
Q ss_pred EeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
+||++ +++.+++.. ...+++..+..++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 477666543 24689999999999999999999997 9999999999999999999999999988654321
Q ss_pred cCCCcccccccCccccCcccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhc-CcccCC-CCCC
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISA-AEFTCP-PWLS 238 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~-~~~~~~-~~~~ 238 (269)
.......++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||.... ..+....... .....+ ..++
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS 234 (283)
T ss_pred ---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence 1112234677899999886522 23588999999999999999999997532 2222223222 223333 3478
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 239 FTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++.++|..||+.||++||++ .+.+.|+|
T Consensus 235 ~~l~~li~~~l~~~p~~Rp~~--~~il~~~~ 263 (283)
T cd06617 235 PEFQDFVNKCLKKNYKERPNY--PELLQHPF 263 (283)
T ss_pred HHHHHHHHHHccCChhhCcCH--HHHhcCch
Confidence 999999999999999999999 77787776
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=281.04 Aligned_cols=258 Identities=26% Similarity=0.347 Sum_probs=206.8
Q ss_pred ccCCeEE-eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHH-----------HHHHHHHHHHHhhhCCCCCceee
Q 024347 9 RVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----------MAEQIKREVATMKLVKHPNVVRL 76 (269)
Q Consensus 9 ~~~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~~~~i~~~ 76 (269)
..++|.. .+.||.|++|.||+|.+..+++.+++|.+......... ....+.+|+++++.++|+|++++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3467764 57799999999999999989999999998654322100 11246789999999999999999
Q ss_pred eEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCC
Q 024347 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (269)
Q Consensus 77 ~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~ 156 (269)
++++......+++|||+. +++.+.+.....++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 999999999999999996 5888888877789999999999999999999999999999999999999999999999999
Q ss_pred Ccccccccc------------CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 024347 157 LSALSQQVR------------DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK 224 (269)
Q Consensus 157 ~~~~~~~~~------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 224 (269)
.+....... .........++..|+|||.+.+....+.++|+||||+++|++++|..||...+..+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~ 244 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 886544110 01111122356789999998776555689999999999999999999998877665444
Q ss_pred HHhcCc--c--------------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 225 KISAAE--F--------------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 225 ~~~~~~--~--------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.... . ...+..+..+.++|+.||+.||++||++ .+.+.|+|
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~--~~~l~~~~ 315 (335)
T PTZ00024 245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA--KEALKHEY 315 (335)
T ss_pred HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCH--HHHhcCcc
Confidence 332100 0 0012357889999999999999999999 88888887
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=273.10 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=194.3
Q ss_pred CCe-EEeeeeeccCCcEEEEEEE----cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--C
Q 024347 11 GKY-EVGRTIGEGTFAKVKFARN----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--K 83 (269)
Q Consensus 11 ~~~-~~~~~lg~g~~~~v~~~~~----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 83 (269)
++| ++.+.||+|++|+||++.. ..+++.+++|.+.... .......+.+|+++++.++|||++++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 456 8999999999999987653 3467889999986542 22334677889999999999999999998755 3
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
...+++|||+++++|.+++... .+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 4688999999999998888654 589999999999999999999999999999999999999999999999998875543
Q ss_pred ccCCCc-ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHh
Q 024347 164 VRDDGL-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------------NLYKKIS 227 (269)
Q Consensus 164 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~~~~~ 227 (269)
...... .....++..|+|||.+.+... +.++||||||+++++|++|..||...... ...+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 221111 111234567999999877665 48999999999999999999998643211 1111111
Q ss_pred c-CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 228 A-AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 228 ~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
. ...+.+..++..+.+++..||++||++|||++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i 274 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSL 274 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHH
Confidence 1 1223455678999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=282.03 Aligned_cols=250 Identities=22% Similarity=0.376 Sum_probs=196.6
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEE-----cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEee
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 82 (269)
..++|++.+.||.|+||.||+|.+ ..+++.||+|.+..... ......+.+|+.++.++ +|+||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTK 82 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeec
Confidence 456899999999999999999984 34578899999865332 23356788899999999 68999999998754
Q ss_pred -CCeEEEEEeccCCCchhHHHHhc--------------------------------------------------------
Q 024347 83 -KTKIFIVLEFVTGGELFDKIVNH-------------------------------------------------------- 105 (269)
Q Consensus 83 -~~~~~~v~~~~~~~~l~~~~~~~-------------------------------------------------------- 105 (269)
....+++|||+++++|.+++...
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (343)
T cd05103 83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE 162 (343)
T ss_pred CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence 45688999999999998887542
Q ss_pred -----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccc
Q 024347 106 -----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (269)
Q Consensus 106 -----------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 174 (269)
..++...+..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||++................
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 135677888899999999999999999999999999999999999999999886543221111111223
Q ss_pred cCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhcC-cccCCCCCCHHHHHHHHHhcCC
Q 024347 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISAA-EFTCPPWLSFTARKLIARILDP 251 (269)
Q Consensus 175 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~-~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~ 251 (269)
++..|+|||.+.+..+ +.++|+||||+++|++++ |..||...... .....+..+ ....+...++++.+++..||+.
T Consensus 243 ~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 243 LPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 4567999999877665 489999999999999996 99999765433 233333332 3344556788999999999999
Q ss_pred CCCCcCCCCc
Q 024347 252 NPMTVSIYPF 261 (269)
Q Consensus 252 dP~~Rps~~~ 261 (269)
||++|||+.+
T Consensus 322 ~p~~Rps~~e 331 (343)
T cd05103 322 EPSQRPTFSE 331 (343)
T ss_pred ChhhCcCHHH
Confidence 9999999843
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=281.32 Aligned_cols=253 Identities=27% Similarity=0.427 Sum_probs=200.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC------
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 83 (269)
-++|++.+.||.|++|.||+|.++.+++.+++|.+..... ...+.+.+|+++++.++|+|++++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 3789999999999999999999999999999999865432 3356788899999999999999998766443
Q ss_pred --------CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-CCCEEEee
Q 024347 84 --------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSD 154 (269)
Q Consensus 84 --------~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-~~~~~l~d 154 (269)
...++++||+. +++.+.+.. +.+++..+..++.|+++||.+||+.|++|+||+|+||+++. ++.++++|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35789999996 478776653 46899999999999999999999999999999999999974 55689999
Q ss_pred CCCccccccccC-CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----
Q 024347 155 FGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---- 229 (269)
Q Consensus 155 f~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---- 229 (269)
||.+........ ........++..|+|||.+.+....+.++|+||||+++|++++|+.||...............
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 998865432211 111122345778999998766554568999999999999999999999876654443332211
Q ss_pred --------------------cc------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 --------------------EF------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 --------------------~~------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ...+..+.++.+||++||++||++|||+ .+++.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~ell~h~~ 302 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA--EEALMHPY 302 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH--HHHhCCCc
Confidence 00 0123477889999999999999999999 67788887
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=280.63 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=199.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC------
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 83 (269)
.++|.+.+.||.|++|.||+|.+..+|+.+|+|.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 4799999999999999999999988999999999864322 223346678899999999999999999988644
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
...+++++|+.. ++.... ...++...+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 346899999854 665543 34689999999999999999999999999999999999999999999999998764322
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-------------
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------- 230 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 230 (269)
......++..|+|||.+.+....+.++|+||||+++|++++|+.||.+.+.......+....
T Consensus 170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07879 170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED 244 (342)
T ss_pred -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence 11223457789999998765444689999999999999999999998876554443322100
Q ss_pred ----------ccC--------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ----------FTC--------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ----------~~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
... .+..++.+.+||+.||+.||++||++ .+++.|+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~--~e~l~h~~ 299 (342)
T cd07879 245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTA--TEALEHPY 299 (342)
T ss_pred cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCH--HHHhcCcc
Confidence 000 12367889999999999999999999 77888877
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=283.61 Aligned_cols=253 Identities=27% Similarity=0.386 Sum_probs=201.3
Q ss_pred CccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe
Q 024347 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (269)
Q Consensus 2 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 81 (269)
+-.++..+++.|.....||+|+||.||+|.... ++.||||.+....... ...+.+|+.++.+++|||+++++|+|.
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 345677888999999999999999999999864 5889999876544322 345999999999999999999999999
Q ss_pred eCC-eEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcEeecCCCCceEecCCCCEEEeeC
Q 024347 82 SKT-KIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSR---GVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 82 ~~~-~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~---~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
+.+ ..++|+||++.|+|.+.+.... ++++.++.+|+.+++.||.|||+. .|+|+|||++|||++.+...||+||
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF 221 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF 221 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence 888 5999999999999999998764 899999999999999999999985 3999999999999999999999999
Q ss_pred CCccccccccCCCccccc-ccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC------HHHHHHH-Hh
Q 024347 156 GLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN------LMNLYKK-IS 227 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~------~~~~~~~-~~ 227 (269)
|+++..+.. ....... .++.+|.|||++..+.. +.++||||||+++.++++|+.+.+... ..+.... +.
T Consensus 222 GLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 222 GLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCcccCCcc--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 999644331 1111111 78999999999988665 499999999999999999998887432 1121111 11
Q ss_pred cCc---c---cCC-CCCC-----HHHHHHHHHhcCCCCCCcCCCCc
Q 024347 228 AAE---F---TCP-PWLS-----FTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 228 ~~~---~---~~~-~~~~-----~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
.+. . ... ...+ ..+..+...|++.+|++||++.+
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~ 344 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ 344 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence 111 1 111 1222 12667889999999999999866
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=274.84 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=202.1
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
-++|+..+.||+|++|.||++.+..+++ .+++|.+.... .......+.+|+.+++.++|+||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 3578999999999999999999877776 46888775432 223345688899999999999999999998654 4
Q ss_pred EEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..++++|++++++.+.+..+. .++...+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 678999999999999887654 5889999999999999999999999999999999999999999999999998754432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 242 (269)
..........++..|+|||.+.+... +.++||||||+++|++++ |..||.+.........+..+. ++.++.++..+.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 22212222334668999999877665 489999999999999997 899998877666665555443 445566889999
Q ss_pred HHHHHhcCCCCCCcCCCCc
Q 024347 243 KLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~ 261 (269)
+++..||..||++||++++
T Consensus 242 ~li~~c~~~~p~~Rp~~~~ 260 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKE 260 (303)
T ss_pred HHHHHHcCCChhhCcCHHH
Confidence 9999999999999999855
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=272.71 Aligned_cols=244 Identities=22% Similarity=0.341 Sum_probs=198.8
Q ss_pred eeeeccCCcEEEEEEEcCCC------CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 17 RTIGEGTFAKVKFARNSETG------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+.||.|++|.||+|+.+... +.+++|.+.... .......+.+|+.+++.++||||+++++++......++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999876433 678999875432 1233567888999999999999999999999999999999
Q ss_pred eccCCCchhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-----CEEEeeCCCc
Q 024347 91 EFVTGGELFDKIVNH-------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-----NLKVSDFGLS 158 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~-------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-----~~~l~df~~~ 158 (269)
||+++++|.+++... ..++..++..++.+++.+|.|||+.+++|+||+|+||+++.++ .++++|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999888642 2377889999999999999999999999999999999999877 8999999988
Q ss_pred cccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCC
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPW 236 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~ 236 (269)
.................+..|+|||.+.+... +.++|+||||+++|+|++ |..||......+....+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 65432221111122234578999999987766 589999999999999998 99999887777766666543 3455667
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
++..+.++|.+||+.+|++||+++++.
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~ 264 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQ 264 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 899999999999999999999986543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=280.96 Aligned_cols=256 Identities=30% Similarity=0.423 Sum_probs=203.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeC--Ce
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK--TK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~ 85 (269)
..++|++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.+++++ +|+||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 34689999999999999999999988899999998754322 222345677899999999 999999999988543 46
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++|+||+.+ +|...+... .++...+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence 8999999974 888877665 78888999999999999999999999999999999999999999999999887554322
Q ss_pred CC---CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 024347 166 DD---GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------- 229 (269)
Q Consensus 166 ~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------- 229 (269)
.. .......++..|+|||.+.+....+.++|+||||+++|+|++|+.||...........+...
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK 241 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence 21 12223356788999999876554568999999999999999999999765544333222110
Q ss_pred --------------cc----cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 --------------EF----TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 --------------~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ...+.++.++.++|..||+.||++|||+ .+++.|+|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~--~~il~~~~ 297 (337)
T cd07852 242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA--EEALEHPY 297 (337)
T ss_pred hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCH--HHHhhChh
Confidence 00 1112368899999999999999999999 77787776
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=280.72 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=204.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe--
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-- 85 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 85 (269)
...++|++.+.||.|++|.||+|.+..+++.+++|.+..... .....+.+.+|+.+++.+.|+|++++.+++.....
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLE 90 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccc
Confidence 456789999999999999999999999999999999865322 22334667789999999999999999888765544
Q ss_pred ----EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 86 ----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 86 ----~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
.+++++|+ +++|.+++.. ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999998 6688887765 57899999999999999999999999999999999999999999999999988654
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc----------
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------- 231 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------- 231 (269)
... .....++..|+|||.+.+....+.++|+||||+++|++++|+.||...........+.....
T Consensus 169 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 321 22234577899999986644446899999999999999999999987766554444322110
Q ss_pred ---------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 ---------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ---------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.....+++.+.++|++||+.||++|||+ .+++.|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~--~ell~h~~ 300 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITA--AEALAHPY 300 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCH--HHHhcCCC
Confidence 0012358899999999999999999999 67788887
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=267.46 Aligned_cols=240 Identities=26% Similarity=0.438 Sum_probs=200.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||.|++|.||.+.. +++.+++|.+.... ..+.+.+|+.+++.++|+|++++++.+... ..++
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 457899999999999999999874 67889999985432 235778899999999999999999998654 4689
Q ss_pred EEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 89 VLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+|||+.+++|.+++.... .++...+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999887543 5789999999999999999999999999999999999999999999999987643221
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKL 244 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 244 (269)
......+..|+|||.+.+... +.++|+||||+++|++++ |..||......+....+..+. ...+..++..+.++
T Consensus 154 ---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 229 (254)
T cd05083 154 ---VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL 229 (254)
T ss_pred ---CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence 111223567999999877665 489999999999999997 999999888777776665543 33345688999999
Q ss_pred HHHhcCCCCCCcCCCCcc
Q 024347 245 IARILDPNPMTVSIYPFA 262 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~ 262 (269)
+++||+.+|++||++++.
T Consensus 230 i~~~l~~~p~~Rp~~~~l 247 (254)
T cd05083 230 MTSCWETEPKKRPSFHKL 247 (254)
T ss_pred HHHHcCCChhhCcCHHHH
Confidence 999999999999998544
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=276.70 Aligned_cols=256 Identities=25% Similarity=0.392 Sum_probs=202.1
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC------
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 83 (269)
.++|++.+.||.|++|.||+|.+..+++.+++|.+....... .......+|+.+++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 689999999999999999999999999999999986543211 1234567899999999999999999887433
Q ss_pred --CeEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 84 --TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 84 --~~~~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
...+++++|+.+ ++...+.. ...+++.++..++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 346999999865 66666654 34799999999999999999999999999999999999999999999999998875
Q ss_pred cccccCCCc---------ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-
Q 024347 161 SQQVRDDGL---------LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE- 230 (269)
Q Consensus 161 ~~~~~~~~~---------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~- 230 (269)
......... .....+++.|+|||.+.+....+.++|+||||+++|+|++|..||.+.......+.+...-
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 443222111 1112346779999998765544689999999999999999999998777665554432110
Q ss_pred -c---------------------cCC-------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 -F---------------------TCP-------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 -~---------------------~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ..+ ...++.+.++|+.||+.||++|||+ .+++.|+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~--~ell~~~~ 310 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA--SDALEHPY 310 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCH--HHHhcCCC
Confidence 0 000 1245778999999999999999998 88888887
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=273.56 Aligned_cols=251 Identities=31% Similarity=0.468 Sum_probs=206.7
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEec
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|+.+++.++|+|++++++++.+....++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 67789999999999999999989999999998654432 23356788899999999999999999999999999999999
Q ss_pred cCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 93 ~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
+++ ++.+.+... ..++...+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 975 777777663 578999999999999999999999999999999999999999999999999876544322 1222
Q ss_pred ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-c------------------c-
Q 024347 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-E------------------F- 231 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~------------------~- 231 (269)
...++..|+|||.+.+....+.++|+||||+++|++++|+.||...+..+....+... . .
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 2346778999999877644568999999999999999999999877765544443211 0 0
Q ss_pred ----------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 ----------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.++.++.++|..||++||.+||++ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~--~~ll~~~~ 282 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITA--EQALAHPY 282 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCH--HHHhhCCC
Confidence 0112367899999999999999999999 78888887
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=288.44 Aligned_cols=250 Identities=26% Similarity=0.466 Sum_probs=214.8
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhh-hhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe--
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK-- 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-- 85 (269)
++.+|. ..||+|+|.+||+|.+..+|-.||.-.++.... ..+...+.+..|+.+|+.|+|+||+++++.+.+...
T Consensus 40 Ry~k~~--evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 40 RYLKFD--EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred ceeehh--hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCce
Confidence 344444 789999999999999999999998877664433 345567999999999999999999999999977554
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEec-CCCCEEEeeCCCccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLD-AYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~-~~~~~~l~df~~~~~~~ 162 (269)
+.+|.|.+.+|+|..++.+++.++...++.|++||+.||.|||++. |+|+|||.+||||+ .-|.||++|+|+|....
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 8899999999999999999999999999999999999999999984 99999999999998 45679999999987654
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHhcCcccCC--CCCCH
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCP--PWLSF 239 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~--~~~~~ 239 (269)
... .....|||.|||||.+. ..+. ...||||||+++.+|+|+.+||+ ..++..+++++..|..|.. .--++
T Consensus 198 ~s~----aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dP 271 (632)
T KOG0584|consen 198 KSH----AKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDP 271 (632)
T ss_pred ccc----cceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCH
Confidence 322 22357999999999998 4444 88999999999999999999996 5788999999988876443 33588
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++++||..||.. .++|||+ .+.|.++|
T Consensus 272 evr~fIekCl~~-~~~R~sa--~eLL~d~F 298 (632)
T KOG0584|consen 272 EVREFIEKCLAT-KSERLSA--KELLKDPF 298 (632)
T ss_pred HHHHHHHHHhcC-chhccCH--HHHhhChh
Confidence 999999999999 9999999 88888776
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=260.70 Aligned_cols=255 Identities=24% Similarity=0.383 Sum_probs=209.9
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 85 (269)
....++.+.++.||.|..|+||++....+|...|||...... +.+..+++...+++...-+ .|+|++.+|+|..+..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 445667778889999999999999999999999999986543 4555678888888877765 8999999999999998
Q ss_pred EEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 86 IFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
+++.||.+. .-...++.. .+++++..+..+...+..||.||.+ +||+|+|+||+||++++.|++||||||++...-
T Consensus 166 V~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv- 243 (391)
T KOG0983|consen 166 VFICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV- 243 (391)
T ss_pred HHHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee-
Confidence 888888874 334444433 3579999999999999999999997 489999999999999999999999999876432
Q ss_pred ccCCCcccccccCccccCcccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcCcccCCCC---C
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEFTCPPW---L 237 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~---~ 237 (269)
.+.......|.+.|+|||.+... +.+..++||||||++++++.||..||.+. ..-+....+.+.+++..+. +
T Consensus 244 --dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gF 321 (391)
T KOG0983|consen 244 --DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGF 321 (391)
T ss_pred --cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCc
Confidence 34444556789999999998754 23358899999999999999999999874 4446666666666655432 8
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 238 SFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++.+++|+..||++|+.+||.. .+.|+|+|
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y--~~Ll~h~F 351 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKY--NKLLEHPF 351 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcch--HHHhcCcc
Confidence 9999999999999999999999 77888876
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=270.60 Aligned_cols=234 Identities=23% Similarity=0.302 Sum_probs=190.1
Q ss_pred eeeeccCCcEEEEEEEcCCCC-------eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 17 RTIGEGTFAKVKFARNSETGE-------PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~-------~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
+.||.|+||.||+|.+...++ .+++|.+.... ....+.+.+|+.+++.++|||++++++++......+++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999998865444 37888764322 33456788899999999999999999999998899999
Q ss_pred EeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC--------EEEeeCCCccc
Q 024347 90 LEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--------LKVSDFGLSAL 160 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~--------~~l~df~~~~~ 160 (269)
|||+++++|..++..++ .++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++++|||.+..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999999887654 5899999999999999999999999999999999999987665 68999997754
Q ss_pred cccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcCcccCCCCCCH
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAEFTCPPWLSF 239 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
... .....++..|+|||++.+....+.++|+||||+++|++++| ..|+.......... ........+...+.
T Consensus 158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQLPAPKWT 230 (258)
T ss_pred cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHccccCCCCCcH
Confidence 321 12234577899999998755456899999999999999998 57776655544332 33344555666778
Q ss_pred HHHHHHHHhcCCCCCCcCCCC
Q 024347 240 TARKLIARILDPNPMTVSIYP 260 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~ 260 (269)
++.+++++||+.||++|||++
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~ 251 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFR 251 (258)
T ss_pred HHHHHHHHHhccChhhCCCHH
Confidence 999999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=267.97 Aligned_cols=245 Identities=19% Similarity=0.220 Sum_probs=189.3
Q ss_pred eeeeccCCcEEEEEEEc--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccC
Q 024347 17 RTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
+.||+|+||.||+|... .++..+++|.+..... ......+.+|+.++++++|||++++++.+.+....+++|||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999754 3456789998765432 2234578889999999999999999999998889999999999
Q ss_pred CCchhHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 95 GGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 95 ~~~l~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
+++|.+++.... .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 999998886432 356677888999999999999999999999999999999999999999998764322111111
Q ss_pred ccccccCccccCcccccCCC------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh-cCcc--cCC---CC
Q 024347 170 LHTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS-AAEF--TCP---PW 236 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~-~~~~--~~~---~~ 236 (269)
.....++..|+|||++.+.. ..+.++|+||||+++|++++ |..||......+...... .... +.+ ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 12234567899999986432 12578999999999999996 999998766555433322 2111 111 23
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCcccc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
.+..+.++++.|+ .+|++|||++++..
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 6788999999999 68999999966554
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=277.50 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=201.9
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-- 83 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 83 (269)
+-...++|++.+.||+|++|.||++.+..+++.||+|.+..... .....+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~ 90 (345)
T cd07877 12 IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 90 (345)
T ss_pred HhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccc
Confidence 34456899999999999999999999988999999999865322 222346678899999999999999999988543
Q ss_pred ----CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 84 ----TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 84 ----~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
...+++++++ +++|.+.+.. +.+++..+..++.|++.||++||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus 91 ~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~ 168 (345)
T cd07877 91 LEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168 (345)
T ss_pred ccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccc
Confidence 3467888876 6788776654 468999999999999999999999999999999999999999999999999876
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc--------
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-------- 231 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-------- 231 (269)
.... ......++..|+|||.+.+....+.++|+||||+++|++++|..||...+.......+.....
T Consensus 169 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T cd07877 169 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243 (345)
T ss_pred cccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 4322 122234677899999987644445899999999999999999999987665444333211000
Q ss_pred ---------------cC--------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 ---------------TC--------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ---------------~~--------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ....++.+.++|..||+.||.+||++ .+++.|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~--~e~l~h~~ 302 (345)
T cd07877 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA--AQALAHAY 302 (345)
T ss_pred hcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH--HHHhcChh
Confidence 00 01257789999999999999999999 78888876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=267.41 Aligned_cols=247 Identities=28% Similarity=0.499 Sum_probs=204.3
Q ss_pred CeEEeeeeeccCCcEEEEEEEcC-CCCeEEEEEeehhh-------hhhHHHHHHHHHHHHHhhh-CCCCCceeeeEEEee
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEK-------VLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGS 82 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~K~~~~~~-------~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~ 82 (269)
.|++.+.||.|++|.||.+.+.. .++.+++|.+.... .........+.+|+.++.. ++|+|++++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999887 68899999875322 1223345667788888865 789999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 83 KTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
.+..++++||+++++|.+.+.. ...++...++.++.|++.+|.+||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999887643 3468999999999999999999996 6899999999999999999999999998
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC-CC-
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PP- 235 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~- 235 (269)
+....... ......++..|+|||.+.+... +.++|+||||+++|++++|..||...........+....... +.
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 87543322 2234457788999999987665 589999999999999999999998877777666665544322 22
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+++.+.+++++||+.||++||++.++
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~ 263 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQV 263 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHH
Confidence 578999999999999999999998544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=271.91 Aligned_cols=245 Identities=29% Similarity=0.483 Sum_probs=204.8
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
...||.|++|.||++....+++.+++|.+.... ......+.+|+.+++.++|+|++++++.+...+..+++|||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence 467999999999999999999999999975432 23356788999999999999999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccccc
Q 024347 96 GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175 (269)
Q Consensus 96 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~ 175 (269)
++|.+.+. ...+++..+..++.|++.+|++||+.|++||||+|+||+++.++.++|+|||.+...... ........+
T Consensus 102 ~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~ 178 (292)
T cd06657 102 GALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVG 178 (292)
T ss_pred CcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccc--ccccccccc
Confidence 99987664 446899999999999999999999999999999999999999999999999987644321 112223446
Q ss_pred CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc---ccCCCCCCHHHHHHHHHhcCCC
Q 024347 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARKLIARILDPN 252 (269)
Q Consensus 176 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~d 252 (269)
+..|+|||.+.+... +.++|+||+|+++|++++|..||...........+.... ......+++.+.+++.+||+.|
T Consensus 179 ~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (292)
T cd06657 179 TPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRD 257 (292)
T ss_pred CccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCC
Confidence 788999999877665 489999999999999999999998876665555443322 2233457899999999999999
Q ss_pred CCCcCCCCccccccccC
Q 024347 253 PMTVSIYPFADILYMRF 269 (269)
Q Consensus 253 P~~Rps~~~~~~l~~~~ 269 (269)
|.+||++ .+.+.|+|
T Consensus 258 P~~R~~~--~~ll~~~~ 272 (292)
T cd06657 258 PAQRATA--AELLKHPF 272 (292)
T ss_pred cccCcCH--HHHhcChH
Confidence 9999999 77888876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=272.22 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=206.6
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEec
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
|++.+.||.|++|.||+|....+++.+++|.+.... ......+.+.+|+.+++.++|+|++++++++......++++||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677899999999999999999999999999987654 2233356778899999999999999999999999999999999
Q ss_pred cCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 93 ~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
++ ++|.+.+... ..++...+..++.+++.+|++||+.|++||||+|+||+++.++.++|+|||.+........ ...
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~ 156 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYT 156 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccC
Confidence 97 4898888776 5799999999999999999999999999999999999999999999999998865433211 112
Q ss_pred ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------------cc
Q 024347 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------------EF 231 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------------~~ 231 (269)
....+..|+|||.+.+....+.++|+||||++++++++|..||..........++... .+
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 2234667999999877644568999999999999999999999887665544433210 00
Q ss_pred ---------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 ---------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+..+..+.++|+.||+.||++||++ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~--~~~l~~p~ 281 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISA--KEALKHPY 281 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCH--HHHhhCcC
Confidence 0011247889999999999999999999 88888887
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=272.61 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=199.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~ 88 (269)
.++|+..+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+.++.++. |+||+++++++......++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 35677888999999999999999999999999998654322 33567888999999996 9999999999988888999
Q ss_pred EEeccCCCchhHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 89 VLEFVTGGELFDKI---V--NHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 89 v~~~~~~~~l~~~~---~--~~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
+++|+.+ ++.... . ....+++..+..++.+++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999854 544332 2 235689999999999999999999975 99999999999999999999999999886433
Q ss_pred cccCCCcccccccCccccCcccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCcc-cC----C
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEF-TC----P 234 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~-~~----~ 234 (269)
.. .......++..|+|||.+.+. ...+.++|+||+|+++|++++|..||..... .+...+...+.. .. +
T Consensus 160 ~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd06616 160 DS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE 236 (288)
T ss_pred cC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence 21 111223467789999998776 2445899999999999999999999976542 122222222222 11 1
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..++.++.+|++.||+.||++|||+ .+++.|+|
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rpt~--~~i~~~~~ 269 (288)
T cd06616 237 REFSPSFVNFINLCLIKDESKRPKY--KELLEHPF 269 (288)
T ss_pred CccCHHHHHHHHHHccCChhhCcCH--HHHhcChh
Confidence 2378899999999999999999999 77777766
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=269.91 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=195.0
Q ss_pred CeEEeeeeeccCCcEEEEEEE----cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--Ce
Q 024347 12 KYEVGRTIGEGTFAKVKFARN----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--TK 85 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~~ 85 (269)
-|++.+.||+|++|.||++.. ..++..+++|.+.... .......+.+|+.+++.+.|+|++++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 368899999999999999974 4568889999986443 233356789999999999999999999998765 56
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++|||++|++|.+++... ..++..++..++.+++.||.+||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999988664 35899999999999999999999999999999999999999999999999988754322
Q ss_pred cCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---------------CHHHHHHHHhc
Q 024347 165 RDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------------NLMNLYKKISA 228 (269)
Q Consensus 165 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---------------~~~~~~~~~~~ 228 (269)
... .......++..|+|||++.+... +.++|+||||+++|+++++..|.... ........+..
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHc
Confidence 111 11112334567999999877665 48999999999999999977654221 01111111222
Q ss_pred -CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 229 -AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 229 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
...+.+..++..+.+|+.+||+.||++||+++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 276 (284)
T cd05079 242 GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276 (284)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHH
Confidence 2234456689999999999999999999998443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=267.92 Aligned_cols=248 Identities=24% Similarity=0.383 Sum_probs=199.2
Q ss_pred eEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC-----
Q 024347 13 YEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----- 84 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 84 (269)
|.+.+.||+|++|.||+|.+. .+++.+++|.+...... ....+.+.+|+..++.++|||++++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677899999999999999864 35789999998654332 333567889999999999999999999885432
Q ss_pred -eEEEEEeccCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 85 -KIFIVLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 85 -~~~~v~~~~~~~~l~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
..+++++|+.++++..++... ..++...+..++.|++.+|+|||++|++|+||+|+||+++.++.++++|||.
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 246888999999998776432 2478889999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCC
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPP 235 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~ 235 (269)
++...............+++.|++||........ .++||||||+++|++++ |..||...+..+....+.... ...++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8754332211111222345679999998776654 89999999999999998 899998887777766665443 44456
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+..+.+++.+||+.+|++|||++++
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~ 265 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHL 265 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 688999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=265.56 Aligned_cols=235 Identities=21% Similarity=0.282 Sum_probs=187.1
Q ss_pred eeeeccCCcEEEEEEEcCC------------CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 17 RTIGEGTFAKVKFARNSET------------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~------------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
+.||.|++|.||.|..... ...+++|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4689999999999985432 2358888865432 334567888999999999999999999999888
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC-------EEEeeCC
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-------LKVSDFG 156 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~-------~~l~df~ 156 (269)
..++++||++++++..++... ..++...+..++.|+++||+|||+.|++|+||+|+||+++.++. ++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988777653 46899999999999999999999999999999999999986654 8999999
Q ss_pred CccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhcCcccCCC
Q 024347 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISAAEFTCPP 235 (269)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
.+...... ....++..|+|||.+......+.++||||||+++|+|+ +|..||......+.. ...........
T Consensus 158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 87543211 12335678999999875554568999999999999997 689998766544432 22333333344
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
..+.++.+|++.||+.||++||++.+
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~ 256 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRA 256 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHH
Confidence 45688999999999999999999843
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=276.48 Aligned_cols=250 Identities=19% Similarity=0.309 Sum_probs=196.4
Q ss_pred eeeecc--CCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccC
Q 024347 17 RTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 17 ~~lg~g--~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
..||.| ++|+||.+.+..+|+.|++|.+...... ....+.+.+|+.+++.++||||+++++++...+..++++||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 456666 8899999999999999999998754333 2345788999999999999999999999999999999999999
Q ss_pred CCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC----
Q 024347 95 GGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG---- 168 (269)
Q Consensus 95 ~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~---- 168 (269)
++++.+++... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99998888764 358899999999999999999999999999999999999999999999997543221110000
Q ss_pred -cccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---------------
Q 024347 169 -LLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--------------- 231 (269)
Q Consensus 169 -~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------------- 231 (269)
......++..|+|||++.+.. ..+.++|+||||+++|++++|..||.................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011112345699999987642 235899999999999999999999987654443332221110
Q ss_pred --------------------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 --------------------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 --------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+....++..+.+|++.||+.||++|||+ .+++.|+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta--~e~l~~~~ 310 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSA--SSLLSHAF 310 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCH--HHHhhCHH
Confidence 1112256789999999999999999999 88888876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=269.53 Aligned_cols=249 Identities=31% Similarity=0.459 Sum_probs=201.0
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEEEEEe
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
|++.+.||.|++|+||+|....+++.+++|.+........ .....+|+..++++. |+|++++++.+...+..+++||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh--HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6889999999999999999988899999999765432211 233456889999999 9999999999999999999999
Q ss_pred ccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 92 FVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|+ ++++.+.+.... .++..++..++.|++.+|.+||++|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence 99 778888887654 7899999999999999999999999999999999999999999999999987644321 11
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------c
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------E 230 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------~ 230 (269)
.....++..|+|||++.+....+.++|+||||++++++++|+.||..........+.... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 222346778999999866554568999999999999999999999776554443332210 0
Q ss_pred c-----------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 F-----------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ~-----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ...+..+..+.++|+.||+.||++||++ .+++.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~--~ei~~~~~ 282 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA--SQALQHPY 282 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH--HHHhhCCC
Confidence 0 0011236789999999999999999999 77788877
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=267.25 Aligned_cols=252 Identities=28% Similarity=0.487 Sum_probs=207.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh--hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
||.+.+.||.|++|.||++.+...+..+++|........ .......+..|+.+++.++|||++++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 689999999999999999999877777777766432211 122234566789999999999999999999888899999
Q ss_pred EeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 90 LEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+||+++++|...+.. ...+++.++..++.|++.||.+||+.|++|+||+|+||+++. +.++|+|||.+......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~- 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS- 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC-
Confidence 999999999877753 346899999999999999999999999999999999999975 66999999987654321
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKL 244 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 244 (269)
........++..|+|||.+.+.... .++|+||+|+++|++++|..||...........+..+.. ..+..++.++.++
T Consensus 159 -~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 159 -CDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred -cccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 1122233467789999998766654 789999999999999999999988777766666655543 3345688999999
Q ss_pred HHHhcCCCCCCcCCCCccccccccC
Q 024347 245 IARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|++||+.||++||++ .+++.|+|
T Consensus 237 i~~~l~~~p~~Rp~~--~~il~~~~ 259 (260)
T cd08222 237 MQSMLNKDPSLRPSA--AEILRNPF 259 (260)
T ss_pred HHHHhcCChhhCcCH--HHHhhCCC
Confidence 999999999999999 89999988
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=267.10 Aligned_cols=248 Identities=23% Similarity=0.391 Sum_probs=194.6
Q ss_pred CCeEEeeeeeccCCcEEEEEEE----cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--CC
Q 024347 11 GKYEVGRTIGEGTFAKVKFARN----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KT 84 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 84 (269)
..|++.+.||.|++|.||.+.. ..+++.+++|.+.... ....+.+.+|+++++.++|||++++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4789999999999999999974 4568899999986443 3345778899999999999999999998743 34
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++++||+++++|.+++... ..++...+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 689999999999999988764 4689999999999999999999999999999999999999999999999998875433
Q ss_pred ccCCCc-ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHHHH
Q 024347 164 VRDDGL-LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----------------NLYKKI 226 (269)
Q Consensus 164 ~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~~~ 226 (269)
...... .....++..|+|||.+.+... +.++|+||||+++++|++|..|+...... ...+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 211100 111122345899999877665 48999999999999999987765432211 111111
Q ss_pred hc-CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 227 SA-AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 227 ~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.. ...+.+..++..+.+|+.+||+.+|++|||++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 276 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 11 2234455688999999999999999999998554
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=266.92 Aligned_cols=244 Identities=20% Similarity=0.244 Sum_probs=188.9
Q ss_pred eeeeccCCcEEEEEEEcC--CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccC
Q 024347 17 RTIGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+..++.++|+||+++++.+......+++|||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996432 34578888765432 23335677889999999999999999999999999999999999
Q ss_pred CCchhHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 95 GGELFDKIVNHG-----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 95 ~~~l~~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
+++|.+++.... ..+...+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999886643 245778889999999999999999999999999999999999999999998764322111111
Q ss_pred ccccccCccccCcccccCC------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc-Cccc-----CCCC
Q 024347 170 LHTTCGTPNYVAPEVLNDR------GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-AEFT-----CPPW 236 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~-~~~~-----~~~~ 236 (269)
.....++..|+|||++... ...+.++|+||||+++|++++ |..||......+....... .... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 1223345679999997431 223579999999999999998 8899987766655544432 2221 2335
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
+++.+.+++..|+ .||++||+++++.
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~ 264 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVH 264 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHH
Confidence 7888999999999 5999999986544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=268.22 Aligned_cols=249 Identities=30% Similarity=0.427 Sum_probs=199.1
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC---CCCCceeeeEEEeeCCe----
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGSKTK---- 85 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~~~---- 85 (269)
|++.+.||.|++|.||++.+..+++.+++|.+...... ......+.+|+.+++++ .|+|++++++.+.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 68899999999999999999888999999998644322 22234455677766655 59999999999987776
Q ss_pred -EEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 86 -IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 86 -~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
.++++||+.+ ++.+++.... .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||.+....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 7877776543 58999999999999999999999999999999999999999999999999886543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-----c--c---
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-----F--T--- 232 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~--~--- 232 (269)
... ......++..|+|||++.+... +.++|+||||+++|+|++|..||......+....+.... . +
T Consensus 159 ~~~---~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FEM---ALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CCc---ccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 321 1122235778999999987765 489999999999999999999998877665555442210 0 0
Q ss_pred -----------------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 -----------------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 -----------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+..+..+.++|..||+.||.+||++ .+++.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~--~~il~~~~ 286 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA--FEALQHPY 286 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH--HHHhcCcC
Confidence 001246778999999999999999999 78888887
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=272.08 Aligned_cols=251 Identities=27% Similarity=0.419 Sum_probs=200.6
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-CCeEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIF 87 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 87 (269)
..++|++.+.||.|++|.||++.+..+++.+++|.+..... .....+.+.+|+.+++.++|||++++.+++.. ....+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 45789999999999999999999999999999998754322 22334677889999999999999999998865 56788
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+++||+ +++|...+.. ..++...+..++.|+++||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---- 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---- 160 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence 999998 5578766653 4678888999999999999999999999999999999999999999999998764322
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------------
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA------------------- 228 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------------------- 228 (269)
......++..|+|||.+.+....+.++|+||||+++|++++|..||...........+..
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 112234577899999987644456899999999999999999999977654322211110
Q ss_pred -------C--ccc---CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 -------A--EFT---CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 -------~--~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ..+ ..+.+++.+.++|+.||+.+|++||++ .+.+.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~--~ell~~~~ 290 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISA--AEALAHPY 290 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCH--HHHhcCCc
Confidence 0 000 112467899999999999999999999 67777776
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=263.89 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=193.0
Q ss_pred eeeeccCCcEEEEEEEcC---CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe-eCCeEEEEEec
Q 024347 17 RTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-SKTKIFIVLEF 92 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~~~~~~~v~~~ 92 (269)
+.||+|+||.||+|.+.. .+..+++|.+... ......+.+.+|+.+++.++|||++++++++. ..+..+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998643 3457899987432 12334577888999999999999999999764 45568899999
Q ss_pred cCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC--CCc
Q 024347 93 VTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGL 169 (269)
Q Consensus 93 ~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~--~~~ 169 (269)
+.+++|.+++... ..++...+..++.++++||.|||+.+++|+||+|+||+++.++.++|+|||+++....... ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 9999999988764 3467778889999999999999999999999999999999999999999998864332110 011
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKLIAR 247 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~ 247 (269)
.....++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+..+....+..+.. ..+..++..+.+++..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 112234568999999877665 489999999999999999 5777887777776666655543 3345578999999999
Q ss_pred hcCCCCCCcCCCCcc
Q 024347 248 ILDPNPMTVSIYPFA 262 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~ 262 (269)
||+.+|++||++.++
T Consensus 238 cl~~~p~~Rp~~~~i 252 (262)
T cd05058 238 CWHPKPEMRPTFSEL 252 (262)
T ss_pred HcCCChhhCCCHHHH
Confidence 999999999998443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=266.62 Aligned_cols=233 Identities=23% Similarity=0.281 Sum_probs=185.5
Q ss_pred eeeccCCcEEEEEEEcC------------------------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc
Q 024347 18 TIGEGTFAKVKFARNSE------------------------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73 (269)
Q Consensus 18 ~lg~g~~~~v~~~~~~~------------------------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 73 (269)
.||+|+||.||+|.... ....+++|.+.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999997532 22457888875432 2334678889999999999999
Q ss_pred eeeeEEEeeCCeEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC----
Q 024347 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---- 148 (269)
Q Consensus 74 ~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~---- 148 (269)
+++++++......++||||+++++|..++.. .+.++...+..++.|++.||+|||+.|++|+||+|+||+++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999888765 45789999999999999999999999999999999999997543
Q ss_pred ---CEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHH-HcCCCCCCCCCHHHHHH
Q 024347 149 ---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL-LAGYLPFDDSNLMNLYK 224 (269)
Q Consensus 149 ---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l-~~g~~p~~~~~~~~~~~ 224 (269)
.++++|||.+...... ....++..|+|||.+.+....+.++|+||||+++|++ ++|..||......+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 3799999976432211 1223567799999887654446899999999999998 47999998766554433
Q ss_pred HHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCC
Q 024347 225 KISAAEFTCPPWLSFTARKLIARILDPNPMTVSIYP 260 (269)
Q Consensus 225 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 260 (269)
.. ......+...++.+.++|..||+.+|++|||++
T Consensus 233 ~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~ 267 (274)
T cd05076 233 FY-EKKHRLPEPSCKELATLISQCLTYEPTQRPSFR 267 (274)
T ss_pred HH-HhccCCCCCCChHHHHHHHHHcccChhhCcCHH
Confidence 22 223334444667899999999999999999983
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=272.51 Aligned_cols=254 Identities=27% Similarity=0.403 Sum_probs=200.3
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCC--CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEee----CC
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSET--GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS----KT 84 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~----~~ 84 (269)
+|++.+.||.|++|.||++.+..+ ++.+|+|.+.... ......+.+.+|+++++++ +|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999887 8999999975432 2223356778899999999 59999999987532 24
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..+++++++. ++|...+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5788889885 588888877778999999999999999999999999999999999999999999999999988754332
Q ss_pred cCC--CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Q 024347 165 RDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA-------------- 228 (269)
Q Consensus 165 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-------------- 228 (269)
... .......++..|+|||.+.+....+.++|+||+|+++|++++|..||...+.......+..
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 111 1122345788899999887654446899999999999999999999986554332222110
Q ss_pred -------------C-cc---cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 -------------A-EF---TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 -------------~-~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. .. ...+..+..+.+|+.+||+.||++|||+ .+++.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~--~~ll~~~~ 294 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV--EEALEHPY 294 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH--HHHhcChh
Confidence 0 00 1112357899999999999999999999 67788877
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=263.33 Aligned_cols=249 Identities=31% Similarity=0.560 Sum_probs=213.0
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEEEEEeccC
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
.+.||.|+++.|-.+....+|..||||++.+.. .....++.+|++++.+.+ |+||++++++|+++..+|+|||.+.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 368999999999999999999999999997653 344688999999999996 9999999999999999999999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC---EEEeeCCCccccccc-----cC
Q 024347 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQV-----RD 166 (269)
Q Consensus 95 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~---~~l~df~~~~~~~~~-----~~ 166 (269)
||+|+..+..++.+++.+.-++.++|+.||.+||.+||.|+|+||+||+...-+. |||+||.+..-.... ..
T Consensus 160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas 239 (463)
T KOG0607|consen 160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS 239 (463)
T ss_pred CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence 9999999999999999999999999999999999999999999999999976554 899999876433221 11
Q ss_pred CCcccccccCccccCccccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---------------CHHHHHHHHh
Q 024347 167 DGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------------NLMNLYKKIS 227 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---------------~~~~~~~~~~ 227 (269)
........|+..|||||+.. ....+..+.|.||||+++|-|++|++||.+. -...+++.|.
T Consensus 240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 22223345778999999853 2334568899999999999999999999642 2246788889
Q ss_pred cCcccCCCC----CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 228 AAEFTCPPW----LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 228 ~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.+.+|.. ++.+.+++|+.+|..||..|.++ +..+.|+|
T Consensus 320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa--~~vlnhPw 363 (463)
T KOG0607|consen 320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSA--AQVLNHPW 363 (463)
T ss_pred ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhh--hhccCCcc
Confidence 998888854 89999999999999999999999 88899988
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=269.32 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=200.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcC----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--CC
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSE----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KT 84 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 84 (269)
..|++.+.||.|++|.||++.+.. +++.+++|.+...... ...+.+.+|++.++.+.|+|++++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 568888999999999999998653 4789999998755432 345788999999999999999999999877 55
Q ss_pred eEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++++||+++++|.+++.... .++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 7899999999999999887654 589999999999999999999999999999999999999999999999998876542
Q ss_pred ccCCC-cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHh
Q 024347 164 VRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------------NLYKKIS 227 (269)
Q Consensus 164 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~~~~~ 227 (269)
..... .......+..|+|||.+.+... +.++|+||||+++++|++|..|+...... ...+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 21111 1111233456999999877665 48999999999999999999998653221 1222222
Q ss_pred c-CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcccc
Q 024347 228 A-AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 228 ~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
. ...+.+..++.++.+++.+||+.||++||+++++..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2 223445567899999999999999999999855443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=267.78 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=202.4
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEee
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS 82 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 82 (269)
.+.....++|++.+.||.|++|.||+|.+..+++.+++|.+..... ......+..|+.++.... |+||+++++++.+
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 3456678899999999999999999999998899999999865432 222345556666666664 9999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
....++++||+.+ ++...+.. ...+++..+..++.+++.+|+|||+ .|++|+||+|+||+++.++.++|+|||.+..
T Consensus 86 ~~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~ 164 (296)
T cd06618 86 DSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGR 164 (296)
T ss_pred CCeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence 9999999999854 66665554 3578999999999999999999997 5999999999999999999999999998764
Q ss_pred cccccCCCcccccccCccccCcccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCcc-cCC-
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEF-TCP- 234 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~-~~~- 234 (269)
... ........++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||..... .+....+..... ..+
T Consensus 165 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T cd06618 165 LVD---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPP 241 (296)
T ss_pred ccC---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCC
Confidence 322 11122234677899999987553 235789999999999999999999976332 233333333322 222
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 -PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 -~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..++.++.+|+++||+.||++||++ .+++.|+|
T Consensus 242 ~~~~~~~l~~li~~~l~~~p~~Rp~~--~~il~~~~ 275 (296)
T cd06618 242 NEGFSPDFCSFVDLCLTKDHRKRPKY--RELLQHPF 275 (296)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCH--HHHhcChh
Confidence 2378899999999999999999999 77777776
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=277.12 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=205.8
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK 83 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 83 (269)
-|.+.-..|++.+.||.||.+.||++.... .+.+++|.+..... +...+.-+.+|+..|.+|+ |.+|++++++-..+
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~-D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEA-DNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhc-CHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 345566789999999999999999999754 45577776654443 4566899999999999996 89999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
+.+|+||||-+ .+|.+.+..... ...-.+..+..|++.++.++|++||||.||||.|+++-. |.+||+|||++..+.
T Consensus 433 ~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99999999864 588888877654 333478889999999999999999999999999998865 789999999998777
Q ss_pred cccCCCcccccccCccccCcccccCCCC----------CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGY----------DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--- 229 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~----------~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--- 229 (269)
....+-......||+.||+||.+..... .+.++|||||||++|+|+-|+.||.... ..+.++...
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P 588 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDP 588 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCC
Confidence 6555556667789999999999865432 2578999999999999999999997532 222333221
Q ss_pred --cccCCCCCCH-HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 --EFTCPPWLSF-TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 --~~~~~~~~~~-~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+..++..-+. ++.++++.||.+||.+||++ -+.|+|+|
T Consensus 589 ~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si--~eLLqhpF 629 (677)
T KOG0596|consen 589 NHEIEFPDIPENDELIDVMKCCLARDPKKRWSI--PELLQHPF 629 (677)
T ss_pred CccccccCCCCchHHHHHHHHHHhcCcccCCCc--HHHhcCcc
Confidence 2233332222 39999999999999999999 78889887
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.48 Aligned_cols=150 Identities=31% Similarity=0.633 Sum_probs=139.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|+||.||+|.+..+++.||+|++.............+.+|+.+++.++|+||+++++.+......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999999766555556667889999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
|||+.|++|.+++...+.+++..++.++.|++.||.|||+.||+|+||+|+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999877789999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=262.91 Aligned_cols=232 Identities=20% Similarity=0.257 Sum_probs=186.0
Q ss_pred eeeeccCCcEEEEEEEcCCC----------CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 17 RTIGEGTFAKVKFARNSETG----------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~----------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+.||+|++|.||+|.+..++ ..+++|.+..... ....+.+|+.+++.++|+|++++++.+.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999998766 3477787654321 15778889999999999999999999877 778
Q ss_pred EEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-------CEEEeeCCCc
Q 024347 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-------NLKVSDFGLS 158 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-------~~~l~df~~~ 158 (269)
++++||+++++|.+++.... .++...+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999887765 789999999999999999999999999999999999999877 7999999987
Q ss_pred cccccccCCCcccccccCccccCcccccCC-CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcccCCCC
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCPPW 236 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
..... .....+...|+|||++.+. ...+.++|+||||+++|++++ |..||.............. ....+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CCCCCCC
Confidence 65332 1223345679999998776 334589999999999999998 6888876654333332221 1112222
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCC
Q 024347 237 LSFTARKLIARILDPNPMTVSIYP 260 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~ 260 (269)
....+.+++.+||+.||++||++.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~ 252 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFR 252 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHH
Confidence 347899999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=288.07 Aligned_cols=255 Identities=24% Similarity=0.405 Sum_probs=187.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCC-CCeEEEE--------------EeehhhhhhHHHHHHHHHHHHHhhhCCCCCce
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSET-GEPVALK--------------ILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~K--------------~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~ 74 (269)
.++|++++.||+|+||.||++..+.. +...+.| .+.............+.+|+.++++++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46899999999999999999875432 2222222 11111112223456788999999999999999
Q ss_pred eeeEEEeeCCeEEEEEeccCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC
Q 024347 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (269)
Q Consensus 75 ~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~ 149 (269)
++++++...+..+++++++.+ ++..++... .......+..++.|++.||.|||+.||+|+||||+||+++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999854 666665432 22345677889999999999999999999999999999999999
Q ss_pred EEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCC-CCCCCC--H-HHHHHH
Q 024347 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDSN--L-MNLYKK 225 (269)
Q Consensus 150 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~-p~~~~~--~-~~~~~~ 225 (269)
++|+|||++........ .......++..|+|||++.+..+. .++||||||+++|+|++|.. |+.... . ..+.+.
T Consensus 306 vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~ 383 (501)
T PHA03210 306 IVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383 (501)
T ss_pred EEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence 99999999875432211 112234578999999999887764 89999999999999999875 443221 1 111111
Q ss_pred Hhc-----Cccc----------------C----------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 226 ISA-----AEFT----------------C----------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 226 ~~~-----~~~~----------------~----------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.. .+++ . ...++..+.++|.+||++||.+|||+ .++|.|+|
T Consensus 384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa--~elL~hp~ 456 (501)
T PHA03210 384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA--AELLALPL 456 (501)
T ss_pred HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCH--HHHhhChh
Confidence 110 0000 0 01256678889999999999999999 78888887
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=310.14 Aligned_cols=255 Identities=32% Similarity=0.523 Sum_probs=217.7
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|+....||.|.||.||.|.+..+|+..|+|.+...... ......+.+|+.++..+.|||+++.+|+-.+.+..++-||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 788889999999999999999999999999998765554 4556788999999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc--CCCc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR--DDGL 169 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~--~~~~ 169 (269)
||+||+|.+.+..++-.++.....+..|++.|++|||+.||||+||||.||+++.+|.+|++|||.+....... -.+.
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 99999999988877667777777888999999999999999999999999999999999999999987655432 1233
Q ss_pred ccccccCccccCcccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHhcCcccCCCCCCHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNL--MNLYKKISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li 245 (269)
.....||+.|||||++.+.. ....+.|||||||++.+|+||+-||...+. ..++.--....+++|..++++-++||
T Consensus 1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence 45568999999999998754 225789999999999999999999976433 34444444556778888999999999
Q ss_pred HHhcCCCCCCcCCCCccccccccC
Q 024347 246 ARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..||+.||.+|.++ .+++.|.|
T Consensus 1475 e~Cl~~dP~~Rw~~--~qlle~~f 1496 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTA--SQLLEHAF 1496 (1509)
T ss_pred HHHHhcCchhhhHH--HHHHHhhc
Confidence 99999999999987 45555554
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=261.22 Aligned_cols=243 Identities=17% Similarity=0.226 Sum_probs=188.2
Q ss_pred eeeeccCCcEEEEEEEcCC--CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccC
Q 024347 17 RTIGEGTFAKVKFARNSET--GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~--~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
+.||+|+||.||++..... ...+++|.+.... .....+.+.+|+..++.++|||++++++.+.+....+++|||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999975433 3346677665432 22345788899999999999999999999999999999999999
Q ss_pred CCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 95 GGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 95 ~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
+++|.+++... ...+...+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||.+............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999888753 24566778899999999999999999999999999999999999999999987532211111122
Q ss_pred cccccCccccCcccccCCC------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc------ccCCCCC
Q 024347 171 HTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE------FTCPPWL 237 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~------~~~~~~~ 237 (269)
....++..|+|||++.... ..+.++|+||||+++|+|++ +..||......+....+..+. ...+..+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 2344678899999985321 12478999999999999986 578998777766666543332 1223347
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 238 SFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
++.+.+++..|| .+|++||+++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i 262 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEV 262 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHH
Confidence 888999999999 679999998654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=263.71 Aligned_cols=253 Identities=16% Similarity=0.172 Sum_probs=187.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhh--hHH------HHHHHHHHHHHhhhCCCCCceee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVL--KHK------MAEQIKREVATMKLVKHPNVVRL 76 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~--~~~------~~~~~~~e~~~l~~l~~~~i~~~ 76 (269)
..-++|++.+.||+|+||.||+|.+..+ +..+++|........ .+. .......++..+..+.|++++++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3346899999999999999999998776 667777764322111 010 01122334455667789999999
Q ss_pred eEEEeeCC----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEE
Q 024347 77 YEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (269)
Q Consensus 77 ~~~~~~~~----~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l 152 (269)
++.+.... ..+++++++. .++.+.+......++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 3467777763 366666655555788889999999999999999999999999999999999999999
Q ss_pred eeCCCccccccccC-----CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-H------
Q 024347 153 SDFGLSALSQQVRD-----DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-M------ 220 (269)
Q Consensus 153 ~df~~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~------ 220 (269)
+|||+++....... ........+++.|+|||++.+..+ +.++||||||+++++|++|..||..... .
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 99999875432111 111122358899999999987766 5999999999999999999999986522 2
Q ss_pred --HHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 221 --NLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 221 --~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
+....+..+... .+..++.+.++++.|++.+|++||++++..
T Consensus 247 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 247 KCDFIKRLHEGKIK-IKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred HHHHHHHhhhhhhc-cCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 122333333332 345789999999999999999999986544
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=285.32 Aligned_cols=246 Identities=28% Similarity=0.442 Sum_probs=206.0
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG 96 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~ 96 (269)
-.||.|.||+||-|++..+.-.+|+|.+... .....+.+++|+.+-++|+|.||++.+|.+..++.+-+.||-.+||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 3699999999999999999999999998543 2445789999999999999999999999999999999999999999
Q ss_pred chhHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-CCCEEEeeCCCccccccccCCCcccc
Q 024347 97 ELFDKIVNH-GRM--KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHT 172 (269)
Q Consensus 97 ~l~~~~~~~-~~l--~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-~~~~~l~df~~~~~~~~~~~~~~~~~ 172 (269)
+|..++... +++ ++.++.-..+||++||.|||++.|||+|||-+||+++. .|-+|++|||.++.... .+..+..
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET 735 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET 735 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence 999988765 677 78889999999999999999999999999999999984 56789999998865432 2333444
Q ss_pred cccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HhcCcccCCCCCCHHHHHHHHHh
Q 024347 173 TCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK---ISAAEFTCPPWLSFTARKLIARI 248 (269)
Q Consensus 173 ~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~ 248 (269)
.-|+..|||||++..+. .++.++|||||||++.+|.||++||-....-...-. .-...+++|..++.+.++||..|
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 55899999999997554 457999999999999999999999964332222211 12345678888999999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+||.+||++ -+.|..+|
T Consensus 816 Fepd~~~R~sA--~~LL~DpF 834 (1226)
T KOG4279|consen 816 FEPDPCDRPSA--KDLLQDPF 834 (1226)
T ss_pred cCCCcccCccH--HHhccCcc
Confidence 99999999998 66666554
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=257.83 Aligned_cols=246 Identities=36% Similarity=0.639 Sum_probs=202.0
Q ss_pred cCCeEEe-eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhh-CCCCCceeeeEEEee----C
Q 024347 10 VGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGS----K 83 (269)
Q Consensus 10 ~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~----~ 83 (269)
.++|++. +.||.|-.|.|-.+.++.+++.+|+|++... ....+|++.-=. -.||||+.+++++.+ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 3455543 6799999999999999999999999986432 233445554322 359999999998844 4
Q ss_pred CeEEEEEeccCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC---CCEEEeeCCCc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLS 158 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~--l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~---~~~~l~df~~~ 158 (269)
..+.+|||.++||.|.+.+..++. +++.++..|.+||..|+.|||+.+|.|+||||+|+|.... -.+||+|||++
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 567899999999999999988764 9999999999999999999999999999999999999743 35899999998
Q ss_pred cccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCcccCC
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCP 234 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~ 234 (269)
+.... ........-++.|.|||++....+. ...|+||+|+++|-|++|.+||..+.. -....+|..+.+.+|
T Consensus 212 K~t~~---~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 212 KETQE---PGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred cccCC---CccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 75432 3444556679999999999888765 889999999999999999999976543 246677777777666
Q ss_pred C--C--CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 P--W--LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 ~--~--~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. | +|+..+++|+.+|..+|.+|.++ .+.+.|+|
T Consensus 288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI--~~~m~hpw 324 (400)
T KOG0604|consen 288 EPEWSCVSEAAKDLIRKLLKTEPTERLTI--EEVMDHPW 324 (400)
T ss_pred ChhHhHHHHHHHHHHHHHhcCCchhheeH--HHhhcCch
Confidence 3 2 79999999999999999999999 77778877
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=256.46 Aligned_cols=230 Identities=29% Similarity=0.395 Sum_probs=187.7
Q ss_pred cCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCchhHH
Q 024347 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDK 101 (269)
Q Consensus 22 g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~ 101 (269)
|.++.||+++++.+++.+++|.+..... ..+|...+....|||++++++.+......+++|||++|++|.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8899999999999999999999865431 12344444556799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccC
Q 024347 102 IVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181 (269)
Q Consensus 102 ~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~a 181 (269)
+.....+++..+..++.|+++||.++|+.|++|+||+|+||+++.++.++++|||.+...... ......+..|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccC
Confidence 887778999999999999999999999999999999999999999999999999976543321 112234567999
Q ss_pred cccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCC-
Q 024347 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVSIYP- 260 (269)
Q Consensus 182 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~- 260 (269)
||.+.+... +.++|+||+|+++|++++|..|+....... ........+..+++.++++|++||+.||++||++.
T Consensus 151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 999876665 489999999999999999998876432211 01122345667899999999999999999999963
Q ss_pred --ccccccccC
Q 024347 261 --FADILYMRF 269 (269)
Q Consensus 261 --~~~~l~~~~ 269 (269)
..+++.|+|
T Consensus 226 ~~~~~~~~h~~ 236 (237)
T cd05576 226 AGVEDIKSHPF 236 (237)
T ss_pred cchHHHHcCCC
Confidence 246678887
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=264.83 Aligned_cols=244 Identities=20% Similarity=0.343 Sum_probs=190.7
Q ss_pred CCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCchhHHH
Q 024347 23 TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI 102 (269)
Q Consensus 23 ~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~ 102 (269)
+.+.||.++...+++.+|+|++..... .....+.+.+|+.+++.++|+||+++++.+......++++||++++++.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 456677777777899999999876532 2344678999999999999999999999999999999999999999999888
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC-----CCccccccc
Q 024347 103 VNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----DGLLHTTCG 175 (269)
Q Consensus 103 ~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~~~ 175 (269)
... ..+++..+..++.|++.||+|||+.||+|+||+|+||+++.++.++++||+.+........ ........+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence 753 4588999999999999999999999999999999999999999999999998764432111 111122235
Q ss_pred CccccCcccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHhcCc-----------------------
Q 024347 176 TPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY-KKISAAE----------------------- 230 (269)
Q Consensus 176 ~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~----------------------- 230 (269)
+..|+|||++.+. ...+.++|+||+|+++|++++|..||......... +.+....
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (314)
T cd08216 171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250 (314)
T ss_pred cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence 6689999998764 22358899999999999999999999875544332 2211100
Q ss_pred ----------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ----------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
......++.++.+|++.||+.||++|||+ .+++.|+|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~--~~ll~~p~ 297 (314)
T cd08216 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSA--SQLLNHSF 297 (314)
T ss_pred cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCH--HHHhcCch
Confidence 00011134678899999999999999999 77777876
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=276.98 Aligned_cols=244 Identities=32% Similarity=0.541 Sum_probs=206.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhh-CCCCCceeeeEEEeeCCeE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL-VKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~ 86 (269)
...+.|.+...+|.|+|+.|..+.+..+++..++|++.... .+..+|+.++.. -+|+|+++..+.+.+....
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCcee
Confidence 35788999999999999999999999999999999986652 233456655444 4699999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe-cCCCCEEEeeCCCcccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-DAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~-~~~~~~~l~df~~~~~~~~~~ 165 (269)
++|||.+.|+-+.+.+...+.+. ..+..|+.+|+.|+.+||+.|++|||++|+|||+ +..++++|+|||.++.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999998887777655554 7777899999999999999999999999999999 68899999999987754432
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCcccCCCCCCHHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCPPWLSFTARKL 244 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l 244 (269)
....+-+..|.|||+.....+ +.++|+||||+++|+|++|+.||...+.. ++...+..+++. ..+|...++|
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdL 542 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDL 542 (612)
T ss_pred ----hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHH
Confidence 333345778999999997666 49999999999999999999999877666 666666666655 7799999999
Q ss_pred HHHhcCCCCCCcCCCCccccccccC
Q 024347 245 IARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|++||+.||.+||++ .++..|+|
T Consensus 543 l~~LL~~dP~~Rl~~--~~i~~h~w 565 (612)
T KOG0603|consen 543 LQQLLQVDPALRLGA--DEIGAHPW 565 (612)
T ss_pred HHHhccCChhhCcCh--hhhccCcc
Confidence 999999999999999 67777776
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=275.16 Aligned_cols=244 Identities=32% Similarity=0.600 Sum_probs=213.5
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCC
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG 95 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~ 95 (269)
.+.||.|.||+||-|++..+|+.||||++.+..+..... ..+.+|+.+|+++.||+|+.+.-.|++.+.+++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 478999999999999999999999999998877665543 7889999999999999999999999999999999999955
Q ss_pred CchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC---CCEEEeeCCCccccccccCCCcc
Q 024347 96 GELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 96 ~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~---~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
+++..+.. .+++++...+-++.||+.||.|||-.+|+|+|+||+||++... .++||||||++++++. ....
T Consensus 648 -DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFR 723 (888)
T KOG4236|consen 648 -DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE---KSFR 723 (888)
T ss_pred -hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch---hhhh
Confidence 77777654 4689999999999999999999999999999999999999744 4699999999997664 3334
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCC----CCHHHHHHHH
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW----LSFTARKLIA 246 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~ 246 (269)
....|++.|.|||++..+.+. ..-|+||+|+++|.-++|+.||... +++.+++.+..+.+|+. +++...+||.
T Consensus 724 rsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn 800 (888)
T KOG4236|consen 724 RSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLIN 800 (888)
T ss_pred hhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHH
Confidence 456799999999999998886 8889999999999999999999754 67778888888777653 8999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+|+..-.+|-|. .+.|-|+|
T Consensus 801 ~LLqVkm~kRysv--dk~lsh~W 821 (888)
T KOG4236|consen 801 NLLQVKMRKRYSV--DKSLSHPW 821 (888)
T ss_pred HHHHHHHHHhcch--Hhhccchh
Confidence 9999999999998 66666666
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=265.78 Aligned_cols=251 Identities=29% Similarity=0.436 Sum_probs=217.6
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
++...+.|..-..||.|+||.|+-++...+|+.+|.|.+............-..+|-.+|.+++.+.|+.+-..|.+.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 46667789999999999999999999999999999999876655555545667889999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
+|+|+..++||+|.-.+.+.+ .+++..+.-.+.+|+-+|.+||+.+||++|+||.|||+++.|++.|+|+|++.-+.
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~- 338 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP- 338 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC-
Confidence 999999999999977776655 79999999999999999999999999999999999999999999999999986433
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCcccCCCCCCH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLSF 239 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~ 239 (269)
.........||.+|||||++....+ +...|.|||||++|+|+.|+.||..... .++-..+.......+..+++
T Consensus 339 --~g~~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 339 --EGKPIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred --CCCccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence 3333444579999999999998885 5999999999999999999999976433 34555556666777788999
Q ss_pred HHHHHHHHhcCCCCCCcCCCC
Q 024347 240 TARKLIARILDPNPMTVSIYP 260 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~ 260 (269)
+.+++.+.+|++||++|.-..
T Consensus 416 eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred HHHHHHHHHHccCHHHhccCC
Confidence 999999999999999998753
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=294.04 Aligned_cols=259 Identities=31% Similarity=0.514 Sum_probs=223.1
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
....++|.+++.||+|+||.|..++++++++-||.|.++.-.+........|.+|=+++..-..+=|+.++-.|++..++
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence 44567899999999999999999999999999999998764444333356788899999998899999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
|+||+|++||+|..++.+.+.++++...-++..|.-||..+|+.|+||+||||+|||++..|+++|+|||.|-.+.. +.
T Consensus 151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~-dG 229 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-DG 229 (1317)
T ss_pred EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-CC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999876543 22
Q ss_pred CCcccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cccCC--CCCC
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP--PWLS 238 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~--~~~~ 238 (269)
.-......|||.|.+||++... ..++..+|.||+|+++|+|+.|..||......+-+.+|.+- .+.+| ..+|
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VS 309 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVS 309 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccC
Confidence 2334456799999999998532 44579999999999999999999999999999999999665 45666 5699
Q ss_pred HHHHHHHHHhcCCCCCCcCC---CCccccccccC
Q 024347 239 FTARKLIARILDPNPMTVSI---YPFADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps---~~~~~~l~~~~ 269 (269)
...++||...+. +|+.|.. + .++-.|+|
T Consensus 310 eeakdLI~~ll~-~~e~RLgrngi--edik~HpF 340 (1317)
T KOG0612|consen 310 EEAKDLIEALLC-DREVRLGRNGI--EDIKNHPF 340 (1317)
T ss_pred HHHHHHHHHHhc-ChhhhcccccH--HHHHhCcc
Confidence 999999999985 7888887 5 44445655
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=271.42 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=215.5
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
++..-.+...-++||.|.||.||.|.|+.-.--||||.++.+.+ ..+.|..|+.+++.++|||+++++|+|.....
T Consensus 262 WEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 262 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 34444566677899999999999999998888899999876543 36789999999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
+|+|.||+..|+|++++.+.. .++.-.++.++.||.+|+.||...+++|+|+...|.|++++..||+.|||+++++..
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 999999999999999997753 477778899999999999999999999999999999999999999999999998654
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 241 (269)
.-.. .........-|.|||-+.-..+. .++|||+||+++|+|.| |-.||.+.+....+..+..+ +...|..|++.+
T Consensus 418 DTYT-AHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkV 495 (1157)
T KOG4278|consen 418 DTYT-AHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKV 495 (1157)
T ss_pred Ccee-cccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHH
Confidence 2211 11111234579999998777664 99999999999999998 89999999999999888665 456678899999
Q ss_pred HHHHHHhcCCCCCCcCCCCcc
Q 024347 242 RKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+|+++||+|+|..||++.+.
T Consensus 496 YeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 496 YELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred HHHHHHHhcCCcccCccHHHH
Confidence 999999999999999999443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=272.10 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=210.2
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCC----CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSET----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 81 (269)
++.+-+.....+.||.|.||.||.|.+..- .--||||+++.+. +.+..+.|.+|+.+++++.||||++++|++.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 344555666778999999999999987633 3357888876544 3444789999999999999999999999996
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
.. ..++|||.++-|.|..++..++ .++..++..++.|++.||.|||+...||+||...||++.....|||+|||+++.
T Consensus 462 e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 462 EQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred cc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 54 6799999999999999998764 699999999999999999999999999999999999999999999999999987
Q ss_pred cccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc-CcccCCCCCC
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-AEFTCPPWLS 238 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 238 (269)
......-... ...-+.-|+|||.++-... +.++|||.||+++|+++. |..||.+-...+..-.+.+ .+.+.|++||
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCP 618 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCP 618 (974)
T ss_pred ccccchhhcc-ccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCC
Confidence 6543222111 1222457999999977666 489999999999999875 9999988766666666654 4689999999
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 239 FTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
+.+..|+.+||..||.+||.+.+..
T Consensus 619 p~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 619 PALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred hHHHHHHHHHhccCcccCCcHHHHH
Confidence 9999999999999999999986654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=260.63 Aligned_cols=249 Identities=31% Similarity=0.533 Sum_probs=224.3
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 85 (269)
-+...+|..+..||.|+||.|-++..+++.+.+|+|+++.+..-..+..+.-+.|-++|..-. -|.+++++..|++-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 345668999999999999999999999999999999998877766666677777888888775 5778999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+++||||++||+|--.++.-+.+.+....-.+..|+-+|-+||+.||+++|++.+||+++.+|+++++|||+|.- ..-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--ccc
Confidence 999999999999988888888899999999999999999999999999999999999999999999999999863 222
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 245 (269)
.........|+|.|+|||++...++. ..+|.||+|+++|+|+.|++||++.+..++++.+.......|..+|.+..++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 33344556899999999999988875 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCcCC
Q 024347 246 ARILDPNPMTVSI 258 (269)
Q Consensus 246 ~~~l~~dP~~Rps 258 (269)
+..|.+.|.+|.-
T Consensus 582 kg~ltK~P~kRLG 594 (683)
T KOG0696|consen 582 KGLLTKHPGKRLG 594 (683)
T ss_pred HHHhhcCCccccC
Confidence 9999999999975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=246.85 Aligned_cols=239 Identities=45% Similarity=0.790 Sum_probs=204.0
Q ss_pred CCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCchhHHH
Q 024347 23 TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI 102 (269)
Q Consensus 23 ~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~ 102 (269)
++|.||++.+..+++.+++|.+........ .+.+.+|++.+++++|+|++++++.+......++++|++.+++|...+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 578999999998899999999875543222 578889999999999999999999999989999999999999999988
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCc
Q 024347 103 VNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182 (269)
Q Consensus 103 ~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aP 182 (269)
.....++...+..++.+++.++.+||+.+++|+||+|+||+++.++.++++|||.+....... ......+...|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCH
Confidence 776668999999999999999999999999999999999999999999999999887554322 22334467789999
Q ss_pred ccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCcccCCCC---CCHHHHHHHHHhcCCCCCCcCC
Q 024347 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW---LSFTARKLIARILDPNPMTVSI 258 (269)
Q Consensus 183 E~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~~dP~~Rps 258 (269)
|........ .++|+|+||++++++++|..||.. .......+.+.......... ++.++.+++.+||..||++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999866664 799999999999999999999987 66666666666555544333 8899999999999999999999
Q ss_pred CCccccccccC
Q 024347 259 YPFADILYMRF 269 (269)
Q Consensus 259 ~~~~~~l~~~~ 269 (269)
+ .+.+.++|
T Consensus 235 ~--~~~~~~~~ 243 (244)
T smart00220 235 A--EEALQHPF 243 (244)
T ss_pred H--HHHhhCCC
Confidence 9 77888876
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=284.36 Aligned_cols=252 Identities=30% Similarity=0.504 Sum_probs=198.6
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-------
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------- 82 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 82 (269)
.++|+..+.||+||||.||+++++=+|+.||+|.+.... +......+.+|+..+.+|+|||+++++..+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 457788899999999999999999999999999998765 44556788999999999999999998621100
Q ss_pred --------------------------------------------------------------------------------
Q 024347 83 -------------------------------------------------------------------------------- 82 (269)
Q Consensus 83 -------------------------------------------------------------------------------- 82 (269)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CeEEEEEeccCCCchhHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 024347 83 ------------------------K--------TKIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLINAVDYCHS 129 (269)
Q Consensus 83 ------------------------~--------~~~~~v~~~~~~~~l~~~~~~~~~l-~~~~~~~i~~~i~~~l~~lh~ 129 (269)
. ..+|+-||||+..++.+++..+... .....++++++|++||.|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 0 1357889999887777766665444 477899999999999999999
Q ss_pred CCcEeecCCCCceEecCCCCEEEeeCCCccccc----c------------ccCCCcccccccCccccCcccccCCC--CC
Q 024347 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ----Q------------VRDDGLLHTTCGTPNYVAPEVLNDRG--YD 191 (269)
Q Consensus 130 ~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~----~------------~~~~~~~~~~~~~~~~~aPE~~~~~~--~~ 191 (269)
.|++||||||.|||+++++.|||+|||++.... . ...........||..|+|||++.+.. .+
T Consensus 716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999999999999999999987611 0 01111233456889999999998777 56
Q ss_pred CCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCcccCCCCC----CHHHHHHHHHhcCCCCCCcCCCCcccccc
Q 024347 192 GSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPWL----SFTARKLIARILDPNPMTVSIYPFADILY 266 (269)
Q Consensus 192 ~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~~~~----~~~l~~li~~~l~~dP~~Rps~~~~~~l~ 266 (269)
..|+|+||||+++++|+ .||.. ........++..+.++.++.+ -+.-..+|++||+.||.+|||+ .+.|.
T Consensus 796 n~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA--~eLL~ 870 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTA--TELLN 870 (1351)
T ss_pred cchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCH--HHHhh
Confidence 79999999999999998 55653 344566667777777766321 2345689999999999999999 66665
Q ss_pred cc
Q 024347 267 MR 268 (269)
Q Consensus 267 ~~ 268 (269)
..
T Consensus 871 s~ 872 (1351)
T KOG1035|consen 871 SE 872 (1351)
T ss_pred cc
Confidence 43
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=265.99 Aligned_cols=253 Identities=20% Similarity=0.297 Sum_probs=211.6
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++..+.+.||+|.||.|.+++-.. +..||+|+.+..... ...+++.+|+++|.+++||||+.++++|..++.++++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 3567788999999999999998743 689999999876643 3468999999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 90 LEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~--l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+||++.|+|.+++..+.. ........|+.||+++++||.+.++||||+.+.|++++.++++|++|||.++-.-..+.-
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999999988743 344556789999999999999999999999999999999999999999998743332222
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHhcC--------cccCCCCC
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA--GYLPFDDSNLMNLYKKISAA--------EFTCPPWL 237 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~--------~~~~~~~~ 237 (269)
..-....-+.+|+|||.+.-+..+ .++|+|++|+++|++++ ...||+........++.... -++.|+-+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 222222235689999999887775 89999999999999864 78999988887777776422 23556679
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCCcccccc
Q 024347 238 SFTARKLIARILDPNPMTVSIYPFADILY 266 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~~~~~l~ 266 (269)
+..+.+++-.||+.|-++|||+++...+.
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh~~l 801 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLHLFL 801 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHHHHH
Confidence 99999999999999999999998876653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=267.76 Aligned_cols=259 Identities=32% Similarity=0.558 Sum_probs=231.4
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
...+.+++++..||-|+||.|=++..+....-+|+|.++..........+.+..|-+++-..+.|.|+++|-.|.++..+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 34567788899999999999999988766666899988776666666678899999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
|++||-|-||.++..+..++.+...+..-++..+++|+.|||+.||+++|+||+|.+++.+|-+||+|||+++....
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~--- 572 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS--- 572 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986554
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--ccCCCCCCHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKL 244 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~l 244 (269)
...+...+|++.|.|||++....+. .++|.||||+++|++++|.+||++.+++..++.+..+- ..+|..++....+|
T Consensus 573 g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L 651 (732)
T KOG0614|consen 573 GRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL 651 (732)
T ss_pred CCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence 4555677899999999999999987 99999999999999999999999999999999998764 57788899999999
Q ss_pred HHHhcCCCCCCcCCCCc---cccccccC
Q 024347 245 IARILDPNPMTVSIYPF---ADILYMRF 269 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~---~~~l~~~~ 269 (269)
|+.+...+|.+|.-.+. .++-.|+|
T Consensus 652 ik~LCr~~P~ERLG~~~~gI~DIkkH~W 679 (732)
T KOG0614|consen 652 IKKLCRDNPTERLGYQKGGINDIKKHRW 679 (732)
T ss_pred HHHHHhcCcHhhhccccCChHHHHhhhh
Confidence 99999999999987322 34445555
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.31 Aligned_cols=257 Identities=28% Similarity=0.419 Sum_probs=221.1
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEee-
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS- 82 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~- 82 (269)
..+...+.|++.+.+|.|.+|.||+++++.+++..|+|+..... +.-+.+..|+++++.+. |||++.+++++.-
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 34667889999999999999999999999999999999976543 22366778999999885 9999999999843
Q ss_pred ----CCeEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCC
Q 024347 83 ----KTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (269)
Q Consensus 83 ----~~~~~~v~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~ 156 (269)
.+.+++|||||.|||..+++.. ...+.++.++-|++.++.|+.+||.+.++|+||+-.||+++.++.|||+|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeee
Confidence 5679999999999999998876 3578899999999999999999999999999999999999999999999999
Q ss_pred CccccccccCCCcccccccCccccCcccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc
Q 024347 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 232 (269)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (269)
.+....... +......|++.|||||++.... .+...+|+||||++..+|..|.+|+....++...-.+-...++
T Consensus 169 vSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP 246 (953)
T KOG0587|consen 169 VSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP 246 (953)
T ss_pred eeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc
Confidence 987655433 3344456899999999986543 2247899999999999999999999999998887777666554
Q ss_pred C---CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 C---PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 ~---~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. +..+++++.+||..||.+|.++||+. .+.|+|+|
T Consensus 247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~--~~ll~hpF 284 (953)
T KOG0587|consen 247 KLKRPKKWSKKFNDFISTCLVKDYEQRPST--EELLKHPF 284 (953)
T ss_pred cccchhhHHHHHHHHHHHHHhhccccCcch--hhhccCCc
Confidence 3 34589999999999999999999999 89999987
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=271.68 Aligned_cols=242 Identities=32% Similarity=0.510 Sum_probs=192.3
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC------
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT------ 84 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------ 84 (269)
.-|.--+.||.|+||.||+++++.+|+.||+|.++..... .-.+....|++++++++|+|||+..++-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 3566678999999999999999999999999999765533 33577889999999999999999998865443
Q ss_pred eEEEEEeccCCCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec--CCCC--EEEeeCCC
Q 024347 85 KIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD--AYGN--LKVSDFGL 157 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~--~~~~--~~l~df~~ 157 (269)
.-.++||||.||+|...+.+ +..+++.++..++.++..||.+||++||+||||||.||++- .+|+ .||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 45789999999999999865 35799999999999999999999999999999999999985 3343 69999999
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHh------
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKIS------ 227 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~------ 227 (269)
++- .+.+.......||..|.+||.+.....++..+|.||||+++|+..||..||...... +....+.
T Consensus 171 Are---l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARE---LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred ccc---CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 873 344556677789999999999996555679999999999999999999999542111 1222221
Q ss_pred ---------cC------cccCCCCCCHH----HHHHHHHhcCCCCCCcC
Q 024347 228 ---------AA------EFTCPPWLSFT----ARKLIARILDPNPMTVS 257 (269)
Q Consensus 228 ---------~~------~~~~~~~~~~~----l~~li~~~l~~dP~~Rp 257 (269)
++ .++.+-.+++. +-.++..||.++|++|-
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11 12222223333 45668889999999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=273.39 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=217.3
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
+..+...+.+.||.|.||.|++|..+..| ..||+|+++.. .++....+|..|+.++-++.||||+++.|+.....
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 44566789999999999999999987654 57899998643 35666889999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
...++.||++.|+|..++..+ +.++..++..+++.|+++++||.+.++||+||...|||++.+..+|++|||+++....
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999999999765 5799999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCCccccc--ccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc-CcccCCCCCCH
Q 024347 164 VRDDGLLHTT--CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA-AEFTCPPWLSF 239 (269)
Q Consensus 164 ~~~~~~~~~~--~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (269)
.. ....... .-+.+|.|||.+....++ .++||||+|++|||.|+ |.-||=+....+..+.+.. -+++.|..+|.
T Consensus 784 d~-~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~ 861 (996)
T KOG0196|consen 784 DP-EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPA 861 (996)
T ss_pred CC-CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcH
Confidence 33 1111111 124689999999888875 99999999999999887 8999988888887777755 56888899999
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcc
Q 024347 240 TARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.|.+|+..||++|=.+||.++|+
T Consensus 862 aL~qLMldCWqkdR~~RP~F~qi 884 (996)
T KOG0196|consen 862 ALYQLMLDCWQKDRNRRPKFAQI 884 (996)
T ss_pred HHHHHHHHHHHHHhhcCCCHHHH
Confidence 99999999999999999999654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=247.61 Aligned_cols=249 Identities=23% Similarity=0.381 Sum_probs=198.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHh-hhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
..+-++.||.|+||+|++..++.+|+..|||.+..... +...+++..|.+.. +.-+.|||+++||+....+.+++.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 44556789999999999999999999999999976553 44466777777755 4446899999999999999999999
Q ss_pred eccCCCchhHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 91 EFVTGGELFDKIV-----NHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 91 ~~~~~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
|.++ .|+..+.. ....+++.-+..+......||.||-.. .|+|+|+||+||+++..|.+||||||+|....
T Consensus 143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv-- 219 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV-- 219 (361)
T ss_pred HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHH--
Confidence 9995 46543332 134689999999999999999999975 89999999999999999999999999986433
Q ss_pred cCCCcccccccCccccCcccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCcccCCC------C
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGY-DGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTCPP------W 236 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~------~ 236 (269)
.+-......|...|+|||.+..... +..+||+||||+++|++.||..||...+. .+...++..+.++... .
T Consensus 220 -~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~ 298 (361)
T KOG1006|consen 220 -DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH 298 (361)
T ss_pred -HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence 2223344568889999999976543 45899999999999999999999987543 3444444556554432 2
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCcccccccc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
++..+..+|..||.+|-..||.+ .+.+.++
T Consensus 299 ~s~~~~~fintCl~Kd~~~Rpky--~~Lk~~~ 328 (361)
T KOG1006|consen 299 YSFSMVRFINTCLIKDRSDRPKY--DDLKKFP 328 (361)
T ss_pred cCHHHHHHHHHHhhcccccCcch--hhhhcCc
Confidence 78899999999999999999998 4444444
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=244.86 Aligned_cols=251 Identities=30% Similarity=0.548 Sum_probs=224.7
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 83 (269)
+......+|.++..||+|+|..|-+++.+.+.+.+|+|+++.+-.+..+.+++.+.|-.+..+- +||.++.++..|++.
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 3456678999999999999999999999999999999999998888888889998888887666 589999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
+++++|.||.+||+|--.+...+.++++...-....|.-||.|||++||+++|+|.+|++++..|++||+|+|.|+- .
T Consensus 324 srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke--~ 401 (593)
T KOG0695|consen 324 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--G 401 (593)
T ss_pred ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc--C
Confidence 99999999999999977777778899999999999999999999999999999999999999999999999999863 3
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC--------CCCHHHHHHHHhcCcccCCC
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD--------DSNLMNLYKKISAAEFTCPP 235 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~--------~~~~~~~~~~~~~~~~~~~~ 235 (269)
......+....|+|.|.|||++.+..+. ...|.|+||+++++|+.|+.||+ .+....+++-+......+|.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeyg-fsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr 480 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR 480 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccC-ceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc
Confidence 3445566777899999999999998875 99999999999999999999995 24555677777888888888
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCC
Q 024347 236 WLSFTARKLIARILDPNPMTVSI 258 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps 258 (269)
.++-....+++.-|++||.+|.-
T Consensus 481 slsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 481 SLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred eeehhhHHHHHHhhcCCcHHhcC
Confidence 89999999999999999999864
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=265.31 Aligned_cols=248 Identities=25% Similarity=0.421 Sum_probs=211.7
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCC-CC--eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSET-GE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
++....+.||+|.||.|++|.|+.. |+ .||||.+..+.... ...+|.+|+.++.+|+|+|++++||+.-+ ....
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence 3455678999999999999988743 33 67999987666543 47899999999999999999999999877 6788
Q ss_pred EEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+|+|.++.|+|++.+... ..|....+..++.||+.|++||.+++.||+|+...|+++-....||++|||+.+......
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999999772 457788899999999999999999999999999999999998999999999988665432
Q ss_pred CCC-cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHH
Q 024347 166 DDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (269)
Q Consensus 166 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 242 (269)
.-- ......-.+.|+|||.+....++ .++|+|++|+++|||++ |..||.+.....+.+++-.+ +.+.+..|++++.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY 345 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIY 345 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHH
Confidence 211 11122235689999999988875 99999999999999998 89999999999999998654 4788889999999
Q ss_pred HHHHHhcCCCCCCcCCCCcc
Q 024347 243 KLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~ 262 (269)
++++.||..+|++||++..+
T Consensus 346 ~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 346 QIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred HHHHHhccCCccccccHHHH
Confidence 99999999999999998554
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=249.52 Aligned_cols=247 Identities=30% Similarity=0.471 Sum_probs=199.7
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC--CCC----ceeeeEEEeeC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--HPN----VVRLYEVMGSK 83 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~----i~~~~~~~~~~ 83 (269)
.+||.+++.+|+|.||.|-.+++..++..+|+|+++.- ....+...-|+++|+++. .|+ +++..++|...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 68999999999999999999999999999999997542 233566777999999994 232 66777889999
Q ss_pred CeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC---------------
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--------------- 146 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~--------------- 146 (269)
+..|+|+|.+ |.|+.+++.+++ +++..++..+..|+++++++||+.+++|.|+||+||++-.
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999998 679999998764 6899999999999999999999999999999999999831
Q ss_pred -----CCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 024347 147 -----YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (269)
Q Consensus 147 -----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 221 (269)
+..++++|||.+....... .....|..|+|||++.+-+++ ..+||||+||+++|+.+|...|...+..+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCCcHH
Confidence 2348999999887544322 344578899999999999996 99999999999999999999997655333
Q ss_pred ---HHHHHhc------------------CcccCCCC-------------------------CCHHHHHHHHHhcCCCCCC
Q 024347 222 ---LYKKISA------------------AEFTCPPW-------------------------LSFTARKLIARILDPNPMT 255 (269)
Q Consensus 222 ---~~~~~~~------------------~~~~~~~~-------------------------~~~~l~~li~~~l~~dP~~ 255 (269)
+.+.+.. ++...+.. .-..|.+|++.||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 3333221 11111100 1235889999999999999
Q ss_pred cCCCCccccccccC
Q 024347 256 VSIYPFADILYMRF 269 (269)
Q Consensus 256 Rps~~~~~~l~~~~ 269 (269)
|+|+ .++|.|+|
T Consensus 397 RiTl--~EAL~HpF 408 (415)
T KOG0671|consen 397 RITL--REALSHPF 408 (415)
T ss_pred cccH--HHHhcCHH
Confidence 9999 99999987
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=245.78 Aligned_cols=129 Identities=29% Similarity=0.511 Sum_probs=113.7
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-----C---CCceeeeEEEee
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----H---PNVVRLYEVMGS 82 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~---~~i~~~~~~~~~ 82 (269)
+||.+.++||+|-||+||++++.++.+.||+|+.+... .+.+....|+.+|+++. + .+|+++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh 153 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH 153 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence 59999999999999999999999999999999987654 34567788999999885 2 469999999954
Q ss_pred ----CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEe
Q 024347 83 ----KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLL 144 (269)
Q Consensus 83 ----~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~ 144 (269)
..++|+|+|++ |.+|+.++... +.++...+++|++|++.||.|||. +||+|.||||+|||+
T Consensus 154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred cCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 45799999999 77898888764 569999999999999999999996 599999999999998
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=239.51 Aligned_cols=256 Identities=27% Similarity=0.385 Sum_probs=196.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-CC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KT 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 84 (269)
...|++.+.||+|.||.||+|..+.++. .+|+|.|..++..+ ......-+|+.+++.++|||++.+..+|-. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3479999999999999999996554422 68999987653222 223566789999999999999999988855 88
Q ss_pred eEEEEEeccCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC----CCEEEeeC
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY----GNLKVSDF 155 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~----~~~~l~df 155 (269)
.++++++|.+. +|.+.+.-+ +.++...++.++-||+.++.|||++=|+|+|+||.||++..+ |.||++|+
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 89999999976 888877543 468999999999999999999999999999999999999988 88999999
Q ss_pred CCccccccccCCC-cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHH
Q 024347 156 GLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------NLYKK 225 (269)
Q Consensus 156 ~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~~~~~ 225 (269)
|++++....-..- ......-+.-|+|||.+.+..++|++.|+|++||++.||++-.+.|.+.... +....
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 9999876533222 2222334667999999999999999999999999999999987777432111 11111
Q ss_pred Hh-------cCcccC----CC--------------------------CCCHHHHHHHHHhcCCCCCCcCCCCcccccccc
Q 024347 226 IS-------AAEFTC----PP--------------------------WLSFTARKLIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 226 ~~-------~~~~~~----~~--------------------------~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
|. ....+. |. .-++...+|+..||+.||.+|.|+ .+++.|.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta--~qAleh~ 338 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITA--EQALEHP 338 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccH--HHHhccc
Confidence 10 000000 00 024557799999999999999999 5666665
Q ss_pred C
Q 024347 269 F 269 (269)
Q Consensus 269 ~ 269 (269)
|
T Consensus 339 y 339 (438)
T KOG0666|consen 339 Y 339 (438)
T ss_pred c
Confidence 4
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=260.09 Aligned_cols=250 Identities=18% Similarity=0.242 Sum_probs=169.7
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCC----CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEE-----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSET----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV----- 79 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~----- 79 (269)
..++|++.+.||+|+||.||+|.+..+ +..+|+|.+...... +...++ .+....+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 678999999999999999999999988 899999987532211 111111 1111122222221111
Q ss_pred -EeeCCeEEEEEeccCCCchhHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCC
Q 024347 80 -MGSKTKIFIVLEFVTGGELFDKIVNHGR--------------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLK 138 (269)
Q Consensus 80 -~~~~~~~~~v~~~~~~~~l~~~~~~~~~--------------------l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~ 138 (269)
.......+++++|+.+++|.+++..... .....+..++.|++.||.|||+.||+|+|||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2355678999999999999888865321 1123466799999999999999999999999
Q ss_pred CCceEecC-CCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCC---------------------CCchh
Q 024347 139 PENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD---------------------GSTAD 196 (269)
Q Consensus 139 ~~nIl~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---------------------~~~~D 196 (269)
|+|||++. ++.++|+|||++....... ........+++.|+|||.+...... +.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 5789999999986433211 1122334578899999976432211 23569
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---------------------cCCCCCCHHHHHHHHHhcCCCCCC
Q 024347 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------------------TCPPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 197 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~l~~li~~~l~~dP~~ 255 (269)
|||+||++|+|+++..|++.. .......+..... ......+....+||+.||+.||++
T Consensus 362 VwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999987665432 1111111111100 000112334568999999999999
Q ss_pred cCCCCccccccccC
Q 024347 256 VSIYPFADILYMRF 269 (269)
Q Consensus 256 Rps~~~~~~l~~~~ 269 (269)
|||+ .++|.|+|
T Consensus 441 R~ta--~e~L~Hpf 452 (566)
T PLN03225 441 RISA--KAALAHPY 452 (566)
T ss_pred CCCH--HHHhCCcC
Confidence 9999 88899988
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=238.17 Aligned_cols=254 Identities=25% Similarity=0.413 Sum_probs=201.1
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC-----e
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----K 85 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 85 (269)
-+.+.-+.||.|+||.||.+.+..+|+.+++|++.. .+.+-..-+.+.+|+.+|..++|.|++..+++..... .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 345566789999999999999999999999999754 3334444578899999999999999999998876543 3
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++++.|.+. .+|.+.+-....++.+.++-++.||+.+|+|||+.+|.|+||||.|.+++.|-.+|+||||+++.-....
T Consensus 132 iYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 566777764 3677777777789999999999999999999999999999999999999999999999999998654433
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh------------------
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS------------------ 227 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------------------ 227 (269)
..... ...-+.+|+|||++.+...++.+.||||+||++.+++..+..|...++.+..+-+.
T Consensus 211 ~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA 289 (449)
T KOG0664|consen 211 RLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA 289 (449)
T ss_pred hhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence 33322 23347789999999999988999999999999999999999997766654444331
Q ss_pred -----cCcccCCC-----------CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 228 -----AAEFTCPP-----------WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 228 -----~~~~~~~~-----------~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+....|+ ....+..+++..||.+||.+|.+. .+++.|++
T Consensus 290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~--~~A~~~~~ 345 (449)
T KOG0664|consen 290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISV--EEALQHRY 345 (449)
T ss_pred HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccH--hhhccccc
Confidence 11111111 123456789999999999999998 77777653
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=216.01 Aligned_cols=252 Identities=32% Similarity=0.477 Sum_probs=206.9
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|.-.+.||+|.+|+|+++++..+++.||+|.+..+..+ +..-....+|+-+++.++|+||+++++....+....+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 566678999999999999999999999999999765432 3334567889999999999999999999999999999999
Q ss_pred ccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcc
Q 024347 92 FVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL 170 (269)
Q Consensus 92 ~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~ 170 (269)
||. ..|..+... ++.++.+....+..|++.+|.+.|++++.|+|++|.|.+++.+|.++|.|||+++..+... ...
T Consensus 82 ~cd-qdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv--rcy 158 (292)
T KOG0662|consen 82 FCD-QDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--RCY 158 (292)
T ss_pred Hhh-HHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--Eee
Confidence 995 477777765 5789999999999999999999999999999999999999999999999999988644321 122
Q ss_pred cccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc--C-----cccCCC-------
Q 024347 171 HTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA--A-----EFTCPP------- 235 (269)
Q Consensus 171 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~--~-----~~~~~~------- 235 (269)
....-+.-|++|.++.+...++...|+||-||++.++.. |++.|.+++..+....+.. + ..+.-.
T Consensus 159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence 223346679999999999988889999999999999975 8888999888877777631 1 111000
Q ss_pred ---------------CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 236 ---------------WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 236 ---------------~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+...-++++..+|.-+|..|.++ ..+++|++
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisa--eaalqhpy 285 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISA--EAALQHPY 285 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCH--HHHhcCcc
Confidence 123456799999999999999999 67777764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=259.09 Aligned_cols=256 Identities=21% Similarity=0.346 Sum_probs=209.9
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcC-------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeee
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLY 77 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~ 77 (269)
++...++..+.+.||.|.||.|++|.-.. ....||||........ ...+.+..|+++++.+. |+|++.++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 44455556777899999999999997431 1457899998655433 55789999999999995 99999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 024347 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (269)
Q Consensus 78 ~~~~~~~~~~~v~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~n 141 (269)
+.+...+..++++||+..|+|..++...+ .++...+..++.||+.|++||++.+++|||+...|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999997765 38889999999999999999999999999999999
Q ss_pred eEecCCCCEEEeeCCCccccccccCCC-cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC-
Q 024347 142 LLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN- 218 (269)
Q Consensus 142 Il~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~- 218 (269)
|++..+..+|++|||+++.......-. ......-+..|+|||.+....+ +.++||||+|+++|++++ |..||.+..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999997432211111 1000002456999999998554 599999999999999998 899998855
Q ss_pred HHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcccc
Q 024347 219 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 219 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
..++.+.+..|. ...|..++.++.++++.||+.+|++||++.++-.
T Consensus 528 ~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 528 TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 666677777665 4777889999999999999999999999966543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=277.05 Aligned_cols=234 Identities=18% Similarity=0.284 Sum_probs=179.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
..+...+.||+|++|.||+|.+..++..||+|.+..... ...+|++.+++++||||+++++++.+....++||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 345667889999999999999988999999999754321 1124578899999999999999999999999999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH---SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
||+++++|.+++. .++...+..++.+++.||+||| +.+++|+||+|+||+++.++..++. ++.......
T Consensus 763 Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 763 EYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred eCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 9999999999885 3788999999999999999999 6699999999999999988887765 554332111
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHhcC---------cc--
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-----LMNLYKKISAA---------EF-- 231 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~~~~~~~~~~---------~~-- 231 (269)
.....+++.|+|||++.+..+ +.++||||||+++|+|++|+.||.... ..+........ ..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 111246789999999987766 489999999999999999999985321 11111111000 00
Q ss_pred --cCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 232 --TCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 232 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
........++.+++.+||+.||++||+++++
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ev 944 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDV 944 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHH
Confidence 0011122357789999999999999998543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=257.71 Aligned_cols=247 Identities=22% Similarity=0.361 Sum_probs=213.3
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..-.++||+|+||+||+|.+-..|+ +|++|++.... ..+....+.+|+-++..+.|||++++++++.... .-+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3456899999999999999877655 67888875443 3344578899999999999999999999997665 778
Q ss_pred EEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
|.+|+++|.|.+++..+ +.+.....+.|+.||++|++|||+.+++||||-..||||..-+.|++.|||+++........
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 89999999999999775 46888999999999999999999999999999999999999999999999999887765554
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 245 (269)
-......-..-|+|-|.+....+ +.++||||+|+++||++| |..||.+....++.+.+..+ +.+.|+.++.++..++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 44444445678999999877776 499999999999999998 99999999999999988665 5788899999999999
Q ss_pred HHhcCCCCCCcCCCCccc
Q 024347 246 ARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~ 263 (269)
..||..|+..||.+++.-
T Consensus 934 vkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELA 951 (1177)
T ss_pred HHHhccCcccCccHHHHH
Confidence 999999999999986543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=241.67 Aligned_cols=250 Identities=30% Similarity=0.433 Sum_probs=205.6
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHH----HHHHHHHHHHHhhhCCCCCceeeeEEEee-CC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK----MAEQIKREVATMKLVKHPNVVRLYEVMGS-KT 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 84 (269)
-++|-.+..||+|+|+.||++.+....++||+|+-.....+.++ ..+...+|.++-+.|.||.|+++|++|.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35788899999999999999999999999999998776666543 34566789999999999999999999954 56
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CcEeecCCCCceEecC---CCCEEEeeCCCcc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--GVYHRDLKPENLLLDA---YGNLKVSDFGLSA 159 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~i~h~di~~~nIl~~~---~~~~~l~df~~~~ 159 (269)
.+|-|.|||+|.+|.-++..++.+++.+...|+-||+.||.||.+. .|+|-|++|.||++-. -|.++++|||++.
T Consensus 542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 7899999999999998898899999999999999999999999976 5999999999999964 3458999999998
Q ss_pred ccccccCCC-----cccccccCccccCcccccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHH--H-h
Q 024347 160 LSQQVRDDG-----LLHTTCGTPNYVAPEVLND---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LYKK--I-S 227 (269)
Q Consensus 160 ~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~---~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~--~-~ 227 (269)
++.....+. ......|+.-|.+||.+.- ++..+.++||||+|+++|..+-|+.||..+.... +.+. + .
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk 701 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK 701 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence 876544432 2334467888999998753 3344689999999999999999999998654432 2222 2 2
Q ss_pred cCc--ccCCCCCCHHHHHHHHHhcCCCCCCcCCC
Q 024347 228 AAE--FTCPPWLSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 228 ~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
.-+ ++.-+.++.+.++||+.||+..-+.|.+.
T Consensus 702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV 735 (775)
T KOG1151|consen 702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDV 735 (775)
T ss_pred ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhH
Confidence 233 44456799999999999999999988875
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=242.85 Aligned_cols=258 Identities=20% Similarity=0.238 Sum_probs=183.2
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEc----------------CCCCeEEEEEeehhhhhhH-H----------HHHHHHHH
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNS----------------ETGEPVALKILDKEKVLKH-K----------MAEQIKRE 61 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~----------------~~~~~~~~K~~~~~~~~~~-~----------~~~~~~~e 61 (269)
..++|.+.++||+|+||+||+|... ..++.||||.+........ + ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4679999999999999999999752 2356799999864321110 0 11223346
Q ss_pred HHHhhhCCCCCc-----eeeeEEEee--------CCeEEEEEeccCCCchhHHHHhcC----------------------
Q 024347 62 VATMKLVKHPNV-----VRLYEVMGS--------KTKIFIVLEFVTGGELFDKIVNHG---------------------- 106 (269)
Q Consensus 62 ~~~l~~l~~~~i-----~~~~~~~~~--------~~~~~~v~~~~~~~~l~~~~~~~~---------------------- 106 (269)
+.++.+++|.++ +++++++.. .+..++|+||+++++|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766554 556666532 346799999999999988876421
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCccc
Q 024347 107 --RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184 (269)
Q Consensus 107 --~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 184 (269)
.++...+..++.|++.+|.|+|+.+++|+||+|+||+++.++.++|+|||++....... .........++.|+|||.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhh
Confidence 13456788899999999999999999999999999999999999999999886433211 111112234789999999
Q ss_pred ccCCCCC---------------------CCchhHHHHHHHHHHHHcCCC-CCCCCCH-----------HHHHHHHhcCc-
Q 024347 185 LNDRGYD---------------------GSTADLWSCGVILFVLLAGYL-PFDDSNL-----------MNLYKKISAAE- 230 (269)
Q Consensus 185 ~~~~~~~---------------------~~~~Di~slG~~l~~l~~g~~-p~~~~~~-----------~~~~~~~~~~~- 230 (269)
+...... ..+.|+||+|+++++|+++.. ||..... ...........
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 7643211 134799999999999999875 7653211 11111122222
Q ss_pred -ccCCCCCCHHHHHHHHHhcCCCC---CCcCCCCccccccccC
Q 024347 231 -FTCPPWLSFTARKLIARILDPNP---MTVSIYPFADILYMRF 269 (269)
Q Consensus 231 -~~~~~~~~~~l~~li~~~l~~dP---~~Rps~~~~~~l~~~~ 269 (269)
++.....++..++|+..||..+| .+|+|+ .++|.|+|
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa--~eaL~Hp~ 502 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSV--GQALSHRF 502 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCH--HHHhCCCC
Confidence 33334578999999999999876 689999 89999998
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=231.10 Aligned_cols=258 Identities=28% Similarity=0.400 Sum_probs=201.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-----
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----- 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----- 82 (269)
...++|.-...+|+|.||.|++|+.+.+|+.|++|++-.+.- .+.+-....+|+++|+.++|+|++.+++++..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 345678888999999999999999999999999987532110 11223456789999999999999998877633
Q ss_pred ---CCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCc
Q 024347 83 ---KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (269)
Q Consensus 83 ---~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~ 158 (269)
...+++|+.+|+. +|...+.+. ..++..++..+.++++++|.|+|+..|+|+|+++.|++++.++.++|+|||++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 2358999999975 787777665 47999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCc--ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---hcC----
Q 024347 159 ALSQQVRDDGL--LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI---SAA---- 229 (269)
Q Consensus 159 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~---- 229 (269)
+.......... .....-+.-|++||.+.+...++++.|+|+-||++.+|+++.+.+.++........+ +..
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 76544322211 222334778999999999888889999999999999999999999887776544443 111
Q ss_pred ccc---------------CCC-------------CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EFT---------------CPP-------------WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~~---------------~~~-------------~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.++ .+. .-+++..+|+..+|..||.+|+++ .+++.|.|
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~a--d~alnh~~ 317 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDA--DQALNHDF 317 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcch--Hhhhchhh
Confidence 000 000 024577899999999999999999 45555543
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=245.46 Aligned_cols=206 Identities=30% Similarity=0.566 Sum_probs=180.3
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHH-----HHHHHHHHHhhhCC---CCCceeeeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-----EQIKREVATMKLVK---HPNVVRLYE 78 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~-----~~~~~e~~~l~~l~---~~~i~~~~~ 78 (269)
...+..|...+.||.|+||.|++|.++.+...|++|.+.++...-..-. -.+-.|+++|..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 4556789999999999999999999999999999999876554322111 12345899999997 999999999
Q ss_pred EEeeCCeEEEEEecc-CCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 79 VMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 79 ~~~~~~~~~~v~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
+|++++.+++++|.. +|.+|.+++.-+..+++.+.+.|++|++.++++||+.||+|||||-+|+.++.+|.++|+|||.
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 999999999999964 4668999999988999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (269)
+.. -+++......|+..|.|||++.+..+.+..-|||+||+++|.++-...||.+
T Consensus 717 aa~----~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 717 AAY----TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhh----hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 754 3445556677999999999999999988999999999999999999888864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=240.67 Aligned_cols=253 Identities=33% Similarity=0.521 Sum_probs=208.7
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
.-+-|..++.||-|+||.|-++....+...||.|++.+...........++.|-++|..-..+-|+++|-.|++.+.+|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 33458899999999999999999998999999999987666666666778889999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC-
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD- 167 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~- 167 (269)
||+|++||++-.++.+-+-|.++...-.+..+.-|+.+.|..|++|+||||+||||+.+|++||+|||+|.-.......
T Consensus 707 VMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred EEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 9999999999999988888999988889999999999999999999999999999999999999999997532111000
Q ss_pred ----C-------c----------------------------ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHH
Q 024347 168 ----G-------L----------------------------LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208 (269)
Q Consensus 168 ----~-------~----------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 208 (269)
+ . .....|++.|+|||++....+. ..+|.||.|+++|+|+
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~ 865 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEML 865 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHh
Confidence 0 0 0111388999999999988875 8899999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHhc----CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 209 AGYLPFDDSNLMNLYKKISA----AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 209 ~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.|+.||-...+.+-..++.+ ..++..-.++++..++|.++. -+++.|.--.-+|
T Consensus 866 ~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d 923 (1034)
T KOG0608|consen 866 VGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGAD 923 (1034)
T ss_pred hCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchh
Confidence 99999988777665555432 223444568999999988765 3677776644444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=240.79 Aligned_cols=248 Identities=26% Similarity=0.414 Sum_probs=200.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCC------CCceeeeEEEeeC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH------PNVVRLYEVMGSK 83 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~------~~i~~~~~~~~~~ 83 (269)
=++|.|....|+|=||+|..|.+...|+.||||++..+. ...+.=..|+++|++|.. -|+++++-.|...
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE----~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE----VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch----HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 368999999999999999999999999999999987543 334555679999999963 4789999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC-EEEeeCCCcc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSA 159 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~-~~l~df~~~~ 159 (269)
+++|+|+|.+ ..+|...+...+ .|....+..++.|++-||..|-.+||+|.||+|+||||+++.+ ++|||||.+.
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS 585 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence 9999999988 568888887754 4777888999999999999999999999999999999997665 7999999876
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--hcCcccCCC--
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPP-- 235 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~~-- 235 (269)
.... .....+.-+.-|.|||++.+.++. ...|+||+||++|++.||...|.+.....+.... +.|.++.--
T Consensus 586 ~~~e----neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 586 FASE----NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred cccc----ccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 4332 222233446679999999999986 9999999999999999999999876655444432 111111000
Q ss_pred -------------------------------------------------C-------CCHHHHHHHHHhcCCCCCCcCCC
Q 024347 236 -------------------------------------------------W-------LSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 236 -------------------------------------------------~-------~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
. .-..|++|+..||..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 0 12258899999999999999999
Q ss_pred CccccccccC
Q 024347 260 PFADILYMRF 269 (269)
Q Consensus 260 ~~~~~l~~~~ 269 (269)
.++|.|+|
T Consensus 741 --nqAL~HpF 748 (752)
T KOG0670|consen 741 --NQALKHPF 748 (752)
T ss_pred --HHHhcCCc
Confidence 78899987
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=217.07 Aligned_cols=247 Identities=24% Similarity=0.456 Sum_probs=195.2
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeC--Ce
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK--TK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~--~~ 85 (269)
..++|++++.+|+|.+|.|+.|....+++.+++|++++-. .+.+.+|+.+|+.|. ||||++++++..+. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 5678999999999999999999999999999999986543 578899999999997 99999999998664 45
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-CEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-~~~l~df~~~~~~~~~ 164 (269)
..+++||.+..+...+. ..++...+...+.+++.||.|.|+.||.|+|++|.|++++... .++|+|||++.++.+
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp- 185 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP- 185 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-
Confidence 68899999876665443 2477788889999999999999999999999999999999544 599999999987665
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCC-CCCHH-------------HHHHHHhcCc
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLM-------------NLYKKISAAE 230 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~-------------~~~~~~~~~~ 230 (269)
.........+..|--||.+.....+...-|+|||||.+..|+..+.||- +.+.. ++..-+..-.
T Consensus 186 --~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~ 263 (338)
T KOG0668|consen 186 --GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ 263 (338)
T ss_pred --CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence 2333344557778899999888777788999999999999999888883 22111 1111111111
Q ss_pred ccCCC------------------------CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 FTCPP------------------------WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ~~~~~------------------------~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...++ ..+++..+|+..+|..|-++|+|+ -++..|+|
T Consensus 264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTa--kEam~Hpy 324 (338)
T KOG0668|consen 264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTA--KEAMAHPY 324 (338)
T ss_pred cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccch--HHHhcCch
Confidence 11111 257899999999999999999999 55555554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=250.85 Aligned_cols=243 Identities=29% Similarity=0.463 Sum_probs=192.3
Q ss_pred eEEeeeeeccCCcE-EEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEEEEE
Q 024347 13 YEVGRTIGEGTFAK-VKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 13 ~~~~~~lg~g~~~~-v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 90 (269)
|...+.+|.|+.|+ ||+|.. .|+.||||.+-.. .-.-..+|+..|+.-. ||||+++++.-.+.+..|+..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 44457889999986 899998 5889999987433 3456778999998884 999999999999999999999
Q ss_pred eccCCCchhHHHHhcC-C---CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC---CC--CEEEeeCCCcccc
Q 024347 91 EFVTGGELFDKIVNHG-R---MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YG--NLKVSDFGLSALS 161 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~-~---l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~---~~--~~~l~df~~~~~~ 161 (269)
|.|. .+|.+++...+ . .........+.|+++||++||+.+|||+|++|.||+|.. ++ .++|+|||+|...
T Consensus 583 ELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9995 59999887741 1 111345678899999999999999999999999999975 33 5899999999876
Q ss_pred ccccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcCcccCC---CC
Q 024347 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAEFTCP---PW 236 (269)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~---~~ 236 (269)
...... .......|+-+|+|||.+...... .++|||||||++|+.++| ..||... .+...+|..+..... +.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~--~~R~~NIl~~~~~L~~L~~~ 738 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDS--LERQANILTGNYTLVHLEPL 738 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCch--HHhhhhhhcCccceeeeccC
Confidence 654332 223445689999999999877764 799999999999998885 9999764 444455666554332 22
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.+..+||.+|+++||..||++ .+.|.|+|
T Consensus 739 ~d~eA~dLI~~ml~~dP~~RPsa--~~VL~HPl 769 (903)
T KOG1027|consen 739 PDCEAKDLISRMLNPDPQLRPSA--TDVLNHPL 769 (903)
T ss_pred chHHHHHHHHHhcCCCcccCCCH--HHHhCCCc
Confidence 22379999999999999999999 88888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=247.21 Aligned_cols=254 Identities=27% Similarity=0.420 Sum_probs=219.6
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
.-++|...+.+|.|.+|.||+++++.+++..++|+++....+. ..-+++|+-+++..+|+||+.+++.+-.....++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 3468999999999999999999999999999999998776543 5677889999999999999999999988889999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
.||||.||+|.+.-+-.+++++.++...++..+.+|+|||+.|-+|+||+-.||++++.|.|++.|||.+..+... ..
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat--i~ 167 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IA 167 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh--hh
Confidence 9999999999888777789999999999999999999999999999999999999999999999999988765542 22
Q ss_pred cccccccCccccCcccc--cCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC-----CCCHHH
Q 024347 169 LLHTTCGTPNYVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-----WLSFTA 241 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~--~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l 241 (269)
......|+++|+|||+- .....+...+|+|++|+...++-.-+.|.-...++....-.....+..+. .+++.+
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f 247 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF 247 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence 33456799999999985 23333458899999999999999888898887788777766655554432 388999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+|++.+|.++|.+||++ ...|+|+|
T Consensus 248 h~fvK~altknpKkRpta--eklL~h~f 273 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTA--EKLLQHPF 273 (829)
T ss_pred HHHHHHHhcCCCccCCCh--hhheecee
Confidence 999999999999999998 77777876
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=207.49 Aligned_cols=221 Identities=20% Similarity=0.359 Sum_probs=175.9
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCC
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 84 (269)
+.+.-+....+..||+|++|.|-+.++..+|+..|+|.+...- +.+.......|+++..+. ..|.++.++|...+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4445556667789999999999999999999999999986543 234456777788876555 5899999999999999
Q ss_pred eEEEEEeccCCCchhHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 85 KIFIVLEFVTGGELFDKI----VNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
.+++.||.++ .||..+- ..++.+++..+.+|+..+..||.+||+. .++|+|+||+|||++.+|+||+||||++.
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999985 4665443 3356799999999999999999999986 89999999999999999999999999886
Q ss_pred ccccccCCCcccccccCccccCcccccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcCccc
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRG---YDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEFT 232 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~~ 232 (269)
.... +-......|...|+|||.+.... .++.++||||||+++++|.+++.||... .+-+...++.....+
T Consensus 198 ~L~d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P 271 (282)
T KOG0984|consen 198 YLVD---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSP 271 (282)
T ss_pred eehh---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCC
Confidence 5432 22223345788999999986432 3468999999999999999999999763 445555555544433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=211.88 Aligned_cols=210 Identities=42% Similarity=0.781 Sum_probs=180.8
Q ss_pred eeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCch
Q 024347 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (269)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l 98 (269)
||.|++|.||++....+++.+++|.+....... ..+.+.+|++.++.+.|++++++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987654322 357789999999999999999999999998999999999998999
Q ss_pred hHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-CCCEEEeeCCCccccccccCCCcccccccC
Q 024347 99 FDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176 (269)
Q Consensus 99 ~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~ 176 (269)
.+++... ..++...+..++.+++.++++||+.|++|+||+|.||+++. ++.++++||+.+........ ........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9988765 47899999999999999999999999999999999999999 89999999998865433221 12334467
Q ss_pred ccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCc
Q 024347 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTV 256 (269)
Q Consensus 177 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 256 (269)
..|.+||........+.++|+|++|++++++ ..+.+++..|++.||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8899999987763445899999999999998 679999999999999999
Q ss_pred CCCCccccc
Q 024347 257 SIYPFADIL 265 (269)
Q Consensus 257 ps~~~~~~l 265 (269)
|++ .+.+
T Consensus 206 ~~~--~~l~ 212 (215)
T cd00180 206 PSA--KEIL 212 (215)
T ss_pred cCH--HHHh
Confidence 998 4444
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=222.65 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=201.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC---
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 84 (269)
....||.-++.+|.|+. .|-.+.+.-.+++|++|...... .+....++..+|+..+..+.|+|+++.+.+|....
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 44568888999999999 78888888899999999987663 33445688889999999999999999999996654
Q ss_pred ---eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 85 ---KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 85 ---~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
..++|||++.. ++.+.+.. .++=+++..++.|++.|+++||+.||+|+|++|+||+++.+..+|+.|||+++..
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 47899999954 77776663 4666789999999999999999999999999999999999999999999998753
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------ 229 (269)
... -....+..+..|+|||++.+..+ ...+||||+||++.+|++|+..|.+.+..+.+.++...
T Consensus 169 ~~~---~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 169 DTD---FMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred Ccc---cccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 331 23344556788999999998885 48899999999999999999999876555444332100
Q ss_pred ---------------cccCCC---------------CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ---------------EFTCPP---------------WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ---------------~~~~~~---------------~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.. .-...+++++..||-.||++|.|+ .++|.|++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv--~daL~HPY 312 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISV--DDALRHPY 312 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccH--HHHhcCCe
Confidence 000000 113358899999999999999999 88999885
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=226.40 Aligned_cols=240 Identities=23% Similarity=0.377 Sum_probs=185.4
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC--CCCCceeeeEEEee----CC
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KHPNVVRLYEVMGS----KT 84 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~~~~~~----~~ 84 (269)
.+.++.+.||+|.||.||+|.+. |+.||||+|.... .+..++|.++.+.. +|+||+.+++.-.. ..
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 35788999999999999999985 8899999985422 35667788877654 89999999876522 34
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCceEecCCCCEEEeeCC
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDFG 156 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--------~i~h~di~~~nIl~~~~~~~~l~df~ 156 (269)
.+++|.+|.+.|||.+++.+ ..++.+...+++..++.||++||.. .|.|+|||..||+|..++.+-++|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 68999999999999999988 5799999999999999999999963 39999999999999999999999999
Q ss_pred Ccccccccc--CCCcccccccCccccCcccccCCC----CCC-CchhHHHHHHHHHHHHc----------CCCCCCC---
Q 024347 157 LSALSQQVR--DDGLLHTTCGTPNYVAPEVLNDRG----YDG-STADLWSCGVILFVLLA----------GYLPFDD--- 216 (269)
Q Consensus 157 ~~~~~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~----~~~-~~~Di~slG~~l~~l~~----------g~~p~~~--- 216 (269)
++-...... ..-......||.+|||||++...- ..+ ..+||||||.++||+.. -.+||.+
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp 441 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP 441 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC
Confidence 985543321 122344567999999999986532 111 45899999999999874 2577743
Q ss_pred --CCHHHHHHHHhc--CcccCCCCCC-----HHHHHHHHHhcCCCCCCcCCC
Q 024347 217 --SNLMNLYKKISA--AEFTCPPWLS-----FTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 217 --~~~~~~~~~~~~--~~~~~~~~~~-----~~l~~li~~~l~~dP~~Rps~ 259 (269)
....++.+-++. .++..|..+. ..+..+++.||..||.-|.|+
T Consensus 442 ~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 442 SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 223334433333 3344444432 246788999999999999986
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=229.68 Aligned_cols=241 Identities=22% Similarity=0.309 Sum_probs=191.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhh--hCCCCCceeeeEEEeeCC---
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK--LVKHPNVVRLYEVMGSKT--- 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~--~l~~~~i~~~~~~~~~~~--- 84 (269)
....+..+.+|+|.||.||+|+.+ ++.||||+|.... .+.+.+|-++.+ .++|+||+++++.-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 345677899999999999999985 6899999986433 566777777665 457999999998875554
Q ss_pred -eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeecCCCCceEecCCCCEEEee
Q 024347 85 -KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR---------GVYHRDLKPENLLLDAYGNLKVSD 154 (269)
Q Consensus 85 -~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---------~i~h~di~~~nIl~~~~~~~~l~d 154 (269)
.+.+|++|.+.|+|.+++..+ .++.....+++..++.||+|||+. .|+|||||+.|||+..|++..|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 789999999999999998765 789999999999999999999973 499999999999999999999999
Q ss_pred CCCccccccccCCCcccccccCccccCcccccCCCCCC-----CchhHHHHHHHHHHHHcCC------------CCCC--
Q 024347 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG-----STADLWSCGVILFVLLAGY------------LPFD-- 215 (269)
Q Consensus 155 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~-----~~~Di~slG~~l~~l~~g~------------~p~~-- 215 (269)
||++.........+......||.+|||||++.+.--.. .+.||||+|.++|++++.- .||.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 99998877666655566678999999999998754321 3589999999999998742 2232
Q ss_pred ---CCCHHHHHHHHh--cCcccCCCC-----CCHHHHHHHHHhcCCCCCCcCCC
Q 024347 216 ---DSNLMNLYKKIS--AAEFTCPPW-----LSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 216 ---~~~~~~~~~~~~--~~~~~~~~~-----~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
.....++.+... +.++.++.. ....+++.+..||+.||+-|.|+
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 112233333332 333444433 34569999999999999999997
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-31 Score=210.65 Aligned_cols=216 Identities=45% Similarity=0.768 Sum_probs=182.2
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEec
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
|.+.+.||.|+++.||++....+++.+++|.+...... ...+.+.+|++.++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56789999999999999999888999999998754432 2467888999999999999999999999888999999999
Q ss_pred cCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 93 VTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 93 ~~~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
+++++|.+.+..... ++...+..++.+++.++.+||+.+++|+|++|+||+++.++.++|+|||.+........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 999999998887666 89999999999999999999999999999999999999999999999998876543321 1222
Q ss_pred ccccCccccCcccc-cCCCCCCCchhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHhcCccc
Q 024347 172 TTCGTPNYVAPEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKISAAEFT 232 (269)
Q Consensus 172 ~~~~~~~~~aPE~~-~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~ 232 (269)
...+...|++||.+ ..... +.++|+|+||++++++++|+.||.. .+.....+.+..+...
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred ceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence 33467789999998 44444 4799999999999999999999977 4555677777766543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=222.63 Aligned_cols=256 Identities=18% Similarity=0.224 Sum_probs=212.6
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCC-----CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEE
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV 79 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 79 (269)
++...-.|++....+-+|.||.||.|.+... .+.+.+|++.... ++-....+..|.-.+...+|||+.++.++
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455567888889999999999999976543 3345566553322 22235667888889999999999999998
Q ss_pred Eee-CCeEEEEEeccCCCchhHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCE
Q 024347 80 MGS-KTKIFIVLEFVTGGELFDKIVNH--------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 80 ~~~-~~~~~~v~~~~~~~~l~~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~ 150 (269)
... ....++++++..-|+|..++... ..++..++..++.|++.|+.+||+.|++|.||...|.++++..+|
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 744 45567788888888998888622 247788899999999999999999999999999999999999999
Q ss_pred EEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 024347 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 229 (269)
||+|=.+++-..+.+..........+..|++||.+....++ .++|+||||+++|+++| |..||..-++.+...-++.|
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG 514 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG 514 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence 99999998877666665555555678899999999887775 99999999999999998 99999999999999988876
Q ss_pred -cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 230 -EFTCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
+..-|.++|.++..++.-||..+|++||+++|..
T Consensus 515 yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 515 YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 4677888999999999999999999999997653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=218.74 Aligned_cols=254 Identities=26% Similarity=0.378 Sum_probs=197.6
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcC---CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG 81 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 81 (269)
++.-.+.|.++++||.|.|++||++.+.. .++.|++|.+..... -..+.+|+++|..+. +.||+++.+.+.
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhc
Confidence 34456789999999999999999998776 788999999865432 356889999999996 899999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-CCCEEEeeCCCccc
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSAL 160 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-~~~~~l~df~~~~~ 160 (269)
..+...+|+||++.....++... ++..++...++.++.||+++|.+||+|+||||+|++.+. -+.-.|+|||++..
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~ 182 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQR 182 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHH
Confidence 99999999999999887776543 678899999999999999999999999999999999984 45689999999762
Q ss_pred cccc---------------c----------------C-----------CCcccccccCccccCcccccCCCCCCCchhHH
Q 024347 161 SQQV---------------R----------------D-----------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW 198 (269)
Q Consensus 161 ~~~~---------------~----------------~-----------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~ 198 (269)
.... . . ........|+++|+|||++...+..+.++|||
T Consensus 183 ~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiw 262 (418)
T KOG1167|consen 183 YDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIW 262 (418)
T ss_pred HHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcccee
Confidence 1100 0 0 00011124899999999999888778999999
Q ss_pred HHHHHHHHHHcCCCCCCCC-CHHHHHHH----------------------------------------H-----hcCcc-
Q 024347 199 SCGVILFVLLAGYLPFDDS-NLMNLYKK----------------------------------------I-----SAAEF- 231 (269)
Q Consensus 199 slG~~l~~l~~g~~p~~~~-~~~~~~~~----------------------------------------~-----~~~~~- 231 (269)
|.|+++..++++..||-.. +......+ + ...+.
T Consensus 263 s~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~ 342 (418)
T KOG1167|consen 263 SAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQP 342 (418)
T ss_pred eccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccc
Confidence 9999999999999998210 00000000 0 00000
Q ss_pred -----cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 -----TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 -----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
......+..+.+|+.+||..||.+|.|+ .++|.|+|
T Consensus 343 n~~~~~~~d~~~~~~~dlLdk~le~np~kRitA--EeALkHpF 383 (418)
T KOG1167|consen 343 NTEREIGSDVFPALLLDLLDKCLELNPQKRITA--EDALKHPF 383 (418)
T ss_pred ceeeccccccccHHHHHHHHHHccCChhhcccH--HHHhcCcC
Confidence 0011146689999999999999999999 88899887
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=202.22 Aligned_cols=242 Identities=25% Similarity=0.438 Sum_probs=188.0
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEE-Eee
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEV-MGS 82 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~-~~~ 82 (269)
+.-+..+.|.+.+.||.|.||.+-++.++++++.+++|.+..... ...++.+|...--.|+ |.||+..|+. |++
T Consensus 18 ~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt 93 (378)
T KOG1345|consen 18 KKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQT 93 (378)
T ss_pred cccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence 334566889999999999999999999999999999999876543 3578888888776775 8999988765 577
Q ss_pred CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC--CCCEEEeeCCCccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSAL 160 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~--~~~~~l~df~~~~~ 160 (269)
.+.+++++||++.|+|..-+... .+.+..-+.++.|+++||.|+|+.++||+|||.+|||+-. .-.|||||||..+.
T Consensus 94 ~d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 94 SDAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred CceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccc
Confidence 88899999999999998877654 4778888899999999999999999999999999999953 33699999998775
Q ss_pred cccccCCCcccccccCccccCcccccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhc-Ccc
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRG----YDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISA-AEF 231 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~-~~~ 231 (269)
.+.... .......|.+||+..... ...+.+|+|.||+++|.+++|..||.....+ -.+.+-.. ...
T Consensus 173 ~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 173 VGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred cCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc
Confidence 443222 122355788999875432 1146799999999999999999999742221 12222222 222
Q ss_pred cCCC---CCCHHHHHHHHHhcCCCCCCc
Q 024347 232 TCPP---WLSFTARKLIARILDPNPMTV 256 (269)
Q Consensus 232 ~~~~---~~~~~l~~li~~~l~~dP~~R 256 (269)
..|. .+++.+..+.+.-|..+|++|
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCccccc
Confidence 2232 378889999999999999999
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=227.82 Aligned_cols=198 Identities=17% Similarity=0.231 Sum_probs=138.5
Q ss_pred hhCCC-CCceeeeEEE-------eeCCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeec
Q 024347 66 KLVKH-PNVVRLYEVM-------GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136 (269)
Q Consensus 66 ~~l~~-~~i~~~~~~~-------~~~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~d 136 (269)
+.++| +||.++++.+ .....+..++|+. +++|.+++... ..++..+++.++.||++||.|||++||+|+|
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 34445 5666777766 2223566778877 56999998653 4689999999999999999999999999999
Q ss_pred CCCCceEecCCCCEEEe-------------------eCCCccccccccCC--------------CcccccccCccccCcc
Q 024347 137 LKPENLLLDAYGNLKVS-------------------DFGLSALSQQVRDD--------------GLLHTTCGTPNYVAPE 183 (269)
Q Consensus 137 i~~~nIl~~~~~~~~l~-------------------df~~~~~~~~~~~~--------------~~~~~~~~~~~~~aPE 183 (269)
|||+|||++..+.++++ |||+++........ .......+++.|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 99999999765555555 45544321100000 0001124677899999
Q ss_pred cccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc-CCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT-CPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 184 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
++.+..+ +.++|||||||++|+|++|..|+.... .....+.....+ ......+...+++..||++||.+||++ .
T Consensus 186 ~~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~--~ 260 (793)
T PLN00181 186 EDNGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSM--S 260 (793)
T ss_pred hhccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcCh--H
Confidence 9988776 599999999999999999988875422 122222221111 111234567799999999999999999 7
Q ss_pred ccccccC
Q 024347 263 DILYMRF 269 (269)
Q Consensus 263 ~~l~~~~ 269 (269)
+++.|+|
T Consensus 261 eil~h~~ 267 (793)
T PLN00181 261 ELLQSEF 267 (793)
T ss_pred HHhhchh
Confidence 7888876
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=184.15 Aligned_cols=155 Identities=21% Similarity=0.252 Sum_probs=120.8
Q ss_pred CchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccc
Q 024347 96 GELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (269)
Q Consensus 96 ~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 174 (269)
|+|.+++... +.+++.+++.++.|++.||.|||+.+ +|+||+++.++.+++ ||.+....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-------~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-------SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-------CC
Confidence 5788888764 56999999999999999999999998 999999999999999 99887543311 24
Q ss_pred cCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCcccC-------CCCCCH--HHHHH
Q 024347 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTC-------PPWLSF--TARKL 244 (269)
Q Consensus 175 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~-------~~~~~~--~l~~l 244 (269)
+++.|+|||++.+..+. .++||||||+++|+|++|..||...... .....+....... +..++. .+.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 68999999999887764 8999999999999999999999764332 2233332221111 112333 69999
Q ss_pred HHHhcCCCCCCcCCCCcccccccc
Q 024347 245 IARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
++.||+.||.+||++ .+.+.|.
T Consensus 145 i~~cl~~~p~~Rp~~--~~ll~~~ 166 (176)
T smart00750 145 MRVCASRLPQRREAA--NHYLAHC 166 (176)
T ss_pred HHHHHhcccccccCH--HHHHHHH
Confidence 999999999999999 5666554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-26 Score=192.06 Aligned_cols=246 Identities=25% Similarity=0.289 Sum_probs=189.5
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCC-CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC----CCCceeeeEEE-eeCCe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVK----HPNVVRLYEVM-GSKTK 85 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~----~~~i~~~~~~~-~~~~~ 85 (269)
+|.+.+.||.|+||.||.+.+..++ ..+|+|.......... ..+..|..++..+. .+++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987764 5788888754322111 15666778887776 36899999998 57788
Q ss_pred EEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC-----CCEEEeeCCCc
Q 024347 86 IFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-----GNLKVSDFGLS 158 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~-----~~~~l~df~~~ 158 (269)
.++||+.+ |.+|.++.... +.++..++..++.|++.+|.++|+.|++|+||+|.|+.++.. ..+++.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 77998877543 579999999999999999999999999999999999999865 35999999999
Q ss_pred cccc--cccCC------CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---Hh
Q 024347 159 ALSQ--QVRDD------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK---IS 227 (269)
Q Consensus 159 ~~~~--~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~ 227 (269)
+... ..... .......|+..|.++.++.+.... .+.|+||+++++.+++.|..||........... ..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~-r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQG-RRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccC-CchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 8322 21111 112234589999999999998885 999999999999999999999976543222222 22
Q ss_pred cCc-cc-CCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 228 AAE-FT-CPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 228 ~~~-~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
... .. .....+.++..+...+-..+...+|.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~ 290 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKL 290 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHH
Confidence 211 11 234456788888888888999999987443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=176.29 Aligned_cols=251 Identities=22% Similarity=0.309 Sum_probs=198.3
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~ 86 (269)
...++|.+++.||.|+||.+|.|....+|+.||+|+-..... ...+.-|..+.+.|+ ..+|..+..++.....-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 456799999999999999999999999999999999644322 234566888888887 47788888888888889
Q ss_pred EEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC---CEEEeeCCCccccc
Q 024347 87 FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQ 162 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~---~~~l~df~~~~~~~ 162 (269)
.+||+.. |-||.++++- .+.++..+++-++.|++.-+.|+|.++++|+||||+|.+++-+- .+.|+|||++..+-
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999998 6688887754 46799999999999999999999999999999999999997544 58999999997654
Q ss_pred cccCCC-----cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCcccCC
Q 024347 163 QVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCP 234 (269)
Q Consensus 163 ~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~ 234 (269)
...... ......|+.+|.+-..+.+...+ .+.|+-|+|+++.++-.|..||.+... ..-++.+...+.+.+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqS-RRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ 244 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQS-RRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP 244 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhh-hhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence 322211 11122478888888888776654 889999999999999999999986443 445555655555444
Q ss_pred C-----CCCHHHHHHHHHhcCCCCCCcCCCCccccc
Q 024347 235 P-----WLSFTARKLIARILDPNPMTVSIYPFADIL 265 (269)
Q Consensus 235 ~-----~~~~~l~~li~~~l~~dP~~Rps~~~~~~l 265 (269)
. .+|.++.-.+..|-..--++-|+....+.+
T Consensus 245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrql 280 (341)
T KOG1163|consen 245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQL 280 (341)
T ss_pred HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence 3 378899999999988888888876544433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-28 Score=215.60 Aligned_cols=253 Identities=27% Similarity=0.472 Sum_probs=200.9
Q ss_pred EEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehh---hhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKE---KVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
.....+|.|++|.++.+......+.+..|.+... ..........+..|+-+-..++|+|++...............|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3457899999998888887766676777765421 1112223333778888889999999988777766665555569
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC--C
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--G 168 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~--~ 168 (269)
||+++ +|..++...+.++...+-.+++|++.|++|+|+.|+.|+|++++|+++..++.++++|||.+......... .
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~ 479 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIH 479 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhh
Confidence 99998 99998888778999999999999999999999999999999999999999999999999988765544443 4
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH-------HhcCcccCCCCCCH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY--KK-------ISAAEFTCPPWLSF 239 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--~~-------~~~~~~~~~~~~~~ 239 (269)
......++..|.|||++.+..+.....||||.|+++..|.+|+.||......+.. .. +..+.......++.
T Consensus 480 ~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~ 559 (601)
T KOG0590|consen 480 ESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPR 559 (601)
T ss_pred hhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchh
Confidence 4555678899999999999999989999999999999999999999765444332 11 12222333445889
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+.+|..||++||.+|.++ .++++..|
T Consensus 560 ~~~~~~~~~l~~~P~~R~ti--~~i~~d~W 587 (601)
T KOG0590|consen 560 ETRIIIYRMLQLDPTKRITI--EQILNDEW 587 (601)
T ss_pred hHHHHHHHHccCChhheecH--HHHhhChH
Confidence 99999999999999999999 66666665
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-26 Score=188.03 Aligned_cols=173 Identities=22% Similarity=0.218 Sum_probs=130.7
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcC-CCCeEEEEEeehhhh--hhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
.....++|++.+.||+|+||+||+|.++. +++.+|+|....... ......+.+.+|++++++++|+|+++.+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 35567889999999999999999998876 677789998653211 123345678999999999999998853322
Q ss_pred CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecC-CCCceEecCCCCEEEeeCCCcccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL-KPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di-~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
.+..++||||++|++|.. .. ... ...++.+++++|.++|+.||+|||| ||+||+++.++.++|+|||+++..
T Consensus 90 ~~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred cCCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 245799999999988852 21 111 1467889999999999999999999 999999998899999999998865
Q ss_pred ccccCCCc------ccccccCccccCcccccCC
Q 024347 162 QQVRDDGL------LHTTCGTPNYVAPEVLNDR 188 (269)
Q Consensus 162 ~~~~~~~~------~~~~~~~~~~~aPE~~~~~ 188 (269)
........ .....+++.|+|||.+...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 43211111 1223467789999988643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=177.98 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=205.1
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSK 83 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 83 (269)
.+.+.-..|.|.++||.|+||.++.|.+.-++++||+|.-...+ .+-.+..|++..+.|. .++|..+|-+....
T Consensus 22 ~~~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG 96 (449)
T KOG1165|consen 22 GVLMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEG 96 (449)
T ss_pred CceEecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeecccc
Confidence 34455568999999999999999999999999999999753322 2567888999999996 69999999888888
Q ss_pred CeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-----CEEEeeCCC
Q 024347 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-----NLKVSDFGL 157 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-----~~~l~df~~ 157 (269)
.+-.+|+|.+ |-||.+++.-+ +.++..+++.++.|++.-++++|++.+|.+||||+|+||+.-+ .+.++|||+
T Consensus 97 ~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 97 KYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred chhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 8888999998 67998888654 5799999999999999999999999999999999999998544 389999999
Q ss_pred ccccccccCCC-----cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcC
Q 024347 158 SALSQQVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAA 229 (269)
Q Consensus 158 ~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~ 229 (269)
+..+....... ......|+.+||+-..+.+...+ .+.|+-|||=++++++.|..||.+. +..+-+++|...
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 98664422211 11223488999999999998875 9999999999999999999999764 344555556544
Q ss_pred cccCC-----CCCCHHHHHHHHHhcCCCCCCcCCCCcccccc
Q 024347 230 EFTCP-----PWLSFTARKLIARILDPNPMTVSIYPFADILY 266 (269)
Q Consensus 230 ~~~~~-----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~ 266 (269)
+...+ ..+|.++..-++..-..+-.+-|+.+....|+
T Consensus 255 Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf 296 (449)
T KOG1165|consen 255 KRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLF 296 (449)
T ss_pred cccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 44333 34788888888888888888888877666554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.7e-27 Score=185.29 Aligned_cols=242 Identities=24% Similarity=0.303 Sum_probs=156.7
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCC----------CCce
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH----------PNVV 74 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~----------~~i~ 74 (269)
..+.........+.||.|+++.||.+.+..+|+.+++|++...........+.+++|.-....+.+ -.++
T Consensus 6 ~~~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l 85 (288)
T PF14531_consen 6 ELGQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFL 85 (288)
T ss_dssp SSS--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B-
T ss_pred cCCCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEE
Confidence 344555578889999999999999999999999999999976554444556777777766665432 1223
Q ss_pred eeeEEEeeC------------C-----eEEEEEeccCCCchhHHHHh---cCC----CCHHHHHHHHHHHHHHHHHHHhC
Q 024347 75 RLYEVMGSK------------T-----KIFIVLEFVTGGELFDKIVN---HGR----MKEDEARRYFQQLINAVDYCHSR 130 (269)
Q Consensus 75 ~~~~~~~~~------------~-----~~~~v~~~~~~~~l~~~~~~---~~~----l~~~~~~~i~~~i~~~l~~lh~~ 130 (269)
..++..... . ..+++|+-+. ++|...+.. ... +.......+..|+...+++||+.
T Consensus 86 ~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~ 164 (288)
T PF14531_consen 86 VPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY 164 (288)
T ss_dssp --SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence 333332211 1 2366777663 477665432 221 22233456668999999999999
Q ss_pred CcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCC-------CCCCCchhHHHHHHH
Q 024347 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-------GYDGSTADLWSCGVI 203 (269)
Q Consensus 131 ~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~~ 203 (269)
|++||||+|+|++++.+|.+.|+||+.....+... .....+..|.|||..... ...+.+.|.|+||++
T Consensus 165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred ceEecccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 99999999999999999999999998665433211 112235678999976442 123588999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCc
Q 024347 204 LFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTV 256 (269)
Q Consensus 204 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 256 (269)
+|.|.++..||........... .+......|+.+++||+.+|++||++|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999975432221111 344444789999999999999999988
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=179.57 Aligned_cols=246 Identities=19% Similarity=0.349 Sum_probs=198.7
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
++.++...+..+|.....|..|+|++. |..++.|++..... +....+++.+|.-.|+-+.||||+++++.+......
T Consensus 186 gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 186 GIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred CcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 455666677788999999999999985 55788888765543 344457899999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
.++..|++.++|...++... ..+..+..+++.+++.+++|||+.. |.--.++...++++++.+.++. .+-.++..
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee
Confidence 99999999999999998753 3667788999999999999999975 3344789999999998887765 22111111
Q ss_pred cccCCCcccccccCccccCcccccCCCCC--CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCcccCCCCCC
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYD--GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS--AAEFTCPPWLS 238 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~ 238 (269)
.. ....-.+.|++||.+...+-. ..++|+|||++++|++.|...||....+++.--++. ..+..+|+.++
T Consensus 342 --qe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis 415 (448)
T KOG0195|consen 342 --QE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGIS 415 (448)
T ss_pred --ec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCcc
Confidence 11 112236789999998766533 467999999999999999999999999998777764 45678899999
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 239 FTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.+..|++-|++.||.+||.++++
T Consensus 416 ~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 416 RHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred HHHHHHHHHHhcCCCCcCCCccee
Confidence 999999999999999999998764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-24 Score=176.97 Aligned_cols=245 Identities=37% Similarity=0.627 Sum_probs=200.5
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCC-CceeeeEEEeeCCeEEEEEe
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP-NVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~~ 91 (269)
|.+.+.||.|+++.||.+.+. ..+++|.+.............+.+|+..++.+.|+ +++++.+.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999986 67899998776655544578899999999999988 79999999977777899999
Q ss_pred ccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-CEEEeeCCCccccccccCC
Q 024347 92 FVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-~~~l~df~~~~~~~~~~~~ 167 (269)
++.++++.+.+.... .++......+..+++.++.++|+.+++|+|++|+||+++..+ .++++|||.+.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999986666654 689999999999999999999999999999999999999988 6999999988744332222
Q ss_pred C----cccccccCccccCcccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCccc-CCCC
Q 024347 168 G----LLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFT-CPPW 236 (269)
Q Consensus 168 ~----~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~-~~~~ 236 (269)
. ......++..|+|||.+.+. ...+...|+|++|++++++++|..||..... ......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 1 23556789999999999874 3445899999999999999999999877653 4555555444433 2222
Q ss_pred C--------CHHHHHHHHHhcCCCCCCcCCCC
Q 024347 237 L--------SFTARKLIARILDPNPMTVSIYP 260 (269)
Q Consensus 237 ~--------~~~l~~li~~~l~~dP~~Rps~~ 260 (269)
. ...+.+++..++..+|..|.+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~ 270 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSS 270 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHH
Confidence 1 15799999999999999999873
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=169.03 Aligned_cols=173 Identities=14% Similarity=0.212 Sum_probs=132.4
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHH------HHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQ------IKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~------~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
-++|++.+.||.|++|.||++.. ++..+|+|++.......+..... +.+|+..+.++.|++|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 47899999999999999999765 46679999997665555555444 57899999999999999998886543
Q ss_pred --------CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeC
Q 024347 84 --------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 84 --------~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
+..+++|||++|.+|.+.. .+++. ...++..++..+|+.|++|||++|+||++++++ ++++||
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDf 178 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDL 178 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEEC
Confidence 3578999999999987752 23332 456899999999999999999999999999988 999999
Q ss_pred CCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHH
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLL 208 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 208 (269)
|............ .+.....+. .++|+||||+++..+.
T Consensus 179 g~~~~~~e~~a~d--------------~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 179 SGKRCTAQRKAKD--------------RIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCcccccchhhHH--------------HHHHHhHhc-ccccccceeEeehHHH
Confidence 9765332110000 022223343 7899999998877553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-24 Score=163.42 Aligned_cols=140 Identities=21% Similarity=0.285 Sum_probs=110.4
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHH-----------------------HHHHHHHHHHHhhhCCCCC
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-----------------------MAEQIKREVATMKLVKHPN 72 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~~~~ 72 (269)
.+.||.|++|.||.|.+. +|+.||+|++......... .......|+.+++.+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 478999999999999986 8999999998754221100 1123456999999998887
Q ss_pred ceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCceEecCCCCEE
Q 024347 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYHRDLKPENLLLDAYGNLK 151 (269)
Q Consensus 73 i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~l-h~~~i~h~di~~~nIl~~~~~~~~ 151 (269)
+.....+... ..++||||++|+++.........++...+..++.|++.+|.++ |+.||+|+||||+||+++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6444333222 2379999999877765544556789999999999999999999 799999999999999998 47899
Q ss_pred EeeCCCcc
Q 024347 152 VSDFGLSA 159 (269)
Q Consensus 152 l~df~~~~ 159 (269)
|+|||++.
T Consensus 158 LiDFG~a~ 165 (190)
T cd05147 158 IIDVSQSV 165 (190)
T ss_pred EEEccccc
Confidence 99999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-25 Score=197.74 Aligned_cols=239 Identities=23% Similarity=0.333 Sum_probs=176.3
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhh--hhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK--VLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.|...+.||.+.|=.|.+|++. +|. |++|+|-... ..-... .+...|++ ...+++||.+++.-+...+...++|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~-~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPF-KQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHH-HHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHH
Confidence 7888999999999999999985 466 9999986433 111122 22223334 5666899999998887777778888
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
-+|... +|.+.+..+.-+..-+.+.|+-|++.||...|..||||||||.+|||++.-+.+.|+||...+..-....+..
T Consensus 100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 888855 8999888877788888999999999999999999999999999999999999999999987654332222221
Q ss_pred -----ccccccCccccCcccccCCC---------C-CCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcccC
Q 024347 170 -----LHTTCGTPNYVAPEVLNDRG---------Y-DGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTC 233 (269)
Q Consensus 170 -----~~~~~~~~~~~aPE~~~~~~---------~-~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 233 (269)
......-.+|.|||.+.... . -+++.||||+||++.|+++ |++||.- ..+.+- ..+....
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~aY-r~~~~~~ 254 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLLAY-RSGNADD 254 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHHhH-hccCccC
Confidence 12223456899999986522 1 3578999999999999987 6888841 111111 1111000
Q ss_pred -----CCCCCHHHHHHHHHhcCCCCCCcCCC
Q 024347 234 -----PPWLSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 234 -----~~~~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
..--+..++.+|..|++.||.+|.|+
T Consensus 255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSA 285 (1431)
T KOG1240|consen 255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSA 285 (1431)
T ss_pred HHHHHHhCcCccHHHHHHHHHccCchhccCH
Confidence 01134579999999999999999996
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-23 Score=157.86 Aligned_cols=141 Identities=21% Similarity=0.266 Sum_probs=112.1
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh-----------------------HHHHHHHHHHHHHhhhCCCCC
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----------------------HKMAEQIKREVATMKLVKHPN 72 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----------------------~~~~~~~~~e~~~l~~l~~~~ 72 (269)
.+.||+|++|.||+|.+. +|+.||+|++....... .........|.+.+.++.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 89999999987642110 011234567899999999998
Q ss_pred ceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEE
Q 024347 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLK 151 (269)
Q Consensus 73 i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~ 151 (269)
+.....+.... .++||||++|+++.........++......++.+++.++.++|+ .|++|+||+|+||+++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 75544443332 47999999987654443344568888999999999999999999 9999999999999999 78999
Q ss_pred EeeCCCccc
Q 024347 152 VSDFGLSAL 160 (269)
Q Consensus 152 l~df~~~~~ 160 (269)
|+|||++..
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999998864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-24 Score=170.79 Aligned_cols=193 Identities=25% Similarity=0.365 Sum_probs=142.6
Q ss_pred CCCCceeeeEEEeeC---------------------------CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHH
Q 024347 69 KHPNVVRLYEVMGSK---------------------------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121 (269)
Q Consensus 69 ~~~~i~~~~~~~~~~---------------------------~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~ 121 (269)
+||||++++++|.+. ...|+||.... .+|..++-.+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 499999998776432 24688888764 4888887664 456777888999999
Q ss_pred HHHHHHHhCCcEeecCCCCceEecC--CC--CEEEeeCCCcccccc----ccCCCcccccccCccccCcccccCCCCC--
Q 024347 122 NAVDYCHSRGVYHRDLKPENLLLDA--YG--NLKVSDFGLSALSQQ----VRDDGLLHTTCGTPNYVAPEVLNDRGYD-- 191 (269)
Q Consensus 122 ~~l~~lh~~~i~h~di~~~nIl~~~--~~--~~~l~df~~~~~~~~----~~~~~~~~~~~~~~~~~aPE~~~~~~~~-- 191 (269)
+|+.+||.+||.|+|+|.+||++.- ++ .+++.|||.|-.... .+...-....-|+-..+|||+....+..
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999953 33 378899998743221 1111112223466788999998654311
Q ss_pred ---CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 192 ---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK-ISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 192 ---~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
-.++|.|+.|.+.||+++...||.+...+.+... ....+ +..++.+++.+++++..+|+.||.+|+|..-+.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAA 508 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAA 508 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHH
Confidence 2579999999999999999999987555432222 22223 455677999999999999999999999975543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-24 Score=183.96 Aligned_cols=227 Identities=35% Similarity=0.572 Sum_probs=190.9
Q ss_pred eeccCCcEEEEEE---EcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEEEEEeccC
Q 024347 19 IGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 19 lg~g~~~~v~~~~---~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
+|.|++|.|+++. ....|+.+++|+........... ..-..|-.++...+ ||.++++...++.....+++.++..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 6889999888654 33457888888876543332221 24556777888887 9999999999999999999999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccc
Q 024347 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174 (269)
Q Consensus 95 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~ 174 (269)
|+.+...+.....+++.........++-++.++|+.+++++|+|++||+++.+|.+++.|||.++..-.... ..
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~------~c 154 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI------AC 154 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh------cc
Confidence 999988777777778888888888999999999999999999999999999999999999998764322111 16
Q ss_pred cCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCC
Q 024347 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPM 254 (269)
Q Consensus 175 ~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 254 (269)
|+..|+|||++. .+ ..+.|-||+|++++++++|..||.. +....|...++..|...+...++++..++..+|.
T Consensus 155 gt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~ 227 (612)
T KOG0603|consen 155 GTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPE 227 (612)
T ss_pred cchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHH
Confidence 799999999998 33 4789999999999999999999987 7888888889999999999999999999999999
Q ss_pred CcCCC
Q 024347 255 TVSIY 259 (269)
Q Consensus 255 ~Rps~ 259 (269)
+|.-.
T Consensus 228 nrLg~ 232 (612)
T KOG0603|consen 228 NRLGA 232 (612)
T ss_pred HHhcc
Confidence 99875
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.7e-22 Score=149.82 Aligned_cols=191 Identities=16% Similarity=0.187 Sum_probs=139.0
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHH-HHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEEEEE
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~-~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+-+...|++|+||+|+.+.. .+.+++.+.+.....+.... ...+.+|+++|+++. ++++++++++ ...+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678999999999997765 57888988887666543322 235789999999995 5789999886 3468999
Q ss_pred eccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecC-CCCceEecCCCCEEEeeCCCccccccccCC--
Q 024347 91 EFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDL-KPENLLLDAYGNLKVSDFGLSALSQQVRDD-- 167 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di-~~~nIl~~~~~~~~l~df~~~~~~~~~~~~-- 167 (269)
+|+.|.+|.+.... . ...++.++..+|.++|+.||+|+|| +|+||+++.++.++|+|||++.........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r 150 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR 150 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence 99999888643211 1 1357789999999999999999999 799999999999999999998743321110
Q ss_pred --Cc-------ccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 024347 168 --GL-------LHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDD 216 (269)
Q Consensus 168 --~~-------~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (269)
.. ......++.+.+|+...-.. ......+.++.|+-+|.++|+..+.-.
T Consensus 151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 00 11112356666666543221 222567888999999999999888643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=180.50 Aligned_cols=202 Identities=23% Similarity=0.317 Sum_probs=164.7
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
.+..-.+|.|.+.||.|+||.||.|.... |+.||||+-.....+.-..-..++..+. ..--+.|..+.....-.+.
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk---~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK---PQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc---hhhhcchHHHHHHHccCCc
Confidence 34556789999999999999999999876 9999999977666554332233333333 1113455666666666777
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-------CCCEEEeeCCCc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------YGNLKVSDFGLS 158 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-------~~~~~l~df~~~ 158 (269)
..+|++|.+.|+|.++++..+.+++..+..++.|++..+..||..+||||||||+|.++.. +.-++|+|||.+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~s 848 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRS 848 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccc
Confidence 7899999999999999998889999999999999999999999999999999999999952 224899999988
Q ss_pred cccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCC
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL 212 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 212 (269)
--+............+++-.+-.+|...+.+|+ ...|.|.|+.+++.|+.|+.
T Consensus 849 iDm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 849 IDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eeeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHH
Confidence 666666666666677889999999999999996 99999999999999999854
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=150.33 Aligned_cols=143 Identities=20% Similarity=0.272 Sum_probs=112.7
Q ss_pred CeEEeeeeeccCCcEEEEEE-EcCCCCeEEEEEeehhhhh---------------------hHHHHHHHHHHHHHhhhCC
Q 024347 12 KYEVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVL---------------------KHKMAEQIKREVATMKLVK 69 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~-~~~~~~~~~~K~~~~~~~~---------------------~~~~~~~~~~e~~~l~~l~ 69 (269)
-|++.+.||.|++|.||+|. +..+|+.||+|++...... .......+..|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47889999999999999998 6678999999998753210 0011234678999999997
Q ss_pred CCC--ceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-cEeecCCCCceEecC
Q 024347 70 HPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG-VYHRDLKPENLLLDA 146 (269)
Q Consensus 70 ~~~--i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-i~h~di~~~nIl~~~ 146 (269)
+.+ ++++++. ...++||||++|.++.........+...+...++.|++.++++||+.| ++|+||+|+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 3444443 234799999999887665544455666777899999999999999999 99999999999999
Q ss_pred CCCEEEeeCCCcc
Q 024347 147 YGNLKVSDFGLSA 159 (269)
Q Consensus 147 ~~~~~l~df~~~~ 159 (269)
++.++|+|||.+.
T Consensus 184 ~~~i~LiDFg~a~ 196 (237)
T smart00090 184 DGKVVIIDVSQSV 196 (237)
T ss_pred CCCEEEEEChhhh
Confidence 7889999999765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=161.67 Aligned_cols=200 Identities=21% Similarity=0.322 Sum_probs=158.4
Q ss_pred hhhCCCCCceeeeEEEeeCCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc-EeecCCCCce
Q 024347 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGV-YHRDLKPENL 142 (269)
Q Consensus 65 l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i-~h~di~~~nI 142 (269)
|+.+.|.|+.+++|.+.+....+.|.+||..|+|.+.+... -.++......++++++.+|.|+|+..| .||.++++|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 46788999999999999999999999999999999998873 357777888999999999999999865 9999999999
Q ss_pred EecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCC------CCCchhHHHHHHHHHHHHcCCCCCCC
Q 024347 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY------DGSTADLWSCGVILFVLLAGYLPFDD 216 (269)
Q Consensus 143 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~------~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (269)
+++....+|++|||+....................-|.|||.+..... .+.+.|+||+|++++++++...||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999998876543112222222234567999999876421 25779999999999999999999965
Q ss_pred ----CCHHHHHHHHhc-CcccCCC------CCCHHHHHHHHHhcCCCCCCcCCCCcccc
Q 024347 217 ----SNLMNLYKKISA-AEFTCPP------WLSFTARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 217 ----~~~~~~~~~~~~-~~~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
..+.++...+.. +..++.+ ..++++..+++.||..+|++||+++++..
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 233455555555 3332322 24557999999999999999999876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-21 Score=170.37 Aligned_cols=209 Identities=34% Similarity=0.611 Sum_probs=159.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
-+.|..++.+..|++|-||.++++.+.+.++.|. +.+.. +.+. ++..-..|.++
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--cccccCCccee---------------
Confidence 4589999999999999999999999999999954 32211 1000 22222233222
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|+-...+...+.++.+. +.+++|||+-||+|+|++|+|.+|..-|++|+.|||++...........
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 22233344444554443 6779999999999999999999999999999999998765322111111
Q ss_pred -------------ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCC
Q 024347 170 -------------LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW 236 (269)
Q Consensus 170 -------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
....++++.|.|||++....+. ..+|.|++|+++|+++-|..||.+..+.+++..........++.
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~ 280 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEE 280 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccccc
Confidence 1122589999999999888875 88999999999999999999999999999999998877666543
Q ss_pred ---CCHHHHHHHHHhcCCCCCCcCCC
Q 024347 237 ---LSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 237 ---~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
.+++.+++|.++|+.+|..|.-.
T Consensus 281 dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 281 DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 78899999999999999999764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-19 Score=141.10 Aligned_cols=137 Identities=24% Similarity=0.332 Sum_probs=114.0
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh-----hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+.||+|++|.||+|.+ .|..+++|........ .......+.+|++++..+.++++.....++.+....+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 5778999986543221 12223567889999999999998877777777778899999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999888765432 7888999999999999999999999999999999 78899999998764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-20 Score=141.26 Aligned_cols=132 Identities=20% Similarity=0.280 Sum_probs=103.5
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-----CCCCceeeeEEEeeCC---eEE
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-----KHPNVVRLYEVMGSKT---KIF 87 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-----~~~~i~~~~~~~~~~~---~~~ 87 (269)
.+.||+|+++.||. +..++.. ++|++...... ..+.+.+|+.+++.+ .||||+++++++.+.. ..+
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 47899999999995 6555554 79988654321 246789999999999 5799999999998864 433
Q ss_pred -EEEec--cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCcEeecCCCCceEecCC----CCEEEeeCC
Q 024347 88 -IVLEF--VTGGELFDKIVNHGRMKEDEARRYFQQLINAV-DYCHSRGVYHRDLKPENLLLDAY----GNLKVSDFG 156 (269)
Q Consensus 88 -~v~~~--~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~lh~~~i~h~di~~~nIl~~~~----~~~~l~df~ 156 (269)
+|+|| +.+++|.+++.+. .+++. ..++.+++.++ .|||+++|+|+||+|+||+++.. ..++|+|++
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5578999999664 46555 35567777777 99999999999999999999743 379999954
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.3e-19 Score=136.10 Aligned_cols=133 Identities=20% Similarity=0.249 Sum_probs=107.2
Q ss_pred eeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh-----hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEec
Q 024347 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
.||+|++|.||++.+ ++..+++|........ .......+.+|+++++.+.++++.....++......+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 479999999999995 5678999986543221 122246678899999999988766555555566677899999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 93 ~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
++|+++.+.+..... .++.+++.+|.++|+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999887654321 7888999999999999999999999999999 78999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-19 Score=135.24 Aligned_cols=137 Identities=22% Similarity=0.330 Sum_probs=106.6
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh-------------------HHHHHHHHHHHHHhhhCCCCC
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------HKMAEQIKREVATMKLVKHPN 72 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------------------~~~~~~~~~e~~~l~~l~~~~ 72 (269)
.|.+.+.||.|++|.||++... +|+.+++|++....... .........|+.++..+.+++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 4888899999999999999875 79999999876432100 011123677888898887774
Q ss_pred --ceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCE
Q 024347 73 --VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 73 --i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~ 150 (269)
+...++ ....+++|||++|+++..... ......++.+++.++.++|+.|++|+||+|+||+++.++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 444443 244589999999988865432 13456788899999999999999999999999999999999
Q ss_pred EEeeCCCcc
Q 024347 151 KVSDFGLSA 159 (269)
Q Consensus 151 ~l~df~~~~ 159 (269)
+|+|||.+.
T Consensus 165 ~liDfg~~~ 173 (198)
T cd05144 165 YIIDWPQMV 173 (198)
T ss_pred EEEECCccc
Confidence 999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-18 Score=151.49 Aligned_cols=138 Identities=20% Similarity=0.233 Sum_probs=110.7
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhh-----hhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK-----VLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
.|...+.||+|++|+||++.+... .+++|...... .......+.+.+|+++++.++|++++....+..+....
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 445678999999999999987543 45555432211 11222346788999999999999998887777777778
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
+++|||++|++|.+.+. ....++.+++.+|.+||+.|++|||++|+||++ .++.++++|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 89999999999988764 346788999999999999999999999999999 578899999998864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.5e-18 Score=129.14 Aligned_cols=137 Identities=24% Similarity=0.392 Sum_probs=97.2
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHH---------------------HHHHHHHHhhhCCCCC--
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE---------------------QIKREVATMKLVKHPN-- 72 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~---------------------~~~~e~~~l~~l~~~~-- 72 (269)
.+.||+|++|.||.|.+. +++.|++|++............ ....|...+..+.+.+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 468999999999999986 7999999998754322111111 1135666666664433
Q ss_pred ceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEE
Q 024347 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLK 151 (269)
Q Consensus 73 i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~ 151 (269)
+.+.++. ...+++|||++++.+.......... ......++.+++.++.++|+ .|++|+||+|+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 3444433 2358999999985432211111111 16677899999999999999 9999999999999999 88999
Q ss_pred EeeCCCcc
Q 024347 152 VSDFGLSA 159 (269)
Q Consensus 152 l~df~~~~ 159 (269)
++|||.+.
T Consensus 155 liDfg~a~ 162 (187)
T cd05119 155 IIDVPQAV 162 (187)
T ss_pred EEECcccc
Confidence 99999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-20 Score=161.37 Aligned_cols=253 Identities=32% Similarity=0.503 Sum_probs=196.6
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCC-CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 87 (269)
...|.+.+.||.|+++.+-......+ ...++.|-+.... ........+..|..+-+.+. |+|++..++.....+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 56789999999999999988877543 3334444443322 23444566677888888887 999999999999999999
Q ss_pred EEEeccCCCchhHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCceEecCCC-CEEEeeCCCcccccc
Q 024347 88 IVLEFVTGGELFDKI-VNHG-RMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQ 163 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~-~~~~-~l~~~~~~~i~~~i~~~l~~lh-~~~i~h~di~~~nIl~~~~~-~~~l~df~~~~~~~~ 163 (269)
+..++..|+++...+ .... ..+.......+.|+..++.|+| ..++.|+||+|+|.+++..+ ..+..|||++.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999998887 5443 5667777889999999999999 99999999999999999999 999999999876555
Q ss_pred -ccCCCccccccc-CccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHhc--Cc--ccCCCC
Q 024347 164 -VRDDGLLHTTCG-TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY-KKISA--AE--FTCPPW 236 (269)
Q Consensus 164 -~~~~~~~~~~~~-~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~--~~--~~~~~~ 236 (269)
...........+ ++.|.|||...+..+..+..|+||.|+++..+++|..|+......... ..... +. ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 333334445567 899999999998766678999999999999999999999754333211 11111 11 233344
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.+....+++..++..+|..|.+.++..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred CChhhhhcccccccCCchhcccccccc
Confidence 788899999999999999999986544
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.5e-16 Score=126.03 Aligned_cols=137 Identities=20% Similarity=0.305 Sum_probs=103.5
Q ss_pred eeee-ccCCcEEEEEEEcCCCCeEEEEEeehhhh----------hhHHHHHHHHHHHHHhhhCCCCCc--eeeeEEEeeC
Q 024347 17 RTIG-EGTFAKVKFARNSETGEPVALKILDKEKV----------LKHKMAEQIKREVATMKLVKHPNV--VRLYEVMGSK 83 (269)
Q Consensus 17 ~~lg-~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----------~~~~~~~~~~~e~~~l~~l~~~~i--~~~~~~~~~~ 83 (269)
..|| .|+.|+||.+... +..++||.+..... .+......+.+|++++..+.++++ +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4677 8899999998874 77899998853211 111234567889999999998875 6666654332
Q ss_pred -Ce---EEEEEeccCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCc
Q 024347 84 -TK---IFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (269)
Q Consensus 84 -~~---~~~v~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~ 158 (269)
.. .++|+|+++| .+|.+.+.. ..++... +.+++.+|.++|+.||+|+||+|.||+++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 2599999997 578776654 3555543 568999999999999999999999999999889999999977
Q ss_pred cc
Q 024347 159 AL 160 (269)
Q Consensus 159 ~~ 160 (269)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 63
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-16 Score=116.60 Aligned_cols=131 Identities=23% Similarity=0.307 Sum_probs=109.8
Q ss_pred EeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCC--CCceeeeEEEeeCCeEEEEEec
Q 024347 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
+++.||.|.++.||++.... ..+++|.+..... ...+.+|+..++.+++ .++++++.+....+..++++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999853 6799999754432 3567788999999976 5888988888777889999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR---GVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 93 ~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
++|..+... +......++.++++++..+|.. +++|+|++|+||+++..+.++++||+.+.
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 988777543 5566778889999999999985 69999999999999998899999999765
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.5e-18 Score=141.63 Aligned_cols=168 Identities=24% Similarity=0.363 Sum_probs=126.8
Q ss_pred eEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
+.++.|.+|.-.+|.+++.... ..+....+.++.|++.++.| +|.+|+|++|.||+...+..+++.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5788999999999999886543 35677888999999999999 99999999999999999999999999986543
Q ss_pred cccc----CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcccCCCC
Q 024347 162 QQVR----DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTCPPW 236 (269)
Q Consensus 162 ~~~~----~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
.... .........++..|++||.+.+..+. .++|||+||.++++++. -..++. .......+..+.++....
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~e---r~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFE---RIATLTDIRDGIIPPEFL 482 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHH---HHHhhhhhhcCCCChHHh
Confidence 3222 12233445689999999999988875 99999999999999986 222221 123334445555542211
Q ss_pred -CCHHHHHHHHHhcCCCCCCcCCC
Q 024347 237 -LSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 237 -~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
-.+.-.+|+.+||.+.|.+||++
T Consensus 483 ~d~p~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 483 QDYPEEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hcCcHHHHHHHHhcCCCcccCchH
Confidence 12334599999999999999965
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.5e-15 Score=127.82 Aligned_cols=179 Identities=17% Similarity=0.298 Sum_probs=136.5
Q ss_pred eeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccCCCch
Q 024347 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL 98 (269)
Q Consensus 19 lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l 98 (269)
..-++.+.+-.|..+.++.++.+........ .......+.+..++.++||||+++++.+...+..|+|.|.+. .|
T Consensus 20 ~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl 94 (690)
T KOG1243|consen 20 TAFSSEALWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PL 94 (690)
T ss_pred ccCCCcccccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cH
Confidence 3333443332466777899999998876553 334667888999999999999999999999999999999875 55
Q ss_pred hHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCc
Q 024347 99 FDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177 (269)
Q Consensus 99 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh-~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 177 (269)
..++.+ ++...+...+.||+.||.+|| +.+++||||+.+.|+++..|..+|++|.++........ .....+..-
T Consensus 95 ~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~ 169 (690)
T KOG1243|consen 95 ETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIE 169 (690)
T ss_pred HHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhh
Confidence 555654 346777788999999999998 57899999999999999999999999998764333221 112222334
Q ss_pred cccCcccccCCCCCCCchhHHHHHHHHHHHHcC
Q 024347 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 210 (269)
Q Consensus 178 ~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 210 (269)
.|..|+.+.... -..|.|.||+++++++.|
T Consensus 170 s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 170 SFDDPEEIDPSE---WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccChhhcCccc---cchhhhhHHHHHHHHhCc
Confidence 567777765443 346999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.1e-16 Score=125.13 Aligned_cols=202 Identities=14% Similarity=0.256 Sum_probs=141.2
Q ss_pred HHHHhhhCCCCCceeeeEEEeeC-----CeEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 024347 61 EVATMKLVKHPNVVRLYEVMGSK-----TKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRG 131 (269)
Q Consensus 61 e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~ 131 (269)
-.+.+-++-|.|+++++.++.+. ....++.+|+..+++.+++.+ +..+....+.+|+.||++||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34556667799999999998654 357889999999999998865 346888899999999999999999984
Q ss_pred --cEeecCCCCceEecCCCCEEEeeCCCccccccc--cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHH
Q 024347 132 --VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV--RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 207 (269)
Q Consensus 132 --i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 207 (269)
|+||++..+.|++..++.+++.--.-...-... ..........+.++|.+||.=...+. +.++|||++|++..+|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHH
Confidence 999999999999999888877522111100000 11111222345788999987555444 3789999999999998
Q ss_pred HcCCCC-CCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcccccccc
Q 024347 208 LAGYLP-FDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 208 ~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
.-+..- -......+...++.+--+.. ....-++++..|++..|+.||++ .+.++|+
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~a--r~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDA--RLLLFHP 332 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcch--hhhhcCc
Confidence 765432 22222222223332222211 12345688999999999999999 7888876
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.5e-14 Score=109.97 Aligned_cols=139 Identities=15% Similarity=0.242 Sum_probs=100.6
Q ss_pred eeeeeccCCcEEEEEEEcC------CCCeEEEEEeehhhh-----------------------hhHHHHHHHHHHHHHhh
Q 024347 16 GRTIGEGTFAKVKFARNSE------TGEPVALKILDKEKV-----------------------LKHKMAEQIKREVATMK 66 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~------~~~~~~~K~~~~~~~-----------------------~~~~~~~~~~~e~~~l~ 66 (269)
...||.|..+.||.|.... .+..+|+|++..... .......+..+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998653 357899998742110 01112234558999999
Q ss_pred hCCC--CCceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcEeecCCCCceE
Q 024347 67 LVKH--PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC-HSRGVYHRDLKPENLL 143 (269)
Q Consensus 67 ~l~~--~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~l-h~~~i~h~di~~~nIl 143 (269)
++.. -+++.++++ ...++||||+.+..+.........++..+...+..+++.+|..+ |+.|++|||+++.||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9864 355666654 45679999997643322222223455666778889999999988 8999999999999999
Q ss_pred ecCCCCEEEeeCCCcc
Q 024347 144 LDAYGNLKVSDFGLSA 159 (269)
Q Consensus 144 ~~~~~~~~l~df~~~~ 159 (269)
+.+ +.++++||+.+-
T Consensus 158 ~~~-~~v~iIDF~qav 172 (197)
T cd05146 158 WHD-GKVWFIDVSQSV 172 (197)
T ss_pred EEC-CcEEEEECCCce
Confidence 974 779999999765
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-14 Score=124.26 Aligned_cols=148 Identities=20% Similarity=0.331 Sum_probs=99.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh-------------------------------HHHHH--
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------------------HKMAE-- 56 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------------------------------~~~~~-- 56 (269)
+..|. .+.||.|+.|+||+|+.+ +|+.||||+.++..... .+...
T Consensus 117 F~~fd-~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l 194 (437)
T TIGR01982 117 FAEFE-EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTL 194 (437)
T ss_pred HhhCC-CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHH
Confidence 44444 368999999999999975 68999999985432110 00001
Q ss_pred ----HHHHHHHHhhhCC-----CCCceeeeEEEeeCCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHH-HHH
Q 024347 57 ----QIKREVATMKLVK-----HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLIN-AVD 125 (269)
Q Consensus 57 ----~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~-~l~ 125 (269)
++.+|++.+.++. ++++.-..-+....+..+++|||++|.++.+..... .... ...++..++. .+.
T Consensus 195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLN 271 (437)
T ss_pred HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHH
Confidence 2444555555552 233222212223345578999999999987765432 1222 2345555555 477
Q ss_pred HHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 126 ~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
.+|..|++|+|++|.||+++.++.++++|||++....
T Consensus 272 ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8999999999999999999999999999999886544
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.4e-15 Score=130.71 Aligned_cols=148 Identities=20% Similarity=0.390 Sum_probs=96.9
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh-------------------------------HHHH
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------------------HKMA 55 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------------------------------~~~~ 55 (269)
...+..|.. +.||.|+.|+||.|+.+.+|+.||||+..+..... .+..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 344667887 89999999999999998779999999986432100 1122
Q ss_pred HHH------HHHHHHhhhCC----CCCceeeeEEE-eeCCeEEEEEeccCCCchhHH--HHhcC----CCCHHHHHHHHH
Q 024347 56 EQI------KREVATMKLVK----HPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDK--IVNHG----RMKEDEARRYFQ 118 (269)
Q Consensus 56 ~~~------~~e~~~l~~l~----~~~i~~~~~~~-~~~~~~~~v~~~~~~~~l~~~--~~~~~----~l~~~~~~~i~~ 118 (269)
+.+ .+|+..+.++. +...+.+=.++ .-.+..++||||++|+.+.+. +...+ .+....+..++.
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~ 274 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT 274 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH
Confidence 223 33444444442 33323222222 224567899999999998763 22222 133333333344
Q ss_pred HHHHHHHHHHhCCcEeecCCCCceEecCCC----CEEEeeCCCccccc
Q 024347 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQ 162 (269)
Q Consensus 119 ~i~~~l~~lh~~~i~h~di~~~nIl~~~~~----~~~l~df~~~~~~~ 162 (269)
| +...|++|+|++|.||+++.++ .++++|||++....
T Consensus 275 Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 275 Q-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred H-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 4 4469999999999999999888 89999999876544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.6e-14 Score=102.16 Aligned_cols=145 Identities=21% Similarity=0.249 Sum_probs=112.9
Q ss_pred EeeeeeccCCcEEEEEEEcCCCCeEEEEEe-----ehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 15 VGRTIGEGTFAKVKFARNSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~-----~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
....+.+|+.+.|+++.+ .|+..++|.- ..+..+..-..++.++|++.|.++.--+|.-..-++.+...-.+.
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 668899999999999997 4777788753 345555555667889999999999877776666677777777899
Q ss_pred EeccCC-CchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC---EEEeeCCCcccc
Q 024347 90 LEFVTG-GELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALS 161 (269)
Q Consensus 90 ~~~~~~-~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~---~~l~df~~~~~~ 161 (269)
|||++| .++.+++.... .........+++++-+.+..||.++++|||+.++||++..++. +.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999987 35666665532 2223334788999999999999999999999999999976554 589999987643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.8e-14 Score=103.04 Aligned_cols=134 Identities=21% Similarity=0.263 Sum_probs=104.3
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEee-----hhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILD-----KEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~-----~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
..+++|+.+.++.+.+. |.++++|.-. .+..+..-....-.+|++++.++..-++.-..-+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 45789999999999764 5557787642 2333333344667889999999987777666666677778889999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
|.+|..|.+.+... ...++..+-..+..||.+||+|||+.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888787765 245667777778889999999999999999999755 99999998763
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.3e-15 Score=127.12 Aligned_cols=249 Identities=19% Similarity=0.200 Sum_probs=181.6
Q ss_pred CCeEEeeeeec--cCCcEEEEEEE--cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCe
Q 024347 11 GKYEVGRTIGE--GTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (269)
Q Consensus 11 ~~~~~~~~lg~--g~~~~v~~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 85 (269)
..|.+.+.+|. |.+|.+|.+.. ..++..+++|.-+.... .......-.+++..-..++ |++.++.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCCc
Confidence 35778889999 99999999988 78899999997332221 1111233344555555664 8999998888989999
Q ss_pred EEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHH----HHHHHHhCCcEeecCCCCceEecCC-CCEEEeeCCCcc
Q 024347 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLIN----AVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSA 159 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~----~l~~lh~~~i~h~di~~~nIl~~~~-~~~~l~df~~~~ 159 (269)
.++-.|.+. .++..+.+... .++...++..+.+..+ |+.++|+.+++|-|++|.||+...+ ...+++||+...
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 999999985 68888877654 4788889999999999 9999999999999999999999998 779999999877
Q ss_pred ccccccCCCccc---ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CcccCC
Q 024347 160 LSQQVRDDGLLH---TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA--AEFTCP 234 (269)
Q Consensus 160 ~~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~ 234 (269)
......-..... ...+...|++||..++.. +.+.|+|++|.++.+..++..+.......... ++.. ....+.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~-~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWS-QLRQGYIPLEFC 348 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCcc-ccccccCchhhh
Confidence 665543222211 225678899999998765 57899999999999887765544332111111 1111 111222
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCcccc
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
...+..+...+.+|++.+|..|++.+....
T Consensus 349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 234666777999999999999999855443
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.1e-13 Score=104.34 Aligned_cols=127 Identities=20% Similarity=0.299 Sum_probs=93.9
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeCCeEEEEEeccC
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~~~~~ 94 (269)
++.|+.|..+.||++... +..+++|....... ....+..|+.+++.+.+.++ .+++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999864 77899999754321 12345678888888865554 34554432 33579999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----EeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV-----YHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 95 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i-----~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
|.++... .. .......+++++|..||+.++ +|||++|+||+++ ++.++++||+.+.
T Consensus 75 G~~l~~~-----~~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-----DF---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-----cc---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9877543 11 112356789999999999885 9999999999999 6789999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.2e-11 Score=101.93 Aligned_cols=233 Identities=18% Similarity=0.197 Sum_probs=150.7
Q ss_pred EeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEE------Eee-CCeE
Q 024347 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV------MGS-KTKI 86 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~------~~~-~~~~ 86 (269)
....||+|+.+.+|..-... ..+.|+++....... . +....|... .||-+-.-+.+ ..+ +..+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~---a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQ---A---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHH---H---HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 35679999999999665432 257788765442211 1 123333333 34432221111 112 2237
Q ss_pred EEEEeccCCCchhHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 87 FIVLEFVTGGELFDKIVN-------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
.++|+...|..=-..+.+ ......+.+.+..+.++.+.+.||..|.+-||++++|+|+++++.|.|+|=+.-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 788888877532222211 1236788899999999999999999999999999999999999999999876432
Q ss_pred ccccccCCCcccccccCccccCccccc-----CCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCH-----HHHHHHHhc
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLN-----DRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNL-----MNLYKKISA 228 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~-----~~~~~~~~~ 228 (269)
+ .......-...+...|.+||.-. +... +..+|.|.||+++++++.| +.||++... .-....|..
T Consensus 166 i---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 166 I---NANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred e---ccCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 2 12222333456788999999765 2222 4779999999999998775 999975211 111113333
Q ss_pred Ccc-----------cCCC-----CCCHHHHHHHHHhcCC--CCCCcCCCC
Q 024347 229 AEF-----------TCPP-----WLSFTARKLIARILDP--NPMTVSIYP 260 (269)
Q Consensus 229 ~~~-----------~~~~-----~~~~~l~~li~~~l~~--dP~~Rps~~ 260 (269)
+.+ +.|. -+++.+..++.+|+.. +|.-|||.+
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 322 2221 2788999999999976 467899963
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.9e-13 Score=123.00 Aligned_cols=253 Identities=26% Similarity=0.416 Sum_probs=184.2
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
-...+.+.+.+.+..|+++.+..+.-..+|.-...|+......-.....+.+..+-.++-.-.+|-++...--+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 35778899999999999999999888877765555554322211110011111111111111123333322223345568
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
.++++|..++++...+++.+..+.+-....+..+..++.+||+..+.|+|++|.|.+...++...+.+|+..........
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 89999999999999988877666666666667788889999999999999999999999999999999974322211100
Q ss_pred -----------------------------CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 024347 167 -----------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (269)
Q Consensus 167 -----------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (269)
........+++.|.+||...+.... ..+|.|++|.++++.++|-.||...
T Consensus 960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg-s~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG-SAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC-CcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0111223478899999999988875 8899999999999999999999999
Q ss_pred CHHHHHHHHhcCcccCC---CCCCHHHHHHHHHhcCCCCCCcCCCC
Q 024347 218 NLMNLYKKISAAEFTCP---PWLSFTARKLIARILDPNPMTVSIYP 260 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rps~~ 260 (269)
.+...++++.....+.+ ...+...++++...+..+|.+|..+.
T Consensus 1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999988877665 34789999999999999999999874
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.36 E-value=6e-13 Score=113.52 Aligned_cols=242 Identities=21% Similarity=0.170 Sum_probs=170.1
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEc-CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 87 (269)
..+|..+..||.|.++.++..... ..+..|++|............+.. ..|.-+...+ .|.+.+..+..+...+..+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~s-l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFS-LGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcc-hhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 568899999999999999987655 567788888764433322222222 2344444444 4777777777776667777
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC-CCEEEeeCCCccccccccC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~-~~~~l~df~~~~~~~~~~~ 166 (269)
+-.||++++++.........+.+..++.+..|++.++.++|+..++|.|++|+||++..+ +..++.||+.........
T Consensus 343 ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~- 421 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS- 421 (524)
T ss_pred CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccceec-
Confidence 889999998876555444457788889999999999999999999999999999999875 677889998764211100
Q ss_pred CCcccccccCcccc-CcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHH
Q 024347 167 DGLLHTTCGTPNYV-APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 167 ~~~~~~~~~~~~~~-aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 245 (269)
....+...+. .+|++........+.|+++||..+.+..++... ... ......+..+..+..+.....+..+.
T Consensus 422 ----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~l-s~~--~~~~~~i~~~~~p~~~~~~~~~q~~~ 494 (524)
T KOG0601|consen 422 ----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPL-SES--GVQSLTIRSGDTPNLPGLKLQLQVLL 494 (524)
T ss_pred ----ccccccccccccchhhccccccccccccccccccccccccCccc-Ccc--cccceeeecccccCCCchHHhhhhhh
Confidence 0111223344 244444433334899999999999998887532 211 23344455666666666668899999
Q ss_pred HHhcCCCCCCcCCCC
Q 024347 246 ARILDPNPMTVSIYP 260 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~ 260 (269)
+.|+.+|+..||++.
T Consensus 495 kv~~~~~~~~~~l~~ 509 (524)
T KOG0601|consen 495 KVMINPDRKRRPSAV 509 (524)
T ss_pred hhhcCCccccchhhh
Confidence 999999999999983
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.1e-11 Score=99.25 Aligned_cols=210 Identities=20% Similarity=0.221 Sum_probs=150.3
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe----eCCeEEEEEe
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG----SKTKIFIVLE 91 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~v~~ 91 (269)
.+..+.=...+.|++....+|..|++|.++...... ......-+++++++.|.|++++.++|. .+..+++|++
T Consensus 281 l~~~~~~~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYD 357 (655)
T KOG3741|consen 281 LELLNDLFSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYD 357 (655)
T ss_pred cccccccccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEe
Confidence 344443244689999999999999999984433222 223334578899999999999988875 3567899999
Q ss_pred ccCC-CchhHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeC
Q 024347 92 FVTG-GELFDKIVNH---------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 92 ~~~~-~~l~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
|.++ .+|.++.... ...++..+|.++.|+..||.++|+.|+...-+.+.+|++..+..+++..+
T Consensus 358 YyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 358 YYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred cCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecc
Confidence 9875 4666655322 13567899999999999999999999999999999999999889999998
Q ss_pred CCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHH-HHHHhcCcccC
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNL-YKKISAAEFTC 233 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~-~~~~~~~~~~~ 233 (269)
|+.......+. +.+.+ -.+-|.-.||.++..+.+|..- +........ .+.+
T Consensus 438 ~i~Dvl~~d~~----------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I------- 490 (655)
T KOG3741|consen 438 GIMDVLQEDPT----------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI------- 490 (655)
T ss_pred cceeeecCCCC----------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------
Confidence 87665443220 11111 2567999999999999998532 222222222 2211
Q ss_pred CCCCCHHHHHHHHHhcCCCCCC
Q 024347 234 PPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP~~ 255 (269)
-+.++.+++++|......++++
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc
Confidence 2236788888998888888885
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-11 Score=96.45 Aligned_cols=136 Identities=21% Similarity=0.325 Sum_probs=103.4
Q ss_pred EEeeeeeccCCcEEEEEEEcCCCCeEEEEEeeh-------------------hhhhhHHHHHHHHHHHHHhhhCCCC--C
Q 024347 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDK-------------------EKVLKHKMAEQIKREVATMKLVKHP--N 72 (269)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~-------------------~~~~~~~~~~~~~~e~~~l~~l~~~--~ 72 (269)
.+...||.|..|.||.|.+. +|.++++|.-.. ...+..-.....++|.++|+.|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45689999999999999985 789999996421 1111123345678899999999765 6
Q ss_pred ceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEE
Q 024347 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152 (269)
Q Consensus 73 i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l 152 (269)
+++.+++ +..++|||+.+|..|...- ++.+....++..|+.-+..+-..|++|||+++-||+++++|.+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 7777654 5678999999997665432 234445566667777777777999999999999999999999999
Q ss_pred eeCCCcc
Q 024347 153 SDFGLSA 159 (269)
Q Consensus 153 ~df~~~~ 159 (269)
+||-.+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9998654
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.3e-11 Score=93.57 Aligned_cols=126 Identities=25% Similarity=0.376 Sum_probs=82.3
Q ss_pred EEEEEEEcCCCCeEEEEEeehh-----------------------hhhhHHHHHHHHHHHHHhhhCCCCC--ceeeeEEE
Q 024347 26 KVKFARNSETGEPVALKILDKE-----------------------KVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVM 80 (269)
Q Consensus 26 ~v~~~~~~~~~~~~~~K~~~~~-----------------------~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~ 80 (269)
.||.|... +|..+|+|.+... ..+......+..+|++.|..+...+ +++++++.
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 47888874 6788999987421 1122333467788999999998764 56666542
Q ss_pred eeCCeEEEEEeccC--CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 81 GSKTKIFIVLEFVT--GGELFDKIVNHGRMKEDEARRYFQQLINAVDY-CHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 81 ~~~~~~~~v~~~~~--~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
...+||||++ |..+..+.... ++.+....++.+++..+.. +|+.|++|||+++.||+++++ .++++|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3469999998 66664433221 1234455677777774444 689999999999999999987 899999997
Q ss_pred cc
Q 024347 158 SA 159 (269)
Q Consensus 158 ~~ 159 (269)
+.
T Consensus 153 av 154 (188)
T PF01163_consen 153 AV 154 (188)
T ss_dssp EE
T ss_pred ce
Confidence 65
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.4e-11 Score=95.49 Aligned_cols=139 Identities=21% Similarity=0.314 Sum_probs=100.0
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC--ceeeeEEEeeC---CeEEEEEe
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVMGSK---TKIFIVLE 91 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~---~~~~~v~~ 91 (269)
+.|+.|..+.+|++... +|+.+++|........ .....+..|+.+++.+.+.+ +.+++.+.... +..+++|+
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999874 3678999997543221 12456788999999997644 56677766543 25689999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS------------------------------------------ 129 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~------------------------------------------ 129 (269)
|++|.++...+.. ..++......++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999877654321 235555555666666666666663
Q ss_pred --------------CCcEeecCCCCceEecC--CCCEEEeeCCCcc
Q 024347 130 --------------RGVYHRDLKPENLLLDA--YGNLKVSDFGLSA 159 (269)
Q Consensus 130 --------------~~i~h~di~~~nIl~~~--~~~~~l~df~~~~ 159 (269)
..++|||+++.||+++. ++.+.++||+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 5668999999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.9e-12 Score=111.12 Aligned_cols=142 Identities=18% Similarity=0.314 Sum_probs=103.2
Q ss_pred HHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccccccccC-------CCcccccccCccccCcccccCCC
Q 024347 118 QQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-------DGLLHTTCGTPNYVAPEVLNDRG 189 (269)
Q Consensus 118 ~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~-------~~~~~~~~~~~~~~aPE~~~~~~ 189 (269)
.++..|+.++|. .++||++|.|++|.++.++..|++.|+++........ ............|.|||++.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 345599999996 5999999999999999999999999998754333111 11111112456899999998855
Q ss_pred CCCCchhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHH----hcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCC
Q 024347 190 YDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKI----SAAEFTCPPWLSFTARKLIARILDPNPMTVSIYP 260 (269)
Q Consensus 190 ~~~~~~Di~slG~~l~~l~-~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 260 (269)
. +.++|+||+|+++|.+. .|...+...+....+..- ..+.+.....+|.++++-+.++|..++..||++.
T Consensus 186 ~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 186 N-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred c-cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchh
Confidence 4 59999999999999998 455555544333222221 2223444567999999999999999999999653
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.5e-10 Score=90.79 Aligned_cols=134 Identities=17% Similarity=0.086 Sum_probs=94.3
Q ss_pred CCcEEEEEEEcCCCCeEEEEEeehhhhhhHHH---------HHHHHHHHHHhhhCCCCCc--eeeeEEEee-----CCeE
Q 024347 23 TFAKVKFARNSETGEPVALKILDKEKVLKHKM---------AEQIKREVATMKLVKHPNV--VRLYEVMGS-----KTKI 86 (269)
Q Consensus 23 ~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~---------~~~~~~e~~~l~~l~~~~i--~~~~~~~~~-----~~~~ 86 (269)
....|.++.. .|+.+.+|........ +-. ...+.+|.+.+..+...+| +.+++++.. ....
T Consensus 34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s 110 (268)
T PRK15123 34 EGRRTLRFEL--AGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTS 110 (268)
T ss_pred CCceEEEEEE--CCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcccee
Confidence 3334556554 5778999976433211 100 1136788888888864443 334444432 2347
Q ss_pred EEEEeccCCC-chhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-------CCCEEEeeCC
Q 024347 87 FIVLEFVTGG-ELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-------YGNLKVSDFG 156 (269)
Q Consensus 87 ~~v~~~~~~~-~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-------~~~~~l~df~ 156 (269)
++|+|++++. ++.+++.. ..+.+......++.+++..+..||+.|++|||++++||+++. +..+.|+||+
T Consensus 111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 8999999876 77777653 234566777899999999999999999999999999999975 4579999999
Q ss_pred Ccc
Q 024347 157 LSA 159 (269)
Q Consensus 157 ~~~ 159 (269)
-+.
T Consensus 191 r~~ 193 (268)
T PRK15123 191 RAQ 193 (268)
T ss_pred ccc
Confidence 664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-09 Score=83.79 Aligned_cols=106 Identities=19% Similarity=0.365 Sum_probs=82.8
Q ss_pred HHHHHHHHHHhhhCCCCC--ceeeeEEEeeC----CeEEEEEeccCCC-chhHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 024347 55 AEQIKREVATMKLVKHPN--VVRLYEVMGSK----TKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127 (269)
Q Consensus 55 ~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~----~~~~~v~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~l 127 (269)
.....+|...+..+...+ .+.++++.... ...+++++++++. +|.+.+......+......++.+++..+..|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 345777888887776443 34555555432 2458899999874 6888777644567777889999999999999
Q ss_pred HhCCcEeecCCCCceEecCCC---CEEEeeCCCccc
Q 024347 128 HSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSAL 160 (269)
Q Consensus 128 h~~~i~h~di~~~nIl~~~~~---~~~l~df~~~~~ 160 (269)
|++|++|+|+++.|||++.++ .+.++||+-++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 799999996653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.06 E-value=9e-09 Score=79.02 Aligned_cols=139 Identities=17% Similarity=0.273 Sum_probs=91.1
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHH------HHHHHHhhhCC---CCCceeeeEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI------KREVATMKLVK---HPNVVRLYEVM 80 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~------~~e~~~l~~l~---~~~i~~~~~~~ 80 (269)
-++|.+.+.+.......|.+..- +|+.+++|.......-.+.....+ .+.+..+..+. -.....++.+.
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 35788889999888888887775 578899999865433222222222 22333333332 22233332222
Q ss_pred -----eeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeC
Q 024347 81 -----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 81 -----~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
.-....+++|||++|..+.+... +++ .+...+.+++..+|+.|++|||.+|+|++++.+ .++++|+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~ 178 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDT 178 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEEC
Confidence 22344678999999988765421 222 244567788999999999999999999999964 4999999
Q ss_pred CCcc
Q 024347 156 GLSA 159 (269)
Q Consensus 156 ~~~~ 159 (269)
+..+
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8543
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.4e-09 Score=79.18 Aligned_cols=137 Identities=16% Similarity=0.161 Sum_probs=96.7
Q ss_pred eccCCcEEEEEEEcCCCCeEEEEEeehhhhhh---HHHHHHHHHHHHHhhhCCCCC--ceeeeEEEe-e----CCeEEEE
Q 024347 20 GEGTFAKVKFARNSETGEPVALKILDKEKVLK---HKMAEQIKREVATMKLVKHPN--VVRLYEVMG-S----KTKIFIV 89 (269)
Q Consensus 20 g~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~-~----~~~~~~v 89 (269)
|+||.|.|+..... |+.+-+|.-......+ +--...+.+|+..++++..-+ ++++. ++. . .-..++|
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56899999988763 4468888643110000 112456888999888886433 44444 221 1 1235788
Q ss_pred EeccCC-CchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC--EEEeeCCCcc
Q 024347 90 LEFVTG-GELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSA 159 (269)
Q Consensus 90 ~~~~~~-~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~--~~l~df~~~~ 159 (269)
++-+.| .+|.+.+.+. .+.+..+...++.+++..+..||+.|+.|+|+.+.||+++.++. +.++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 886654 4676666553 34577778899999999999999999999999999999986677 9999998655
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.4e-08 Score=77.58 Aligned_cols=138 Identities=20% Similarity=0.241 Sum_probs=93.4
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHH---------------------HHHHHHHHHHHhhhCCCC--C
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK---------------------MAEQIKREVATMKLVKHP--N 72 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~---------------------~~~~~~~e~~~l~~l~~~--~ 72 (269)
...|+.|..+.||.|.. .++..+|+|++......... ...+..+|+..|+++... .
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34677888889999986 46889999998643332211 123456678888777533 3
Q ss_pred ceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEE
Q 024347 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLK 151 (269)
Q Consensus 73 i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~ 151 (269)
+++.+++. ...++||++.......=....-++..+....+..++++.+.-|-. .|+||||++.-|||+. ++.++
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 44455543 245899998543111111111123344566777888888888777 8999999999999999 78999
Q ss_pred EeeCCCcc
Q 024347 152 VSDFGLSA 159 (269)
Q Consensus 152 l~df~~~~ 159 (269)
++|++.+.
T Consensus 207 iID~~QaV 214 (268)
T COG1718 207 IIDVSQAV 214 (268)
T ss_pred EEECcccc
Confidence 99999764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.8e-08 Score=86.48 Aligned_cols=150 Identities=20% Similarity=0.316 Sum_probs=95.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh-------------------------------HHHHH
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-------------------------------HKMAE 56 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------------------------------~~~~~ 56 (269)
..+..|.. +.|+.++-|+||.|+.+. |+.||||+.++.-... ++..+
T Consensus 123 e~F~eF~~-~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~ 200 (517)
T COG0661 123 ELFSEFEP-EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEK 200 (517)
T ss_pred HHHHHcCC-CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHH
Confidence 34445543 788999999999999874 9999999874321110 11111
Q ss_pred ------HHHHHHHHhhhCC-----CCCceeeeEEEeeCCeEEEEEeccCCCchhHHH--HhcCCCCHHHHHHHHHHHHHH
Q 024347 57 ------QIKREVATMKLVK-----HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEARRYFQQLINA 123 (269)
Q Consensus 57 ------~~~~e~~~l~~l~-----~~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~ 123 (269)
++.+|+..+.++. .+++.-..-++.-.+...++|||++|..+.+.. .. ...+...+...+.++.
T Consensus 201 ~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f-- 277 (517)
T COG0661 201 RLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF-- 277 (517)
T ss_pred HHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--
Confidence 2233444444442 233322222334455678999999998887763 33 3455444443322221
Q ss_pred HHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 124 l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
+..+=..|++|+|.+|.||+++.++.+.+.|||+.....
T Consensus 278 ~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 278 LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 233334899999999999999999999999999876443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.3e-08 Score=75.52 Aligned_cols=133 Identities=15% Similarity=0.182 Sum_probs=83.4
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC--ceeeeEEEeeCCeEEEEEeccC
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
..||+|..+.||+. .+..+++|...... . ...+.+|.++++.+..-+ +.+++++..+.+...++|++++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--D---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC--C---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 24568899975422 1 345688999998886443 4677888877778889999999
Q ss_pred CCc-hh--------------HH-------HHhc--CCCCHHHHH-HHHH----------HHHHH-HHHHHh----CCcEe
Q 024347 95 GGE-LF--------------DK-------IVNH--GRMKEDEAR-RYFQ----------QLINA-VDYCHS----RGVYH 134 (269)
Q Consensus 95 ~~~-l~--------------~~-------~~~~--~~l~~~~~~-~i~~----------~i~~~-l~~lh~----~~i~h 134 (269)
|.+ +. .. ++.. ......... .+.. .+.+. ..+|.+ ..++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 863 11 00 1110 011111100 1100 11111 112221 24799
Q ss_pred ecCCCCceEecCCCCEEEeeCCCcc
Q 024347 135 RDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 135 ~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
||++|.||++++++ +.++||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999888 9999999765
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.8e-06 Score=67.12 Aligned_cols=78 Identities=21% Similarity=0.296 Sum_probs=54.6
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCC--CceeeeEEE---eeCCeEEEEE
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEVM---GSKTKIFIVL 90 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~---~~~~~~~~v~ 90 (269)
++.|+.|..+.+|.+.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+.+|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 4788999999999999764 47999997554 2245666788887777533 345666543 3344578999
Q ss_pred eccCCCchhH
Q 024347 91 EFVTGGELFD 100 (269)
Q Consensus 91 ~~~~~~~l~~ 100 (269)
++++|..+..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999877665
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.54 E-value=1.3e-06 Score=69.76 Aligned_cols=135 Identities=14% Similarity=0.074 Sum_probs=82.2
Q ss_pred eeeeccCC-cEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEEEEEeccC
Q 024347 17 RTIGEGTF-AKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 17 ~~lg~g~~-~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
..|..|.. ..||++... +..+++|...... ...+..|+++++.+. +-.+.+++++....+..+++|++++
T Consensus 4 ~~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~ 75 (244)
T cd05150 4 ERVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP 75 (244)
T ss_pred eecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence 34555666 788988753 4678999864432 234567888887774 3345677777766667889999999
Q ss_pred CCchhHHH-------------------HhcC----CCCHH--HHHHHHH--------------------HHHHHHHHHH-
Q 024347 95 GGELFDKI-------------------VNHG----RMKED--EARRYFQ--------------------QLINAVDYCH- 128 (269)
Q Consensus 95 ~~~l~~~~-------------------~~~~----~l~~~--~~~~i~~--------------------~i~~~l~~lh- 128 (269)
|.++.... +... ++... ....... .+...+..|-
T Consensus 76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 155 (244)
T cd05150 76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA 155 (244)
T ss_pred CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence 87665331 1100 11100 0000000 0111222221
Q ss_pred ------hCCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 129 ------SRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 129 ------~~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
...++|||+.|.||++++++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1248999999999999997778899999664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=9.1e-07 Score=65.31 Aligned_cols=129 Identities=19% Similarity=0.303 Sum_probs=92.7
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCce-eeeEEEeeCCeEEEEEe
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV-RLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~v~~ 91 (269)
-++.+.|+.|..|.||++.+. |..+++|+-..++ ....+..|+++|..+...++. +++.+..+ ++.||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me 92 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRME 92 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhh
Confidence 356788999999999999985 5589999865443 257888999999999877764 45554432 34599
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCC-CCceEecCCCCEEEeeCCCcc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLK-PENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~-~~nIl~~~~~~~~l~df~~~~ 159 (269)
|..|..|....... +.. -+..+++.-.-|-..||-|+.|+ |...++-.++.++++||..+.
T Consensus 93 ~i~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 93 YIDGRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhcCcchhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 99998886544321 223 33456666666778899999998 445555555699999999765
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.3e-06 Score=74.57 Aligned_cols=145 Identities=22% Similarity=0.315 Sum_probs=88.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh----------------------------HHHHHH----
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----------------------------HKMAEQ---- 57 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----------------------------~~~~~~---- 57 (269)
+..|.. +.||..+.++||+|+.+. |+.||||+-++.-... ++..+.
T Consensus 161 f~~f~~-~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E 238 (538)
T KOG1235|consen 161 FSEFDE-EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE 238 (538)
T ss_pred HHhcCc-chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh
Confidence 334433 789999999999999875 9999999864321111 111111
Q ss_pred --HHHHHHHh----hhCCCCC------ceeeeEEEeeCCeEEEEEeccCCCchhHH--HHhcCCCCHHHHHHHHHHHHHH
Q 024347 58 --IKREVATM----KLVKHPN------VVRLYEVMGSKTKIFIVLEFVTGGELFDK--IVNHGRMKEDEARRYFQQLINA 123 (269)
Q Consensus 58 --~~~e~~~l----~~l~~~~------i~~~~~~~~~~~~~~~v~~~~~~~~l~~~--~~~~~~l~~~~~~~i~~~i~~~ 123 (269)
+.+|++.. +.+.|-+ |++++-. -.+...++|||++|..+.+. +.+. .++...+..-+.++..
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~- 314 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL- 314 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH-
Confidence 12222222 3333444 4444332 34457899999999866443 3333 3555544433333222
Q ss_pred HHHHHhCCcEeecCCCCceEecC----CCCEEEeeCCCcccc
Q 024347 124 VDYCHSRGVYHRDLKPENLLLDA----YGNLKVSDFGLSALS 161 (269)
Q Consensus 124 l~~lh~~~i~h~di~~~nIl~~~----~~~~~l~df~~~~~~ 161 (269)
.-+=..|++|+|-+|.||++.. +..+.+.|||+....
T Consensus 315 -~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 315 -EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred -HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 1233578999999999999994 556999999987643
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=2.1e-07 Score=75.09 Aligned_cols=137 Identities=20% Similarity=0.251 Sum_probs=97.5
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhh-------------------hhHHHHHHHHHHHHHhhhCCC--
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-------------------LKHKMAEQIKREVATMKLVKH-- 70 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-------------------~~~~~~~~~~~e~~~l~~l~~-- 70 (269)
-+.++..||-|.-|.+|.+-+. .|++.++|.-..... |-.-..-...+|...++.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 4678899999999999999874 689999996432111 111112234567777777753
Q ss_pred CCceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCE
Q 024347 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 71 ~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~ 150 (269)
-.+++.++ .++.++||+...|-.|.+..+- .+.. .+...+...+--|..+|++|||.+--||++.+++.+
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v---~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRHV---EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeeec---CChH---HHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 23444444 3467899999998877654321 2233 345567777778899999999999999999999999
Q ss_pred EEeeCCCcc
Q 024347 151 KVSDFGLSA 159 (269)
Q Consensus 151 ~l~df~~~~ 159 (269)
+++||-.+-
T Consensus 242 ~vIDFPQmv 250 (465)
T KOG2268|consen 242 VVIDFPQMV 250 (465)
T ss_pred EEeechHhh
Confidence 999998654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.7e-05 Score=60.52 Aligned_cols=99 Identities=20% Similarity=0.309 Sum_probs=77.3
Q ss_pred HHHHHHhhhCCC-CCceeeeEEEeeCCeEEEEEeccCCCchhHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 024347 59 KREVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDK---IVNHGRMKEDEARRYFQQLINAVDYCHS---RG 131 (269)
Q Consensus 59 ~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~~lh~---~~ 131 (269)
.+|.-+++.+++ +++++++|.+.+ +.+.||...+++... +..-...+...+.+++.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888976 689999998843 467788876655321 1111245789999999999999999997 34
Q ss_pred cEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 132 i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
+..+|++++|+-+++++.++++|.+.....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.37 E-value=6.8e-06 Score=76.41 Aligned_cols=199 Identities=18% Similarity=0.174 Sum_probs=134.0
Q ss_pred HHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE----EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 024347 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTKI----FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130 (269)
Q Consensus 55 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~----~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~ 130 (269)
+....-|+..+.+..|+|+...+.+....... .+..+++.+.++...+..-+..+..+...+..+...+|.++|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 44455677888888999999998887443322 23456788888888888888899999999999999999999999
Q ss_pred CcEeecCCCC---ceEecCCCCEEEe--eCCCccccccccCCCcccccccCccccCcccccCCCCC-CCchhHHHHHHHH
Q 024347 131 GVYHRDLKPE---NLLLDAYGNLKVS--DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD-GSTADLWSCGVIL 204 (269)
Q Consensus 131 ~i~h~di~~~---nIl~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~~Di~slG~~l 204 (269)
...|.-+..+ +--++.++.+..+ ||+.+..... ............+.++|........ ....|+|.+|...
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~ 382 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL 382 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence 7666666555 3444555556665 7876654332 2222222345567788877655433 2347999999999
Q ss_pred HHHHcCCCCCCCCCHHHHHHHHhcCcccCCC-CCCHHHHHHHHHhcCCCCCCcCCCCcccccccc
Q 024347 205 FVLLAGYLPFDDSNLMNLYKKISAAEFTCPP-WLSFTARKLIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 205 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
..+..|..+-... ........ .......+....|+..++++|+++ .+.+-|+
T Consensus 383 ~~~~~~~~i~~~~----------~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~--~~ll~~~ 435 (1351)
T KOG1035|consen 383 LQLSQGEDISEKS----------AVPVSLLDVLSTSELLDALPKCLDEDSEERLSA--LELLTHP 435 (1351)
T ss_pred hhhhhcCcccccc----------cchhhhhccccchhhhhhhhhhcchhhhhccch--hhhhhch
Confidence 9988875442211 00011111 112268899999999999999999 5555444
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.36 E-value=8.5e-06 Score=76.15 Aligned_cols=145 Identities=19% Similarity=0.394 Sum_probs=90.6
Q ss_pred eeeeeccCCcEEEEEEEcCCC--CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCc--eeeeEEEeeC---CeEE
Q 024347 16 GRTIGEGTFAKVKFARNSETG--EPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNV--VRLYEVMGSK---TKIF 87 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i--~~~~~~~~~~---~~~~ 87 (269)
++.++.|.+..+|+......+ ..+++|........ .....+.+|+++++.+. |.++ .+++.++.+. +..+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577898999999998765432 46888876432211 11356788999999995 5654 7777777654 4578
Q ss_pred EEEeccCCCchhH--------------------H---HHhcC--C--C---------CHHHHHHHHH-------------
Q 024347 88 IVLEFVTGGELFD--------------------K---IVNHG--R--M---------KEDEARRYFQ------------- 118 (269)
Q Consensus 88 ~v~~~~~~~~l~~--------------------~---~~~~~--~--l---------~~~~~~~i~~------------- 118 (269)
+||||++|..+.+ . ++.-. . + ...++..|..
T Consensus 121 lVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~ 200 (822)
T PLN02876 121 YIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPR 200 (822)
T ss_pred EEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCC
Confidence 9999998864321 0 11100 0 0 0123322222
Q ss_pred --HHHHHHHHHHh-----------CCcEeecCCCCceEecCC-CC-EEEeeCCCccccc
Q 024347 119 --QLINAVDYCHS-----------RGVYHRDLKPENLLLDAY-GN-LKVSDFGLSALSQ 162 (269)
Q Consensus 119 --~i~~~l~~lh~-----------~~i~h~di~~~nIl~~~~-~~-~~l~df~~~~~~~ 162 (269)
.+...+.+|.. ..+||||+++.||+++.+ +. .-+.||+.+..-.
T Consensus 201 ~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 201 NPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 12334556642 249999999999999853 33 5789999876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.9e-06 Score=66.59 Aligned_cols=73 Identities=10% Similarity=0.059 Sum_probs=45.5
Q ss_pred eeeeeccCCc-EEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCC---CceeeeEEEeeC---CeEEE
Q 024347 16 GRTIGEGTFA-KVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP---NVVRLYEVMGSK---TKIFI 88 (269)
Q Consensus 16 ~~~lg~g~~~-~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~---~~~~~ 88 (269)
++.++.|+.+ .||... ..+++|...... ....+.+|+++++.+... .+..+++..... ...++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567766666 488652 348888754321 245788899999888632 344444443322 23478
Q ss_pred EEeccCCCch
Q 024347 89 VLEFVTGGEL 98 (269)
Q Consensus 89 v~~~~~~~~l 98 (269)
+|++++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 8999988655
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.33 E-value=2.2e-05 Score=60.16 Aligned_cols=132 Identities=20% Similarity=0.266 Sum_probs=90.6
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhh-------------hhHHHHHHHHHHHHHhhhCC------CCCceee
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-------------LKHKMAEQIKREVATMKLVK------HPNVVRL 76 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-------------~~~~~~~~~~~e~~~l~~l~------~~~i~~~ 76 (269)
...||.|+.-.||.-- .+...+||+...... ......+...+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3678999999998433 345589999876550 00112345556666665555 7889999
Q ss_pred eEEEeeCCeEEEEEeccCC------CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC--
Q 024347 77 YEVMGSKTKIFIVLEFVTG------GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-- 148 (269)
Q Consensus 77 ~~~~~~~~~~~~v~~~~~~------~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-- 148 (269)
+|+..++....+|+|.... .+|.+++.+ +.++. . +...+-+...+|-+++|+.+|++|+||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999888999886532 357666643 34555 3 334455566778899999999999999996333
Q ss_pred --CEEEeeC
Q 024347 149 --NLKVSDF 155 (269)
Q Consensus 149 --~~~l~df 155 (269)
.++++|-
T Consensus 158 ~~~lvlIDG 166 (199)
T PF10707_consen 158 EFRLVLIDG 166 (199)
T ss_pred ceEEEEEeC
Confidence 3666654
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=3.4e-08 Score=85.76 Aligned_cols=236 Identities=19% Similarity=0.190 Sum_probs=150.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC-ceeeeEEEeeCCeEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKIFI 88 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~ 88 (269)
...+...+.++.++++.+++.+...+.... .+.+... ....-++++|.+++||| .+..++-+..+....+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i 311 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWI 311 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccch
Confidence 334455577888999999887766543332 4443221 33445789999999999 5555555566777889
Q ss_pred EEeccCCC-chhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 89 VLEFVTGG-ELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 89 v~~~~~~~-~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+++++.++ +....... .-.+...+...+++.-+.+++++|+..=+|+| ||+..+ +.++..+|+....+....
T Consensus 312 ~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~- 385 (829)
T KOG0576|consen 312 PMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM- 385 (829)
T ss_pred hhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence 99999776 22111111 11344556777888899999999998767777 665554 778999999776544332
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCC-----CCHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW-----LSFTA 241 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l 241 (269)
......+++.++|||+....... .+.|.|++|.-..++..|..|-...... ...+..+ +..+.. +++..
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~~~--~~~~g~~-p~s~~L~~~~aw~~~~ 459 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPPAV--LPMIGNG-PNSPMLTDKSAWSPVF 459 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCccc--cCCCCCC-CCccccchhhhcCccc
Confidence 23344578899999998877765 8899999998777777776664321000 0000000 001110 11122
Q ss_pred H-HHHHHhcCCCCCCcCCCCcccccccc
Q 024347 242 R-KLIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 242 ~-~li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
. ++.+.|+..-|..|+.. +.+++++
T Consensus 460 ~~~~~~~~~~g~P~~pkv~--mgacfsK 485 (829)
T KOG0576|consen 460 HRDFPAPCLNGLPPTPKVH--MGACFSK 485 (829)
T ss_pred ccCCcccccCCCCCCCcch--hhHHHHH
Confidence 2 47788888888888887 6666654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.25 E-value=4.5e-05 Score=58.20 Aligned_cols=127 Identities=21% Similarity=0.274 Sum_probs=88.6
Q ss_pred CCeEEeeeeeccCC-cEEEEEEEcCCCCeEEEEEeeh---h-------hhh-h-------HHHHHHHHHHHHHhhhCC--
Q 024347 11 GKYEVGRTIGEGTF-AKVKFARNSETGEPVALKILDK---E-------KVL-K-------HKMAEQIKREVATMKLVK-- 69 (269)
Q Consensus 11 ~~~~~~~~lg~g~~-~~v~~~~~~~~~~~~~~K~~~~---~-------~~~-~-------~~~~~~~~~e~~~l~~l~-- 69 (269)
.+++.++.||.|.- |.||+++- .|+.+|+|++.. . ... . ......+..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999997 577999999421 0 000 0 123457788888887775
Q ss_pred -CCCc--eeeeEEEeeC------------------CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 024347 70 -HPNV--VRLYEVMGSK------------------TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128 (269)
Q Consensus 70 -~~~i--~~~~~~~~~~------------------~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh 128 (269)
++++ ++++|+..-. ....+|.||.+... .++... +.++.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~----~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD----IPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH----HHHHHHHHHHHH
Confidence 4556 8999987322 11355666554432 233333 445666678899
Q ss_pred hCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 129 ~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
..||+-+|+++.|.. .-+|+|||.
T Consensus 182 k~gI~~~Dv~~~ny~-----~G~lvDfs~ 205 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR-----GGKLVDFSS 205 (207)
T ss_pred HCCeeeccCcccccc-----CCEEEeccc
Confidence 999999999999985 248999984
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.17 E-value=4e-05 Score=60.76 Aligned_cols=75 Identities=20% Similarity=0.313 Sum_probs=47.5
Q ss_pred eeeeeccCCcEEEEEEEcC-CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeCCeEEEEEecc
Q 024347 16 GRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFV 93 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~~~~ 93 (269)
++.|..|-...+|++.... .++.+++|....... . .-+..+|+.+++.+...++ ++++..+. + .+++||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---L-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---c-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4677888888999987542 356799998653211 1 1233468888888864443 34444332 2 3799999
Q ss_pred CCCch
Q 024347 94 TGGEL 98 (269)
Q Consensus 94 ~~~~l 98 (269)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.8e-05 Score=63.68 Aligned_cols=133 Identities=14% Similarity=0.191 Sum_probs=75.9
Q ss_pred eeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeCCeEEEEEeccCCC
Q 024347 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFVTGG 96 (269)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~~~~~~~ 96 (269)
.+..|-...+|+... +++.+++|...... ....-+..+|..+++.+...++ .+++.... -++|++|++|.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVC---KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCccc---ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 456677888998873 56679999754321 1111134678888888865443 34444332 25899999886
Q ss_pred chhHH-----------------HHhcC----CCCHH-HHHHHHHH---------HHHHHHHHHh--------CCcEeecC
Q 024347 97 ELFDK-----------------IVNHG----RMKED-EARRYFQQ---------LINAVDYCHS--------RGVYHRDL 137 (269)
Q Consensus 97 ~l~~~-----------------~~~~~----~l~~~-~~~~i~~~---------i~~~l~~lh~--------~~i~h~di 137 (269)
.+... ++... +++.. .+.....+ +...+..+-+ ..+||+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 54211 11111 11111 11121111 1111222221 14899999
Q ss_pred CCCceEecCCCCEEEeeCCCccc
Q 024347 138 KPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 138 ~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
+|.||++++++ +.++||+.+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999876 78999997754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.11 E-value=0.00012 Score=62.25 Aligned_cols=79 Identities=19% Similarity=0.241 Sum_probs=52.1
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh--h--HHHHHHHHHHHHHhhhCC---CCCceeeeEEEeeCCeEEE
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--K--HKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~--~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~ 88 (269)
.+.||.|....||++.....++.++||.-...... . .-..+....|.+.|+.+. ..++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 36789999999999998643358999984311100 0 112355666777777763 2456777666 4455789
Q ss_pred EEeccCCC
Q 024347 89 VLEFVTGG 96 (269)
Q Consensus 89 v~~~~~~~ 96 (269)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998764
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.04 E-value=8.3e-05 Score=61.54 Aligned_cols=142 Identities=20% Similarity=0.271 Sum_probs=97.2
Q ss_pred EEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhh----------------------hh-hHHHHHHHHHHHHHhhhCCC
Q 024347 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK----------------------VL-KHKMAEQIKREVATMKLVKH 70 (269)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~----------------------~~-~~~~~~~~~~e~~~l~~l~~ 70 (269)
.+-..|.-|....||.+... +|..+|+|++.-+. .+ ..-..-+...|++.|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 35567888999999999874 68889999873110 00 11223567889999999987
Q ss_pred CCceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCceEecCCCC
Q 024347 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYGN 149 (269)
Q Consensus 71 ~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh-~~~i~h~di~~~nIl~~~~~~ 149 (269)
.+|.-.--+.- ....+||+++.......-......++...+..+-.+++..+.-|- .+++||.||+--|+++.+ |.
T Consensus 226 aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~ 302 (520)
T KOG2270|consen 226 AGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GK 302 (520)
T ss_pred cCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CE
Confidence 66543322221 234689999853222111222346777777777788887777664 679999999999999986 78
Q ss_pred EEEeeCCCcc
Q 024347 150 LKVSDFGLSA 159 (269)
Q Consensus 150 ~~l~df~~~~ 159 (269)
++++|.+.+-
T Consensus 303 lyiIDVSQSV 312 (520)
T KOG2270|consen 303 LYIIDVSQSV 312 (520)
T ss_pred EEEEEccccc
Confidence 9999998653
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00025 Score=58.28 Aligned_cols=79 Identities=15% Similarity=0.142 Sum_probs=55.5
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCC---CCceeeeEEEee---CCeE
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH---PNVVRLYEVMGS---KTKI 86 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~~~~---~~~~ 86 (269)
-.-.+.||.|..+.||..... ++ .+++|...... ....+..|+..++.+.. -.++++++.+.. .+..
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS-QG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hheeeecCCccceeEEEEEcC-CC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 344578999999999988643 23 47778743210 12567788998888853 357788877644 4668
Q ss_pred EEEEeccCCCch
Q 024347 87 FIVLEFVTGGEL 98 (269)
Q Consensus 87 ~~v~~~~~~~~l 98 (269)
++|||+++|.++
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999998654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=59.94 Aligned_cols=138 Identities=22% Similarity=0.235 Sum_probs=77.9
Q ss_pred EeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC--ceeeeEE------EeeCCeE
Q 024347 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEV------MGSKTKI 86 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~~ 86 (269)
..+.++.|....+|++... ++ .+++|.+.... . ...+..+++++..|...+ +.+++.. ....+..
T Consensus 26 ~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eccccCCccccceEEEEeC-CC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 3566777777899988742 34 58899875421 1 123344566666664322 3333321 1224567
Q ss_pred EEEEeccCCCchh--------------HHHHhc-CCC--------CHHHHH---------------HHHHHHHHHHHHHH
Q 024347 87 FIVLEFVTGGELF--------------DKIVNH-GRM--------KEDEAR---------------RYFQQLINAVDYCH 128 (269)
Q Consensus 87 ~~v~~~~~~~~l~--------------~~~~~~-~~l--------~~~~~~---------------~i~~~i~~~l~~lh 128 (269)
+++++|++|..+. ..++.. ..+ ...... .....+...+.++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 8999999885421 011110 000 001000 00112233444443
Q ss_pred h-------CCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 129 S-------RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 129 ~-------~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
. .++||||+++.||+++.++.+.++||+.+.
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2 579999999999999988767899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00033 Score=57.56 Aligned_cols=138 Identities=20% Similarity=0.184 Sum_probs=81.5
Q ss_pred EeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC--ceeeeE------EEeeCCeE
Q 024347 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYE------VMGSKTKI 86 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~------~~~~~~~~ 86 (269)
-.+.+..|....+|+... .+..+++|.+... . ...+..|+++++.+...+ +.+++. +....+..
T Consensus 18 ~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~---~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~ 89 (296)
T cd05153 18 SFEGISAGIENTNYFVTT--DSGRYVLTLFEKV---S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP 89 (296)
T ss_pred heecccCccccceEEEEe--CCCcEEEEEcCCC---C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence 356788788889998865 3446999987541 1 245666777777775333 334332 12334567
Q ss_pred EEEEeccCCCchhH--------------HHHhc-CCCC--------HHHH------------HHHHHHHHHHHHHHHh--
Q 024347 87 FIVLEFVTGGELFD--------------KIVNH-GRMK--------EDEA------------RRYFQQLINAVDYCHS-- 129 (269)
Q Consensus 87 ~~v~~~~~~~~l~~--------------~~~~~-~~l~--------~~~~------------~~i~~~i~~~l~~lh~-- 129 (269)
+.++++.+|..+.. .++.. ..+. .... ......+..++.++.+
T Consensus 90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~ 169 (296)
T cd05153 90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD 169 (296)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence 89999998865421 01110 0000 0000 0011122333444443
Q ss_pred -----CCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 130 -----RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 130 -----~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
.++||||++|.||+++.++.+.++||+.+..
T Consensus 170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3699999999999999877678999997653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00019 Score=59.26 Aligned_cols=75 Identities=17% Similarity=0.235 Sum_probs=47.6
Q ss_pred eeeeeccCCcEEEEEEEcC------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeCCeEEE
Q 024347 16 GRTIGEGTFAKVKFARNSE------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFI 88 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~ 88 (269)
++.+..|-...+|++.... .++.+++|++.... ....+..+|..+++.+...++ .+++..+.. ..
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3556667777899887543 25789999975432 113456678888888864443 345555432 25
Q ss_pred EEeccCCCch
Q 024347 89 VLEFVTGGEL 98 (269)
Q Consensus 89 v~~~~~~~~l 98 (269)
|++|++|.++
T Consensus 75 v~e~i~G~~l 84 (302)
T cd05156 75 IEEFIPSRTL 84 (302)
T ss_pred hhheeCCCcC
Confidence 7888887654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.0005 Score=57.20 Aligned_cols=31 Identities=32% Similarity=0.410 Sum_probs=26.1
Q ss_pred CCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 130 ~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
.++||||++|+||+++.+...-++||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999999665568999997753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00077 Score=55.46 Aligned_cols=149 Identities=18% Similarity=0.199 Sum_probs=89.3
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCC--CCceeeeEEEeeCC--eE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSKT--KI 86 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~~--~~ 86 (269)
....+++.+..|....+|....+ ++.++++ ... ............+|+..++.+.. -.....++.+.+.. ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 34556666666666677777654 7889999 321 22233446777888998888864 23445566665544 67
Q ss_pred EEEEeccCCCch---------h-HHHH-----------hc----CC-------CCHHHHHHHHH--------------HH
Q 024347 87 FIVLEFVTGGEL---------F-DKIV-----------NH----GR-------MKEDEARRYFQ--------------QL 120 (269)
Q Consensus 87 ~~v~~~~~~~~l---------~-~~~~-----------~~----~~-------l~~~~~~~i~~--------------~i 120 (269)
+.||+|.+|..+ . ++.. .- .+ ....++..+.. ..
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 999999988322 1 1111 00 00 01111221111 12
Q ss_pred HHHHHHHHhC--------CcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 121 INAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 121 ~~~l~~lh~~--------~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
.....+++.+ .++|||+++.|+++++++.+-+.||+.+....+
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 2223444432 379999999999999999999999998765443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00074 Score=56.76 Aligned_cols=138 Identities=16% Similarity=0.213 Sum_probs=79.8
Q ss_pred EeeeeeccCCcEEEEEEEcC----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCce-eeeEEEeeCCeEEEE
Q 024347 15 VGRTIGEGTFAKVKFARNSE----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV-RLYEVMGSKTKIFIV 89 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~v 89 (269)
-++.|..|-...+|++.... .++.+++|...... ...+ +..+|..+++.+...++. ++++.+... .+
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceee-chHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence 33566668888899987532 24679999875432 2222 236788888888755543 455655332 47
Q ss_pred EeccCCCchhHH-----------------HHhcC-C----CC-HHHHHHHHHH-----------------HHHHHHHHH-
Q 024347 90 LEFVTGGELFDK-----------------IVNHG-R----MK-EDEARRYFQQ-----------------LINAVDYCH- 128 (269)
Q Consensus 90 ~~~~~~~~l~~~-----------------~~~~~-~----l~-~~~~~~i~~~-----------------i~~~l~~lh- 128 (269)
.+|++|.++... ++... + .. .+.+..+..+ +...+..|.
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 888877554211 11111 0 11 1222222211 111122221
Q ss_pred -------hCCcEeecCCCCceEecC-CCCEEEeeCCCccc
Q 024347 129 -------SRGVYHRDLKPENLLLDA-YGNLKVSDFGLSAL 160 (269)
Q Consensus 129 -------~~~i~h~di~~~nIl~~~-~~~~~l~df~~~~~ 160 (269)
...+||+|+++.||++++ ++.+.++||..+..
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 125899999999999986 46799999998764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0013 Score=55.95 Aligned_cols=77 Identities=14% Similarity=0.120 Sum_probs=49.5
Q ss_pred EeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh-hH---HHHHHHHHHHHHhhhCC---CCCceeeeEEEeeCCeEE
Q 024347 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-KH---KMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-~~---~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~ 87 (269)
..+.||.|....||++... +..++||.-...... .+ ....+...|++.|+.+. ..++++++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3578899999999998863 456999975411110 00 12344445567676654 346778887766 4457
Q ss_pred EEEeccCC
Q 024347 88 IVLEFVTG 95 (269)
Q Consensus 88 ~v~~~~~~ 95 (269)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 78999976
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0015 Score=54.56 Aligned_cols=141 Identities=18% Similarity=0.288 Sum_probs=79.1
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCce-eeeEEEeeCCeEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV-RLYEVMGSKTKIF 87 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~ 87 (269)
..++ +.|..|-...+|++..... +..+++|+..... + ..-+..+|..+++.+..-++. ++++++. .+
T Consensus 16 ~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--- 86 (330)
T PLN02421 16 DFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG--- 86 (330)
T ss_pred ceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCc---C-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---
Confidence 4444 5555577778998865432 3479999875422 1 123345788888888765553 4555553 22
Q ss_pred EEEeccCCCchhH-----------------HHHhcC-C----CC-HHHHHHHHHHH----------------------HH
Q 024347 88 IVLEFVTGGELFD-----------------KIVNHG-R----MK-EDEARRYFQQL----------------------IN 122 (269)
Q Consensus 88 ~v~~~~~~~~l~~-----------------~~~~~~-~----l~-~~~~~~i~~~i----------------------~~ 122 (269)
++.+|++|.++.. .++... + .+ ...+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 4788887754411 011111 0 11 11222222111 11
Q ss_pred HHHHHH----hCC----cEeecCCCCceEecC-CCCEEEeeCCCcccc
Q 024347 123 AVDYCH----SRG----VYHRDLKPENLLLDA-YGNLKVSDFGLSALS 161 (269)
Q Consensus 123 ~l~~lh----~~~----i~h~di~~~nIl~~~-~~~~~l~df~~~~~~ 161 (269)
.+..+. ..+ .||+|+.+.||++++ ++.++++||..+...
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n 214 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS 214 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence 122221 112 799999999999975 468999999987653
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0051 Score=50.92 Aligned_cols=29 Identities=34% Similarity=0.574 Sum_probs=25.4
Q ss_pred CCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 130 ~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
.++||||++++||+++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0033 Score=52.63 Aligned_cols=76 Identities=14% Similarity=0.145 Sum_probs=46.7
Q ss_pred eeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh----hHHHHHHHHHHHHHhhhCC--CC-CceeeeEEEeeCCeEEEEE
Q 024347 18 TIGEGTFAKVKFARNSETGEPVALKILDKEKVL----KHKMAEQIKREVATMKLVK--HP-NVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~----~~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~~v~ 90 (269)
.+|.|....||++.....++.++||.-..-... -+-..++..-|...|+... .| .+++++.+ +.....++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478899999999997533367999963211110 0112345556777776664 24 45555443 566667889
Q ss_pred eccCC
Q 024347 91 EFVTG 95 (269)
Q Consensus 91 ~~~~~ 95 (269)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 98854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0012 Score=57.25 Aligned_cols=149 Identities=19% Similarity=0.252 Sum_probs=93.3
Q ss_pred HHHHHHHHHhhhCCCCCceeeeEEEeeC-CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEe
Q 024347 56 EQIKREVATMKLVKHPNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134 (269)
Q Consensus 56 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h 134 (269)
..+.-...+++.+.|+|....+++-... .+..+|+|++ +.|+.+.+..+. +...... .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccce
Confidence 3455668889999999999998887443 3477889998 568888776653 2111111 122221
Q ss_pred ecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 024347 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (269)
Q Consensus 135 ~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 214 (269)
- |+ .+.+| ..+. +. | ...++++|||++|.++.++.-|...+
T Consensus 91 ~-----~~-------~~~td-~~~t-------------------~~-~------~~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 L-----NI-------IYITD-HFLT-------------------KY-P------SPIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred e-----hh-------hhccc-cccc-------------------cC-C------CCCCcchhhhhHHHHHHHHHHhhHHH
Confidence 1 11 12222 0000 00 1 11135999999999999999988777
Q ss_pred CCCCHHHHHHHHhcCcccCCC------------CCCHHHHHHHHHhcCCCCCCcCCC
Q 024347 215 DDSNLMNLYKKISAAEFTCPP------------WLSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
......+....+..-...... .++..+.++.+.|+-..|..||..
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 655555555444332221111 268889999999999999999965
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.011 Score=48.98 Aligned_cols=29 Identities=17% Similarity=0.170 Sum_probs=26.8
Q ss_pred CcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 131 ~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
++||||+.++|+++++++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 69999999999999999999999999665
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0067 Score=49.36 Aligned_cols=30 Identities=23% Similarity=0.407 Sum_probs=24.9
Q ss_pred CcEeecCCCCceEecCCCC-EEEeeCCCccc
Q 024347 131 GVYHRDLKPENLLLDAYGN-LKVSDFGLSAL 160 (269)
Q Consensus 131 ~i~h~di~~~nIl~~~~~~-~~l~df~~~~~ 160 (269)
.++|||+++.||++++++. +-++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999997555 56999997653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0045 Score=50.53 Aligned_cols=76 Identities=14% Similarity=0.190 Sum_probs=46.9
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC---CCCceeeeEEEeeCCeEEEE
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~v 89 (269)
-+-.+.++.|..+.+|+.. .+++.+.+|+-.... ...+..|++-|+.|. .-.+++++++....+..+++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3455788889999999888 568889999865222 244566777777763 44577888888777777999
Q ss_pred EeccCCC
Q 024347 90 LEFVTGG 96 (269)
Q Consensus 90 ~~~~~~~ 96 (269)
+||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0035 Score=53.12 Aligned_cols=78 Identities=18% Similarity=0.242 Sum_probs=49.2
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh---HHHHHHHHHHHHHhhhCC--CC-CceeeeEEEeeCCeEEEE
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK---HKMAEQIKREVATMKLVK--HP-NVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~---~~~~~~~~~e~~~l~~l~--~~-~i~~~~~~~~~~~~~~~v 89 (269)
.+.||.|....||++.+...++.++||.=..-.... +-..++..-|.+.|+... .| .+++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 578899999999999984335679998632111000 112455566777777664 34 45556543 55566788
Q ss_pred EeccCC
Q 024347 90 LEFVTG 95 (269)
Q Consensus 90 ~~~~~~ 95 (269)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888754
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0089 Score=50.91 Aligned_cols=76 Identities=17% Similarity=0.238 Sum_probs=45.1
Q ss_pred EeeeeeccCCcEEEEEEEcCC-CCe-----EEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeCCeEE
Q 024347 15 VGRTIGEGTFAKVKFARNSET-GEP-----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIF 87 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~-~~~-----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~ 87 (269)
.++.|..|-...+|++..... +.. |.++.... .....-+-.+|+.+++.+...++ .++++.+.. +
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 345666688889999875432 122 44443211 11112234568999999976554 456666642 4
Q ss_pred EEEeccCCCch
Q 024347 88 IVLEFVTGGEL 98 (269)
Q Consensus 88 ~v~~~~~~~~l 98 (269)
++.+|++|.++
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 88899988654
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.077 Score=44.30 Aligned_cols=29 Identities=21% Similarity=0.205 Sum_probs=24.3
Q ss_pred CCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 130 ~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
.++||||+.+.||+++ + .+.++||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 3689999999999995 3 578999997653
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.051 Score=47.28 Aligned_cols=75 Identities=15% Similarity=0.123 Sum_probs=46.1
Q ss_pred EeeeeeccCCcEEEEEEEcCC--------CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCce-eeeEEEeeCCe
Q 024347 15 VGRTIGEGTFAKVKFARNSET--------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV-RLYEVMGSKTK 85 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~--------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~ 85 (269)
-++.|..|-.-.+|++..... ++.|++|++-... +... +..+|..+++.+...++. ++++.+. +
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~-g-- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS-G-- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC-C--
Confidence 456777677778888875421 4679999864322 2222 445677777777655554 4555543 2
Q ss_pred EEEEEeccCCCc
Q 024347 86 IFIVLEFVTGGE 97 (269)
Q Consensus 86 ~~~v~~~~~~~~ 97 (269)
..+.+|++|.+
T Consensus 182 -g~I~efi~g~~ 192 (442)
T PTZ00296 182 -GRIEEWLYGDP 192 (442)
T ss_pred -CEEEEeeCCcc
Confidence 34678888753
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.26 E-value=1.2 Score=43.19 Aligned_cols=30 Identities=33% Similarity=0.488 Sum_probs=25.2
Q ss_pred CCcEeecCCCCceEecCCC--CEE-EeeCCCcc
Q 024347 130 RGVYHRDLKPENLLLDAYG--NLK-VSDFGLSA 159 (269)
Q Consensus 130 ~~i~h~di~~~nIl~~~~~--~~~-l~df~~~~ 159 (269)
.++||+|+++.||+++.++ .+. |+|||.+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 4799999999999999875 554 99999654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.025 Score=47.27 Aligned_cols=106 Identities=21% Similarity=0.310 Sum_probs=68.7
Q ss_pred CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
..+.+++|++. |+++. .+ +.-...++..++.+++..+.-+... ..-|+|+...||+++ +|+|.|+||.+++..
T Consensus 298 ~~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 298 TLYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred ceEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecc
Confidence 33456777765 44543 22 2234577888899999888887764 789999999999999 899999999998842
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHH
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVI 203 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~ 203 (269)
.. .... .....--|-.+.|.. ...-|||-+=..
T Consensus 372 ~~--q~~i-----sy~rldhp~lF~G~d--d~QFeIYrlMr~ 404 (488)
T COG5072 372 YS--QGII-----SYNRLDHPDLFNGVD--DYQFEIYRLMRR 404 (488)
T ss_pred cC--Ccee-----eccccCchhhhcCcc--ceeeeHHHHHHH
Confidence 21 1111 112233444555443 356677765433
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.034 Score=43.23 Aligned_cols=30 Identities=33% Similarity=0.626 Sum_probs=21.4
Q ss_pred CcEeecCCCCceEe-cCCCCEEEeeCCCccc
Q 024347 131 GVYHRDLKPENLLL-DAYGNLKVSDFGLSAL 160 (269)
Q Consensus 131 ~i~h~di~~~nIl~-~~~~~~~l~df~~~~~ 160 (269)
-++|+|+.+.||++ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8889999999998763
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.027 Score=45.63 Aligned_cols=44 Identities=32% Similarity=0.465 Sum_probs=33.6
Q ss_pred HHHHHHHHHHHHhC--CcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 117 FQQLINAVDYCHSR--GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 117 ~~~i~~~l~~lh~~--~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
+..+-.++.-++.. -+||+|+.|+|++.++.+.++|+||..+..
T Consensus 138 ~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 138 LKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 33444444444433 489999999999999999999999998764
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.013 Score=44.48 Aligned_cols=28 Identities=29% Similarity=0.432 Sum_probs=24.9
Q ss_pred cEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 132 VYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 132 i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
.+|+|+.|.|+++++++ ++++||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998877 89999997754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.001 Score=64.48 Aligned_cols=154 Identities=16% Similarity=0.122 Sum_probs=102.0
Q ss_pred HHHHHHhhhCCCCCceeeeEEEee--CCeEEEEEeccCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC-C
Q 024347 59 KREVATMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSR-G 131 (269)
Q Consensus 59 ~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~~v~~~~~~~~l~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~-~ 131 (269)
..|.+-++...|+++.....-..+ ....+..++|+.+|.+...+.++- ++...-+...-++........|+. +
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 334444555677777665444322 334567888898999888886541 222222222222225555555543 2
Q ss_pred ----cEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHH
Q 024347 132 ----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVL 207 (269)
Q Consensus 132 ----i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 207 (269)
.+|.++++-|.++..+-.+++.++|+.+... +.........+++.|++|++.+.-... .++|+|..|+.+|..
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn--p~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN--PVLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCcccccccccccccC--chHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHH
Confidence 6788999999999999999999999887322 222233344567788889888776664 669999999999999
Q ss_pred HcCCCCCC
Q 024347 208 LAGYLPFD 215 (269)
Q Consensus 208 ~~g~~p~~ 215 (269)
..|..+|.
T Consensus 1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred hcccHHHH
Confidence 88877763
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.15 Score=43.52 Aligned_cols=62 Identities=18% Similarity=0.193 Sum_probs=41.7
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCCceEecCCC
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPENLLLDAYG 148 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh-~~~i~h~di~~~nIl~~~~~ 148 (269)
..++.+|..|.++..++... ..++.....++.-...|+..+- --+.+|.|++|.||++--+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhcc-cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 35666788888888777654 3344455555555555554433 35799999999999996433
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 269 | ||||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-70 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-69 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-68 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-68 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-68 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-68 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-68 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-66 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-61 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-60 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-60 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-60 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-60 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-59 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-59 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-59 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-59 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-58 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-57 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-51 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 7e-51 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-50 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-50 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-49 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-48 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 9e-48 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-47 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-47 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-47 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-47 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-47 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-47 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-47 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-47 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-47 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-47 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-47 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-47 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-47 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-47 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-47 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-47 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-47 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-47 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 7e-47 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-47 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-47 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-47 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-47 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-47 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-47 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-46 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-46 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-46 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-46 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-46 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-46 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-46 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-46 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-45 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-45 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-45 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-45 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-45 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-45 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-45 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-45 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-45 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-45 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-45 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-45 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-45 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-45 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-45 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-45 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-44 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-44 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-44 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-44 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-44 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-44 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-44 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-44 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-44 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-43 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-43 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-43 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-43 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-43 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-43 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-43 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-43 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-43 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-43 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-43 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-42 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-42 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-42 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-42 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-42 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-42 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-41 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-41 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-41 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-41 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-41 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-41 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-41 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-41 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-41 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-40 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-40 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-40 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-40 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-40 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-40 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-40 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-40 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-40 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-40 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-40 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-40 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-40 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-40 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-40 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-40 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-40 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-40 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-40 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-40 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-40 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-40 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-40 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-40 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-40 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-40 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-40 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-40 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-40 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-40 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-40 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-40 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-40 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-40 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-40 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-40 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 6e-40 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-40 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-40 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-40 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 9e-40 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 9e-40 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-39 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-39 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-39 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-39 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-39 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-39 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-39 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-39 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-39 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-39 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-39 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-39 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-39 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-39 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-39 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-38 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-38 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-38 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-38 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-38 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-38 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-38 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-38 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-38 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-38 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-38 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-38 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-38 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-38 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-38 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-38 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-38 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-38 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-37 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-37 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-37 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-37 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-37 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-37 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-37 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-37 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-37 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-37 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-37 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-37 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-37 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-37 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-37 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-37 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-36 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-36 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-36 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-36 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-36 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-36 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-36 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-36 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-36 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-36 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-36 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-36 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-36 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-36 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-36 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-36 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-36 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-36 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-36 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-36 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-36 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-36 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-36 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 9e-36 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-36 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-36 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-36 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-35 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-35 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-35 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-35 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-35 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-35 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-35 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-35 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-35 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-35 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-35 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-35 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-35 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-35 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-35 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-35 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-35 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-35 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-35 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-34 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-34 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-34 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-34 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-34 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-34 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-34 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-34 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-33 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-33 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-33 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-33 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-33 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-33 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-32 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-32 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-32 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-32 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-32 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-32 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-32 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 7e-32 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-31 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-31 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-31 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-31 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-30 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-30 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-30 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-30 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-30 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-29 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-29 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-29 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-28 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-28 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-28 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-27 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-27 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-27 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-27 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-27 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-27 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-27 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-27 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-27 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-27 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-27 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-27 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-27 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 8e-27 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 8e-27 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-26 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-26 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-26 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-25 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-25 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-25 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-25 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-25 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-25 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-25 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-25 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-25 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-25 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-25 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-25 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-24 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-24 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-24 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-24 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-24 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-24 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-24 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-24 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-24 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-24 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-24 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-24 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-24 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-24 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-24 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-24 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-24 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-24 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-24 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-24 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-23 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-23 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-23 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-23 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-23 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-23 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-23 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-23 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-23 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-23 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-23 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-23 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-23 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-23 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-23 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-23 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-23 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-23 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-23 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-23 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-23 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-23 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-23 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-23 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-23 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-23 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-23 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-23 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-23 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-23 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-23 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-23 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-23 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-23 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-23 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-23 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-23 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-23 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-23 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-23 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-23 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 5e-23 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-23 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-23 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-23 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-23 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-23 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-23 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-23 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-23 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-23 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-23 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-23 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-23 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-22 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-22 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-22 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-22 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-22 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-22 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-22 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-22 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-22 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-22 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 8e-22 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-21 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-21 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-20 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-20 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-20 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-19 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-19 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-19 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-19 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-19 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-19 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-19 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-19 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-18 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-18 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-18 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-18 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-18 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-18 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-18 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-18 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-18 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-18 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-18 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-18 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-18 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-18 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-18 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-18 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-18 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-18 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-18 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-18 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-18 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-18 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-18 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-18 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-18 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-18 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-18 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-18 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-18 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-17 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-17 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-17 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-16 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-16 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-16 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-16 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-16 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-16 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-16 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-16 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-16 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-15 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-15 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-15 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-15 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-15 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-15 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-15 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-15 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-15 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-15 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-15 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-15 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-15 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-15 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-15 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-15 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-15 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-15 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-15 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-15 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-15 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-15 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-15 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 7e-15 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-15 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-15 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-14 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-14 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-14 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-14 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-14 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-14 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-14 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-14 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-14 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 9e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-13 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 6e-13 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 8e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-12 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-12 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-12 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-11 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-11 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-11 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-11 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-11 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-11 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-11 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-11 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-11 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-11 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-11 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-11 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-11 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-11 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 9e-11 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 9e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-10 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 5e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 5e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 7e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 7e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 8e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 8e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 8e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 8e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 9e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 5e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 6e-09 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 6e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 6e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 6e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-09 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 6e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-08 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-08 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-08 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 8e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-08 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 9e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 |
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 472 bits (1217), Expect = e-171
Identities = 121/254 (47%), Positives = 176/254 (69%), Gaps = 3/254 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S+ + ++G Y +G T+G GTF KVK + TG VA+KIL+++K+ + +IKRE
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ +KL +HP++++LY+V+ + T F+V+E+V+GGELFD I HGR++E EARR FQQ++
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+AVDYCH V HRDLKPEN+LLDA+ N K++DFGLS + + D L T+CG+PNY A
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAA 178
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEV++ R Y G D+WSCGVIL+ LL G LPFDD ++ L+KKI F P +L+ +
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSV 238
Query: 242 RKLIARILDPNPMT 255
L+ +L +P+
Sbjct: 239 ATLLMHMLQVDPLK 252
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 468 bits (1206), Expect = e-169
Identities = 98/258 (37%), Positives = 147/258 (56%), Gaps = 9/258 (3%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ P + +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+
Sbjct: 1 MAVPFV----EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKK 54
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW--L 237
APE+L R + D+WSCG++L +LAG LP+D S+ Y + PW +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 238 SFTARKLIARILDPNPMT 255
L+ +IL NP
Sbjct: 235 DSAPLALLHKILVENPSA 252
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 469 bits (1208), Expect = e-169
Identities = 98/258 (37%), Positives = 147/258 (56%), Gaps = 9/258 (3%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
M+ P + +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+
Sbjct: 1 MAVPFV----EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKK 54
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
E+ K++ H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ V Y H G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPW--L 237
APE+L R + D+WSCG++L +LAG LP+D S+ Y + PW +
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI 234
Query: 238 SFTARKLIARILDPNPMT 255
L+ +IL NP
Sbjct: 235 DSAPLALLHKILVENPSA 252
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 469 bits (1208), Expect = e-166
Identities = 116/254 (45%), Positives = 174/254 (68%), Gaps = 3/254 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++G Y +G T+G GTF KVK ++ TG VA+KIL+++K+ + +I+RE
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ +KL +HP++++LY+V+ + + IF+V+E+V+GGELFD I +GR+ E E+RR FQQ++
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ VDYCH V HRDLKPEN+LLDA+ N K++DFGLS + + D L T+CG+PNY A
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAA 183
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PEV++ R Y G D+WS GVIL+ LL G LPFDD ++ L+KKI F P +L+ +
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSV 243
Query: 242 RKLIARILDPNPMT 255
L+ +L +PM
Sbjct: 244 ISLLKHMLQVDPMK 257
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 461 bits (1189), Expect = e-166
Identities = 117/252 (46%), Positives = 176/252 (69%), Gaps = 4/252 (1%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
KR +G Y + T+GEG+F KVK A + +T + VALK + ++ + K M +++RE++
Sbjct: 2 AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
+KL++HP++++LY+V+ + T I +V+E+ GGELFD IV RM EDE RR+FQQ+I A
Sbjct: 62 YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
++YCH + HRDLKPENLLLD N+K++DFGLS + + D L T+CG+PNY APE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPE 177
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V+N + Y G D+WSCG++L+V+L G LPFDD + NL+KK+++ + P +LS A+
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237
Query: 244 LIARILDPNPMT 255
LI R++ +PM
Sbjct: 238 LIRRMIVADPMQ 249
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 459 bits (1183), Expect = e-165
Identities = 81/254 (31%), Positives = 137/254 (53%), Gaps = 7/254 (2%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-MAEQIKREVATMK 66
+ +GKY +G +GEG++ KVK +SET A+KIL K+K+ + +K+E+ ++
Sbjct: 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 67 LVKHPNVVRLYEVMG--SKTKIFIVLEFVTGG--ELFDKIVNHGRMKEDEARRYFQQLIN 122
++H NV++L +V+ K K+++V+E+ G E+ D + R +A YF QLI+
Sbjct: 62 RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLID 120
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
++Y HS+G+ H+D+KP NLLL G LK+S G++ D T+ G+P + P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180
Query: 183 EVLND-RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
E+ N + G D+WS GV L+ + G PF+ N+ L++ I + P
Sbjct: 181 EIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240
Query: 242 RKLIARILDPNPMT 255
L+ +L+ P
Sbjct: 241 SDLLKGMLEYEPAK 254
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 447 bits (1152), Expect = e-160
Identities = 102/262 (38%), Positives = 149/262 (56%), Gaps = 15/262 (5%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
I +Y+ + IG G F + R+ T E VA+K +++ + E ++RE
Sbjct: 11 LDMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQRE 66
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ + ++HPN+VR EV+ + T + I++E+ +GGEL+++I N GR EDEAR +FQQL+
Sbjct: 67 IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL 126
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ V YCHS + HRDLK EN LLD LK+ DFG S S +T GTP Y
Sbjct: 127 SGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKSTVGTPAY 183
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK----ISAAEFTCPP 235
+APEVL + YDG AD+WSCGV L+V+L G PF+D Y+K I + +++ P
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243
Query: 236 --WLSFTARKLIARILDPNPMT 255
+S LI+RI +P T
Sbjct: 244 DIRISPECCHLISRIFVADPAT 265
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 444 bits (1144), Expect = e-159
Identities = 83/249 (33%), Positives = 127/249 (51%), Gaps = 3/249 (1%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +Y GR +G+G FAK +++T E A KI+ K +LK E++ E++ +
Sbjct: 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ H +VV + +F+VLE L + + E EAR Y +Q++ Y
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H V HRDLK NL L+ +K+ DFGL+ + D CGTPNY+APEVL+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLS 188
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
+G+ D+WS G I++ LL G PF+ S L Y +I E++ P ++ A LI
Sbjct: 189 KKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247
Query: 247 RILDPNPMT 255
++L +P
Sbjct: 248 KMLQTDPTA 256
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 444 bits (1144), Expect = e-159
Identities = 83/249 (33%), Positives = 127/249 (51%), Gaps = 3/249 (1%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +Y GR +G+G FAK +++T E A KI+ K +LK E++ E++ +
Sbjct: 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ H +VV + +F+VLE L + + E EAR Y +Q++ Y
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
H V HRDLK NL L+ +K+ DFGL+ + D CGTPNY+APEVL+
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLS 214
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
+G+ D+WS G I++ LL G PF+ S L Y +I E++ P ++ A LI
Sbjct: 215 KKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273
Query: 247 RILDPNPMT 255
++L +P
Sbjct: 274 KMLQTDPTA 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 439 bits (1131), Expect = e-158
Identities = 87/253 (34%), Positives = 140/253 (55%), Gaps = 4/253 (1%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
I ++ ++VG +G+G+FA V A + TG VA+K++DK+ + K M ++++ EV
Sbjct: 4 TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLIN 122
+KHP+++ LY +++VLE GE+ + N E+EAR + Q+I
Sbjct: 64 IHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT 123
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ Y HS G+ HRDL NLLL N+K++DFGL+ + +T CGTPNY++P
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISP 181
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
E+ + G +D+WS G + + LL G PFD + N K+ A++ P +LS A+
Sbjct: 182 EIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK 240
Query: 243 KLIARILDPNPMT 255
LI ++L NP
Sbjct: 241 DLIHQLLRRNPAD 253
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 434 bits (1118), Expect = e-155
Identities = 111/254 (43%), Positives = 165/254 (64%), Gaps = 4/254 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S + +G Y + +TIG+G FAKVK AR+ TG VA+KI+DK + L +++ RE
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFRE 64
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
V MK++ HPN+V+L+EV+ ++ +++++E+ +GGE+FD +V HGRMKE EAR F+Q++
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+AV YCH + + HRDLK ENLLLDA N+K++DFG S + G L CG P Y A
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFCGAPPYAA 181
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE+ + YDG D+WS GVIL+ L++G LPFD NL L +++ ++ P ++S
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDC 241
Query: 242 RKLIARILDPNPMT 255
L+ R L NP+
Sbjct: 242 ENLLKRFLVLNPIK 255
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 430 bits (1108), Expect = e-154
Identities = 89/283 (31%), Positives = 149/283 (52%), Gaps = 32/283 (11%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-------- 53
++ +Y + IG+G++ VK A N A+K+L K+K+++
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 54 ---------------MAEQIKREVATMKLVKHPNVVRLYEVMG--SKTKIFIVLEFVTGG 96
EQ+ +E+A +K + HPNVV+L EV+ ++ +++V E V G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 97 ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156
+ + + + ED+AR YFQ LI ++Y H + + HRD+KP NLL+ G++K++DFG
Sbjct: 124 PVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPF 214
+S + D LL T GTP ++APE L++ + + G D+W+ GV L+ + G PF
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 215 DDSNLMNLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMT 255
D +M L+ KI + P P ++ + LI R+LD NP +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPES 283
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 429 bits (1105), Expect = e-154
Identities = 87/254 (34%), Positives = 147/254 (57%), Gaps = 5/254 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
PK K + +++GR +G+G F V AR + +ALK+L K ++ K + Q++RE
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
+ ++HPN++R+Y + +I+++LEF GEL+ ++ HGR E + + ++L
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELA 124
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A+ YCH R V HRD+KPENLL+ G LK++DFG S + +R T CGT +Y+
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLP 180
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ + +D DLW GV+ + L G PFD + +++I + PP+LS +
Sbjct: 181 PEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239
Query: 242 RKLIARILDPNPMT 255
+ LI+++L +P
Sbjct: 240 KDLISKLLRYHPPQ 253
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 419 bits (1079), Expect = e-150
Identities = 92/252 (36%), Positives = 145/252 (57%), Gaps = 5/252 (1%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
K + + +E+GR +G+G F V AR ++ +ALK+L K ++ K + Q++REV
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
++HPN++RLY T+++++LE+ G ++ ++ + E Y +L NA
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ YCHS+ V HRD+KPENLLL + G LK++DFG S + R CGT +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
++ R +D DLWS GV+ + L G PF+ + YK+IS EFT P +++ AR
Sbjct: 178 MIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 244 LIARILDPNPMT 255
LI+R+L NP
Sbjct: 237 LISRLLKHNPSQ 248
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 407 bits (1049), Expect = e-144
Identities = 76/260 (29%), Positives = 125/260 (48%), Gaps = 15/260 (5%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE----- 56
KY +G G F V A + E + V +K + KEKVL+ E
Sbjct: 15 LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 57 QIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEARR 115
++ E+A + V+H N++++ ++ ++ +V+E +G +LF I H R+ E A
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASY 134
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
F+QL++AV Y + + HRD+K EN+++ +K+ DFG +A + L +T CG
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCG 191
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235
T Y APEVL Y G ++WS GV L+ L+ PF + ++ A P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPY 245
Query: 236 WLSFTARKLIARILDPNPMT 255
+S L++ +L P P
Sbjct: 246 LVSKELMSLVSGLLQPVPER 265
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 400 bits (1031), Expect = e-142
Identities = 80/264 (30%), Positives = 123/264 (46%), Gaps = 19/264 (7%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQ--- 57
+ +Y +G +G+G F V VA+K++ + +VL
Sbjct: 21 PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80
Query: 58 IKREVATMKLV----KHPNVVRLYEVMGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDE 112
EVA + V HP V+RL + ++ +VLE + +LFD I G + E
Sbjct: 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLH 171
+R +F Q++ A+ +CHSRGV HRD+K EN+L+D G K+ DFG AL D
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYT 196
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231
GT Y PE ++ Y A +WS G++L+ ++ G +PF+ ++I AE
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAEL 250
Query: 232 TCPPWLSFTARKLIARILDPNPMT 255
P +S LI R L P P +
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSS 274
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 397 bits (1023), Expect = e-141
Identities = 75/262 (28%), Positives = 123/262 (46%), Gaps = 17/262 (6%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQ 57
+ + +Y+VG +G G F V PVA+K ++K+++ +
Sbjct: 33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTR 92
Query: 58 IKREVATMKLVKH--PNVVRLYEVMGSKTKIFIVLEFVTG-GELFDKIVNHGRMKEDEAR 114
+ EV +K V V+RL + ++LE +LFD I G ++E+ AR
Sbjct: 93 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 152
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTT 173
+F Q++ AV +CH+ GV HRD+K EN+L+D G LK+ DFG AL + D +
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDF 208
Query: 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233
GT Y PE + Y G +A +WS G++L+ ++ G +PF+ ++I +
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFF 262
Query: 234 PPWLSFTARKLIARILDPNPMT 255
+S + LI L P
Sbjct: 263 RQRVSSECQHLIRWCLALRPSD 284
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 380 bits (978), Expect = e-133
Identities = 58/298 (19%), Positives = 118/298 (39%), Gaps = 50/298 (16%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK-------- 53
+ + + Y + RT+ +G F K+ + + ALK +K + K +
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNND 79
Query: 54 ------MAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR 107
+ K E+ + +K+ + ++ + +++I+ E++ +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 108 MK--------EDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLS 158
+ + + ++N+ Y H+ + + HRD+KP N+L+D G +K+SDFG S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDD- 216
D + + GT ++ PE ++ Y+G+ D+WS G+ L+V+ +PF
Sbjct: 200 EYMV----DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255
Query: 217 SNLMNLYKKISAAEFTCP-------------------PWLSFTARKLIARILDPNPMT 255
+L+ L+ I P +LS + L NP
Sbjct: 256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAE 313
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-109
Identities = 76/276 (27%), Positives = 124/276 (44%), Gaps = 36/276 (13%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R +E +G+G F +V ARN+ A+K + + + I EV +
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLAS 58
Query: 68 VKHPNVVRLYEV-------------MGSKTKIFIVLEFVTGGELFDKIVNHGRMK-EDEA 113
+ H VVR Y + K+ +FI +E+ G L+D I + + DE
Sbjct: 59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118
Query: 114 RRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ---------- 163
R F+Q++ A+ Y HS+G+ HRDLKP N+ +D N+K+ DFGL+ +
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 164 --VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221
L + GT YVA EVL+ G+ D++S G+I F ++ Y +N
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236
Query: 222 LYKKISAAEFTCPPWL----SFTARKLIARILDPNP 253
+ KK+ + PP +K+I ++D +P
Sbjct: 237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDP 272
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-108
Identities = 92/258 (35%), Positives = 145/258 (56%), Gaps = 19/258 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMK 66
+Y + +T+G G +VK A +T + VA+KI+ K K + A ++ E+ +K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ HP ++++ ++ +IVLE + GGELFDK+V + R+KE + YF Q++ AV Y
Sbjct: 71 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129
Query: 127 CHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
H G+ HRDLKPEN+LL + +K++DFG S + + + L+ T CGTP Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 186
Query: 184 VLNDRGYD--GSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW-- 236
VL G D WS GVILF+ L+GY PF + ++L +I++ F W
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246
Query: 237 LSFTARKLIARILDPNPM 254
+S A L+ ++L +P
Sbjct: 247 VSEKALDLVKKLLVVDPK 264
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-104
Identities = 93/249 (37%), Positives = 147/249 (59%), Gaps = 12/249 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+V +G+G F+ V+ + TG A KI++ +K L + ++++RE + ++HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + ++ ++V + VTGGELF+ IV E +A QQ++ ++ YCHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 132 VYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LKPENLLL + +K++DFG L+ +V D H GTP Y++PEVL
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFG---LAIEVNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+W+CGVIL++LL GY PF D + LY +I A ++ P W ++ A+ L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 245 IARILDPNP 253
I +L NP
Sbjct: 242 IDSMLTVNP 250
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-104
Identities = 94/250 (37%), Positives = 134/250 (53%), Gaps = 15/250 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + TIG G++ +VK A T A K + K V + ++ K+E+ MK + HP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++RLYE T I++V+E TGGELF+++V+ +E +A R + +++AV YCH
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
V HRDLKPEN L LK+ DFGL+A + ++ T GTP YV+P+VL
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKVGTPYYVSPQVLE-G 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y G D WS GV+++VLL GY PF + KI F W +S A L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241
Query: 245 IARILDPNPM 254
I R+L +P
Sbjct: 242 IRRLLTKSPK 251
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 307 bits (788), Expect = e-104
Identities = 92/258 (35%), Positives = 146/258 (56%), Gaps = 21/258 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMK 66
+Y + +T+G G +VK A +T + VA++I+ K K + A ++ E+ +K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ HP ++++ ++ +IVLE + GGELFDK+V + R+KE + YF Q++ AV Y
Sbjct: 196 KLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254
Query: 127 CHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
H G+ HRDLKPEN+LL + +K++DFG S + + + L+ T CGTP Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPE 311
Query: 184 VLND---RGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW- 236
VL GY D WS GVILF+ L+GY PF + ++L +I++ F W
Sbjct: 312 VLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 370
Query: 237 -LSFTARKLIARILDPNP 253
+S A L+ ++L +P
Sbjct: 371 EVSEKALDLVKKLLVVDP 388
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 305 bits (782), Expect = e-103
Identities = 88/259 (33%), Positives = 133/259 (51%), Gaps = 20/259 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMK 66
KY+ IG G + V+ + TG A+KI++ ++ E +RE ++
Sbjct: 95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 67 LVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
V HP+++ L + S + +F+V + + GELFD + + E E R + L+ AV
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
+ H+ + HRDLKPEN+LLD +++SDFG S + L CGTP Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 186 ------NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW- 236
GY G DLW+CGVILF LLAG PF + + + I +F+ P W
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 237 -LSFTARKLIARILDPNPM 254
S T + LI+R+L +P
Sbjct: 331 DRSSTVKDLISRLLQVDPE 349
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 299 bits (769), Expect = e-102
Identities = 85/260 (32%), Positives = 131/260 (50%), Gaps = 21/260 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK------HKMAEQIKREVATM 65
YE +G G + V+ + T + A+KI+D ++ E +EV +
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 66 KLVK-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
+ V HPN+++L + + T F+V + + GELFD + + E E R+ + L+ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + HRDLKPEN+LLD N+K++DFG S Q+ L CGTP+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFG---FSCQLDPGEKLREVCGTPSYLAPEI 194
Query: 185 L------NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW 236
+ N GY G D+WS GVI++ LLAG PF M + + I + +F P W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 237 --LSFTARKLIARILDPNPM 254
S T + L++R L P
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQ 273
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 310 bits (795), Expect = e-102
Identities = 70/265 (26%), Positives = 113/265 (42%), Gaps = 19/265 (7%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
S + G +E+ +G G F V + +TGE VA+K +E K++ E+ E
Sbjct: 5 SPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNR--ERWCLE 62
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKI------FIVLEFVTGGELFDKIVNHGR---MKEDE 112
+ MK + HPNVV EV K+ + +E+ GG+L + +KE
Sbjct: 63 IQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP 122
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGL 169
R + +A+ Y H + HRDLKPEN++L K+ D G ++++ L
Sbjct: 123 IRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG---YAKELDQGEL 179
Query: 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISA 228
GT Y+APE+L + Y T D WS G + F + G+ PF + + + K+
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE 238
Query: 229 AEFTCPPWLSFTARKLIARILDPNP 253
+ + P P
Sbjct: 239 KSNEHIVVYDDLTGAVKFSSVLPTP 263
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = e-101
Identities = 93/249 (37%), Positives = 147/249 (59%), Gaps = 12/249 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+V +G+G F+ V+ + TG A KI++ +K L + ++++RE + ++HP
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 88
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + ++ ++V + VTGGELF+ IV E +A QQ++ ++ YCHS G
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148
Query: 132 VYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LKPENLLL + +K++DFGL+ +V D H GTP Y++PEVL
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+W+CGVIL++LL GY PF D + LY +I A ++ P W ++ A+ L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264
Query: 245 IARILDPNP 253
I +L NP
Sbjct: 265 IDSMLTVNP 273
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = e-101
Identities = 92/249 (36%), Positives = 141/249 (56%), Gaps = 15/249 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F++V + TG+ ALK + K + ++ E+A +K +KH
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS---LENEIAVLKKIKHE 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L ++ S T ++V++ V+GGELFD+I+ G E +A QQ+++AV Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL + + ++DFGLS ++ +G++ T CGTP YVAPEVL +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D WS GVI ++LL GY PF + L++KI EF P W +S +A+
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 245 IARILDPNP 253
I +L+ +P
Sbjct: 242 ICHLLEKDP 250
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 294 bits (756), Expect = e-100
Identities = 62/268 (23%), Positives = 117/268 (43%), Gaps = 19/268 (7%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + Y + + IG G +KV N E + A+K ++ E+ ++ + +
Sbjct: 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRN 75
Query: 61 EVATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E+A + ++ + ++RLY+ + I++V+E +L + + E + Y++
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWK 134
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + + GT N
Sbjct: 135 NMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 179 YVAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKI 226
Y+ PE + D +D+WS G IL+ + G PF + + L+ I
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 227 -SAAEFTCPPWLSFTARKLIARILDPNP 253
E P + ++ L +P
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDP 281
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = e-100
Identities = 87/249 (34%), Positives = 141/249 (56%), Gaps = 13/249 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G+G+F +V ++ T + A+K+++K K+K I REV +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L+E++ + +IV E TGGELFD+I+ R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPEN+LL + ++K+ DFGLS + + + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF N ++ K++ F P W +S A+ L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 245 IARILDPNP 253
I ++L +P
Sbjct: 257 IRKMLTFHP 265
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 294 bits (755), Expect = e-100
Identities = 58/270 (21%), Positives = 110/270 (40%), Gaps = 25/270 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + +G+G A V R+ +TG+ A+K+ + L+ + RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68
Query: 73 VVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
+V+L+ + T +++EF G L+ + + E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 128 HSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
G+ HR++KP N++ D K++DFG + ++ DD + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 184 VLNDRGYD-------GSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFT 232
+ G+T DLWS GV + G LPF + KI + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 233 CPPWLSFTARKLIARILDPNPMTVSIYPFA 262
A P++ S+
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGL 275
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 297 bits (761), Expect = e-100
Identities = 58/270 (21%), Positives = 110/270 (40%), Gaps = 25/270 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ + +G+G A V R+ +TG+ A+K+ + L+ + RE +K + H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68
Query: 73 VVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYC 127
+V+L+ + T +++EF G L+ + + E E + ++ +++
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 128 HSRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
G+ HR++KP N++ D K++DFG + ++ DD + GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 184 VLNDRGYD-------GSTADLWSCGVILFVLLAGYLPFDD----SNLMNLYKKISAAEFT 232
+ G+T DLWS GV + G LPF + KI + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 233 CPPWLSFTARKLIARILDPNPMTVSIYPFA 262
A P++ S+
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGL 275
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 291 bits (747), Expect = 2e-99
Identities = 77/253 (30%), Positives = 128/253 (50%), Gaps = 17/253 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ R +G G F V +G +K ++K++ EQI+ E+ +K + HP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYC 127
N+++++EV ++IV+E GGEL ++IV + E +Q++NA+ Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
HS+ V H+DLKPEN+L + +K+ DFGL+ L + D GT Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEV 197
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW-LSFTA 241
R D+WS GV+++ LL G LPF ++L + +K + E + L+ A
Sbjct: 198 FK-RDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255
Query: 242 RKLIARILDPNPM 254
L+ ++L +P
Sbjct: 256 VDLLKQMLTKDPE 268
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 1e-97
Identities = 62/267 (23%), Positives = 116/267 (43%), Gaps = 19/267 (7%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ I + Y + + IG G +KV N E + A+K ++ E+ ++ + + E
Sbjct: 47 ANECISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNE 104
Query: 62 VATMKLVKHPN--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
+A + ++ + ++RLY+ + I++V+E +L + + E + Y++
Sbjct: 105 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKN 163
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
++ AV H G+ H DLKP N L+ G LK+ DFG++ Q + + G NY
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222
Query: 180 VAPEVLNDRGYD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKI- 226
+ PE + D +D+WS G IL+ + G PF + + L+ I
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282
Query: 227 SAAEFTCPPWLSFTARKLIARILDPNP 253
E P + ++ L +P
Sbjct: 283 PNHEIEFPDIPEKDLQDVLKCCLKRDP 309
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 2e-97
Identities = 91/249 (36%), Positives = 144/249 (57%), Gaps = 11/249 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y++ +G+G F+ V+ G+ A I++ +K+ ++++RE +L+KHP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDH-QKLEREARICRLLKHP 70
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++ + + +++ + VTGGELF+ IV E +A QQ++ AV +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
V HR+LKPENLLL +K++DFGL+ + + GTP Y++PEVL
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPGYLSPEVLRKD 188
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
Y G DLW+CGVIL++LL GY PF D + LY++I A +F P W ++ A+ L
Sbjct: 189 PY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 245 IARILDPNP 253
I ++L NP
Sbjct: 248 INKMLTINP 256
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 4e-97
Identities = 62/257 (24%), Positives = 114/257 (44%), Gaps = 19/257 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + + IG G +KV N E + A+K ++ E+ ++ + + E+A + ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67
Query: 72 N--VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ ++RLY+ + I++V+E +L + + E + Y++ ++ AV H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ H DLKP N L+ G LK+ DFG++ Q + + GT NY+ PE + D
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 190 YD----------GSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKKISA-AEFTCPPW 236
+D+WS G IL+ + G PF + + L+ I E P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 237 LSFTARKLIARILDPNP 253
+ ++ L +P
Sbjct: 246 PEKDLQDVLKCCLKRDP 262
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 2e-96
Identities = 92/250 (36%), Positives = 139/250 (55%), Gaps = 17/250 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+EV +G G + V + T +P ALK+L K + ++ E+ + + HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHP 108
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L E+ + T+I +VLE VTGGELFD+IV G E +A +Q++ AV Y H G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL LK++DFG LS+ V L+ T CGTP Y APE+L
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFG---LSKIVEHQVLMKTVCGTPGYCAPEILRGC 225
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA--EFTCPPW--LSFTARK 243
Y G D+WS G+I ++LL G+ PF D+ ++++I F P W +S A+
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284
Query: 244 LIARILDPNP 253
L+ +++ +P
Sbjct: 285 LVRKLIVLDP 294
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 284 bits (728), Expect = 1e-95
Identities = 86/256 (33%), Positives = 137/256 (53%), Gaps = 19/256 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVK 69
YE+ IG+G F+ V+ N ETG+ A+KI+D K E +KRE + ++K
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLINAVD 125
HP++V L E S +++V EF+ G +L +IV E A Y +Q++ A+
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 126 YCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYVA 181
YCH + HRD+KP +LL + +K+ FG++ Q+ + G + GTP+++A
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMA 201
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--L 237
PEV+ Y G D+W CGVILF+LL+G LPF + L++ I + W +
Sbjct: 202 PEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI 259
Query: 238 SFTARKLIARILDPNP 253
S +A+ L+ R+L +P
Sbjct: 260 SESAKDLVRRMLMLDP 275
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 5e-95
Identities = 86/253 (33%), Positives = 140/253 (55%), Gaps = 15/253 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
YE+G +G G FA V+ R TG+ A K + K ++ + E+I+REV ++ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPN++ L+++ +KT + ++LE V+GGELFD + + EDEA ++ +Q+++ V Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S+ + H DLKPEN++L +K+ DFG ++ ++ GTP +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFG---IAHKIEAGNEFKNIFGTPEFVAPEI 182
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF ISA +F + S
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 241 ARKLIARILDPNP 253
A+ I R+L +P
Sbjct: 242 AKDFIRRLLVKDP 254
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 285 bits (732), Expect = 1e-94
Identities = 87/249 (34%), Positives = 142/249 (57%), Gaps = 13/249 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y + +G+G+F +V ++ T + A+K+++K K+K I REV +K + HP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILREVELLKKLDHP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++L+E++ + +IV E TGGELFD+I+ R E +A R +Q+ + + Y H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPEN+LL + ++K+ DFG LS + + + GT Y+APEVL
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFG---LSTCFQQNTKMKDRIGTAYYIAPEVLR-G 197
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF N ++ K++ + F P W +S A+ L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256
Query: 245 IARILDPNP 253
I ++L +P
Sbjct: 257 IRKMLTFHP 265
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 280 bits (718), Expect = 3e-94
Identities = 83/254 (32%), Positives = 133/254 (52%), Gaps = 22/254 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKH 70
YEV IG G+++ K + T A+KI+DK K E+ + + +H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-------RDPTEEIEILLRYGQH 75
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN++ L +V +++V E + GGEL DKI+ E EA + V+Y H++
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 131 GVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
GV HRDLKP N+L ++++ DFG + + ++GLL T C T N+VAPEVL
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAPEVLE 193
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKISAA--EFTCPPW--LSF 239
+GYD + D+WS GV+L+ +L GY PF + + +I + + W +S
Sbjct: 194 RQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 240 TARKLIARILDPNP 253
TA+ L++++L +P
Sbjct: 253 TAKDLVSKMLHVDP 266
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 1e-93
Identities = 91/249 (36%), Positives = 144/249 (57%), Gaps = 12/249 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ R +G+G+F +V ++ TG+ A+K++ K +V + E + REV +K + HP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++LYE K ++V E TGGELFD+I++ R E +A R +Q+++ + Y H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLLL N+++ DFG LS + GT Y+APEVL+
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFG---LSTHFEASKKMKDKIGTAYYIAPEVLH-G 202
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVIL++LL+G PF+ +N ++ KK+ + F P W +S +A+ L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 245 IARILDPNP 253
I ++L P
Sbjct: 262 IRKMLTYVP 270
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 2e-93
Identities = 91/294 (30%), Positives = 137/294 (46%), Gaps = 53/294 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV--LKHKMAEQIKREVATMKLVK 69
KY + IG+G++ V+ A ++T A+KI++K K+ + K E+IK EV MK +
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK-------------------- 109
HPN+ RLYEV + I +V+E GG L DK+
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 110 --------------------EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL--DAY 147
E +Q+ +A+ Y H++G+ HRD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 148 GNLKVSDFGLSAL--SQQVRDDGLLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVI 203
+K+ DFGLS + + T GTP +VAPEVLN + Y G D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVL 265
Query: 204 LFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKLIARILDPNP 253
L +LL G +PF N + ++ + F P + LS AR L++ +L+ N
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNV 319
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-93
Identities = 91/253 (35%), Positives = 134/253 (52%), Gaps = 15/253 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y+ G +G G FA VK R TG A K + K + + E I+REV+ +K +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPNV+ L+EV +KT + ++LE V GGELFD + + E+EA + +Q++N V Y H
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S + H DLKPEN++L +K+ DFG L+ ++ GTP +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEI 188
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF +SA EF + S
Sbjct: 189 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 241 ARKLIARILDPNP 253
A+ I R+L +P
Sbjct: 248 AKDFIRRLLVKDP 260
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 4e-93
Identities = 83/253 (32%), Positives = 137/253 (54%), Gaps = 15/253 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y++G +G G FA VK R TG A K + K + + E+I+REV+ ++ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
H NV+ L++V ++T + ++LE V+GGELFD + + E+EA + +Q+++ V+Y H
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
++ + H DLKPEN++L ++K+ DFG L+ ++ D GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF I++ +F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 241 ARKLIARILDPNP 253
A+ I ++L
Sbjct: 249 AKDFIRKLLVKET 261
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 7e-93
Identities = 84/253 (33%), Positives = 138/253 (54%), Gaps = 15/253 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---EQIKREVATMKLV 68
Y++G +G G FA VK R TG A K + K + + E+I+REV+ ++ V
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
HPN++ L++V ++T + ++LE V+GGELFD + + E+EA + +Q+++ V+Y H
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 129 SRGVYHRDLKPENLLL----DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
++ + H DLKPEN++L ++K+ DFG L+ ++ D GTP +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG---LAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
+N G AD+WS GVI ++LL+G PF I+A +F + S
Sbjct: 190 VNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 241 ARKLIARILDPNP 253
A+ I ++L
Sbjct: 249 AKDFIRKLLVKET 261
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 7e-92
Identities = 87/249 (34%), Positives = 136/249 (54%), Gaps = 13/249 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ + +G G + +V R+ T A+KI+ K + ++ EVA +KL+ HP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDHP 96
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+++LY+ K ++V+E GGELFD+I++ + E +A +Q+++ V Y H
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLLL + +K+ DFGLSA+ + + GT Y+APEVL +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYIAPEVLR-K 212
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW--LSFTARKL 244
Y D+WS GVILF+LLAGY PF + +K+ + F P W +S A+ L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271
Query: 245 IARILDPNP 253
I ++L +
Sbjct: 272 IKQMLQFDS 280
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 1e-91
Identities = 84/259 (32%), Positives = 138/259 (53%), Gaps = 22/259 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA----------EQIKRE 61
Y R +G G + +V + A+K++ K + K + + E+I E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ +K + HPN+++L++V K ++V EF GGELF++I+N + E +A +Q++
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156
Query: 122 NAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + Y H + HRD+KPEN+LL ++ N+K+ DFG LS D L GT
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG---LSSFFSKDYKLRDRLGTAY 213
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCPPW 236
Y+APEVL + Y D+WSCGVI+++LL GY PF N ++ KK+ + F W
Sbjct: 214 YIAPEVLK-KKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271
Query: 237 --LSFTARKLIARILDPNP 253
+S A++LI +L +
Sbjct: 272 KNISDEAKELIKLMLTYDY 290
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 270 bits (693), Expect = 1e-90
Identities = 90/260 (34%), Positives = 140/260 (53%), Gaps = 27/260 (10%)
Query: 12 KYEVG---RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
Y++ + +GEG+F+ + + ++ + A+KI+ K ++E+ +KL
Sbjct: 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62
Query: 69 K-HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
+ HPN+V+L+EV + F+V+E + GGELF++I E EA ++L++AV +
Sbjct: 63 EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H GV HRDLKPENLL + +K+ DFG + L D+ L T C T +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKISAA--EFTCPP 235
LN GYD S DLWS GVIL+ +L+G +PF + + + KKI F
Sbjct: 181 LNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239
Query: 236 W--LSFTARKLIARILDPNP 253
W +S A+ LI +L +P
Sbjct: 240 WKNVSQEAKDLIQGLLTVDP 259
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 1e-89
Identities = 76/253 (30%), Positives = 128/253 (50%), Gaps = 16/253 (6%)
Query: 12 KYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
Y + + +G G FA V+ + TG+ A K L K + +I E+A ++L K
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKS 87
Query: 71 -PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV--NHGRMKEDEARRYFQQLINAVDYC 127
P V+ L+EV + ++I ++LE+ GGE+F + + E++ R +Q++ V Y
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147
Query: 128 HSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + H DLKP+N+LL G++K+ DFG +S+++ L GTP Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG---MSRKIGHACELREIMGTPEYLAPEI 204
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFT 240
LN + D+W+ G+I ++LL PF + Y IS +++ + +S
Sbjct: 205 LNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263
Query: 241 ARKLIARILDPNP 253
A I +L NP
Sbjct: 264 ATDFIQSLLVKNP 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 266 bits (683), Expect = 2e-89
Identities = 58/249 (23%), Positives = 115/249 (46%), Gaps = 15/249 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + +G G F V + + + K + + + +K+E++ + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
N++ L+E S ++ ++ EF++G ++F++I + E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 131 GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D++PEN++ + +K+ +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFG---QARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
+ D+WS G +++VLL+G PF + + I A F + +S A
Sbjct: 179 VV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 245 IARILDPNP 253
+ R+L
Sbjct: 238 VDRLLVKER 246
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 265 bits (678), Expect = 9e-88
Identities = 67/249 (26%), Positives = 120/249 (48%), Gaps = 14/249 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++ +G G F V TG K ++ L +K E++ M + HP
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHHP 108
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
++ L++ K ++ ++LEF++GGELFD+I +M E E Y +Q + + H
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168
Query: 131 GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D+KPEN++ + +K+ DFG L+ ++ D ++ T T + APE+++
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAEFAAPEIVDRE 225
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
G D+W+ GV+ +VLL+G PF + + + + EF + +S A+
Sbjct: 226 PV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284
Query: 245 IARILDPNP 253
I +L P
Sbjct: 285 IKNLLQKEP 293
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 1e-87
Identities = 78/252 (30%), Positives = 132/252 (52%), Gaps = 1/252 (0%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
K+R ++ G+ +GEG+F+ V AR T A+KIL+K ++K + RE
Sbjct: 21 PPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRE 80
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
M + HP V+LY K++ L + GEL I G E R Y +++
Sbjct: 81 RDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV 140
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A++Y H +G+ HRDLKPEN+LL+ +++++DFG + + ++ GT YV+
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE+L ++ ++DLW+ G I++ L+AG PF N +++KI E+ P A
Sbjct: 201 PELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKA 259
Query: 242 RKLIARILDPNP 253
R L+ ++L +
Sbjct: 260 RDLVEKLLVLDA 271
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 4e-87
Identities = 81/276 (29%), Positives = 130/276 (47%), Gaps = 38/276 (13%)
Query: 12 KYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
Y++ +GEG A+V+ N T + A+KI++K+ + ++ REV + +
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQG 69
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H NV+ L E + + ++V E + GG + I E EA Q + +A+D+ H+
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129
Query: 130 RGVYHRDLKPENLLL---DAYGNLKVSDFGLSAL-----SQQVRDDGLLHTTCGTPNYVA 181
+G+ HRDLKPEN+L + +K+ DF L + L T CG+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 182 PEVLN-----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN--------------- 221
PEV+ YD DLWS GVIL++LL+GY PF +
Sbjct: 190 PEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 222 LYKKISAA--EFTCPPW--LSFTARKLIARILDPNP 253
L++ I EF W +S A+ LI+++L +
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDA 284
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 4e-87
Identities = 90/270 (33%), Positives = 130/270 (48%), Gaps = 31/270 (11%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
Q K + Y+V + +G G KV N T E ALK+L + +RE
Sbjct: 53 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARRE 104
Query: 62 VATMK-LVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEAR 114
V + P++VR+ +V + + IV+E + GGELF +I + G E EA
Sbjct: 105 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 164
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLH 171
+ + A+ Y HS + HRD+KPENLL LK++DFG +++ L
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---FAKETTSHNSLT 221
Query: 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKIS 227
T C TP YVAPEVL YD S D+WS GVI+++LL GY PF ++ + + +I
Sbjct: 222 TPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 228 AA--EFTCPPW--LSFTARKLIARILDPNP 253
EF P W +S + LI +L P
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEP 310
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 2e-86
Identities = 82/261 (31%), Positives = 127/261 (48%), Gaps = 32/261 (12%)
Query: 12 KYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVK 69
Y++ + +G G KV + TG+ ALK+L + ++EV +
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80
Query: 70 HPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINA 123
P++V + +V K + I++E + GGELF +I G E EA + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 124 VDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ + HS + HRD+KPENLL + LK++DFG + + L T C TP YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA----KETTQNALQTPCYTPYYV 196
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAA--EFTCP 234
APEVL YD S D+WS GVI+++LL G+ PF + + ++I F P
Sbjct: 197 APEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255
Query: 235 PW--LSFTARKLIARILDPNP 253
W +S A++LI +L +P
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDP 276
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 261 bits (668), Expect = 2e-86
Identities = 78/258 (30%), Positives = 133/258 (51%), Gaps = 19/258 (7%)
Query: 12 KYEVGRT--IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
Y V +T +G G F +V + TG +A KI+ + K E++K E++ M +
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLD 144
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCH 128
H N+++LY+ SK I +V+E+V GGELFD+I++ + E + + +Q+ + + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 129 SRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
+ H DLKPEN+L +K+ DFG L+++ + L GTP ++APEV+N
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFG---LARRYKPREKLKVNFGTPEFLAPEVVN 261
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTAR 242
+ D+WS GVI ++LL+G PF N I A + + +S A+
Sbjct: 262 -YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 243 KLIARILDPNP---MTVS 257
+ I+++L ++ S
Sbjct: 321 EFISKLLIKEKSWRISAS 338
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 265 bits (679), Expect = 9e-86
Identities = 72/256 (28%), Positives = 123/256 (48%), Gaps = 17/256 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y++ +G G F V TG A K + E +++E+ TM +++HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHP 214
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR 130
+V L++ ++ ++ EF++GGELF+K+ + H +M EDEA Y +Q+ + + H
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 131 GVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
H DLKPEN++ LK+ DFG L+ + + T GT + APEV +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFG---LTAHLDPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW--LSFTARKL 244
G D+WS GV+ ++LL+G PF N + + + + +S +
Sbjct: 332 PV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390
Query: 245 IARILDPNP---MTVS 257
I ++L +P MT+
Sbjct: 391 IRKLLLADPNTRMTIH 406
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 259 bits (662), Expect = 2e-85
Identities = 47/296 (15%), Positives = 94/296 (31%), Gaps = 53/296 (17%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ ++ R G +G+ A + ETGE + + + +Q+K EV
Sbjct: 65 ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124
Query: 63 ATMKL----------------------VKHPNVVRLYEVMGSKTKIFIVLEFV------- 93
++L VK P ++ V + ++++ F
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 94 ----TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149
G L H + + Q+I + H G+ H L+P +++LD G
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244
Query: 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG----------YDGSTADLWS 199
+ ++ F DG + + + PE+ R + D W+
Sbjct: 245 VFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298
Query: 200 CGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMT 255
G++++ + LP + + I F + R L+ L
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKED 350
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 3e-84
Identities = 76/270 (28%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
+ V R + EG FA V A++ +G ALK L + + I +EV MK L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGH 85
Query: 71 PNVVRLY-------EVMGSKTKIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQL 120
PN+V+ E + F++L + G+L + + G + D + F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 121 INAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSA-------LSQQVRDDGLLH 171
AV + H + + HRDLK ENLLL G +K+ DFG + S + L+
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 172 ---TTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
T TP Y PE+++ G D+W+ G IL++L PF+D + +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RI 261
Query: 227 SAAEFTCPPWLSFTA--RKLIARILDPNPM 254
+++ PP + LI +L NP
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPE 291
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 8e-83
Identities = 60/263 (22%), Positives = 109/263 (41%), Gaps = 23/263 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + +GEG F+ V G ALK + + + E+ +RE +L HP
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHP 86
Query: 72 NVVRLYEV----MGSKTKIFIVLEFVTGGELFDKI----VNHGRMKEDEARRYFQQLINA 123
N++RL G+K + +++L F G L+++I + ED+ +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHTTCGT 176
++ H++G HRDLKP N+LL G + D G S+Q T
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 177 PNYVAPEVLNDRGYD--GSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTC 233
+Y APE+ + + + D+WS G +L+ ++ G P+D + + +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266
Query: 234 PPWLSFT--ARKLIARILDPNPM 254
P + +L+ ++ +P
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPH 289
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 3e-80
Identities = 82/257 (31%), Positives = 126/257 (49%), Gaps = 16/257 (6%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R YEV TIG G++ + + R G+ + K LD + + + EV ++ +
Sbjct: 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLREL 62
Query: 69 KHPNVVRLYE--VMGSKTKIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLIN 122
KHPN+VR Y+ + + T ++IV+E+ GG+L I + + E+ R QL
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 123 AVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
A+ CH R V HRDLKP N+ LD N+K+ DFGL+ + D T GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPW 236
Y++PE +N Y+ +D+WS G +L+ L A PF + L KI +F P
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239
Query: 237 LSFTARKLIARILDPNP 253
S ++I R+L+
Sbjct: 240 YSDELNEIITRMLNLKD 256
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 3e-79
Identities = 83/252 (32%), Positives = 140/252 (55%), Gaps = 6/252 (2%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++ +++ +T+G G+F +V ++ E+G A+KILDK+KV+K K E E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ V P +V+L + +++V+E+V GGE+F + GR E AR Y Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+Y HS + +RDLKPENLL+D G ++V+DFG + R G T CGTP +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ +GY D W+ GV+++ + AGY PF + +Y+KI + + P S
Sbjct: 207 PEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 242 RKLIARILDPNP 253
+ L+ +L +
Sbjct: 266 KDLLRNLLQVDL 277
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 1e-78
Identities = 86/250 (34%), Positives = 148/250 (59%), Gaps = 8/250 (3%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA 63
PK + +++ RT+G G+F +V R+ G A+K+L KE V++ K E E
Sbjct: 1 PKYS--LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL 58
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINA 123
+ +V HP ++R++ +IF++++++ GGELF + R A+ Y ++ A
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
++Y HS+ + +RDLKPEN+LLD G++K++DFG + + +T CGTP+Y+APE
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE 173
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
V++ + Y + D WS G++++ +LAGY PF DSN M Y+KI AE PP+ + +
Sbjct: 174 VVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKD 232
Query: 244 LIARILDPNP 253
L++R++ +
Sbjct: 233 LLSRLITRDL 242
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-78
Identities = 71/245 (28%), Positives = 131/245 (53%), Gaps = 7/245 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + IGEG+F K +++E G +K ++ + + K E+ +REVA + +KHP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLANMKHP 83
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI--VNHGRMKEDEARRYFQQLINAVDYCHS 129
N+V+ E ++IV+++ GG+LF +I +ED+ +F Q+ A+ + H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R + HRD+K +N+ L G +++ DFG++ + L GTP Y++PE+ ++
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKP 201
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSFTARKLIARI 248
Y+ + +D+W+ G +L+ L F+ ++ NL KI + F S+ R L++++
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 249 LDPNP 253
NP
Sbjct: 261 FKRNP 265
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 1e-77
Identities = 68/288 (23%), Positives = 114/288 (39%), Gaps = 44/288 (15%)
Query: 2 SQPKIKRRVGK-YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ P ++ + + +G G+ V F S G PVA+K + + +
Sbjct: 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFC------DIALM 57
Query: 61 EVATM-KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMKEDE 112
E+ + + HPNV+R Y + ++I LE L D + + KE
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-------------AYGNLKVSDFGLSA 159
+Q+ + V + HS + HRDLKP+N+L+ + +SDFGL
Sbjct: 117 PISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 160 L--SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD------GSTADLWSCGVILFVLL-AG 210
S Q L+ GT + APE+L + + D++S G + + +L G
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 211 YLPFDDSNLMN---LYKKISAAEFTCPPW--LSFTARKLIARILDPNP 253
PF D + S E C L A LI++++D +P
Sbjct: 237 KHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 7e-77
Identities = 62/265 (23%), Positives = 109/265 (41%), Gaps = 33/265 (12%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
KR ++ IG G F +V A++ G+ +K + E+ +REV +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA 59
Query: 67 LVKHPNVVRLYE----------------VMGSKTKIFIVLEFVTGGELFDKIV--NHGRM 108
+ H N+V +FI +EF G L I ++
Sbjct: 60 KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168
+ A F+Q+ VDY HS+ + +RDLKP N+ L +K+ DFGL +++DG
Sbjct: 120 DKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLKNDG 176
Query: 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA 228
+ GT Y++PE ++ + Y DL++ G+IL LL +++ + +
Sbjct: 177 KRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD 233
Query: 229 AEFTCPPWLSFTARKLIARILDPNP 253
+ L+ ++L P
Sbjct: 234 GII--SDIFDKKEKTLLQKLLSKKP 256
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 1e-74
Identities = 61/263 (23%), Positives = 104/263 (39%), Gaps = 24/263 (9%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
VGK + +G G + + R VA+K + E REV
Sbjct: 18 VVIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQL 70
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM-KEDEARRYFQQLIN 122
++ +HPNV+R + + +I +E L + + E QQ +
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTS 129
Query: 123 AVDYCHSRGVYHRDLKPENLLL-----DAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGT 176
+ + HS + HRDLKP N+L+ +SDFGL L+ GT
Sbjct: 130 GLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGT 189
Query: 177 PNYVAPEVLNDRGYDGST--ADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTC 233
++APE+L++ + T D++S G + + +++ G PF S + A C
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249
Query: 234 PPW---LSFTARKLIARILDPNP 253
AR+LI +++ +P
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDP 272
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 3e-74
Identities = 76/259 (29%), Positives = 112/259 (43%), Gaps = 51/259 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
+ +G G KV N T E ALK+L + +REV + + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71
Query: 72 NVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVD 125
++VR+ +V + + IV+E + GGELF +I + G E EA + + A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 126 YCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
Y HS + HRD+KPENLL LK++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAA--EFTCPPW 236
E YD S D+WS GVI+++LL GY PF ++ + + +I EF P W
Sbjct: 169 ETTG-EKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 237 --LSFTARKLIARILDPNP 253
+S + LI +L P
Sbjct: 227 SEVSEEVKMLIRNLLKTEP 245
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 9e-74
Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 15/263 (5%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + + + IG G F++V A G PVALK + ++ K +
Sbjct: 22 LRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK 81
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRY 116
E+ +K + HPNV++ Y ++ IVLE G+L I + + + E +Y
Sbjct: 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
F QL +A+++ HSR V HRD+KP N+ + A G +K+ D GL H+ GT
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGT 199
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF--DDSNLMNLYKKISAAEFTCP 234
P Y++PE +++ GY+ +D+WS G +L+ + A PF D NL +L KKI ++ P
Sbjct: 200 PYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--P 256
Query: 235 PW----LSFTARKLIARILDPNP 253
P S R+L+ ++P+P
Sbjct: 257 PLPSDHYSEELRQLVNMCINPDP 279
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-73
Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 10/244 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ +G G++ +V R+ E G A+K A ++ + K+ +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
VRL + +++ E G L G + E + Y + + A+ + HS+
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
G+ H D+KP N+ L G K+ DFGL ++ G G P Y+APE+L Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232
Query: 191 DGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
+ AD++S G+ + + LP L + EF LS R ++ +L
Sbjct: 233 G-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289
Query: 250 DPNP 253
+P+P
Sbjct: 290 EPDP 293
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 3e-73
Identities = 41/293 (13%), Positives = 80/293 (27%), Gaps = 47/293 (16%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ + K ++ + G + V R+ E E ALK+ E++
Sbjct: 54 DSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEAT 113
Query: 63 ATMKLVKHPNVVRLYEVMG--------------------------SKTKIFIVLEFVTG- 95
+ + + + +++ +
Sbjct: 114 FAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVD 173
Query: 96 ----GELFDKIVNHGRMKEDEARRYF-QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150
D + + A QLI S+G+ H P+NL + G L
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRL 233
Query: 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD-GSTADLWSCGVILFVLLA 209
+ D + + Y E LN + W G+ ++ +
Sbjct: 234 MLGDVSAL-----WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288
Query: 210 GYLPFDDSN--LMNLYKKISAAE-------FTCPPWLSFTARKLIARILDPNP 253
+LPF + +K+ S F L + LI R L+ +
Sbjct: 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDR 341
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 227 bits (579), Expect = 1e-72
Identities = 46/285 (16%), Positives = 90/285 (31%), Gaps = 42/285 (14%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM 65
+ R G +G+ A + ETGE + + + +Q+K EV +
Sbjct: 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 66 KL----------------------VKHPNVVRLYEVMGSKTKIFIVLEFVT--------- 94
+L VK P ++ V + ++++ F
Sbjct: 133 RLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQ 192
Query: 95 --GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV 152
G L H + + Q+I + H G+ H L+P +++LD G + +
Sbjct: 193 TFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFL 252
Query: 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLL 208
+ F + + P A +L + + D W+ G+ ++ +
Sbjct: 253 TGFEH-LVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 209 AGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
LP D + + I + P R L+ L
Sbjct: 312 CADLPNTDDAALGGSEWIFRSCKNIPQP----VRALLEGFLRYPK 352
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 5e-72
Identities = 69/243 (28%), Positives = 132/243 (54%), Gaps = 10/243 (4%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
R IG+G+F KV + ++T + A+K ++K+K ++ + +E+ M+ ++HP +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ + +F+V++ + GG+L + + KE+ + + +L+ A+DY ++ + HRD
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR---GYDGS 193
+KP+N+LLD +G++ ++DF ++A + + + T GT Y+APE+ + R GY
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY-SF 196
Query: 194 TADLWSCGVILFVLLAGYLPF---DDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
D WS GV + LL G P+ ++ + T P S L+ ++L+
Sbjct: 197 AVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLE 256
Query: 251 PNP 253
PNP
Sbjct: 257 PNP 259
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 224 bits (571), Expect = 5e-72
Identities = 44/275 (16%), Positives = 97/275 (35%), Gaps = 33/275 (12%)
Query: 3 QPKIKRRVG--KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMA 55
+PK + ++G V +GEG FA+V A +++ + LK+ + +
Sbjct: 55 KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114
Query: 56 EQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-----NHGRMKE 110
Q+ +K ++ Y + +V E + G L + I M +
Sbjct: 115 TQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 111 DEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL-----------DAYGNLKVSDFGLSA 159
+ +++ ++ H + H D+KP+N +L D L + D G S
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSN 218
+ + C T + E+L+++ ++ D + ++ +L G Y+ +
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEG 290
Query: 219 LMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
+ + W + +L+
Sbjct: 291 GECKPEGLFRRLPHLDMW-----NEFFHVMLNIPD 320
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 4e-69
Identities = 84/237 (35%), Positives = 131/237 (55%), Gaps = 3/237 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+ +G+GTF KV R TG A+KIL KE ++ E ++ +HP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136
+ ++ V+E+ GGELF + E+ AR Y ++++A++Y HSR V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTAD 196
+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL D Y G D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 197 LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
W GV+++ ++ G LPF + + L++ I E P LS A+ L+A +L +P
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 1e-68
Identities = 84/238 (35%), Positives = 131/238 (55%), Gaps = 4/238 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVR 75
+ IG+G+F KV AR+ A+K+L K+ +LK K + I E + K VKHP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + K++ VL+++ GGELF + E AR Y ++ +A+ Y HS + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLKPEN+LLD+ G++ ++DFGL + + + T CGTP Y+APEVL+ + Y T
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTV 220
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
D W G +L+ +L G PF N +Y I P ++ +AR L+ +L +
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR 278
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-68
Identities = 83/241 (34%), Positives = 134/241 (55%), Gaps = 7/241 (2%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKHPN 72
R +G+G + KV R + TG+ A+K+L K ++ K K E ++ VKHP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V L + K++++LE+++GGELF ++ G ED A Y ++ A+ + H +G+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN++L+ G++K++DFGL S + D + HT CGT Y+APE+L G+
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLCKES--IHDGTVTHTFCGTIEYMAPEILMRSGH-N 199
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
D WS G +++ +L G PF N KI + PP+L+ AR L+ ++L N
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRN 259
Query: 253 P 253
Sbjct: 260 A 260
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 4e-68
Identities = 61/272 (22%), Positives = 105/272 (38%), Gaps = 31/272 (11%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
R + +E + +G G F V A+N A+K + + E++ REV +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAK 59
Query: 68 VKHPNVVRLYEV------------MGSKTKIFIVLEFVTGGELFDKIVNHGRMK---EDE 112
++HP +VR + K ++I ++ L D + ++
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 113 ARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL----------SQ 162
F Q+ AV++ HS+G+ HRDLKP N+ +KV DFGL
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL 222
+ GT Y++PE ++ Y D++S G+ILF LL Y +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELL--YPFSTQMERVRT 236
Query: 223 YKKISAAEF-TCPPWLSFTARKLIARILDPNP 253
+ +F ++ +L P+P
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSP 268
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 5e-68
Identities = 82/240 (34%), Positives = 137/240 (57%), Gaps = 7/240 (2%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G+F KV + S+ + A+K+L K + K E + V HP +
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TKMERDILVEVNHPFI 88
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVY 133
V+L+ ++ K++++L+F+ GG+LF ++ E++ + Y +L A+D+ HS G+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS 193
+RDLKPEN+LLD G++K++DFGLS S + + ++ CGT Y+APEV+N RG+
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLSKES--IDHEKKAYSFCGTVEYMAPEVVNRRGH-TQ 205
Query: 194 TADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
+AD WS GV++F +L G LPF + I A+ P +LS A+ L+ + NP
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 9e-68
Identities = 76/255 (29%), Positives = 135/255 (52%), Gaps = 6/255 (2%)
Query: 2 SQPKIKRRVG--KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
+P ++ ++ + + + +G+G+F KV A +T + A+K L K+ VL E
Sbjct: 6 ERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM 65
Query: 60 REVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + L +HP + ++ +K +F V+E++ GG+L I + + A Y
Sbjct: 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA 125
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++I + + HS+G+ +RDLK +N+LLD G++K++DFG+ + + D +T CGTP+
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPD 183
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLS 238
Y+APE+L + Y + D WS GV+L+ +L G PF + L+ I P WL
Sbjct: 184 YIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 242
Query: 239 FTARKLIARILDPNP 253
A+ L+ ++ P
Sbjct: 243 KEAKDLLVKLFVREP 257
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 9e-68
Identities = 84/250 (33%), Positives = 135/250 (54%), Gaps = 14/250 (5%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YEV + IG G F +V+ R+ T + A+K+L K +++K + E M P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
VV+L+ +++V+E++ GG+L ++++ + E AR Y +++ A+D HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIHSMGF 189
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVAPEVLNDRGY 190
HRD+KP+N+LLD G+LK++DFG ++ +G++ T GTP+Y++PEVL +G
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246
Query: 191 D---GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----FTCPPWLSFTARK 243
D G D WS GV L+ +L G PF +L+ Y KI + F +S A+
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306
Query: 244 LIARIL-DPN 252
LI L D
Sbjct: 307 LICAFLTDRE 316
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 4e-67
Identities = 86/253 (33%), Positives = 140/253 (55%), Gaps = 4/253 (1%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
++PK + + ++E + +G+GTF KV + TG A+KIL KE ++ E
Sbjct: 139 AKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ +HP + L + ++ V+E+ GGELF + ED AR Y +++
Sbjct: 199 NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 122 NAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+A+DY HS + V +RDLK ENL+LD G++K++DFGL + ++D + T CGTP Y+
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYL 316
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFT 240
APEVL D Y G D W GV+++ ++ G LPF + + L++ I E P L
Sbjct: 317 APEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPE 375
Query: 241 ARKLIARILDPNP 253
A+ L++ +L +P
Sbjct: 376 AKSLLSGLLKKDP 388
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 6e-67
Identities = 84/238 (35%), Positives = 135/238 (56%), Gaps = 4/238 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R +G+G+F KV AR ETG+ A+K+L K+ +L+ E E + L HP + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + ++F V+EFV GG+L I R E AR Y ++I+A+ + H +G+ +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD G+ K++DFG+ + + + T CGTP+Y+APE+L + Y G
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAV 205
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
D W+ GV+L+ +L G+ PF+ N +L++ I E P WL A ++ + NP
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNP 263
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 2e-66
Identities = 74/238 (31%), Positives = 130/238 (54%), Gaps = 4/238 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+G+G+F KV + T E A+KIL K+ V++ E E + L K P + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++ V+E+V GG+L I GR KE A Y ++ + + S+G+ +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G +
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 202
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
D W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 260
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 5e-66
Identities = 70/254 (27%), Positives = 124/254 (48%), Gaps = 17/254 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E+ + IG G F +V + + A+KIL+K ++LK + E +
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
+ L+ +++V+++ GG+L + R+ E+ AR Y +++ A+D H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVAPEVLND-- 187
HRD+KP+N+L+D G+++++DFG ++ +DG + GTP+Y++PE+L
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVGTPDYISPEILQAME 252
Query: 188 ---RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTCPPW---LSF 239
Y G D WS GV ++ +L G PF +L+ Y KI F P +S
Sbjct: 253 GGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 240 TARKLIARILDPNP 253
A+ LI R++
Sbjct: 312 NAKDLIRRLICSRE 325
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 9e-65
Identities = 79/247 (31%), Positives = 137/247 (55%), Gaps = 13/247 (5%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
R IG G++AKV R +T A+K++ KE V + + ++ E + HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ +++++F V+E+V GG+L + ++ E+ AR Y ++ A++Y H RG+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N+LLD+ G++K++D+G+ + +R T CGTPNY+APE+L Y G +
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 191
Query: 196 DLWSCGVILFVLLAGYLPF---------DDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
D W+ GV++F ++AG PF D + L++ I + P LS A ++
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
Query: 247 RILDPNP 253
L+ +P
Sbjct: 252 SFLNKDP 258
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-64
Identities = 73/263 (27%), Positives = 129/263 (49%), Gaps = 20/263 (7%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
+ R+ + +E+ + IG G F++V + +TG+ A+KI++K +LK + E
Sbjct: 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDV 114
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINA 123
+ + +L+ + +++V+E+ GG+L + G R+ + AR Y +++ A
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLL--HTTCGTPNYVA 181
+D H G HRD+KP+N+LLD G+++++DFG ++R DG + GTP+Y++
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLS 231
Query: 182 PEVLNDRGYD------GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI--SAAEFTC 233
PE+L G G D W+ GV + + G PF + Y KI +
Sbjct: 232 PEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSL 291
Query: 234 P---PWLSFTARKLIARIL-DPN 252
P + AR I R+L P
Sbjct: 292 PLVDEGVPEEARDFIQRLLCPPE 314
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 3e-64
Identities = 80/264 (30%), Positives = 143/264 (54%), Gaps = 15/264 (5%)
Query: 2 SQPKIKRRVG--KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK 59
K +G +++ R IG G++AKV R +T A++++ KE V + + ++
Sbjct: 41 ESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ 100
Query: 60 REVATMKLV-KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ 118
E + HP +V L+ +++++F V+E+V GG+L + ++ E+ AR Y
Sbjct: 101 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA 160
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
++ A++Y H RG+ +RDLK +N+LLD+ G++K++D+G+ + +R T CGTPN
Sbjct: 161 EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPN 218
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF---------DDSNLMNLYKKISAA 229
Y+APE+L Y G + D W+ GV++F ++AG PF D + L++ I
Sbjct: 219 YIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277
Query: 230 EFTCPPWLSFTARKLIARILDPNP 253
+ P LS A ++ L+ +P
Sbjct: 278 QIRIPRSLSVKAASVLKSFLNKDP 301
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 1e-63
Identities = 72/261 (27%), Positives = 125/261 (47%), Gaps = 16/261 (6%)
Query: 3 QPKIKRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----HKMA 55
++ + + V R IG G F +V R ++TG+ A+K LDK+++ +
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN 238
Query: 56 EQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARR 115
E + ++ + P +V + + K+ +L+ + GG+L + HG E + R
Sbjct: 239 E--RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF 296
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
Y ++I +++ H+R V +RDLKP N+LLD +G++++SD GL+ H + G
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVG 352
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN---LYKKISAAEFT 232
T Y+APEVL S+AD +S G +LF LL G+ PF + + +
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 233 CPPWLSFTARKLIARILDPNP 253
P S R L+ +L +
Sbjct: 413 LPDSFSPELRSLLEGLLQRDV 433
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 210 bits (535), Expect = 1e-63
Identities = 74/238 (31%), Positives = 130/238 (54%), Gaps = 4/238 (1%)
Query: 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75
+G+G+F KV + T E A+KIL K+ V++ E E + L K P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
L+ + +++ V+E+V GG+L I GR KE A Y ++ + + S+G+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA 195
DLK +N++LD+ G++K++DFG+ + + D T CGTP+Y+APE++ + Y G +
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKEN--IWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSV 523
Query: 196 DLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNP 253
D W+ GV+L+ +LAG PF+ + L++ I P +S A + ++ +P
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 581
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 2e-63
Identities = 68/257 (26%), Positives = 122/257 (47%), Gaps = 13/257 (5%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
+ +G+ + R +G G F +V + TG+ A K L+K+++ K K + E
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQL 120
+ V +V L +KT + +V+ + GG++ I N + +E A Y Q+
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
++ +++ H R + +RDLKPEN+LLD GN+++SD GL+ + GTP ++
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFM 356
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEFTCPPW 236
APE+L Y + D ++ GV L+ ++A PF L +++ T P
Sbjct: 357 APELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK 415
Query: 237 LSFTARKLIARILDPNP 253
S ++ +L +P
Sbjct: 416 FSPASKDFCEALLQKDP 432
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-63
Identities = 76/248 (30%), Positives = 139/248 (56%), Gaps = 13/248 (5%)
Query: 17 RTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKH-P 71
+ +G G + KV R +TG+ A+K+L K ++ K K E + E ++ ++ P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V L+ ++TK+ ++L+++ GGELF + R E E + Y +++ A+++ H G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG 189
+ +RD+K EN+LLD+ G++ ++DFGLS + + CGT Y+AP+++ D G
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSG 238
Query: 190 YDGSTADLWSCGVILFVLLAGYLPF----DDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245
+D + D WS GV+++ LL G PF + ++ + ++I +E P +S A+ LI
Sbjct: 239 HDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLI 297
Query: 246 ARILDPNP 253
R+L +P
Sbjct: 298 QRLLMKDP 305
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-63
Identities = 70/255 (27%), Positives = 122/255 (47%), Gaps = 12/255 (4%)
Query: 7 KRRVGK--YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT 64
++ V K + R +G+G F +V + TG+ A K L+K+++ K K E
Sbjct: 178 RQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQI 237
Query: 65 MKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRM--KEDEARRYFQQLIN 122
++ V VV L +K + +VL + GG+L I + G+ E A Y ++
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC 297
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
++ H + +RDLKPEN+LLD +G++++SD G L+ V + + GT Y+AP
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLG---LAVHVPEGQTIKGRVGTVGYMAP 354
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPPWLS 238
EV+ + Y + D W+ G +L+ ++AG PF + + + S
Sbjct: 355 EVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFS 413
Query: 239 FTARKLIARILDPNP 253
AR L +++L +P
Sbjct: 414 PQARSLCSQLLCKDP 428
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 6e-57
Identities = 53/268 (19%), Positives = 89/268 (33%), Gaps = 35/268 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ IG G F V G A+K K ++ A L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLINAVDYC 127
+VVR + + I E+ GG L D I + R KE E + Q+ + Y
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 128 HSRGVYHRDLKPENLLLDAYGNL-------------------KVSDFGLSALSQQVRDDG 168
HS + H D+KP N+ + K+ D G V
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH------VTRIS 185
Query: 169 LLHTTCGTPNYVAPEVLN-DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS 227
G ++A EVL + + AD+++ + + + + +I
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGDQW---HEIR 241
Query: 228 AAEF-TCPPWLSFTARKLIARILDPNPM 254
P LS +L+ ++ P+P
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPE 269
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 5e-54
Identities = 63/251 (25%), Positives = 107/251 (42%), Gaps = 22/251 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G G+F +V ++ +TG A+K + E E+ + P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--------EELVACAGLSSPR 111
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+V LY + + I +E + GG L I G + ED A Y Q + ++Y H+R +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 133 YHRDLKPENLLLDAYGNL-KVSDFGLSALSQQVRDDGLLHTTC------GTPNYVAPEVL 185
H D+K +N+LL + G+ + DFG + ++ DGL + GT ++APEV+
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHAL---CLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTAR 242
+ D D+WS ++ +L G P+ L KI++ PP +
Sbjct: 229 MGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287
Query: 243 KLIARILDPNP 253
+ I L P
Sbjct: 288 QAIQEGLRKEP 298
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 7e-53
Identities = 68/247 (27%), Positives = 117/247 (47%), Gaps = 15/247 (6%)
Query: 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR 75
+G+GT+ V R+ +A+K + + + ++ + E+A K +KH N+V+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQ 83
Query: 76 LYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEA--RRYFQQLINAVDYCHSRGV 132
I I +E V GG L + G +K++E Y +Q++ + Y H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 133 YHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN--DRG 189
HRD+K +N+L++ Y G LK+SDFG S + T GT Y+APE+++ RG
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRG 201
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEF--TCPPWLSFTARKLIA 246
Y + AD+WS G + + G PF + K+ + P +S A+ I
Sbjct: 202 YGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260
Query: 247 RILDPNP 253
+ +P+P
Sbjct: 261 KCFEPDP 267
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-51
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 27/211 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVATMKLVK 69
KYE IGEG++ V RN +TG+ VA+K + ++ + K+A RE+ +K +K
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL---REIRMLKQLK 60
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+V L EV K ++ +V E+ + ++ + R + E + Q + AV++CH
Sbjct: 61 HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYV------A 181
HRD+KPEN+L+ + +K+ DFG + L+ + + V +
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY----YD-----DEVATRWYRS 170
Query: 182 PEVL-NDRGYDGSTA-DLWSCGVILFVLLAG 210
PE+L D Y D+W+ G + LL+G
Sbjct: 171 PELLVGDTQY--GPPVDVWAIGCVFAELLSG 199
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 8e-51
Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----RE 61
+ + KYE +GEG++ V RN +TG VA+K + + + +K RE
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD-------KMVKKIAMRE 74
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQ 119
+ +K ++H N+V L EV K + ++V EFV + + + ++Y Q
Sbjct: 75 IKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLEL--FPNGLDYQVVQKYLFQ 132
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN 178
+IN + +CHS + HRD+KPEN+L+ G +K+ DFG + L+ + +
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV----YD-----D 183
Query: 179 YV------APEVL-NDRGYDGSTA-DLWSCGVILFVLLAG 210
V APE+L D Y A D+W+ G ++ + G
Sbjct: 184 EVATRWYRAPELLVGDVKY--GKAVDVWAIGCLVTEMFMG 221
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 8e-51
Identities = 60/311 (19%), Positives = 106/311 (34%), Gaps = 72/311 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILD-------KEKVLK------------- 51
+E + +G G F V A+N A+K + +EKV++
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 52 -----------------------------------HKMAEQIKREVATMKLVKHPNVVRL 76
+ ++ M N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDE---ARRYFQQLINAVDYCHSRGVY 133
+ K ++I ++ L D + +++ E F Q+ AV++ HS+G+
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLM 186
Query: 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----------GLLHTTCGTPNYVAPE 183
HRDLKP N+ +KV DFGL Q ++ GT Y++PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF-TAR 242
++ Y D++S G+ILF LL Y + + + +F +
Sbjct: 247 QIHGNNYSHK-VDIFSLGLILFELL--YSFSTQMERVRIITDVRNLKFPLLFTQKYPQEH 303
Query: 243 KLIARILDPNP 253
++ +L P+P
Sbjct: 304 MMVQDMLSPSP 314
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 1e-49
Identities = 69/219 (31%), Positives = 101/219 (46%), Gaps = 28/219 (12%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKREVA 63
+K R +YE +GEG FA V AR+ T + VA+K L K + RE+
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLI 121
++ + HPN++ L + G K+ I +V +F+ + N + + Y +
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTL 122
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTT 173
++Y H + HRDLKP NLLLD G LK++DFGL+ A + QV
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-------- 174
Query: 174 CGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG 210
T Y APE+L R Y D+W+ G IL LL
Sbjct: 175 --TRWYRAPELLFGARMY--GVGVDMWAVGCILAELLLR 209
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-48
Identities = 63/254 (24%), Positives = 118/254 (46%), Gaps = 18/254 (7%)
Query: 11 GKYE-VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
G++ IG G+F V ++ET VA L K+ K ++ K E +K ++
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 83
Query: 70 HPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
HPN+VR Y + K I +V E +T G L + MK R + +Q++ +
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 126 YCHSRG--VYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ H+R + HRDLK +N+ + G++K+ D GL+ L + GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAP 199
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAE--FTCPPWLSF 239
E+ + YD S D+++ G+ + + P+ + N +Y+++++ +
Sbjct: 200 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 240 TARKLIARILDPNP 253
+++I + N
Sbjct: 258 EVKEIIEGCIRQNK 271
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-48
Identities = 78/221 (35%), Positives = 112/221 (50%), Gaps = 39/221 (17%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
KYE IGEGT+ V A+N ET E VALK LD + E + RE+ +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-------EGVPSSALREICLL 55
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+VRL++V+ S K+ +V EF + FD +G + + + + QL+
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFLFQLLKG 113
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTTCG 175
+ +CHSR V HRDLKP+NLL++ G LK+++FGL+ S +V
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV---------- 163
Query: 176 TPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAGYLPF 214
T Y P+VL + Y ST+ D+WS G I L P
Sbjct: 164 TLWYRPPDVLFGAKLY--STSIDMWSAGCIFAELANAGRPL 202
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 6e-48
Identities = 65/231 (28%), Positives = 107/231 (46%), Gaps = 41/231 (17%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQI 58
+S + +Y +GEGT+ +V A ++ T E VA+K L+ E+ E +
Sbjct: 24 VSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-------EGV 76
Query: 59 K----REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
REV+ +K ++H N++ L V+ ++ ++ E+ +L + + + +
Sbjct: 77 PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK 135
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-----GNLKVSDFGLS--------ALS 161
+ QLIN V++CHSR HRDLKP+NLLL LK+ DFGL+ +
Sbjct: 136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFT 195
Query: 162 QQVRDDGLLHTTCGTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG 210
++ T Y PE+L R Y ST+ D+WS I +L
Sbjct: 196 HEII----------TLWYRPPEILLGSRHY--STSVDIWSIACIWAEMLMK 234
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 2e-47
Identities = 71/221 (32%), Positives = 108/221 (48%), Gaps = 37/221 (16%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REV 62
+++ +G GT+A V N TG VALK LD E E RE+
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--------EGTPSTAIREI 54
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGG-----ELFDKIVNHGRMKEDEARRYF 117
+ MK +KH N+VRLY+V+ ++ K+ +V EF+ + ++ + + +
Sbjct: 55 SLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGT 176
QL+ + +CH + HRDLKP+NLL++ G LK+ DFGL+ A V +
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--------TFS 166
Query: 177 PN-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG 210
Y AP+VL R Y ST+ D+WSCG IL ++ G
Sbjct: 167 SEVVTLWYRAPDVLMGSRTY--STSIDIWSCGCILAEMITG 205
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-47
Identities = 72/254 (28%), Positives = 117/254 (46%), Gaps = 27/254 (10%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ IG G+F V A G VA+KIL ++ + + REVA MK ++HPN+
Sbjct: 40 NIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNI 96
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ---QLINAVDYCHSR 130
V + + IV E+++ G L+ + G ++ + RR + ++Y H+R
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 131 G--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HR+LK NLL+D +KV DFGLS L + + GTP ++APEVL D
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------TCPPWLSF 239
+ +D++S GVIL+ L P+ + +N + ++A F P +
Sbjct: 215 PSN-EKSDVYSFGVILWELATLQQPWGN---LNPAQVVAAVGFKCKRLEIPRNLNPQV-- 268
Query: 240 TARKLIARILDPNP 253
+I P
Sbjct: 269 --AAIIEGCWTNEP 280
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 9e-47
Identities = 74/220 (33%), Positives = 116/220 (52%), Gaps = 36/220 (16%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----R 60
+ + KY+ +GEGT+ V A++S G VALK LD E E I R
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAED-------EGIPSTAIR 68
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQ 118
E++ +K + HPN+V L +V+ S+ + +V EF+ ++ D+ N +++ + + Y
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYLY 126
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTP 177
QL+ V +CH + HRDLKP+NLL+++ G LK++DFGL+ A VR T
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--------SYTH 178
Query: 178 N-----YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG 210
Y AP+VL + Y ST+ D+WS G I ++ G
Sbjct: 179 EVVTLWYRAPDVLMGSKKY--STSVDIWSIGCIFAEMITG 216
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-46
Identities = 79/215 (36%), Positives = 113/215 (52%), Gaps = 36/215 (16%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
KY IGEGT+ V A+N GE ALK L+KE E I RE++ +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-------EGIPSTTIREISIL 54
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+V+LY+V+ +K ++ +V E + +L D G ++ A+ + QL+N
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLLNG 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN---- 178
+ YCH R V HRDLKP+NLL++ G LK++DFGL+ A VR T
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--------KYTHEIVTL 164
Query: 179 -YVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG 210
Y AP+VL + Y ST D+WS G I ++ G
Sbjct: 165 WYRAPDVLMGSKKY--STTIDIWSVGCIFAEMVNG 197
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-46
Identities = 72/225 (32%), Positives = 105/225 (46%), Gaps = 35/225 (15%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----RE 61
V KYE IG+GTF +V AR+ +TG+ VALK +++ EK E RE
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-------EGFPITALRE 66
Query: 62 VATMKLVKHPNVVRLYEVM--------GSKTKIFIVLEFV----TGGELFDKIVNHGRMK 109
+ ++L+KH NVV L E+ K I++V +F G L + +
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFT 122
Query: 110 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDG 168
E +R Q L+N + Y H + HRD+K N+L+ G LK++DFGL+ A S
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 169 LLHTTC-GTPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG 210
+T T Y PE+L +R Y DLW G I+ +
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDY--GPPIDLWGAGCIMAEMWTR 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-46
Identities = 71/246 (28%), Positives = 123/246 (50%), Gaps = 15/246 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ IG+G+F +V ++ T + VA+KI+D E+ E I++E+ + P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 81
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
V + Y TK++I++E++ GG D ++ G + E + ++++ +DY HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYD 191
HRD+K N+LL +G +K++DFG++ Q+ D + T GTP ++APEV+ YD
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL----SFTARKLIAR 247
AD+WS G+ L G P + + M + I PP L S ++ +
Sbjct: 198 SK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN---PPTLEGNYSKPLKEFVEA 253
Query: 248 ILDPNP 253
L+ P
Sbjct: 254 CLNKEP 259
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-46
Identities = 56/254 (22%), Positives = 114/254 (44%), Gaps = 24/254 (9%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
VG+ IG G+F V + + + VA+K+L + + K EV ++ +H N
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD----VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRG 131
++ + ++ IV ++ G L+ + + + + + +Q +DY H++
Sbjct: 82 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS 140
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLK N+ L +K+ DFGL+ + G+ ++APEV+ + +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 192 GST--ADLWSCGVILFVLLAGYLPFDDSNLM----------NLYKKISAAEFTCPPWLSF 239
+ +D+++ G++L+ L+ G LP+ + N +L +S CP +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM-- 258
Query: 240 TARKLIARILDPNP 253
++L+A L
Sbjct: 259 --KRLMAECLKKKR 270
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-46
Identities = 67/227 (29%), Positives = 101/227 (44%), Gaps = 33/227 (14%)
Query: 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIKRE 61
P +YE IG G + V AR+ +G VALK + + RE
Sbjct: 2 PLGSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE 61
Query: 62 VATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIVNHGRMKED 111
VA ++ ++ HPNVVRL +V + K+ +V E V DK + +
Sbjct: 62 VALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA-PPPGLPAE 120
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQQV 164
+ +Q + +D+ H+ + HRDLKPEN+L+ + G +K++DFGL+ AL+ V
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAG 210
T Y APEVL Y +T D+WS G I +
Sbjct: 181 V----------TLWYRAPEVLLQSTY--ATPVDMWSVGCIFAEMFRR 215
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-46
Identities = 62/217 (28%), Positives = 100/217 (46%), Gaps = 40/217 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK--ILDKEKVLKHKMAEQIK----REVATM 65
Y +GEGT+A V ++ T VALK L+ E E REV+ +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--------EGAPCTAIREVSLL 54
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTG--GELFDKIVNHGRMKEDEARRYFQQLINA 123
K +KH N+V L++++ ++ + +V E++ + D + + + QL+
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRG 112
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS--------ALSQQVRDDGLLHTTCG 175
+ YCH + V HRDLKP+NLL++ G LK++DFGL+ +V
Sbjct: 113 LAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---------- 162
Query: 176 TPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG 210
T Y P++L Y ST D+W G I + + G
Sbjct: 163 TLWYRPPDILLGSTDY--STQIDMWGVGCIFYEMATG 197
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-45
Identities = 68/256 (26%), Positives = 106/256 (41%), Gaps = 37/256 (14%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
EV +G G F V A+ + VA+K ++ E K E+ + V HPN+
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERK-----AFIVELRQLSRVNHPNI 63
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI---NAVDYCHSR 130
V+LY + +V+E+ GG L++ + + A + V Y HS
Sbjct: 64 VKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 131 ---GVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
+ HRDLKP NLLL A G LK+ DFG + Q + G+ ++APEV
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFE 176
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------TCPPWL 237
Y D++S G+IL+ ++ PFD+ + +I A P +
Sbjct: 177 GSNYS-EKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 238 SFTARKLIARILDPNP 253
L+ R +P
Sbjct: 234 ----ESLMTRCWSKDP 245
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-45
Identities = 65/268 (24%), Positives = 110/268 (41%), Gaps = 44/268 (16%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
G +G+G F + + ETGE + +K L + + +EV M+ ++HPNV
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG---------RMKEDEARRYFQQLINAV 124
++ V+ ++ + E++ GG L I + +D A +
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIAS--------GM 121
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL------------SQQVRDDGLLHT 172
Y HS + HRDL N L+ N+ V+DFGL+ L S + D +T
Sbjct: 122 AYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181
Query: 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF- 231
G P ++APE++N R YD D++S G++L ++ D + ++ F
Sbjct: 182 VVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240
Query: 232 ------TCPPWLSFTARKLIARILDPNP 253
CPP + R D +P
Sbjct: 241 DRYCPPNCPPSF----FPITVRCCDLDP 264
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-45
Identities = 56/259 (21%), Positives = 109/259 (42%), Gaps = 29/259 (11%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
E+G IG+G F +V R + E VA++++D E+ + KREV + +H N
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE----VAIRLIDIER-DNEDQLKAFKREVMAYRQTRHEN 90
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSRG 131
VV S + I+ G L+ + + ++ R+ Q+++ + Y H++G
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLS---ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H+DLK +N+ D G + ++DFGL + Q R + L G ++APE++
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 189 GYDGST--------ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI------SAAEFTCP 234
D +D+++ G I + L A PF + ++ + ++
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269
Query: 235 PWLSFTARKLIARILDPNP 253
+ ++
Sbjct: 270 KEI----SDILLFCWAFEQ 284
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-44
Identities = 60/191 (31%), Positives = 103/191 (53%), Gaps = 7/191 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IG+G V A + TG+ VA++ ++ ++ K E I E+ M+ K+P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +N+LL G++K++DFG A Q + T GTP ++APEV+ + Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 192 GSTADLWSCGV 202
D+WS G+
Sbjct: 195 PK-VDIWSLGI 204
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-44
Identities = 64/251 (25%), Positives = 122/251 (48%), Gaps = 13/251 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y++ +G G + V A ++ VA+K + K + ++ +REV + H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V + +V ++V+E++ G L + I +HG + D A + Q+++ + + H
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTC--GTPNYVAPEVLND 187
+ HRD+KP+N+L+D+ LK+ DFG++ ALS+ L T GT Y +PE
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET----SLTQTNHVLGTVQYFSPEQAKG 186
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCP----PWLSFTAR 242
D T D++S G++L+ +L G PF+ ++ + K I + + +
Sbjct: 187 EATDECT-DIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 243 KLIARILDPNP 253
+I R + +
Sbjct: 246 NVILRATEKDK 256
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-44
Identities = 64/191 (33%), Positives = 107/191 (56%), Gaps = 7/191 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ IGEG+ V AR +G VA+K++D K + E + EV M+ +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHF 102
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
NVV +Y+ ++++++EF+ GG L D IV+ R+ E++ + ++ A+ Y H++G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+K +++LL G +K+SDFG A Q +D + GTP ++APEV++ Y
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 192 GSTADLWSCGV 202
D+WS G+
Sbjct: 220 TE-VDIWSLGI 229
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-44
Identities = 43/258 (16%), Positives = 95/258 (36%), Gaps = 36/258 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ E ++ R G + +K+L + + E +++ HPNV
Sbjct: 13 NFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNV 69
Query: 74 VRLYEVM--GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD------ 125
+ + ++ ++ G L++ + D+++ + A+D
Sbjct: 70 LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA----VKFALDMARGMA 125
Query: 126 YCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+ H+ + L ++++D ++S + Q P +VAPE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPE 178
Query: 184 VLNDRGYDGST--ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------TCPP 235
L + D + AD+WS V+L+ L+ +PF D + M + K++ P
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 236 WLSFTARKLIARILDPNP 253
+ KL+ ++ +P
Sbjct: 239 HV----SKLMKICMNEDP 252
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-44
Identities = 75/235 (31%), Positives = 110/235 (46%), Gaps = 45/235 (19%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALK--ILDKEKVLKHKMAEQ 57
M + + R +YE IGEG + KV AR+ G VALK + + E
Sbjct: 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-------EG 53
Query: 58 IK----REVATMKLVK---HPNVVRLYEV-----MGSKTKIFIVLEFVTG--GELFDKIV 103
+ REVA ++ ++ HPNVVRL++V +TK+ +V E V DK+
Sbjct: 54 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV- 112
Query: 104 NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS----- 158
+ + + QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+
Sbjct: 113 PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 172
Query: 159 --ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAG 210
AL+ V T Y APEVL Y +T DLWS G I +
Sbjct: 173 QMALTSVVV----------TLWYRAPEVLLQSSY--ATPVDLWSVGCIFAEMFRR 215
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-44
Identities = 67/262 (25%), Positives = 112/262 (42%), Gaps = 34/262 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL----DKEKVLKHKMAEQIKREVATMKLVK 69
E + IG+G F V R + VA+K L + + + ++ +REV M +
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
HPN+V+LY + +V+EFV G+L+ ++++ +K R + ++Y
Sbjct: 82 HPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 129 SRGVY--HRDLKPENLLLDAYG-----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
++ HRDL+ N+ L + KV+DFGLS S + G ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA 194
Query: 182 PEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------F 231
PE + Y AD +S +IL+ +L G PFD+ + + E
Sbjct: 195 PETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253
Query: 232 TCPPWLSFTARKLIARILDPNP 253
CPP L R +I +P
Sbjct: 254 DCPPRL----RNVIELCWSGDP 271
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-43
Identities = 55/217 (25%), Positives = 105/217 (48%), Gaps = 8/217 (3%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
++ + + G Y + R +G G V A ++ VALK++ + +++RE
Sbjct: 25 AESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQRE 84
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
T ++ P+VV +++ ++++ + + G +L + G + A +Q+
Sbjct: 85 ARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIG 144
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDDGLLHT--TCGTPN 178
+A+D H+ G HRD+KPEN+L+ A + DFG+ SA + D+ L T GT
Sbjct: 145 SALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT----DEKLTQLGNTVGTLY 200
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215
Y+APE ++ AD+++ +L+ L G P+
Sbjct: 201 YMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQ 236
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 150 bits (379), Expect = 3e-43
Identities = 59/224 (26%), Positives = 97/224 (43%), Gaps = 19/224 (8%)
Query: 11 GKYEVGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
G YE+ IG+G V AR TGE V ++ ++ E +M ++ E+ KL
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLF 83
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDY 126
HPN+V + ++++V F+ G D I H M E Q ++ A+DY
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC--------GTPN 178
H G HR +K ++L+ G + +S + + G
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNL---SMISHGQRQRVVHDFPKYSVKVLP 200
Query: 179 YVAPEVL--NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
+++PEVL N +GYD +D++S G+ L G++PF D
Sbjct: 201 WLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPAT 243
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 9e-43
Identities = 59/257 (22%), Positives = 104/257 (40%), Gaps = 10/257 (3%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG- 131
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S L + + + GT +Y++PE L Y
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-----SFVGTRSYMSPERLQGTHY 207
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILD 250
+D+WS G+ L + G P + L R +
Sbjct: 208 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266
Query: 251 PNPMTVSIYPFADILYM 267
+ ++L
Sbjct: 267 FGMDSRPPMAIFELLDY 283
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 15/220 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
YE+ IG G A V+ A + E VA+K ++ EK +++ +E+ M HPN
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM--DELLKEIQAMSQCHHPN 74
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD--------KIVNHGRMKEDEARRYFQQLINAV 124
+V Y K ++++V++ ++GG + D G + E ++++ +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLL--HTTCGTPNYVA 181
+Y H G HRD+K N+LL G+++++DFG+SA L+ T GTP ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 182 PEVL-NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
PEV+ RGYD AD+WS G+ L G P+ M
Sbjct: 195 PEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPM 233
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 62/192 (32%), Positives = 106/192 (55%), Gaps = 9/192 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++V +GEG++ V A + ETG+ VA+K + E L ++I +E++ M+ P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHSR 130
+VV+ Y T ++IV+E+ G + D I + + + EDE Q + ++Y H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
HRD+K N+LL+ G+ K++DFG++ Q +T GTP ++APEV+ + GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202
Query: 191 DGSTADLWSCGV 202
+ AD+WS G+
Sbjct: 203 NCV-ADIWSLGI 213
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-42
Identities = 68/253 (26%), Positives = 115/253 (45%), Gaps = 12/253 (4%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+G +G G ++V AR+ VA+K+L + + +RE + H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 71 PNVVRLY---EVMGSKTKI-FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
P +V +Y E + +IV+E+V G L D + G M A A+++
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 131
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ HRD+KP N+++ A +KV DFG++ A++ GT Y++PE
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCP----PWLSFT 240
D + D++S G +L+ +L G PF DS + Y+ + + P LS
Sbjct: 192 RGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR-EDPIPPSARHEGLSAD 249
Query: 241 ARKLIARILDPNP 253
++ + L NP
Sbjct: 250 LDAVVLKALAKNP 262
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-42
Identities = 66/261 (25%), Positives = 109/261 (41%), Gaps = 36/261 (13%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA-EQIKREVATMKLVKHPN 72
+ IG G F KV A G+ VA+K + E +++E ++KHPN
Sbjct: 10 TLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++ L V + + +V+EF GG L + R+ D + Q+ ++Y H +
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 133 Y---HRDLKPENLLLDAYG--------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
HRDLK N+L+ LK++DFGL+ + + G ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMA 182
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------T 232
PEV+ + +D+WS GV+L+ LL G +PF ++ T
Sbjct: 183 PEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRG---IDGLAVAYGVAMNKLALPIPST 238
Query: 233 CPPWLSFTARKLIARILDPNP 253
CP KL+ +P+P
Sbjct: 239 CPEPF----AKLMEDCWNPDP 255
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-42
Identities = 62/215 (28%), Positives = 113/215 (52%), Gaps = 12/215 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+ +G+G F KV A+N ETG A K+++ + + E E+ + HP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE---LEDYIVEIEILATCDHP 76
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V+L K++I++EF GG + ++ + E + + +Q++ A+++ HS+
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-----L 185
+ HRDLK N+L+ G+++++DFG+SA + ++ + GTP ++APEV +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
D YD AD+WS G+ L + P + N M
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPM 228
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-41
Identities = 69/221 (31%), Positives = 105/221 (47%), Gaps = 44/221 (19%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + IG G+F V A+ ++GE VA+K KVL+ K + RE+ M+ + H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQDKRFKN--RELQIMRKLDHC 107
Query: 72 NVVRLYEVMGSKT------KIFIVLEFVTGGELFDKIVNHGRMK----EDEARRYFQQLI 121
N+VRL S + +VL++V ++ ++ R K + Y QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN- 178
++ Y HS G+ HRD+KP+NLLLD LK+ DFG + L + G PN
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------------GEPNV 214
Query: 179 -YV------APEV-LNDRGYDGSTA-DLWSCGVILFVLLAG 210
Y+ APE+ Y +++ D+WS G +L LL G
Sbjct: 215 SYICSRYYRAPELIFGATDY--TSSIDVWSAGCVLAELLLG 253
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-40
Identities = 56/212 (26%), Positives = 101/212 (47%), Gaps = 18/212 (8%)
Query: 1 MSQPKIKRRVGK------YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM 54
+ P + K + R IG G+F V FAR+ E VA+K + ++
Sbjct: 38 LKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK 97
Query: 55 AEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR 114
+ I +EV ++ ++HPN ++ + ++V+E+ G V+ ++E E
Sbjct: 98 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 157
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTT 173
+ + Y HS + HRD+K N+LL G +K+ DFG ++ ++ ++
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSF 210
Query: 174 CGTPNYVAPEV---LNDRGYDGSTADLWSCGV 202
GTP ++APEV +++ YDG D+WS G+
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGK-VDVWSLGI 241
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-40
Identities = 67/224 (29%), Positives = 112/224 (50%), Gaps = 21/224 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G +E+ +G GT+ +V R+ +TG+ A+K++D + E+IK+E+ +K
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 70 HPNVVRLYE------VMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLI 121
H N+ Y G ++++V+EF G + D K +KE+ ++++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+ + H V HRD+K +N+LL +K+ DFG+SA Q R G +T GTP ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 182 PEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
PEV+ D YD +DLWS G+ + G P D + M
Sbjct: 198 PEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPM 240
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-40
Identities = 61/232 (26%), Positives = 103/232 (44%), Gaps = 15/232 (6%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHP 71
E +G GT +V R +TG +A+K + + + ++I ++ +K P
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-R 130
+V+ + + T +FI +E + K G + E + ++ A+ Y
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GV HRD+KP N+LLD G +K+ DFG+S ++ DD + G Y+APE ++
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 191 DGST----ADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCPPWL 237
AD+WS G+ L L G P+ + + K+ E PP L
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE---PPLL 250
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 65/254 (25%), Positives = 104/254 (40%), Gaps = 35/254 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKIL----DKEKVLKHKMAEQIKREVATM 65
G+YEV I G + A + G PV LK L D E E +
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAE------AQAMAMAERQFL 133
Query: 66 KLVKHPNVVRLYEV-----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQL 120
V HP++V+++ +IV+E+V G L ++ EA Y ++
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEI 191
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL-SALSQQVRDDGLLHTTCGTPNY 179
+ A+ Y HS G+ + DLKPEN++L LK+ D G S ++ G L GTP +
Sbjct: 192 LPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRINS----FGYL---YGTPGF 243
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF 239
APE++ R D+++ G L L + + L + +
Sbjct: 244 QAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKT--YDSY-- 297
Query: 240 TARKLIARILDPNP 253
+L+ R +DP+P
Sbjct: 298 --GRLLRRAIDPDP 309
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 29/213 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + IG G+F V A+ E+ E VA+K KVL+ K RE+ M++VKHP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIK-----KVLQDK--RFKNRELQIMRIVKHP 92
Query: 72 NVVRLYEVMGS------KTKIFIVLEFVTGGELFDKIVNH-----GRMKEDEARRYFQQL 120
NVV L S + + +VLE+V E + H M + Y QL
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYV--PETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ ++ Y HS G+ HRD+KP+NLLLD G LK+ DFG + + + + C + Y
Sbjct: 151 LRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA--KILIAGEPNVSYIC-SRYY 207
Query: 180 VAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAG 210
APE+ Y +T D+WS G ++ L+ G
Sbjct: 208 RAPELIFGATNY--TTNIDIWSTGCVMAELMQG 238
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-39
Identities = 58/209 (27%), Positives = 109/209 (52%), Gaps = 20/209 (9%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
Y++ R +G G +++V A N E V +KIL K ++IKRE+ ++ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGG 90
Query: 71 PNVVRLYEVM---GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
PN++ L +++ S+T + E V + ++ + + + R Y +++ A+DYC
Sbjct: 91 PNIITLADIVKDPVSRTPALVF-EHVNNTDF-KQLYQ--TLTDYDIRFYMYEILKALDYC 146
Query: 128 HSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL- 185
HS G+ HRD+KP N+++D + L++ D+GL+ ++ + + + PE+L
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLV 203
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+ + YD S D+WS G +L ++ PF
Sbjct: 204 DYQMYDYSL-DMWSLGCMLASMIFRKEPF 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-38
Identities = 56/229 (24%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIK 59
+ +R +E G +G GT+ V A+ + + ALK ++ +
Sbjct: 12 SSERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC----- 66
Query: 60 REVATMKLVKHPNVVRLYEVMGSKT--KIFIVLEFV--------TGGELFDKIVNHGRMK 109
RE+A ++ +KHPNV+ L +V S K++++ ++ ++
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 126
Query: 110 EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN----LKVSDFGLSALSQQVR 165
+ Q+++ + Y H+ V HRDLKP N+L+ G +K++D G A
Sbjct: 127 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF-ARLFNSP 185
Query: 166 DDGLLHTTCG--TPNYVAPEVL-NDRGYDGSTA-DLWSCGVILFVLLAG 210
L T Y APE+L R Y + A D+W+ G I LL
Sbjct: 186 LKPLADLDPVVVTFWYRAPELLLGARHY--TKAIDIWAIGCIFAELLTS 232
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-38
Identities = 55/220 (25%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHP 71
+ IG G + V + +G+ +A+K + + K +Q+ ++ M+ P
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST--VDEKEQKQLLMDLDVVMRSSDCP 81
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV------NHGRMKEDEARRYFQQLINAVD 125
+V+ Y + + +I +E ++ FDK + E+ + + A++
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 126 YCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+ + HRD+KP N+LLD GN+K+ DFG+S Q+ D G Y+APE
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPER 196
Query: 185 L----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220
+ + +GYD +D+WS G+ L+ L G P+ N +
Sbjct: 197 IDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-36
Identities = 43/210 (20%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G+G + +V GE VA+KI + + + E+ +++H N+
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSR----DEKSWFRETELYNTVMLRHENI 64
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ S T+++++ + G L+D + + R + + + + H
Sbjct: 65 LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSAL--SQQVRDDGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ + + D + GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVIL 204
+APEVL++ D+W+ G++L
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-36
Identities = 55/217 (25%), Positives = 101/217 (46%), Gaps = 19/217 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHP 71
E +G G + V+ R+ +G+ +A+K + + + +++ ++ +M+ V P
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT--VNSQEQKRLLMDLDISMRTVDCP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-----NHGRMKEDEARRYFQQLINAVDY 126
V Y + + ++I +E + DK + ED + ++ A+++
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 127 CHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV- 184
HS V HRD+KP N+L++A G +K+ DFG+S + DD G Y+APE
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERI 181
Query: 185 ---LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN 218
LN +GY +D+WS G+ + L P+D
Sbjct: 182 NPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWG 217
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-35
Identities = 41/250 (16%), Positives = 79/250 (31%), Gaps = 39/250 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+Y + G + A ++ VAL +D + VL + ++ + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
P V R+ +V+ ++ +V E++ GG L + V A R Q L A D H
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQE--VADTSPSPVGAIRAMQSLAAAADAAHRA 148
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
GV P + + G++ ++ +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA------- 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-------PWLSFTARK 243
D+ G L+ LL P ++ + + P + F
Sbjct: 180 -NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISA 238
Query: 244 LIARILDPNP 253
+ AR + +
Sbjct: 239 VAARSVQGDG 248
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-35
Identities = 51/235 (21%), Positives = 93/235 (39%), Gaps = 23/235 (9%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + + ++ G F V + E VA+KI + K + Q +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVW--KAQLLNEYVAVKIFPIQ----DKQSWQNEY 67
Query: 61 EVATMKLVKHPNVVRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHG-------RMK 109
EV ++ +KH N+++ ++++ F G L D + + +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 110 EDEAR--RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
E AR Y + I + H + HRD+K +N+LL ++DFGL+ + +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGST----ADLWSCGVILFVLLAGYLPFDDSN 218
G H GT Y+APEVL D+++ G++L+ L + D
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 62/229 (27%), Positives = 110/229 (48%), Gaps = 32/229 (13%)
Query: 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+ + ++ + +++V R G+GTF V+ + TG VA+K KV++ R
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQDPRFR--NR 65
Query: 61 EVATMKL---VKHPNVVRLYEVMGSKTK-------IFIVLEFVTGGELFDKIVNHGRMK- 109
E+ M+ + HPN+V+L + + + +V+E+V L N+ R +
Sbjct: 66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQV 124
Query: 110 ---EDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQ 163
+ + QLI ++ H S V HRD+KP N+L++ A G LK+ DFG + +
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA--KKL 182
Query: 164 VRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTA-DLWSCGVILFVLLAG 210
+ + C + Y APE+ ++ Y +TA D+WS G I ++ G
Sbjct: 183 SPSEPNVAYIC-SRYYRAPELIFGNQHY--TTAVDIWSVGCIFAEMMLG 228
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-35
Identities = 46/210 (21%), Positives = 96/210 (45%), Gaps = 26/210 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ + IG+G + +V + GE VA+K+ + + + E+ L++H N+
Sbjct: 40 QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT----EEASWFRETEIYQTVLMRHENI 93
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ + GS T+++++ ++ G L+D + + + + ++ + + H+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ + D +T GT Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVIL 204
+ PEVL++ AD++S G+IL
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLIL 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-34
Identities = 48/210 (22%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +IG+G F +V + GE VA+KI + + + E+ +++H N+
Sbjct: 45 VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENI 98
Query: 74 VRLY----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ + G+ T++++V ++ G LFD +N + + + + + + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFD-YLNRYTVTVEGMIKLALSTASGLAHLHM 157
Query: 130 R--------GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGTPNY 179
+ HRDLK +N+L+ G ++D GL+ D D + GT Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 180 VAPEVLNDRGYDGST-----ADLWSCGVIL 204
+APEVL+D AD+++ G++
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVF 247
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 58/228 (25%), Positives = 100/228 (43%), Gaps = 42/228 (18%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALK-ILDKEKVLKHKM-AEQIKREVATMKLVK 69
+YE+ IG G++ V A + VA+K IL V + + ++I RE+A + +
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR---VFEDLIDCKRILREIAILNRLN 110
Query: 70 HPNVVRLYEVMGSKT-----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINA 123
H +VV++ +++ K ++++VLE + K+ + + L+
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDF-KKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPN---- 178
V Y HS G+ HRDLKP N L++ ++KV DFGL+ + + L + +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 179 --------------YV------APEV-LNDRGYDGSTA-DLWSCGVIL 204
+V APE+ L Y + A D+WS G I
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIF 274
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 2e-33
Identities = 62/243 (25%), Positives = 104/243 (42%), Gaps = 56/243 (23%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY +G+T+G G+F V + E+G+ ALK KVL+ RE+ MK++ H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQD--PRYKNRELDIMKVLDHV 60
Query: 72 NVVRLYEVMGSKTK--------------------------------------IFIVLEFV 93
N+++L + + + +++E+V
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 94 TGGELFDKIVNHGRMK----EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-G 148
L + + R + Y QL AV + HS G+ HRD+KP+NLL+++
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV-LNDRGYDGSTADLWSCGVILFVL 207
LK+ DFG + + + + + C + Y APE+ L Y + DLWS G + L
Sbjct: 180 TLKLCDFGSA--KKLIPSEPSVAYIC-SRFYRAPELMLGATEYT-PSIDLWSIGCVFGEL 235
Query: 208 LAG 210
+ G
Sbjct: 236 ILG 238
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-33
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 24/212 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y IGEG + V A ++ VA+K K +H+ ++ RE+ + +H
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFRH 84
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
N++ + +++ + T ++IV + + +L K++ + D + Q++ +
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHICYFLYQILRGLK 142
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV----- 180
Y HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D T YV
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWY 197
Query: 181 -APEV-LNDRGYDGSTADLWSCGVILFVLLAG 210
APE+ LN +GY + D+WS G IL +L+
Sbjct: 198 RAPEIMLNSKGYT-KSIDIWSVGCILAEMLSN 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-33
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 21/214 (9%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+++ +GEG + V A + TGE VA+K K + + A + RE+ +K KH
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFKH 68
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
N++ ++ + + ++I+ E + +L ++++ + +D + + Q + AV
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL--SALSQQVRDDGLLHTTCGTPNYV--- 180
H V HRDLKP NLL+++ +LKV DFGL + G +V
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 181 ---APEV-LNDRGYDGSTADLWSCGVILFVLLAG 210
APEV L Y D+WSCG IL L
Sbjct: 187 WYRAPEVMLTSAKYS-RAMDVWSCGCILAELFLR 219
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 30/229 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y+ +G G + V A +++TG VA+K L + + + A++ RE+ +K +KH
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V +++V + G +L + IV ++ +D + Q++ +
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y HS + HRDLKP NL ++ LK+ DFGL+ + D + YV
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA----RHTADEM-------TGYVATRW 194
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
APE+ LN Y+ T D+WS G I+ LL G F ++ ++ K I
Sbjct: 195 YRAPEIMLNWMHYN-QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 68/229 (29%), Positives = 112/229 (48%), Gaps = 30/229 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y + +G G + V A + TG VA+K L + + ++ A++ RE+ +K ++H
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRH 83
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V ++V+ F+ G +L K++ H ++ ED + Q++ +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ R T YV
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTRW 190
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
APEV LN Y T D+WS G I+ ++ G F S+ ++ K+I
Sbjct: 191 YRAPEVILNWMRYT-QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 238
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-32
Identities = 61/224 (27%), Positives = 110/224 (49%), Gaps = 20/224 (8%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y+ + IG G V A ++ VA+K L + +++ A++ RE+ MK V H
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMK-EDEARRYFQ-QLIN 122
N++ L V + ++IV+E + L I +M+ + E Y Q++
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI----QMELDHERMSYLLYQMLC 138
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ + HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y AP
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAP 195
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
EV+ GY D+WS G I+ ++ G + F ++ ++ + K+
Sbjct: 196 EVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 238
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 62/247 (25%), Positives = 113/247 (45%), Gaps = 31/247 (12%)
Query: 1 MSQPKIKRRVGKYEVGRT-------------IGEGTFAKVKFARNSETGEPVALKILDKE 47
MS+ K+ + EVG + IG G V A ++ VA+K L
Sbjct: 39 MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL--S 96
Query: 48 KVLKHKM-AEQIKREVATMKLVKHPNVVRLYEVMGSKTK------IFIVLEFVTGGELFD 100
+ +++ A++ RE+ MK V H N++ L V + +++V+E + L
Sbjct: 97 RPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANL-C 154
Query: 101 KIVNHGRMKEDEARRYFQ-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
+++ + E Y Q++ + + HS G+ HRDLKP N+++ + LK+ DFG
Sbjct: 155 QVIQMEL--DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG--- 209
Query: 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL 219
L++ ++ T Y APEV+ GY D+WS G I+ ++ + F +
Sbjct: 210 LARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDY 268
Query: 220 MNLYKKI 226
++ + K+
Sbjct: 269 IDQWNKV 275
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-32
Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 21/215 (9%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
+Y + +G G V A +++ + VA+K + VL + RE+ ++ + H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI----VLTDPQSVKHALREIKIIRRLDH 67
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGG--------ELFD----KIVNHGRMKEDEARRYFQ 118
N+V+++E++G E + ++ G + E+ AR +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLS-ALSQQVRDDGLLHTTCGT 176
QL+ + Y HS V HRDLKP NL ++ LK+ DFGL+ + G L T
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 177 PNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAG 210
Y +P + L+ Y D+W+ G I +L G
Sbjct: 188 KWYRSPRLLLSPNNYT-KAIDMWAAGCIFAEMLTG 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 56/227 (24%), Positives = 100/227 (44%), Gaps = 33/227 (14%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y + IG G++ V A + T + VA+K + ++ + + ++I RE+ + +K
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKS 84
Query: 71 PNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAV 124
++RLY+++ ++IVLE +L K+ +E + L+
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDL-KKLFKTPIFLTEEHIKTILYNLLLGE 142
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP------- 177
++ H G+ HRDLKP N LL+ ++KV DFGL+ +D +++
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 178 -------NYV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG 210
++V APE+ L Y + D+WS G I LL
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYT-KSIDIWSTGCIFAELLNM 248
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 64/229 (27%), Positives = 108/229 (47%), Gaps = 31/229 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMKLVKH 70
Y +G G + V A + +GE VA+K L + + ++ A++ RE+ +K ++H
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 71 PNVVRLYEVMGSKTK------IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
NV+ L +V + ++V+ F+ +L + + E++ + Q++ +
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKGL 139
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---- 180
Y HS GV HRDLKP NL ++ LK+ DFGL+ R T YV
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTRW 188
Query: 181 --APEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
APEV L+ Y+ T D+WS G I+ +L G F + ++ +I
Sbjct: 189 YRAPEVILSWMHYN-QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI 236
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-31
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 33/217 (15%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ IG G + V + S PVA+K+ ++ ++ + + L++H N+
Sbjct: 16 KLLELIGRGRYGAVY--KGSLDERPVAVKVFSFA----NRQNFINEKNIYRVPLMEHDNI 69
Query: 74 VRLY-----EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
R + + +V+E+ G L + H + R + + Y H
Sbjct: 70 ARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLH 128
Query: 129 S---------RGVYHRDLKPENLLLDAYGNLKVSDFGLS------ALSQQVRDDGLLHTT 173
+ + HRDL N+L+ G +SDFGLS L + +D +
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 174 CGTPNYVAPEVLNDR------GYDGSTADLWSCGVIL 204
GT Y+APEVL D+++ G+I
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 56/229 (24%), Positives = 98/229 (42%), Gaps = 35/229 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
+Y + R +G G F+ V A++ VA+KI+ +K E + E+ ++ V
Sbjct: 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74
Query: 70 ----------HPNVVRLY---EVMGSKTK-IFIVLEFVTGGELFD--KIVNHGRMKEDEA 113
++++L G + +V E V G L K H +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133
Query: 114 RRYFQQLINAVDYCHSR-GVYHRDLKPENLLLD------AYGNLKVSDFGLSALSQQVRD 166
++ +QL+ +DY H R G+ H D+KPEN+L++ +K++D G +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188
Query: 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFD 215
D + T Y +PEVL + AD+WS ++F L+ G F+
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFE 236
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 61/277 (22%), Positives = 112/277 (40%), Gaps = 34/277 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM--------AEQIKREVA 63
Y V R I G++ V +S G PVA+K + + +++ RE+
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 64 TMKLVKHPNVVRLYEVMGSKTK-----IFIVLEFVTGGELFDKIVNHGRMK-EDEARRYF 117
+ HPN++ L ++ + +++V E + +L ++++ R+ + +YF
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDL-AQVIHDQRIVISPQHIQYF 139
Query: 118 Q-QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
++ + H GV HRDL P N+LL ++ + DF L+++ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN---LAREDTADANKTHYVTH 196
Query: 177 PNYVAPEV-LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI-------SA 228
Y APE+ + +G+ D+WS G ++ + F S N KI
Sbjct: 197 RWYRAPELVMQFKGFT-KLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 229 AEFTCPPWLSFTARKLIARILDPNPMT--VSIYPFAD 263
+ S +AR + L P ++ P AD
Sbjct: 256 EDVVMFS--SPSARDYLRNSLSNVPARAWTAVVPTAD 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM-AEQIKREVATMK-LVK 69
KYE+ + +G+G + V + + TGE VA+K + ++ A++ RE+ + L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSG 67
Query: 70 HPNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQ-QLINAVDY 126
H N+V L V+ + +++V +++ +L ++ + E ++Y QLI + Y
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANIL-EPVHKQYVVYQLIKVIKY 124
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-------- 178
HS G+ HRD+KP N+LL+A ++KV+DFGLS +R N
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 179 -----YV------APEV-LNDRGYDGSTADLWSCGVILFVLLAG 210
YV APE+ L Y D+WS G IL +L G
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYT-KGIDMWSLGCILGEILCG 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-28
Identities = 63/226 (27%), Positives = 99/226 (43%), Gaps = 21/226 (9%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVK 69
+YEV + IG+G+F +V A + + + VALK++ EK + Q E+ + L K
Sbjct: 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRK 152
Query: 70 HP-----NVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLIN 122
NV+ + E + I + E + L++ K R++ ++
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+D H + H DLKPEN+LL G +KV DFG S Q ++T + Y
Sbjct: 212 CLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYR 266
Query: 181 APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
APEV+ Y D+WS G IL LL GY + + +
Sbjct: 267 APEVILGARYGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACM 311
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-27
Identities = 54/235 (22%), Positives = 95/235 (40%), Gaps = 18/235 (7%)
Query: 15 VGRTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F VK + + + VA+KIL K + + +++ E M+ + +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
+VR+ + +V+E G L + + +K+ Q+ + Y
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLNDRG 189
HRDL N+LL K+SDFGLS + D+ P + APE +N
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 190 YDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
+ S+ D+WS GV+++ G P+ + + E CP +
Sbjct: 197 F--SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM 249
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 20/236 (8%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+G IG G F +V R VA+K +E + A+ +E +K HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAK-FLQEARILKQYSHPNI 174
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGV 132
VRL V K I+IV+E V GG+ + G ++ + ++Y S+
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY----VAPEVLNDR 188
HRDL N L+ LK+SDFG+S + DG+ + G APE LN
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEALNYG 290
Query: 189 GYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA-----AEFTCPPWL 237
Y S+ D+WS G++L+ G P+ + + + + CP +
Sbjct: 291 RY--SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV 344
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-26
Identities = 58/197 (29%), Positives = 87/197 (44%), Gaps = 13/197 (6%)
Query: 16 GRTIGEGTFAKVKFAR-NSETGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+G+G+F V+ ++ +G+ VA+K L + + + + + REV M + H N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG 131
++RLY V+ + +V E G L D++ H G RY Q+ + Y S+
Sbjct: 83 LIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLNDR 188
HRDL NLLL +K+ DFGL Q +D APE L R
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 189 GYDGSTA-DLWSCGVIL 204
+ S A D W GV L
Sbjct: 200 TF--SHASDTWMFGVTL 214
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-25
Identities = 58/219 (26%), Positives = 98/219 (44%), Gaps = 13/219 (5%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ +G G + +V + VA+K L KE E+ +E A MK +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KED---TMEVEEFLKEAAVMKEIKHPNL 278
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRG 131
V+L V + +I+ EF+T G L D + R + Q+ +A++Y +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY--VAPEVLNDRG 189
HR+L N L+ +KV+DFG LS+ + D APE L
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395
Query: 190 YDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 396 FS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 23/228 (10%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+ IG+G+F +V A + E VA+KI+ +K Q + EV ++L+
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNK 109
Query: 71 P------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLIN 122
+V L + + +V E + L+D + N + + R++ QQ+
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 123 AVDYCHSR--GVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
A+ + + + H DLKPEN+LL +K+ DFG S Q ++ +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRF 223
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
Y +PEVL YD + D+WS G IL + G F +N ++ KI
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKI 270
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E + PVA+K L +E E I E M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMASVDNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V RL + + + ++ + + G L D + H + + Q+ ++Y R
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
+ HRDL N+L+ ++K++DFGL+ L + + + G P ++A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R Y + D+WS GV ++ ++ G P+D + + E C +
Sbjct: 194 RIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-24
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ +TIG+G F V G VA+K + K A+ E + M ++H N+
Sbjct: 24 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KNDA----TAQAFLAEASVMTQLRHSNL 76
Query: 74 VRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
V+L V + K ++IV E++ G L D + + GR ++ + A++Y
Sbjct: 77 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLND 187
HRDL N+L+ KVSDFGL+ + +D G L P V APE L +
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEALRE 188
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ + + +D+WS G++L+ + G +P+ L ++ ++
Sbjct: 189 KKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-24
Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 33/228 (14%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMKLV 68
+ +G G + +V + VA+K L + E+ LK E A MK +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---------EAAVMKEI 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD--KIVNHGRMKEDEARRYFQQLINAVDY 126
KHPN+V+L V + +I+ EF+T G L D + N + Q+ +A++Y
Sbjct: 67 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYV 180
+ HRDL N L+ +KV+DFG LS+ + D T
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFG---LSRLMTGDTYTAHAGAKFPIKWT---- 179
Query: 181 APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
APE L + S D+W+ GV+L+ + G P+ +L +Y+ +
Sbjct: 180 APESLAYNKF--SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 225
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 6e-24
Identities = 52/220 (23%), Positives = 94/220 (42%), Gaps = 17/220 (7%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G+G F +V N T VA+K L + + E MK ++H
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTLKPGTMSPEAFLQ----EAQVMKKLRHEK 323
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
+V+LY V+ S+ I+IV E+++ G L D + + Q+ + + Y
Sbjct: 324 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 382
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL+ N+L+ KV+DFG L++ + D+ P + APE
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 189 GYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+WS G++L + G +P+ + ++
Sbjct: 440 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 6e-24
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 17/220 (7%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G+G F +V N T VA+K L K + E +E MK ++H
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT--RVAIKTL-KPGTMSP---EAFLQEAQVMKKLRHEK 240
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
+V+LY V+ S+ I+IV E+++ G L D + + Q+ + + Y
Sbjct: 241 LVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 299
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT-P-NYVAPEVLNDR 188
HRDL+ N+L+ KV+DFG L++ + D+ P + APE
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFG---LARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 189 GYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ +D+WS G++L + G +P+ + ++
Sbjct: 357 RFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 8e-24
Identities = 53/205 (25%), Positives = 95/205 (46%), Gaps = 28/205 (13%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F V+ R TGE VA+K L + +H +RE+ +K ++H
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHL--RDFEREIEILKSLQHD 71
Query: 72 NVVRLYEV--MGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ V + + +++E++ G L D + H R+ + +Y Q+ ++Y
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG--------TPNYV 180
++ HRDL N+L++ +K+ DFG L++ + D
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFG---LTKVLPQDKEFFKVKEPGESPIFWY---- 184
Query: 181 APEVLNDRGYDGSTA-DLWSCGVIL 204
APE L + + S A D+WS GV+L
Sbjct: 185 APESLTESKF--SVASDVWSFGVVL 207
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 9e-24
Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 21/220 (9%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ +TIG+G F V G VA+K + K A+ E + M ++H N+
Sbjct: 196 KLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-KN----DATAQAFLAEASVMTQLRHSNL 248
Query: 74 VRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSR 130
V+L V + K ++IV E++ G L D + + GR ++ + A++Y
Sbjct: 249 VQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP-NYVAPEVLNDRG 189
HRDL N+L+ KVSDFGL+ + +D G L P + APE L ++
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREKK 362
Query: 190 YDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ ST D+WS G++L+ + G +P+ L ++ ++
Sbjct: 363 F--STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 400
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 9e-24
Identities = 58/239 (24%), Positives = 108/239 (45%), Gaps = 42/239 (17%)
Query: 11 GKYEV-------GRTIGEGTFAKVKFAR-NSETGEPVALKIL-----DKEKVLKHKMAEQ 57
G E+ + +G G F VK + + VA+K++ +++ +
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSEDEFFQ------ 52
Query: 58 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRY 116
E TM + HP +V+ Y V + I+IV E+++ G L + + +HG+ ++ +
Sbjct: 53 ---EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM 109
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG- 175
+ + + S HRDL N L+D +KVSDFG +++ V DD + +
Sbjct: 110 CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFG---MTRYVLDDQYVSSVGTK 166
Query: 176 -----TPNYVAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
+ APEV + Y S+ D+W+ G++++ V G +P+D + K+S
Sbjct: 167 FPVKWS----APEVFHYFKY--SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-23
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 26/204 (12%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F V+ R TGE VA+K L + +H +RE+ +K ++H
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL-QHSTEEHL--RDFEREIEILKSLQHD 102
Query: 72 NVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ V + + + +++E++ G L D + H R+ + +Y Q+ ++Y
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-NYVA 181
++ HRDL N+L++ +K+ DFGL+ + Q V++ G P + A
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES------PIFWYA 216
Query: 182 PEVLNDRGYDGSTA-DLWSCGVIL 204
PE L + + S A D+WS GV+L
Sbjct: 217 PESLTESKF--SVASDVWSFGVVL 238
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-23
Identities = 56/236 (23%), Positives = 99/236 (41%), Gaps = 43/236 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ V R +G+GTF +V ++ + + A+K++ K K K E +K +++
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQN 90
Query: 71 -----PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINA 123
N+V+ + + ++ E G L++ I + ++ + Y +++ A
Sbjct: 91 DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYG-------------------------NLKVSDFGLS 158
++Y + H DLKPEN+LLD +K+ DFG
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-C 208
Query: 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
A + T Y APEV+ + G+D S +D+WS G +L L G L F
Sbjct: 209 A----TFKSDYHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLF 259
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-23
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +GEG F KV N TGE VA+K L + +H+ K+E+ ++ + H
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHE 93
Query: 72 NVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
++++ + + +V+E+V G L D + H + + + QQ+ + Y H+
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA 152
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLS-ALSQ-----QVRDDGLLHTTCGTPNYV--- 180
+ HRDL N+LLD +K+ DFGL+ A+ + +VR+DG P V
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VFWY 204
Query: 181 APEVLNDRGYDGSTA-DLWSCGVIL 204
APE L + + A D+WS GV L
Sbjct: 205 APECLKEYKF--YYASDVWSFGVTL 227
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-23
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 15/224 (6%)
Query: 14 EVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ + IG G +V + + PVA+K L K + + E + M H
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTE-RQRRDFLSEASIMGQFDH 109
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
PN++RL V+ IV E++ G L + H G+ + + + + Y
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLN 186
G HRDL N+L+D+ KVSDFGLS + + D +TT G + APE +
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISA 228
R + S+A D+WS GV+++ VL G P+ + ++ +
Sbjct: 228 FRTF--SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE 269
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-23
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 25/204 (12%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
R +GEG F KV+ R TGE VA+K L E H +K+E+ ++ + H
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHE 83
Query: 72 NVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
N+V+ + I +++EF+ G L + + + ++ + +Y Q+ +DY
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG 143
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-NYVA 181
SR HRDL N+L+++ +K+ DFGL+ + V+DD P + A
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PVFWYA 197
Query: 182 PEVLNDRGYDGSTA-DLWSCGVIL 204
PE L + A D+WS GV L
Sbjct: 198 PECLMQSKF--YIASDVWSFGVTL 219
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-23
Identities = 55/237 (23%), Positives = 100/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E + PVA+K L +E E I E M V +P
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKE-ILDEAYVMASVDNP 77
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V RL + + + ++ + + G L D + H + + Q+ ++Y R
Sbjct: 78 HVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
+ HRDL N+L+ ++K++DFGL+ L + + + G P ++A E +
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R Y + D+WS GV ++ ++ G P+D + + E C +
Sbjct: 194 RIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-23
Identities = 48/237 (20%), Positives = 101/237 (42%), Gaps = 23/237 (9%)
Query: 16 GRTIGEGTFAKV---KFARNSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G F V + E+ + PV +K++ ++K + + + + + H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQA-VTDHMLAIGSLDHA 75
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
++VRL + + + +V +++ G L D + H G + + Q+ + Y
Sbjct: 76 HIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLND 187
G+ HR+L N+LL + ++V+DFG++ L + D P ++A E ++
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 188 RGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
Y + D+WS GV ++ ++ G P+ L + + E C +
Sbjct: 192 GKY--THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV 246
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-23
Identities = 61/232 (26%), Positives = 92/232 (39%), Gaps = 20/232 (8%)
Query: 19 IGEGTFAKVKFAR-NSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ + VA+K+L + E++ RE M + +P +VRL
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 75
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 76 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT--P-NYVAPEVLNDRGYDG 192
DL N+LL K+SDFGLS DD P + APE +N R +
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKF-- 190
Query: 193 STA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
S+ D+WS GV ++ L G P+ + I + CPP L
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 242
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-23
Identities = 61/240 (25%), Positives = 100/240 (41%), Gaps = 46/240 (19%)
Query: 11 GKYEV-------GRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQ-IKRE 61
GK+ + + IG G F V ++ VA+K + +E M+E+ E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKD--KVAIKTI-RE----GAMSEEDFIEE 53
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQL 120
M + HP +V+LY V + I +V EF+ G L D + G + +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV 180
+ Y V HRDL N L+ +KVSDFG +++ V DD Y
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFG---MTRFVLDD----------QYT 160
Query: 181 ------------APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
+PEV + Y S+ D+WS GV+++ V G +P+++ + + + I
Sbjct: 161 SSTGTKFPVKWASPEVFSFSRY--SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-23
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 32/207 (15%)
Query: 16 GRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIK---REVATMKLV 68
+G+G F V+ R TG VA+K L+H +Q + RE+ +K +
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVK------QLQHSGPDQQRDFQREIQILKAL 81
Query: 69 KHPNVVRLYEV-MGSKTK-IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
+V+ V G + + +V+E++ G L D + H R+ Y Q+ ++
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ------VRDDGLLHTTCGTP-N 178
Y SR HRDL N+L+++ ++K++DFGL+ L VR+ G P
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------PIF 195
Query: 179 YVAPEVLNDRGYDGSTA-DLWSCGVIL 204
+ APE L+D + S D+WS GV+L
Sbjct: 196 WYAPESLSDNIF--SRQSDVWSFGVVL 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-23
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
E+GR IGEG F V N VA+K K + + +E TM+
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPAL--AVAIKTC-KNCTSDSVREKFL-QEALTMRQF 73
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYC 127
HP++V+L V+ ++ ++I++E T GEL + + Y QL A+ Y
Sbjct: 74 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 132
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYVA 181
S+ HRD+ N+L+ + +K+ DFG LS+ + D + G A
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWM----A 185
Query: 182 PEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
PE +N R + ++A D+W GV ++ +L+ G PF ++ +I
Sbjct: 186 PESINFRRF--TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-22
Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 22/238 (9%)
Query: 15 VGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ + +G G F +V + S+ VA+K L K + E + M HP
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQR--RDFLGEASIMGQFDHP 106
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
N++RL V+ + IV E++ G L + H + + + + + + Y
Sbjct: 107 NIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM 166
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG-LLHTTCGTPNYV---APEVLN 186
G HRDL N+L+++ KVSDFG L + + DD +TT G + +PE +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFG---LGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
R + ++A D+WS G++L+ V+ G P+ + + ++ K + CP L
Sbjct: 224 YRKF--TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 2e-22
Identities = 59/232 (25%), Positives = 91/232 (39%), Gaps = 20/232 (8%)
Query: 19 IGEGTFAKVKFAR-NSETGE-PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ + VA+K+L + E++ RE M + +P +VRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMREAQIMHQLDNPYIVRL 401
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 402 IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLNDRGYDG 192
+L N+LL K+SDFGLS DD + APE +N R +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKF-- 516
Query: 193 STA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-----FTCPPWL 237
S+ D+WS GV ++ L G P+ + I + CPP L
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-22
Identities = 53/230 (23%), Positives = 98/230 (42%), Gaps = 37/230 (16%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMKL 67
++ +G G F +V N T VA+K L + L E MK
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPDAFLA---------EANLMKQ 64
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVD 125
++H +VRLY V+ ++ I+I+ E++ G L D + +K + Q+ +
Sbjct: 65 LQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMA 123
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNY 179
+ R HRDL+ N+L+ + K++DFG L++ + D+ T
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFG---LARLIEDNEYTAREGAKFPIKWT--- 177
Query: 180 VAPEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKIS 227
APE +N + + D+WS G++L ++ G +P+ + + +
Sbjct: 178 -APEAINYGTF--TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 52/237 (21%)
Query: 4 PKIKRRVGKYEV-------GRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHK 53
++K ++ + GR +G+G F V + + + VA+K+L K ++
Sbjct: 9 DELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASS 67
Query: 54 MAEQIKREVATMKLVKHPNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGR 107
E+ RE A MK HP+V +L V G ++L F+ G+L ++ R
Sbjct: 68 DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-R 126
Query: 108 MKEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160
+ E+ Q L+ VD Y SR HRDL N +L + V+DFGLS
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS-- 184
Query: 161 SQQVRDDGLLHTTCGTPNY-------------VAPEVLNDRGYDGSTADLWSCGVIL 204
R +++ +Y +A E L D Y +D+W+ GV +
Sbjct: 185 ----RK---IYSG----DYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTM 229
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-22
Identities = 57/215 (26%), Positives = 100/215 (46%), Gaps = 17/215 (7%)
Query: 15 VGRTIGEGTFAKVKFAR-NSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ IG G F +V + +G+ PVA+K L K + + + E M H
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVD-FLGEAGIMGQFSH 105
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
N++RL V+ + I+ E++ G L + G + + + + Y +
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---APEVLN 186
HRDL N+L+++ KVSDFGLS + + D +TT G + APE ++
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAPEAIS 223
Query: 187 DRGYDGSTA-DLWSCGVILF-VLLAGYLPFDD-SN 218
R + ++A D+WS G++++ V+ G P+ + SN
Sbjct: 224 YRKF--TSASDVWSFGIVMWEVMTYGERPYWELSN 256
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 3e-22
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 18/220 (8%)
Query: 16 GRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
GR IGEG F V N VA+K K + +E TM+ H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAM--AVAIKTC-KNCTSDSVREK-FLQEALTMRQFDH 450
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHS 129
P++V+L V+ ++ ++I++E T GEL + + Y QL A+ Y S
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG-TP-NYVAPEVLND 187
+ HRD+ N+L+ + +K+ DFG LS+ + D + G P ++APE +N
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 188 RGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
R + S +D+W GV ++ +L+ G PF ++ +I
Sbjct: 567 RRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-22
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 11 GKYEVGRT-------IGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKR 60
+Y + R +GEG F +V + + VA+K K+ L +K E+
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMS 62
Query: 61 EVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQ 119
E MK + HP++V+L ++ + +I++E GEL + + +K Y Q
Sbjct: 63 EAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG---- 175
+ A+ Y S HRD+ N+L+ + +K+ DFG LS+ + D+ +
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG---LSRYIEDEDYYKASVTRLPI 178
Query: 176 --TPNYVAPEVLNDRGYDGSTA-DLWSCGVIL 204
+PE +N R + +TA D+W V +
Sbjct: 179 KWM----SPESINFRRF--TTASDVWMFAVCM 204
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-22
Identities = 61/238 (25%), Positives = 95/238 (39%), Gaps = 51/238 (21%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+YE+ T+GEG F KV + + G VA+KI+ + E + E+ ++ +
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 70 HP------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLI 121
V++ E I IV E + G +D I +G + D R+ Q+
Sbjct: 70 TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGN-------------------LKVSDFGLSALSQ 162
+V++ HS + H DLKPEN+L +KV DFG +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 163 QVRDDGLLHTTCGTPNYV------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+ H+T V APEV+ G+ D+WS G IL G+ F
Sbjct: 189 EH------HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVF 234
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-22
Identities = 58/238 (24%), Positives = 90/238 (37%), Gaps = 51/238 (21%)
Query: 11 GKYEVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+YE+ +GEGTF KV ++ VALKI+ K E + E+ +K +K
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIK 74
Query: 70 HP------NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLI 121
V + + + I E + G F+ + + R QL
Sbjct: 75 EKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGN-------------------LKVSDFGLSALSQ 162
+A+ + H + H DLKPEN+L ++V+DFG +
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 163 QVRDDGLLHTTCGTPNYV------APEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214
+ HTT V PEV+ + G+ D+WS G ILF G+ F
Sbjct: 194 EH------HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 239
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 2e-21
Identities = 49/200 (24%), Positives = 92/200 (46%), Gaps = 24/200 (12%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
++ + +G G F +V A ++ VA+K + + E MK ++H +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 245
Query: 74 VRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEAR--RYFQQLINAVDYCHSRG 131
V+L+ V+ +K I+I+ EF+ G L D + + K+ + + Q+ + + R
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG------TPNYVAPEVL 185
HRDL+ N+L+ A K++DFG L++ + D+ T APE +
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFG---LARVIEDNEYTAREGAKFPIKWT----APEAI 357
Query: 186 NDRGYDGSTA-DLWSCGVIL 204
N + + D+WS G++L
Sbjct: 358 NFGSF--TIKSDVWSFGILL 375
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-21
Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 39/230 (16%)
Query: 14 EVGRTIGEGTFAKVKFAR-NSETGEPVALKILDKEKVLKHKMAEQ-IKREVATMKLVKHP 71
+ +G G F VK+ + + VA+K++ KE M+E E M + H
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQY--DVAIKMI-KE----GSMSEDEFIEEAKVMMNLSHE 79
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSR 130
+V+LY V + IFI+ E++ G L + + R + + + + A++Y S+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYV---------- 180
HRDL N L++ G +KVSDFG LS+ V DD Y
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFG---LSRYVLDD----------EYTSSVGSKFPVR 186
Query: 181 --APEVLNDRGYDGSTA-DLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
PEVL + S+ D+W+ GV+++ + G +P++ + I
Sbjct: 187 WSPPEVLMYSKF--SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-21
Identities = 59/238 (24%), Positives = 92/238 (38%), Gaps = 27/238 (11%)
Query: 5 KIKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
I IG G F V N A+K L Q E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NRI-TDIGEVSQFLTE 76
Query: 62 VATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQ 119
MK HPNV+ L + + S+ +VL ++ G+L + I N + + Q
Sbjct: 77 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 136
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHT 172
+ + Y S+ HRDL N +LD +KV+DFGL+ S + L
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-- 194
Query: 173 TCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
P V A E L + + + +D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 195 ----P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-20
Identities = 59/270 (21%), Positives = 99/270 (36%), Gaps = 77/270 (28%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK- 69
G+Y V R +G G F+ V + + + + VA+K++ E E+ +K V+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLKSVRN 92
Query: 70 ----HPN---VVRLY---EVMGSKTK-IFIVLEFVTGGELFD--KIVNHGRMKEDEARRY 116
PN VV+L ++ G I +V E V G L N+ + ++
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 117 FQQLINAVDYCHSR-GVYHRDLKPENLLL------------------------------- 144
QQ++ +DY H++ + H D+KPEN+LL
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 145 ------------------DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN-YVAPEVL 185
+K++D G + + T Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFD 215
GY+ + AD+WS + F L G F+
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFE 294
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-20
Identities = 60/220 (27%), Positives = 88/220 (40%), Gaps = 46/220 (20%)
Query: 14 EVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+G+ +GEG F V + T VA+K + K + E+ E A MK H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 71 PNVVRLYEV-----MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AV 124
PNV+RL V K ++L F+ G+L ++ R++ Q L+ V
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154
Query: 125 D------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD-----------D 167
D Y +R HRDL N +L + V+DFGLS +
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208
Query: 168 GLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+ P V A E L DR Y S +D+W+ GV +
Sbjct: 209 AKM------P--VKWIAIESLADRVYT-SKSDVWAFGVTM 239
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 6e-20
Identities = 58/237 (24%), Positives = 93/237 (39%), Gaps = 27/237 (11%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
I IG G F V N A+K L + Q E
Sbjct: 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-NR-ITDIGEVSQFLTEG 141
Query: 63 ATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQL 120
MK HPNV+ L + + S+ +VL ++ G+L + I N + + Q+
Sbjct: 142 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS-------ALSQQVRDDGLLHTT 173
+ + S+ HRDL N +LD +KV+DFGL+ S + L
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL--- 258
Query: 174 CGTPNYV---APEVLNDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKI 226
P V A E L + + + +D+WS GV+L+ ++ G P+ D N ++ +
Sbjct: 259 ---P--VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-20
Identities = 58/215 (26%), Positives = 87/215 (40%), Gaps = 37/215 (17%)
Query: 16 GRTIGEGTFAKVKFAR--NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPN 72
IGEG F +V AR A+K + KE K + E+ + L HPN
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRD-FAGELEVLCKLGHHPN 87
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------FQQLIN- 122
++ L + +++ +E+ G L D + ++ D A QQL++
Sbjct: 88 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
A D Y + HRDL N+L+ K++DFGLS R +
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYVKKTMG 201
Query: 177 --PNYV---APEVLNDRGYDGSTA-DLWSCGVILF 205
P V A E LN Y +T D+WS GV+L+
Sbjct: 202 RLP--VRWMAIESLNYSVY--TTNSDVWSYGVLLW 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-19
Identities = 52/222 (23%), Positives = 78/222 (35%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G G F +V N + VA+K L E +++ E +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV---CSEQDELDFLMEALIIS 88
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD 125
H N+VR V FI++E + GG+L + + L++ A D
Sbjct: 89 KFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 126 ------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD---------- 166
Y HRD+ N LL G K+ DFG++ RD
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKG 202
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+L P V PE + + T D WS GV+L
Sbjct: 203 GCAML------P--VKWMPPEAFMEGIFTSKT-DTWSFGVLL 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-19
Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G+G+F V K E VA+K + E M E+I+ E + MK
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEA---ASMRERIEFLNEASVMK 83
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---FQQLIN- 122
+VVRL V+ +++E +T G+L + + + ++I
Sbjct: 84 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 143
Query: 123 AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD---------- 166
A + Y ++ HRDL N ++ +K+ DFG++ RD
Sbjct: 144 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKG 197
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
GLL P V +PE L D + + +D+WS GV+L
Sbjct: 198 GKGLL------P--VRWMSPESLKDGVFT-TYSDVWSFGVVL 230
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-19
Identities = 53/222 (23%), Positives = 78/222 (35%), Gaps = 50/222 (22%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIK--REVATMK 66
+ R +G G F +V N + VA+K L E +++ E +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV---CSEQDELDFLMEALIIS 129
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN-AVD 125
H N+VR V FI+LE + GG+L + + L++ A D
Sbjct: 130 KFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 189
Query: 126 ------YCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD---------- 166
Y HRD+ N LL G K+ DFG++ RD
Sbjct: 190 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYYRKG 243
Query: 167 -DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVIL 204
+L P V PE + + S D WS GV+L
Sbjct: 244 GCAML------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLL 276
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-19
Identities = 44/214 (20%), Positives = 73/214 (34%), Gaps = 39/214 (18%)
Query: 14 EVGRTIGEGTFAKV-------KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
++G+GTF K+ V LK+LDK +E + M
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMS 67
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVD 125
+ H ++V Y V + +V EFV G L + + + +QL A+
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH 127
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNL--------KVSDFGLSALSQQVRDDGLLHTTCGTP 177
+ + H ++ +N+LL + K+SD G +S V
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG---ISITVLPK---------- 174
Query: 178 NY-------VAPEVLNDRGYDGSTADLWSCGVIL 204
+ V PE + + D WS G L
Sbjct: 175 DILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-19
Identities = 52/208 (25%), Positives = 84/208 (40%), Gaps = 30/208 (14%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R IG+G F V + A+K L + + E RE M+ +
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRI--QCAIKSL-SRIT-EMQQVEAFLREGLLMRGL 79
Query: 69 KHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDY 126
HPNV+ L + + + ++L ++ G+L I + R + + Q+ ++Y
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY 139
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL-------SQQVRDDGLLHTTCGTPNY 179
+ HRDL N +LD +KV+DFGL+ S Q L P
Sbjct: 140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P-- 191
Query: 180 V---APEVLNDRGYDGSTADLWSCGVIL 204
V A E L + + +D+WS GV+L
Sbjct: 192 VKWTALESLQTYRFT-TKSDVWSFGVLL 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 6e-19
Identities = 62/239 (25%), Positives = 97/239 (40%), Gaps = 36/239 (15%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+ VG+ IG G F +++ +N T E VA+K+ E + Q+ E K L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRAP--QLHLEYRFYKQLGS 63
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ ++Y +VLE G +LFD QLI+ ++Y
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLEL-LGPSLEDLFDL--CDRTFSLKTVLMIAIQLISRMEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVS-----DFGLSALSQQVRD-DGLLH-------TT 173
HS+ + +RD+KPEN L+ GN DF L+++ D + H +
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA---LAKEYIDPETKKHIPYREHKSL 177
Query: 174 CGTPNYVAPEVLND-RGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKIS 227
GT Y++ +N G + S DL + G + L G LP L Y+KI
Sbjct: 178 TGTARYMS---INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-19
Identities = 54/228 (23%), Positives = 89/228 (39%), Gaps = 51/228 (22%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
G+T+G G F KV A S+ VA+K+L L + A + E+ + L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA--LMSELKVLSYL 83
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------FDKIVNHGRMKEDEARRY 116
H N+V L ++ E+ G+L + M++DE
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 117 FQQLI-------NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169
+ L+ + + S+ HRDL N+LL K+ DFG L++ +++D
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG---LARDIKNDS- 199
Query: 170 LHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
NYV APE + + Y +D+WS G+ L+
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLW 238
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 3e-18
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 25/217 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
K+ +GR IG G+F ++ N +T E VA+K+ E V Q+ E + L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHP--QLLYESKIYRILQG 61
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCH 128
+ + +V++ + G L D R + Q+IN V++ H
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 129 SRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRD-DGLLHTT-------CGTP 177
S+ HRD+KP+N L+ + + DFG L+++ RD H GT
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFG---LAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 178 NYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLP 213
Y + V G + S DL S G +L L G LP
Sbjct: 178 RYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-18
Identities = 52/222 (23%), Positives = 88/222 (39%), Gaps = 47/222 (21%)
Query: 16 GRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G+T+G G F KV A + VA+K+L K + + E+ M L +
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALM-SELKIMSHLGQ 108
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY-------FQQLIN 122
H N+V L + ++ E+ G+L + + R+ E + + L++
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 123 -AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
+ + S+ HRD+ N+LL K+ DFGL+ RD
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD------IMN 216
Query: 176 TPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
NY+ APE + D Y +D+WS G++L+
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLW 257
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 53/226 (23%), Positives = 84/226 (37%), Gaps = 54/226 (23%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ +GEG F KV + VA+K L KE + +RE + ++
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQ--DFQREAELLTML 100
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL--------FDKIVNHGRMKEDEARRYFQQL 120
+H ++VR + V + +V E++ G+L D + G QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 121 IN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------- 166
+ A Y HRDL N L+ +K+ DFG+S RD
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYSTDYY 214
Query: 167 ----DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
+L P + PE + R + +T D+WS GV+L
Sbjct: 215 RVGGRTML------P--IRWMPPESILYRKF--TTESDVWSFGVVL 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-17
Identities = 52/227 (22%), Positives = 84/227 (37%), Gaps = 54/227 (23%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+GE F KV E + VA+K L K+K E + E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREE-FRHEAMLRARL 69
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRY---------FQQ 119
+HPNVV L V+ + ++ + + G+L + +V + +
Sbjct: 70 QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 120 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD------ 166
++ Y S V H+DL N+L+ N+K+SD GL R+
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVYAADY 183
Query: 167 -----DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
+ LL P + APE + + S D+WS GV+L
Sbjct: 184 YKLLGNSLL------P--IRWMAPEAIMYGKF--SIDSDIWSYGVVL 220
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 57/236 (24%), Positives = 94/236 (39%), Gaps = 32/236 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
+Y +GR IG G+F + + GE VA+K+ E V Q+ E K +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHP--QLHIESKIYKMMQG 63
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ + +V+E + G +LF+ + Q+I+ ++Y
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQVRDD-GLLHTT-------CG 175
HS+ HRD+KP+N L+ + + DFG L+++ RD H G
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG---LAKKYRDARTHQHIPYRENKNLTG 177
Query: 176 TPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKIS 227
T Y + + G + S DL S G +L G LP + Y++IS
Sbjct: 178 TARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-17
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 55/228 (24%)
Query: 16 GRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
G+ +GEG F +V A VA+K+L K + +++ I E+ MK +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLI-SEMEMMKMI 131
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRYFQ 118
KH N++ L +++++E+ + G L + ++ E + +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 119 QLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD----- 166
L++ A Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------RDIHHID 245
Query: 167 ------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+L+
Sbjct: 246 YYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 61/240 (25%), Positives = 99/240 (41%), Gaps = 61/240 (25%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQ 57
IKRR + R +GEG F KV ++ VA+K L K+ +A +
Sbjct: 9 VQHIKRR--DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPT----LAAR 61
Query: 58 IK--REVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHG 106
RE + ++H ++V+ Y V G + +V E++ G+L I+ G
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 107 RMKEDEARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159
+ ++ + Q+++ A Y S+ HRDL N L+ A +K+ DFG+S
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS- 180
Query: 160 LSQQVRD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
RD +L P + PE + R + +T D+WS GVIL
Sbjct: 181 -----RDVYSTDYYRVGGHTML------P--IRWMPPESIMYRKF--TTESDVWSFGVIL 225
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 38/223 (17%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
+G G F KV R G VA+K L +E+ ++ Q + EV + + H N++RL
Sbjct: 38 LGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLR- 93
Query: 79 VMG---SKTKIFIVLEFVTGG----ELFDKIVNHG------RMK--EDEAR--RYFQQLI 121
G + T+ +V ++ G L ++ + R + AR Y
Sbjct: 94 --GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--- 148
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPN 178
D+C + + HRD+K N+LLD V DFGL+ L D H T GT
Sbjct: 149 ---DHCDPK-IIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTTAVRGTIG 200
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221
++APE L+ G D++ GV+L L+ G FD + L N
Sbjct: 201 HIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-17
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 55/230 (23%)
Query: 14 EVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+ +GEG F +V A + VA+K+L K+ + +++ + E+ MK
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 95
Query: 67 -LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRY 116
+ KH N++ L +++++E+ + G L + ++ + E +
Sbjct: 96 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 155
Query: 117 FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--- 166
F+ L++ Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 156 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 209
Query: 167 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+++
Sbjct: 210 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-17
Identities = 58/231 (25%), Positives = 91/231 (39%), Gaps = 56/231 (24%)
Query: 16 GRTIGEGTF-----AKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+T+GEG F A + VA+K+L KE ++ + + E +K V H
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRD-LLSEFNVLKQVNH 85
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------------FDKIVNHGRMKEDEA 113
P+V++LY + +++E+ G L + DE
Sbjct: 86 PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 114 RRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166
LI+ A Y + HRDL N+L+ +K+SDFGLS RD
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS------RD 199
Query: 167 DGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
++ +YV A E L D Y + +D+WS GV+L+
Sbjct: 200 ---VYE---EDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 6e-17
Identities = 61/237 (25%), Positives = 88/237 (37%), Gaps = 54/237 (22%)
Query: 8 RRVGKYEVGRTIGEGTFAKV-KFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATM 65
G +GEG F V K N VA+K L + ++ +Q +E+ M
Sbjct: 28 DERPISVGGNKMGEGGFGVVYKGYVN---NTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84
Query: 66 KLVKHPNVVRL-------------YEVM--GSKTKIFIVLEFVTGGELFDKIVNHG---- 106
+H N+V L Y M GS L L
Sbjct: 85 AKCQHENLVELLGFSSDGDDLCLVYVYMPNGS-------LLDR----LSCLDGTPPLSWH 133
Query: 107 -RMK--EDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163
R K + A +++ H HRD+K N+LLD K+SDFGL+ S+
Sbjct: 134 MRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASE- 184
Query: 164 VRDDGLLHTT---CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217
T GT Y+APE L RG +D++S GV+L ++ G D+
Sbjct: 185 --KFAQTVMTSRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 8e-17
Identities = 56/230 (24%), Positives = 101/230 (43%), Gaps = 55/230 (23%)
Query: 14 EVGRTIGEGTFAKVKFAR-------NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+G+ +GEG F +V A + VA+K+L K+ + +++ + E+ MK
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLV-SEMEMMK 141
Query: 67 -LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRY 116
+ KH N++ L +++++E+ + G L + ++ + E +
Sbjct: 142 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT 201
Query: 117 FQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--- 166
F+ L++ Y S+ HRDL N+L+ +K++DFGL+ RD
Sbjct: 202 FKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINN 255
Query: 167 --------DGLLHTTCGTPNYV---APEVLNDRGYDGSTADLWSCGVILF 205
+G L P V APE L DR Y +D+WS GV+++
Sbjct: 256 IDYYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-17
Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 50/225 (22%)
Query: 16 GRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
G+ +G G F +V A + T VA+K+L KE + + E+ + +
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRA-LMSELKILIHIGH 89
Query: 70 HPNVVRLYEV-MGSKTKIFIVLEFVTGGELFD---------KIVNHGRMKEDEARRYFQQ 119
H NVV L + +++EF G L + +
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 120 LIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172
LI + + SR HRDL N+LL +K+ DFGL+ RD ++
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD---IYK 200
Query: 173 TCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
P+YV APE + DR Y +D+WS GV+L+
Sbjct: 201 ---DPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLW 241
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 8e-17
Identities = 55/246 (22%), Positives = 92/246 (37%), Gaps = 34/246 (13%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVK 69
Y+VGR IGEG+F + N + VA+K E Q++ E T K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK---FEPRRSDAP--QLRDEYRTYKLLAG 64
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTG---GELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+ +Y +V++ G +L D + +Q++ V
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDL-LGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQS 121
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLK-----VSDFGLSALSQQVRD-DGLLH-------TT 173
H + + +RD+KP+N L+ + V DFG + + RD H
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG---MVKFYRDPVTKQHIPYREKKNL 178
Query: 174 CGTPNYVAPEVLNDRGYDGSTA-DLWSCGVILFVLLAGYLP---FDDSNLMNLYKKISAA 229
GT Y++ + G + S DL + G + L G LP + Y++I
Sbjct: 179 SGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236
Query: 230 EFTCPP 235
+ + P
Sbjct: 237 KQSTPL 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 55/235 (23%), Positives = 85/235 (36%), Gaps = 62/235 (26%)
Query: 14 EVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
E R IGEG F +V E VA+K+L KE+ A+ +RE A M
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQAD-FQREAALMAEF 107
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGEL-----------------FDKIVNHGRMKED 111
+PN+V+L V + ++ E++ G+L D
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 112 EARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164
+ + A Y R HRDL N L+ +K++DFGLS
Sbjct: 168 PPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 221
Query: 165 RD-----------DGLLHTTCGTPNYV---APEVLNDRGYDGSTA-DLWSCGVIL 204
R+ + + P + PE + Y +T D+W+ GV+L
Sbjct: 222 RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRY--TTESDVWAYGVVL 266
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 1e-16
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 19 IGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78
IG G F KV + G VALK E + + + E+ T+ +HP++V L
Sbjct: 47 IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102
Query: 79 VMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD------YCHSRGV 132
+ ++ ++ +++ G L + +G + + Q+L + Y H+R +
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPNYVAPE-----V 184
HRD+K N+LLD K++DFG+S + H + GT Y+ PE
Sbjct: 161 IHRDVKSINILLDENFVPKITDFGISKKGT---ELDQTHLSTVVKGTLGYIDPEYFIKGR 217
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217
L ++ +D++S GV+LF +L S
Sbjct: 218 LTEK------SDVYSFGVVLFEVLCARSAIVQS 244
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 77.2 bits (189), Expect = 1e-16
Identities = 39/192 (20%), Positives = 59/192 (30%), Gaps = 48/192 (25%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKIL-----DKEKVLKHKMAEQIKREVATMK 66
K + IGEG F +V PVA+KI+ D K E+I E+ K
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 67 LV---------KHPNVVRLYEV------------------------------MGSKTKIF 87
+ + + L V ++F
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDA 146
IVLEF GG +++ A+ QL ++ + HRDL N+LL
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197
Query: 147 YGNLKVSDFGLS 158
K+
Sbjct: 198 TSLKKLHYTLNG 209
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 57/233 (24%), Positives = 90/233 (38%), Gaps = 56/233 (24%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
E G+ +G G F KV A + VA+K+L KEK + + E+ M L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREA-LMSELKMMTQL 105
Query: 68 VKHPNVVRLYEVMGSKTKIFIVLEFVTGGEL----------------FDKIVNHGRMKED 111
H N+V L I+++ E+ G+L + +ED
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165
Query: 112 EARRYFQQLIN-AVD------YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164
F+ L+ A + + HRDL N+L+ +K+ DFGL+
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219
Query: 165 RDDGLLHTTCGTPNYV------------APEVLNDRGYDGSTADLWSCGVILF 205
RD + + NYV APE L + Y +D+WS G++L+
Sbjct: 220 RD---IMS---DSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 46/236 (19%), Positives = 88/236 (37%), Gaps = 46/236 (19%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++ +G+ IG G F + A + E A + KV + + E+ + V
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHV---VKVEYQE-NGPLFSELKFYQRVAK 92
Query: 71 PNVVRLYEVMGSKTKI-------------------FIVLEFVTGGELFDKIVNHGRMKED 111
+ ++ + + F+V+E + G +L +G K+
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151
Query: 112 EARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRDDGL 169
+ ++++ ++Y H H D+K NLLL +V +D+G LS + +G
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG---LSYRYCPNGN 208
Query: 170 L----------HTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 213
H GT + + L+ +G S +D+ G + L G LP
Sbjct: 209 HKQYQENPRKGHN--GTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 41/237 (17%), Positives = 84/237 (35%), Gaps = 45/237 (18%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
++VG IG+G F + + + + E V KV + E+ +
Sbjct: 35 AAWKVGLPIGQGGFGCI-YLADMNSSESVGSDAPCVVKVEPSD-NGPLFTELKFYQRAAK 92
Query: 71 PNVVRLYEVMGSKTKI-------------------FIVLEFVTG---GELFDKIVNHGRM 108
P ++ + + F++++ G ++++ N R
Sbjct: 93 PEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRF 149
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALSQQVRD 166
+ ++++ ++Y H H D+K NLLL+ +V D+G L+ +
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG---LAYRYCP 206
Query: 167 DGLL--------HTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLAGYLP 213
+G+ GT + + ++ G S DL G + L G+LP
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 36/244 (14%), Positives = 78/244 (31%), Gaps = 59/244 (24%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETG--------EPVALKI------LDKEKVLKHKMA- 55
++++ + A + T + +LK+ L E+ + A
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 56 -EQIKREVATMKLVKHPNVVRLYEVMGSKTKI--FIVLEFVTGGELFDKIVNHGRMKEDE 112
Q+ + + G F+VL + G L + +
Sbjct: 102 PLQVNKWKKLYST-PLLAIPTCMG-FGVHQDKYRFLVLPSL-GRSLQSALDVSPK----- 153
Query: 113 ARRYF---------QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKV--SDFGLSALS 161
+L++A+++ H H ++ EN+ +D +V + +G +
Sbjct: 154 --HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG---FA 208
Query: 162 QQVRDDG----------LLHTTCGTPNYVAPEVLND-RGYDGS-TADLWSCGVILFVLLA 209
+ G H G +++ ++ +G S +DL S G + L
Sbjct: 209 FRYCPSGKHVAYVEGSRSPHE--GDLEFIS---MDLHKGCGPSRRSDLQSLGYCMLKWLY 263
Query: 210 GYLP 213
G+LP
Sbjct: 264 GFLP 267
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 2e-07
Identities = 32/99 (32%), Positives = 46/99 (46%), Gaps = 25/99 (25%)
Query: 119 QLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
Q+ +++ SR HRDL N+LL +K+ DFGL+ RD P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPD 248
Query: 179 YV------------APEVLNDRGYDGSTADLWSCGVILF 205
YV APE + DR Y + D+WS GV+L+
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQS-DVWSFGVLLW 286
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-06
Identities = 22/99 (22%), Positives = 40/99 (40%), Gaps = 9/99 (9%)
Query: 14 EVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-L 67
++G+ +G G F +V A + T VA+K+L + A E+ + +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM--SELKILIHI 82
Query: 68 VKHPNVVRLYEVM-GSKTKIFIVLEFVTGGELFDKIVNH 105
H NVV L + +++EF G L + +
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK 121
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-06
Identities = 25/159 (15%), Positives = 58/159 (36%), Gaps = 28/159 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQI-------------- 58
+G+ +GEG + V + + +K K+ E+
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150
Query: 59 -KREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 117
+ E ++ ++ V ++Y G+ +++E + EL+ ++ +
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAWEGNA----VLMELIDAKELYR-------VRVENPDEVL 199
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156
++ V + RG+ H DL N+L+ + + DF
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFP 237
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 5e-05
Identities = 43/249 (17%), Positives = 80/249 (32%), Gaps = 72/249 (28%)
Query: 42 KILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIVL------EFVT 94
++ K V + + ++++ A ++L NV+ + V+GS KT + +
Sbjct: 124 QVFAKYNVSRLQPYLKLRQ--ALLELRPAKNVL-IDGVLGSGKT----WVALDVCLSYKV 176
Query: 95 GGELFDKI--VNHGRMKEDEAR-RYFQQLINAVD--YC----HSRGVYHR--DLK----- 138
++ KI +N E Q+L+ +D + HS + R ++
Sbjct: 177 QCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 139 -------PENLL-LDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
LL L N K +A + + +L TT R
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKA----WNAFNLSCK---ILLTT--------------R-- 273
Query: 191 DGSTAD-LWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249
D L + L + + +L K +L + L +L
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK----------YLDCRPQDLPREVL 323
Query: 250 DPNPMTVSI 258
NP +SI
Sbjct: 324 TTNPRRLSI 332
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 8e-05
Identities = 42/289 (14%), Positives = 76/289 (26%), Gaps = 97/289 (33%)
Query: 20 GEGTFAKV------KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV 73
+ K R T P L I+ AE I+ +AT KH N
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTNPRRLSII----------AESIRDGLATWDNWKHVNC 352
Query: 74 VRLYEVMGSKTKIFI-VLEFVTGGELFDKIVNHGRMKEDEARRYFQQL--------I--- 121
+L ++ + + VLE E R+ F +L I
Sbjct: 353 DKLTTII----ESSLNVLE------------------PAEYRKMFDRLSVFPPSAHIPTI 390
Query: 122 ---------------NAVDYCHSRGVYHRDLKPENL-LLDAYGNLKVSDFGLSALSQQVR 165
V+ H + + K + + Y LK ++
Sbjct: 391 LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK----------VKLE 440
Query: 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGST-ADLWSCGVILFVLLAGYLPFDDSNLMNLYK 224
++ LH + +Y P + +D + + G+ +L N+
Sbjct: 441 NEYALHRSI-VDHYNIP-----KTFDSDDLIPPYLDQYFYSHI--GH------HLKNIEH 486
Query: 225 KISAAEFTCPPW---LSFTARKLIARILDPNPMTVSIYPFADI-LYMRF 269
F F +K+ N + + Y +
Sbjct: 487 PERMTLF--RMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPY 533
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 2e-04
Identities = 31/168 (18%), Positives = 56/168 (33%), Gaps = 26/168 (15%)
Query: 13 YEVGRTIGEGTFAKVKFARN--SETGEPVALKI-------LDKEKVLKHKMAEQIKREVA 63
+G I G A V +A +A+KI DK + R ++
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 64 TMKLVK------HPNVVRLYEVMGSKTKIF------IVLEFVTGGELFDKIVNH--GRMK 109
+ V N+ R E S + + +++EF+ EL + +K
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 110 EDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFG 156
E + F ++ V + + H DL N++ + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYI--DKVYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 269 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.78 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.31 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.04 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.98 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.86 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.69 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.53 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.17 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.15 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.03 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.98 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.79 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.77 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.74 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.62 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.55 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.54 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.26 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.21 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.06 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.64 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.0 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.54 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.06 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 84.65 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-65 Score=416.57 Aligned_cols=261 Identities=30% Similarity=0.545 Sum_probs=239.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||+|+||+||+|+++.+|+.||+|++...........+.+.+|++++++++||||+++++++.+.+.++
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y 108 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 108 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999998766555555678999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+||||++||+|.+++.+.+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999876544444
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 247 (269)
.......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+...++..+++.++..+++++++||++
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 267 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence 44556689999999999988776 48999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCcCCCCccc----cccccC
Q 024347 248 ILDPNPMTVSIYPFAD----ILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~----~l~~~~ 269 (269)
||+.||++|||++++. ++.|+|
T Consensus 268 lL~~dp~~R~t~~e~~~~~~i~~Hp~ 293 (311)
T 4aw0_A 268 LLVLDATKRLGCEEMEGYGPLKAHPF 293 (311)
T ss_dssp HSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred HccCCHhHCcChHHHcCCHHHHCCCC
Confidence 9999999999997652 567776
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-64 Score=406.52 Aligned_cols=257 Identities=47% Similarity=0.858 Sum_probs=218.4
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+...++|++.+.||+|+||+||+|.++.+|+.||+|++...........+.+.+|++++++++||||+++++++.+.+.+
T Consensus 9 G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 88 (275)
T 3hyh_A 9 GAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEI 88 (275)
T ss_dssp -----CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence 56678999999999999999999999999999999999876655555567899999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||+ +|+|.+.+..++.+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--- 164 (275)
T 3hyh_A 89 IMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--- 164 (275)
T ss_dssp EEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred EEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---
Confidence 9999999 679999999888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
........||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+.....+.+..+..+.+..+|+++++||+
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 244 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK 244 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 22233457999999999999888777899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||+.||++|||+ .+++.|+|
T Consensus 245 ~~L~~dP~~R~s~--~eil~hpw 265 (275)
T 3hyh_A 245 RMLIVNPLNRISI--HEIMQDDW 265 (275)
T ss_dssp HHSCSSGGGSCCH--HHHHHCHH
T ss_pred HHccCChhHCcCH--HHHHcCcc
Confidence 9999999999999 77888887
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-62 Score=406.34 Aligned_cols=256 Identities=29% Similarity=0.558 Sum_probs=221.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
+..++|++++.||+|+||.||+|+++.+|+.||+|++...... ....+.+.+|++++++++||||+++++++.+.+.++
T Consensus 21 ~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp SCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 4568999999999999999999999999999999999866543 344678999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 88 IVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+||||++||+|.+++... ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 999999999999999754 357899999999999999999999999999999999999999999999999997543211
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTARKL 244 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 244 (269)
.......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+...++..+.+ +.+..+|+++++|
T Consensus 180 --~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~l 256 (350)
T 4b9d_A 180 --ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSL 256 (350)
T ss_dssp --HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred --ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 112334689999999999887764 899999999999999999999999999999999888775 4567799999999
Q ss_pred HHHhcCCCCCCcCCCCccccccccC
Q 024347 245 IARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||+.||++|||+ .++|.|+|
T Consensus 257 i~~~L~~dP~~R~s~--~e~l~hp~ 279 (350)
T 4b9d_A 257 VSQLFKRNPRDRPSV--NSILEKGF 279 (350)
T ss_dssp HHHHTCSSGGGSCCH--HHHHTSHH
T ss_pred HHHHccCChhHCcCH--HHHhcCHH
Confidence 999999999999999 77788876
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-61 Score=397.72 Aligned_cols=251 Identities=28% Similarity=0.457 Sum_probs=223.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
...|++.+.||+|+||.||+|.++.+|+.||+|++....... .+.+.+|+++++.++||||+++++++.+.+.+++|
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357999999999999999999999999999999997654322 45678999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||++||+|.+++.. +.+++.++..++.|++.||.|||++||+|+||||+|||++.++.+||+|||+++.... ....
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 226 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR 226 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCc
Confidence 999999999988765 5799999999999999999999999999999999999999999999999999875432 2223
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIA 246 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~ 246 (269)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+..... ..+..+++++++||+
T Consensus 227 ~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 305 (346)
T 4fih_A 227 RKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305 (346)
T ss_dssp BCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence 345679999999999988776 5999999999999999999999999999888888876543 333458999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.||+.||++|||+ .++|.|+|
T Consensus 306 ~~L~~dP~~R~ta--~e~l~Hp~ 326 (346)
T 4fih_A 306 RLLVRDPAQRATA--AELLKHPF 326 (346)
T ss_dssp HHSCSSTTTSCCH--HHHTTCGG
T ss_pred HHcCCChhHCcCH--HHHhcCHh
Confidence 9999999999999 88899988
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-62 Score=397.03 Aligned_cols=257 Identities=33% Similarity=0.567 Sum_probs=222.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
..++|++++.||+|+||+||+|++. .+++.||+|++......... ...+.+|++++++++||||+++++++.+.+.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3468999999999999999999874 45789999998754332211 2457789999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+++||||++||+|.+++.+.+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-- 178 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-- 178 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--
Confidence 999999999999999999988999999999999999999999999999999999999999999999999999875332
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 245 (269)
.........||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+....+..+.++.+..+|+++++||
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 257 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 257 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 22233445799999999999887775 89999999999999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCcCCCC---ccccccccC
Q 024347 246 ARILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
+.||+.||++|||+. ..+++.|+|
T Consensus 258 ~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 258 RMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp HHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred HHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 999999999999974 247788887
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-60 Score=398.82 Aligned_cols=251 Identities=28% Similarity=0.457 Sum_probs=223.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.+.|++.+.||+|+||.||+|.++.+|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 467999999999999999999999999999999997654322 45688999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||++||+|.+++.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.... ....
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~ 303 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPR 303 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCC
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCcc
Confidence 999999999988765 5699999999999999999999999999999999999999999999999999875432 2223
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTARKLIA 246 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~ 246 (269)
.....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+..... ..+..+++++++||+
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~ 382 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 382 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred ccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence 345679999999999988776 4999999999999999999999999999988888876543 334568999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.||+.||++|||+ .++|.|+|
T Consensus 383 ~~L~~dP~~R~ta--~ell~Hp~ 403 (423)
T 4fie_A 383 RLLVRDPAQRATA--AELLKHPF 403 (423)
T ss_dssp HHSCSSTTTSCCH--HHHTTCGG
T ss_pred HHcCCChhHCcCH--HHHhcCHH
Confidence 9999999999999 88899988
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=380.49 Aligned_cols=250 Identities=26% Similarity=0.481 Sum_probs=215.8
Q ss_pred CCe-EEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee----CCe
Q 024347 11 GKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTK 85 (269)
Q Consensus 11 ~~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~ 85 (269)
++| ++.+.||+|+||.||+|.++.+++.||+|.+...... ....+.+.+|++++++++||||+++++++.+ ...
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 355 7778899999999999999999999999999765543 3446789999999999999999999999865 356
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEec-CCCCEEEeeCCCccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLD-AYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~-~~~~~~l~df~~~~~~~ 162 (269)
+++||||++||+|.+++.+.+.+++..+..++.|++.||+|||++| |+||||||+|||++ .++.+||+|||+++...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 8999999999999999998889999999999999999999999998 99999999999997 47899999999987432
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcCcc--cCCCCCCH
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEF--TCPPWLSF 239 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~ 239 (269)
........||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||... ....+...+..+.. ..+..+++
T Consensus 184 ----~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (290)
T 3fpq_A 184 ----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ----CCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCH
Confidence 223345679999999999875 34 59999999999999999999999764 45566666666543 33456889
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++++||..||+.||++|||+ .++|.|+|
T Consensus 258 ~~~~li~~~L~~dP~~R~s~--~e~l~Hp~ 285 (290)
T 3fpq_A 258 EVKEIIEGCIRQNKDERYSI--KDLLNHAF 285 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred HHHHHHHHHccCChhHCcCH--HHHhcCcc
Confidence 99999999999999999999 88899998
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-60 Score=391.56 Aligned_cols=246 Identities=25% Similarity=0.347 Sum_probs=214.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...+.|++.+.||+|+||.||+|+++.+|+.||+|+++.+... .+|+.+++.++||||+++++++.+.+.++
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 3456799999999999999999999999999999999765432 36999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-CEEEeeCCCccccccccC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-~~~l~df~~~~~~~~~~~ 166 (269)
+||||++||+|.+++...+.+++.++..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999999888999999999999999999999999999999999999999887 599999999986543221
Q ss_pred CC---cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHH
Q 024347 167 DG---LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFT 240 (269)
Q Consensus 167 ~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 240 (269)
.. ......||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.........+..... ..++.+++.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~ 285 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPL 285 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHH
T ss_pred ccceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHH
Confidence 11 12234689999999999987764 899999999999999999999998777777777766654 356789999
Q ss_pred HHHHHHHhcCCCCCCcCCCCcc
Q 024347 241 ARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.+||+.||+.||.+|||++++
T Consensus 286 ~~~li~~~L~~dP~~R~sa~el 307 (336)
T 4g3f_A 286 TAQAIQEGLRKEPVHRASAMEL 307 (336)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHccCCHhHCcCHHHH
Confidence 9999999999999999998654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-59 Score=381.64 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=217.2
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
..++|.+.+.||+|+||.||+|++. .+++.||+|.++.. .....+.+.+|++++++++||||+++++++.+.
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3468999999999999999999875 35788999998653 234467899999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCE
Q 024347 84 TKIFIVLEFVTGGELFDKIVNH-------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~-------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~ 150 (269)
+..++||||+++|+|.+++... ..+++.++..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcE
Confidence 9999999999999999999764 368999999999999999999999999999999999999999999
Q ss_pred EEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 024347 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 229 (269)
||+|||+++...............+++.|+|||++.+..++ .++||||||+++|+|+| |+.||.+.+..+....+..+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~ 246 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG 246 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC
Confidence 99999999765443333333344588999999999887764 99999999999999998 89999999999988888776
Q ss_pred c-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 230 E-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 230 ~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
. .+.|..+|+++.+|+..||+.||++|||++++
T Consensus 247 ~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i 280 (299)
T 4asz_A 247 RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI 280 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 5 56678899999999999999999999998665
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-58 Score=378.44 Aligned_cols=250 Identities=21% Similarity=0.308 Sum_probs=210.7
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
..++|.+.+.||+|+||.||+|++. .+++.||||.+... .....+.+.+|++++++++||||+++++++.+.
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 4568999999999999999999865 35889999998643 344567899999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC
Q 024347 84 TKIFIVLEFVTGGELFDKIVNH---------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~---------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~ 148 (269)
+..++||||+++|+|.+++... +++++.++..++.|++.||.|||+.+|+||||||+|||++.++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC
Confidence 9999999999999999998653 3589999999999999999999999999999999999999999
Q ss_pred CEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 024347 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (269)
Q Consensus 149 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 227 (269)
.+||+|||+++...............+++.|+|||++.+..++ .++||||||+++|+|+| |+.||......+....+.
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~ 274 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999865443333333445689999999999887764 99999999999999998 899999998888888887
Q ss_pred cC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 228 AA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 228 ~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+ +.+.|..+++++.+|+..||+.||++|||++++
T Consensus 275 ~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei 310 (329)
T 4aoj_A 275 QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDV 310 (329)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHH
Confidence 65 467778899999999999999999999998554
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=375.84 Aligned_cols=252 Identities=21% Similarity=0.341 Sum_probs=205.1
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
++...+++++.+.||+|+||+||+|++.. .||||+++.... +.+..+.+.+|++++++++||||+++++++.. +.
T Consensus 31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~ 105 (307)
T 3omv_A 31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN 105 (307)
T ss_dssp CBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred cEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence 46678899999999999999999998753 499999865432 34456889999999999999999999998854 56
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++||||++||+|.+++... ..+++.++..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 106 ~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 89999999999999999764 57999999999999999999999999999999999999999999999999999866544
Q ss_pred cCCCcccccccCccccCcccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHhcCcc-----cCCCC
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY-KKISAAEF-----TCPPW 236 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~-----~~~~~ 236 (269)
..........||+.|+|||++.+.. .++.++||||||+++|+|+||+.||...+..... ..+..+.. ..++.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 265 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN 265 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence 4444445567999999999986532 3468999999999999999999999876554433 33333321 23456
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+++.+.+|+..||+.||++|||++++
T Consensus 266 ~~~~l~~li~~cl~~dP~~RPs~~ei 291 (307)
T 3omv_A 266 CPKAMKRLVADCVKKVKEERPLFPQI 291 (307)
T ss_dssp SCHHHHHHHHHHTCSSSTTSCCHHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHH
Confidence 89999999999999999999998654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=376.93 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=218.6
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
...+++++.+.||+|+||+||+|.+. .+++.||||.+.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 45678999999999999999999864 357889999986543 22335789999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA 146 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~ 146 (269)
.+..++||||+++|+|.+++... ..+++.++..++.|++.||.|||+.+|+||||||+|||++.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 99999999999999999998643 35889999999999999999999999999999999999999
Q ss_pred CCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 024347 147 YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKK 225 (269)
Q Consensus 147 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~ 225 (269)
++.+||+|||+++...............+++.|+|||++.+..+ +.++||||||+++|||+| |..||.+.+..+....
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999986654443334445568999999999988776 499999999999999998 8999999999998888
Q ss_pred HhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 226 ISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 226 ~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+..+. .+.|+.+|+++.+|+..||+.||++|||++++
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei 297 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDI 297 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 87765 56778899999999999999999999998554
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-57 Score=380.74 Aligned_cols=255 Identities=28% Similarity=0.388 Sum_probs=218.0
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee------CC
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------KT 84 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 84 (269)
++|++++.||+|+||+||+|+++.+|+.||+|++..... .....+.+.+|+++|+.++||||+++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 589999999999999999999999999999999965433 33445778899999999999999999999754 35
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++||||++ |+|.+.+...+.+++.++..++.|++.||.|||++||+|+||||+|||++.++.+|++|||+++.....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 7899999996 579999988889999999999999999999999999999999999999999999999999999765332
Q ss_pred c--CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC---------
Q 024347 165 R--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--------- 233 (269)
Q Consensus 165 ~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 233 (269)
. .........||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+..+....+.......
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~ 291 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG 291 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence 1 22234456799999999999887776799999999999999999999999988888777764321100
Q ss_pred ----------------------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 234 ----------------------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 234 ----------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.+++++.+||++||+.||++|||+ .++|.|+|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta--~e~L~Hp~ 347 (398)
T 4b99_A 292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISA--AAALRHPF 347 (398)
T ss_dssp --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCH--HHHTTSGG
T ss_pred hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCH--HHHhcCHh
Confidence 12368899999999999999999999 88899998
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-57 Score=367.12 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=197.7
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC-----
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----- 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 84 (269)
.++|++++.||+|+||+||+|+++.+|+.||+|++.... .+...+.+.+|++++++++||||+++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 81 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL 81 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence 467999999999999999999999999999999987543 3444678899999999999999999999986544
Q ss_pred -------eEEEEEeccCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEee
Q 024347 85 -------KIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSD 154 (269)
Q Consensus 85 -------~~~~v~~~~~~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~d 154 (269)
.++++|||++|++|.+++..... .....+..++.|+++||+|||++||+|+||||+|||++.++.+||+|
T Consensus 82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence 37899999999999999987654 34566889999999999999999999999999999999999999999
Q ss_pred CCCccccccccCCC----------cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHH
Q 024347 155 FGLSALSQQVRDDG----------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLY 223 (269)
Q Consensus 155 f~~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~ 223 (269)
||+++......... ......||+.|+|||++.+..+ +.++|||||||++|+|++ ||..... ....
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~~ 237 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTL 237 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence 99997654322211 1223468999999999988776 499999999999999996 7765322 2333
Q ss_pred HHHhcCccc-CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 224 KKISAAEFT-CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 224 ~~~~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+....++ ..+..++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~--~eil~h~~ 282 (299)
T 4g31_A 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEA--INIIENAV 282 (299)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCH--HHHHTSGG
T ss_pred HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCH--HHHhcCHh
Confidence 334443332 223356778899999999999999999 77888876
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=389.05 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=225.8
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHH---HHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK---MAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
.....++|++.+.||+|+||.||+|+++.+|+.||+|++......... ......+++.+++.++||||++++++|.+
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 456778999999999999999999999999999999999765443222 22333445777888899999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
.+.+++||||++||+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|....
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999997543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCcccCCCCCCH
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEFTCPPWLSF 239 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
. .......||+.|+|||++.+...++.++|+|||||++|+|++|..||.+. +...+...+.......+..+|+
T Consensus 344 ~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~ 419 (689)
T 3v5w_A 344 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 419 (689)
T ss_dssp S----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence 2 22344579999999999976544569999999999999999999999753 4456677778888888999999
Q ss_pred HHHHHHHHhcCCCCCCcCCCC---ccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
++++||+.||+.||.+|++.. ..+++.|+|
T Consensus 420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred HHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 999999999999999999952 367888887
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-56 Score=368.55 Aligned_cols=253 Identities=21% Similarity=0.348 Sum_probs=212.0
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCC-----CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCC-CCceeeeEE
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEV 79 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~ 79 (269)
++...++|++.+.||+|+||.||+|.+... ++.||+|.+..... ....+.+.+|++++.++.| |||++++++
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~ 136 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGA 136 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence 456678999999999999999999997654 35799999865432 3345789999999999965 899999999
Q ss_pred Eee-CCeEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCce
Q 024347 80 MGS-KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (269)
Q Consensus 80 ~~~-~~~~~~v~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nI 142 (269)
+.. .+.+++||||+++|+|.+++... ..+++.++..++.|++.||.|||+++|+||||||+||
T Consensus 137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI 216 (353)
T 4ase_A 137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 216 (353)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence 865 45789999999999999999653 2488999999999999999999999999999999999
Q ss_pred EecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH-H
Q 024347 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL-M 220 (269)
Q Consensus 143 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~-~ 220 (269)
|++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||||+++|+|+| |..||.+... .
T Consensus 217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 999999999999999986543332223334567899999999988776 499999999999999998 8999987553 4
Q ss_pred HHHHHHhcC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 221 NLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 221 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
.....+..+ +++.|+.+++++.+|+..||+.||++|||+++
T Consensus 296 ~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~e 337 (353)
T 4ase_A 296 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 337 (353)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHH
Confidence 455555444 46778889999999999999999999999844
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=357.78 Aligned_cols=259 Identities=43% Similarity=0.801 Sum_probs=235.2
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
+.....++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+++++.++||||+++++++.+.+
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 87 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK 87 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 345667899999999999999999999999999999999976544 3444678889999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..++||||++|++|.+++...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~- 166 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV- 166 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS-
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCC-
Confidence 9999999999999999998888999999999999999999999999999999999999999999999999998865432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 244 (269)
........+++.|+|||++.+..+.+.++||||||+++|+|++|..||.+.+.......+..+....+..+++.+.+|
T Consensus 167 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 244 (328)
T 3fe3_A 167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENL 244 (328)
T ss_dssp --SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred --CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 223344568999999999998887668999999999999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCcCCCCccccccccC
Q 024347 245 IARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||+.||.+|||+ .+++.|+|
T Consensus 245 i~~~L~~dP~~R~t~--~eil~h~~ 267 (328)
T 3fe3_A 245 LKRFLVLNPIKRGTL--EQIMKDRW 267 (328)
T ss_dssp HHHHCCSSTTTSCCH--HHHTTCTT
T ss_pred HHHHCCCChhHCcCH--HHHhcCHh
Confidence 999999999999999 88888987
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=361.99 Aligned_cols=254 Identities=26% Similarity=0.428 Sum_probs=205.5
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 81 (269)
++.-.++|++.+.||+|+||+||+|+++ .+++.||+|.+..... ...+.+|+++++.+ +||||+++++++.
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 4555688999999999999999999875 4578999999865432 34577899999988 6999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC-CCEEEeeCCCccc
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSAL 160 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~-~~~~l~df~~~~~ 160 (269)
+.+.+++||||++|++|.+.+. .+++.++..++.|++.||+|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999999998873 58999999999999999999999999999999999999876 7899999999875
Q ss_pred cccccC--------------------------CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 024347 161 SQQVRD--------------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (269)
Q Consensus 161 ~~~~~~--------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 214 (269)
...... ........||+.|+|||++.+...++.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 432111 111223468999999999988766679999999999999999999999
Q ss_pred CC-CCHHHHHHHHhc--------------------------------------Cc----------------ccCCCCCCH
Q 024347 215 DD-SNLMNLYKKISA--------------------------------------AE----------------FTCPPWLSF 239 (269)
Q Consensus 215 ~~-~~~~~~~~~~~~--------------------------------------~~----------------~~~~~~~~~ 239 (269)
.. .+..+....+.. .. ......+++
T Consensus 248 ~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~ 327 (361)
T 4f9c_A 248 YKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPD 327 (361)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCH
Confidence 54 333333222210 00 011234788
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++.+||++||+.||++|||+ .++|.|+|
T Consensus 328 ~a~DLl~~lL~~dP~~R~ta--~eaL~Hp~ 355 (361)
T 4f9c_A 328 EAYDLLDKLLDLNPASRITA--EEALLHPF 355 (361)
T ss_dssp HHHHHHHHHTCSCTTTSCCH--HHHHTSGG
T ss_pred HHHHHHHHHCcCChhHCcCH--HHHhcCcc
Confidence 99999999999999999999 88999998
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=380.24 Aligned_cols=251 Identities=29% Similarity=0.557 Sum_probs=224.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||+|+||.||+|.++.+|+.||+|.+.... ....+.+.+|+++|+.++||||+++++++.+.+.++++
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999987543 22356788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC--CCEEEeeCCCccccccccC
Q 024347 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~--~~~~l~df~~~~~~~~~~~ 166 (269)
|||++||+|.+++.. .+.+++.++..++.||+.||.|||++||+|+||||+||+++.+ +.+||+|||+++....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~--- 309 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--- 309 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT---
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccC---
Confidence 999999999998864 4579999999999999999999999999999999999999854 7899999999976432
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTAR 242 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 242 (269)
........|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+.......+ ..++++++
T Consensus 310 ~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 388 (573)
T 3uto_A 310 KQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388 (573)
T ss_dssp TSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred CCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 233344578999999999998776 4999999999999999999999999999999999988766554 45899999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||+.||+.||.+|||+ .++|.|+|
T Consensus 389 dli~~~L~~dp~~R~t~--~e~l~Hpw 413 (573)
T 3uto_A 389 DFIRKLLLADPNTRMTI--HQALEHPW 413 (573)
T ss_dssp HHHHTTSCSSGGGSCCH--HHHHHSTT
T ss_pred HHHHHHccCChhHCcCH--HHHhcCcC
Confidence 99999999999999999 77899988
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=349.27 Aligned_cols=257 Identities=33% Similarity=0.599 Sum_probs=230.2
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||+|+||.||+++++.+|+.||+|++.............+.+|+++++.++||||+++++++.+.+..+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 35689999999999999999999999999999999998765444444577889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+||||++|++|...+...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..... ..
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~ 159 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999874321 12
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 247 (269)
.......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+.......+..+++++.+||+.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 238 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred CcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 23344568999999999987766 49999999999999999999999999999999999888888888999999999999
Q ss_pred hcCCCCCCcC-----CCCccccccccC
Q 024347 248 ILDPNPMTVS-----IYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rp-----s~~~~~~l~~~~ 269 (269)
||+.||++|| ++ .+++.|+|
T Consensus 239 lL~~dP~~R~g~~~~~~--~ei~~h~~ 263 (337)
T 1o6l_A 239 LLKKDPKQRLGGGPSDA--KEVMEHRF 263 (337)
T ss_dssp HTCSSTTTSTTCSTTTH--HHHHTSGG
T ss_pred HhhcCHHHhcCCCCCCH--HHHHcCCC
Confidence 9999999999 55 67778876
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-53 Score=352.35 Aligned_cols=259 Identities=34% Similarity=0.598 Sum_probs=227.8
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 86 (269)
...++|++.+.||+|+||.||+|+++.+++.||+|++...........+.+.+|.++++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4568999999999999999999999999999999999876655555567788999999988 699999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||++|++|..++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..... .
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~--~ 177 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--N 177 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--C
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999864221 2
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+..+....+..+....+..+++.+.+||+
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 256 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILK 256 (353)
T ss_dssp --------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 223334568999999999987766 4899999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCcCCCCc----cccccccC
Q 024347 247 RILDPNPMTVSIYPF----ADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~----~~~l~~~~ 269 (269)
.||+.||++||++.+ .+++.|+|
T Consensus 257 ~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 257 SFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp HHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred HHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 999999999999832 56778876
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=348.74 Aligned_cols=261 Identities=30% Similarity=0.555 Sum_probs=229.0
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 83 (269)
......++|++.+.||+|+||.||+|+++.+|+.||+|.+...........+.+..|..++..+ +||||+++++++.+.
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~ 90 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 90 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence 4466789999999999999999999999999999999999876543334456778889998876 899999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
+..++||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170 (345)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999864322
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (269)
.........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||.+.+.......+.......+..+++++.+
T Consensus 171 --~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 247 (345)
T 1xjd_A 171 --GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD 247 (345)
T ss_dssp --TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred --CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence 1222344568999999999988766 4999999999999999999999999999999999998888888899999999
Q ss_pred HHHHhcCCCCCCcCCCCccccccccC
Q 024347 244 LIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+.||+.||++||++. .+++.|+|
T Consensus 248 li~~lL~~dp~~R~~~~-~~i~~hp~ 272 (345)
T 1xjd_A 248 LLVKLFVREPEKRLGVR-GDIRQHPL 272 (345)
T ss_dssp HHHHHSCSSGGGSBTTB-SCGGGSGG
T ss_pred HHHHHhcCCHhHcCCCh-HHHHcCcc
Confidence 99999999999999983 16777876
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=343.80 Aligned_cols=253 Identities=34% Similarity=0.676 Sum_probs=229.3
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||.|+||.||++++..+|+.||+|++...........+.+.+|..+++.++||||+++++++.+....++
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 46799999999999999999999999999999999987654443445778899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----- 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----- 158 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-----
Confidence 999999999999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHh
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (269)
......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+.......++.+++++.++|+.|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 2234568999999999987766 489999999999999999999999999999999999888888999999999999999
Q ss_pred cCCCCCCcC-----CCCccccccccC
Q 024347 249 LDPNPMTVS-----IYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rp-----s~~~~~~l~~~~ 269 (269)
|+.||++|| ++ .+++.|+|
T Consensus 238 L~~dp~~R~~~~~~~~--~~i~~hp~ 261 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGT--EDVKNHPW 261 (318)
T ss_dssp TCSCTTTCTTSSTTTT--HHHHTSGG
T ss_pred hccCHHHcCCCcCCCH--HHHhcCcc
Confidence 999999999 55 67778877
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=347.56 Aligned_cols=257 Identities=32% Similarity=0.599 Sum_probs=231.5
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
....++|++.+.||+|+||.||++++..+|+.||+|++...........+.+.+|+++++.++||||+++++++.+....
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 35678999999999999999999999999999999999876554444467888999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+..+....+..+++.+.+||+
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 2234468999999999988766 4999999999999999999999999999999999999998889999999999999
Q ss_pred HhcCCCCCCcCCCC---ccccccccC
Q 024347 247 RILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
.||+.||.+||+.. ..+++.|+|
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcC
Confidence 99999999999821 266777776
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=354.19 Aligned_cols=257 Identities=46% Similarity=0.860 Sum_probs=227.3
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+...++|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 84 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDI 84 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45678999999999999999999999999999999999765544444456788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||+ ++++.+.+...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~--- 160 (336)
T 3h4j_B 85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--- 160 (336)
T ss_dssp EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT---
T ss_pred EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccC---
Confidence 9999999 679999998888999999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
........+++.|+|||++.+..+.+.++||||||+++|+|++|..||...........+.......+..+++.+.+||+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 240 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIR 240 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 22233456899999999998877656899999999999999999999988766666666666667778889999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.||+.||.+|||+ .+++.|+|
T Consensus 241 ~~L~~dP~~Rpt~--~eil~hp~ 261 (336)
T 3h4j_B 241 RMIVADPMQRITI--QEIRRDPW 261 (336)
T ss_dssp TTSCSSGGGSCCH--HHHTTCHH
T ss_pred HHcCCChhHCcCH--HHHHhChh
Confidence 9999999999999 78888876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=342.95 Aligned_cols=259 Identities=32% Similarity=0.569 Sum_probs=228.5
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 86 (269)
...++|++.+.||+|+||.||+++++.+++.||+|++...........+.+.+|..+++++ +||||+++++++.+....
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 4567999999999999999999999999999999999877666666678889999999988 899999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||++|++|..++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++.... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~ 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--P 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--T
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--C
Confidence 99999999999999998888899999999999999999999999999999999999999999999999998864221 1
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHhcCcccCCCCC
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---------SNLMNLYKKISAAEFTCPPWL 237 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~~ 237 (269)
........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||.. .........+.......+..+
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 223344568999999999988766 4999999999999999999999965 344556777777888888899
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCC----ccccccccC
Q 024347 238 SFTARKLIARILDPNPMTVSIYP----FADILYMRF 269 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~----~~~~l~~~~ 269 (269)
++.+.+||+.||+.||.+||++. ..+++.|+|
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 99999999999999999999974 357788877
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=345.66 Aligned_cols=257 Identities=32% Similarity=0.560 Sum_probs=226.9
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
....++|++.+.||.|+||.||++.++.+|+.||+|.+........ ...+.+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 87 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR 87 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC
Confidence 3455789999999999999999999999999999999975433211 1246788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC----CEEEeeCCCcc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSA 159 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~----~~~l~df~~~~ 159 (269)
...++||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++.
T Consensus 88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~ 167 (361)
T 2yab_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence 99999999999999999998888899999999999999999999999999999999999998776 79999999987
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----C
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~ 235 (269)
.... ........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||.+.+..+....+......++ .
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred EcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 5433 222334568999999999987766 4999999999999999999999999999999999988776655 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+++.+++||+.||+.||++|||+ .+++.|+|
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~--~e~l~hp~ 275 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTI--QEALRHPW 275 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCH--HHHHTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCcCH--HHHhcCcC
Confidence 589999999999999999999999 88899988
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=345.41 Aligned_cols=260 Identities=30% Similarity=0.513 Sum_probs=229.6
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 85 (269)
....++|++.+.||+|+||.||+++++.+++.||+|++...........+.+..|..++..+ +||+|+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 45678999999999999999999999999999999999876544444457788899999888 79999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999874221
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 245 (269)
.........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+..+..+.+.......+..+++++.+||
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 252 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 1223344568999999999987776 499999999999999999999999999999999999998889999999999999
Q ss_pred HHhcCCCCCCcCCC---CccccccccC
Q 024347 246 ARILDPNPMTVSIY---PFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~---~~~~~l~~~~ 269 (269)
+.||+.||.+||+. ...+++.|+|
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 99999999999976 2356677776
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=348.85 Aligned_cols=260 Identities=32% Similarity=0.571 Sum_probs=226.4
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~ 85 (269)
....++|++.+.||+|+||.||+++++.+++.+|+|++...........+.+.+|..++.++ +||||+++++++.+.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 34567999999999999999999999999999999999876665555567788899999877 89999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||++|++|...+...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++... .
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~--~ 205 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--R 205 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--C
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc--c
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999987422 1
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHhcCcccCCCC
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---------SNLMNLYKKISAAEFTCPPW 236 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~---------~~~~~~~~~~~~~~~~~~~~ 236 (269)
.........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||.. .......+.+.......+..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~ 284 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS 284 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred CCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence 2233444568999999999988776 4999999999999999999999953 23445777788888888999
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCC----ccccccccC
Q 024347 237 LSFTARKLIARILDPNPMTVSIYP----FADILYMRF 269 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~----~~~~l~~~~ 269 (269)
+++++.+||+.||+.||.+||++. ..+++.|+|
T Consensus 285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 999999999999999999999974 367888887
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=357.71 Aligned_cols=258 Identities=45% Similarity=0.854 Sum_probs=233.4
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
....++|++.+.||.|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~ 91 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDI 91 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45678999999999999999999999999999999999876544444467889999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~--- 168 (476)
T 2y94_A 92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--- 168 (476)
T ss_dssp EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT---
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
........+++.|+|||++.+..+.+.++||||||+++|+|++|..||...........+..+....+..+++.+.+||+
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~ 248 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLK 248 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHH
T ss_pred cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHH
Confidence 22233456899999999998877666899999999999999999999999988999999999988888889999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.||+.||++|||+ .+++.|+|
T Consensus 249 ~~L~~dP~~Rpt~--~eil~hp~ 269 (476)
T 2y94_A 249 HMLQVDPMKRATI--KDIREHEW 269 (476)
T ss_dssp HHTCSSTTTSCCH--HHHHTCHH
T ss_pred HHcCCCchhCcCH--HHHHhCHH
Confidence 9999999999999 77777776
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=352.88 Aligned_cols=263 Identities=35% Similarity=0.627 Sum_probs=226.6
Q ss_pred CCccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEE
Q 024347 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (269)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 80 (269)
|.........++|++.+.||+|+||.||++.+..+|+.+|+|.+...... ....+.+.+|+.+++.++||||+++++++
T Consensus 1 M~~~~~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~ 79 (444)
T 3soa_A 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSI 79 (444)
T ss_dssp ------CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred CCccccccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEE
Confidence 34444556678999999999999999999999999999999999765433 33457789999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec---CCCCEEEeeCCC
Q 024347 81 GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGL 157 (269)
Q Consensus 81 ~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~---~~~~~~l~df~~ 157 (269)
.+.+..++||||++|++|.+.+...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++ .++.++|+|||+
T Consensus 80 ~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 80 SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp ECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 99999999999999999999999888999999999999999999999999999999999999998 457899999999
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC---
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--- 234 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 234 (269)
+...... ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+..+....+
T Consensus 160 a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 160 AIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp CBCCCTT--CCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred eEEecCC--CceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccc
Confidence 8654321 222234568999999999987766 4899999999999999999999999999999999888766554
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 -PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 -~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+++++.+||+.||+.||++|||+ .++|.|+|
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta--~e~L~hp~ 270 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITA--AEALKHPW 270 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCH--HHHHHSCT
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCH--HHHhcCcc
Confidence 3589999999999999999999999 88899988
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=332.60 Aligned_cols=256 Identities=35% Similarity=0.676 Sum_probs=228.9
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
....++|++.+.||.|++|.||+|.+..+++.+++|++...........+.+.+|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 45678999999999999999999999999999999999776555444567789999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+++|||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999998754332
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
.......+++.|+|||.+.+... +.++||||||+++|+|++|..||...........+.......+..+++.+.+||+
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred -ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 12233457899999999987766 4899999999999999999999999999999999988888888999999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.||+.||++|||+ .+++.|+|
T Consensus 240 ~~l~~~p~~Rps~--~e~l~h~~ 260 (279)
T 3fdn_A 240 RLLKHNPSQRPML--REVLEHPW 260 (279)
T ss_dssp HHCCSSGGGSCCH--HHHHHCHH
T ss_pred HHhccChhhCCCH--HHHhhCcc
Confidence 9999999999999 88888876
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-51 Score=333.66 Aligned_cols=256 Identities=28% Similarity=0.482 Sum_probs=222.6
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.++...++|++.+.||+|++|+||+|.+..+++.||+|.+....... .+.+.+|+.+++.++||||+++++++...+
T Consensus 14 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (297)
T 3fxz_A 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGD 90 (297)
T ss_dssp BSSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CcCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECC
Confidence 35667789999999999999999999999999999999987654333 356888999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..++||||++|++|.+++... .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 91 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 91 ELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp EEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 999999999999999988764 6899999999999999999999999999999999999999999999999988754432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---cccCCCCCCHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTA 241 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 241 (269)
........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+... ....+..+++.+
T Consensus 170 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T 3fxz_A 170 --QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (297)
T ss_dssp --TCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHH
T ss_pred --ccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHH
Confidence 222334568999999999988776 48999999999999999999999988777666655433 234456689999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+||..||+.||++|||+ .+++.|+|
T Consensus 247 ~~li~~~l~~dp~~Rps~--~ell~h~~ 272 (297)
T 3fxz_A 247 RDFLNRCLEMDVEKRGSA--KELLQHQF 272 (297)
T ss_dssp HHHHHHHSCSSTTTSCCH--HHHTTCGG
T ss_pred HHHHHHHccCChhHCcCH--HHHhhChh
Confidence 999999999999999999 88888887
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-51 Score=343.71 Aligned_cols=260 Identities=27% Similarity=0.516 Sum_probs=226.4
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
-....++|++.+.||.|+||.||++.+..+++.||+|.+...........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999999999999999999987655444456788899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||+.|++|..++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 167 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-- 167 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccC--
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccCccccCcccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCcccCCCCCCHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDD---SNLMNLYKKISAAEFTCPPWLSFT 240 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
........+++.|+|||++.+. ..++.++|+||||+++|+|++|..||.. .........+.......+..+++.
T Consensus 168 -~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~ 246 (384)
T 4fr4_A 168 -ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE 246 (384)
T ss_dssp -TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred -CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHH
Confidence 2333445689999999999743 2335899999999999999999999974 445566677777778888899999
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+||+.||+.||.+||+. ..+++.|+|
T Consensus 247 ~~~li~~lL~~dP~~R~s~-~~~l~~hp~ 274 (384)
T 4fr4_A 247 MVSLLKKLLEPNPDQRFSQ-LSDVQNFPY 274 (384)
T ss_dssp HHHHHHHHSCSSGGGSCCS-HHHHHTSGG
T ss_pred HHHHHHHHhcCCHhHhccc-HHHHHcChh
Confidence 9999999999999999994 144556655
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=343.29 Aligned_cols=260 Identities=33% Similarity=0.549 Sum_probs=221.7
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHH-hhhCCCCCceeeeEEEeeCCe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVAT-MKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~-l~~l~~~~i~~~~~~~~~~~~ 85 (269)
....++|++.+.||+|+||.||+++++.+++.||+|++.............+.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3456799999999999999999999999999999999987665555555667777776 578899999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||++|++|..++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999874322
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 245 (269)
.........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+..+....+.......++.++..+++||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 2223344568999999999988776 499999999999999999999999999999999999988888889999999999
Q ss_pred HHhcCCCCCCcCCCCc--cccccccC
Q 024347 246 ARILDPNPMTVSIYPF--ADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~--~~~l~~~~ 269 (269)
+.||+.||.+||++.. .+++.|+|
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCcc
Confidence 9999999999999842 45667765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=353.30 Aligned_cols=258 Identities=34% Similarity=0.600 Sum_probs=221.5
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
....++|++.+.||.|+||.||++.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence 34568899999999999999999999999999999999876655555567788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++||||+++++|...+...+.+++..+..++.|++.||.|||+ .||+|+||+|+||+++.++.++|+|||++.....
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-- 301 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-- 301 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence 9999999999999999888899999999999999999999998 9999999999999999999999999999864322
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 245 (269)
.........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+.......+..+++++.+||
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 380 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 1222334568999999999988776 499999999999999999999999999999999999988888999999999999
Q ss_pred HHhcCCCCCCcC-----CCCccccccccC
Q 024347 246 ARILDPNPMTVS-----IYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rp-----s~~~~~~l~~~~ 269 (269)
+.||+.||.+|| ++ .+++.|+|
T Consensus 381 ~~~L~~dP~~R~~~~~~t~--~ell~hp~ 407 (446)
T 4ejn_A 381 SGLLKKDPKQRLGGGSEDA--KEIMQHRF 407 (446)
T ss_dssp HHHTCSSTTTSTTCSTTTH--HHHHTSGG
T ss_pred HHHcccCHHHhCCCCCCCH--HHHHhCcc
Confidence 999999999999 77 77888887
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=331.25 Aligned_cols=261 Identities=46% Similarity=0.851 Sum_probs=224.0
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
..-....++|++.+.||.|++|.||+|.+..+|+.|++|.+...........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 33455678999999999999999999999989999999999776544444467889999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
+..+++|||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999998865432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (269)
. .......+++.|+|||++.+....+.++|+||||+++|+|++|..||.........+.+..+....+..++..+.+
T Consensus 164 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 G---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred C---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 1 1223345788999999998876656899999999999999999999999988888888888888888889999999
Q ss_pred HHHHhcCCCCCCcCCCCccccccccC
Q 024347 244 LIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+|+.||+.||++|||+ .+++.|+|
T Consensus 241 li~~~l~~~p~~Rps~--~~~l~h~~ 264 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATI--KDIREHEW 264 (276)
T ss_dssp HHHHHTCSSGGGSCCH--HHHHHSHH
T ss_pred HHHHHccCChhhCCCH--HHHHhChh
Confidence 9999999999999999 77777765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=341.02 Aligned_cols=253 Identities=36% Similarity=0.669 Sum_probs=223.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|+||.||++.+..+++.||+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999999765443 34457889999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC---CEEEeeCCCccccccccC
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~---~~~l~df~~~~~~~~~~~ 166 (269)
|||++|++|.+.+...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++.....
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~--- 183 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--- 183 (362)
T ss_dssp ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT---
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC---
Confidence 99999999999998888899999999999999999999999999999999999998654 599999999875432
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC----CCCHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTAR 242 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~ 242 (269)
........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+.......+..+....+. .+++++.
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 262 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK 262 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence 222234568999999999988766 48999999999999999999999999998888888877665543 4799999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||..||+.||++||++ .++|.|+|
T Consensus 263 ~li~~~L~~dP~~R~t~--~e~l~hp~ 287 (362)
T 2bdw_A 263 SLIDSMLTVNPKKRITA--DQALKVPW 287 (362)
T ss_dssp HHHHHHSCSSGGGSCCH--HHHTTSHH
T ss_pred HHHHHHcCCChhhCcCH--HHHhcCcc
Confidence 99999999999999999 88888876
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=339.01 Aligned_cols=257 Identities=38% Similarity=0.632 Sum_probs=217.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 56899999999999999999999999999999999865432 2234678899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
||||+++++|.+++.....+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 162 (323)
T 3tki_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (323)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence 99999999999999887789999999999999999999999999999999999999999999999999987654433333
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCcc--cCCCCCCHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEF--TCPPWLSFTARKLI 245 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~~~~~~~l~~li 245 (269)
......+++.|+|||++.+....+.++||||||+++|+|++|..||...... ........... .....+++.+.+||
T Consensus 163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (323)
T 3tki_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (323)
T ss_dssp CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence 3345568999999999988776567899999999999999999999765443 22333322222 22345899999999
Q ss_pred HHhcCCCCCCcCCCCccccccccC
Q 024347 246 ARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.||+.||++|||+ .+++.|+|
T Consensus 243 ~~~L~~dP~~R~t~--~eil~h~~ 264 (323)
T 3tki_A 243 HKILVENPSARITI--PDIKKDRW 264 (323)
T ss_dssp HHHSCSSTTTSCCH--HHHTTCTT
T ss_pred HHHccCChhhCcCH--HHHhhChh
Confidence 99999999999999 78888887
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=335.76 Aligned_cols=245 Identities=20% Similarity=0.274 Sum_probs=190.0
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC----eE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----KI 86 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~ 86 (269)
.+|.+.+.||+|+||+||+|++ +|+.||||++...... ......|+..+.+++||||+++++++...+ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~----~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4689999999999999999998 5889999998654321 123345777788999999999999997653 58
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCceEecCCCCEEEeeCCCc
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--------~i~h~di~~~nIl~~~~~~~~l~df~~~ 158 (269)
++||||+++|+|.+++... .++.+.+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 9999999999999988764 689999999999999999999987 9999999999999999999999999998
Q ss_pred cccccccCC--CcccccccCccccCcccccCCCC-----CCCchhHHHHHHHHHHHHcCCCCCCC---------------
Q 024347 159 ALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDD--------------- 216 (269)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~--------------- 216 (269)
+........ .......||+.|+|||++.+... ++.++||||||+++|+|+||..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 765432221 12233568999999999976531 24689999999999999999766531
Q ss_pred CCHHHHHHHHhcCc--ccCCCC-----CCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 217 SNLMNLYKKISAAE--FTCPPW-----LSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 217 ~~~~~~~~~~~~~~--~~~~~~-----~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.........+.... ++.+.. +++.+.+|+..||+.||++|||++++
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei 288 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 12233333333332 223322 33578999999999999999998554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=330.19 Aligned_cols=259 Identities=34% Similarity=0.624 Sum_probs=205.9
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
++...++|++.+.||+|++|.||+|.+..+++.|++|.+...........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 56778999999999999999999999998999999999976654444445788999999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++++||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999999988775 57999999999999999999999999999999999999999999999999988754322
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 244 (269)
. .......+++.|+|||.+.+... +.++|+||||+++|+|++|..||...........+.......+..++.++.++
T Consensus 166 ~--~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 242 (278)
T 3cok_A 166 H--EKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDL 242 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHH
T ss_pred C--CcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHH
Confidence 1 12223457889999999987666 48999999999999999999999887766666666666667777899999999
Q ss_pred HHHhcCCCCCCcCCCCccccccccC
Q 024347 245 IARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|++||+.||++|||+ .+++.|+|
T Consensus 243 i~~~l~~dp~~Rps~--~~~l~h~~ 265 (278)
T 3cok_A 243 IHQLLRRNPADRLSL--SSVLDHPF 265 (278)
T ss_dssp HHHHSCSSGGGSCCH--HHHTTSTT
T ss_pred HHHHcccCHhhCCCH--HHHhcCcc
Confidence 999999999999999 88888887
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=329.20 Aligned_cols=256 Identities=32% Similarity=0.675 Sum_probs=229.5
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
....++|++.+.||.|++|.||+|.+..+++.+++|.+...........+.+.+|+++++.++||||+++++++.+.+..
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 45578999999999999999999999999999999999765544433456788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+++|||+++++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999987644321
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
......+++.|+|||++.+... +.++|+||||+++|+|++|..||...........+.......++.++..+.++|+
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 244 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS 244 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred --ccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHH
Confidence 2233457899999999987766 4899999999999999999999999988888888888888888889999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.||+.||.+|||+ .+++.|+|
T Consensus 245 ~~l~~~p~~Rps~--~~ll~h~~ 265 (284)
T 2vgo_A 245 KLLRYHPPQRLPL--KGVMEHPW 265 (284)
T ss_dssp HHSCSSGGGSCCH--HHHHTCHH
T ss_pred HHhhcCHhhCCCH--HHHhhCHH
Confidence 9999999999999 77788876
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=326.86 Aligned_cols=258 Identities=33% Similarity=0.537 Sum_probs=231.4
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+...++|++.+.||+|++|.||++.+..+++.+++|.+...........+.+.+|+.+++.++|+||+++++++.+.+..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence 34567899999999999999999999999999999999876655566678899999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+++|||+++++|.+.+...+.+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 168 (294)
T 2rku_A 91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-- 168 (294)
T ss_dssp EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST--
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC--
Confidence 999999999999999888888999999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
........+++.|+|||++.+... +.++|+||||+++|+|++|..||......+....+.......+..+++.+.++|+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (294)
T 2rku_A 169 GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 247 (294)
T ss_dssp TCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred ccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence 122233457889999999987665 4899999999999999999999999988888888888888888889999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.||+.||++|||+ .+++.|+|
T Consensus 248 ~~l~~~p~~Rps~--~~ll~~~~ 268 (294)
T 2rku_A 248 KMLQTDPTARPTI--NELLNDEF 268 (294)
T ss_dssp HHTCSSGGGSCCG--GGGGGSHH
T ss_pred HHcccChhhCcCH--HHHhhChh
Confidence 9999999999999 77777765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=335.64 Aligned_cols=257 Identities=35% Similarity=0.569 Sum_probs=224.3
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
....++|++.+.||.|+||.||++.+..+|+.+|+|.+........ ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 86 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK 86 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 3445689999999999999999999999999999999875432211 1246788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC----CEEEeeCCCcc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSA 159 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~----~~~l~df~~~~ 159 (269)
...++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999999998888899999999999999999999999999999999999998877 79999999987
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----C
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~ 235 (269)
..... .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+....+....+.......+ +
T Consensus 167 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 167 KIDFG---NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp ECCTT---SCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred ECCCC---CccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 54322 22234468999999999987766 4899999999999999999999999888888888776655444 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~--~e~l~hp~ 274 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTI--QDSLQHPW 274 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCH--HHHHHSTT
T ss_pred cCCHHHHHHHHHHccCChhhCCCH--HHHhcCCC
Confidence 589999999999999999999999 88888887
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-51 Score=335.92 Aligned_cols=251 Identities=24% Similarity=0.444 Sum_probs=222.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||+|+||.||++.+..+++.+++|.+.... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence 4679999999999999999999999999999999986443 224668899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC--CCCEEEeeCCCcccccccc
Q 024347 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~--~~~~~l~df~~~~~~~~~~ 165 (269)
||||++|++|.+.+... ..+++.++..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 79 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-- 156 (321)
T 1tki_A 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC--
Confidence 99999999999988765 37999999999999999999999999999999999999987 78999999999875432
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l 241 (269)
........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.......+ +.+++++
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T 1tki_A 157 -GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred -CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHH
Confidence 222334568899999999987665 4899999999999999999999999999998888888776655 3689999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+||+.||+.||.+|||+ .++|.|+|
T Consensus 235 ~~li~~~L~~dp~~Rpt~--~e~l~hp~ 260 (321)
T 1tki_A 235 MDFVDRLLVKERKSRMTA--SEALQHPW 260 (321)
T ss_dssp HHHHHTTSCSSGGGSCCH--HHHHHSHH
T ss_pred HHHHHHHcCCChhHCcCH--HHHhcChh
Confidence 999999999999999999 77888876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=329.86 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=213.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
-++|++.+.||+|++|.||++.+..+++.+|+|.+...........+.+.+|+.++++++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999999999999999998766555666678899999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||++|++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 168 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQ 168 (294)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc-ccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999987543321 112
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-----cCCCCCCHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-----TCPPWLSFTARKL 244 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~l 244 (269)
.....+++.|+|||.+.+... +.++||||||+++|+|++|..||................. ..++.+++.+.++
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 247 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV 247 (294)
T ss_dssp ------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred cCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence 233457999999999988776 4899999999999999999999998887766555544433 2345689999999
Q ss_pred HHHhcCCCCCCcCCC
Q 024347 245 IARILDPNPMTVSIY 259 (269)
Q Consensus 245 i~~~l~~dP~~Rps~ 259 (269)
|..||+.||++||+.
T Consensus 248 i~~~l~~dp~~R~~~ 262 (294)
T 4eqm_A 248 ILRATEKDKANRYKT 262 (294)
T ss_dssp HHHHSCSSGGGSCSS
T ss_pred HHHHhcCCHhHcccc
Confidence 999999999999965
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=327.38 Aligned_cols=254 Identities=32% Similarity=0.481 Sum_probs=211.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||+|++|+||+|.+..+++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 3689999999999999999999999999999999976543 233356788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+++ ++...+.. .+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 999976 55555544 57899999999999999999999999999999999999999999999999999875432 122
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHhcCc-----------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAE----------------- 230 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~----------------- 230 (269)
......+++.|+|||++.+....+.++||||||+++|+|++|..| |...+.......+....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 233445788999999998777556999999999999999987777 56666665555543210
Q ss_pred ------------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ------------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+.+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~e~l~hp~ 285 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA--EEALQHPY 285 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCH--HHHhcCcc
Confidence 01122478899999999999999999999 88899987
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=334.12 Aligned_cols=260 Identities=33% Similarity=0.569 Sum_probs=217.9
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
....++|++.+.||+|+||.||++++. .+++.+|+|++...... .......+.+|+.+++.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 92 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT 92 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence 456789999999999999999999985 57999999998754322 22334667889999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
.+..++||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999886432
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHH
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (269)
. .........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...+.......+.......++.+++.+.
T Consensus 173 ~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 249 (327)
T 3a62_A 173 H--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR 249 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred c--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 2 1122233468899999999987766 489999999999999999999999999999999998888888899999999
Q ss_pred HHHHHhcCCCCCCcCCCC---ccccccccC
Q 024347 243 KLIARILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
+||+.||+.||++||++. ..+++.|+|
T Consensus 250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp HHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred HHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 999999999999999652 256777776
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=324.12 Aligned_cols=255 Identities=35% Similarity=0.663 Sum_probs=224.8
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||.|++|.||+|.+..+++.+++|++...... ....+.+.+|+.++++++||||+++++++...+..+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEE
Confidence 3468999999999999999999999999999999999765543 344578889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC---EEEeeCCCccccccc
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALSQQV 164 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~---~~l~df~~~~~~~~~ 164 (269)
++|||+++++|.+.+.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~- 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND- 160 (284)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc-
Confidence 99999999999999988888999999999999999999999999999999999999986655 99999999865432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 240 (269)
........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+..+....+ ..+++.
T Consensus 161 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T 3kk8_A 161 --SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE 237 (284)
T ss_dssp --SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred --CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence 222233567899999999988766 4899999999999999999999999998888888877665444 358999
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+||+.||+.||++|||+ .+++.|+|
T Consensus 238 ~~~li~~~l~~dp~~Rps~--~~~l~h~~ 264 (284)
T 3kk8_A 238 AKSLIDSMLTVNPKKRITA--DQALKVPW 264 (284)
T ss_dssp HHHHHHHHSCSSTTTSCCH--HHHTTSHH
T ss_pred HHHHHHHHcccChhhCCCH--HHHhcCcc
Confidence 9999999999999999999 78888876
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-50 Score=332.42 Aligned_cols=257 Identities=33% Similarity=0.540 Sum_probs=231.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||+|+||.||++.+..+++.+++|.+...........+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34578999999999999999999999999999999998766555666788999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
++|||+++++|.+++...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... .
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~ 195 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD--G 195 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCST--T
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccC--c
Confidence 99999999999999888888999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 247 (269)
.......+++.|+|||++.+... +.++||||||+++|+|++|..||......+....+.......+..+++.+.+||+.
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 274 (335)
T 2owb_A 196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274 (335)
T ss_dssp CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 22234457899999999987766 48999999999999999999999998888888888888888888899999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+.||++|||+ .+++.|+|
T Consensus 275 ~l~~dp~~Rps~--~ell~~~~ 294 (335)
T 2owb_A 275 MLQTDPTARPTI--NELLNDEF 294 (335)
T ss_dssp HTCSSGGGSCCG--GGGGGSHH
T ss_pred HccCChhHCcCH--HHHhcCcc
Confidence 999999999999 77787765
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=338.14 Aligned_cols=255 Identities=40% Similarity=0.709 Sum_probs=210.9
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+....++|++.+.||+|+||.||++++..+++.||+|.+....... +.+.+|+.+++.++||||+++++++.+.+.
T Consensus 15 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 90 (361)
T 3uc3_A 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTH 90 (361)
T ss_dssp CCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence 3456789999999999999999999999999999999997644322 457789999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC--EEEeeCCCcccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSALSQQ 163 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~--~~l~df~~~~~~~~ 163 (269)
.++||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||+++....
T Consensus 91 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred EEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999999999999988888999999999999999999999999999999999999987665 99999998863222
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCcccCCC--CC
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPP--WL 237 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~~~--~~ 237 (269)
........+++.|+|||++.+..+.+.++||||||+++|+|++|..||.... .......+.......+. .+
T Consensus 171 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (361)
T 3uc3_A 171 ---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCC
T ss_pred ---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCC
Confidence 2222334689999999999888776566999999999999999999997643 34555555555554443 58
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 238 SFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++.+.+||++||+.||++|||+ .+++.|+|
T Consensus 248 s~~~~~li~~~L~~dP~~Rps~--~ell~hp~ 277 (361)
T 3uc3_A 248 SPECCHLISRIFVADPATRISI--PEIKTHSW 277 (361)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCH--HHHHTSHH
T ss_pred CHHHHHHHHHHccCChhHCcCH--HHHHhCcc
Confidence 9999999999999999999999 77888876
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=323.26 Aligned_cols=252 Identities=38% Similarity=0.629 Sum_probs=224.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||+|++|.||+|.+..++..+++|.+....... .+.+.+|+.+++.++||||+++++++.+....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 34568999999999999999999999999999999987654332 467889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---cCCCCEEEeeCCCccccccc
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~---~~~~~~~l~df~~~~~~~~~ 164 (269)
+||||+++++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~- 161 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP- 161 (277)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT-
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC-
Confidence 999999999999999888889999999999999999999999999999999999999 7888999999998865432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC----CCCHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFT 240 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~ 240 (269)
........+++.|+|||++.+. .+.++||||||+++|+|++|..||...........+..+....+. .+++.
T Consensus 162 --~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (277)
T 3f3z_A 162 --GKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQ 237 (277)
T ss_dssp --TSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHH
T ss_pred --ccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHH
Confidence 2233345688999999998765 358999999999999999999999999998888888887776664 58999
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+||+.||+.||++|||+ .+++.|+|
T Consensus 238 ~~~li~~~l~~dp~~R~s~--~~~l~h~~ 264 (277)
T 3f3z_A 238 AESLIRRLLTKSPKQRITS--LQALEHEW 264 (277)
T ss_dssp HHHHHHHHTCSSTTTSCCH--HHHTTSHH
T ss_pred HHHHHHHHccCChhhCcCH--HHHhcCHH
Confidence 9999999999999999999 88888876
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-50 Score=328.30 Aligned_cols=258 Identities=35% Similarity=0.637 Sum_probs=214.8
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh-----------------------HHHHHHHHHHHH
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-----------------------HKMAEQIKREVA 63 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-----------------------~~~~~~~~~e~~ 63 (269)
....++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+.+.+|++
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 88 (298)
T 2zv2_A 9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA 88 (298)
T ss_dssp -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence 345789999999999999999999999999999999987543221 122466889999
Q ss_pred HhhhCCCCCceeeeEEEee--CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 024347 64 TMKLVKHPNVVRLYEVMGS--KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (269)
Q Consensus 64 ~l~~l~~~~i~~~~~~~~~--~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~n 141 (269)
+++.++||||+++++++.+ ....++||||+++++|.+.. ..+.+++.++..++.|++.||.|||+.|++|+||+|+|
T Consensus 89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 9999999999999999976 56899999999999987754 34579999999999999999999999999999999999
Q ss_pred eEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCH
Q 024347 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDSNL 219 (269)
Q Consensus 142 Il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 219 (269)
|+++.++.++|+|||++...... ........+++.|+|||++.+... .+.++||||||+++|+|++|..||.....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999998754321 122233468999999999976553 35789999999999999999999999888
Q ss_pred HHHHHHHhcCcccCC--CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 220 MNLYKKISAAEFTCP--PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 220 ~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
......+.......+ +.+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~--~e~l~hp~ 295 (298)
T 2zv2_A 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVV--PEIKLHPW 295 (298)
T ss_dssp HHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCH--HHHTTCHH
T ss_pred HHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCH--HHHhcCcc
Confidence 887777766654443 5689999999999999999999999 78888887
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=337.96 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=216.3
Q ss_pred ccccccCCeEEeeeeecc--CCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 5 KIKRRVGKYEVGRTIGEG--TFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g--~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
.+....++|++.+.||+| ++|.||++.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 456677899999999999 999999999999999999999976543 34556788999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||.+..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 99999999999999999998775 6799999999999999999999999999999999999999999999999998754
Q ss_pred ccccc-----CCCcccccccCccccCcccccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---
Q 024347 161 SQQVR-----DDGLLHTTCGTPNYVAPEVLNDR-GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--- 231 (269)
Q Consensus 161 ~~~~~-----~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--- 231 (269)
..... .........+++.|+|||++.+. ..++.++||||||+++|+|++|..||.+............+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 257 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcc
Confidence 32211 11122233578889999999873 2345899999999999999999999987554444333322211
Q ss_pred -------------------------------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCcccccccc
Q 024347 232 -------------------------------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMR 268 (269)
Q Consensus 232 -------------------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~ 268 (269)
+.+..+++.+.+||+.||+.||++|||+ .++|.|+
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta--~ell~hp 335 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA--STLLNHS 335 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCH--HHHTTSG
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCH--HHHhcCH
Confidence 1334578899999999999999999999 7888888
Q ss_pred C
Q 024347 269 F 269 (269)
Q Consensus 269 ~ 269 (269)
|
T Consensus 336 ~ 336 (389)
T 3gni_B 336 F 336 (389)
T ss_dssp G
T ss_pred H
Confidence 7
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=334.65 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=215.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC---
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--- 84 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--- 84 (269)
...++|++.+.||.|++|.||++.+..+++.||+|++.............+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 34678999999999999999999999999999999998766666666788999999999999999999999986644
Q ss_pred -eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 -KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 -~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++||||++|++|.+++...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 168 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred cccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence 3499999999999999998888899999999999999999999999999999999999999999999999999875443
Q ss_pred ccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC----CCCCC
Q 024347 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----PPWLS 238 (269)
Q Consensus 164 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~ 238 (269)
.... .......+++.|+|||++.+..+. .++||||||+++|+|++|..||................... ...++
T Consensus 169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (311)
T 3ork_A 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 247 (311)
T ss_dssp -------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred cccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence 2211 222334579999999999887664 89999999999999999999999988877766665544322 24589
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 239 FTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+++.+||..||+.||++||++ ++.+.+.|
T Consensus 248 ~~l~~li~~~l~~dP~~R~~~--~~~l~~~l 276 (311)
T 3ork_A 248 ADLDAVVLKALAKNPENRYQT--AAEMRADL 276 (311)
T ss_dssp HHHHHHHHHHTCSSGGGSCSS--HHHHHHHH
T ss_pred HHHHHHHHHHHhcCHhhChhh--HHHHHHHH
Confidence 999999999999999999998 66665543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-50 Score=334.00 Aligned_cols=254 Identities=33% Similarity=0.606 Sum_probs=215.1
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH--HHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH--KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
-++|++.+.||+|+||.||++.+..+++.||+|++........ ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3679999999999999999999999999999999976443211 12467889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC---EEEeeCCCccc
Q 024347 88 IVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSAL 160 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~---~~l~df~~~~~ 160 (269)
+||||++|++|.+.+... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++. ++|+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998777543 35899999999999999999999999999999999999986654 99999999875
Q ss_pred cccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CC
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PW 236 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~ 236 (269)
.... ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||... .......+..+....+ ..
T Consensus 183 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~ 258 (351)
T 3c0i_A 183 LGES--GLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH 258 (351)
T ss_dssp CCTT--SCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred ecCC--CeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence 4431 112234468999999999987766 49999999999999999999999875 3455666665555444 45
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 259 ~s~~~~~li~~~L~~dP~~R~s~--~e~l~hp~ 289 (351)
T 3c0i_A 259 ISESAKDLVRRMLMLDPAERITV--YEALNHPW 289 (351)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCH--HHHHTSHH
T ss_pred CCHHHHHHHHHHCCCChhHCcCH--HHHhcChh
Confidence 89999999999999999999999 77888876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=346.31 Aligned_cols=260 Identities=26% Similarity=0.364 Sum_probs=227.1
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+...++|++.+.||+|+||.||+++++.+|+.||+|++...........+.+.+|+++++.++||||+++++++.+....
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence 45678999999999999999999999999999999999876554444457788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 87 FIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
++||||++|++|..++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++....
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999888763 369999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhcCcccCCCCCC
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLS 238 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~ 238 (269)
.. ........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||... ........+.......+..++
T Consensus 341 ~~--~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s 417 (543)
T 3c4z_A 341 AG--QTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFS 417 (543)
T ss_dssp TT--CCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred CC--CcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccC
Confidence 22 112233468999999999988766 49999999999999999999999765 456777777778888888999
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCc---cccccccC
Q 024347 239 FTARKLIARILDPNPMTVSIYPF---ADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~---~~~l~~~~ 269 (269)
+.+.+||+.||+.||++||++.+ .+++.|+|
T Consensus 418 ~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf 451 (543)
T 3c4z_A 418 PASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451 (543)
T ss_dssp HHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred HHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence 99999999999999999998743 56777776
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=329.11 Aligned_cols=257 Identities=32% Similarity=0.545 Sum_probs=224.7
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
....++|++.+.||.|++|.||++.+..+|+.+|+|.+........ ...+.+.+|+.++++++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 3445789999999999999999999999999999999875432211 1246788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC----CEEEeeCCCcc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSA 159 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~----~~~l~df~~~~ 159 (269)
...++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999999998888899999999999999999999999999999999999999887 79999999987
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----C
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~ 235 (269)
..... .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||......+....+.......+ .
T Consensus 168 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 168 EIEDG---VEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp ECCTT---CCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ecCcc---ccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 54432 22233457899999999987766 4899999999999999999999999888888888877665554 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~--~e~l~hp~ 275 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTI--QEALRHPW 275 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCH--HHHHHSTT
T ss_pred ccCHHHHHHHHHHcCCChhhCcCH--HHHhcCcc
Confidence 589999999999999999999999 78888887
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=334.90 Aligned_cols=254 Identities=26% Similarity=0.500 Sum_probs=221.2
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+...++|++.+.||.|+||.||+|.+..+|+.+|+|.+..... .....+.+|+++++.++||||+++++++.+....
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEE
Confidence 4556799999999999999999999999999999999875432 2245788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC--CCCEEEeeCCCcccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~--~~~~~l~df~~~~~~~~ 163 (269)
++||||++|++|.+.+...+ .+++..+..++.|++.||.|||+.||+|+||+|+||+++. ++.++|+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 99999999999999887653 7999999999999999999999999999999999999974 46799999999875432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 239 (269)
........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+ ..+++
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 279 (387)
T 1kob_A 204 ---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279 (387)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCH
Confidence 222334468999999999987766 4899999999999999999999999888888888776654433 45899
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++.+||+.||+.||++|||+ .+++.|+|
T Consensus 280 ~~~~li~~~L~~dP~~Rpt~--~ell~hp~ 307 (387)
T 1kob_A 280 EAKDFIKNLLQKEPRKRLTV--HDALEHPW 307 (387)
T ss_dssp HHHHHHHTTSCSSGGGSCCH--HHHHTSTT
T ss_pred HHHHHHHHHcCCChhHCcCH--HHHhhCcc
Confidence 99999999999999999999 88888887
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=342.09 Aligned_cols=260 Identities=32% Similarity=0.527 Sum_probs=223.6
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+....++|++.+.||+|+||.||+|+++.+++.||+|++...........+.+.+|..+++.++||||+++++++.+...
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 45667899999999999999999999999999999999976443333333457889999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 144 ~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~ 222 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG 222 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence 9999999999999988765 468999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCccccCcccccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc----ccCCCCCC
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGY---DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----FTCPPWLS 238 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~ 238 (269)
........+++.|+|||++.+... ++.++|+||||+++|+|++|..||.+.+......++.... ++....++
T Consensus 223 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s 301 (410)
T 3v8s_A 223 -MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301 (410)
T ss_dssp -EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred -cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence 111234568999999999986542 3589999999999999999999999999999888887643 33334699
Q ss_pred HHHHHHHHHhcCCCCCC--cCCCCccccccccC
Q 024347 239 FTARKLIARILDPNPMT--VSIYPFADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~--Rps~~~~~~l~~~~ 269 (269)
+++++||+.||+.+|.+ ||++ .+++.|+|
T Consensus 302 ~~~~~li~~lL~~~~~rlgR~~~--~ei~~Hp~ 332 (410)
T 3v8s_A 302 KEAKNLICAFLTDREVRLGRNGV--EEIKRHLF 332 (410)
T ss_dssp HHHHHHHHHHSSCGGGCTTSSCH--HHHHTSGG
T ss_pred HHHHHHHHHHccChhhhCCCCCH--HHHhcCcc
Confidence 99999999999999988 9998 77888887
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=327.82 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=210.4
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
......++|++.+.||.|+||+||+|.+. +++.||+|.+..... .....+.+.+|+++++.++||||+++++++.+..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 34556789999999999999999999985 589999999865432 2333567889999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++||||+++ ++.+.+... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+.....
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred EEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99999999975 777777664 4599999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---Ccc---------
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISA---AEF--------- 231 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~---~~~--------- 231 (269)
. ........+++.|+|||++.+....+.++||||||+++|+|++|..||.+....+....+.. ...
T Consensus 172 ~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 172 P--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp C--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred C--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 2 22223345789999999998755556999999999999999999999987665554444422 000
Q ss_pred ------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 ------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.+++++.+||+.||++||++|||+ .+++.|+|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~ 303 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISA--RDAMNHPY 303 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCH--HHHHTSGG
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCH--HHHhcCcc
Confidence 0112367899999999999999999999 88899987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=342.71 Aligned_cols=261 Identities=27% Similarity=0.485 Sum_probs=223.3
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+....++|++.+.||+|+||.||+|+++.+++.||+|++.............+.+|..++..++||||+++++++.+.+.
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 34567899999999999999999999999999999999976544333334458889999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++||||++|++|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 9999999999999999987 468999999999999999999999999999999999999999999999999998654321
Q ss_pred cCCCcccccccCccccCcccccC----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cccCCC---
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPP--- 235 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~--- 235 (269)
.........|++.|+|||++.. ...++.++|+||||+++|+|++|..||.+.+..+....+... .+..+.
T Consensus 229 -~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 307 (437)
T 4aw2_A 229 -GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT 307 (437)
T ss_dssp -SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred -CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence 1112233568999999999862 233358999999999999999999999999998888888653 244443
Q ss_pred CCCHHHHHHHHHhcCCCCCC--cCCCCccccccccC
Q 024347 236 WLSFTARKLIARILDPNPMT--VSIYPFADILYMRF 269 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~--Rps~~~~~~l~~~~ 269 (269)
.+++++++||+.||..+|++ ||++ .+++.|+|
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~--~eil~Hpf 341 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGI--EDFKKHPF 341 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTT--HHHHTSGG
T ss_pred cCCHHHHHHHHHHhcccccccCCCCH--HHHhCCCc
Confidence 48999999999999999888 9998 78888887
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=329.91 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=199.5
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||+|++|.||+|.+..+|+.||+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence 45789999999999999999999999999999999875432 1223567789999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 89 VLEFVTGGELFDKIVNH------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
||||+++ +|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+....
T Consensus 81 v~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 81 VFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp EEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred EEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 9999985 888887653 358999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--c----------
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--E---------- 230 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~---------- 230 (269)
.. ........+++.|+|||++.+....+.++||||||+++|+|++|..||.+....+....+... .
T Consensus 160 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IP--VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SC--CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CC--cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 21 122234457899999999987554569999999999999999999999988877766655321 0
Q ss_pred ----------------------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ----------------------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ----------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
......+++++.+||+.||+.||++|||+ .+++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~--~e~l~hp~ 296 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA--KQALHHPW 296 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH--HHHTTSGG
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH--HHHhCChh
Confidence 01122478899999999999999999999 88888887
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=328.25 Aligned_cols=255 Identities=27% Similarity=0.429 Sum_probs=210.9
Q ss_pred CccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe
Q 024347 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (269)
Q Consensus 2 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 81 (269)
+...+....++|++.+.||+|+||.||+|.+ +|+.||+|++..... .....+.+.+|+.++++++||||+++++++.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 104 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 3445677889999999999999999999987 578899999875543 3344678899999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEecCCCCEEEeeCC
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHGR---MKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFG 156 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~~~~~~~l~df~ 156 (269)
+.+..++||||+++++|.+++...+. +++..+..++.|++.||.|||+.| ++|+||+|+||+++.++.++|+|||
T Consensus 105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg 184 (309)
T 3p86_A 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFG 184 (309)
T ss_dssp STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC
T ss_pred ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCC
Confidence 99999999999999999999887543 899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCcccCC
Q 024347 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKIS--AAEFTCP 234 (269)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~ 234 (269)
++...... ........+++.|+|||++.+... +.++||||||+++|+|++|..||...........+. ......+
T Consensus 185 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 261 (309)
T 3p86_A 185 LSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 261 (309)
T ss_dssp -------------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred CCcccccc--ccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 98743321 112234467899999999988776 489999999999999999999999988887777663 4455667
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+++.+.+||+.||+.||.+|||++++
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~l 289 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATI 289 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 8899999999999999999999998554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=324.76 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=212.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||+|++|.||+|.+..+|+.||+|.+.... ......+.+.+|+.++++++||||+++++++...+..++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 478999999999999999999999999999999986543 2344467788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||++++++...+...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 158 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS--DY 158 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--cc
Confidence 9999999998888877889999999999999999999999999999999999999999999999999987544221 12
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------------
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------------- 229 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------------- 229 (269)
.....+++.|+|||++.+....+.++||||||+++|+|++|..||.+....+....+...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238 (311)
T ss_dssp -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence 233457889999999987555569999999999999999999999988776655544221
Q ss_pred -cccCC----------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 -EFTCP----------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 -~~~~~----------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+.+ +.+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~ 287 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC--EQLLHHPY 287 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCH--HHHHTSGG
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCH--HHHhcChH
Confidence 01111 3478889999999999999999999 88888887
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=320.40 Aligned_cols=257 Identities=38% Similarity=0.637 Sum_probs=218.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||.|++|.||+|.+..+++.|++|.+...... ...+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEE
Confidence 457899999999999999999999999999999998755432 235778899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
++||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 162 (276)
T 2yex_A 83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162 (276)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence 99999999999988877789999999999999999999999999999999999999999999999999987654332222
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCcc--cCCCCCCHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEF--TCPPWLSFTARKLI 245 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~--~~~~~~~~~l~~li 245 (269)
......+++.|+|||++.+....+.++|+||||+++|+|++|..||...... ........... .....+++.+.+||
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 242 (276)
T 2yex_A 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 242 (276)
T ss_dssp CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHH
Confidence 3344567899999999987776557899999999999999999999865432 22333332222 22345899999999
Q ss_pred HHhcCCCCCCcCCCCccccccccC
Q 024347 246 ARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.||+.||++|||+ .+++.|+|
T Consensus 243 ~~~l~~~p~~Rps~--~~il~~~~ 264 (276)
T 2yex_A 243 HKILVENPSARITI--PDIKKDRW 264 (276)
T ss_dssp HHHSCSSTTTSCCH--HHHTTCTT
T ss_pred HHHCCCCchhCCCH--HHHhcCcc
Confidence 99999999999999 78888887
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=328.22 Aligned_cols=249 Identities=35% Similarity=0.659 Sum_probs=198.1
Q ss_pred cCCeEEe---eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCe
Q 024347 10 VGKYEVG---RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (269)
Q Consensus 10 ~~~~~~~---~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 85 (269)
+++|++. +.||+|+||.||++.+..+++.||+|.+.... .....+|+.+++.+. ||||+++++++.+...
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~ 80 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFHDQLH 80 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence 4667775 78999999999999999999999999986542 356678999999997 9999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC---CEEEeeCCCccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALSQ 162 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~---~~~l~df~~~~~~~ 162 (269)
.++||||++|++|.+++...+.+++.++..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~ 160 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160 (325)
T ss_dssp EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence 999999999999999999888999999999999999999999999999999999999998665 79999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHhcCcccCCC
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN-------LMNLYKKISAAEFTCPP 235 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------~~~~~~~~~~~~~~~~~ 235 (269)
.. ........+++.|+|||++.+..+. .++||||||+++|+|++|..||.... ..+....+..+....+.
T Consensus 161 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~ 237 (325)
T 3kn6_A 161 PD--NQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG 237 (325)
T ss_dssp C------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred CC--CCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence 22 2222334578999999999877764 89999999999999999999997643 35667777777665553
Q ss_pred ----CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 236 ----WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 236 ----~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+++++.+||+.||+.||++|||+ .+++.|+|
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~--~ell~h~w 273 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKM--SGLRYNEW 273 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCT--TTSTTCGG
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCH--HHHhcChh
Confidence 489999999999999999999999 77888887
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-50 Score=349.87 Aligned_cols=255 Identities=36% Similarity=0.628 Sum_probs=225.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||+|+||.||++.+..+++.||+|++...........+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34578999999999999999999999999999999997654433344678899999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---cCCCCEEEeeCCCccccccc
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~---~~~~~~~l~df~~~~~~~~~ 164 (269)
+||||+.+++|.+.+...+.+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++.....
T Consensus 103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~- 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA- 181 (484)
T ss_dssp EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc-
Confidence 999999999999999888899999999999999999999999999999999999999 5678899999998865432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFT 240 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~ 240 (269)
........+++.|+|||++.+ .+ +.++||||||+++|+|++|..||.+.+..+....+..+....+ ..+++.
T Consensus 182 --~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 257 (484)
T 3nyv_A 182 --SKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257 (484)
T ss_dssp --CCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred --ccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence 222334568999999999976 33 5899999999999999999999999999999888887765443 358999
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+++||+.||+.||++|||+ .++|.|+|
T Consensus 258 ~~~li~~~L~~dp~~R~s~--~e~l~h~~ 284 (484)
T 3nyv_A 258 AKDLIRKMLTYVPSMRISA--RDALDHEW 284 (484)
T ss_dssp HHHHHHHHTCSSGGGSCCH--HHHHTSHH
T ss_pred HHHHHHHHCCCChhHCcCH--HHHhhChh
Confidence 9999999999999999999 88888887
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=345.11 Aligned_cols=256 Identities=33% Similarity=0.624 Sum_probs=221.7
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH----------HHHHHHHHHHHHhhhCCCCCceee
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH----------KMAEQIKREVATMKLVKHPNVVRL 76 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~ 76 (269)
+.-.++|++.+.||+|+||+||+|.++.+++.+|+|++........ ...+.+.+|+.++++++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3456789999999999999999999999999999999976543221 235678899999999999999999
Q ss_pred eEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC---CEEEe
Q 024347 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVS 153 (269)
Q Consensus 77 ~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~---~~~l~ 153 (269)
++++.+....++||||++|++|.+.+...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999998888899999999999999999999999999999999999998776 69999
Q ss_pred eCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC
Q 024347 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC 233 (269)
Q Consensus 154 df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 233 (269)
|||++..... ........+++.|+|||++.+. + +.++||||||+++|+|++|..||.+.+..+....+..+....
T Consensus 192 Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~ 266 (504)
T 3q5i_A 192 DFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKKK-Y-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF 266 (504)
T ss_dssp CCTTCEECCT---TSCBCCCCSCTTTCCHHHHTTC-B-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred ECCCCEEcCC---CCccccccCCcCCCCHHHhccC-C-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9999875433 2223345689999999998753 3 589999999999999999999999999999999998887655
Q ss_pred C----CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 234 P----PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 234 ~----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+ ..+++++++||+.||++||.+|||+ .++|.|+|
T Consensus 267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~--~e~l~h~~ 304 (504)
T 3q5i_A 267 DFNDWKNISDEAKELIKLMLTYDYNKRCTA--EEALNSRW 304 (504)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCH--HHHHTSHH
T ss_pred CccccCCCCHHHHHHHHHHcCCChhHCCCH--HHHhcCHh
Confidence 4 5689999999999999999999999 88888887
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-49 Score=354.98 Aligned_cols=259 Identities=30% Similarity=0.512 Sum_probs=230.5
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 86 (269)
...++|++.+.||+|+||.||+|+++.+++.||+|++...........+.+..|..++..+ +|++|+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4567899999999999999999999999999999999876544444567788899999887 699999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||++|++|..++...+.+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||+++.... .
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--T
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--C
Confidence 99999999999999999888999999999999999999999999999999999999999999999999999874322 2
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 246 (269)
........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||.+.+..+..+.+......++..+++++.+||+
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 223344568999999999987776 4999999999999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCCcCCCC---ccccccccC
Q 024347 247 RILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
.||+.||++||++. ..+++.|+|
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAF 600 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCcc
Confidence 99999999999972 245667766
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=338.15 Aligned_cols=261 Identities=27% Similarity=0.480 Sum_probs=221.9
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
++....++|++.+.||+|+||.||+++++.+|+.||+|++...........+.+.+|.+++..++||||+++++++.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 34556789999999999999999999999999999999997655444444556889999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++||||++|++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++.....
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999999999999775 4799999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCccccCcccccC------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--ccCC-
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLND------RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FTCP- 234 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~- 234 (269)
.. ........+++.|+|||++.. ...++.++|+||||+++|+|++|+.||...+..+...++.... ...+
T Consensus 215 ~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~ 293 (412)
T 2vd5_A 215 DG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL 293 (412)
T ss_dssp TS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred CC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence 11 111223468999999999873 2223589999999999999999999999999888888886532 3333
Q ss_pred --CCCCHHHHHHHHHhcCCCCCCcC---CCCccccccccC
Q 024347 235 --PWLSFTARKLIARILDPNPMTVS---IYPFADILYMRF 269 (269)
Q Consensus 235 --~~~~~~l~~li~~~l~~dP~~Rp---s~~~~~~l~~~~ 269 (269)
..+++++++||++||. +|++|+ ++ .+++.|+|
T Consensus 294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~--~ei~~Hpf 330 (412)
T 2vd5_A 294 VDEGVPEEARDFIQRLLC-PPETRLGRGGA--GDFRTHPF 330 (412)
T ss_dssp ---CCCHHHHHHHHTTSS-CGGGCTTTTTH--HHHHTSGG
T ss_pred cccCCCHHHHHHHHHHcC-ChhhcCCCCCH--HHHhcCCC
Confidence 4689999999999999 999995 66 67788877
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=346.87 Aligned_cols=259 Identities=26% Similarity=0.393 Sum_probs=225.0
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+...++|++.+.||.|+||.||++.+..+|+.||+|++.............+.+|+++++.++||||+++++++.+.+..
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 45678899999999999999999999999999999999876544444456788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
++||||++|++|..++...+ .+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~- 338 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE- 338 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT-
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc-
Confidence 99999999999998887654 499999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhcCcccCCCCCCHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS----NLMNLYKKISAAEFTCPPWLSFT 240 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 240 (269)
........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||... ........+.......+..++++
T Consensus 339 --~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~ 415 (576)
T 2acx_A 339 --GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQ 415 (576)
T ss_dssp --TCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred --CccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHH
Confidence 222234568999999999988766 49999999999999999999999865 34566677777777778889999
Q ss_pred HHHHHHHhcCCCCCCcCCC---CccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIY---PFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~---~~~~~l~~~~ 269 (269)
+++||+.||+.||.+||+. ...+++.|+|
T Consensus 416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred HHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 9999999999999999953 1267788887
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=344.52 Aligned_cols=255 Identities=33% Similarity=0.588 Sum_probs=222.0
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+...++|++.+.||+|+||+||++.+..+++.||+|++........ ....+.+|+.++++++||||+++++++.+....
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccch-HHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 4456789999999999999999999999999999999976543222 246788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec---CCCCEEEeeCCCcccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~---~~~~~~l~df~~~~~~~~ 163 (269)
++||||+.|++|.+.+...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++ .++.++|+|||++.....
T Consensus 97 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 99999999999999998888999999999999999999999999999999999999995 455799999999875432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 239 (269)
........+++.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+..+....+ ..+++
T Consensus 177 ---~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 251 (486)
T 3mwu_A 177 ---NTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (486)
T ss_dssp ---C----CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCH
T ss_pred ---CCccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCH
Confidence 2223345689999999999764 45899999999999999999999999999988888877765443 35899
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+++||+.||+.||++|||+ .++|.|+|
T Consensus 252 ~~~~li~~~L~~dp~~R~t~--~~~l~hp~ 279 (486)
T 3mwu_A 252 DAKDLIRKMLTFHPSLRITA--TQCLEHPW 279 (486)
T ss_dssp HHHHHHHHHTCSSTTTSCCH--HHHHHCHH
T ss_pred HHHHHHHHHcCCChhhCcCH--HHHhcCHh
Confidence 99999999999999999999 78888876
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=329.57 Aligned_cols=251 Identities=36% Similarity=0.637 Sum_probs=203.6
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||+|++|.||+|.+..+++.||+|++.... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34567999999999999999999999999999999987542 2456788999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC---CCCEEEeeCCCccccccc
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~---~~~~~l~df~~~~~~~~~ 164 (269)
+||||+++++|.+.+...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~- 203 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH- 203 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc-
Confidence 99999999999999988888999999999999999999999999999999999999975 78899999998875432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCcccCC----CCCCH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP----PWLSF 239 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~----~~~~~ 239 (269)
........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...... .....+.......+ ..++.
T Consensus 204 --~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 280 (349)
T 2w4o_A 204 --QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSL 280 (349)
T ss_dssp -----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCH
T ss_pred --ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCH
Confidence 112233457899999999988766 48999999999999999999999765544 36666665554332 45899
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~--~e~l~hp~ 308 (349)
T 2w4o_A 281 NAKDLVRKLIVLDPKKRLTT--FQALQHPW 308 (349)
T ss_dssp HHHHHHHTTSCSSGGGSCCH--HHHHHSTT
T ss_pred HHHHHHHHHccCChhhCcCH--HHHhcCcc
Confidence 99999999999999999999 88888887
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=322.14 Aligned_cols=253 Identities=30% Similarity=0.448 Sum_probs=209.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||.|+||.||+|.+ .+++.+|+|.+...... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 36899999999999999999998 57899999998654322 22236678899999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+++ +|.+.+... +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc--cc
Confidence 999976 888888764 67999999999999999999999999999999999999999999999999988654321 11
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cc---------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EF--------------- 231 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------------- 231 (269)
......+++.|+|||++.+....+.++||||||+++|+|++|..||...........+... ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 2233457899999999977655569999999999999999999999988776665554321 00
Q ss_pred ------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 ------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.....+++.+.+||++||+.||++|||+ .+++.|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~e~l~hp~ 283 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA--KQALEHAY 283 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH--HHHHTSGG
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCH--HHHhcCcc
Confidence 1123478999999999999999999999 88888887
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=329.75 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=208.2
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
......++|++.+.||+|++|.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (329)
T 3gbz_A 28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH 106 (329)
T ss_dssp ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence 446678899999999999999999999999999999999865432 2333567789999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec-----CCCCEEEeeCCCcc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-----AYGNLKVSDFGLSA 159 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~-----~~~~~~l~df~~~~ 159 (269)
..++||||+++ +|.+++.....+++..+..++.|++.||.|||+.||+|+||+|+||+++ .++.++|+|||.+.
T Consensus 107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99999999975 9999998888899999999999999999999999999999999999995 44459999999987
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-ccC-----
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTC----- 233 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~----- 233 (269)
..... ........+++.|+|||++.+....+.++||||||+++|+|++|..||...........+.... .+.
T Consensus 186 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 186 AFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence 54321 1222334568899999999876655699999999999999999999999888776666653210 000
Q ss_pred ------------------------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 234 ------------------------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 234 ------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+..+++++.+||+.||+.||++|||+ .+++.|+|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~e~l~hp~ 321 (329)
T 3gbz_A 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA--KNALEHPY 321 (329)
T ss_dssp TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH--HHHHTSGG
T ss_pred hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH--HHHhCCcc
Confidence 01167899999999999999999999 88899987
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=333.56 Aligned_cols=256 Identities=30% Similarity=0.422 Sum_probs=204.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCC--e
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT--K 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~--~ 85 (269)
..++|++.+.||.|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.+. ||||+++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3579999999999999999999999999999999986432 23444677889999999997 999999999997544 7
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||++ ++|...+.. +.++...+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 899999997 488877765 579999999999999999999999999999999999999999999999999987543211
Q ss_pred C-------------------CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 024347 166 D-------------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226 (269)
Q Consensus 166 ~-------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 226 (269)
. ........+++.|+|||++.+...++.++|||||||++|+|++|..||.+.+.......+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1 112233468899999999987555569999999999999999999999988877766665
Q ss_pred hcCc-c----------------------------------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCC
Q 024347 227 SAAE-F----------------------------------------------TCPPWLSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 227 ~~~~-~----------------------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
...- . .....+++.+.+||++||+.||++|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 3210 0 0112578899999999999999999999
Q ss_pred CccccccccC
Q 024347 260 PFADILYMRF 269 (269)
Q Consensus 260 ~~~~~l~~~~ 269 (269)
.++|.|+|
T Consensus 324 --~e~l~Hp~ 331 (388)
T 3oz6_A 324 --NDALKHPF 331 (388)
T ss_dssp --HHHTTSTT
T ss_pred --HHHhCCHH
Confidence 88899987
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=319.04 Aligned_cols=254 Identities=31% Similarity=0.553 Sum_probs=215.2
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+...++|++.+.||.|++|.||++.+..+++.+++|.+...... ...+.+.+|+++++.++||||+++++++.+....
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 95 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNM 95 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeE
Confidence 44567899999999999999999999999999999999765432 2257788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---cCCCCEEEeeCCCcc
Q 024347 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSA 159 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~---~~~~~~~l~df~~~~ 159 (269)
++||||+++++|.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999999888854 3679999999999999999999999999999999999999 456789999999986
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC---CC
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---PW 236 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 236 (269)
.... ........+++.|+|||++.+ .. +.++||||||+++|+|++|..||.................... ..
T Consensus 176 ~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (285)
T 3is5_A 176 LFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP 250 (285)
T ss_dssp C-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CC
T ss_pred ecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCc
Confidence 5433 222234457899999999864 33 5899999999999999999999999888888777765554433 23
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 251 ~~~~~~~li~~~L~~dP~~Rps~--~e~l~hp~ 281 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPERRPSA--AQVLHHEW 281 (285)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCH--HHHHTSGG
T ss_pred CCHHHHHHHHHHccCChhhCcCH--HHHhcCHH
Confidence 78999999999999999999999 88888887
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=319.03 Aligned_cols=260 Identities=31% Similarity=0.504 Sum_probs=222.3
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhh------hhhHHHHHHHHHHHHHhhhCC-CCCceeee
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK------VLKHKMAEQIKREVATMKLVK-HPNVVRLY 77 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~ 77 (269)
......++|++.+.||.|++|.||+|.++.+++.||+|++.... .......+.+.+|+++++++. ||||++++
T Consensus 11 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp ----CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred CCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 34567899999999999999999999999999999999987543 112334577889999999996 99999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 78 ~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
+++......++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccc
Confidence 99999999999999999999999998888899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCCcccccccCccccCcccccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLND-----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 232 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (269)
+..... ........+++.|+|||++.+ ....+.++||||||+++|+|++|..||...........+..+...
T Consensus 171 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 171 SCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp CEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred hhhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence 865432 222334457889999999852 223358999999999999999999999998888888877766554
Q ss_pred CC----CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 CP----PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 ~~----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+ ..++..+.++|+.||+.||++|||+ .+++.|+|
T Consensus 248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--~~ll~h~~ 286 (298)
T 1phk_A 248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTA--EEALAHPF 286 (298)
T ss_dssp CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCH--HHHTTSGG
T ss_pred cCcccccccCHHHHHHHHHHccCCcccCCCH--HHHHhChH
Confidence 43 3588999999999999999999999 78888887
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=326.17 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=214.7
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
-...++|++.+.||.|++|.||++.+..+|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEE
Confidence 3567899999999999999999999999999999999865432 344457788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||||++++++..+....+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 100 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 177 (331)
T 4aaa_A 100 YLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-- 177 (331)
T ss_dssp EEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC--
Confidence 999999999888887777778999999999999999999999999999999999999999999999999998654332
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc----------------
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---------------- 230 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------------- 230 (269)
........+++.|+|||++.+....+.++||||||+++|+|++|..||...........+....
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV 257 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence 1222334578899999999876555699999999999999999999999887766554442110
Q ss_pred ---cc------------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ---FT------------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ---~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. ..+.+++.+.+||+.||+.||++|||+ .++|.|+|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~--~ell~hp~ 309 (331)
T 4aaa_A 258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC--AELLHHDF 309 (331)
T ss_dssp GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG--GGGGGSHH
T ss_pred cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH--HHHhcCch
Confidence 00 012478999999999999999999999 88888887
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=327.35 Aligned_cols=255 Identities=33% Similarity=0.571 Sum_probs=221.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhh-----hhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK-----VLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSK 83 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-----~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~ 83 (269)
.++|++.+.||.|++|.||+|.+..+|+.||||++.... .......+.+.+|+.+++.+ +||||+++++++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 467999999999999999999999899999999987543 22234457788999999999 799999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
+..++||||++|++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999998865432
Q ss_pred ccCCCcccccccCccccCcccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---- 234 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 234 (269)
........+++.|+|||++.+. ...+.++||||||+++|+|++|..||...........+..+....+
T Consensus 253 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 329 (365)
T 2y7j_A 253 ---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW 329 (365)
T ss_dssp ---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred ---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence 2223345689999999998632 2235899999999999999999999999888888887776655443
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..++..+.+||+.||+.||++|||+ .+++.|+|
T Consensus 330 ~~~~~~~~~li~~~L~~dP~~Rps~--~ell~hp~ 362 (365)
T 2y7j_A 330 DDRSSTVKDLISRLLQVDPEARLTA--EQALQHPF 362 (365)
T ss_dssp SSSCHHHHHHHHHHSCSSTTTSCCH--HHHHHSGG
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCH--HHHhcCcc
Confidence 4588999999999999999999999 88889887
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=343.26 Aligned_cols=253 Identities=34% Similarity=0.583 Sum_probs=216.7
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||+|+||.||+|.++.+++.+|+|++....... .....+.+|+.+++.++||||+++++++.+....++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 3457999999999999999999999999999999987644322 224678899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC---CCEEEeeCCCcccccccc
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~---~~~~l~df~~~~~~~~~~ 165 (269)
||||++|++|.+.+.....+++..+..++.|++.||.|||+.||+|+||+|+||+++.. +.++|+|||++......
T Consensus 114 v~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 99999999999999888889999999999999999999999999999999999999764 45999999998754432
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l 241 (269)
.......+++.|+|||++.+ . ++.++||||||+++|+|++|..||.+....+....+..+....+ ..+++.+
T Consensus 193 --~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 268 (494)
T 3lij_A 193 --KKMKERLGTAYYIAPEVLRK-K-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268 (494)
T ss_dssp --BCBCCCCSCTTTCCHHHHTT-C-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHH
T ss_pred --ccccccCCCcCeeCHHHHcc-c-CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHH
Confidence 22334568999999999864 3 35899999999999999999999999999999998887766543 3589999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++||+.||+.||.+|||+ .++|.|+|
T Consensus 269 ~~li~~~L~~dp~~R~s~--~e~l~hp~ 294 (494)
T 3lij_A 269 KDLIKQMLQFDSQRRISA--QQALEHPW 294 (494)
T ss_dssp HHHHHHHTCSSTTTSCCH--HHHHTCHH
T ss_pred HHHHHHHCCCChhhCccH--HHHhcCcc
Confidence 999999999999999999 78888887
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=330.05 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=216.5
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEc-------CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 78 (269)
....++|++.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 445689999999999999999999875 245679999986543 344567899999999999 8999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCce
Q 024347 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (269)
Q Consensus 79 ~~~~~~~~~~v~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nI 142 (269)
++.+.+..++||||+++++|.+++...+ .++..++..++.|++.||.|||+.||+|+||+|+||
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 234 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234 (370)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence 9999999999999999999999987643 478899999999999999999999999999999999
Q ss_pred EecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 024347 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221 (269)
Q Consensus 143 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~ 221 (269)
+++.++.++|+|||+++...............+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+
T Consensus 235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~ 313 (370)
T 2psq_A 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 313 (370)
T ss_dssp EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999875544332233333446778999999988766 489999999999999999 999999888888
Q ss_pred HHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 222 LYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 222 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
....+..+. ...+..++.++.++|+.||+.||++||+++++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~el 355 (370)
T 2psq_A 314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 355 (370)
T ss_dssp HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 777776654 45667799999999999999999999998443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=322.17 Aligned_cols=258 Identities=31% Similarity=0.562 Sum_probs=220.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh-HHHHHHHHHHHHHhhhCCCCCceeeeEEE--eeCCe
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVM--GSKTK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~--~~~~~ 85 (269)
..++|++.+.||.|++|.||++.+..+++.+++|.+....... ....+.+.+|+.+++.++||||+++++++ .....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 4579999999999999999999999999999999997654322 23457789999999999999999999998 44567
Q ss_pred EEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 86 IFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
.++||||++++ +.+.+.. ...+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 89999999875 6666655 35699999999999999999999999999999999999999999999999999876544
Q ss_pred ccCCCcccccccCccccCcccccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGY-DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 242 (269)
...........+++.|+|||++.+... .+.++||||||+++|+|++|..||...........+..+....+..+++.+.
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~ 241 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence 333333344568899999999976443 2478999999999999999999999999999999998888888889999999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||+.||+.||.+|||+ .+++.|+|
T Consensus 242 ~li~~~l~~dp~~Rps~--~~ll~~~~ 266 (305)
T 2wtk_C 242 DLLKGMLEYEPAKRFSI--RQIRQHSW 266 (305)
T ss_dssp HHHHHHTCSSTTTSCCH--HHHHHSHH
T ss_pred HHHHHHccCChhhCCCH--HHHhcCcc
Confidence 99999999999999999 77777765
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=330.85 Aligned_cols=250 Identities=34% Similarity=0.611 Sum_probs=214.7
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~ 86 (269)
...++|++.+.||.|+||.||++.++.+++.||+|.+..... ...+|++++.++ +||||+++++++.+....
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 346789999999999999999999999999999999976542 234577777777 799999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC-C---CEEEeeCCCccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-G---NLKVSDFGLSALSQ 162 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~-~---~~~l~df~~~~~~~ 162 (269)
++||||++|++|.+.+...+.+++..+..++.|++.||.|||+.||+|+||+|+||++..+ + .++|+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 9999999999999999888889999999999999999999999999999999999998543 2 49999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCcccCC----C
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---SNLMNLYKKISAAEFTCP----P 235 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~---~~~~~~~~~~~~~~~~~~----~ 235 (269)
.. ........+++.|+|||++.+..+ +.++|+||||+++|+|++|..||.. ....+....+..+.+..+ .
T Consensus 172 ~~--~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 248 (342)
T 2qr7_A 172 AE--NGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248 (342)
T ss_dssp CT--TCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTT
T ss_pred CC--CCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccc
Confidence 32 222334567899999999987655 4899999999999999999999975 456677788877776554 4
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+++++.+||+.||+.||++||++ .+++.|+|
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~--~~il~hp~ 280 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTA--ALVLRHPW 280 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCH--HHHTTSHH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCH--HHHhcCCe
Confidence 589999999999999999999999 78888876
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=320.35 Aligned_cols=249 Identities=28% Similarity=0.478 Sum_probs=216.0
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
.|...+.||+|++|.||+|.+..+|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 388889999999999999999989999999998754432 24668899999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
|+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~ 199 (321)
T 2c30_A 123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK 199 (321)
T ss_dssp CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBC
T ss_pred cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccc
Confidence 9999999887654 579999999999999999999999999999999999999999999999999987544321 1223
Q ss_pred ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC---CCCCCHHHHHHHHHh
Q 024347 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC---PPWLSFTARKLIARI 248 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~ 248 (269)
...+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.....+. ...+++.+.++|..|
T Consensus 200 ~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 278 (321)
T 2c30_A 200 SLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278 (321)
T ss_dssp CCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHH
T ss_pred cccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHH
Confidence 4568999999999987766 489999999999999999999999888887777776554332 335889999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||++|||+ .+++.|+|
T Consensus 279 l~~dp~~Rps~--~ell~hp~ 297 (321)
T 2c30_A 279 LVRDPQERATA--QELLDHPF 297 (321)
T ss_dssp SCSSTTTSCCH--HHHHTSGG
T ss_pred ccCChhhCcCH--HHHhcChh
Confidence 99999999999 77888876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-49 Score=318.91 Aligned_cols=253 Identities=34% Similarity=0.604 Sum_probs=218.4
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
++|++.+.||.|++|.||++.+..+++.+++|.+........ ...+.+.+|+.++++++||||+++++++.+....+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 579999999999999999999999999999999875432211 12467889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC----CEEEeeCCCcccccc
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQQ 163 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~----~~~l~df~~~~~~~~ 163 (269)
++|||+++++|.+++.....++...+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888899999999999999999999999999999999999998777 799999998875433
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 239 (269)
. .......+++.|+|||++.+..+ +.++|+||||+++|+|++|..||...........+.......+ +.+++
T Consensus 165 ~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T 3bhy_A 165 G---NEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE 240 (283)
T ss_dssp ----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred C---CcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence 2 12233457889999999987766 4899999999999999999999999888888888776655444 45889
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.+|++.||+.||++|||+ .+++.|+|
T Consensus 241 ~~~~li~~~l~~dp~~Rps~--~~~l~h~~ 268 (283)
T 3bhy_A 241 LAKDFIRRLLVKDPKRRMTI--AQSLEHSW 268 (283)
T ss_dssp HHHHHHHTTSCSSGGGSCCH--HHHHHCHH
T ss_pred HHHHHHHHHccCCHhHCcCH--HHHHhCHH
Confidence 99999999999999999999 77888776
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=328.78 Aligned_cols=261 Identities=34% Similarity=0.524 Sum_probs=216.7
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh--hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL--KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
....++|++.+.||+|++|.||+|.+..+++.+|+|++...... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 34457899999999999999999999999999999999765432 2344678999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhc----------------------------------------CCCCHHHHHHHHHHHHHHH
Q 024347 85 KIFIVLEFVTGGELFDKIVNH----------------------------------------GRMKEDEARRYFQQLINAV 124 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~----------------------------------------~~l~~~~~~~i~~~i~~~l 124 (269)
..++||||++|++|.+.+... ..+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999998887420 1235678889999999999
Q ss_pred HHHHhCCcEeecCCCCceEecCCC--CEEEeeCCCccccccccCCC--cccccccCccccCcccccCC-CCCCCchhHHH
Q 024347 125 DYCHSRGVYHRDLKPENLLLDAYG--NLKVSDFGLSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDR-GYDGSTADLWS 199 (269)
Q Consensus 125 ~~lh~~~i~h~di~~~nIl~~~~~--~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s 199 (269)
.|||+.|++|+||+|+||+++.++ .++|+|||.+.......... ......+++.|+|||++.+. ...+.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999999999999999999998776 89999999987654322221 22345688999999998753 33468999999
Q ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 200 CGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 200 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+++|+|++|..||......+....+.......+ ..+++.+.+||+.||+.||.+||++ .+++.|+|
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~~~l~hp~ 333 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA--MRALQHPW 333 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCH--HHHHHSHH
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCH--HHHhcChh
Confidence 99999999999999999888888888766654333 2379999999999999999999999 88888876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=320.74 Aligned_cols=251 Identities=36% Similarity=0.653 Sum_probs=218.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
-.++|++.+.||.|++|.||++.+..+|+.|++|.+..... ...+.+.+|+.+++.++||||+++++++.+....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYL 83 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEE
Confidence 34689999999999999999999999999999999875432 223568899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---cCCCCEEEeeCCCcccccccc
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~---~~~~~~~l~df~~~~~~~~~~ 165 (269)
+|||+++++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-- 161 (304)
T 2jam_A 84 VMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-- 161 (304)
T ss_dssp EECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--
T ss_pred EEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--
Confidence 99999999999999888889999999999999999999999999999999999999 7788999999998764322
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l 241 (269)
.......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+..+....+ ..+++.+
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (304)
T 2jam_A 162 --GIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA 238 (304)
T ss_dssp --BTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHH
T ss_pred --CccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHH
Confidence 22233457899999999987766 4899999999999999999999999888888888877654333 4589999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+||..||+.||++|||+ .+++.|+|
T Consensus 239 ~~li~~~l~~dp~~Rps~--~~~l~h~~ 264 (304)
T 2jam_A 239 KDFICHLLEKDPNERYTC--EKALSHPW 264 (304)
T ss_dssp HHHHHHHHCSSTTTSCCH--HHHHTSHH
T ss_pred HHHHHHHcCCChhHCcCH--HHHhcCcc
Confidence 999999999999999999 77777775
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=332.07 Aligned_cols=251 Identities=30% Similarity=0.483 Sum_probs=215.6
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH-----HHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH-----KMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
...++|++.+.||.|+||.||+|.+..+++.||+|.+........ ...+.+.+|+.+++.++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 345789999999999999999999999999999999976542211 123456779999999999999999999999
Q ss_pred CCeEEEEEeccCCC-chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 83 KTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 83 ~~~~~~v~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
.+..++||||+.++ +|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999998666 99999988888999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHH
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (269)
.. ........+++.|+|||++.+..+.+.++||||||+++|+|++|..||.... .........+..+++++
T Consensus 181 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~l 251 (335)
T 3dls_A 181 ER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKEL 251 (335)
T ss_dssp CT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHHH
T ss_pred CC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHHH
Confidence 32 2223345689999999999887775689999999999999999999997632 22334445566789999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+||+.||+.||++|||+ .+++.|+|
T Consensus 252 ~~li~~~L~~dP~~Rps~--~ell~hp~ 277 (335)
T 3dls_A 252 MSLVSGLLQPVPERRTTL--EKLVTDPW 277 (335)
T ss_dssp HHHHHHHTCSSGGGSCCH--HHHHHCTT
T ss_pred HHHHHHHccCChhhCcCH--HHHhcCcc
Confidence 999999999999999999 88888887
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=326.98 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=215.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||+|+||.||+|.+..+++.||+|.+...........+.+.+|+++++.++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 46999999999999999999999999999999997655445555678999999999999999999999999999999999
Q ss_pred eccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||+. +++.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 206 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence 9997 477777754 56799999999999999999999999999999999999999999999999999875432
Q ss_pred ccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC--CCCCCHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--PPWLSFTARKLI 245 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 245 (269)
.....+++.|+|||++.+ ....+.++||||||+++|+|++|..||...........+.....+. +..+++.+.+||
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 286 (348)
T 1u5q_A 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV 286 (348)
T ss_dssp BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence 123457899999999853 2333589999999999999999999999887777666665544322 346899999999
Q ss_pred HHhcCCCCCCcCCCCccccccccC
Q 024347 246 ARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..||+.||++|||+ .+++.|+|
T Consensus 287 ~~~l~~dP~~Rps~--~~ll~h~~ 308 (348)
T 1u5q_A 287 DSCLQKIPQDRPTS--EVLLKHRF 308 (348)
T ss_dssp HHHTCSSGGGSCCH--HHHTTCHH
T ss_pred HHHcccChhhCcCH--HHHhhChh
Confidence 99999999999999 77787776
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=319.06 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=207.3
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
...+..+++|++.+.||.|++|.||++.+..+++.|++|.+...........+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 2h34_A 27 SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID 106 (309)
T ss_dssp -------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred cCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC
Confidence 34567889999999999999999999999999999999999876655666678899999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
+..++++||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 107 GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999998865433
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFT 240 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 240 (269)
.. ........+++.|+|||++.+... +.++||||||+++|+|++|..||...........+..... ..++.+++.
T Consensus 187 ~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 187 EK-LTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp -----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred cc-cccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence 21 112223457889999999987766 4899999999999999999999998776655555443322 345668999
Q ss_pred HHHHHHHhcCCCCCCcC-CC
Q 024347 241 ARKLIARILDPNPMTVS-IY 259 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rp-s~ 259 (269)
+.++|+.||+.||++|| ++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~ 284 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTC 284 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSH
T ss_pred HHHHHHHhccCCHHHHHHhH
Confidence 99999999999999999 54
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=321.67 Aligned_cols=258 Identities=31% Similarity=0.529 Sum_probs=211.9
Q ss_pred ccccCCeEEe-eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCC
Q 024347 7 KRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (269)
Q Consensus 7 ~~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 84 (269)
+...++|++. +.||+|++|.||+|.+..+++.||+|++..... ...+.+.+|+.++.++ +||||+++++++.+.+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~ 84 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEED 84 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 3455789995 789999999999999999999999999875432 2246788899999885 7999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC---EEEeeCCCcccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALS 161 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~---~~l~df~~~~~~ 161 (269)
..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++...
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 85 RFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 99999999999999999988888999999999999999999999999999999999999998776 999999988654
Q ss_pred ccccC-----CCcccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCC--------------
Q 024347 162 QQVRD-----DGLLHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSN-------------- 218 (269)
Q Consensus 162 ~~~~~-----~~~~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-------------- 218 (269)
..... ........+++.|+|||++.+. ...+.++||||||+++|+|++|..||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32111 1112234588999999998752 123589999999999999999999997653
Q ss_pred -HHHHHHHHhcCcccCC----CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 219 -LMNLYKKISAAEFTCP----PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 219 -~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.......+..+....+ ..+++.+.+||+.||+.||.+|||+ .+++.|+|
T Consensus 245 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~--~e~l~hp~ 298 (316)
T 2ac3_A 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA--AQVLQHPW 298 (316)
T ss_dssp HHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH--HHHHHSTT
T ss_pred HHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCH--HHHhcChh
Confidence 2345566666665555 3589999999999999999999999 88899987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=321.04 Aligned_cols=254 Identities=28% Similarity=0.401 Sum_probs=206.5
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh--HHHHHHHHHHHHHhhhC---CCCCceeeeEEEeeC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLV---KHPNVVRLYEVMGSK 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~~ 83 (269)
..++|++.+.||+|++|+||+|.+..+++.||+|.+....... ......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4579999999999999999999999999999999986432111 00112344556555555 599999999999775
Q ss_pred C-----eEEEEEeccCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCC
Q 024347 84 T-----KIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (269)
Q Consensus 84 ~-----~~~~v~~~~~~~~l~~~~~~~~~--l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~ 156 (269)
. ..+++|||+.+ +|.+++..... +++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 5 58999999974 99998887643 9999999999999999999999999999999999999999999999999
Q ss_pred CccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--c---
Q 024347 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F--- 231 (269)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~--- 231 (269)
.+..... ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.... .
T Consensus 166 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (308)
T 3g33_A 166 LARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 241 (308)
T ss_dssp CTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 9875432 222334567999999999988776 489999999999999999999999988877776654311 0
Q ss_pred ----------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 ----------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ----------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.+++.+.+||+.||++||++|||+ .++|.|+|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~e~l~h~~ 299 (308)
T 3g33_A 242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA--FRALQHSY 299 (308)
T ss_dssp TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH--HHHHTSTT
T ss_pred hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH--HHHhcCcc
Confidence 0113478899999999999999999999 88999998
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=333.40 Aligned_cols=255 Identities=24% Similarity=0.370 Sum_probs=217.0
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.+....++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+.+|++++++++||||+++++++...+
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34456679999999999999999999999899999999986432 3344567889999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++||||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 999999999999999998765 3699999999999999999999999999999999999999999999999999875332
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 241 (269)
...........++..|+|||++.+..+ +.++||||||+++|+|++ |..||......+..+.+..+ ..+.+..+++.+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 344 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAV 344 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 111111112234567999999987665 489999999999999998 99999998888777776554 456677899999
Q ss_pred HHHHHHhcCCCCCCcCCCCcc
Q 024347 242 RKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+|+..||+.||++|||++++
T Consensus 345 ~~li~~cl~~dP~~Rps~~~i 365 (377)
T 3cbl_A 345 FRLMEQCWAYEPGQRPSFSTI 365 (377)
T ss_dssp HHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCCchhCcCHHHH
Confidence 999999999999999998544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=318.88 Aligned_cols=257 Identities=32% Similarity=0.529 Sum_probs=219.4
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--CC
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KT 84 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 84 (269)
+...++|++.+.||+|++|.||++.+..+++.+++|.+...... ....+.+.+|+.++++++||||+++++++.. ..
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGT
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCc
Confidence 56788999999999999999999999999999999999765432 3446789999999999999999999998743 67
Q ss_pred eEEEEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeecCCCCceEecCCCCEEEeeC
Q 024347 85 KIFIVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~-----i~h~di~~~nIl~~~~~~~~l~df 155 (269)
..+++|||+++++|.+++... ..+++..+..++.|++.||.+||+.| ++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 899999999999999988653 34999999999999999999999999 999999999999999999999999
Q ss_pred CCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCC
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCP 234 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~ 234 (269)
|.+...... ........+++.|+|||++.+..+. .++||||||+++|+|++|..||...........+..+.. ..+
T Consensus 161 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 237 (279)
T 2w5a_A 161 GLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP 237 (279)
T ss_dssp CHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCC
T ss_pred chheeeccc--cccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCC
Confidence 988654321 1112234578899999999887664 899999999999999999999999888888888877665 556
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..++..+.++|+.||+.||++|||+ .+++.++|
T Consensus 238 ~~~~~~l~~li~~~l~~~p~~Rps~--~~ll~~~~ 270 (279)
T 2w5a_A 238 YRYSDELNEIITRMLNLKDYHRPSV--EEILENPL 270 (279)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCH--HHHHTSTT
T ss_pred cccCHHHHHHHHHHcCCCcccCCCH--HHHHhChh
Confidence 6789999999999999999999999 77777765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=322.34 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=214.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
...++|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 456789999999999999999999986555 49999986543 3344678899999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++||||+++++|.+++... +.++..++..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999999998654 5799999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCC-cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHH
Q 024347 164 VRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (269)
Q Consensus 164 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (269)
..... ......+++.|+|||++.+..+. .++||||||+++|+|++ |..||...........+..+ ..+.+..+++.
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence 22211 11222346689999999876664 89999999999999999 99999998888888887665 45667789999
Q ss_pred HHHHHHHhcCCCCCCcCCCCcc
Q 024347 241 ARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.+||..||+.||++|||++++
T Consensus 283 l~~li~~~l~~dp~~Rps~~ei 304 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQI 304 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHH
Confidence 9999999999999999998544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=327.34 Aligned_cols=259 Identities=30% Similarity=0.386 Sum_probs=213.5
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee----
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS---- 82 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 82 (269)
....++|++.+.||+|++|.||+|.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 34678999999999999999999999999999999998654322 2223566789999999999999999999876
Q ss_pred ----CCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 83 ----KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 83 ----~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
.+..++||||+++ ++...+... ..+++.++..++.|++.||.+||+.||+|+||+|+||+++.++.++|+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 3468999999976 676666553 5799999999999999999999999999999999999999999999999999
Q ss_pred ccccccccC--CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC
Q 024347 158 SALSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP 235 (269)
Q Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (269)
+........ ........+++.|+|||++.+....+.++||||||+++|+|++|..||.+.........+.......++
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 876543222 222234467899999999987655569999999999999999999999998887776666432111111
Q ss_pred C--------------------------------CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 236 W--------------------------------LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 236 ~--------------------------------~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. .++.+.+||+.||+.||++|||+ .++|.|+|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~e~l~hp~ 314 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS--DDALNHDF 314 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCH--HHHhCCCC
Confidence 1 26779999999999999999999 88899987
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=324.61 Aligned_cols=250 Identities=25% Similarity=0.410 Sum_probs=211.6
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-----CCCceeeeEEEe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----HPNVVRLYEVMG 81 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----~~~i~~~~~~~~ 81 (269)
....++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+....|+.+++.+. ||||+++++++.
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 345679999999999999999999999999999999986422 33456777899999886 999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-------------
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA------------- 146 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~------------- 146 (269)
..+..++||||+ +++|.+++.... .++...+..++.|++.||.|||+.||+|+||||+||+++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999999 889999987754 5999999999999999999999999999999999999975
Q ss_pred ------------CCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 024347 147 ------------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (269)
Q Consensus 147 ------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 214 (269)
++.++|+|||++..... ......+++.|+|||++.+..+. .++||||||+++|+|++|..||
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHHCCCCC
Confidence 78899999999875332 22344578999999999887764 9999999999999999999999
Q ss_pred CCCCHHHHHHHHhcCcccCCC----------------------------------------------CCCHHHHHHHHHh
Q 024347 215 DDSNLMNLYKKISAAEFTCPP----------------------------------------------WLSFTARKLIARI 248 (269)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~----------------------------------------------~~~~~l~~li~~~ 248 (269)
......+....+.....+.+. ..++.+.+||+.|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 339 (360)
T 3llt_A 260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI 339 (360)
T ss_dssp CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence 988777666555332211110 1247788999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||++|||+ .++|.|+|
T Consensus 340 L~~dP~~Rpta--~elL~hp~ 358 (360)
T 3llt_A 340 LQIDPTLRPSP--AELLKHKF 358 (360)
T ss_dssp CCSSGGGSCCH--HHHTTSGG
T ss_pred hcCChhhCCCH--HHHhcCcc
Confidence 99999999999 88999988
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-49 Score=326.10 Aligned_cols=253 Identities=26% Similarity=0.397 Sum_probs=206.5
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
+++|++.+.||+|++|.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 4789999999999999999999999999999999865432 11122455799999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+++ +|.+++... ..++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+...... ..
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP--TK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC--cc
Confidence 999975 888887764 46999999999999999999999999999999999999999999999999988754322 22
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--c---------------
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F--------------- 231 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~--------------- 231 (269)
......+++.|+|||++.+....+.++||||||+++|+|++|..||.+....+....+.... +
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 22334578999999999875555699999999999999999999999988777666553310 0
Q ss_pred -------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 -------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 -------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~e~l~hp~ 284 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISA--EDAMKHPF 284 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCH--HHHTTSGG
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCH--HHHhcChh
Confidence 1112468899999999999999999999 88999987
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=328.38 Aligned_cols=249 Identities=31% Similarity=0.512 Sum_probs=210.8
Q ss_pred CeEE--eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 12 KYEV--GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 12 ~~~~--~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.|.+ .+.||.|+||.||+|.+..+|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 3444 6789999999999999999999999999876432 3356788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe--cCCCCEEEeeCCCccccccccC
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~--~~~~~~~l~df~~~~~~~~~~~ 166 (269)
|||+++++|.+.+... ..+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||++......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-- 242 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-- 242 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--
Confidence 9999999998888654 469999999999999999999999999999999999999 56678999999998755432
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTAR 242 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 242 (269)
.......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..+...++.......+ ..+++++.
T Consensus 243 -~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 320 (373)
T 2x4f_A 243 -EKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320 (373)
T ss_dssp -CBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHH
T ss_pred -cccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHH
Confidence 22233458999999999987665 4899999999999999999999999988888888877655443 45899999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||+.||+.||++|||+ .+++.|+|
T Consensus 321 ~li~~~L~~dp~~Rps~--~e~l~hp~ 345 (373)
T 2x4f_A 321 EFISKLLIKEKSWRISA--SEALKHPW 345 (373)
T ss_dssp HHHHTTSCSSGGGSCCH--HHHHHSHH
T ss_pred HHHHHHcCCChhhCCCH--HHHhcCcC
Confidence 99999999999999999 77888876
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=326.90 Aligned_cols=255 Identities=22% Similarity=0.384 Sum_probs=219.8
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCC-------CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceee
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRL 76 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~ 76 (269)
.+....++|++.+.||+|+||.||+|.+... ++.||+|.+.... .....+.+.+|+++++.+ +||||+++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 3456678999999999999999999997543 3579999987543 344467889999999999 89999999
Q ss_pred eEEEeeCCeEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCC
Q 024347 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPE 140 (269)
Q Consensus 77 ~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~ 140 (269)
++++...+..++||||+++++|.+++.... .+++.++..++.|++.||.+||+.||+|+||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 999999999999999999999999997653 4899999999999999999999999999999999
Q ss_pred ceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH
Q 024347 141 NLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL 219 (269)
Q Consensus 141 nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~ 219 (269)
||+++.++.++|+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.....
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999876554333333344456788999999988766 489999999999999999 9999999988
Q ss_pred HHHHHHHhcC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 220 MNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 220 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+....+..+ ....+..+++++.+||+.||+.||++|||++++
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 343 (382)
T 3tt0_A 300 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 343 (382)
T ss_dssp HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 8888888765 455667799999999999999999999998443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=323.33 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=198.6
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 81 (269)
.+....++|++.+.||+|++|.||+|.+..+++ .||+|.+....... ...+.+.+|+.++++++||||+++++++.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS-SDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------C-HHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCH-HHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 445667899999999999999999999887665 79999987654333 33678899999999999999999999997
Q ss_pred eCCeE------EEEEeccCCCchhHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC
Q 024347 82 SKTKI------FIVLEFVTGGELFDKIVNHG------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (269)
Q Consensus 82 ~~~~~------~~v~~~~~~~~l~~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~ 149 (269)
..... ++++||+++++|.+++.... .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 76654 89999999999999886532 5899999999999999999999999999999999999999999
Q ss_pred EEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc
Q 024347 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISA 228 (269)
Q Consensus 150 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 228 (269)
++|+|||.+................+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||......+....+..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 99999999876544333333333446778999999987766 499999999999999999 9999998888877777766
Q ss_pred Cc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 229 AE-FTCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 229 ~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
+. ...++.+++.+.+|++.||+.||++|||+++
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 288 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTC 288 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 54 5667789999999999999999999999643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=330.81 Aligned_cols=257 Identities=26% Similarity=0.362 Sum_probs=204.9
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 83 (269)
-.++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++|+||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3579999999999999999999999999999999997543 3344567889999999999999999999999765
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
...++||||+. ++|.+.+.....+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999986 59999998888899999999999999999999999999999999999999999999999999986543
Q ss_pred ccCC--------------------CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCC----------
Q 024347 164 VRDD--------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLP---------- 213 (269)
Q Consensus 164 ~~~~--------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p---------- 213 (269)
.... .......+++.|+|||++.....++.++|||||||++|+|++|..|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p 261 (432)
T 3n9x_A 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261 (432)
T ss_dssp -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence 2211 1224456899999999976555556999999999999999985443
Q ss_pred -CCCCCH-----------------HHH------------------------HHHHhcCcccC-------CCCCCHHHHHH
Q 024347 214 -FDDSNL-----------------MNL------------------------YKKISAAEFTC-------PPWLSFTARKL 244 (269)
Q Consensus 214 -~~~~~~-----------------~~~------------------------~~~~~~~~~~~-------~~~~~~~l~~l 244 (269)
|.+... ... ...+....... .+.+++.+.+|
T Consensus 262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL 341 (432)
T 3n9x_A 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL 341 (432)
T ss_dssp SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence 433220 011 11111111111 13479999999
Q ss_pred HHHhcCCCCCCcCCCCccccccccC
Q 024347 245 IARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|++||+.||.+|||+ .++|.|+|
T Consensus 342 l~~mL~~dP~~R~ta--~e~L~Hp~ 364 (432)
T 3n9x_A 342 LESMLKFNPNKRITI--DQALDHPY 364 (432)
T ss_dssp HHHHSCSSTTTSCCH--HHHHTCGG
T ss_pred HHHHhcCCcccCCCH--HHHhcChh
Confidence 999999999999999 88889987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=325.62 Aligned_cols=250 Identities=26% Similarity=0.395 Sum_probs=206.4
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC-----
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----- 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----- 84 (269)
.++|++.+.||.|+||.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 478999999999999999999999999999999986543 33455678899999999999999999999997653
Q ss_pred -eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 -KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 -~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
.+++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 7799887765 5799999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-------------
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------- 230 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 230 (269)
......+++.|+|||++.+...++.++|||||||++++|++|+.||.+.+.......+....
T Consensus 181 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~ 255 (367)
T 1cm8_A 181 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS 255 (367)
T ss_dssp -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred -----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence 22334578899999999875545699999999999999999999999887766655543210
Q ss_pred ------------------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ------------------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+..++.+.+||++||+.||++|||+ .++|.|+|
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~--~e~l~hp~ 310 (367)
T 1cm8_A 256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA--GEALAHPY 310 (367)
T ss_dssp HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH--HHHHHSGG
T ss_pred HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCH--HHHhcChH
Confidence 01224578999999999999999999999 78888887
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=324.59 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=218.1
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEE
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 80 (269)
+....++|++.+.||+|+||.||+|.+.. +++.||+|.+.... .....+.+.+|+.+++.++||||+++++++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 35567899999999999999999999873 45889999987543 344467899999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeec
Q 024347 81 GSKTKIFIVLEFVTGGELFDKIVNH------------------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRD 136 (269)
Q Consensus 81 ~~~~~~~~v~~~~~~~~l~~~~~~~------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~d 136 (269)
.+.+..++||||+++++|.+++... ..+++.+++.++.|++.||.|||+.|++|+|
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 9999999999999999999998763 4689999999999999999999999999999
Q ss_pred CCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 024347 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD 215 (269)
Q Consensus 137 i~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~ 215 (269)
|+|+||+++.++.++|+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999876543332223334456888999999987765 489999999999999999 999999
Q ss_pred CCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 216 DSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 216 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.....+....+..+.. ..+..+++.+.++++.||+.||++|||++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 326 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 326 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHH
Confidence 9888888888776654 5567799999999999999999999998544
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=321.23 Aligned_cols=257 Identities=23% Similarity=0.350 Sum_probs=218.7
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeee
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY 77 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 77 (269)
.+++....++|++.+.||.|++|.||++.+. .+++.||+|.+.... .....+.+.+|+.+++.++||||++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~ 92 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLY 92 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEE
Confidence 4555667789999999999999999999873 445889999986543 344467889999999999999999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCcE
Q 024347 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGR------------------------MKEDEARRYFQQLINAVDYCHSRGVY 133 (269)
Q Consensus 78 ~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~------------------------l~~~~~~~i~~~i~~~l~~lh~~~i~ 133 (269)
+++.+.+..+++|||+++++|.+++..... +++.++..++.|++.||.|||+.|++
T Consensus 93 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 93 GACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 999999999999999999999999976533 88999999999999999999999999
Q ss_pred eecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCC
Q 024347 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYL 212 (269)
Q Consensus 134 h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~ 212 (269)
|+||+|+||+++.++.++|+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..
T Consensus 173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999875543222222233445778999999987665 489999999999999999 999
Q ss_pred CCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 213 PFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 213 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
||...........+..+. ...+..+++.+.++|..||+.||++|||++++
T Consensus 252 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 252 PYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp SSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999888877777776654 45567799999999999999999999998543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=320.23 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=209.2
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
......++|++.+.||+|+||.||++.+..+++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 80 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDK 80 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCC
Confidence 3345678999999999999999999999999999999988542 3445678999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++||||+++++|.+++.. ...+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 81 RLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp EEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred eeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 99999999999999999987 46799999999999999999999999999999999999999999999999999876543
Q ss_pred ccCCC------------cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHhc
Q 024347 164 VRDDG------------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISA 228 (269)
Q Consensus 164 ~~~~~------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~ 228 (269)
..... ......+++.|+|||++.+..+. .++||||||+++|+|++|..|+.......... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 22211 11134588999999999887764 89999999999999999999986432110000 0000
Q ss_pred CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 229 AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.....++.+++.+.+++..||+.||++|||++++.
T Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~ 274 (310)
T 3s95_A 240 LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE 274 (310)
T ss_dssp HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 11234567889999999999999999999985543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=312.60 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=210.5
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 87 (269)
..++|++.+.||+|++|.||+|.+..+++.||+|.+........ ....+.+|+..+..+ +||||+++++++.+.+..+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~ 87 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHML 87 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEE
Confidence 35789999999999999999999999999999999876443332 346777889999998 8999999999999999999
Q ss_pred EEEeccCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC----------------
Q 024347 88 IVLEFVTGGELFDKIVNH----GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---------------- 147 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~---------------- 147 (269)
+||||+++++|.+++... ..+++.++..++.|++.||.+||+.|++|+||+|+||+++.+
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999998764 679999999999999999999999999999999999999844
Q ss_pred ---CCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 024347 148 ---GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK 224 (269)
Q Consensus 148 ---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~ 224 (269)
..++|+|||.+...... ....+++.|+|||++.+....+.++||||||+++|++++|..|+.... ...
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~ 238 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWH 238 (289)
T ss_dssp --CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHH
T ss_pred CCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHH
Confidence 37999999988754331 223478999999999876555579999999999999999988775542 233
Q ss_pred HHhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 225 KISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 225 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+..+. ...+..+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~~ll~h~~ 282 (289)
T 1x8b_A 239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSA--MALVKHSV 282 (289)
T ss_dssp HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCH--HHHHTCTT
T ss_pred HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCH--HHHhhChH
Confidence 344443 35566799999999999999999999999 88899987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=323.16 Aligned_cols=256 Identities=25% Similarity=0.397 Sum_probs=212.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC----
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK---- 83 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---- 83 (269)
...++|++.+.||+|++|.||+|.+..+++.||+|.+.... .....+.+.+|+.++++++||||+++++++...
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 101 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccc
Confidence 33469999999999999999999999999999999986432 344457888999999999999999999999654
Q ss_pred -CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 84 -~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
...++++||+.+ +|.+.+.. +.+++.++..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+....
T Consensus 102 ~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 102 MKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 468999999975 88887765 469999999999999999999999999999999999999999999999999987654
Q ss_pred cccC-CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-----------
Q 024347 163 QVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE----------- 230 (269)
Q Consensus 163 ~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 230 (269)
.... ........+++.|+|||++.+....+.++||||||+++|+|++|..||.+....+....+....
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 4322 2223345689999999997766545699999999999999999999998876655555442100
Q ss_pred --------------------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 --------------------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 --------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+.+++.+.+||+.||++||++|||+ .++|.|+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~e~l~hp~ 316 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV--EQALAHPY 316 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCH--HHHHTSGG
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCH--HHHhcCcc
Confidence 00113478999999999999999999999 88888887
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=311.94 Aligned_cols=249 Identities=23% Similarity=0.365 Sum_probs=214.5
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+....++|++.+.||+|++|.||++.+. +++.||+|++...... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 4556789999999999999999999987 4778999999765432 2568899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++|||+++++|.+++... +.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999988664 46899999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~ 242 (269)
... ......+++.|+|||++.+..+ +.++|+||||+++|+|++ |..||...........+... ....+...++.+.
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T 4hcu_A 160 QYT-SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 237 (269)
T ss_dssp HHH-STTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred ccc-cccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHH
Confidence 111 1122335678999999987766 489999999999999999 99999999998888888776 4455667899999
Q ss_pred HHHHHhcCCCCCCcCCCCc
Q 024347 243 KLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~ 261 (269)
++++.||+.||++|||+++
T Consensus 238 ~li~~~l~~~p~~Rps~~~ 256 (269)
T 4hcu_A 238 QIMNHCWRERPEDRPAFSR 256 (269)
T ss_dssp HHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHccCCcccCcCHHH
Confidence 9999999999999999843
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=310.06 Aligned_cols=252 Identities=25% Similarity=0.439 Sum_probs=214.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee----CC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KT 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~ 84 (269)
.-..|++.+.||+|++|.||+|.+..++..|++|.+...... ....+.+.+|+.+++.++||||+++++++.. ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 344589999999999999999999999999999999765543 3446788999999999999999999999865 45
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEec-CCCCEEEeeCCCcccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLD-AYGNLKVSDFGLSALS 161 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~-~~~~~~l~df~~~~~~ 161 (269)
..++||||+++++|.+++...+.++...+..++.|++.||.|||+.| ++|+||+|+||+++ .++.++|+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 68999999999999999988888999999999999999999999999 99999999999997 7889999999988643
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcCcc--cCCCCCC
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEF--TCPPWLS 238 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~ 238 (269)
.. .......+++.|+|||++.+. .+.++||||||+++|+|++|..||... ........+..+.. ..+...+
T Consensus 183 ~~----~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (290)
T 1t4h_A 183 RA----SFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 256 (290)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred cc----cccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCC
Confidence 22 222344578999999998754 358999999999999999999999874 44455555544432 3345578
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 239 FTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+.+||+.||+.||.+|||+ .+++.|+|
T Consensus 257 ~~l~~li~~~l~~dp~~Rps~--~ell~h~~ 285 (290)
T 1t4h_A 257 PEVKEIIEGCIRQNKDERYSI--KDLLNHAF 285 (290)
T ss_dssp HHHHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred HHHHHHHHHHccCChhhCCCH--HHHhhCcc
Confidence 999999999999999999999 88888887
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=326.34 Aligned_cols=254 Identities=22% Similarity=0.433 Sum_probs=219.3
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHH--------------HHHHHHHHHHHhhhCCCCCc
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK--------------MAEQIKREVATMKLVKHPNV 73 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~--------------~~~~~~~e~~~l~~l~~~~i 73 (269)
...++|++.+.||+|++|.||+|.+ +++.||+|.+......... ..+.+.+|+.+++.++||||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 105 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYC 105 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTB
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCc
Confidence 3468999999999999999999998 7999999999765433211 11778899999999999999
Q ss_pred eeeeEEEeeCCeEEEEEeccCCCchhHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEe
Q 024347 74 VRLYEVMGSKTKIFIVLEFVTGGELFDK------IVN--HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLL 144 (269)
Q Consensus 74 ~~~~~~~~~~~~~~~v~~~~~~~~l~~~------~~~--~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~ 144 (269)
+++++++.+.+..++||||+++++|.++ +.. ...++...+..++.|++.||.+||+ .|++|+||+|+||++
T Consensus 106 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 106 LTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185 (348)
T ss_dssp CCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred ceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence 9999999999999999999999999887 555 4679999999999999999999999 999999999999999
Q ss_pred cCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCC-chhHHHHHHHHHHHHcCCCCCCCCCH-HHH
Q 024347 145 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGS-TADLWSCGVILFVLLAGYLPFDDSNL-MNL 222 (269)
Q Consensus 145 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~-~~~ 222 (269)
+.++.++|+|||.+...... ......+++.|+|||++.+....+. ++||||||+++|+|++|..||..... ...
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999999999998754332 2334557899999999987733334 89999999999999999999988776 777
Q ss_pred HHHHhcCcccCC-------------------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 223 YKKISAAEFTCP-------------------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 223 ~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+..+....+ ..+++.+.+||+.||+.||.+|||+ .+++.|+|
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~--~e~l~hp~ 325 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS--EDALKHEW 325 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCH--HHHHTSGG
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCH--HHHhcCcc
Confidence 778777766665 5689999999999999999999999 88888887
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=328.52 Aligned_cols=251 Identities=20% Similarity=0.291 Sum_probs=213.3
Q ss_pred cccCCeEEeeeeeccCCcEEEEEE-----EcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
...++|++.+.||+|+||.||+|. +..+++.||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 345789999999999999999999 44567889999986432 23345678889999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC---CEEE
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKV 152 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~---~~~l 152 (269)
....++||||+++++|.+++...+ .++..+++.++.|++.||.|||+.||+||||+|+||+++.++ .++|
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 999999999999999999987643 489999999999999999999999999999999999999555 4999
Q ss_pred eeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-
Q 024347 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE- 230 (269)
Q Consensus 153 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~- 230 (269)
+|||+++...............+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999875544333333444557889999999987766 489999999999999998 999999999988888887664
Q ss_pred ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 231 FTCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
...+..++..+.+|++.||+.||++|||+++
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 335 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 335 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence 4556779999999999999999999999843
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=333.73 Aligned_cols=251 Identities=25% Similarity=0.409 Sum_probs=204.9
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK----- 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 83 (269)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 3578999999999999999999999999999999997653 3344567888999999999999999999999654
Q ss_pred -CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 84 -TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 84 -~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
...++||||+++ .+.+.+.. .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++...
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred CCeEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 457999999976 46555543 58999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc------------
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 230 (269)
. ........+++.|+|||++.+..+. .++||||||+++|+|++|+.||.+.+..+....+...-
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 2223445689999999999887764 89999999999999999999999888776665553210
Q ss_pred ----------ccCC-----CC---------------CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ----------FTCP-----PW---------------LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ----------~~~~-----~~---------------~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.... .. .++.+.+||++||+.||++|||+ .++|.|+|
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta--~e~L~Hp~ 358 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV--DDALQHPY 358 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH--HHHHTSTT
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCH--HHHhcChh
Confidence 0000 00 14678999999999999999999 88999988
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=324.74 Aligned_cols=260 Identities=28% Similarity=0.393 Sum_probs=207.2
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh--HHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
.++...++|++.+.||.|++|.||+|.+..+|+.||+|.+....... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ---------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hhHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 46677899999999999999999999999999999999986543221 1123467889999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
.+..++||||+++ ++...+... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999999976 787777654 36899999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--ccc-------
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFT------- 232 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~------- 232 (269)
... ........+++.|+|||++.+...++.++||||||+++|+|++|..||.+.........+... ...
T Consensus 163 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 163 GSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred cCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 321 222334567899999999977655568999999999999999999999988877766665331 000
Q ss_pred -------------------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 -------------------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 -------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....++..+.+||+.||+.||++|||+ .+++.|+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~h~~ 294 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA--TQALKMKY 294 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH--HHHHTSGG
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCH--HHHhcChh
Confidence 013467899999999999999999999 78888887
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=323.17 Aligned_cols=252 Identities=25% Similarity=0.402 Sum_probs=214.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||.|++|.||++.+..+++.+|+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 108 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 108 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEE
Confidence 3578999999999999999999999999999999987643 34446788999999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
||||+++++|.+++...+.++...+..++.+++.+|.|||+. |++|+||+|+||+++.++.++|+|||.+......
T Consensus 109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 999999999999998888899999999999999999999996 9999999999999999999999999988654322
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----------------------
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKK---------------------- 225 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~---------------------- 225 (269)
......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 1223457899999999988766 4899999999999999999999987665443222
Q ss_pred --------------------HhcCcccC--CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 226 --------------------ISAAEFTC--PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 226 --------------------~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.....+. ...++.++.+||+.||+.||++|||+ .+++.|+|
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~ 327 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL--KQLMVHAF 327 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCH--HHHHTSHH
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCH--HHHhhChH
Confidence 12222111 12378899999999999999999999 88888887
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=321.74 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=210.4
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCC--CCceeeeEEEee
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGS 82 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~ 82 (269)
.+...-++|++.+.||+|+||.||++.+. +++.||+|.+..... .....+.+.+|+.+++.++| +||+++++++.+
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 80 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 80 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence 45666788999999999999999999985 688999999876543 34446788999999999986 999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
....++|||+ .+++|.+++...+.+++.++..++.|++.||.|||+.||+|+||+|+||+++ ++.++|+|||++....
T Consensus 81 ~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 81 DQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp SSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred CCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 9999999995 5779999999888999999999999999999999999999999999999997 5789999999987654
Q ss_pred cccCCCcccccccCccccCcccccC----------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhc--C
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLND----------RGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISA--A 229 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~----------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~--~ 229 (269)
............+++.|+|||++.+ ....+.++||||||+++|+|++|..||..... ......+.. .
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 238 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 238 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCc
Confidence 4333333344568999999999864 12335899999999999999999999986433 233333332 3
Q ss_pred cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EFTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+...+..+.+||+.||+.||.+|||+ .+++.|+|
T Consensus 239 ~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~--~e~l~hp~ 276 (343)
T 3dbq_A 239 EIEFPDIPEKDLQDVLKCCLKRDPKQRISI--PELLAHPY 276 (343)
T ss_dssp CCCCCCCSCHHHHHHHHHHTCSSTTTSCCH--HHHHTSHH
T ss_pred ccCCcccCCHHHHHHHHHHcCCChhHCCCH--HHHHhCcc
Confidence 345566788999999999999999999999 77888876
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=313.00 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=219.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
.-++|++.+.||.|++|.||+|.+..+++.|++|.+...... ...+.+.+|+.+++.++||||+++++++......++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 346799999999999999999999999999999999765432 235788999999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
||||+++++|.+++.. +.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 174 (303)
T 3a7i_A 98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--I 174 (303)
T ss_dssp EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--C
T ss_pred EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc--c
Confidence 9999999999887764 579999999999999999999999999999999999999999999999999986544321 1
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIAR 247 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~ 247 (269)
......+++.|+|||++.+..+. .++||||||+++|+|++|..||...........+.... ...+..++..+.+||..
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 253 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA 253 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred ccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence 22334578899999999877664 89999999999999999999999888877776665544 34456789999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+.||++|||+ .+++.|+|
T Consensus 254 ~l~~dp~~Rps~--~~ll~~~~ 273 (303)
T 3a7i_A 254 CLNKEPSFRPTA--KELLKHKF 273 (303)
T ss_dssp HCCSSGGGSCCH--HHHTTCHH
T ss_pred HcCCChhhCcCH--HHHhhChh
Confidence 999999999999 77777765
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=314.01 Aligned_cols=255 Identities=33% Similarity=0.588 Sum_probs=219.8
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+...++|++.+.||.|++|.||+|.+..+++.|++|++....... ...+.+.+|++++++++||||+++++++.+....
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccch-HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 445679999999999999999999999899999999997654322 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC---CCEEEeeCCCcccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY---GNLKVSDFGLSALSQQ 163 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~---~~~~l~df~~~~~~~~ 163 (269)
++++||+++++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~ 176 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence 9999999999999998888889999999999999999999999999999999999999754 3699999998875432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 239 (269)
. .......+++.|+|||++.+. .+.++|+||||+++|+|++|..||...........+..+....+ ..+++
T Consensus 177 ~---~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T 2wei_A 177 N---TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD 251 (287)
T ss_dssp C---SSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred C---CccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence 2 122233468899999998764 35899999999999999999999999888888888877655433 45899
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.++|+.||+.||++|||+ .+++.|+|
T Consensus 252 ~~~~li~~~l~~dp~~Rps~--~ell~hp~ 279 (287)
T 2wei_A 252 DAKDLIRKMLTFHPSLRITA--TQCLEHPW 279 (287)
T ss_dssp HHHHHHHHHTCSSGGGSCCH--HHHHHSHH
T ss_pred HHHHHHHHHcccChhhCcCH--HHHhcCHH
Confidence 99999999999999999999 77777775
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-48 Score=329.78 Aligned_cols=254 Identities=35% Similarity=0.626 Sum_probs=205.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh-----hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.++|++.+.||+|+||.||+|.+..+++.||+|++...... .......+.+|+.++++++||||+++++++. ..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 57899999999999999999999999999999999765432 1222345789999999999999999999985 45
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC---CEEEeeCCCcccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG---NLKVSDFGLSALS 161 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~---~~~l~df~~~~~~ 161 (269)
..++||||+++++|.+.+...+.+++.++..++.|++.||.|||+.||+|+||+|+||+++.++ .++|+|||++...
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5789999999999999888888899999999999999999999999999999999999997544 5999999998754
Q ss_pred ccccCCCcccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCcccCC----
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNL-MNLYKKISAAEFTCP---- 234 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~---- 234 (269)
.. ........+++.|+|||++.+ ...++.++||||||+++|+|++|..||..... ......+..+.....
T Consensus 293 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 293 GE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp C--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred CC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 32 222234568999999999864 23335799999999999999999999976433 344455555554443
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~--~e~l~hp~ 402 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTT--EEALRHPW 402 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCH--HHHHHSGG
T ss_pred cccCHHHHHHHHHHccCChhHCcCH--HHHhCCcc
Confidence 3589999999999999999999999 88899987
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=320.26 Aligned_cols=262 Identities=27% Similarity=0.457 Sum_probs=195.5
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
.......++|++.+.||.|++|.||++.+..+++.||+|.+..... ....+.+.+|+.++++++||||+++++++...
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 3456677899999999999999999999988999999999865432 23356788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeC
Q 024347 84 TKIFIVLEFVTGGELFDKIVN--------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~--------~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
+..+++|||+++++|.+++.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 999999999999999988864 346899999999999999999999999999999999999999999999999
Q ss_pred CCccccccccC---CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc
Q 024347 156 GLSALSQQVRD---DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT 232 (269)
Q Consensus 156 ~~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 232 (269)
|.+........ ........+++.|+|||++.+....+.++||||||+++|+|++|..||.................+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 98865433211 112233457889999999876333458999999999999999999999887665554444332221
Q ss_pred ----------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 ----------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 ----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+++.+.++|..||+.||.+|||+ .+++.|+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~~ll~h~~ 290 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTA--AELLRHKF 290 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCH--HHHHTSTT
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCH--HHHhhChh
Confidence 223578899999999999999999999 88888887
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=324.56 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=209.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC--CCCceeeeEEEeeCCeE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--HPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~~ 86 (269)
.-.+|++.+.||.|+||.||++.+.. ++.||+|.+..... .....+.+.+|+.+++.+. |+||+++++++...+..
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 34569999999999999999999865 89999999976543 3445678999999999996 59999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++||| +.+++|.+++.....+++.++..++.|++.||.|||+.||+|+||+|+||+++ ++.++|+|||++........
T Consensus 132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 99999 55789999998888899999999999999999999999999999999999996 58899999999876543332
Q ss_pred CCcccccccCccccCcccccCC----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcC--cccC
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDR----------GYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISAA--EFTC 233 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~--~~~~ 233 (269)
........+++.|+|||++.+. ..++.++||||||+++|+|++|..||.... .......+... ....
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~ 289 (390)
T 2zmd_A 210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF 289 (390)
T ss_dssp ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence 2233445689999999998752 234589999999999999999999998643 33444444433 3455
Q ss_pred CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 234 PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 234 ~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+...+..+.+||+.||+.||.+|||+ .+++.|+|
T Consensus 290 ~~~~~~~~~~li~~~L~~dP~~Rps~--~ell~hp~ 323 (390)
T 2zmd_A 290 PDIPEKDLQDVLKCCLKRDPKQRISI--PELLAHPY 323 (390)
T ss_dssp CCCSCHHHHHHHHHHTCSSTTTSCCH--HHHHTSHH
T ss_pred CccchHHHHHHHHHHcccChhhCCCH--HHHhhCcC
Confidence 66778999999999999999999999 77788776
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=327.12 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=205.2
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee---
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--- 82 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 82 (269)
+....++|++.+.||.|+||.||+|.+..+|+.||+|.+..+.. ...+|+.+++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 74 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGD 74 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC--
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCc
Confidence 45667899999999999999999999999999999999865432 23369999999999999999999844
Q ss_pred -----------------------------------CCeEEEEEeccCCCchhHHHH----hcCCCCHHHHHHHHHHHHHH
Q 024347 83 -----------------------------------KTKIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINA 123 (269)
Q Consensus 83 -----------------------------------~~~~~~v~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~ 123 (269)
....++||||+++ +|.+.+. ....+++..+..++.|++.|
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a 153 (383)
T 3eb0_A 75 EEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRA 153 (383)
T ss_dssp -----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Confidence 3348899999985 6655554 35679999999999999999
Q ss_pred HHHHHhCCcEeecCCCCceEec-CCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHH
Q 024347 124 VDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGV 202 (269)
Q Consensus 124 l~~lh~~~i~h~di~~~nIl~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 202 (269)
|.|||+.||+|+||+|+||+++ .++.++|+|||.+...... .......+++.|+|||++.+...++.++||||+|+
T Consensus 154 L~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 230 (383)
T 3eb0_A 154 VGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS---EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230 (383)
T ss_dssp HHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT---SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred HHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC---CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHH
Confidence 9999999999999999999997 6788999999998754332 22334457889999999987665569999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHHhcC-----------------c------------ccCCCCCCHHHHHHHHHhcCCCC
Q 024347 203 ILFVLLAGYLPFDDSNLMNLYKKISAA-----------------E------------FTCPPWLSFTARKLIARILDPNP 253 (269)
Q Consensus 203 ~l~~l~~g~~p~~~~~~~~~~~~~~~~-----------------~------------~~~~~~~~~~l~~li~~~l~~dP 253 (269)
++|+|++|..||.+....+....+... . ...+..+++++.+||+.||+.||
T Consensus 231 il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 231 VFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 999999999999988777666655321 0 01334578899999999999999
Q ss_pred CCcCCCCccccccccC
Q 024347 254 MTVSIYPFADILYMRF 269 (269)
Q Consensus 254 ~~Rps~~~~~~l~~~~ 269 (269)
++|||+ .+++.|+|
T Consensus 311 ~~R~t~--~e~l~hp~ 324 (383)
T 3eb0_A 311 DLRINP--YEAMAHPF 324 (383)
T ss_dssp GGSCCH--HHHHTSGG
T ss_pred hhCCCH--HHHhcCHH
Confidence 999999 88888887
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=315.41 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=212.6
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||.|++|.||+|.+..+++.+++|.+..... ...+.+.+|+.+++.++||||+++++++...+..+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 345789999999999999999999999999999999865432 23567889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++|||+++++|..++.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 171 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL- 171 (302)
T ss_dssp EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence 99999999999888765 4579999999999999999999999999999999999999999999999999865322111
Q ss_pred CCcccccccCccccCccccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc---CCCCCCH
Q 024347 167 DGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT---CPPWLSF 239 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~ 239 (269)
.......+++.|+|||++. .....+.++||||||+++|+|++|..||...+.......+.....+ .+..++.
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV 250 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence 1112345788999999984 2233358999999999999999999999988887777766555432 3456899
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.++|+.||+.||++|||+ .+++.|+|
T Consensus 251 ~l~~li~~~l~~dp~~Rps~--~~ll~h~~ 278 (302)
T 2j7t_A 251 EFRDFLKIALDKNPETRPSA--AQLLEHPF 278 (302)
T ss_dssp HHHHHHHHHSCSCTTTSCCH--HHHTTSTT
T ss_pred HHHHHHHHHcccChhhCCCH--HHHhcChH
Confidence 99999999999999999999 88888887
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=320.52 Aligned_cols=253 Identities=23% Similarity=0.396 Sum_probs=204.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC--e
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--K 85 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 85 (269)
..-++|++.+.||+|+||.||+|.+..+++.||+|++........ .+.+.+|+++++.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSC--HHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccch--HHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 345789999999999999999999999999999999976443222 466789999999999999999999987655 7
Q ss_pred EEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----cCCCCEEEeeCCCc
Q 024347 86 IFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~----~~~~~~~l~df~~~ 158 (269)
.++||||+++++|.+++.... .+++.++..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 899999999999999987643 39999999999999999999999999999999999999 77777999999998
Q ss_pred cccccccCCCcccccccCccccCcccccC-------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHh
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLND-------RGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKIS 227 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----~~~~~~~~~ 227 (269)
...... .......+++.|+|||++.. ....+.++||||||+++|+|++|..||.... .......+.
T Consensus 164 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 754332 22233458899999999862 2333589999999999999999999996422 233444443
Q ss_pred cCcc---------------------c----CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccc
Q 024347 228 AAEF---------------------T----CPPWLSFTARKLIARILDPNPMTVSIYPFADILYM 267 (269)
Q Consensus 228 ~~~~---------------------~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~ 267 (269)
.+.+ + .+..++..+.+||+.||+.||++|||+ .++|.|
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~--~ell~h 303 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF--DQFFAE 303 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCH--HHHHHH
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccH--HHhhhc
Confidence 3322 1 111245679999999999999999999 666654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=326.47 Aligned_cols=249 Identities=34% Similarity=0.593 Sum_probs=201.1
Q ss_pred ccccCCeEEe-eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHh-hhCCCCCceeeeEEEee--
Q 024347 7 KRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGS-- 82 (269)
Q Consensus 7 ~~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~-- 82 (269)
....++|.+. +.||.|+||.||++.+..+++.||+|++... ..+.+|+.++ +..+||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 3456788887 7899999999999999999999999998632 2345677776 55689999999999865
Q ss_pred --CCeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC---CCCEEEeeC
Q 024347 83 --KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDF 155 (269)
Q Consensus 83 --~~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~---~~~~~l~df 155 (269)
....++||||++|++|.+++...+ .+++.++..++.|++.||.|||+.||+|+||+|+||+++. ++.++|+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 567899999999999999998753 5999999999999999999999999999999999999997 788999999
Q ss_pred CCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCcc
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN----LYKKISAAEF 231 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~ 231 (269)
|+++.... ........+++.|+|||++.+..+. .++||||||+++|+|++|..||....... ....+..+..
T Consensus 209 G~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 209 GFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ccccccCC---CCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 99875432 1222345678999999999877664 89999999999999999999997654321 3444444444
Q ss_pred cCC----CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 TCP----PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+ ..++.++.+||+.||+.||++|||+ .+++.|+|
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~--~eil~hp~ 324 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI--TEFMNHPW 324 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCH--HHHHHSHH
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCH--HHHhcCcc
Confidence 333 4589999999999999999999999 77888876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=332.37 Aligned_cols=256 Identities=27% Similarity=0.336 Sum_probs=194.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----C
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 84 (269)
.++|++.+.||.|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++... .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 478999999999999999999999999999999986533 2344467889999999999999999999998443 5
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++||||+ +++|.+.+.....+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++.....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 689999998 5689998888888999999999999999999999999999999999999999999999999999765432
Q ss_pred cCC-------------------------CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc----------
Q 024347 165 RDD-------------------------GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA---------- 209 (269)
Q Consensus 165 ~~~-------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~---------- 209 (269)
... .......+++.|+|||++.....++.++|||||||++|+|++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~ 289 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence 111 112334578899999987655555699999999999999998
Q ss_pred -CCCCCCCCCH--------------------HHHHHHHh---cC----------------------------cccCCCCC
Q 024347 210 -GYLPFDDSNL--------------------MNLYKKIS---AA----------------------------EFTCPPWL 237 (269)
Q Consensus 210 -g~~p~~~~~~--------------------~~~~~~~~---~~----------------------------~~~~~~~~ 237 (269)
|..+|.+... ......+. .. .....+..
T Consensus 290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 369 (458)
T 3rp9_A 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS 369 (458)
T ss_dssp GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence 6677755331 11111110 00 00112346
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 238 SFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++++.+||++||+.||++|||+ .++|.|+|
T Consensus 370 s~~~~dLl~~mL~~dP~~R~t~--~e~L~Hp~ 399 (458)
T 3rp9_A 370 SADAIHLLKRMLVFNPNKRITI--NECLAHPF 399 (458)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCH--HHHHHSGG
T ss_pred CHHHHHHHHHHhccCccccCCH--HHHhcCHh
Confidence 8999999999999999999999 88899987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=313.81 Aligned_cols=252 Identities=29% Similarity=0.465 Sum_probs=210.7
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||.|++|.||+|.+..+|+.|++|.+..... .+.+.+|+.+++.++||||+++++++...+..+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW 100 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 345789999999999999999999999999999999875432 356788999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
++|||+++++|.+++.. ...++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~- 179 (314)
T 3com_A 101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM- 179 (314)
T ss_dssp EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB-
T ss_pred EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc-
Confidence 99999999999998863 5679999999999999999999999999999999999999999999999999986543321
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc---ccCCCCCCHHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTCPPWLSFTARK 243 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~ 243 (269)
.......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+.... ...+..++..+.+
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 257 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD 257 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred -cccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence 12233457889999999987765 489999999999999999999999877766655554432 2334558999999
Q ss_pred HHHHhcCCCCCCcCCCCccccccccC
Q 024347 244 LIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+.||+.||.+|||+ .+++.|+|
T Consensus 258 li~~~l~~dp~~Rpt~--~~ll~~~~ 281 (314)
T 3com_A 258 FVKQCLVKSPEQRATA--TQLLQHPF 281 (314)
T ss_dssp HHHHHTCSCTTTSCCH--HHHTTSHH
T ss_pred HHHHHccCChhhCcCH--HHHHhCHH
Confidence 9999999999999999 77788776
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=312.90 Aligned_cols=257 Identities=22% Similarity=0.356 Sum_probs=200.0
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+....++|++.+.||+|++|.||++.+..+|+.||+|.+..... .....+.+.++...++.++||||+++++++.+.+.
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~ 80 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD 80 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC
Confidence 45667899999999999999999999999999999999875432 23334555666667889999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 86 IFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
.++||||+++ ++.+.+.. ...+++..+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|||.+..
T Consensus 81 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 81 VWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred EEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence 9999999975 77666543 46799999999999999999999998 999999999999999999999999998865
Q ss_pred cccccCCCcccccccCccccCccccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHH-HHhcCcccCC-
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYK-KISAAEFTCP- 234 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~-~~~~~~~~~~- 234 (269)
.... .......+++.|+|||++. .....+.++||||||+++|+|++|..||.. ........ .........+
T Consensus 160 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (290)
T 3fme_A 160 LVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236 (290)
T ss_dssp -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT
T ss_pred cccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccc
Confidence 4332 2223335789999999973 223335899999999999999999999985 33333333 3333333333
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+++.+.+||..||+.||++|||+ .+++.|+|
T Consensus 237 ~~~~~~~~~li~~~l~~~p~~Rpt~--~e~l~hp~ 269 (290)
T 3fme_A 237 DKFSAEFVDFTSQCLKKNSKERPTY--PELMQHPF 269 (290)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCH--HHHTTSHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCcCH--HHHHhCcc
Confidence 4589999999999999999999999 78888876
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=318.74 Aligned_cols=256 Identities=23% Similarity=0.401 Sum_probs=216.6
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEc-------CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCcee
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNS-------ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 75 (269)
+.+....++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .....+.+.+|+.+++.+ +||||++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 445666789999999999999999999975 357789999987543 344467889999999999 8999999
Q ss_pred eeEEEeeCCeEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 024347 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (269)
Q Consensus 76 ~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~ 139 (269)
+++++...+..++||||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 9999999999999999999999999987653 388999999999999999999999999999999
Q ss_pred CceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 024347 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (269)
Q Consensus 140 ~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 218 (269)
+||+++.++.++|+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||....
T Consensus 186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~ 264 (334)
T 2pvf_A 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIP 264 (334)
T ss_dssp GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCC
Confidence 999999999999999999875543222222233345778999999977665 489999999999999999 999999988
Q ss_pred HHHHHHHHhcCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 219 LMNLYKKISAAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 219 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+....+..+. ...+..++..+.++|+.||+.||.+|||++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 309 (334)
T 2pvf_A 265 VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQL 309 (334)
T ss_dssp HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 888877776554 45567799999999999999999999998543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=316.22 Aligned_cols=248 Identities=23% Similarity=0.358 Sum_probs=200.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
++|++.+.||+|+||+||+|.+..+++.||+|.+...........+.+.++..+.+..+|+||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 67999999999999999999999999999999986544333333344444444445558999999999999999999999
Q ss_pred eccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||+ +++|.+.+... ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++...... ..
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~---~~ 212 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA---GA 212 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-------
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC---CC
Confidence 999 56888877664 46999999999999999999999999999999999999999999999999998654332 22
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc--cCCCCCCHHHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF--TCPPWLSFTARKLIAR 247 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 247 (269)
.....+++.|+|||++.+ .+ +.++||||||+++|+|++|..|+... .....+..+.. ..+..+++++.+||+.
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 287 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGG---EGWQQLRQGYLPPEFTAGLSSELRSVLVM 287 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSH---HHHHHHTTTCCCHHHHTTSCHHHHHHHHH
T ss_pred CcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHhccCCCcccccCCCHHHHHHHHH
Confidence 333458999999999876 34 58999999999999999997666542 22333333322 2345689999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||++||++|||+ .+++.|+|
T Consensus 288 ~L~~dP~~Rpt~--~ell~hp~ 307 (311)
T 3p1a_A 288 MLEPDPKLRATA--EALLALPV 307 (311)
T ss_dssp HSCSSTTTSCCH--HHHHTSGG
T ss_pred HcCCChhhCcCH--HHHHhCcc
Confidence 999999999999 88888887
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=324.56 Aligned_cols=259 Identities=29% Similarity=0.514 Sum_probs=216.3
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHhhhC-CCCCceeeeEEEee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLV-KHPNVVRLYEVMGS 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~ 82 (269)
...++|++.+.||+|+||.||++++. .+++.||+|++...... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 34579999999999999999999984 47999999998643211 111234566789999999 69999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
....++||||+++++|.+++...+.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++...
T Consensus 131 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~ 210 (355)
T 1vzo_A 131 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 210 (355)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred CceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHhcCcccCCCCC
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDD----SNLMNLYKKISAAEFTCPPWL 237 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~----~~~~~~~~~~~~~~~~~~~~~ 237 (269)
... ........+++.|+|||++.+.. ..+.++||||||+++|+|++|..||.. .........+.....+.+..+
T Consensus 211 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T 1vzo_A 211 ADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289 (355)
T ss_dssp GGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred cCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCccc
Confidence 211 12223346899999999998633 345899999999999999999999964 344566666677777888889
Q ss_pred CHHHHHHHHHhcCCCCCCcC-----CCCccccccccC
Q 024347 238 SFTARKLIARILDPNPMTVS-----IYPFADILYMRF 269 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rp-----s~~~~~~l~~~~ 269 (269)
+..+.+||+.||+.||++|| ++ .+++.|+|
T Consensus 290 ~~~~~~li~~~L~~dP~~R~~~~~~s~--~ell~h~~ 324 (355)
T 1vzo_A 290 SALAKDLIQRLLMKDPKKRLGCGPRDA--DEIKEHLF 324 (355)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTSSTTTH--HHHHTSGG
T ss_pred CHHHHHHHHHHhhhCHHHhcCCCCCCH--HHHHcCcc
Confidence 99999999999999999999 65 66777765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=336.09 Aligned_cols=250 Identities=16% Similarity=0.184 Sum_probs=199.8
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHH---HHhhhCCCCCceeee-----
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV---ATMKLVKHPNVVRLY----- 77 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~---~~l~~l~~~~i~~~~----- 77 (269)
+....++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+ +.++.++||||++++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 344468899999999999999999999889999999999755444444567888999 555566799999988
Q ss_pred --EEEeeCC-----------------eEEEEEeccCCCchhHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCC
Q 024347 78 --EVMGSKT-----------------KIFIVLEFVTGGELFDKIVNHGRMKE-------DEARRYFQQLINAVDYCHSRG 131 (269)
Q Consensus 78 --~~~~~~~-----------------~~~~v~~~~~~~~l~~~~~~~~~l~~-------~~~~~i~~~i~~~l~~lh~~~ 131 (269)
+++.+.+ ..+++|||+ +|+|.+++...+.+++ ..+..++.|++.||.|||+.|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 226 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 226 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 6665553 278999999 5799999987554554 788889999999999999999
Q ss_pred cEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCC-----------CCCCCchhHHHH
Q 024347 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-----------GYDGSTADLWSC 200 (269)
Q Consensus 132 i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~~Di~sl 200 (269)
|+|+||||+||+++.++.++|+|||+++.... ......+ +.|+|||++.+. .+ +.++|||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSl 299 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWAL 299 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHH
Confidence 99999999999999999999999999874222 2233456 899999999876 44 599999999
Q ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 201 GVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 201 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+++|+|++|..||...........+ ......+++.+.+||..||+.||++|||+ .+++.|+|
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~--~e~l~hp~ 362 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLP--LQAMETPE 362 (377)
T ss_dssp HHHHHHHHHSSCCC------CCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGCCCH--HHHHTSHH
T ss_pred HHHHHHHHHCCCCCcccccccchhhh----hhhccCCCHHHHHHHHHHcCCCchhCCCH--HHHhhChH
Confidence 99999999999999765443322222 23345689999999999999999999999 77888876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=308.23 Aligned_cols=249 Identities=23% Similarity=0.372 Sum_probs=212.8
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+....++|++.+.||+|++|.||++.+. ++..||+|.+...... .+.+.+|+.++++++||||+++++++.+...
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCc
Confidence 3456689999999999999999999876 5677999998765432 2568899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++||||+++++|.+++...+ .+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 999999999999999887753 5999999999999999999999999999999999999999999999999998754332
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcc-cCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 242 (269)
.. .......+++.|+|||++.+..+. .++||||||+++|+|++ |..||...........+..+.. ..+...++.+.
T Consensus 158 ~~-~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 235 (268)
T 3sxs_A 158 QY-VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIY 235 (268)
T ss_dssp CE-EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred hh-hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHH
Confidence 11 111223346679999999876664 89999999999999999 9999999888888887776653 44566899999
Q ss_pred HHHHHhcCCCCCCcCCCCc
Q 024347 243 KLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~ 261 (269)
++++.||+.||++|||+++
T Consensus 236 ~li~~~l~~~p~~Rps~~~ 254 (268)
T 3sxs_A 236 QIMYSCWHELPEKRPTFQQ 254 (268)
T ss_dssp HHHHHTTCSSGGGSCCHHH
T ss_pred HHHHHHcCCChhhCcCHHH
Confidence 9999999999999999844
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=325.16 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=210.5
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEE-----EcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeE
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 78 (269)
.+....++|++.+.||+|+||.||+|. +..+++.||+|.+.... .....+.+.+|+.+++++ +||||+++++
T Consensus 16 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 345667899999999999999999998 55667899999997543 233457789999999999 7899999999
Q ss_pred EEeeCC-eEEEEEeccCCCchhHHHHhcCC--------------------------------------------------
Q 024347 79 VMGSKT-KIFIVLEFVTGGELFDKIVNHGR-------------------------------------------------- 107 (269)
Q Consensus 79 ~~~~~~-~~~~v~~~~~~~~l~~~~~~~~~-------------------------------------------------- 107 (269)
++...+ ..+++|||+++++|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 987754 48999999999999999876432
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 108 ----------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 108 ----------------l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++.............
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 8899999999999999999999999999999999999999999999999987554333323333
Q ss_pred ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhc-CcccCCCCCCHHHHHHHHHh
Q 024347 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLM-NLYKKISA-AEFTCPPWLSFTARKLIARI 248 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~l~~li~~~ 248 (269)
...+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.... .....+.. .....+..+++++.+++..|
T Consensus 254 ~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 332 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 332 (359)
T ss_dssp -CEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHH
T ss_pred ccCCCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHH
Confidence 4457788999999987666 489999999999999998 99999876533 33333333 34566777999999999999
Q ss_pred cCCCCCCcCCCCc
Q 024347 249 LDPNPMTVSIYPF 261 (269)
Q Consensus 249 l~~dP~~Rps~~~ 261 (269)
|+.||++|||+++
T Consensus 333 l~~dP~~Rps~~e 345 (359)
T 3vhe_A 333 WHGEPSQRPTFSE 345 (359)
T ss_dssp TCSSGGGSCCHHH
T ss_pred ccCChhhCCCHHH
Confidence 9999999999844
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=311.97 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=204.6
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEE
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV 79 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 79 (269)
...+....++|++.+.||+|+||.||+|.+..+ +..+++|.+.... .....+.+.+|+.++++++||||++++++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 84 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGV 84 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEE
Confidence 445677789999999999999999999998654 4569999875432 34456788999999999999999999999
Q ss_pred EeeCCeEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCc
Q 024347 80 MGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (269)
Q Consensus 80 ~~~~~~~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~ 158 (269)
+. .+..++||||+++++|.+++...+ .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++
T Consensus 85 ~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 163 (281)
T 1mp8_A 85 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163 (281)
T ss_dssp EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred Ec-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccc
Confidence 84 456789999999999999987654 6999999999999999999999999999999999999999999999999998
Q ss_pred cccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPW 236 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 236 (269)
........ .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..+. .+.++.
T Consensus 164 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 241 (281)
T 1mp8_A 164 RYMEDSTY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPN 241 (281)
T ss_dssp ----------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred cccCcccc-cccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCC
Confidence 75433211 11222345678999999987666 489999999999999996 999999887777777776543 566778
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+++.+.++++.||+.||++|||++++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rps~~~l 267 (281)
T 1mp8_A 242 CPPTLYSLMTKCWAYDPSRRPRFTEL 267 (281)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHH
Confidence 99999999999999999999998543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=317.86 Aligned_cols=255 Identities=30% Similarity=0.509 Sum_probs=215.3
Q ss_pred cccCCeEEe-eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCe
Q 024347 8 RRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTK 85 (269)
Q Consensus 8 ~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~ 85 (269)
..-++|.+. +.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 344678887 89999999999999999999999999987543322 22467888999999995 6999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC---CCCEEEeeCCCccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFGLSAL 160 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~---~~~~~l~df~~~~~ 160 (269)
.++||||+++++|.+++... +.+++.++..++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||.+..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999999999888553 57999999999999999999999999999999999999987 78999999999875
Q ss_pred cccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CC
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PW 236 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~ 236 (269)
.... .......+++.|+|||++.+..+. .++||||||+++|+|++|..||...........+.......+ ..
T Consensus 184 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 259 (327)
T 3lm5_A 184 IGHA---CELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSS 259 (327)
T ss_dssp C------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred cCCc---cccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcc
Confidence 4332 122334689999999999877764 899999999999999999999999888888777765544333 45
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~--~~ll~h~~ 290 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTA--EICLSHSW 290 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCH--HHHTTCGG
T ss_pred cCHHHHHHHHHHcCCChhhCcCH--HHHhCCHh
Confidence 89999999999999999999999 77888887
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=315.75 Aligned_cols=256 Identities=18% Similarity=0.256 Sum_probs=217.9
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeE
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYE 78 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 78 (269)
.++....++|++.+.||+|++|.||+|.+. .+++.|++|.+.... .......+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 455677789999999999999999999876 357889999986543 2334567889999999999999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC
Q 024347 79 VMGSKTKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (269)
Q Consensus 79 ~~~~~~~~~~v~~~~~~~~l~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~ 148 (269)
++.+.+..+++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999988652 3568999999999999999999999999999999999999999
Q ss_pred CEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 024347 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (269)
Q Consensus 149 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 227 (269)
.++|+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+.
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 254 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH
Confidence 999999999875543322222233345788999999987666 489999999999999999 899999988888888776
Q ss_pred cCc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 228 AAE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 228 ~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+. ...+..++..+.++|+.||+.||++|||++++
T Consensus 255 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~ 290 (322)
T 1p4o_A 255 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 290 (322)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 654 35567799999999999999999999998443
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=310.48 Aligned_cols=250 Identities=22% Similarity=0.362 Sum_probs=211.8
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.+....++|++.+.||.|++|.||++.+. ++..||+|.+...... .+.+.+|+++++.++||||+++++++.+.+
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 34566789999999999999999999886 5778999999765433 256788999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++||||+++++|.+++.. ...+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999999876 45799999999999999999999999999999999999999999999999999875433
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTA 241 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 241 (269)
.... ......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+..+. ...+...++.+
T Consensus 173 ~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 250 (283)
T 3gen_A 173 DEYT-SSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 250 (283)
T ss_dssp HHHH-STTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccc-cccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHH
Confidence 2111 1122335678999999987766 489999999999999998 999999988888888887664 44566789999
Q ss_pred HHHHHHhcCCCCCCcCCCCc
Q 024347 242 RKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~ 261 (269)
.++|+.||+.||++|||+++
T Consensus 251 ~~li~~~l~~~p~~Rps~~~ 270 (283)
T 3gen_A 251 YTIMYSCWHEKADERPTFKI 270 (283)
T ss_dssp HHHHHHTTCSSGGGSCCHHH
T ss_pred HHHHHHHccCChhHCcCHHH
Confidence 99999999999999999844
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=312.98 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=218.7
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
.++....++|++.+.||+|++|.||+|.+..+++.+++|.+..... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 4566788899999999999999999999999999999999865432 256788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
...++||||+++++|.+++... ..++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999764 45899999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCH
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (269)
.... ........+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...+.....+.+... ....+..+++
T Consensus 162 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T 3kfa_A 162 TGDT-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 239 (288)
T ss_dssp CSSS-SEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred cCCc-cccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCH
Confidence 4321 112222345678999999987766 489999999999999999 99999988877777776655 4556677999
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcc
Q 024347 240 TARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+.+|++.||+.||++|||++++
T Consensus 240 ~l~~li~~~l~~dp~~Rps~~~~ 262 (288)
T 3kfa_A 240 KVYELMRACWQWNPSDRPSFAEI 262 (288)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhCCChhhCcCHHHH
Confidence 99999999999999999998554
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=323.30 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=195.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC------
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------ 83 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------ 83 (269)
.++|++.+.||.|++|.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 479999999999999999999999999999999986543 2334467888999999999999999999998654
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
...+++++++ +++|.+++.. +.++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5579999998 6788887765 5799999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cc----------
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EF---------- 231 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~---------- 231 (269)
......+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+.......+... .+
T Consensus 185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~ 259 (367)
T 2fst_X 185 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259 (367)
T ss_dssp -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred -----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 1233467899999999987555569999999999999999999999988776655554321 00
Q ss_pred -------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 -------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 -------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+..++.+.+||++||+.||.+|||+ .++|.|+|
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~--~e~L~hp~ 314 (367)
T 2fst_X 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA--AQALAHAY 314 (367)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCH--HHHhcChh
Confidence 0012468889999999999999999999 88888887
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=317.53 Aligned_cols=254 Identities=35% Similarity=0.631 Sum_probs=206.5
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh-----hHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.++|++.+.||.|+||.||+|.+..+++.||+|.+...... .......+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46899999999999999999999999999999998654321 1223356789999999999999999999987655
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC---EEEeeCCCcccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSDFGLSALS 161 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~---~~l~df~~~~~~ 161 (269)
.++||||+++++|.+.+...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988888999999999999999999999999999999999999987664 999999998754
Q ss_pred ccccCCCcccccccCccccCccccc--CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCcccCC----
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLN--DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFTCP---- 234 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~---- 234 (269)
.. ........+++.|+|||++. +....+.++||||||+++|+|++|..||...... .....+..+.....
T Consensus 168 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 168 GE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp CC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred cc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 32 11122345789999999974 2333458999999999999999999999764332 33444444443332
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~--~~~l~h~~ 277 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTT--EEALRHPW 277 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCH--HHHHTSGG
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCH--HHHhhCcC
Confidence 4579999999999999999999999 78888887
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=318.82 Aligned_cols=254 Identities=24% Similarity=0.392 Sum_probs=204.3
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 84 (269)
..++|++.+.||+|+||.||+|++..+|+.||+|++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence 4578999999999999999999999999999999987543 2233578899999999999999999999985543
Q ss_pred -----------------------------------------------------eEEEEEeccCCCchhHHHHhcC---CC
Q 024347 85 -----------------------------------------------------KIFIVLEFVTGGELFDKIVNHG---RM 108 (269)
Q Consensus 85 -----------------------------------------------------~~~~v~~~~~~~~l~~~~~~~~---~l 108 (269)
..+++|||+++++|.+++.... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~ 161 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence 3899999999999999988754 35
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC----------CcccccccCcc
Q 024347 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD----------GLLHTTCGTPN 178 (269)
Q Consensus 109 ~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~----------~~~~~~~~~~~ 178 (269)
+...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......... .......+++.
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 56678999999999999999999999999999999999999999999998765443211 12233458999
Q ss_pred ccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC-CCCCCHHHHHHHHHhcCCCCCCcC
Q 024347 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-PPWLSFTARKLIARILDPNPMTVS 257 (269)
Q Consensus 179 ~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rp 257 (269)
|+|||++.+..+ +.++||||||+++|+|++|..|+.. .............+. ....++.+.+||+.||+.||++||
T Consensus 242 y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 318 (332)
T 3qd2_B 242 YMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318 (332)
T ss_dssp GSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred ccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence 999999988776 4999999999999999998776432 122333333333221 133678899999999999999999
Q ss_pred CCCccccccccC
Q 024347 258 IYPFADILYMRF 269 (269)
Q Consensus 258 s~~~~~~l~~~~ 269 (269)
|+ .+++.|+|
T Consensus 319 s~--~~~l~~~~ 328 (332)
T 3qd2_B 319 EA--TDIIENAI 328 (332)
T ss_dssp CH--HHHHHSTT
T ss_pred CH--HHHhhchh
Confidence 99 88888887
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=313.58 Aligned_cols=259 Identities=26% Similarity=0.394 Sum_probs=212.2
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEe
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMG 81 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~ 81 (269)
...+....++|++.+.||.|++|.||+|.+..+++.|++|.+...... .+.+.+|+.+++++ +||||+++++++.
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 345667789999999999999999999999999999999998654322 35678899999998 7999999999997
Q ss_pred e------CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEe
Q 024347 82 S------KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVS 153 (269)
Q Consensus 82 ~------~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~ 153 (269)
. ....++||||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 6 46789999999999999998764 479999999999999999999999999999999999999999999999
Q ss_pred eCCCccccccccCCCcccccccCccccCcccccC----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Q 024347 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 154 df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (269)
|||++...... ........+++.|+|||++.. ....+.++||||||+++|+|++|..||...........+...
T Consensus 172 Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 249 (326)
T 2x7f_A 172 DFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 249 (326)
T ss_dssp CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred eCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC
Confidence 99988754321 112233457899999999863 222358999999999999999999999888777666665544
Q ss_pred ccc--CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EFT--CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+ .+..++..+.+||+.||+.||.+||++ .+++.|+|
T Consensus 250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--~~ll~hp~ 289 (326)
T 2x7f_A 250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPAT--EQLMKHPF 289 (326)
T ss_dssp CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCH--HHHHTSHH
T ss_pred ccccCCccccCHHHHHHHHHHhccChhhCCCH--HHHhhChH
Confidence 332 235589999999999999999999999 77788776
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=320.48 Aligned_cols=255 Identities=20% Similarity=0.333 Sum_probs=209.7
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEE-----cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeE
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 78 (269)
++....++|++.+.||.|++|.||+|.+ ..+++.||+|.+.... .....+.+.+|+.+++++ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4455678999999999999999999997 3456789999987433 233457889999999999 8999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEee
Q 024347 79 VMGSKTKIFIVLEFVTGGELFDKIVNHG-----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHR 135 (269)
Q Consensus 79 ~~~~~~~~~~v~~~~~~~~l~~~~~~~~-----------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~ 135 (269)
++...+..++||||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999987643 27899999999999999999999999999
Q ss_pred cCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 024347 136 DLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPF 214 (269)
Q Consensus 136 di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~ 214 (269)
||+|+||+++.++.++|+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCc
Confidence 9999999999999999999999876544332222333446778999999987666 489999999999999998 99999
Q ss_pred CCCCHHHHHHH-HhcC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 215 DDSNLMNLYKK-ISAA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 215 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
........... +..+ ....+..+++.+.+||..||+.||.+|||++++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 325 (344)
T 1rjb_A 276 PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 325 (344)
T ss_dssp TTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 87654443333 3332 345567789999999999999999999998543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=318.99 Aligned_cols=250 Identities=18% Similarity=0.335 Sum_probs=209.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCe----EEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEP----VALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~----~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.-++|++.+.||+|+||.||+|.+..+++. +++|.+..... ....+.+.+|+.+++.++||||+++++++. .+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS 87 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence 457899999999999999999999888876 67776643321 112345678999999999999999999986 45
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++|++|+.+++|.+++... +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++....
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 688999999999999988764 5789999999999999999999999999999999999999999999999999987654
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 241 (269)
...........++..|+|||++.+..+ +.++||||||+++|+|++ |..||...........+..+ ....+..++..+
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDV 246 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTT
T ss_pred ccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHH
Confidence 433333444557789999999987766 489999999999999999 99999988877777777665 455667789999
Q ss_pred HHHHHHhcCCCCCCcCCCCcc
Q 024347 242 RKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+++..||+.||++|||++++
T Consensus 247 ~~li~~~l~~dp~~Rps~~el 267 (325)
T 3kex_A 247 YMVMVKCWMIDENIRPTFKEL 267 (325)
T ss_dssp THHHHHHTCSCTTTSCCHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHH
Confidence 999999999999999998543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=315.59 Aligned_cols=247 Identities=23% Similarity=0.418 Sum_probs=204.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEee--CCe
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS--KTK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~ 85 (269)
..++|++.+.||+|++|.||+|.+..+++.||+|++.... .+.+.+|+.++++++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3578999999999999999999999999999999986433 366889999999997 9999999999987 667
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-CEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-~~~l~df~~~~~~~~~ 164 (269)
.+++|||+++++|.+.+. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 899999999999988764 389999999999999999999999999999999999999776 7999999998754332
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHH-------------HhcCc
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKK-------------ISAAE 230 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~-------------~~~~~ 230 (269)
.......++..|+|||++.+....+.++||||||+++|+|++|..||... ........ +....
T Consensus 185 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 261 (330)
T 3nsz_A 185 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261 (330)
T ss_dssp ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ---CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence 22334467889999999987555569999999999999999999999533 22221111 11111
Q ss_pred cc------------------------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 FT------------------------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ~~------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. .+..+++++.+||+.||++||++|||+ .++|.|+|
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta--~e~l~hp~ 322 (330)
T 3nsz_A 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA--REAMEHPY 322 (330)
T ss_dssp CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCH--HHHHTSGG
T ss_pred cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCH--HHHhcCcc
Confidence 11 112278999999999999999999999 88899987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=317.80 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=203.9
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeE----EEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPV----ALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~----~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.-++|++.+.||+|+||.||+|.+..+++.+ ++|.+.... .....+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3468999999999999999999998777765 777764322 2334577899999999999999999999997755
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
.+++++|+.+++|.+++... ..++...+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred -eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 77889999999999998774 5799999999999999999999999999999999999999999999999999876554
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 241 (269)
...........++..|+|||++.+..+. .++||||||+++|+|++ |..||...........+..+ ..+.+..++..+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred CcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 3333333344567789999999877664 99999999999999999 99999988877777777654 356677899999
Q ss_pred HHHHHHhcCCCCCCcCCCCc
Q 024347 242 RKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~ 261 (269)
.+++..||+.||++||++++
T Consensus 249 ~~li~~~l~~~p~~Rps~~e 268 (327)
T 3poz_A 249 YMIMVKCWMIDADSRPKFRE 268 (327)
T ss_dssp HHHHHHHTCSCGGGSCCHHH
T ss_pred HHHHHHHcCCChhhCCCHHH
Confidence 99999999999999999844
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=314.58 Aligned_cols=256 Identities=21% Similarity=0.341 Sum_probs=212.4
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEE-----cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeee
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~ 77 (269)
.++....++|++.+.||+|+||.||+|.+ ..+++.||+|.+.... .....+.+.+|+.+++++ +||||++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 93 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEE
Confidence 34455678999999999999999999985 4567899999987543 233457889999999999 899999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 024347 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHG------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (269)
Q Consensus 78 ~~~~~~~~~~~v~~~~~~~~l~~~~~~~~------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~ 139 (269)
+++.+.+..+++|||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 99999999999999999999999987653 489999999999999999999999999999999
Q ss_pred CceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 024347 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (269)
Q Consensus 140 ~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 218 (269)
+||+++.++.++|+|||.+................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||....
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999999876544332222233446778999999987665 499999999999999998 999998765
Q ss_pred HHHHHHHH-hc-CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 219 LMNLYKKI-SA-AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 219 ~~~~~~~~-~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
........ .. .....+..+++.+.++|+.||+.||.+|||++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 298 (313)
T 1t46_A 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (313)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred chhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 44333333 22 2344456789999999999999999999998443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=320.88 Aligned_cols=251 Identities=25% Similarity=0.407 Sum_probs=202.2
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 84 (269)
..++|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 45799999999999999999999999999999999875432 3444677889999999999999999999997654
Q ss_pred --eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 85 --~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
..++||||+++ ++.+.+. ..++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++....
T Consensus 102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 78999999975 7777775 358999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-----------
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF----------- 231 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 231 (269)
. ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+....-
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 112233467899999999988766 4899999999999999999999998887766665543210
Q ss_pred -----------cC--------------CC------CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 -----------TC--------------PP------WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 -----------~~--------------~~------~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.. +. ..+..+++||++||+.||++|||+ .++|.|+|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~--~e~l~hp~ 321 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV--DEALQHPY 321 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCH--HHHHHSHH
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCH--HHHhCCcc
Confidence 00 00 015679999999999999999999 78888876
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=306.16 Aligned_cols=250 Identities=23% Similarity=0.350 Sum_probs=214.5
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+....++|++.+.||+|++|.||++.+. +++.+++|.+...... .+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4456789999999999999999999986 5778999999765432 2568899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999988765 46899999999999999999999999999999999999999999999999988754321
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTAR 242 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~ 242 (269)
.. .......++..|+|||++.+..+ +.++|+||||+++|+|++ |..||...........+..+. ...+..+++.+.
T Consensus 158 ~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 235 (267)
T 3t9t_A 158 QY-TSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 235 (267)
T ss_dssp HH-HSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHH
T ss_pred cc-cccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHH
Confidence 11 11122345678999999987666 489999999999999999 899999988888888877663 445667899999
Q ss_pred HHHHHhcCCCCCCcCCCCcc
Q 024347 243 KLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~ 262 (269)
++++.||+.||++|||++++
T Consensus 236 ~li~~~l~~~p~~Rps~~~l 255 (267)
T 3t9t_A 236 QIMNHCWRERPEDRPAFSRL 255 (267)
T ss_dssp HHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHccCChhhCcCHHHH
Confidence 99999999999999998443
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-47 Score=316.02 Aligned_cols=258 Identities=26% Similarity=0.403 Sum_probs=210.5
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-- 83 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 83 (269)
.....++|++.+.||.|++|.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSF 83 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCS
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeeccccc
Confidence 3445689999999999999999999999999999999986432 344467788999999999999999999988654
Q ss_pred ---CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 84 ---TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 84 ---~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
...++++||+. ++|.+.+.. +.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 67899999997 588887765 5799999999999999999999999999999999999999999999999999876
Q ss_pred cccccCCC--------cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--c
Q 024347 161 SQQVRDDG--------LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--E 230 (269)
Q Consensus 161 ~~~~~~~~--------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~ 230 (269)
........ ......+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+.......+... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 54322111 1122357889999999876554568999999999999999999999987765544433210 0
Q ss_pred c------------------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 F------------------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ~------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ...+.+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~ 308 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITA--KEALEHPY 308 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCH--HHHhcCcc
Confidence 0 0113578999999999999999999999 88888887
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=319.61 Aligned_cols=249 Identities=27% Similarity=0.404 Sum_probs=207.6
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE---
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI--- 86 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~--- 86 (269)
.++|++.+.||+|++|.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 479999999999999999999999999999999987543 2344567888999999999999999999999876654
Q ss_pred ---EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 87 ---FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 87 ---~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
+++|||+. ++|.+.+. ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||.+.....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999997 57776663 3599999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-------------
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------- 230 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------- 230 (269)
......+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 197 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 271 (371)
T 4exu_A 197 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271 (371)
T ss_dssp --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred -----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence 12234578999999999875545699999999999999999999999887766665553210
Q ss_pred ------------------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ------------------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+.+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~ 326 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA--AQALTHPF 326 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCH--HHHHTSGG
T ss_pred hhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCH--HHHhcCcc
Confidence 01123468999999999999999999999 88888887
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=306.38 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=200.8
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh-HHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK-HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
....++|++.+.||+|++|.||+|.+. ++.+|+|.+....... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 456789999999999999999999984 7899999986543222 2335778899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cEeecCCCCceEecC--------CCCEEEee
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG---VYHRDLKPENLLLDA--------YGNLKVSD 154 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~---i~h~di~~~nIl~~~--------~~~~~l~d 154 (269)
.+++|||+++++|.+++. .+.+++..+..++.|++.||.+||+.| ++|+||+|+||+++. ++.++|+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999988764 457999999999999999999999999 899999999999986 67799999
Q ss_pred CCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--cc
Q 024347 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--FT 232 (269)
Q Consensus 155 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~~ 232 (269)
||.+....... .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||................ .+
T Consensus 160 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 234 (271)
T 3dtc_A 160 FGLAREWHRTT----KMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP 234 (271)
T ss_dssp CCC-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC
T ss_pred CCccccccccc----ccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC
Confidence 99987543321 223457899999999987766 489999999999999999999999888777776665544 45
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 233 CPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
.+..+++.+.++++.||+.||++|||+++
T Consensus 235 ~~~~~~~~~~~li~~~l~~~p~~Rps~~e 263 (271)
T 3dtc_A 235 IPSTCPEPFAKLMEDCWNPDPHSRPSFTN 263 (271)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHH
Confidence 56779999999999999999999999844
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=309.25 Aligned_cols=255 Identities=21% Similarity=0.314 Sum_probs=212.4
Q ss_pred ccccccCCeEEee-eeeccCCcEEEEEEE--cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe
Q 024347 5 KIKRRVGKYEVGR-TIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (269)
Q Consensus 5 ~~~~~~~~~~~~~-~lg~g~~~~v~~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 81 (269)
++....++|++.+ .||.|++|.||+|.+ ..+++.+++|.+..... .....+.+.+|+++++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 3455667899999 999999999999954 56678999999875532 233467899999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
..+..+++|||+++++|.+++...+.++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 56678999999999999999998888999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCC
Q 024347 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLS 238 (269)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 238 (269)
...... .......+++.|+|||++.+..+. .++||||||+++|+|++ |..||...........+..+. ...+..++
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCP 246 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCC
Confidence 332211 111122346789999999776654 89999999999999999 999999988888887776654 45567799
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 239 FTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.+.++|+.||+.||.+|||++++
T Consensus 247 ~~l~~li~~~l~~dp~~Rps~~~l 270 (291)
T 1xbb_A 247 REMYDLMNLCWTYDVENRPGFAAV 270 (291)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHH
Confidence 999999999999999999998554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=305.67 Aligned_cols=248 Identities=18% Similarity=0.312 Sum_probs=212.3
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK- 83 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 83 (269)
..+...++|++.+.||+|++|.||+|.+. ++.+|+|++..... .....+.+.+|+.++++++||||+++++++.+.
T Consensus 4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 80 (271)
T 3kmu_A 4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP 80 (271)
T ss_dssp CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence 34667889999999999999999999984 88899999976543 234457799999999999999999999999876
Q ss_pred -CeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEecCCCCEEEeeCCCc
Q 024347 84 -TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNLKVSDFGLS 158 (269)
Q Consensus 84 -~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~~~~~~~l~df~~~ 158 (269)
...+++|||+++++|.+++.... .+++.++..++.|++.||.|||+.| ++|+||+|+||+++.++.++++||+++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~ 160 (271)
T 3kmu_A 81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160 (271)
T ss_dssp SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence 77899999999999999998765 4899999999999999999999999 999999999999999999999988876
Q ss_pred cccccccCCCcccccccCccccCcccccCCCCC--CCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--cccCC
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD--GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCP 234 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~--~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~ 234 (269)
.... .....+++.|+|||++.+.... +.++||||||+++|+|++|..||...........+... ....+
T Consensus 161 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 161 FSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp CTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred eeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 4321 1223568899999999876543 23799999999999999999999988887776666543 45566
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+++.+.++++.||+.||++|||++++
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~i 261 (271)
T 3kmu_A 234 PGISPHVSKLMKICMNEDPAKRPKFDMI 261 (271)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 7799999999999999999999998543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=321.00 Aligned_cols=251 Identities=21% Similarity=0.344 Sum_probs=203.7
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
..++|++.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.++++++||||+++++++.....
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 4568999999999999999999876 457789999986542 34446789999999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++||||+++++|.+++...+ .++..++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.....
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 999999999999999997754 6999999999999999999999999999999999999999999999999998765432
Q ss_pred cCCC-cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHH
Q 024347 165 RDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (269)
Q Consensus 165 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 241 (269)
.... ......++..|+|||++.+..+. .++||||||+++|++++ |..||......+....+..+ ..+.+..++..+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 279 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279 (373)
T ss_dssp -------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred CccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 2111 11112345689999999877664 89999999999999998 99999988888887777665 345566789999
Q ss_pred HHHHHHhcCCCCCCcCCCCcc
Q 024347 242 RKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+++..||+.||++||+++++
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i 300 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQI 300 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHH
Confidence 999999999999999998554
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=311.47 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=208.5
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCC----CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
....++|++.+.||+|++|.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 345678999999999999999999887553 359999986543 33445678999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
.+..++||||+++++|.+++... +.++..++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999988764 57999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCCC-cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCC
Q 024347 162 QQVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLS 238 (269)
Q Consensus 162 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (269)
....... ......+++.|+|||++.+..+. .++||||||+++|+|++ |..||......+....+..+ ..+.+..++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 276 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred ccccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence 4322111 11222346789999999877664 89999999999999998 99999988888888777665 456667799
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 239 FTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+.++++.||+.||++||++.++
T Consensus 277 ~~l~~li~~~l~~~p~~Rps~~~l 300 (333)
T 1mqb_A 277 SAIYQLMMQCWQQERARRPKFADI 300 (333)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHH
Confidence 999999999999999999998543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=322.79 Aligned_cols=247 Identities=26% Similarity=0.400 Sum_probs=206.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC------CCCCceeeeEEEeeC
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV------KHPNVVRLYEVMGSK 83 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l------~~~~i~~~~~~~~~~ 83 (269)
..+|++.+.||.|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.+ .|+||+++++.+...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 457999999999999999999999999999999986543 2245566677777666 577999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC--EEEeeCCCcc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--LKVSDFGLSA 159 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~--~~l~df~~~~ 159 (269)
...+++|||+. ++|.+++.... .+++..+..++.|++.||.|||+.||+|+||||+||+++.++. ++|+|||++.
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999996 58888887653 4899999999999999999999999999999999999999887 9999999986
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc---------
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--------- 230 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------- 230 (269)
.... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+....
T Consensus 251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~ 324 (429)
T 3kvw_A 251 YEHQ-----RVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324 (429)
T ss_dssp ETTC-----CCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ecCC-----cccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 4332 2233467899999999988776 499999999999999999999999887766555443110
Q ss_pred -------------c-------------------------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCC
Q 024347 231 -------------F-------------------------------------TCPPWLSFTARKLIARILDPNPMTVSIYP 260 (269)
Q Consensus 231 -------------~-------------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 260 (269)
. ..+...++.+.+||+.||++||++|||+
T Consensus 325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta- 403 (429)
T 3kvw_A 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP- 403 (429)
T ss_dssp TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH-
T ss_pred hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH-
Confidence 0 0001237889999999999999999999
Q ss_pred ccccccccC
Q 024347 261 FADILYMRF 269 (269)
Q Consensus 261 ~~~~l~~~~ 269 (269)
.++|.|+|
T Consensus 404 -~e~L~Hpw 411 (429)
T 3kvw_A 404 -GQALRHPW 411 (429)
T ss_dssp -HHHHTSTT
T ss_pred -HHHhCChh
Confidence 88999998
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=315.47 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=204.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeE----EEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPV----ALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~----~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
..++|++.+.||+|+||.||+|.+..+++.+ ++|.+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4578999999999999999999998888766 566554322 1223567889999999999999999999997765
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
.+++++++.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 78889999999999988764 5799999999999999999999999999999999999999999999999999976554
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTA 241 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 241 (269)
...........+++.|+|||++.+..+. .++||||||+++|+|++ |..||...........+..+. .+.+..++..+
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV 248 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHH
T ss_pred ccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHH
Confidence 3333333344467789999999877764 89999999999999999 999999988887777776554 56677899999
Q ss_pred HHHHHHhcCCCCCCcCCCCcc
Q 024347 242 RKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~ 262 (269)
.++|+.||+.||.+|||++++
T Consensus 249 ~~li~~~l~~dp~~Rps~~el 269 (327)
T 3lzb_A 249 YMIMRKCWMIDADSRPKFREL 269 (327)
T ss_dssp HHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHH
Confidence 999999999999999998544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=312.00 Aligned_cols=256 Identities=22% Similarity=0.336 Sum_probs=204.8
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcC---CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 81 (269)
.+....++|++.+.||.|++|.||+|.+.. +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 445667899999999999999999998765 455899999865433 2344678899999999999999999999987
Q ss_pred eCC-----eEEEEEeccCCCchhHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCE
Q 024347 82 SKT-----KIFIVLEFVTGGELFDKIVN------HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 82 ~~~-----~~~~v~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~ 150 (269)
... ..++++||+++++|.+++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 654 35999999999999998843 3469999999999999999999999999999999999999999999
Q ss_pred EEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 024347 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 229 (269)
+|+|||++................+++.|+|||.+.+..+. .++||||||+++|+|++ |..||...........+..+
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG 265 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcC
Confidence 99999998765433222223334567789999999877664 89999999999999999 99999988877777777665
Q ss_pred -cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 230 -EFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 230 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
....+..+++.+.++|..||+.||.+|||++++
T Consensus 266 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (313)
T 3brb_A 266 HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299 (313)
T ss_dssp CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 455667799999999999999999999998544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=325.71 Aligned_cols=245 Identities=23% Similarity=0.423 Sum_probs=209.9
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.+....++|++.+.||+|+||.||+|.+. ++.||+|.+.... ..+.+.+|+.++++++||||+++++++....
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTT
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCC
Confidence 34566789999999999999999999985 7799999987543 2467889999999999999999999986654
Q ss_pred -eEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 85 -KIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 85 -~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
..++||||+++++|.+++...+ .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++..
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence 7999999999999999998754 3799999999999999999999999999999999999999999999999998743
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCH
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (269)
.... ....++..|+|||++.+..++ .++||||||+++|+|++ |..||......+....+..+ +.+.+..+++
T Consensus 340 ~~~~-----~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~ 413 (450)
T 1k9a_A 340 SSTQ-----DTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 413 (450)
T ss_dssp C-----------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred cccc-----cCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 3211 122457789999999887764 89999999999999998 99999987777777776554 4566788999
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcc
Q 024347 240 TARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+.+||+.||+.||++|||+.++
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l 436 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQL 436 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHH
Confidence 99999999999999999998554
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=307.54 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=211.3
Q ss_pred CCccccccccCCeEEeeeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeee
Q 024347 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLY 77 (269)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 77 (269)
|..+.++...++|++.+.||+|++|.||+|.+... +..|++|.+.... .....+.+.+|+.+++.++||||++++
T Consensus 2 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~ 79 (281)
T 3cc6_A 2 MGGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLI 79 (281)
T ss_dssp --CCCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred CCCccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEE
Confidence 56677888999999999999999999999986533 3469999987543 234467889999999999999999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCC
Q 024347 78 EVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (269)
Q Consensus 78 ~~~~~~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~ 156 (269)
+++.+. ..+++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||
T Consensus 80 ~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 158 (281)
T 3cc6_A 80 GIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFG 158 (281)
T ss_dssp EEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCC
T ss_pred EEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccC
Confidence 998654 468999999999999998765 459999999999999999999999999999999999999999999999999
Q ss_pred CccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCC
Q 024347 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCP 234 (269)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~ 234 (269)
.+........ .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+..+ ..+.+
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 159 LSRYIEDEDY-YKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp GGGCC----------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred CCcccccccc-cccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 8875443211 11223345778999999987666 489999999999999998 99999877666666666544 45666
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+++.+.++|+.||+.||++|||+.++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~el 264 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTEL 264 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 7799999999999999999999998443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=311.09 Aligned_cols=251 Identities=22% Similarity=0.365 Sum_probs=203.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEE----EcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS- 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 82 (269)
..-++|++.+.||+|+||.||++. +..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345799999999999999999998 5668999999998653 23446788999999999999999999999854
Q ss_pred -CCeEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 83 -KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 83 -~~~~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
....++||||+++++|.+++...+ .++..++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 356899999999999999997754 599999999999999999999999999999999999999999999999999876
Q ss_pred cccccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHH
Q 024347 161 SQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----------------NLY 223 (269)
Q Consensus 161 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~ 223 (269)
....... .......++..|+|||++.+..+ +.++||||||+++|+|++|..|+...... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 5432211 11222345667999999987776 49999999999999999999998643221 122
Q ss_pred HHH-hcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 224 KKI-SAAEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 224 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.+ .....+.+..+++++.++++.||+.||++|||++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 282 (295)
T 3ugc_A 243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 282 (295)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 222 233456677899999999999999999999998544
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=317.09 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=207.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 87 (269)
.-++|++.+.||.|+||.||+|.+..+++.||+|++..... .+.+.+|+.+++.+ +|+||+++++++......+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 34789999999999999999999999999999999865432 24577899999999 8999999999999999999
Q ss_pred EEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC-----EEEeeCCCcccc
Q 024347 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-----LKVSDFGLSALS 161 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~-----~~l~df~~~~~~ 161 (269)
+||||+ +++|.+++.. .+.+++.++..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++...
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 8899998876 367999999999999999999999999999999999999998887 999999998765
Q ss_pred ccccCCC-----cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCcccC
Q 024347 162 QQVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD---SNLMNLYKKISAAEFTC 233 (269)
Q Consensus 162 ~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~---~~~~~~~~~~~~~~~~~ 233 (269)
....... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.. ....+....+.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 4322211 1234568999999999988776 4899999999999999999999987 34445555554443333
Q ss_pred C-----CCCCHHHHHHHHHhcCCCCCCcCCCCcccc
Q 024347 234 P-----PWLSFTARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 234 ~-----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
+ ..+| ++.+++..||+.||.+||+++++..
T Consensus 240 ~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 240 PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 3 2244 9999999999999999999865543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=306.76 Aligned_cols=252 Identities=31% Similarity=0.533 Sum_probs=202.7
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||.|++|.||+|.+..+|+.||+|.+...........+.+.+|+.+++.++||||+++++++...+..+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 35678999999999999999999999999999999997654445566788999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 88 IVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
++|||+++++|.+++.. ...++...+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999988864 45689999999999999999999999999999999999999999999999998865432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCcccC--CCCCCH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--NLMNLYKKISAAEFTC--PPWLSF 239 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~~~~~~--~~~~~~ 239 (269)
. ........+++.|+|||++.+... +.++||||||+++|+|++|..||... ........+.....+. ...+++
T Consensus 189 ~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (310)
T 2wqm_A 189 K--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE 265 (310)
T ss_dssp ------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred C--CccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence 1 112233457889999999987766 48999999999999999999999653 3344555555544332 245899
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcc
Q 024347 240 TARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
++.++|+.||+.||.+|||++++
T Consensus 266 ~l~~li~~~l~~dp~~Rps~~~i 288 (310)
T 2wqm_A 266 ELRQLVNMCINPDPEKRPDVTYV 288 (310)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHH
Confidence 99999999999999999998544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=313.83 Aligned_cols=249 Identities=21% Similarity=0.351 Sum_probs=210.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeE--EEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCC
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPV--ALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~--~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 84 (269)
..+++|++.+.||.|++|.||+|.+..++..+ ++|.+.... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 45689999999999999999999998888865 888876432 233456788999999999 8999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC
Q 024347 85 KIFIVLEFVTGGELFDKIVNHG----------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~----------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~ 148 (269)
..++||||+++++|.+++...+ .+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999987653 689999999999999999999999999999999999999999
Q ss_pred CEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 024347 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKIS 227 (269)
Q Consensus 149 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 227 (269)
.++|+|||++....... ......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCccccccc---cccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 99999999886433211 1122345778999999977665 489999999999999998 999999998888888876
Q ss_pred cC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 228 AA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 228 ~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+ ....+..+++.+.+||+.||+.||.+|||++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 291 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 291 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 65 345566789999999999999999999998443
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=307.17 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=207.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 87 (269)
.-++|++.+.||+|++|.||+|.+..+++.||+|.+..... .+.+.+|+..++.+ +|++++++++++......+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~ 82 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV 82 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeE
Confidence 45689999999999999999999999999999999864332 24577899999999 7999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC-----EEEeeCCCcccc
Q 024347 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN-----LKVSDFGLSALS 161 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~-----~~l~df~~~~~~ 161 (269)
++|||+ +++|.+++...+ .++...+..++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||.+...
T Consensus 83 lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 83 LVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 999999 889999998754 6999999999999999999999999999999999999987765 999999998765
Q ss_pred ccccCC-----CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCcc--
Q 024347 162 QQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEF-- 231 (269)
Q Consensus 162 ~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~~~-- 231 (269)
...... .......+++.|+|||++.+..+ +.++||||||+++|+|++|+.||... ........+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 443221 12234468899999999988776 49999999999999999999999873 34444444433322
Q ss_pred ---cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 232 ---TCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 232 ---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.....+++.+.+++..||+.||++||+++++.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~ 275 (298)
T 1csn_A 241 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 275 (298)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHH
Confidence 22346899999999999999999999986543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=309.68 Aligned_cols=245 Identities=22% Similarity=0.263 Sum_probs=204.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCC-------CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETG-------EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 80 (269)
...++|++.+.||+|+||.||+|.+..++ ..+++|.+..... ...+.+.+|+.++++++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 45679999999999999999999988776 4699999865432 2346788999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC--------EE
Q 024347 81 GSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--------LK 151 (269)
Q Consensus 81 ~~~~~~~~v~~~~~~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~--------~~ 151 (269)
.+.+..++||||+++++|.+++...+. ++...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999999999987654 999999999999999999999999999999999999998887 99
Q ss_pred EeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcCc
Q 024347 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAE 230 (269)
Q Consensus 152 l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~ 230 (269)
|+|||.+..... .....+++.|+|||++.+....+.++||||||+++|+|++| ..||......... ......
T Consensus 162 l~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYEDR 234 (289)
T ss_dssp ECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHHTT
T ss_pred eccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhhcc
Confidence 999998754322 12234678899999998744446999999999999999995 5555555444433 344445
Q ss_pred ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 231 FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
...+...++.+.+|++.||+.||++|||++++
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 266 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAI 266 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 56666778999999999999999999998443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=314.59 Aligned_cols=255 Identities=20% Similarity=0.339 Sum_probs=211.8
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCC-----eEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeE
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 78 (269)
++....++|++.+.||.|+||.||+|.+..+++ .+++|.+.... .....+.+.+|+.+++.+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 455667899999999999999999999876654 79999986543 234467889999999999 8999999999
Q ss_pred EEeeCCeEEEEEeccCCCchhHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe
Q 024347 79 VMGSKTKIFIVLEFVTGGELFDKIVNH--------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL 144 (269)
Q Consensus 79 ~~~~~~~~~~v~~~~~~~~l~~~~~~~--------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~ 144 (269)
++.+.+..++||||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||++
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999999999988653 357999999999999999999999999999999999999
Q ss_pred cCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 024347 145 DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLY 223 (269)
Q Consensus 145 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~ 223 (269)
+.++.++|+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 9999999999999875543322222233445778999999987666 499999999999999998 99999876544433
Q ss_pred HHHhc--CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 224 KKISA--AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 224 ~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..... .....+..+++.+.++++.||+.||.+|||++++
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l 317 (333)
T 2i1m_A 277 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317 (333)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 33322 2344566789999999999999999999998554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=310.70 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=203.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe--------
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG-------- 81 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-------- 81 (269)
.++|++.+.||.|++|.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 47999999999999999999999999999999998654 2344678889999999999999999999873
Q ss_pred ------eCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec-CCCCEEEee
Q 024347 82 ------SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSD 154 (269)
Q Consensus 82 ------~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~-~~~~~~l~d 154 (269)
.....+++|||++ ++|.+.+.. +.+++..+..++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 3467899999997 588887754 5799999999999999999999999999999999999997 566899999
Q ss_pred CCCccccccccC-CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc--
Q 024347 155 FGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-- 231 (269)
Q Consensus 155 f~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-- 231 (269)
||.+........ ........++..|+|||++.+....+.++||||||+++|+|++|..||...........+.....
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999876543211 22223345688899999987655556899999999999999999999998877666555432211
Q ss_pred ----------------------------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 ----------------------------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~ 308 (320)
T 2i6l_A 245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA--EEALSHPY 308 (320)
T ss_dssp CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH--HHHHTSHH
T ss_pred chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH--HHHhCCcc
Confidence 1124589999999999999999999999 78888876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-47 Score=317.58 Aligned_cols=258 Identities=24% Similarity=0.360 Sum_probs=206.0
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhh--------hhhHHHHHHHHHHHHHhhhCCCCCceee
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEK--------VLKHKMAEQIKREVATMKLVKHPNVVRL 76 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~--------~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 76 (269)
++....++|++.+.||.|++|.||+|.+.. |+.||+|.+.... .......+.+.+|+.++++++||||+++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 94 (362)
T 3pg1_A 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGL 94 (362)
T ss_dssp HHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCC
T ss_pred HHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccce
Confidence 445667899999999999999999999865 8999999985422 2234446789999999999999999999
Q ss_pred eEEEee-----CCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCE
Q 024347 77 YEVMGS-----KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 77 ~~~~~~-----~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~ 150 (269)
++++.. ....++||||+. +++.+.+... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCE
T ss_pred eeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCE
Confidence 999844 346899999997 4777777654 479999999999999999999999999999999999999999999
Q ss_pred EEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc
Q 024347 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (269)
+|+|||.+..... ........+++.|+|||++.+....+.++||||||+++|+|++|..||...........+....
T Consensus 174 kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~ 250 (362)
T 3pg1_A 174 TICDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250 (362)
T ss_dssp EECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EEEecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 9999999864332 2222334578899999999875545699999999999999999999999887766655543210
Q ss_pred --------------------------------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 --------------------------------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 --------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+..++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~ 319 (362)
T 3pg1_A 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST--EQALRHPY 319 (362)
T ss_dssp CCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH--HHHHTSGG
T ss_pred CCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH--HHHHcCch
Confidence 01123468899999999999999999999 88888887
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=310.27 Aligned_cols=261 Identities=31% Similarity=0.417 Sum_probs=209.9
Q ss_pred CCccccccccCCeEEeeeeeccCCcEEEEEEEc-CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC---CCCCceee
Q 024347 1 MSQPKIKRRVGKYEVGRTIGEGTFAKVKFARNS-ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRL 76 (269)
Q Consensus 1 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~ 76 (269)
|.+..+....++|++.+.||.|++|.||+|.+. .+++.||+|.+....... .....+.+|+.+++.+ +||||+++
T Consensus 1 m~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~ 79 (326)
T 1blx_A 1 MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRL 79 (326)
T ss_dssp ----CCCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred CCCccccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEee
Confidence 556677778899999999999999999999995 678999999986543221 1112344566666555 89999999
Q ss_pred eEEEe-----eCCeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC
Q 024347 77 YEVMG-----SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (269)
Q Consensus 77 ~~~~~-----~~~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~ 149 (269)
++++. .....++++||+. ++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.
T Consensus 80 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~ 158 (326)
T 1blx_A 80 FDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ 158 (326)
T ss_dssp EEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred eeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC
Confidence 99986 4567899999997 59988887643 4899999999999999999999999999999999999999999
Q ss_pred EEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Q 024347 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA 229 (269)
Q Consensus 150 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (269)
++|+|||.+....... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...........+...
T Consensus 159 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (326)
T 1blx_A 159 IKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDV 234 (326)
T ss_dssp EEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EEEecCcccccccCCC---CccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 9999999987543221 2233457889999999987776 48999999999999999999999988877666655321
Q ss_pred c---------------------------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 E---------------------------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~---------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ......++..+.+||+.||+.||++|||+ .+++.|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~e~l~hp~ 299 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA--YSALSHPY 299 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH--HHHHTSGG
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH--HHHhcCcc
Confidence 0 01224578999999999999999999999 78888876
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=314.32 Aligned_cols=250 Identities=19% Similarity=0.279 Sum_probs=206.8
Q ss_pred cccCCeEEeeeeeccCCcEEEEEE-----EcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~-----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
...++|++.+.||.|++|.||+|. +..+++.||+|.+.... .......+.+|+.++++++||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 456799999999999999999999 55678899999986432 23445678899999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC---CCCEEE
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHG-------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKV 152 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~---~~~~~l 152 (269)
....++||||+++++|.+++.... .++...++.++.|++.||.+||+.|++|+||+|+||+++. +..++|
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999999997753 4889999999999999999999999999999999999984 446999
Q ss_pred eeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-
Q 024347 153 SDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE- 230 (269)
Q Consensus 153 ~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~- 230 (269)
+|||.+................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+..+.
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~ 263 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 263 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence 99998875443332233334456889999999987665 489999999999999998 999999988888887776654
Q ss_pred ccCCCCCCHHHHHHHHHhcCCCCCCcCCCC
Q 024347 231 FTCPPWLSFTARKLIARILDPNPMTVSIYP 260 (269)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ 260 (269)
...+..+++.+.++|+.||+.||.+||+++
T Consensus 264 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 293 (327)
T 2yfx_A 264 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFA 293 (327)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence 455677999999999999999999999983
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=313.56 Aligned_cols=249 Identities=27% Similarity=0.405 Sum_probs=206.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe----
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK---- 85 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 85 (269)
.++|.+.+.||.|++|.||+|.+..+|+.||+|.+.... ......+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999986543 234456788999999999999999999999977653
Q ss_pred --EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 86 --IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 86 --~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
.+++|||+. ++|.+.+. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 499999997 48877664 3589999999999999999999999999999999999999999999999998875332
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------------- 229 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------------- 229 (269)
. .....+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+.......+...
T Consensus 179 ~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 253 (353)
T 3coi_A 179 E-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253 (353)
T ss_dssp ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred C-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence 1 223457889999999987555568999999999999999999999987766555544221
Q ss_pred --------------c---ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 --------------E---FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 --------------~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ....+.+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~--~e~l~hp~ 308 (353)
T 3coi_A 254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA--AQALTHPF 308 (353)
T ss_dssp HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH--HHHHTSGG
T ss_pred HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH--HHHhcCcc
Confidence 0 11224578999999999999999999999 78888887
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=303.55 Aligned_cols=248 Identities=26% Similarity=0.408 Sum_probs=204.0
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHH----HHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM----AEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
...++|++.+.||+|++|.||+|.+..+++.||+|.+.......... .+.+.+|+.+++.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 44579999999999999999999999999999999986543322221 16788999999999999999999998766
Q ss_pred CeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEecCCCC-----EEEeeC
Q 024347 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGN-----LKVSDF 155 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~~~~~-----~~l~df 155 (269)
. +++|||+++++|.+.+... ..++...+..++.|++.||.+||+.| ++|+||+|+||+++.++. ++|+||
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 5 6899999999998888654 47999999999999999999999999 999999999999988776 999999
Q ss_pred CCccccccccCCCcccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHhc--Cc
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMN--LYKKISA--AE 230 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~--~~ 230 (269)
|++..... ......+++.|+|||++.... ..+.++||||||+++|+|++|..||....... ....+.. ..
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC
Confidence 98863322 233456789999999984322 23589999999999999999999997654332 2333332 33
Q ss_pred ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 231 FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 231 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
...+..+++.+.++|+.||+.||++|||++++
T Consensus 249 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 280 (287)
T 4f0f_A 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYI 280 (287)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCcccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 45667799999999999999999999998544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=326.25 Aligned_cols=251 Identities=21% Similarity=0.367 Sum_probs=213.3
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.+....++|++.+.||+|+||.||+|.+. +++.||+|.+..... ..+.+.+|+.++++++||||+++++++. ..
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 44566789999999999999999999986 467899999876432 2567899999999999999999999986 56
Q ss_pred eEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
..++||||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 789999999999999998754 368899999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHH
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (269)
..... ......++..|+|||++....+ +.++||||||+++|+|++ |..||.+....+....+..+ ..+.+..+++.
T Consensus 336 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 413 (454)
T 1qcf_A 336 DNEYT-AREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEE 413 (454)
T ss_dssp CHHHH-TTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHH
T ss_pred CCcee-ccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 21111 1112234678999999987666 489999999999999999 99999998888887777654 45667789999
Q ss_pred HHHHHHHhcCCCCCCcCCCCccc
Q 024347 241 ARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
+.+||..||+.||++|||++++.
T Consensus 414 l~~li~~cl~~dp~~RPt~~~i~ 436 (454)
T 1qcf_A 414 LYNIMMRCWKNRPEERPTFEYIQ 436 (454)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHccCChhHCcCHHHHH
Confidence 99999999999999999986553
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=306.24 Aligned_cols=251 Identities=31% Similarity=0.510 Sum_probs=202.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-------
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------- 82 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 82 (269)
.++|++.+.||.|++|.||+|.+..+++.|++|.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 46899999999999999999999999999999998643 2345778899999999999999999998754
Q ss_pred ------CCeEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeC
Q 024347 83 ------KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 83 ------~~~~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
....+++|||+++++|.+++...+ .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 456899999999999999997643 5788999999999999999999999999999999999999999999999
Q ss_pred CCccccccccC------------CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHH
Q 024347 156 GLSALSQQVRD------------DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNL 222 (269)
Q Consensus 156 ~~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~ 222 (269)
|.+........ ........+++.|+|||++.+....+.++||||||+++|+|++ ||.. ......
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 98875432110 1122334578899999999876555699999999999999998 5543 233445
Q ss_pred HHHHhcCcccCC----CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 223 YKKISAAEFTCP----PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 223 ~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.......+ ...++.+.++|+.||+.||.+|||+ .+++.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~--~~ll~h~~ 286 (303)
T 1zy4_A 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA--RTLLNSGW 286 (303)
T ss_dssp HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCH--HHHHHSSC
T ss_pred HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCH--HHHhCCCC
Confidence 555555444333 3467789999999999999999999 88888887
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=311.49 Aligned_cols=252 Identities=21% Similarity=0.229 Sum_probs=200.9
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
+++-...++|++.+.||+|+||.||+|++. ++.||+|++..... .......|+.++++++||||+++++++...
T Consensus 17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 345567789999999999999999999875 78999999865432 234456699999999999999999999774
Q ss_pred C----eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CcEeecCCCCceEecCCCC
Q 024347 84 T----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR----------GVYHRDLKPENLLLDAYGN 149 (269)
Q Consensus 84 ~----~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~----------~i~h~di~~~nIl~~~~~~ 149 (269)
. ..++||||+++++|.+++... .+++..+..++.|++.||.|||+. |++|+||+|+||+++.++.
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence 3 479999999999999988764 599999999999999999999999 9999999999999999999
Q ss_pred EEEeeCCCccccccccCCCcccccccCccccCcccccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCC--------
Q 024347 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY----DGSTADLWSCGVILFVLLAGYLPFDDS-------- 217 (269)
Q Consensus 150 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~-------- 217 (269)
++|+|||++................+++.|+|||++.+... .+.++||||||+++|+|++|..||.+.
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999999976554443333444568999999999986422 235789999999999999999999643
Q ss_pred --------CHHHHHHHHhcCcc-c-CCC-----CCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 218 --------NLMNLYKKISAAEF-T-CPP-----WLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 218 --------~~~~~~~~~~~~~~-~-~~~-----~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.............. + .+. ..++.+.+||+.||+.||++|||++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 309 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHH
Confidence 22223333222221 1 111 123459999999999999999998543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=304.91 Aligned_cols=254 Identities=23% Similarity=0.341 Sum_probs=213.3
Q ss_pred ccccccCCeEEee-eeeccCCcEEEEEEEc--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe
Q 024347 5 KIKRRVGKYEVGR-TIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (269)
Q Consensus 5 ~~~~~~~~~~~~~-~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 81 (269)
++....++|.+.+ .||+|++|.||+|.+. .+++.|++|.+.... .....+.+.+|+.++++++||||+++++++
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 4556677888888 9999999999999864 467889999987542 344567899999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
..+..++||||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 556689999999999999988654 4699999999999999999999999999999999999999999999999999876
Q ss_pred cccccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCC
Q 024347 161 SQQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWL 237 (269)
Q Consensus 161 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~ 237 (269)
....... .......+++.|+|||++.+... +.++||||||+++|+|++ |..||......+....+..+. ...++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 238 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPEC 238 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTC
T ss_pred eccCcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCc
Confidence 5432211 11222345788999999977665 489999999999999998 999999888887777776654 5567789
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 238 SFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
++.+.++|+.||+.||++||+++++
T Consensus 239 ~~~l~~li~~~l~~~p~~Rps~~~l 263 (287)
T 1u59_A 239 PPELYALMSDCWIYKWEDRPDFLTV 263 (287)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9999999999999999999998443
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=310.97 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=206.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEE-cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCC------CceeeeEEEe
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARN-SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP------NVVRLYEVMG 81 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~------~i~~~~~~~~ 81 (269)
..++|++.+.||.|++|.||++.+ ..+++.||+|++.... ...+.+.+|+.+++.++|+ +++++++++.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 347999999999999999999998 5678999999986432 3356778889988888765 4999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-------------
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA------------- 146 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~------------- 146 (269)
..+..++||||+ +++|.+++...+ .++...+..++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 789999887765 6899999999999999999999999999999999999987
Q ss_pred ------CCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH
Q 024347 147 ------YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM 220 (269)
Q Consensus 147 ------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 220 (269)
++.++|+|||.+..... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+..
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred ccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 66899999998875332 2233457899999999988776 49999999999999999999999987776
Q ss_pred HHHHHHhcCccc--------------------------------------------CCCCCCHHHHHHHHHhcCCCCCCc
Q 024347 221 NLYKKISAAEFT--------------------------------------------CPPWLSFTARKLIARILDPNPMTV 256 (269)
Q Consensus 221 ~~~~~~~~~~~~--------------------------------------------~~~~~~~~l~~li~~~l~~dP~~R 256 (269)
+....+.....+ .....++.+.+||+.||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 554443221111 011235679999999999999999
Q ss_pred CCCCccccccccC
Q 024347 257 SIYPFADILYMRF 269 (269)
Q Consensus 257 ps~~~~~~l~~~~ 269 (269)
||+ .+++.|+|
T Consensus 321 pt~--~ell~hp~ 331 (339)
T 1z57_A 321 ITL--REALKHPF 331 (339)
T ss_dssp CCH--HHHTTSGG
T ss_pred cCH--HHHhcCHH
Confidence 999 88888887
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=316.75 Aligned_cols=255 Identities=23% Similarity=0.332 Sum_probs=197.9
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
+.....++|++.+.||.|+||.||+|.+..+|+.||+|.+...... .....+++..++.++||||+++++++...+
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 3456788999999999999999999999999999999998654322 234566788888899999999999996543
Q ss_pred e-------EEEEEeccCCCchhHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--hCCcEeecCCCCceEecC-CCCE
Q 024347 85 K-------IFIVLEFVTGGELFDKI----VNHGRMKEDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLDA-YGNL 150 (269)
Q Consensus 85 ~-------~~~v~~~~~~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~lh--~~~i~h~di~~~nIl~~~-~~~~ 150 (269)
. .+++|||+++ ++...+ .....++...+..++.|++.||.+|| +.||+|+||+|+||+++. ++.+
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEE
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcE
Confidence 3 8899999987 443333 34567899999999999999999999 999999999999999996 8899
Q ss_pred EEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc
Q 024347 151 KVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE 230 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 230 (269)
+|+|||++...... .......+++.|+|||++.+....+.++||||||+++|+|++|..||...+.......+....
T Consensus 172 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 99999998754432 222334578899999999776655699999999999999999999999888776666653210
Q ss_pred --------------------------------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 --------------------------------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 --------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.......++.+.+||..||+.||++|||+ .++|.|+|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~e~l~hp~ 317 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKP--YEALCHPY 317 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCH--HHHTTSGG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCH--HHHhcCcc
Confidence 01112256789999999999999999999 88899987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=330.44 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=215.4
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
+....++|++.+.||+|+||.||+|.++.+++.||+|.+...... .+.+.+|+.++++++||||+++++++.....
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 345667899999999999999999999988999999998754322 4678899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
.++||||+++++|.+++... ..++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++....
T Consensus 291 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 99999999999999999764 4589999999999999999999999999999999999999999999999999875432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 241 (269)
... .......++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+.....+.+..+ +...+..+++.+
T Consensus 371 ~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 448 (495)
T 1opk_A 371 DTY-TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 448 (495)
T ss_dssp CCE-ECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred Cce-eecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 111 11122234678999999987665 489999999999999999 99999988877777766554 456677899999
Q ss_pred HHHHHHhcCCCCCCcCCCCcc
Q 024347 242 RKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+||..||+.||++|||++++
T Consensus 449 ~~li~~cl~~dP~~RPs~~el 469 (495)
T 1opk_A 449 YELMRACWQWNPSDRPSFAEI 469 (495)
T ss_dssp HHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCcChhHCcCHHHH
Confidence 999999999999999998554
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=322.49 Aligned_cols=254 Identities=16% Similarity=0.167 Sum_probs=191.5
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC--CCCCceeee-------
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV--KHPNVVRLY------- 77 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l--~~~~i~~~~------- 77 (269)
+....+|++.+.||.|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+ +||||++++
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 34455699999999999999999999999999999999876554555567788885444444 699977754
Q ss_pred EEEeeC-----------------CeEEEEEeccCCCchhHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCcE
Q 024347 78 EVMGSK-----------------TKIFIVLEFVTGGELFDKIVNH-GRMKEDEA------RRYFQQLINAVDYCHSRGVY 133 (269)
Q Consensus 78 ~~~~~~-----------------~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~------~~i~~~i~~~l~~lh~~~i~ 133 (269)
+++... ...++||||++ ++|.+++... ..+....+ ..++.|++.||.|||+.||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv 216 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV 216 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence 555433 33899999998 7999998763 33444555 67779999999999999999
Q ss_pred eecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCC
Q 024347 134 HRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGY 211 (269)
Q Consensus 134 h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~ 211 (269)
|+||||+||+++.++.++|+|||++..... ......+++.|+|||++.+ ..+ +.++||||||+++|+|++|.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999875432 1213445699999999976 444 59999999999999999999
Q ss_pred CCCCCCCHHHH--HHH-----HhcCc--ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 212 LPFDDSNLMNL--YKK-----ISAAE--FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 212 ~p~~~~~~~~~--~~~-----~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.||........ ... ..... ++....+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~e~l~hp~ 355 (371)
T 3q60_A 291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLP--LEAMETPE 355 (371)
T ss_dssp CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCH--HHHTTSHH
T ss_pred CCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCH--HHHhcCHH
Confidence 99976533211 000 01111 22334689999999999999999999999 88888887
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=316.67 Aligned_cols=253 Identities=21% Similarity=0.312 Sum_probs=206.3
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
.++....++|++.+.||.|++|.||+|.+. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 456677899999999999999999999964 689999998765432 2356788999999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
+..++||||+++++|.+++.... .++..++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999998886543 58999999999999999999999999999999999999999999999999987
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH------HH-HHHhcCcc-
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN------LY-KKISAAEF- 231 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~-~~~~~~~~- 231 (269)
...............+++.|+|||++.+..+ +.++||||||+++|+|++|+.||....... .. .....+..
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred ccccccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 6444333333344457899999999987766 499999999999999999999997543221 11 11111111
Q ss_pred ---------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 232 ---------TCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 232 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
..++..+..+.+++..||+.||++|||+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e 305 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGD 305 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHH
Confidence 111224567999999999999999999843
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=324.55 Aligned_cols=252 Identities=22% Similarity=0.362 Sum_probs=209.9
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.+....++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|++++++++||||+++++++.. .
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 345667889999999999999999999875 467999998764422 3578899999999999999999999866 6
Q ss_pred eEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
..++||||+++++|.+++.. ...++..++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 78999999999999999864 3569999999999999999999999999999999999999999999999999987544
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHH
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (269)
.... .......++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+..+ +.+.+..+++.
T Consensus 332 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 409 (452)
T 1fmk_A 332 DNEY-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 409 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHH
T ss_pred CCce-ecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 2111 11122335678999999987665 489999999999999999 99999998888888777655 45667889999
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccc
Q 024347 241 ARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
+.+||..||+.||++|||++++..
T Consensus 410 l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 410 LHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999865543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=310.50 Aligned_cols=254 Identities=22% Similarity=0.362 Sum_probs=209.7
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEE-----cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEE
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARN-----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV 79 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 79 (269)
+....++|++.+.||.|++|.||+|.+ ..+++.||+|.+.... .....+.+.+|+.+++++ +||||++++++
T Consensus 22 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 22 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred eecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 345668999999999999999999985 3567899999987543 233457789999999999 68999999999
Q ss_pred EeeCC-eEEEEEeccCCCchhHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCce
Q 024347 80 MGSKT-KIFIVLEFVTGGELFDKIVNHGR----------------MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENL 142 (269)
Q Consensus 80 ~~~~~-~~~~v~~~~~~~~l~~~~~~~~~----------------l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nI 142 (269)
+...+ ..+++|||+++++|.+++..... ++...+..++.|++.||.+||+.|++|+||+|+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 87654 58999999999999999987543 88999999999999999999999999999999999
Q ss_pred EecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCH-H
Q 024347 143 LLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNL-M 220 (269)
Q Consensus 143 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~-~ 220 (269)
+++.++.++|+|||.+................+++.|+|||++.+..+ +.++||||||+++|+|++ |..||..... .
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 999999999999999875543322222333456788999999987766 489999999999999998 9999987543 3
Q ss_pred HHHHHHhcC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 221 NLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 221 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.....+..+ ....+..+++.+.+++..||+.||.+|||++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el 301 (316)
T 2xir_A 259 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 301 (316)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 333444333 355667789999999999999999999998443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=318.79 Aligned_cols=247 Identities=31% Similarity=0.419 Sum_probs=200.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 84 (269)
...+|++.+.||.|+||.||+|.+..+++ +++|.+..... ...+|+.+++.++||||+++++++...+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSS
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCC
Confidence 34579999999999999999999987666 88888754332 2236999999999999999999995543
Q ss_pred --eEEEEEeccCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec-CCCCEEEeeCCC
Q 024347 85 --KIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGL 157 (269)
Q Consensus 85 --~~~~v~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~-~~~~~~l~df~~ 157 (269)
..++||||++++ +...+. ....+++..+..++.|++.||.|||+.||+|+||+|+||+++ .++.++|+|||+
T Consensus 110 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 110 EVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp CEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 388999999874 333332 246799999999999999999999999999999999999999 788999999999
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA-------- 229 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-------- 229 (269)
++..... .......+++.|+|||++.+...++.++||||||+++|+|++|..||.+.+.......+...
T Consensus 189 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 265 (394)
T 4e7w_A 189 AKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQ 265 (394)
T ss_dssp CEECCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 8754322 22234457889999999987665569999999999999999999999988776655554321
Q ss_pred -----------cc----------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 -----------EF----------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 -----------~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+ .+++.+++++.+||++||+.||.+|||+ .+++.|+|
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~--~e~l~hp~ 324 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTA--IEALCHPF 324 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCH--HHHHTSGG
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCH--HHHhcChh
Confidence 00 1223478999999999999999999999 88888887
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=302.96 Aligned_cols=251 Identities=20% Similarity=0.354 Sum_probs=211.5
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
.++....++|++.+.||.|++|.||+|.+. +++.+++|.+...... .+.+.+|+++++.++||||+++++++. .
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 79 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEc-C
Confidence 345667789999999999999999999976 5678999998654322 467889999999999999999999986 4
Q ss_pred CeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
+..+++|||+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 159 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence 45889999999999999886543 6999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCH
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (269)
..... .......++..|+|||++.+... +.++||||||+++|+|++ |..||......+....+..+ ....+..+++
T Consensus 160 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (279)
T 1qpc_A 160 EDNEY-TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237 (279)
T ss_dssp SSSCE-ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred cCccc-ccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccH
Confidence 43211 11122335678999999987665 489999999999999999 99999998888877777655 3455667899
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcc
Q 024347 240 TARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+.++++.||+.||++|||++++
T Consensus 238 ~l~~li~~~l~~~p~~Rps~~~l 260 (279)
T 1qpc_A 238 ELYQLMRLCWKERPEDRPTFDYL 260 (279)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhccChhhCCCHHHH
Confidence 99999999999999999998554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=307.08 Aligned_cols=261 Identities=23% Similarity=0.388 Sum_probs=210.1
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC--CCCceeeeEEE
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--HPNVVRLYEVM 80 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--~~~i~~~~~~~ 80 (269)
.+.+....++|++.+.||.|++|.||++.+. +++.+|+|.+..... .....+.+.+|+.++++++ |+||+++++++
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 97 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEE
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEe
Confidence 4556777789999999999999999999985 588999999875443 3344678899999999997 59999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 81 GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 81 ~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
...+..+++|| +.+++|.+++...+.++...+..++.|++.||.+||+.|++|+||+|+||++++ +.++|+|||.+..
T Consensus 98 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 98 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred ecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 99999999999 557899999988888999999999999999999999999999999999999964 8899999999876
Q ss_pred cccccCCCcccccccCccccCcccccCC----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhc-
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDR----------GYDGSTADLWSCGVILFVLLAGYLPFDDSN-LMNLYKKISA- 228 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~- 228 (269)
..............+++.|+|||++.+. ...+.++||||||+++|+|++|..||.... .......+..
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 255 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence 5443322223344679999999998752 233589999999999999999999997643 3333333332
Q ss_pred -CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 229 -AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 229 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.....+...+..+.++|+.||+.||.+|||+ .+++.|+|
T Consensus 256 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--~ell~h~~ 295 (313)
T 3cek_A 256 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISI--PELLAHPY 295 (313)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCH--HHHHTSHH
T ss_pred ccccCCcccchHHHHHHHHHHccCCcccCcCH--HHHhcCcc
Confidence 2345566678999999999999999999999 77888776
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=304.64 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=208.4
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
.-.+++|.....||.|++|.||+|.+..+++.|++|.+.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcE
Confidence 334555556669999999999999999999999999986543 23357788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-CCCEEEeeCCCccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQ 162 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-~~~~~l~df~~~~~~~ 162 (269)
+++|||+++++|.+++.... .+++..+..++.|++.||.+||+.|++|+||+|+||+++. ++.++|+|||.+....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 95 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp EEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 99999999999999887652 4678899999999999999999999999999999999987 8899999999887543
Q ss_pred cccCCCcccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH-HH-H-HHhcCcccCCCCCC
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNLMN-LY-K-KISAAEFTCPPWLS 238 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~-~-~~~~~~~~~~~~~~ 238 (269)
... .......+++.|+|||++.+.. ..+.++||||||+++|+|++|..||....... .. . .........+..++
T Consensus 175 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (295)
T 2clq_A 175 GIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMS 252 (295)
T ss_dssp C-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSC
T ss_pred CCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCC
Confidence 221 1223345788999999987543 23589999999999999999999997543222 11 1 12334455667799
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 239 FTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+.++|..||+.||++||++ .+++.|+|
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~--~~ll~~~~ 281 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACA--NDLLVDEF 281 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCH--HHHHTSGG
T ss_pred HHHHHHHHHHccCChhhCCCH--HHHhcChh
Confidence 999999999999999999999 77888876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=303.19 Aligned_cols=253 Identities=22% Similarity=0.345 Sum_probs=209.6
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
++.....|.+.+.||+|++|.||+|.+..+++ .+++|.+... ......+.+.+|+.+++.++||||+++++++.+
T Consensus 16 i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 93 (298)
T 3pls_A 16 IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP 93 (298)
T ss_dssp CCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred ccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence 44455578888999999999999999765544 7999998642 234456788999999999999999999999976
Q ss_pred CCeE-EEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 83 KTKI-FIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 83 ~~~~-~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
.+.. +++++|+.+++|.+++.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred CCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 6554 899999999999999876 35689999999999999999999999999999999999999999999999999875
Q ss_pred ccccc--CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q 024347 161 SQQVR--DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPW 236 (269)
Q Consensus 161 ~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 236 (269)
..... .........+++.|+|||.+.+..+. .++||||||+++|+|++ +.+||...+.......+.... .+.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEY 252 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTT
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCcc
Confidence 43321 12223334567899999999887764 89999999999999999 566677777766666665544 556677
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
+++.+.++++.||+.||.+|||+++
T Consensus 253 ~~~~l~~li~~~l~~~p~~Rps~~~ 277 (298)
T 3pls_A 253 CPDSLYQVMQQCWEADPAVRPTFRV 277 (298)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred chHHHHHHHHHHccCChhhCcCHHH
Confidence 9999999999999999999999844
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=315.36 Aligned_cols=251 Identities=30% Similarity=0.521 Sum_probs=213.1
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHhhhCC--CCCceeeeEEEe
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVK--HPNVVRLYEVMG 81 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~ 81 (269)
....++|++.+.||+|+||.||+|.+..+++.||+|.+........ ...+.+.+|+.+++.++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 4456789999999999999999999999999999999976543210 11245667899999996 599999999999
Q ss_pred eCCeEEEEEeccCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec-CCCCEEEeeCCCcc
Q 024347 82 SKTKIFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGLSA 159 (269)
Q Consensus 82 ~~~~~~~v~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~-~~~~~~l~df~~~~ 159 (269)
..+..++++|++.+ ++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+.
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 99999999999976 89999998888899999999999999999999999999999999999999 77899999999987
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCH
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF 239 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (269)
..... ......+++.|+|||++.+....+.++||||||+++|+|++|..||.... .+.......+..+++
T Consensus 199 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~ 268 (320)
T 3a99_A 199 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSS 268 (320)
T ss_dssp ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCH
T ss_pred ccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCCH
Confidence 54432 22234578999999999877665688999999999999999999997632 234455566778999
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 269 ~~~~li~~~l~~dp~~Rps~--~~ll~hp~ 296 (320)
T 3a99_A 269 ECQHLIRWCLALRPSDRPTF--EEIQNHPW 296 (320)
T ss_dssp HHHHHHHHHTCSSGGGSCCH--HHHHTSGG
T ss_pred HHHHHHHHHccCChhhCcCH--HHHhcCHh
Confidence 99999999999999999999 77788876
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=304.57 Aligned_cols=245 Identities=23% Similarity=0.419 Sum_probs=203.2
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-C
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-K 83 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~ 83 (269)
.+....++|++.+.||.|++|.||++.+. |+.+++|.+.... ..+.+.+|+.++++++||||+++++++.. .
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34567789999999999999999999874 7899999986542 25678899999999999999999998754 4
Q ss_pred CeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
+..++++||+++++|.+++...+ .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 57899999999999999887654 3899999999999999999999999999999999999999999999999988644
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCH
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSF 239 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 239 (269)
.... ....+++.|+|||++.+..+ +.++||||||+++|+|++ |..||...........+..+ ....+..+++
T Consensus 168 ~~~~-----~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (278)
T 1byg_A 168 SSTQ-----DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 241 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCH
T ss_pred cccc-----cCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCH
Confidence 3221 22345778999999987666 489999999999999998 99999988777777776554 4556677999
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcc
Q 024347 240 TARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+.++|+.||+.||++|||++++
T Consensus 242 ~l~~li~~~l~~~p~~Rps~~~l 264 (278)
T 1byg_A 242 AVYEVMKNCWHLDAAMRPSFLQL 264 (278)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhcCChhhCCCHHHH
Confidence 99999999999999999998543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=318.81 Aligned_cols=246 Identities=29% Similarity=0.385 Sum_probs=200.2
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC------C
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------T 84 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~ 84 (269)
.+|++.+.||+|+||.||+|.+..+|+.||+|.+.... ....+|+++++.++|+||+++++++... .
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 47999999999999999999999999999999986543 2234699999999999999999988442 2
Q ss_pred eEEEEEeccCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC-CCEEEeeCCCcc
Q 024347 85 KIFIVLEFVTGGELFDKIV----NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSA 159 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~----~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~-~~~~l~df~~~~ 159 (269)
..++||||+++ ++.+.+. ....+++..+..++.|++.||.|||+.||+|+||||+||+++.+ +.++|+|||+++
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 36799999976 5555443 24679999999999999999999999999999999999999965 458999999987
Q ss_pred ccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Q 024347 160 LSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---------- 229 (269)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---------- 229 (269)
..... .......+++.|+|||++.+...++.++|||||||++|+|++|+.||.+....+...++...
T Consensus 206 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 54322 22233467899999999977654569999999999999999999999988766555444220
Q ss_pred -------ccc------------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 -------EFT------------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 -------~~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+. +++..++++.+||++||+.||.+||++ .+++.|+|
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~--~e~l~hp~ 339 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP--LEACAHSF 339 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCH--HHHhCCHh
Confidence 111 223468999999999999999999999 77888877
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=305.21 Aligned_cols=253 Identities=21% Similarity=0.390 Sum_probs=195.2
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.....-++|++.+.||+|+||.||++.+.. .+++|++..... .....+.+.+|+.++++++|+||++++++. ...
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~ 92 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAP 92 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSS
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCC
Confidence 345667899999999999999999998643 499999865433 344467899999999999999999999965 555
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..+++|||+++++|.+.+... ..++..++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccc
Confidence 689999999999999888543 5699999999999999999999999999999999999999999999999999876554
Q ss_pred ccCCCcccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCccc-----CCC
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFT-----CPP 235 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-----~~~ 235 (269)
...........+++.|+|||++.. ....+.++||||||+++|+|++|..||...... .....+..+... ...
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRS 252 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCT
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccc
Confidence 333334444568999999999862 222357999999999999999999999875444 344444333322 224
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+++.+.+|++.||+.||++|||++++
T Consensus 253 ~~~~~l~~li~~~l~~~p~~Rps~~el 279 (289)
T 3og7_A 253 NCPKRMKRLMAECLKKKRDERPSFPRI 279 (289)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 588999999999999999999998543
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=312.70 Aligned_cols=251 Identities=32% Similarity=0.543 Sum_probs=205.0
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHhhhC----CCCCceeeeEE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLV----KHPNVVRLYEV 79 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l----~~~~i~~~~~~ 79 (269)
....++|++.+.||.|++|.||+|.+..+++.||+|.+........ .....+.+|+.+++++ +|+||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3446789999999999999999999999999999999875543221 1234456788888888 89999999999
Q ss_pred EeeCCeEEEEEec-cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec-CCCCEEEeeCCC
Q 024347 80 MGSKTKIFIVLEF-VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD-AYGNLKVSDFGL 157 (269)
Q Consensus 80 ~~~~~~~~~v~~~-~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~-~~~~~~l~df~~ 157 (269)
+...+..++++++ +.+++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~ 186 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS 186 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence 9988899999999 78899999998888899999999999999999999999999999999999999 788999999999
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCC
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 237 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
+...... ......++..|+|||++.+....+.++||||||+++|+|++|..||... ..+.......+..+
T Consensus 187 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~------~~~~~~~~~~~~~~ 256 (312)
T 2iwi_A 187 GALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHV 256 (312)
T ss_dssp CEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHTCCCCCTTS
T ss_pred hhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh------HHHhhhccCCcccC
Confidence 8754432 2233457889999999987666556899999999999999999999753 23344556677789
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 238 SFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+..+.+||+.||+.||++|||+ .+++.|+|
T Consensus 257 ~~~~~~li~~~l~~~p~~Rps~--~e~l~~~~ 286 (312)
T 2iwi_A 257 SPDCCALIRRCLAPKPSSRPSL--EEILLDPW 286 (312)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCH--HHHHHSTT
T ss_pred CHHHHHHHHHHccCChhhCcCH--HHHhcChh
Confidence 9999999999999999999999 78888877
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=303.84 Aligned_cols=259 Identities=24% Similarity=0.359 Sum_probs=197.9
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
.+.....++|++.+.||.|++|.||+|.+..+|+.||+|.+..... .....+.+.++..+++.++||||+++++++...
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~ 96 (318)
T 2dyl_A 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITN 96 (318)
T ss_dssp SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecC
Confidence 3456778999999999999999999999999999999999976542 223344555666678889999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
+..+++|||+ ++.+...... ...+++..+..++.+++.||.+||+. |++|+||+|+||+++.++.++|+|||.+...
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred CcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 9999999999 5455554443 46799999999999999999999995 9999999999999999999999999988644
Q ss_pred ccccCCCcccccccCccccCcccccC----CCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCcccCC--
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLND----RGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAAEFTCP-- 234 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~~~-- 234 (269)
... .......+++.|+|||++.. ....+.++||||||+++|+|++|..||.. .........+.....+..
T Consensus 176 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (318)
T 2dyl_A 176 VDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPG 252 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCS
T ss_pred cCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCc
Confidence 321 12233457899999999853 22335899999999999999999999986 344555555555443322
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 -PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 -~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..+++.+.+||+.||+.||.+||++ .+++.|+|
T Consensus 253 ~~~~~~~l~~li~~~l~~dp~~Rps~--~~ll~h~~ 286 (318)
T 2dyl_A 253 HMGFSGDFQSFVKDCLTKDHRKRPKY--NKLLEHSF 286 (318)
T ss_dssp SSCCCHHHHHHHHHHTCSCTTTSCCH--HHHTTSHH
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCH--HHHhhCHH
Confidence 3589999999999999999999999 77788775
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=304.43 Aligned_cols=255 Identities=22% Similarity=0.281 Sum_probs=208.1
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEE-
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM- 80 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~- 80 (269)
.++....+|++.+.||+|+||.||+|.+..+ +..+++|.+.... .....+.+.+|+.++++++||||+++++++
T Consensus 19 ~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (298)
T 3f66_A 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICL 96 (298)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEC
T ss_pred ecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEE
Confidence 4566778899999999999999999986543 3357888876432 344467889999999999999999999986
Q ss_pred eeCCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 81 GSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 81 ~~~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
...+..+++|||+++++|.+++... ..++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus 97 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 97 RSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred cCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccc
Confidence 4566789999999999999998763 468999999999999999999999999999999999999999999999999987
Q ss_pred ccccccC--CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcc-cCCC
Q 024347 160 LSQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEF-TCPP 235 (269)
Q Consensus 160 ~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~-~~~~ 235 (269)
....... ........+++.|+|||.+.+..+. .++||||||+++|+|++ +.+||...........+..+.. ..+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE 255 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc
Confidence 5543221 1222334467789999999877664 89999999999999999 7778887776666666655543 4466
Q ss_pred CCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 236 WLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 236 ~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.++..+.++++.||+.||++|||++++
T Consensus 256 ~~~~~l~~li~~~l~~~p~~Rps~~el 282 (298)
T 3f66_A 256 YCPDPLYEVMLKCWHPKAEMRPSFSEL 282 (298)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 789999999999999999999998543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=311.41 Aligned_cols=252 Identities=16% Similarity=0.196 Sum_probs=197.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcC---CCCeEEEEEeehhhhhhHH--------HHHHHHHHHHHhhhCCCCCceeeeE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSE---TGEPVALKILDKEKVLKHK--------MAEQIKREVATMKLVKHPNVVRLYE 78 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~K~~~~~~~~~~~--------~~~~~~~e~~~l~~l~~~~i~~~~~ 78 (269)
-++|++.+.||+|+||.||+|.+.. ++..+|+|.+......... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 7889999998754321111 1234667889999999999999999
Q ss_pred EEee----CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC--CEEE
Q 024347 79 VMGS----KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG--NLKV 152 (269)
Q Consensus 79 ~~~~----~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~--~~~l 152 (269)
++.. ....++||||+ +++|.+++...+.+++.++..++.|++.||.|||+.|++|+||+|+||+++.++ .++|
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9977 77899999999 899999988777899999999999999999999999999999999999998877 9999
Q ss_pred eeCCCccccccccCC-----CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHH
Q 024347 153 SDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD--SNLMNLYKK 225 (269)
Q Consensus 153 ~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~--~~~~~~~~~ 225 (269)
+|||+++........ .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.. .........
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 999999765432211 11233468899999999988765 4999999999999999999999954 233222222
Q ss_pred HhcCcccCC---------CCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 226 ISAAEFTCP---------PWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 226 ~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
........+ ..+++.+.++|..||+.||++|||++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 320 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALK 320 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 221111122 16889999999999999999999986554
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=306.25 Aligned_cols=249 Identities=24% Similarity=0.407 Sum_probs=202.1
Q ss_pred CCeEEeeeeeccCCcEEEEEE----EcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC--C
Q 024347 11 GKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK--T 84 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--~ 84 (269)
.+|++.+.||+|++|.||++. +..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 469999999999999999999 567899999999875432 22357788999999999999999999999776 6
Q ss_pred eEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..+++|||+++++|.+++.. ...++..++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 68999999999999999855 45799999999999999999999999999999999999999999999999999876543
Q ss_pred ccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---------------CHHHHHHHHh
Q 024347 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---------------NLMNLYKKIS 227 (269)
Q Consensus 164 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---------------~~~~~~~~~~ 227 (269)
.... .......++..|+|||++.+..+. .++||||||+++|+|++|..|+... ........+.
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK 257 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence 2211 122234467789999999877664 8999999999999999999886422 1122233333
Q ss_pred c-CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 228 A-AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 228 ~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
. ...+.+..+++.+.+||+.||+.||.+|||++++
T Consensus 258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 293 (302)
T 4e5w_A 258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNL 293 (302)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 2 3456677899999999999999999999998443
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=305.43 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=202.7
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcC-CCC--eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSE-TGE--PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~--~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
....++|++.+.||.|++|.||+|.+.. +++ .|++|.+...........+.+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4456789999999999999999998643 333 6899998765544445578899999999999999999999999776
Q ss_pred CeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
. .++++||+++++|.+.+... +.+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 78999999999999988764 569999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCC-cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc--ccCCCCCC
Q 024347 163 QVRDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLS 238 (269)
Q Consensus 163 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~ 238 (269)
...... ......++..|+|||++.+..+ +.++||||||+++|+|++ |..||...........+.... .+.+..++
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 322111 1222345678999999987665 489999999999999999 999999988888888776543 45556799
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 239 FTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.+.++|..||+.||++|||++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l 275 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVAL 275 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHH
Confidence 999999999999999999998554
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=308.01 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=203.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCC-CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC------ceeeeEEEee
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETG-EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN------VVRLYEVMGS 82 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~------i~~~~~~~~~ 82 (269)
.++|++.+.||+|++|.||+|.+..++ +.||+|++.... ...+.+.+|+.+++.++|++ ++.+++++..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 479999999999999999999998776 689999986432 33567778999998887655 8899999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----------------
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---------------- 144 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~---------------- 144 (269)
.+..++||||+ ++++.+.+... ..+++.++..++.|++.||.|||+.||+|+||+|+||++
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999999 55776777654 369999999999999999999999999999999999999
Q ss_pred ---cCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 024347 145 ---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (269)
Q Consensus 145 ---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 221 (269)
+.++.++|+|||.+..... ......+++.|+|||++.+..+. .++||||||+++|+|++|..||.......
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 5678899999999875332 22334578999999999877764 89999999999999999999999877665
Q ss_pred HHHHHhcCcccC--------------------------------------------CCCCCHHHHHHHHHhcCCCCCCcC
Q 024347 222 LYKKISAAEFTC--------------------------------------------PPWLSFTARKLIARILDPNPMTVS 257 (269)
Q Consensus 222 ~~~~~~~~~~~~--------------------------------------------~~~~~~~l~~li~~~l~~dP~~Rp 257 (269)
....+....-+. ....+..+.+||+.||+.||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 444432211110 111245789999999999999999
Q ss_pred CCCccccccccC
Q 024347 258 IYPFADILYMRF 269 (269)
Q Consensus 258 s~~~~~~l~~~~ 269 (269)
|+ .+++.|+|
T Consensus 327 t~--~e~l~hp~ 336 (355)
T 2eu9_A 327 TL--AEALLHPF 336 (355)
T ss_dssp CH--HHHTTSGG
T ss_pred CH--HHHhcChh
Confidence 99 88888887
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=311.68 Aligned_cols=252 Identities=16% Similarity=0.201 Sum_probs=196.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCC-----CCeEEEEEeehhhhhhHHHH--------HHHHHHHHHhhhCCCCCceee
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSET-----GEPVALKILDKEKVLKHKMA--------EQIKREVATMKLVKHPNVVRL 76 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~-----~~~~~~K~~~~~~~~~~~~~--------~~~~~e~~~l~~l~~~~i~~~ 76 (269)
.++|++.+.||+|+||.||+|.+..+ ++.||+|++........... ....+|+..++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 45899999999999999999998764 58899999875432211111 233456677888999999999
Q ss_pred eEEEeeC----CeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec--CCCC
Q 024347 77 YEVMGSK----TKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD--AYGN 149 (269)
Q Consensus 77 ~~~~~~~----~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~--~~~~ 149 (269)
++++... ...++||||+ |++|.+++... +.+++.++..++.|++.||.|||+.||+|+||+|+||+++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998664 4589999999 89999998775 6799999999999999999999999999999999999999 8899
Q ss_pred EEEeeCCCccccccccCCC-----cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHH
Q 024347 150 LKVSDFGLSALSQQVRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLY 223 (269)
Q Consensus 150 ~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~ 223 (269)
++|+|||+++......... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.... ...
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999997654322211 1123348999999999988776 49999999999999999999999853221 111
Q ss_pred HHHh-c--Ccc-------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 224 KKIS-A--AEF-------TCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 224 ~~~~-~--~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
.... . ... .....+++++.+++..||+.||++||+++++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~ 321 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLR 321 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHH
Confidence 1111 0 000 11245799999999999999999999986554
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=307.02 Aligned_cols=257 Identities=21% Similarity=0.349 Sum_probs=188.5
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHH-HhhhCCCCCceeeeEEEee
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVA-TMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~-~l~~l~~~~i~~~~~~~~~ 82 (269)
..+....++|++.+.||.|+||.||+|.+..+|+.||+|.+..... ......+..|+. +++.++||||+++++++..
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 3455677899999999999999999999999999999999875432 222344445554 7788899999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCCCEEEeeCC
Q 024347 83 KTKIFIVLEFVTGGELFDKIVN-----HGRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYGNLKVSDFG 156 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~~~~l~df~ 156 (269)
.+..++||||+++ ++.+++.. ...+++..+..++.+++.||.+||+. |++|+||+|+||+++.++.++|+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999976 77776653 46799999999999999999999999 99999999999999999999999999
Q ss_pred CccccccccCCCcccccccCccccCccccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCcc
Q 024347 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLN----DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEF 231 (269)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~ 231 (269)
.+...... .......+++.|+|||++. +..+ +.++||||||+++|+|++|..||...... .....+..+..
T Consensus 172 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (327)
T 3aln_A 172 ISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP 247 (327)
T ss_dssp SSCC---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC
T ss_pred Cceecccc---cccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC
Confidence 88654322 1222335788999999984 3333 58999999999999999999999864322 22222222222
Q ss_pred c-C----CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 T-C----PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 ~-~----~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+ . ...+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--~ell~hp~ 288 (327)
T 3aln_A 248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKY--KELLKHPF 288 (327)
T ss_dssp CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCH--HHHTTSHH
T ss_pred CCCCCcccccCCHHHHHHHHHHhhCChhhCcCH--HHHHhChH
Confidence 1 1 13489999999999999999999999 77788876
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=315.80 Aligned_cols=247 Identities=25% Similarity=0.403 Sum_probs=200.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC--------CCCceeeeEEEe
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--------HPNVVRLYEVMG 81 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~--------~~~i~~~~~~~~ 81 (269)
.++|++.+.||+|+||.||+|.+..+++.||+|++... ....+.+.+|+.+++.++ |+||+++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 37899999999999999999999999999999998643 233567888999998885 788999999987
Q ss_pred ----eCCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecCCC------
Q 024347 82 ----SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDAYG------ 148 (269)
Q Consensus 82 ----~~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~~~------ 148 (269)
.....++||||+ ++++.+.+... ..+++..+..++.|++.||.|||++ ||+|+||||+||+++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 456799999999 55666666554 4699999999999999999999998 999999999999999775
Q ss_pred -------------------------------------------CEEEeeCCCccccccccCCCcccccccCccccCcccc
Q 024347 149 -------------------------------------------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185 (269)
Q Consensus 149 -------------------------------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~ 185 (269)
.++|+|||.+...... .....+++.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 7999999998754332 2334578999999999
Q ss_pred cCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHhc--C----------------------------
Q 024347 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL------MNLYKKISA--A---------------------------- 229 (269)
Q Consensus 186 ~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~------~~~~~~~~~--~---------------------------- 229 (269)
.+..+. .++||||||+++|+|++|..||..... ......+.. +
T Consensus 266 ~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred cCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 887764 899999999999999999999975431 111111110 0
Q ss_pred ------------cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ------------EFTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+...++.+.+||+.||+.||++|||+ .++|.|+|
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~e~l~hp~ 394 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA--AECLRHPW 394 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCH--HHHHTSGG
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCH--HHHhhCcc
Confidence 001122235678999999999999999999 88999988
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=305.50 Aligned_cols=254 Identities=23% Similarity=0.358 Sum_probs=201.8
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe----
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG---- 81 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~---- 81 (269)
+...-++|++.+.||+|++|.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 24 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 24 VIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred EEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 3445678999999999999999999999999999999986532 344678889999999999999999999986
Q ss_pred eCCeEEEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
.....++++||+++++|.+++.. ...+++.++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 24478999999999999988875 46799999999999999999999999999999999999999999999999998
Q ss_pred ccccccccCCC-------cccccccCccccCcccccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHH
Q 024347 158 SALSQQVRDDG-------LLHTTCGTPNYVAPEVLNDRGY--DGSTADLWSCGVILFVLLAGYLPFDDSNL--MNLYKKI 226 (269)
Q Consensus 158 ~~~~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~ 226 (269)
+.......... ......+++.|+|||++.+... .+.++||||||+++|+|++|..||..... ......+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 260 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence 76543211111 0112345889999999876542 35899999999999999999999953110 0111111
Q ss_pred -hcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 227 -SAAEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 227 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.....+.++.+++.+.++|+.||+.||.+|||++++
T Consensus 261 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 297 (317)
T 2buj_A 261 QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLL 297 (317)
T ss_dssp HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHH
Confidence 123344556789999999999999999999998443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=301.26 Aligned_cols=247 Identities=21% Similarity=0.285 Sum_probs=201.4
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEE-eeCCeEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM-GSKTKIFI 88 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~ 88 (269)
.++|++.+.||.|++|.||+|.+..+++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 4789999999999999999999999999999999865432 24578899999999988766655554 66778899
Q ss_pred EEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---cCCCCEEEeeCCCccccccc
Q 024347 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~---~~~~~~~l~df~~~~~~~~~ 164 (269)
+|||+ +++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 8899998874 4579999999999999999999999999999999999999 47889999999998765443
Q ss_pred cCCC-----cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCcccC---
Q 024347 165 RDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTC--- 233 (269)
Q Consensus 165 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~--- 233 (269)
.... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.... .......+.......
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH
Confidence 2211 1234468899999999988776 489999999999999999999997632 222333333332222
Q ss_pred --CCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 234 --PPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 234 --~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
+..+++.+.++++.||+.||++|||++++.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~ 272 (296)
T 3uzp_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 272 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHH
T ss_pred HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHH
Confidence 256899999999999999999999985543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=307.58 Aligned_cols=249 Identities=31% Similarity=0.530 Sum_probs=179.1
Q ss_pred ccccCCeEEee-eeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee---
Q 024347 7 KRRVGKYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--- 82 (269)
Q Consensus 7 ~~~~~~~~~~~-~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--- 82 (269)
....++|++.+ .||.|++|.||+|.+..+++.||+|++..... ...+....++.+.||||+++++++..
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 34567999965 69999999999999999999999999865321 12223344677799999999999876
Q ss_pred -CCeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC---CCCEEEeeCC
Q 024347 83 -KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFG 156 (269)
Q Consensus 83 -~~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~---~~~~~l~df~ 156 (269)
....++||||++|++|.+++...+ .+++.++..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 455899999999999999998753 6999999999999999999999999999999999999986 4459999999
Q ss_pred CccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCccc
Q 024347 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL----YKKISAAEFT 232 (269)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~ 232 (269)
.+..... .......+++.|+|||++.+..+. .++||||||+++|+|++|..||........ ...+......
T Consensus 177 ~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (336)
T 3fhr_A 177 FAKETTQ----NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG 251 (336)
T ss_dssp TCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred cceeccc----cccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence 8875432 122334568899999999776654 899999999999999999999976554433 2222222222
Q ss_pred C----CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 C----PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 ~----~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ...+++.+.+||+.||+.||++|||+ .+++.|+|
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~--~ell~hp~ 290 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTI--TQFMNHPW 290 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH--HHHHHSHH
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCH--HHHhcCcc
Confidence 2 24589999999999999999999999 77888876
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=309.99 Aligned_cols=249 Identities=29% Similarity=0.402 Sum_probs=204.9
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CC-----CceeeeEEEe
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HP-----NVVRLYEVMG 81 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~-----~i~~~~~~~~ 81 (269)
...++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+..|+.+++.+. |+ +++++++++.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 45689999999999999999999999999999999986432 33456677888887775 44 4999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCcEeecCCCCceEec--CCCCEEEeeC
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCH--SRGVYHRDLKPENLLLD--AYGNLKVSDF 155 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh--~~~i~h~di~~~nIl~~--~~~~~~l~df 155 (269)
..+..++||||+.+ +|.+++... +.+++..+..++.|++.||.||| +.||+|+||||+||+++ .++.++|+||
T Consensus 127 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 127 FRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp ETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred cCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999999965 998888765 46899999999999999999999 57999999999999995 4678999999
Q ss_pred CCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC--
Q 024347 156 GLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC-- 233 (269)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 233 (269)
|++..... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+.......
T Consensus 206 G~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 279 (382)
T 2vx3_A 206 GSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA 279 (382)
T ss_dssp TTCEETTC-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred cCceeccc-----ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99875432 2234567889999999988776 499999999999999999999999888776666553210000
Q ss_pred ----------------------------------CCC----------------------------CCHHHHHHHHHhcCC
Q 024347 234 ----------------------------------PPW----------------------------LSFTARKLIARILDP 251 (269)
Q Consensus 234 ----------------------------------~~~----------------------------~~~~l~~li~~~l~~ 251 (269)
++. .++.+.+||++||++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 359 (382)
T 2vx3_A 280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY 359 (382)
T ss_dssp HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence 000 013789999999999
Q ss_pred CCCCcCCCCccccccccC
Q 024347 252 NPMTVSIYPFADILYMRF 269 (269)
Q Consensus 252 dP~~Rps~~~~~~l~~~~ 269 (269)
||++|||+ .++|.|+|
T Consensus 360 dP~~Rpta--~e~L~hp~ 375 (382)
T 2vx3_A 360 DPKTRIQP--YYALQHSF 375 (382)
T ss_dssp CTTTSCCH--HHHTTSGG
T ss_pred ChhhCCCH--HHHhcCcc
Confidence 99999999 88899988
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=317.18 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=187.2
Q ss_pred cCCeEE-eeeeeccCCcEEEEEEEc--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--CC
Q 024347 10 VGKYEV-GRTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KT 84 (269)
Q Consensus 10 ~~~~~~-~~~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~ 84 (269)
-+.|++ .+.||+|+||.||+|.+. .+++.||+|.+..... ...+.+|+.+++.++||||+++++++.. ..
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 356777 447999999999999965 5688999999865432 2457789999999999999999999954 67
Q ss_pred eEEEEEeccCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----cCCCCEE
Q 024347 85 KIFIVLEFVTGGELFDKIVNH---------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLK 151 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~---------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~----~~~~~~~ 151 (269)
..++||||+.+ +|.+.+... ..+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 89999999965 777776532 248999999999999999999999999999999999999 6778999
Q ss_pred EeeCCCccccccccC-CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------H
Q 024347 152 VSDFGLSALSQQVRD-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------N 221 (269)
Q Consensus 152 l~df~~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------~ 221 (269)
|+|||+++....... ........+++.|+|||++.+...++.++||||||+++|+|++|..||...... +
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999876543211 122334567899999999988665569999999999999999999999765432 2
Q ss_pred HHHHHhc-CcccC-------------------------------------CCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 222 LYKKISA-AEFTC-------------------------------------PPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 222 ~~~~~~~-~~~~~-------------------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
....+.. ...+. ....++.+.+||+.||+.||++|||+ .+
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta--~e 330 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS--EQ 330 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH--HH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH--HH
Confidence 2222211 00000 01126789999999999999999999 88
Q ss_pred cccccC
Q 024347 264 ILYMRF 269 (269)
Q Consensus 264 ~l~~~~ 269 (269)
+|.|+|
T Consensus 331 ~L~hp~ 336 (405)
T 3rgf_A 331 AMQDPY 336 (405)
T ss_dssp HHTSGG
T ss_pred HhcChh
Confidence 999988
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=325.93 Aligned_cols=252 Identities=22% Similarity=0.364 Sum_probs=213.4
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
.+....++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|++++++++|+||+++++++.. .
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 445667889999999999999999999875 467999999764432 3578899999999999999999999866 6
Q ss_pred eEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
..++||||+++++|.+++.. ...++..++..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 78999999999999999864 3569999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHH
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (269)
..... ......++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+..+ +.+.+..++..
T Consensus 415 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 492 (535)
T 2h8h_A 415 DNEYT-ARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPES 492 (535)
T ss_dssp CHHHH-TTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CCcee-cccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 21110 1112234678999999987665 489999999999999999 99999998888888877665 45667789999
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccc
Q 024347 241 ARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
+.+||..||+.||++|||++++..
T Consensus 493 l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 493 LHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999865543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=306.94 Aligned_cols=250 Identities=24% Similarity=0.387 Sum_probs=206.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEE----EcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe--e
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG--S 82 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~--~ 82 (269)
.-++|++.+.||+|++|.||++. +..+++.|++|.+.... ....+.+.+|++++++++|+||+++++++. .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 34699999999999999999999 56789999999986543 344577899999999999999999999886 4
Q ss_pred CCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
....++||||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 56789999999999999998763 46999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHH
Q 024347 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------------NLYKK 225 (269)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~~~ 225 (269)
...... .......++..|+|||++.+..+ +.++||||||+++|+|++|..||...... .....
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL 256 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 432211 12223346778999999987665 48999999999999999999998643221 22222
Q ss_pred Hhc-CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 226 ISA-AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 226 ~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.. ...+.+..+++.+.+||+.||+.||++|||++++
T Consensus 257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 294 (327)
T 3lxl_A 257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294 (327)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 222 3355667899999999999999999999998554
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=300.43 Aligned_cols=247 Identities=21% Similarity=0.300 Sum_probs=198.6
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEE-eeCCeEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM-GSKTKIFI 88 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-~~~~~~~~ 88 (269)
.++|++.+.||.|++|.||+|.+..+++.||+|++..... .+.+.+|+.+++.++|++++..+..+ ......++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 4789999999999999999999999999999998754432 24577899999999988776666555 67788899
Q ss_pred EEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---cCCCCEEEeeCCCccccccc
Q 024347 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~---~~~~~~~l~df~~~~~~~~~ 164 (269)
+|||+ +++|.+++.. .+.+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 8899998875 4579999999999999999999999999999999999999 78899999999998765443
Q ss_pred cCCC-----cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCcccCC--
Q 024347 165 RDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL---MNLYKKISAAEFTCP-- 234 (269)
Q Consensus 165 ~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~-- 234 (269)
.... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||..... ......+.......+
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 2211 2234467899999999988776 4899999999999999999999976322 223333333322222
Q ss_pred ---CCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 235 ---PWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 235 ---~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
..+++.+.++|+.||+.||++|||++++.
T Consensus 241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~ 272 (296)
T 4hgt_A 241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 272 (296)
T ss_dssp HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHH
T ss_pred hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHH
Confidence 56799999999999999999999985543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=317.81 Aligned_cols=250 Identities=23% Similarity=0.398 Sum_probs=201.7
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC--e
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT--K 85 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~--~ 85 (269)
..-++|++.+.||+|+||.||+|.+..+|+.||+|++....... ..+.+.+|++++++++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34568999999999999999999999999999999997644322 2466788999999999999999999997655 7
Q ss_pred EEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe----cCCCCEEEeeCCCc
Q 024347 86 IFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL----DAYGNLKVSDFGLS 158 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~----~~~~~~~l~df~~~ 158 (269)
.++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+|||.+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 899999999999999887643 39999999999999999999999999999999999999 67777999999998
Q ss_pred cccccccCCCcccccccCccccCcccccCC-------CCCCCchhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHh
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDR-------GYDGSTADLWSCGVILFVLLAGYLPFDD----SNLMNLYKKIS 227 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~~Di~slG~~l~~l~~g~~p~~~----~~~~~~~~~~~ 227 (269)
....... ......+++.|+|||++.+. ...+.++||||||+++|+|++|..||.. ....+....+.
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 7543322 22334589999999998652 1224789999999999999999999963 22334444444
Q ss_pred cCccc---------------------C----CCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 228 AAEFT---------------------C----PPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 228 ~~~~~---------------------~----~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+.++ . ...++..+.++|+.||++||++||+++++
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~ 300 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHH
Confidence 33321 1 11245678999999999999999998543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=299.23 Aligned_cols=237 Identities=25% Similarity=0.392 Sum_probs=200.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-------
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------- 82 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------- 82 (269)
.++|++.+.||.|++|.||+|.+..+++.|++|.+.... +.+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 368999999999999999999999899999999987543 345679999999999999999998854
Q ss_pred ---------CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEE
Q 024347 83 ---------KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLK 151 (269)
Q Consensus 83 ---------~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~ 151 (269)
....+++|||+++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence 44589999999999999998754 5799999999999999999999999999999999999999999999
Q ss_pred EeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc
Q 024347 152 VSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (269)
Q Consensus 152 l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 231 (269)
|+|||.+...... .......+++.|+|||++.+... +.++||||||+++|+|++|..|+.. .......+....
T Consensus 163 l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~~- 235 (284)
T 2a19_B 163 IGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDGI- 235 (284)
T ss_dssp ECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTTC-
T ss_pred ECcchhheecccc---ccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhccc-
Confidence 9999988754332 22233457899999999988766 4899999999999999999988743 223333333332
Q ss_pred cCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 232 TCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 232 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
.+..++..+.++|+.||+.||++|||+.+
T Consensus 236 -~~~~~~~~~~~li~~~l~~dp~~Rps~~e 264 (284)
T 2a19_B 236 -ISDIFDKKEKTLLQKLLSKKPEDRPNTSE 264 (284)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred -ccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 34668999999999999999999999843
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=304.44 Aligned_cols=248 Identities=23% Similarity=0.344 Sum_probs=201.4
Q ss_pred CCe-EEeeeeeccCCcEEEEEEE----cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--C
Q 024347 11 GKY-EVGRTIGEGTFAKVKFARN----SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--K 83 (269)
Q Consensus 11 ~~~-~~~~~lg~g~~~~v~~~~~----~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~ 83 (269)
++| ++++.||+|+||.||++.+ ..+++.||+|.+.... .....+.+.+|+++++.++||||+++++++.+ .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 345 9999999999999987754 4578999999997543 34446788999999999999999999999987 4
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
...++||||+++++|.+++... .+++.++..++.|++.+|.+||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred ceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 6789999999999999988664 599999999999999999999999999999999999999999999999999876543
Q ss_pred ccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHHh
Q 024347 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM---------------NLYKKIS 227 (269)
Q Consensus 164 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---------------~~~~~~~ 227 (269)
.... .......++..|+|||++.+..++ .++||||||+++|+|++|..||...... ...+.+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE 265 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence 2211 112233467789999999877664 8999999999999999999999753221 1222222
Q ss_pred c-CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 228 A-AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 228 ~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
. ...+.+..+++.+.+||+.||+.||++|||++++
T Consensus 266 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 301 (318)
T 3lxp_A 266 RGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENL 301 (318)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred cccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHH
Confidence 2 3455667799999999999999999999998554
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=310.80 Aligned_cols=248 Identities=23% Similarity=0.411 Sum_probs=199.3
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-----------CCCceeee
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----------HPNVVRLY 77 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~ 77 (269)
..++|++.+.||+|++|.||+|.+..+++.||+|++.... ...+.+.+|+.+++++. |+||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 3478999999999999999999999999999999987543 22456778888888876 78999999
Q ss_pred EEEeeCC----eEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEeecCCCCceEecC----
Q 024347 78 EVMGSKT----KIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSR-GVYHRDLKPENLLLDA---- 146 (269)
Q Consensus 78 ~~~~~~~----~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~-~i~h~di~~~nIl~~~---- 146 (269)
+++...+ ..++++|++ +++|.+++... ..++...+..++.|++.||.|||+. ||+|+||+|+||+++.
T Consensus 93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence 9997654 789999999 88999988763 4599999999999999999999998 9999999999999953
Q ss_pred --CCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCH-----
Q 024347 147 --YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNL----- 219 (269)
Q Consensus 147 --~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----- 219 (269)
.+.++|+|||++..... ......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.....
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 33699999999875433 1223457899999999988776 4999999999999999999999986432
Q ss_pred -HHHHHHHh------------------------------------------cCcccCCCCCCHHHHHHHHHhcCCCCCCc
Q 024347 220 -MNLYKKIS------------------------------------------AAEFTCPPWLSFTARKLIARILDPNPMTV 256 (269)
Q Consensus 220 -~~~~~~~~------------------------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~R 256 (269)
......+. ......+..+++.+.+||+.||+.||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111111 11122333456789999999999999999
Q ss_pred CCCCccccccccC
Q 024347 257 SIYPFADILYMRF 269 (269)
Q Consensus 257 ps~~~~~~l~~~~ 269 (269)
||+ .+++.|+|
T Consensus 326 pt~--~ell~hp~ 336 (373)
T 1q8y_A 326 ADA--GGLVNHPW 336 (373)
T ss_dssp BCH--HHHHTCGG
T ss_pred CCH--HHHhhChh
Confidence 999 88889887
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=303.54 Aligned_cols=243 Identities=23% Similarity=0.340 Sum_probs=197.1
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhh-hhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccC
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
.+.||+|++|.||+|.+ +++.+++|.+..... ......+.+.+|+.+++.++||||+++++++.+.+..+++|||++
T Consensus 36 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 113 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113 (307)
T ss_dssp CCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred CCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecC
Confidence 38999999999999986 578999999865321 233446788999999999999999999999999999999999999
Q ss_pred CCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 95 GGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 95 ~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
+++|.+++.. ...++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.............
T Consensus 114 ~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 193 (307)
T 2nru_A 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193 (307)
T ss_dssp TCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECS
T ss_pred CCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccccc
Confidence 9999998864 3468999999999999999999999999999999999999999999999999987654433333333
Q ss_pred ccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCc-----------ccCCCC
Q 024347 172 TTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----NLYKKISAAE-----------FTCPPW 236 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~-----------~~~~~~ 236 (269)
...+++.|+|||++.+. . +.++||||||+++|+|++|..||...... .....+.... ...+..
T Consensus 194 ~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (307)
T 2nru_A 194 RIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADST 271 (307)
T ss_dssp SCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHH
T ss_pred ccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchH
Confidence 45688999999998764 3 58999999999999999999999764332 2222222111 111223
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+..+.+++..||+.||.+|||++++
T Consensus 272 ~~~~l~~li~~cl~~~p~~Rps~~~l 297 (307)
T 2nru_A 272 SVEAMYSVASQCLHEKKNKRPDIKKV 297 (307)
T ss_dssp HHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHHHHHHHHcCCCcccCcCHHHH
Confidence 45679999999999999999998543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=309.77 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=199.2
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe-
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG- 81 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~- 81 (269)
++....+|++.+.||+|+||.||+|.+..+ +..+++|.+.... .....+.+.+|+.++++++||||+++++++.
T Consensus 84 i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 161 (373)
T 3c1x_A 84 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161 (373)
T ss_dssp CCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred cChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence 344455789999999999999999987543 2468899875422 2344678999999999999999999999864
Q ss_pred eCCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
..+..++||||+++++|.+++... ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.
T Consensus 162 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 162 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred CCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccc
Confidence 456789999999999999998764 4588999999999999999999999999999999999999999999999999875
Q ss_pred cccccCC--CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCC
Q 024347 161 SQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPW 236 (269)
Q Consensus 161 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~ 236 (269)
....... .......+++.|+|||++.+..+. .++||||||+++|+|++ |..||......+....+..+. ...+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~ 320 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 320 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTT
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 4332111 112223456789999999877664 89999999999999999 788898766665656655544 445667
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
++..+.+++..||+.||++|||++++
T Consensus 321 ~~~~l~~li~~cl~~dp~~RPs~~el 346 (373)
T 3c1x_A 321 CPDPLYEVMLKCWHPKAEMRPSFSEL 346 (373)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 99999999999999999999998543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=325.66 Aligned_cols=248 Identities=21% Similarity=0.332 Sum_probs=206.5
Q ss_pred CeEEe-eeeeccCCcEEEEEEE--cCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 12 KYEVG-RTIGEGTFAKVKFARN--SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 12 ~~~~~-~~lg~g~~~~v~~~~~--~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
.+.+. +.||.|+||.||+|.+ +.+++.||+|++..... .....+.+.+|+.++++++||||+++++++.. +..++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999954 45678899999876543 23335789999999999999999999999864 45789
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC-
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD- 167 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~- 167 (269)
||||+++++|.+++...+.+++.++..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++........
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998755432211
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLI 245 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li 245 (269)
.......+++.|+|||++.+..+. .++||||||+++|+|++ |..||.+....+....+..+. ...+..+++++.+||
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 605 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLM 605 (635)
T ss_dssp --------CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccCCCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 112223356789999999877764 89999999999999998 999999999888888887664 556778999999999
Q ss_pred HHhcCCCCCCcCCCCcc
Q 024347 246 ARILDPNPMTVSIYPFA 262 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~ 262 (269)
+.||+.||++||+++++
T Consensus 606 ~~cl~~dP~~RPs~~~l 622 (635)
T 4fl3_A 606 NLCWTYDVENRPGFAAV 622 (635)
T ss_dssp HHHTCSSTTTSCCHHHH
T ss_pred HHHcCCCHhHCcCHHHH
Confidence 99999999999998554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=298.97 Aligned_cols=240 Identities=28% Similarity=0.438 Sum_probs=195.5
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||+|++|.||++.+. ++.|++|.+.... ..+.+.+|+.++++++||||+++++++.+ ..+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 35679999999999999999999984 7889999986432 24678899999999999999999998763 478
Q ss_pred EEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcEeecCCCCceEecCCCC-EEEeeCCCccc
Q 024347 88 IVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHS---RGVYHRDLKPENLLLDAYGN-LKVSDFGLSAL 160 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~h~di~~~nIl~~~~~~-~~l~df~~~~~ 160 (269)
+||||+++++|.+++.... .++...+..++.|++.||.|||+ .|++|+||+|+||+++.++. ++|+|||.+..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999988654 47889999999999999999999 89999999999999998887 79999998864
Q ss_pred cccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhc-CcccCCCCC
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS--NLMNLYKKISA-AEFTCPPWL 237 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~--~~~~~~~~~~~-~~~~~~~~~ 237 (269)
.... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||... ........... ...+.+..+
T Consensus 156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (307)
T 2eva_A 156 IQTH-----MTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred cccc-----cccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence 3321 122347899999999987766 48999999999999999999999753 23333333333 344556779
Q ss_pred CHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 238 SFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 238 ~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
++.+.+++..||+.||++|||++++
T Consensus 230 ~~~l~~li~~~l~~dp~~Rps~~el 254 (307)
T 2eva_A 230 PKPIESLMTRCWSKDPSQRPSMEEI 254 (307)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHH
Confidence 9999999999999999999998544
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=307.63 Aligned_cols=255 Identities=23% Similarity=0.309 Sum_probs=202.5
Q ss_pred CccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe
Q 024347 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (269)
Q Consensus 2 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 81 (269)
+..++....++|++.+.||+|++|.||+|.+. +++.||+|.+...... .....+.+|+.+++.++||||+++++++.
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 45566778899999999999999999999854 6899999998654322 11236889999999999999999999999
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcEeecCCCCceEecCCCCEEEee
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHG----RMKEDEARRYFQQLINAVDYCHSR---GVYHRDLKPENLLLDAYGNLKVSD 154 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~h~di~~~nIl~~~~~~~~l~d 154 (269)
+....++||||+++++|.+.+.... .++...+..++.|++.||.+||+. |++|+||+|+||+++.++.++|+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999887643 489999999999999999999999 999999999999999999999999
Q ss_pred CCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-----C---HHHHHHHH
Q 024347 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-----N---LMNLYKKI 226 (269)
Q Consensus 155 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-----~---~~~~~~~~ 226 (269)
||.+....... ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||... . ........
T Consensus 178 fg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 178 FGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred CccccccCccc-ccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 99987554321 222233458999999999977665 48999999999999999999999521 1 11111111
Q ss_pred hcCc-c----------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 227 SAAE-F----------TCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 227 ~~~~-~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
.... . ..+...++.+.+++..||+.||.+|||+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e 301 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSE 301 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHH
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHH
Confidence 1110 0 111123467999999999999999999843
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=307.16 Aligned_cols=243 Identities=15% Similarity=0.185 Sum_probs=197.4
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcC--------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCcee------
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSE--------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVR------ 75 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~--------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~------ 75 (269)
-++|++.+.||.|++|.||+|.+.. .++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 3799999999999999999999987 4889999998643 35678999999999998887
Q ss_pred ---------eeEEEee-CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceE
Q 024347 76 ---------LYEVMGS-KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLL 143 (269)
Q Consensus 76 ---------~~~~~~~-~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl 143 (269)
+++++.. ....++||||+ +++|.+++... ..+++.++..++.|++.||.|||+.|++|+||+|+||+
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6777765 67899999999 99999999875 68999999999999999999999999999999999999
Q ss_pred ecCCC--CEEEeeCCCccccccccCC-----CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 024347 144 LDAYG--NLKVSDFGLSALSQQVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD 216 (269)
Q Consensus 144 ~~~~~--~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (269)
++.++ .++|+|||++......... .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCccc
Confidence 99988 8999999998765432221 11233468899999999988765 4899999999999999999999986
Q ss_pred CC--HHHHHHHHh---cCcccCC------CCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 217 SN--LMNLYKKIS---AAEFTCP------PWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 217 ~~--~~~~~~~~~---~~~~~~~------~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.. ......... ....... ..+++.+.+||+.||+.||++|||++++
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 327 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAML 327 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHH
Confidence 53 333322221 1211111 2468999999999999999999998554
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=307.53 Aligned_cols=243 Identities=16% Similarity=0.193 Sum_probs=196.6
Q ss_pred cccccCCeEEeeeeeccCCcEEEEE-----EEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC---CCCceeee
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFA-----RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLY 77 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~-----~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~ 77 (269)
+....++|++.+.||+|+||.||+| .+..+++.||+|.+.... ...+..|+.+++.++ |+|++.++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 3455678999999999999999999 466789999999986543 234566677777776 89999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC------
Q 024347 78 EVMGSKTKIFIVLEFVTGGELFDKIVN-----HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA------ 146 (269)
Q Consensus 78 ~~~~~~~~~~~v~~~~~~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~------ 146 (269)
+++...+..++||||+++++|.+++.. ...+++.++..++.|++.||.|||+.||+|+||||+||+++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999999874 457999999999999999999999999999999999999998
Q ss_pred -----CCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 024347 147 -----YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN 221 (269)
Q Consensus 147 -----~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 221 (269)
++.++|+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++|+.||.......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999976554444444455678999999999988776 499999999999999999999996432210
Q ss_pred HHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCC
Q 024347 222 LYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
. ...........++.+.+++..||+.+|.+|++.
T Consensus 293 ~----~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~ 326 (365)
T 3e7e_A 293 C----KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPS 326 (365)
T ss_dssp E----EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCC
T ss_pred e----eechhccccCcHHHHHHHHHHHcCCCCCCcchH
Confidence 0 000011111346789999999999999999775
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=301.82 Aligned_cols=250 Identities=28% Similarity=0.398 Sum_probs=184.1
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEe--
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG-- 81 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-- 81 (269)
.+...-.+|++.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 34445568999999999999999999999999999999985442 334567889999999996 999999999983
Q ss_pred ------eCCeEEEEEeccCCCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEecCCCCE
Q 024347 82 ------SKTKIFIVLEFVTGGELFDKIVN---HGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 82 ------~~~~~~~v~~~~~~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~~~~~~ 150 (269)
.....++++||+. ++|.+++.. .+.+++.+++.++.|++.||.|||+.| ++|+||+|+||+++.++.+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 3445899999996 588887754 457999999999999999999999999 9999999999999999999
Q ss_pred EEeeCCCccccccccCCC----------cccccccCccccCccccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCC
Q 024347 151 KVSDFGLSALSQQVRDDG----------LLHTTCGTPNYVAPEVLN---DRGYDGSTADLWSCGVILFVLLAGYLPFDDS 217 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~---~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 217 (269)
+|+|||.+.......... ......+++.|+|||++. +..+ +.++||||||+++|+|++|..||...
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EBCCCTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999987654322211 111334788999999984 3333 58999999999999999999999865
Q ss_pred CHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 218 NLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
......... ...+.....+..+.+||+.||+.||++|||+++
T Consensus 257 ~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 298 (337)
T 3ll6_A 257 AKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAE 298 (337)
T ss_dssp -----------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHH
T ss_pred hHHHhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHH
Confidence 444333221 223334557888999999999999999999843
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=323.58 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=205.8
Q ss_pred ccCCeEEee-eeeccCCcEEEEEEEc--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 9 RVGKYEVGR-TIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 9 ~~~~~~~~~-~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
..+++.+.+ .||+|+||.||+|.+. .++..||+|.+..... ....+.+.+|++++++++||||+++++++.. +.
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~ 409 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA 409 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence 345566666 8999999999999875 3466799999875421 2235788999999999999999999999976 56
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++||||+++++|.+++... ..++...+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||+++.....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 89999999999999988654 46999999999999999999999999999999999999999999999999998765332
Q ss_pred cCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHH
Q 024347 165 RDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTA 241 (269)
Q Consensus 165 ~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l 241 (269)
... .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||......+....+..+. ...+..+++.+
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l 568 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL 568 (613)
T ss_dssp ------------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CceeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence 211 11112234578999999987766 489999999999999998 999999988888888876654 56677899999
Q ss_pred HHHHHHhcCCCCCCcCCCCcc
Q 024347 242 RKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+||..||+.||++||+++++
T Consensus 569 ~~li~~cl~~dP~~RPs~~~l 589 (613)
T 2ozo_A 569 YALMSDCWIYKWEDRPDFLTV 589 (613)
T ss_dssp HHHHHHTTCSSTTTSCCHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHH
Confidence 999999999999999998554
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=304.28 Aligned_cols=254 Identities=21% Similarity=0.334 Sum_probs=207.7
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK 83 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 83 (269)
..+....++|++.+.||+|++|.||+|.+.. .+++|.+...... ....+.+.+|+.++++++|+||+++++++.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 101 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 4556778999999999999999999999854 4999998654321 12235577899999999999999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
...++++||+++++|.+++...+ .+++..+..++.|++.||.+||+.|++|+||+|+||+++ ++.++|+|||++....
T Consensus 102 ~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 102 PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISG 180 (319)
T ss_dssp SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence 99999999999999999887654 689999999999999999999999999999999999998 6799999999876543
Q ss_pred ccc---CCCcccccccCccccCcccccCC--------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc
Q 024347 163 QVR---DDGLLHTTCGTPNYVAPEVLNDR--------GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231 (269)
Q Consensus 163 ~~~---~~~~~~~~~~~~~~~aPE~~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 231 (269)
... .........+++.|+|||++.+. ...+.++||||||+++|+|++|..||...........+..+..
T Consensus 181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~ 260 (319)
T 2y4i_B 181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK 260 (319)
T ss_dssp -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC
T ss_pred cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC
Confidence 221 12222334578899999998752 2235889999999999999999999999888888887766654
Q ss_pred cCC--CCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 232 TCP--PWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 232 ~~~--~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.. ..++.++.+++..||+.||++|||++++
T Consensus 261 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 293 (319)
T 2y4i_B 261 PNLSQIGMGKEISDILLFCWAFEQEERPTFTKL 293 (319)
T ss_dssp CCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHH
T ss_pred CCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 333 3588999999999999999999998554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=296.54 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=190.5
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhh--CCCCCceeeeEEEee---
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGS--- 82 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~--- 82 (269)
...++|++.+.||+|+||.||+|.+ +++.||+|++.... ......|.+++.. ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 3457999999999999999999988 58899999986543 2334455565555 789999999998644
Q ss_pred -CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeecCCCCceEecCCCCEEEe
Q 024347 83 -KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH--------SRGVYHRDLKPENLLLDAYGNLKVS 153 (269)
Q Consensus 83 -~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--------~~~i~h~di~~~nIl~~~~~~~~l~ 153 (269)
....++||||+++++|.+++.. ..++...+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred CCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 3468999999999999998854 57999999999999999999999 9999999999999999999999999
Q ss_pred eCCCccccccccCC--CcccccccCccccCcccccCCCCC-----CCchhHHHHHHHHHHHHcC----------CCCCCC
Q 024347 154 DFGLSALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGYD-----GSTADLWSCGVILFVLLAG----------YLPFDD 216 (269)
Q Consensus 154 df~~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~~l~~l~~g----------~~p~~~ 216 (269)
|||++......... .......+++.|+|||++.+.... +.++||||||+++|+|++| ..||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 99998654332211 112233689999999999876322 2689999999999999999 888854
Q ss_pred C----CHHHHHHHHh-cC--cccCCC-----CCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 217 S----NLMNLYKKIS-AA--EFTCPP-----WLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 217 ~----~~~~~~~~~~-~~--~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
. .......... .. ....+. .+++.+.+|++.||+.||++|||++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 293 (301)
T 3q4u_A 236 VVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293 (301)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred cCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence 2 1122222222 21 122221 145679999999999999999998543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=321.17 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=209.9
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCC---CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSET---GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~---~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
.....++|++.+.||+|+||.||+|.+..+ +..+++|.+.... .....+.+.+|+.++++++||||+++++++.
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 345567899999999999999999998643 4568999876432 3445678999999999999999999999985
Q ss_pred CCeEEEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
.+..++||||+++++|.+++...+ .++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 541 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence 456899999999999999987654 6899999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCH
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSF 239 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (269)
..... .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+..+. .+.++.+++
T Consensus 542 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 619 (656)
T 2j0j_A 542 EDSTY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 619 (656)
T ss_dssp CC-----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCH
T ss_pred CCCcc-eeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence 33211 11122345678999999987765 489999999999999997 999999988888887776554 567788999
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcc
Q 024347 240 TARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+.++|..||+.||.+|||++++
T Consensus 620 ~l~~li~~~l~~dP~~RPs~~el 642 (656)
T 2j0j_A 620 TLYSLMTKCWAYDPSRRPRFTEL 642 (656)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHH
Confidence 99999999999999999998544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=300.32 Aligned_cols=250 Identities=22% Similarity=0.367 Sum_probs=203.0
Q ss_pred ccCCeEEeeeeeccCCcEEEEEE----EcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFAR----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~----~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
..++|++.+.||.|++|.||++. +..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 44679999999999999999998 45679999999986532 334678899999999999999999999986543
Q ss_pred --eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 85 --KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 85 --~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
..++||||+++++|.+++... ..++..++..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+...
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 689999999999999999875 46999999999999999999999999999999999999999999999999998765
Q ss_pred ccccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH----------------HHHH
Q 024347 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM----------------NLYK 224 (269)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----------------~~~~ 224 (269)
...... .......++..|+|||++.+..+ +.++||||||+++|+|++|..|+...... ...+
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE 274 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence 432211 11122345667999999987665 48999999999999999999988642111 1122
Q ss_pred HHh-cCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 225 KIS-AAEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 225 ~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+. ....+.+..+++.+.++|+.||+.||++|||++++
T Consensus 275 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el 313 (326)
T 2w1i_A 275 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDL 313 (326)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 222 23456677899999999999999999999998443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-44 Score=305.33 Aligned_cols=256 Identities=26% Similarity=0.396 Sum_probs=191.7
Q ss_pred CccccccccCCeEE-eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEE
Q 024347 2 SQPKIKRRVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV 79 (269)
Q Consensus 2 ~~~~~~~~~~~~~~-~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 79 (269)
+.++++...+++.+ .+.||.|++|+||.+. ..+|+.||+|.+..+. .+.+.+|+.+++.+ +||||++++++
T Consensus 5 ~~p~~~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~ 77 (434)
T 2rio_A 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCS 77 (434)
T ss_dssp ---CCSCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred cccchhhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEE
Confidence 45667777776655 5789999999998754 4579999999986543 24567899999876 89999999999
Q ss_pred EeeCCeEEEEEeccCCCchhHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC-----
Q 024347 80 MGSKTKIFIVLEFVTGGELFDKIVNHGRM-------KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY----- 147 (269)
Q Consensus 80 ~~~~~~~~~v~~~~~~~~l~~~~~~~~~l-------~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~----- 147 (269)
+.+.+..++||||++ ++|.+++...... ++..+..++.|++.||.|||+.||+|+||+|+||+++.+
T Consensus 78 ~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~ 156 (434)
T 2rio_A 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTA 156 (434)
T ss_dssp EECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHS
T ss_pred EecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccc
Confidence 999999999999996 5999988765432 222456799999999999999999999999999999754
Q ss_pred --------CCEEEeeCCCccccccccCCC--cccccccCccccCcccccCC------CCCCCchhHHHHHHHHHHHHc-C
Q 024347 148 --------GNLKVSDFGLSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDR------GYDGSTADLWSCGVILFVLLA-G 210 (269)
Q Consensus 148 --------~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~~~~Di~slG~~l~~l~~-g 210 (269)
+.++|+|||++.......... ......+++.|+|||++.+. ...+.++||||||+++|+|++ |
T Consensus 157 ~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g 236 (434)
T 2rio_A 157 DQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236 (434)
T ss_dssp CCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTS
T ss_pred ccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCC
Confidence 379999999987654322111 12234689999999999752 334689999999999999998 9
Q ss_pred CCCCCCCCHHHHHHHHhcCcccCC-------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 211 YLPFDDSNLMNLYKKISAAEFTCP-------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 211 ~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..||....... ..+..+....+ ..+++++.+||+.||+.||.+|||+ .+++.|+|
T Consensus 237 ~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~--~eil~hp~ 298 (434)
T 2rio_A 237 KHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA--MKVLRHPL 298 (434)
T ss_dssp CCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH--HHHHTSGG
T ss_pred CCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH--HHHHhCCc
Confidence 99997654433 22323222221 1245789999999999999999999 78888887
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=307.53 Aligned_cols=249 Identities=21% Similarity=0.291 Sum_probs=203.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCC-CCceeeeEEEeeCCeEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 87 (269)
..++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++......+
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 35789999999999999999999999999999998765432 2347789999999987 55666666667888899
Q ss_pred EEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEe---cCCCCEEEeeCCCcccccc
Q 024347 88 IVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~---~~~~~~~l~df~~~~~~~~ 163 (269)
+||||+ +++|.+++.. .+.+++.+++.++.||+.||.|||+.||+|+||||+|||+ +.++.++|+|||++.....
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 8899998875 4679999999999999999999999999999999999999 5888999999999876544
Q ss_pred ccCCC-----cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCcc----
Q 024347 164 VRDDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEF---- 231 (269)
Q Consensus 164 ~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~---- 231 (269)
..... ......+++.|+|||++.+..+. .++||||||+++|+|++|..||.... ....+..+.....
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 32211 12245688999999999887764 89999999999999999999997643 3334444333222
Q ss_pred -cCCCCCCHHHHHHHHHhcCCCCCCcCCCCcccc
Q 024347 232 -TCPPWLSFTARKLIARILDPNPMTVSIYPFADI 264 (269)
Q Consensus 232 -~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~ 264 (269)
.....++.++.+||..||+.||++||+++++..
T Consensus 238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 222568999999999999999999999865543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=321.67 Aligned_cols=255 Identities=27% Similarity=0.390 Sum_probs=200.7
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee----
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS---- 82 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---- 82 (269)
+...++|++.+.||.|+||.||+|.+..+|+.||+|.+.... .....+.+.+|+.+++.++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 456789999999999999999999999999999999986542 34446788999999999999999999998755
Q ss_pred --CCeEEEEEeccCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC---EEEee
Q 024347 83 --KTKIFIVLEFVTGGELFDKIVNHG---RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN---LKVSD 154 (269)
Q Consensus 83 --~~~~~~v~~~~~~~~l~~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~---~~l~d 154 (269)
.+..++||||++|++|.+++.... .+++..+..++.+++.||.|||+.|++|+||+|+||+++.++. ++|+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 667899999999999999987643 5899999999999999999999999999999999999997765 89999
Q ss_pred CCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------HH
Q 024347 155 FGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY---------KK 225 (269)
Q Consensus 155 f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~---------~~ 225 (269)
||.+...... .......+++.|+|||++.+..+. .++||||||+++|+|++|..||......... ..
T Consensus 168 FG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 168 LGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred cccccccccc---cccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 9998754332 222345688999999999877764 8999999999999999999999764332211 00
Q ss_pred H-----hcCcc------c----CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 226 I-----SAAEF------T----CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 226 ~-----~~~~~------~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ..+.. + ....+++.+.+||+.||++||++|||+ .+++.|+|
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa--~elL~hp~ 300 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD--PQNPNVGC 300 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC--TTCCCCTT
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH--HHHhcCHH
Confidence 0 11111 1 112256789999999999999999999 67788877
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=288.55 Aligned_cols=230 Identities=30% Similarity=0.537 Sum_probs=188.0
Q ss_pred ccccccCCeEEe-eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHh-hhCCCCCceeeeEEEee
Q 024347 5 KIKRRVGKYEVG-RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 5 ~~~~~~~~~~~~-~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~ 82 (269)
..+...++|.+. +.||.|++|.||++.+..+++.||+|.+... ....+|+.++ +..+||||+++++++..
T Consensus 11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 345677899998 7899999999999999999999999998642 3455677777 66689999999999876
Q ss_pred ----CCeEEEEEeccCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC---CCCEEEe
Q 024347 83 ----KTKIFIVLEFVTGGELFDKIVNHG--RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVS 153 (269)
Q Consensus 83 ----~~~~~~v~~~~~~~~l~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~---~~~~~l~ 153 (269)
....++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++. ++.++|+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 677899999999999999998754 6999999999999999999999999999999999999998 7889999
Q ss_pred eCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----hcC
Q 024347 154 DFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI----SAA 229 (269)
Q Consensus 154 df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~ 229 (269)
|||++.... +.. .+.++||||||+++|+|++|..||............ ...
T Consensus 163 Dfg~a~~~~------------------------~~~-~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 217 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217 (299)
T ss_dssp CCTTCEECT------------------------TCG-GGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred ccccccccc------------------------ccc-CCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence 999875322 112 248899999999999999999999876544432222 122
Q ss_pred cccCC----CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 EFTCP----PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+ ..+++++.+||+.||+.||++|||+ .+++.|+|
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~--~e~l~hp~ 259 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI--TEFMNHPW 259 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCH--HHHHTSHH
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCH--HHHhcChh
Confidence 22222 4589999999999999999999999 78888876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=293.53 Aligned_cols=244 Identities=21% Similarity=0.346 Sum_probs=188.7
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHh--hhCCCCCceeeeEEEeeC----
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM--KLVKHPNVVRLYEVMGSK---- 83 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l--~~l~~~~i~~~~~~~~~~---- 83 (269)
.++|++.+.||+|+||.||+|.+. ++.||+|++..... .....|.+++ ..++||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 468999999999999999999985 88999999864431 2233344444 445899999999999876
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CcEeecCCCCceEecCCCCEEEeeC
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR--------GVYHRDLKPENLLLDAYGNLKVSDF 155 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--------~i~h~di~~~nIl~~~~~~~~l~df 155 (269)
...++||||+++++|.+++... .++...+..++.|++.||.|||+. |++|+||+|+||+++.++.++|+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 7899999999999999988654 699999999999999999999998 9999999999999999999999999
Q ss_pred CCccccccccCCC--cccccccCccccCcccccCCCCCCC-----chhHHHHHHHHHHHHcC----------CCCCCCC-
Q 024347 156 GLSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDRGYDGS-----TADLWSCGVILFVLLAG----------YLPFDDS- 217 (269)
Q Consensus 156 ~~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~-----~~Di~slG~~l~~l~~g----------~~p~~~~- 217 (269)
|++.......... ......+++.|+|||++.+...... ++||||||+++|+|++| ..||...
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9986543322211 1123468899999999987665422 38999999999999999 7777542
Q ss_pred ----CHHHHHHHHhcC--cccCCC-----CCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 218 ----NLMNLYKKISAA--EFTCPP-----WLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 218 ----~~~~~~~~~~~~--~~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
............ ....+. .+++.+.+|++.||+.||++|||++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 122222222222 222222 356779999999999999999998443
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=295.71 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=187.6
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-- 82 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-- 82 (269)
+.....++|++.+.||+|+||.||+|.+ +++.||+|++...... ......++..+..++|+||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheecccccc
Confidence 4456789999999999999999999987 5889999998754321 1122345555667899999999986532
Q ss_pred ---CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CcEeecCCCCceEecCCCCE
Q 024347 83 ---KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR---------GVYHRDLKPENLLLDAYGNL 150 (269)
Q Consensus 83 ---~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~---------~i~h~di~~~nIl~~~~~~~ 150 (269)
....++||||+++++|.+++... ..+...+..++.|++.||.|||+. ||+|+||+|+||+++.++.+
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred cCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 23578999999999999988665 458899999999999999999999 99999999999999999999
Q ss_pred EEeeCCCccccccccC------CCcccccccCccccCcccccCCC------CCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 024347 151 KVSDFGLSALSQQVRD------DGLLHTTCGTPNYVAPEVLNDRG------YDGSTADLWSCGVILFVLLAGYLPFDDSN 218 (269)
Q Consensus 151 ~l~df~~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~------~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 218 (269)
+|+|||++........ ........+++.|+|||++.+.. ..+.++||||||+++|+|++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999876543211 11222345899999999997632 12368999999999999999976653211
Q ss_pred ------------------HHHHHHHHh--cCcccCCCC------CCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 219 ------------------LMNLYKKIS--AAEFTCPPW------LSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 219 ------------------~~~~~~~~~--~~~~~~~~~------~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
......... ..+...+.. +++.+.+||..||+.||++|||++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~ 309 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHH
Confidence 111111111 112222322 34479999999999999999998554
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=304.49 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=192.6
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~ 87 (269)
.-.+|++.+.||.|++|+|+.. ...+++.||||.+..... ..+.+|+.+++.+ +||||+++++++.+....+
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred ccEEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 3456999999999999996643 335789999999865432 2345799999999 7999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC-----CCEEEeeCCCcccc
Q 024347 88 IVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-----GNLKVSDFGLSALS 161 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~-----~~~~l~df~~~~~~ 161 (269)
++|||+. ++|.+++.... ..+...+..++.|++.||.|||+.||+|+||+|+||+++.+ ..++|+|||++...
T Consensus 95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 9999996 59988887653 45555677899999999999999999999999999999532 35889999998765
Q ss_pred ccccCC-CcccccccCccccCcccccCC--CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCcccC---C
Q 024347 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAEFTC---P 234 (269)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~---~ 234 (269)
...... .......+++.|+|||++.+. ...+.++||||||+++|+|++ |..||................... .
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE 253 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTT
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcc
Confidence 432211 223345689999999999742 233579999999999999999 999997665554444333322222 1
Q ss_pred CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 ~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+..+.+||+.||+.||.+|||+ .+++.|+|
T Consensus 254 ~~~~~~~~~li~~~L~~dP~~Rps~--~evl~hp~ 286 (432)
T 3p23_A 254 KHEDVIARELIEKMIAMDPQKRPSA--KHVLKHPF 286 (432)
T ss_dssp CHHHHHHHHHHHHHSCSSGGGSCCH--HHHHTSTT
T ss_pred ccccHHHHHHHHHHHhCCHhhCCCH--HHHHhCcc
Confidence 2245668999999999999999999 88888887
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=290.56 Aligned_cols=243 Identities=21% Similarity=0.318 Sum_probs=195.3
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhh--CCCCCceeeeEEEeeCC----
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL--VKHPNVVRLYEVMGSKT---- 84 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~--l~~~~i~~~~~~~~~~~---- 84 (269)
++|++.+.||+|++|.||++.+ +++.||+|.+.... ...+.+|.++++. ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 6899999999999999999998 48899999986542 3456678888877 78999999999997765
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCcEeecCCCCceEecCCCCEEEeeCC
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH--------SRGVYHRDLKPENLLLDAYGNLKVSDFG 156 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh--------~~~i~h~di~~~nIl~~~~~~~~l~df~ 156 (269)
..+++|||+++++|.+++.. ..++..+++.++.|++.||.+|| +.|++|+||+|+||+++.++.++|+|||
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 79999999999999998876 46899999999999999999999 8999999999999999999999999999
Q ss_pred CccccccccCCC--cccccccCccccCcccccCCCCC-----CCchhHHHHHHHHHHHHcC----------CCCCCCC--
Q 024347 157 LSALSQQVRDDG--LLHTTCGTPNYVAPEVLNDRGYD-----GSTADLWSCGVILFVLLAG----------YLPFDDS-- 217 (269)
Q Consensus 157 ~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~-----~~~~Di~slG~~l~~l~~g----------~~p~~~~-- 217 (269)
++.......... ......+++.|+|||++.+.... +.++||||||+++|+|++| ..||...
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 987544322111 12334578999999999765322 2579999999999999999 7888653
Q ss_pred ---CHHHHHHHHhcCc--ccCCC-----CCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 218 ---NLMNLYKKISAAE--FTCPP-----WLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 218 ---~~~~~~~~~~~~~--~~~~~-----~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
........+.... ...+. .++..+.+|+..||+.||++|||++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i 327 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 327 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence 2334444443322 22222 234579999999999999999998443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=285.35 Aligned_cols=219 Identities=18% Similarity=0.219 Sum_probs=184.5
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
-++|++.+.||.|++|.||+|.+..+++.||+|++...........+.+.+|+..+..++||||+++++++...+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 37899999999999999999999999999999999876655566678899999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||++|++|.+++..+ ....++..++.|++.||.|||+.||+|+||||+||+++.++.++|++++.
T Consensus 110 ~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~------------ 175 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT------------ 175 (286)
T ss_dssp EECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc------------
Confidence 9999999999988543 46677899999999999999999999999999999999999999985542
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHhcCcc----cCCCCCCHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYK---KISAAEF----TCPPWLSFTAR 242 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~----~~~~~~~~~l~ 242 (269)
++| .+.++||||||+++|+|++|+.||...+...... ....+.. ...+.+++.+.
T Consensus 176 ----------~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (286)
T 3uqc_A 176 ----------MPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237 (286)
T ss_dssp ----------CTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred ----------cCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence 222 2589999999999999999999998754322110 1111111 12346899999
Q ss_pred HHHHHhcCCCCCCcCCCCc
Q 024347 243 KLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~ 261 (269)
+||..||+.||++| |+++
T Consensus 238 ~li~~~l~~dP~~R-s~~e 255 (286)
T 3uqc_A 238 AVAARSVQGDGGIR-SAST 255 (286)
T ss_dssp HHHHHHHCTTSSCC-CHHH
T ss_pred HHHHHHcccCCccC-CHHH
Confidence 99999999999999 8743
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=302.70 Aligned_cols=251 Identities=17% Similarity=0.191 Sum_probs=190.1
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCC-CCc---------ee
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNV---------VR 75 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i---------~~ 75 (269)
++.....|...+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.| ++. +.
T Consensus 73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 34555679999999999999999999999999999999874444444446788999999999987 221 11
Q ss_pred ee------------EEEee-----CCeEEEEEeccCCCchhHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 024347 76 LY------------EVMGS-----KTKIFIVLEFVTGGELFDKIVN-------HGRMKEDEARRYFQQLINAVDYCHSRG 131 (269)
Q Consensus 76 ~~------------~~~~~-----~~~~~~v~~~~~~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~lh~~~ 131 (269)
.. .++.. ....+++|+.+ +++|.+++.. .+.+++..+..++.|++.||.|||+.|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 11 11111 22357777766 5688877741 234677889999999999999999999
Q ss_pred cEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCccccc---------CCCCCCCchhHHHHHH
Q 024347 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN---------DRGYDGSTADLWSCGV 202 (269)
Q Consensus 132 i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---------~~~~~~~~~Di~slG~ 202 (269)
|+|+||||+||+++.++.++|+|||+++..... .....+ +.|+|||++. ....++.++||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999998754332 233456 8999999983 2222357999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 203 ILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 203 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++|+|++|+.||...........+ +.....+|+.+.+||..||+.||++||++ .+++.|+|
T Consensus 306 il~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dP~~Rpt~--~~~l~~~~ 366 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLP--LQAMETPE 366 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGSCCH--HHHTTSHH
T ss_pred HHHHHHHCCCCCCCcchhhhHHHH----HhhcccCCHHHHHHHHHHccCChhhCcCH--HHHHhCHH
Confidence 999999999999876544333322 22334688999999999999999999998 67777765
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=316.59 Aligned_cols=236 Identities=26% Similarity=0.373 Sum_probs=191.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcC-CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe----
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSE-TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK---- 85 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---- 85 (269)
++|++.+.||.|+||.||++.+.. +++.|++|.+.... .......+.+|+.+++.++||||+++++++...+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 799999999999999999999976 78999999886432 33446778899999999999999999999977655
Q ss_pred -EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 -IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 -~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++||||++|++|.+.+.. .+++.++..++.|++.+|.|||+.||+|+||||+||+++.+ .++|+|||++......
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 7999999999999886654 79999999999999999999999999999999999999985 8999999998754321
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHH
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 244 (269)
....+++.|+|||++.+.. +.++||||||+++|+|++|..||......... ........++.+.+|
T Consensus 235 ------~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~~~~l~~l 300 (681)
T 2pzi_A 235 ------GYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVLKTYDSYGRL 300 (681)
T ss_dssp ------SCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHHHHCHHHHHH
T ss_pred ------CccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccccc------ccccccccCHHHHHH
Confidence 3345899999999987654 58999999999999999999888642110000 000001145789999
Q ss_pred HHHhcCCCCCCcCCCCccccccc
Q 024347 245 IARILDPNPMTVSIYPFADILYM 267 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~~~~l~~ 267 (269)
|..||+.||++||+. ++.+.+
T Consensus 301 i~~~l~~dP~~R~~~--~~~l~~ 321 (681)
T 2pzi_A 301 LRRAIDPDPRQRFTT--AEEMSA 321 (681)
T ss_dssp HHHHTCSSGGGSCSS--HHHHHH
T ss_pred HhhhccCChhhCCCH--HHHHHH
Confidence 999999999999987 555543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=287.80 Aligned_cols=241 Identities=22% Similarity=0.263 Sum_probs=186.4
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh-----hHHHHHHHHHHHHHhhhCC---------CCCcee
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-----KHKMAEQIKREVATMKLVK---------HPNVVR 75 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-----~~~~~~~~~~e~~~l~~l~---------~~~i~~ 75 (269)
.++|++.+.||+|+||.||+|++ +|+.||+|.+...... .....+.+.+|+.+++.++ |||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999998 6799999999764321 1222356777888877775 777777
Q ss_pred eeEEE-----------------ee-------------CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 024347 76 LYEVM-----------------GS-------------KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125 (269)
Q Consensus 76 ~~~~~-----------------~~-------------~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~ 125 (269)
+.+.+ .+ .+..++||||+++|++.+.+.. +.+++..+..++.|++.||.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 66654 22 6789999999999977776644 57899999999999999999
Q ss_pred HHH-hCCcEeecCCCCceEecCCC--------------------CEEEeeCCCccccccccCCCcccccccCccccCccc
Q 024347 126 YCH-SRGVYHRDLKPENLLLDAYG--------------------NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184 (269)
Q Consensus 126 ~lh-~~~i~h~di~~~nIl~~~~~--------------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~ 184 (269)
||| +.||+|+||||+|||++.++ .++|+|||+++.... ....+++.|+|||+
T Consensus 176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~ 248 (336)
T 2vuw_A 176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDL 248 (336)
T ss_dssp HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGG
T ss_pred HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhh
Confidence 999 99999999999999999887 899999999976542 13368999999999
Q ss_pred ccCCCCCCCchhHHHHHHH-HHHHHcCCCCCCCCCH-HHHHHHHh-cCcccC------CCCCCHHHHHHHHHhcCCCCCC
Q 024347 185 LNDRGYDGSTADLWSCGVI-LFVLLAGYLPFDDSNL-MNLYKKIS-AAEFTC------PPWLSFTARKLIARILDPNPMT 255 (269)
Q Consensus 185 ~~~~~~~~~~~Di~slG~~-l~~l~~g~~p~~~~~~-~~~~~~~~-~~~~~~------~~~~~~~l~~li~~~l~~dP~~ 255 (269)
+.+.. +.++||||++++ .+++++|..||..... ......+. ...... ++.+++++.+||++||+.|
T Consensus 249 ~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d--- 323 (336)
T 2vuw_A 249 FTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS--- 323 (336)
T ss_dssp GCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred hcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence 98766 489999998776 6778889999854211 11222222 111111 1236888999999999977
Q ss_pred cCCCCccccc-cccC
Q 024347 256 VSIYPFADIL-YMRF 269 (269)
Q Consensus 256 Rps~~~~~~l-~~~~ 269 (269)
|+ .++| .|+|
T Consensus 324 --sa--~e~l~~Hp~ 334 (336)
T 2vuw_A 324 --SA--TDLLCQHSL 334 (336)
T ss_dssp --SH--HHHHHHCGG
T ss_pred --CH--HHHHhcCCC
Confidence 76 8888 8987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-34 Score=249.87 Aligned_cols=186 Identities=16% Similarity=0.144 Sum_probs=133.5
Q ss_pred eeeccCCcEEEEEEEcCCCCeEEEEEeehhh-------hhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCCeEEEE
Q 024347 18 TIGEGTFAKVKFARNSETGEPVALKILDKEK-------VLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 18 ~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~-------~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~v 89 (269)
..+.|+.+....++..-.|+.+++|.+.... ...+...+.+.+|+++|+++ +|+||+++++++.+.+..|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4566777777776766679999999996432 12334457799999999999 699999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||++|++|.+.+...++++.. +++.||++||+|+|++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Ccc
Confidence 9999999999999998888876 47889999999999999999999999999999999999999998754332 222
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcC
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG 210 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g 210 (269)
.....+++.|+|||++.+.. ..++|+||+|++.+.+.++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTT
T ss_pred ccCceechhhccHHHhCCCC--CCcccccccccchhhhccc
Confidence 33456899999999997653 3679999999988766544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=216.56 Aligned_cols=189 Identities=22% Similarity=0.226 Sum_probs=142.5
Q ss_pred EEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhh-----hhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-----LKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
...+.||+|+||.||++.. .++.+++|....... ......+.+.+|++++++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 4467999999999999954 578899998644222 223335678999999999999999966666667777799
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
||||++|++|.+++.. +..++.|++++|.|||++||+|+||||+||+++. .++|+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999988765 5589999999999999999999999999999998 99999999998654322111
Q ss_pred -----cccccccCccccCcccccC--CCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 024347 169 -----LLHTTCGTPNYVAPEVLND--RGYDGSTADLWSCGVILFVLLAGYLPFD 215 (269)
Q Consensus 169 -----~~~~~~~~~~~~aPE~~~~--~~~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (269)
......+++.|+|||++.. ..+ +...|+|+..+-..+-+.++.+|.
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhccccC
Confidence 1123468999999999976 333 367899998888888777776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-26 Score=183.73 Aligned_cols=134 Identities=17% Similarity=0.253 Sum_probs=108.0
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH---------------HHHHHHHHHHHHhhhCCCCCceeee
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---------------KMAEQIKREVATMKLVKHPNVVRLY 77 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~---------------~~~~~~~~e~~~l~~l~~~~i~~~~ 77 (269)
|.+.+.||.|++|.||+|.+ .+|+.+|+|.+........ .....+.+|+.+++.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 33449999999999999999 7899999999864322111 23567899999999999 4 6666
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 78 ~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
+++.. +..++||||++|++|.+ +.. .....++.|++.||.+||+.|++|+||+|+||+++ ++.++|+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 65543 45699999999999987 421 23457999999999999999999999999999999 99999999998
Q ss_pred cc
Q 024347 158 SA 159 (269)
Q Consensus 158 ~~ 159 (269)
+.
T Consensus 239 a~ 240 (282)
T 1zar_A 239 SV 240 (282)
T ss_dssp CE
T ss_pred Ce
Confidence 86
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.8e-22 Score=157.70 Aligned_cols=140 Identities=23% Similarity=0.302 Sum_probs=107.6
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCe--EEEEEeehhhhh---------------------hHHHHHHHHHHHHHhhhC
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVL---------------------KHKMAEQIKREVATMKLV 68 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~--~~~K~~~~~~~~---------------------~~~~~~~~~~e~~~l~~l 68 (269)
-|++.+.||.|++|.||+|.+..+|+. ||+|++...... .......+.+|+.+++.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778888 999987543211 112234688999999999
Q ss_pred CCCCc--eeeeEEEeeCCeEEEEEeccCC-C----chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcEeecCCCC
Q 024347 69 KHPNV--VRLYEVMGSKTKIFIVLEFVTG-G----ELFDKIVNHGRMKEDEARRYFQQLINAVDYCH-SRGVYHRDLKPE 140 (269)
Q Consensus 69 ~~~~i--~~~~~~~~~~~~~~~v~~~~~~-~----~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh-~~~i~h~di~~~ 140 (269)
.|+++ +.+++. ...++||||+.+ | +|.+.... .++..+..++.|++.+|.+|| +.|++|+||+|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88764 334432 346899999942 3 55544322 234567789999999999999 999999999999
Q ss_pred ceEecCCCCEEEeeCCCccc
Q 024347 141 NLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 141 nIl~~~~~~~~l~df~~~~~ 160 (269)
||+++. .++|+|||++..
T Consensus 201 NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SEEESS--SEEECCCTTCEE
T ss_pred HEEEcC--cEEEEECccccc
Confidence 999998 999999998863
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.78 E-value=6.1e-19 Score=146.77 Aligned_cols=139 Identities=19% Similarity=0.203 Sum_probs=101.3
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh-------------------hHHHHHHHHHHHHHhhhCCCCC
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL-------------------KHKMAEQIKREVATMKLVKHPN 72 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~-------------------~~~~~~~~~~e~~~l~~l~~~~ 72 (269)
=|++.+.||.|++|.||.|.+. +|+.||||++...... .....-....|...+.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3899999999999999999985 6999999987532110 0111223456778888886555
Q ss_pred ceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC---
Q 024347 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN--- 149 (269)
Q Consensus 73 i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~--- 149 (269)
+....-+... ..++||||++|.++.+... .+....++.|++.+|.++|++|+|||||||.|||+++++.
T Consensus 175 v~vp~p~~~~--~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPVPEPIAQS--RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSCCCEEEEE--TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCCeeeecc--CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 4322222122 2369999999988865432 1234567899999999999999999999999999987763
Q ss_pred -------EEEeeCCCcc
Q 024347 150 -------LKVSDFGLSA 159 (269)
Q Consensus 150 -------~~l~df~~~~ 159 (269)
++++||+.+-
T Consensus 247 ~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTSEEEEEEECCCTTCE
T ss_pred ccccccceEEEEeCCcc
Confidence 8999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=4.9e-14 Score=112.61 Aligned_cols=144 Identities=17% Similarity=0.150 Sum_probs=112.6
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCC
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKT 84 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~ 84 (269)
+....+.|++...++.|+.+.||++... ++.+++|......... ...+.+|+.+++.+. +..+.++++++.+.+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~ 83 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCC
Confidence 3456678999999999999999999753 6789999986432111 245778899998885 567888999998888
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS----------------------------------- 129 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~----------------------------------- 129 (269)
..+++|+|++|.++.+.+. +......++.++.++|..||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred ceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence 9999999999998876421 122234678899999999998
Q ss_pred ------------------------CCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 130 ------------------------RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 130 ------------------------~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
..++|||++|.||+++++..+.++||+.+.
T Consensus 159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348999999999999875556799999654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.41 E-value=1.8e-12 Score=103.21 Aligned_cols=139 Identities=14% Similarity=0.119 Sum_probs=101.5
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC--ceeeeEEEeeC
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEVMGSK 83 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~~~~~ 83 (269)
+...+..+.+....+.|..+.||++.. .+|+.+++|...... ...+..|+.+++.+.+.+ +.+++++....
T Consensus 15 l~~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 15 WVERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp GTTTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred HHHhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 445566778765555667799999965 457789999975431 245677888888886544 55688888877
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG-------------------------------- 131 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~-------------------------------- 131 (269)
+..+++|+|++|.++. .. ..+. ..++.+++..|..||+..
T Consensus 88 ~~~~~v~e~i~G~~l~--~~---~~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SS---HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp SCEEEEEECCSSEETT--TS---CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCCEEEEEecCCcccC--cC---cCCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 8899999999998873 21 1222 245667777777777643
Q ss_pred --------------------------cEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 132 --------------------------VYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 132 --------------------------i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
++|||++|.||++++++.+.++||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999876656799999765
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.31 E-value=1.3e-11 Score=102.99 Aligned_cols=143 Identities=22% Similarity=0.326 Sum_probs=106.1
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEee--hhhhhhHHHHHHHHHHHHHhhhCCC--CCceeeeEEEeeC---Ce
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILD--KEKVLKHKMAEQIKREVATMKLVKH--PNVVRLYEVMGSK---TK 85 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~--~~~~~~~~~~~~~~~e~~~l~~l~~--~~i~~~~~~~~~~---~~ 85 (269)
...++.|+.|.++.||++... +..+++|... .... ......+.+|+.+++.+.. ..+++++.++.+. +.
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 334678899999999998864 4679999875 3221 1224577889999999874 4577888888665 45
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS------------------------------------ 129 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~------------------------------------ 129 (269)
.++||||++|..+.+.. -..++..+...++.++...|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 78999999998774321 1246788888999999999999997
Q ss_pred ----------------------CCcEeecCCCCceEecCCCC--EEEeeCCCcccc
Q 024347 130 ----------------------RGVYHRDLKPENLLLDAYGN--LKVSDFGLSALS 161 (269)
Q Consensus 130 ----------------------~~i~h~di~~~nIl~~~~~~--~~l~df~~~~~~ 161 (269)
..++|||+++.||+++.++. +.++||+.+...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999997764 689999987653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=1.3e-11 Score=100.58 Aligned_cols=184 Identities=18% Similarity=0.229 Sum_probs=119.2
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCC--ceeeeEEEeeCC---eEEEE
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPN--VVRLYEVMGSKT---KIFIV 89 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~--i~~~~~~~~~~~---~~~~v 89 (269)
++.++.|....||++. ..+++|..... .....+.+|+++++.+. +.. +..++....... ..++|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4568999999999764 45999986432 33567888999998874 333 345555443332 34788
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS---------------------------------------- 129 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~---------------------------------------- 129 (269)
|++++|.++..... ..++..+...++.+++..+..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988865333 246777778888888888888885
Q ss_pred ------------------CCcEeecCCCCceEecC--CCCEEEeeCCCccccccccCCCccccc---ccC-------ccc
Q 024347 130 ------------------RGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTT---CGT-------PNY 179 (269)
Q Consensus 130 ------------------~~i~h~di~~~nIl~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~---~~~-------~~~ 179 (269)
..++|||++|.||++++ +..+.++||+.+............... .+. ..|
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 13699999999999998 455789999987653321110000000 000 001
Q ss_pred --cC-cccccCCCCCCCchhHHHHHHHHHHHHcCCCCC
Q 024347 180 --VA-PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF 214 (269)
Q Consensus 180 --~a-PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 214 (269)
.. |+..... ....+.|+++.++|.+.+|..+|
T Consensus 253 ~~~~~~~~~~r~---~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKY---RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHH---HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHH---HHHHHHHHHHHHHHHHHcCCHHH
Confidence 11 1111111 01268999999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.98 E-value=2e-08 Score=80.15 Aligned_cols=139 Identities=14% Similarity=0.156 Sum_probs=97.0
Q ss_pred cCCeEEeeeeeccCCc-EEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEeeCCeEE
Q 024347 10 VGKYEVGRTIGEGTFA-KVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~-~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 87 (269)
...|+. +.+..|..+ .||+......+..+++|.-.... ...+..|...|+.+. +-.+.+++.++.+.+..+
T Consensus 24 l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~ 96 (272)
T 4gkh_A 24 LYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAW 96 (272)
T ss_dssp HTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEE
Confidence 344554 344445554 68998877778889999865432 456778888888875 334678888888899999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR------------------------------------- 130 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~------------------------------------- 130 (269)
+||++++|.++.+..... ......+..++...|..||+.
T Consensus 97 lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (272)
T 4gkh_A 97 LLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERN 172 (272)
T ss_dssp EEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGT
T ss_pred EEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccccc
Confidence 999999998776544321 122233445555555555532
Q ss_pred ---------------------CcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 131 ---------------------GVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 131 ---------------------~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
.++|||+++.||++++++.+-|+||+.+.
T Consensus 173 ~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 173 GWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred chHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 15999999999999987767799999765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=7.9e-08 Score=78.25 Aligned_cols=135 Identities=19% Similarity=0.250 Sum_probs=91.9
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCC---CceeeeEEEe-eCCeEEEEEe
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP---NVVRLYEVMG-SKTKIFIVLE 91 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~-~~~~~~~v~~ 91 (269)
++.++.|....||+. +..+++|.... ......+..|+++++.+.+. .+.+++.+.. ..+..+++|+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456788888899987 46699998532 23356788999999998752 3556666663 4456789999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR----------------------------------------- 130 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~----------------------------------------- 130 (269)
+++|.++..... ..++..+...++.++...|..||+.
T Consensus 94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 999987765321 1234444444444444444444431
Q ss_pred -------------------CcEeecCCCCceEecC---CCC-EEEeeCCCccccc
Q 024347 131 -------------------GVYHRDLKPENLLLDA---YGN-LKVSDFGLSALSQ 162 (269)
Q Consensus 131 -------------------~i~h~di~~~nIl~~~---~~~-~~l~df~~~~~~~ 162 (269)
.++|||+++.||+++. ++. +.++||+.+....
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 3599999999999997 455 4899999876543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.53 E-value=3.4e-07 Score=77.26 Aligned_cols=80 Identities=15% Similarity=0.150 Sum_probs=48.6
Q ss_pred EeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhh-hhH---HHHHHHHHHHHHhhhCCC--C-CceeeeEEEeeCCeEE
Q 024347 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKV-LKH---KMAEQIKREVATMKLVKH--P-NVVRLYEVMGSKTKIF 87 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~-~~~---~~~~~~~~e~~~l~~l~~--~-~i~~~~~~~~~~~~~~ 87 (269)
..+.||.|..+.||++.....++.+++|....... ..+ ...+.+..|.++++.+.. + .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35789999999999997655678899998643211 000 012345668888877642 3 34455544 344567
Q ss_pred EEEeccCCC
Q 024347 88 IVLEFVTGG 96 (269)
Q Consensus 88 ~v~~~~~~~ 96 (269)
+|||+++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999774
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.35 E-value=1.1e-05 Score=66.41 Aligned_cols=30 Identities=23% Similarity=0.299 Sum_probs=27.2
Q ss_pred CCcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 130 ~~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
..+||||+++.||+++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999765
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=1.8e-06 Score=71.68 Aligned_cols=84 Identities=12% Similarity=0.198 Sum_probs=54.7
Q ss_pred eEEeeee-eccCCcEEEEEEEc--C----CCCeEEEEEeehhh---hhhHHHHHHHHHHHHHhhhCCC---CCceeeeEE
Q 024347 13 YEVGRTI-GEGTFAKVKFARNS--E----TGEPVALKILDKEK---VLKHKMAEQIKREVATMKLVKH---PNVVRLYEV 79 (269)
Q Consensus 13 ~~~~~~l-g~g~~~~v~~~~~~--~----~~~~~~~K~~~~~~---~~~~~~~~~~~~e~~~l~~l~~---~~i~~~~~~ 79 (269)
....+.| +.|....+|++... . +++.+++|...... ... ...+..|+.+++.+.. -.+.+++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~ 98 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI 98 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence 3445778 88888899988753 1 15679999865432 101 1345667777777742 346677777
Q ss_pred EeeC---CeEEEEEeccCCCchh
Q 024347 80 MGSK---TKIFIVLEFVTGGELF 99 (269)
Q Consensus 80 ~~~~---~~~~~v~~~~~~~~l~ 99 (269)
..+. +..+++|++++|..+.
T Consensus 99 ~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 99 ETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp ECSSTTTSSCEEEEECCCCBCCC
T ss_pred ccCCCccCCceEEEEecCCCChh
Confidence 6554 3467899999886543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.17 E-value=2.3e-05 Score=59.44 Aligned_cols=122 Identities=18% Similarity=0.101 Sum_probs=83.5
Q ss_pred CchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccccc
Q 024347 96 GELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT 173 (269)
Q Consensus 96 ~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 173 (269)
.+|.+.+.. +.+++++++|.++.|.+.+|..+-. +.-...-+.|..|++..+|+|-+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 367777766 4689999999999999999988622 2222445678999999999998874 2110
Q ss_pred ccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhcCC
Q 024347 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251 (269)
Q Consensus 174 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 251 (269)
.....+.|||.... ..+.+.=|||||+++|..+-...| ..-+..+|+.|.+||..|...
T Consensus 98 ~~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~-----------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 98 AGEPPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLK-----------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ---------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCC-----------------TTEEECCCHHHHHHHHHHTTC
T ss_pred ccccCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCC-----------------cccchhhCHHHHHHHHHHHhc
Confidence 01234668887642 224788999999999998876554 222445899999999999876
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.15 E-value=3.9e-05 Score=62.32 Aligned_cols=77 Identities=17% Similarity=0.258 Sum_probs=59.4
Q ss_pred EEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC---CCCceeeeEEEeeCCeEEEEE
Q 024347 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK---HPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~---~~~i~~~~~~~~~~~~~~~v~ 90 (269)
.-.+.|+.|....+|+... .+..+++|...... ...+..|++.|+.+. ...+++++.+....+..+++|
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3457789999999999885 46789999875432 456777888887774 356788888887788899999
Q ss_pred eccCCCch
Q 024347 91 EFVTGGEL 98 (269)
Q Consensus 91 ~~~~~~~l 98 (269)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.03 E-value=5.5e-06 Score=67.10 Aligned_cols=71 Identities=14% Similarity=0.070 Sum_probs=44.3
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeCCeEEEEEecc-
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFV- 93 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~~~~- 93 (269)
++.|+.|....+|++ +.+++|...... .. ..+..+|+.+++.+...++ .+++... ....+++++|+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~---~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGT---EE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCc---cc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 688998999999998 459999975421 11 1223457777776653333 4555443 33346789999
Q ss_pred CCCch
Q 024347 94 TGGEL 98 (269)
Q Consensus 94 ~~~~l 98 (269)
+|.++
T Consensus 91 ~g~~l 95 (301)
T 3dxq_A 91 GAQTM 95 (301)
T ss_dssp TCEEC
T ss_pred CCccC
Confidence 66544
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.98 E-value=3.4e-05 Score=65.46 Aligned_cols=33 Identities=18% Similarity=0.269 Sum_probs=28.3
Q ss_pred hCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 129 ~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
...++|||+++.||+++.++ +.++||+.+....
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~ 263 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP 263 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence 45799999999999999876 9999999876543
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.79 E-value=5.9e-05 Score=64.19 Aligned_cols=74 Identities=16% Similarity=0.194 Sum_probs=48.4
Q ss_pred EeeeeeccCCcEEEEEEEcC-------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeCCeE
Q 024347 15 VGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKI 86 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~ 86 (269)
-++.|+.|....+|++.... .++.+++|+.... .. ...+.+|+.+++.+...++ .++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 34678888889999998642 2578999997431 11 1233468888887754444 556665532
Q ss_pred EEEEeccCCCc
Q 024347 87 FIVLEFVTGGE 97 (269)
Q Consensus 87 ~~v~~~~~~~~ 97 (269)
.++++|++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 27899998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=9.3e-05 Score=61.78 Aligned_cols=140 Identities=16% Similarity=0.205 Sum_probs=82.6
Q ss_pred CeEEeeeeeccCCcEEEEEEEcC-------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeC
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSK 83 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~ 83 (269)
..++ +.|..|-...+|++.... +++.+++|...... .....+.+|.++++.+...++ .++++.+.+
T Consensus 52 ~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 52 ELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp GCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred ceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 3443 567778888899988642 35789999863211 123556688888888863333 556666543
Q ss_pred CeEEEEEeccCCCchhH-----------------HHHhc-----CCCC--HHHHHHHHHHHHH-----------------
Q 024347 84 TKIFIVLEFVTGGELFD-----------------KIVNH-----GRMK--EDEARRYFQQLIN----------------- 122 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~-----------------~~~~~-----~~l~--~~~~~~i~~~i~~----------------- 122 (269)
.+|++|++|.++.. .++.. +... ..++..+..++..
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 28999998854421 11111 1111 2455555544322
Q ss_pred --HHHHHH----hC----CcEeecCCCCceEecCC----CCEEEeeCCCccc
Q 024347 123 --AVDYCH----SR----GVYHRDLKPENLLLDAY----GNLKVSDFGLSAL 160 (269)
Q Consensus 123 --~l~~lh----~~----~i~h~di~~~nIl~~~~----~~~~l~df~~~~~ 160 (269)
.+..|. .. .++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 223332 22 48999999999999876 6899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.74 E-value=8.1e-05 Score=60.66 Aligned_cols=140 Identities=15% Similarity=0.135 Sum_probs=76.6
Q ss_pred EEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC--ceeeeEE------EeeCCe
Q 024347 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEV------MGSKTK 85 (269)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~------~~~~~~ 85 (269)
.-.+.|+.|....+|++... +| .+++|...... ....+..|+.+++.+...+ +.+++.. ....+.
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~ 97 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGR 97 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCE
Confidence 34567777888899998763 33 68999986521 1233445666666554222 2233211 123456
Q ss_pred EEEEEeccCCCchh--------------HHHHhc-CC--------CCHHHHHHH---------------HHHHHHHHHHH
Q 024347 86 IFIVLEFVTGGELF--------------DKIVNH-GR--------MKEDEARRY---------------FQQLINAVDYC 127 (269)
Q Consensus 86 ~~~v~~~~~~~~l~--------------~~~~~~-~~--------l~~~~~~~i---------------~~~i~~~l~~l 127 (269)
.+.+++|++|..+. ..++.. .. ......... ...+...+..+
T Consensus 98 ~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l 177 (322)
T 2ppq_A 98 PAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYL 177 (322)
T ss_dssp EEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHH
T ss_pred EEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHH
Confidence 78999999885431 111211 00 111111000 01133445555
Q ss_pred Hh-------CCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 128 HS-------RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 128 h~-------~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
.+ .+++|||+++.||++++++.+.++||+.+..
T Consensus 178 ~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 178 AAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 42 3699999999999999766568999997654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.0001 Score=60.35 Aligned_cols=33 Identities=30% Similarity=0.353 Sum_probs=27.7
Q ss_pred CCcEeecCCCCceEecCC----CCEEEeeCCCccccc
Q 024347 130 RGVYHRDLKPENLLLDAY----GNLKVSDFGLSALSQ 162 (269)
Q Consensus 130 ~~i~h~di~~~nIl~~~~----~~~~l~df~~~~~~~ 162 (269)
..++|||+++.||+++.+ +.+.++||+.+....
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 369999999999999875 679999999876543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.0012 Score=52.89 Aligned_cols=78 Identities=12% Similarity=0.083 Sum_probs=53.1
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCC---CceeeeEEEeeCCeEEE
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP---NVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~---~i~~~~~~~~~~~~~~~ 88 (269)
+..-++.+|.|..+.||++.. .+|+.+++|......... ...+..|+..|+.+... .+++++.+. . -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD--D--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc--C--ceE
Confidence 466778999999999999986 468999999864332111 23466788888877422 344555542 2 367
Q ss_pred EEeccCCCc
Q 024347 89 VLEFVTGGE 97 (269)
Q Consensus 89 v~~~~~~~~ 97 (269)
+|||.+++.
T Consensus 88 v~e~l~~~~ 96 (288)
T 3f7w_A 88 AMEWVDERP 96 (288)
T ss_dssp EEECCCCCC
T ss_pred EEEeecccC
Confidence 889987653
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00026 Score=58.86 Aligned_cols=74 Identities=15% Similarity=0.064 Sum_probs=43.1
Q ss_pred eeeeeccCCcEEEEEEEcC--------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC-ceeeeEEEeeCCeE
Q 024347 16 GRTIGEGTFAKVKFARNSE--------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN-VVRLYEVMGSKTKI 86 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~--------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~ 86 (269)
.+.++.|....+|++.... .+..+++|+....... ..+...|..+++.+...+ ..++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE----LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG----TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc----eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 4677878888999998643 1367999987542211 112356777777775434 34565544 22
Q ss_pred EEEEeccCCCc
Q 024347 87 FIVLEFVTGGE 97 (269)
Q Consensus 87 ~~v~~~~~~~~ 97 (269)
+++++|++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 57899998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00047 Score=56.21 Aligned_cols=137 Identities=17% Similarity=0.128 Sum_probs=76.1
Q ss_pred eeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCC--ceeeeEE-----EeeCCeEEEE
Q 024347 17 RTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN--VVRLYEV-----MGSKTKIFIV 89 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~--i~~~~~~-----~~~~~~~~~v 89 (269)
..++ |....||++.. .+|+.+++|....... . ...+..|..+++.+...+ +++++.. ....+..+.+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~-~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC-C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 77888998765 3466799999864322 1 234455666666664222 3333332 1234566889
Q ss_pred EeccCCCchh--------------HHHHh---cC------CCCHHHH----------------------HHHHHHHHHHH
Q 024347 90 LEFVTGGELF--------------DKIVN---HG------RMKEDEA----------------------RRYFQQLINAV 124 (269)
Q Consensus 90 ~~~~~~~~l~--------------~~~~~---~~------~l~~~~~----------------------~~i~~~i~~~l 124 (269)
+++++|..+. ..++. .. ..+.... ...+..++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875431 00111 00 1111111 11112222222
Q ss_pred HHH----HhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 125 DYC----HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 125 ~~l----h~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
..+ ....++|||+++.||+++ + .+.++||+.+...
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 222 123589999999999999 4 8999999877643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0038 Score=51.20 Aligned_cols=32 Identities=19% Similarity=0.337 Sum_probs=27.9
Q ss_pred CcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 131 ~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
.++|||+++.||+++.++.+.++||+.+....
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence 59999999999999988889999998776533
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0025 Score=54.52 Aligned_cols=76 Identities=13% Similarity=0.158 Sum_probs=47.9
Q ss_pred EeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeCCeEEEEEecc
Q 024347 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIVLEFV 93 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v~~~~ 93 (269)
-++.|+.|-...+|++.....+..+++|+..... .. .-+...|+.+++.+...++ .++++.+. + ..+++|+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 3467888888999999875435789999874321 00 1112468888888875554 46666663 2 2499999
Q ss_pred CCCch
Q 024347 94 TGGEL 98 (269)
Q Consensus 94 ~~~~l 98 (269)
+|.++
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.0044 Score=52.42 Aligned_cols=75 Identities=15% Similarity=0.137 Sum_probs=47.1
Q ss_pred EeeeeeccCCcEEEEEEEcCC-------CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeCCeE
Q 024347 15 VGRTIGEGTFAKVKFARNSET-------GEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKI 86 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~-------~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~ 86 (269)
-++.+..|-...+|++..... ++.+++|...... +. .-+..+|..+++.+...++ .++++.+ .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence 346777788889999987521 5789999964321 11 1233567777777753333 4555533 22
Q ss_pred EEEEeccCCCc
Q 024347 87 FIVLEFVTGGE 97 (269)
Q Consensus 87 ~~v~~~~~~~~ 97 (269)
+.|++|++|.+
T Consensus 146 ~~I~efI~G~~ 156 (424)
T 3mes_A 146 GRIEEFIDGEP 156 (424)
T ss_dssp EEEEECCCSEE
T ss_pred CEEEEEeCCcc
Confidence 67899999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.039 Score=46.32 Aligned_cols=30 Identities=30% Similarity=0.443 Sum_probs=25.4
Q ss_pred cEeecCCCCceEe------cCCCCEEEeeCCCcccc
Q 024347 132 VYHRDLKPENLLL------DAYGNLKVSDFGLSALS 161 (269)
Q Consensus 132 i~h~di~~~nIl~------~~~~~~~l~df~~~~~~ 161 (269)
+||+|+.+.||++ +.++.+.++||.++..-
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 6899999999999 34567999999987653
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.54 E-value=0.87 Score=34.48 Aligned_cols=114 Identities=18% Similarity=0.185 Sum_probs=76.7
Q ss_pred CCCCceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC
Q 024347 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (269)
Q Consensus 69 ~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~ 148 (269)
.||+. -..+-.+.+.+.+.+...+++.-...+ +.++....++++.+++.... -|...-+|--++|+|++++.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~-~~~~~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVK-HHSARRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHS-SCCSSSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHH-HhhhCceeEEEeCceEEEeCCC
Confidence 46777 444556777777777766444333344 34788889998888887543 1234457778999999999999
Q ss_pred CEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHH-HHHHHHHHHHcCCCCC
Q 024347 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW-SCGVILFVLLAGYLPF 214 (269)
Q Consensus 149 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~-slG~~l~~l~~g~~p~ 214 (269)
.+++...|+.. -++|..+ ...|.+ ..=|++..++.+...|
T Consensus 122 ~p~i~hRGi~~-------------------~lpP~e~-------~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 122 EPFFLHVGVKE-------------------SLPPDEW-------DDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CEEESCCEETT-------------------TBSSCSC-------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred cEEEEEcCCcc-------------------cCCCCCC-------CHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999888532 1333221 334555 4678888888887766
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.06 E-value=0.7 Score=34.90 Aligned_cols=115 Identities=21% Similarity=0.297 Sum_probs=77.2
Q ss_pred CCCCceeeeEEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC
Q 024347 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (269)
Q Consensus 69 ~~~~i~~~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~ 148 (269)
.+|+.++. .+-...+.+.+.++.-+.+.-...+ +.++....++++.+++....++ ..-+|--++|+|++++.++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence 47877766 5666667776766655433222223 3468888999999988866333 3346778999999999999
Q ss_pred CEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHH-HHHHHHHHHHcCCCCCC
Q 024347 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLW-SCGVILFVLLAGYLPFD 215 (269)
Q Consensus 149 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~-slG~~l~~l~~g~~p~~ 215 (269)
.+++...|+... ++|.. ....|.+ ..=|++..++++...|.
T Consensus 117 ~p~i~~RGik~~-------------------l~P~~-------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 117 LPIAKTRGLQNV-------------------VDPLP-------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CEEESCCEETTT-------------------BSCCC-------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred CEEEEEccCccC-------------------CCCCC-------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999998875321 22321 1334555 47788888999988773
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=84.65 E-value=0.079 Score=45.36 Aligned_cols=63 Identities=11% Similarity=0.141 Sum_probs=17.2
Q ss_pred EeeeeeccCCcEEEEEEEcCCCCeEEE------EEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEe
Q 024347 15 VGRTIGEGTFAKVKFARNSETGEPVAL------KILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMG 81 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~~~~------K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 81 (269)
+.+.|| ||.||.+.......+||+ |....... ..+....+.++..+.+.++|+|+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~-~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV-SEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccc-cccccccccccccccccccccccCCCcceEE
Confidence 345565 999999998765668888 66543222 2333456788899999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 269 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-86 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-83 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-81 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-76 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-75 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-75 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-75 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-74 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-74 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-73 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-73 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-72 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-72 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-72 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-71 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-71 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-70 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-70 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-69 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-69 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-67 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-67 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-67 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-61 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-61 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-60 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-60 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-59 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-58 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-58 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-58 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-57 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-57 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-56 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-56 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-56 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-55 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-55 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-55 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-52 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-52 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-51 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-48 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-48 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-39 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-24 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (651), Expect = 8e-86
Identities = 91/242 (37%), Positives = 142/242 (58%), Gaps = 5/242 (2%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E+GR +G+G F V AR ++ +ALK+L K ++ K + Q++REV ++HP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++RLY T+++++LE+ G ++ ++ + E Y +L NA+ YCHS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRD+KPENLLL + G LK++DFG S + T CGT +Y+ PE++ R +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
DLWS GV+ + L G PF+ + YK+IS EFT P +++ AR LI+R+L
Sbjct: 183 EK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 252 NP 253
NP
Sbjct: 242 NP 243
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (639), Expect = 1e-83
Identities = 80/251 (31%), Positives = 135/251 (53%), Gaps = 2/251 (0%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
QP+ K+R ++ G+ +GEG+F+ V AR T A+KIL+K ++K + RE
Sbjct: 1 QPR-KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRER 59
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLIN 122
M + HP V+LY K++ L + GEL I G E R Y ++++
Sbjct: 60 DVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119
Query: 123 AVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
A++Y H +G+ HRDLKPEN+LL+ +++++DFG + + ++ GT YV+P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTAR 242
E+L ++ ++DLW+ G I++ L+AG PF N +++KI E+ P AR
Sbjct: 180 ELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKAR 238
Query: 243 KLIARILDPNP 253
L+ ++L +
Sbjct: 239 DLVEKLLVLDA 249
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 4e-81
Identities = 97/247 (39%), Positives = 144/247 (58%), Gaps = 5/247 (2%)
Query: 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
V +++ +T+GEG + +V+ A N T E VA+KI+D ++ + E IK+E+ K++
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCP--ENIKKEICINKMLN 61
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
H NVV+ Y ++ LE+ +GGELFD+I M E +A+R+F QL+ V Y H
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
G+ HRD+KPENLLLD NLK+SDFGL+ + + + LL+ CGT YVAPE+L R
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFD-DSNLMNLYKKISAAEFTCPPW--LSFTARKLIA 246
+ D+WSCG++L +LAG LP+D S+ Y + PW + L+
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241
Query: 247 RILDPNP 253
+IL NP
Sbjct: 242 KILVENP 248
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 233 bits (595), Expect = 3e-76
Identities = 65/258 (25%), Positives = 121/258 (46%), Gaps = 14/258 (5%)
Query: 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ K Y++ +G G F V TG K ++ L +K E+
Sbjct: 21 EVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEI 77
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLI 121
+ M + HP ++ L++ K ++ ++LEF++GGELFD+I +M E E Y +Q
Sbjct: 78 SIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
+ + H + H D+KPEN++ + ++K+ DFG L+ ++ D ++ T T +
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFG---LATKLNPDEIVKVTTATAEF 194
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----P 235
APE+++ D+W+ GV+ +VLL+G PF + + + + ++
Sbjct: 195 AAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS 253
Query: 236 WLSFTARKLIARILDPNP 253
+S A+ I +L P
Sbjct: 254 SVSPEAKDFIKNLLQKEP 271
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 2e-75
Identities = 70/246 (28%), Positives = 122/246 (49%), Gaps = 10/246 (4%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
KY IG+G V A + TG+ VA++ ++ ++ E I E+ M+ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKN 76
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
PN+V + ++++V+E++ GG L D +V M E + ++ + A+++ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
V HRD+K +N+LL G++K++DFG A + T GTP ++APEV+ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIAR 247
D+WS G++ ++ G P+ + N + I+ E P LS R + R
Sbjct: 194 G-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252
Query: 248 ILDPNP 253
LD +
Sbjct: 253 CLDMDV 258
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 229 bits (586), Expect = 3e-75
Identities = 63/246 (25%), Positives = 107/246 (43%), Gaps = 10/246 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ R IG G+F V FAR+ E VA+K + ++ + I +EV ++ ++HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N ++ + ++V+E+ G V+ ++E E + + Y HS
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL--NDRG 189
+ HRD+K N+LL G +K+ DFG +++ ++ GTP ++APEV+ D G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG 189
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPW--LSFTARKLIAR 247
D+WS G+ L P + N M+ I+ E S R +
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249
Query: 248 ILDPNP 253
L P
Sbjct: 250 CLQKIP 255
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 5e-75
Identities = 74/260 (28%), Positives = 129/260 (49%), Gaps = 18/260 (6%)
Query: 6 IKRRVG---KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
+ R + +E+ +G+G F KV A+N ET A K++D + + E E+
Sbjct: 4 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEI 60
Query: 63 ATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR-MKEDEARRYFQQLI 121
+ HPN+V+L + + ++I++EF GG + ++ R + E + + +Q +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+A++Y H + HRDLK N+L G++K++DFG+SA + R + GTP ++A
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMA 178
Query: 182 PEVL-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE---FTC 233
PEV+ DR YD AD+WS G+ L + P + N M + KI+ +E
Sbjct: 179 PEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237
Query: 234 PPWLSFTARKLIARILDPNP 253
P S + + + L+ N
Sbjct: 238 PSRWSSNFKDFLKKCLEKNV 257
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 228 bits (582), Expect = 3e-74
Identities = 72/259 (27%), Positives = 125/259 (48%), Gaps = 14/259 (5%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ K + Y++ +G G F V TG A K + E +++E
Sbjct: 17 VEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKE 73
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQL 120
+ TM +++HP +V L++ ++ ++ EF++GGELF+K+ + H +M EDEA Y +Q+
Sbjct: 74 IQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV 133
Query: 121 INAVDYCHSRGVYHRDLKPENLLL--DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPN 178
+ + H H DLKPEN++ LK+ DFGL+A + + T GT
Sbjct: 134 CKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAE 190
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CP 234
+ APEV + G D+WS GV+ ++LL+G PF N + + + ++
Sbjct: 191 FAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF 249
Query: 235 PWLSFTARKLIARILDPNP 253
+S + I ++L +P
Sbjct: 250 SGISEDGKDFIRKLLLADP 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 6e-74
Identities = 76/242 (31%), Positives = 129/242 (53%), Gaps = 4/242 (1%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHP 71
+ + + +G+G+F KV A +T + A+K L K+ VL E E + L +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+ ++ +K +F V+E++ GG+L I + + A Y ++I + + HS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ +RDLK +N+LLD G++K++DFG+ + D +T CGTP+Y+APE+L + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDP 251
S D WS GV+L+ +L G PF + L+ I P WL A+ L+ ++
Sbjct: 182 HS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 252 NP 253
P
Sbjct: 241 EP 242
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-73
Identities = 81/257 (31%), Positives = 127/257 (49%), Gaps = 16/257 (6%)
Query: 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
R YEV TIG G++ + + R G+ + K LD + + + + + EV ++ +
Sbjct: 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 60
Query: 69 KHPNVVRLYEVMGSKT--KIFIVLEFVTGGELFDKIVNHGR----MKEDEARRYFQQLIN 122
KHPN+VR Y+ + +T ++IV+E+ GG+L I + + E+ R QL
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 123 AVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
A+ CH R V HRDLKP N+ LD N+K+ DFGL+ + D GTP
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 178
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW 236
Y++PE +N Y+ +D+WS G +L+ L A PF + L KI +F P
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237
Query: 237 LSFTARKLIARILDPNP 253
S ++I R+L+
Sbjct: 238 YSDELNEIITRMLNLKD 254
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 223 bits (570), Expect = 6e-73
Identities = 86/241 (35%), Positives = 146/241 (60%), Gaps = 6/241 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+++ RT+G G+F +V R+ G A+K+L KE V++ K E E + +V HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGV 132
++R++ +IF++++++ GGELF + R A+ Y ++ A++Y HS+ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 133 YHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDG 192
+RDLKPEN+LLD G++K++DFG + V +T CGTP+Y+APEV++ + Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNK 180
Query: 193 STADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARILDPN 252
S D WS G++++ +LAGY PF DSN M Y+KI AE PP+ + + L++R++ +
Sbjct: 181 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 253 P 253
Sbjct: 240 L 240
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 219 bits (560), Expect = 7e-72
Identities = 82/258 (31%), Positives = 130/258 (50%), Gaps = 19/258 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH------KMAEQIKREVATM 65
YE +G G + V+ + T + A+KI+D ++ E +EV +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 66 -KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
K+ HPN+++L + + T F+V + + GELFD + + E E R+ + L+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
H + HRDLKPEN+LLD N+K++DFG S Q+ L CGTP+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180
Query: 185 L-----NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--EFTCPPW- 236
+ ++ G D+WS GVI++ LLAG PF M + + I + +F P W
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240
Query: 237 -LSFTARKLIARILDPNP 253
S T + L++R L P
Sbjct: 241 DYSDTVKDLVSRFLVVQP 258
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 7e-72
Identities = 63/248 (25%), Positives = 108/248 (43%), Gaps = 12/248 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+E +G G V + +G +A K++ E +K + QI RE+ + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR- 130
+V Y S +I I +E + GG L + GR+ E + +I + Y +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRD+KP N+L+++ G +K+ DFG+S D + ++ GT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTHY 180
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY----KKISAAEFTCPPWLSFTARKLIA 246
+D+WS G+ L + G P + L ++ PP R L +
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 247 RILDPNPM 254
+D P
Sbjct: 240 YGMDSRPP 247
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (563), Expect = 7e-72
Identities = 92/249 (36%), Positives = 142/249 (57%), Gaps = 13/249 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y+ +G G F++V A + T + VA+K + K+ + ++ E+A + +KHP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHP 67
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V L ++ S ++++++ V+GGELFD+IV G E +A R Q+++AV Y H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 132 VYHRDLKPENLLL---DAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ HRDLKPENLL D + +SDFG LS+ +L T CGTP YVAPEVL +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFG---LSKMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKL 244
Y + D WS GVI ++LL GY PF D N L+++I AE+ +S +A+
Sbjct: 185 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 245 IARILDPNP 253
I +++ +P
Sbjct: 244 IRHLMEKDP 252
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 221 bits (564), Expect = 2e-71
Identities = 75/266 (28%), Positives = 124/266 (46%), Gaps = 13/266 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK--- 69
+ V R IG G F +V R ++TG+ A+K LDK+++ + E + LV
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
P +V + + K+ +L+ + GG+L + HG E + R Y ++I +++ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R V +RDLKP N+LLD +G++++SD GL+ H + GT Y+APEVL
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDF----SKKKPHASVGTHGYMAPEVLQKGV 181
Query: 190 YDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSFTARKLIA 246
S+AD +S G +LF LL G+ PF + + P S R L+
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 247 RILDPNP---MTVSIYPFADILYMRF 269
+L + + ++ F
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPF 267
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 8e-71
Identities = 60/249 (24%), Positives = 114/249 (45%), Gaps = 15/249 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY + +G G F V + + + K + K +K+E++ + + +H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSR 130
N++ L+E S ++ ++ EF++G ++F++I + E E Y Q+ A+ + HS
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 131 GVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
+ H D++PEN++ +K+ +FG ++Q++ P Y APEV
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFG---QARQLKPGDNFRLLFTAPEYYAPEVHQHD 178
Query: 189 GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTARKL 244
+ D+WS G +++VLL+G PF + + I AE+T +S A
Sbjct: 179 VVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237
Query: 245 IARILDPNP 253
+ R+L
Sbjct: 238 VDRLLVKER 246
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 216 bits (552), Expect = 1e-70
Identities = 64/252 (25%), Positives = 115/252 (45%), Gaps = 10/252 (3%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+YE+G +G G ++V AR+ VA+K+L + + +RE + H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 71 PNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
P +V +Y+ ++T +IV+E+V G L D + G M A A+++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSA-LSQQVRDDGLLHTTCGTPNYVAPEVL 185
H G+ HRD+KP N+++ A +KV DFG++ ++ GT Y++PE
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241
D +D++S G +L+ +L G PF + +++ + + P LS
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 242 RKLIARILDPNP 253
++ + L NP
Sbjct: 246 DAVVLKALAKNP 257
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (556), Expect = 2e-70
Identities = 84/247 (34%), Positives = 135/247 (54%), Gaps = 3/247 (1%)
Query: 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K + ++ + +G+GTF KV R TG A+KIL KE ++ E ++
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
+HP + L + ++ V+E+ GGELF + E+ AR Y ++++A++Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLN 186
HSR V +RD+K ENL+LD G++K++DFGL + + D + T CGTP Y+APEVL
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLE 178
Query: 187 DRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIA 246
D Y + D W GV+++ ++ G LPF + + L++ I E P LS A+ L+A
Sbjct: 179 DNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 237
Query: 247 RILDPNP 253
+L +P
Sbjct: 238 GLLKKDP 244
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 4e-69
Identities = 54/252 (21%), Positives = 114/252 (45%), Gaps = 14/252 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
G+ VG+ IG G+F V + VA+K+L+ ++ + K EV ++ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQL-QAFKNEVGVLRKTRH 63
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI-VNHGRMKEDEARRYFQQLINAVDYCHS 129
N++ + ++ IV ++ G L+ + + + + + +Q +DY H+
Sbjct: 64 VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ + HRDLK N+ L +K+ DFGL+ + + G+ ++APEV+ +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 190 YDGST--ADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSF------TA 241
+ + +D+++ G++L+ L+ G LP+ + N + + + P
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 242 RKLIARILDPNP 253
++L+A L
Sbjct: 243 KRLMAECLKKKR 254
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (545), Expect = 8e-69
Identities = 83/252 (32%), Positives = 142/252 (56%), Gaps = 6/252 (2%)
Query: 2 SQPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
+ + ++ +++ +T+G G+F +V ++ E+G A+KILDK+KV+K K E E
Sbjct: 32 TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91
Query: 62 VATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLI 121
++ V P +V+L + +++V+E+V GGE+F + GR E AR Y Q++
Sbjct: 92 KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151
Query: 122 NAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVA 181
+Y HS + +RDLKPENLL+D G ++V+DFG + R G T CGTP +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA-----KRVKGRTWTLCGTPEALA 206
Query: 182 PEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTA 241
PE++ +GY+ + D W+ GV+++ + AGY PF + +Y+KI + + P S
Sbjct: 207 PEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 242 RKLIARILDPNP 253
+ L+ +L +
Sbjct: 266 KDLLRNLLQVDL 277
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-67
Identities = 88/253 (34%), Positives = 131/253 (51%), Gaps = 15/253 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK---MAEQIKREVATMKLV 68
Y+ G +G G FA VK R TG A K + K + + E I+REV+ +K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
+HPNV+ L+EV +KT + ++LE V GGELFD + + E+EA + +Q++N V Y H
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130
Query: 129 SRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
S + H DLKPEN++L +K+ DFG L+ ++ GTP +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG---LAHKIDFGNEFKNIFGTPEFVAPEI 187
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CPPWLSFT 240
+N AD+WS GVI ++LL+G PF +SA + S
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 241 ARKLIARILDPNP 253
A+ I R+L +P
Sbjct: 247 AKDFIRRLLVKDP 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-67
Identities = 64/254 (25%), Positives = 119/254 (46%), Gaps = 18/254 (7%)
Query: 11 GKY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
G++ + IG G+F V ++ET VA L K+ K + ++ K E +K ++
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 66
Query: 70 HPNVVRLYEVMGSKTK----IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
HPN+VR Y+ S K I +V E +T G L + MK R + +Q++ +
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 126 YCHSRG--VYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ H+R + HRDLK +N+ + G++K+ D GL+ L GTP ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAP 182
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAA--EFTCPPWLSF 239
E+ YD S D+++ G+ + + P+ + N +Y+++++ +
Sbjct: 183 EMYE-EKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 240 TARKLIARILDPNP 253
+++I + N
Sbjct: 241 EVKEIIEGCIRQNK 254
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-67
Identities = 75/250 (30%), Positives = 119/250 (47%), Gaps = 17/250 (6%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKM---AEQIKREVATMKL 67
+Y+VG +G G F V PVA+K ++K+++ ++ EV +K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 68 VK--HPNVVRLYEVMGSKTKIFIVLEFVTGG-ELFDKIVNHGRMKEDEARRYFQQLINAV 124
V V+RL + ++LE +LFD I G ++E+ AR +F Q++ AV
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 125 DYCHSRGVYHRDLKPENLLLDA-YGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPE 183
+CH+ GV HRD+K EN+L+D G LK+ DFG AL D + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPE 179
Query: 184 VLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243
+ Y G +A +WS G++L+ ++ G +PF+ +I + +S +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 244 LIARILDPNP 253
LI L P
Sbjct: 234 LIRWCLALRP 243
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-65
Identities = 84/267 (31%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 3 QPKIKRRVGKYEV-GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKRE 61
Q K + Y+V + +G G KV N T E ALK+L + +RE
Sbjct: 3 QIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARRE 54
Query: 62 VATM-KLVKHPNVVRLYEV----MGSKTKIFIVLEFVTGGELFDKIVNHG--RMKEDEAR 114
V + + P++VR+ +V + + IV+E + GGELF +I + G E EA
Sbjct: 55 VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 114
Query: 115 RYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC 174
+ + A+ Y HS + HRD+KPENLL + + +++ L T C
Sbjct: 115 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC 174
Query: 175 GTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA----- 229
TP YVAPEVL YD S D+WS GVI+++LL GY PF ++ + + +
Sbjct: 175 YTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233
Query: 230 -EFTCPPW--LSFTARKLIARILDPNP 253
EF P W +S + LI +L P
Sbjct: 234 YEFPNPEWSEVSEEVKMLIRNLLKTEP 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 7e-64
Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 18/247 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ ++ +TIG+G F V G VA+K + + A+ E + M ++H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHS 60
Query: 72 NVVRLYEV-MGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCH 128
N+V+L V + K ++IV E++ G L D + + GR + D ++ + A++Y
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDR 188
HRDL N+L+ KVSDFGL+ + +D T + APE L ++
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175
Query: 189 GYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIA 246
+ +D+WS G++L+ + + G +P+ L ++ ++ P +++
Sbjct: 176 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234
Query: 247 RILDPNP 253
+
Sbjct: 235 NCWHLDA 241
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-61
Identities = 63/249 (25%), Positives = 99/249 (39%), Gaps = 10/249 (4%)
Query: 13 YEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
+ +G+G+F V+ S VA+K L + + + + + REV M +
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCH 128
H N++RLY V + +V E G L D++ H G RY Q+ + Y
Sbjct: 70 HRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLND 187
S+ HRDL NLLL +K+ DFGL Q D ++ + APE L
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 188 RGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE--FTCPPWLSFTARKL 244
R + + +D W GV L+ + G P+ N + KI P +
Sbjct: 189 RTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247
Query: 245 IARILDPNP 253
+ + P
Sbjct: 248 MVQCWAHKP 256
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 3e-61
Identities = 53/242 (21%), Positives = 97/242 (40%), Gaps = 8/242 (3%)
Query: 17 RTIGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV 74
+ +G G F VK + + + VA+KIL E + +++ E M+ + +P +V
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIV 71
Query: 75 RLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYH 134
R+ + ++ +V+E G L + + +K+ Q+ + Y H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 135 RDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVLNDRGYDGS 193
RDL N+LL K+SDFGLS + + T + APE +N +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 194 TADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDP 251
+D+WS GV+++ + G P+ + + E CP L+
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 252 NP 253
+
Sbjct: 250 DV 251
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 6e-61
Identities = 68/240 (28%), Positives = 102/240 (42%), Gaps = 11/240 (4%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
V KYE IG+GTF +V AR+ +TG+ VALK + E K RE+ ++L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQL 65
Query: 68 VKHPNVVRLYEV--------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
+KH NVV L E+ K I++V +F + E +R Q
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD--GLLHTTCGTP 177
L+N + Y H + HRD+K N+L+ G LK++DFGL+ ++ T
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWL 237
Y PE+L G DLW G I+ + + + IS + P +
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 3e-60
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 10/241 (4%)
Query: 19 IGEGTFAKVKFA--RNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRL 76
+G G F V+ R + VA+K+L + + E++ RE M + +P +VRL
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 77 YEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHR 135
V + +V+E GG L +V + Q+ + Y + HR
Sbjct: 75 IGV-CQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 136 DLKPENLLLDAYGNLKVSDFGLS-ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGST 194
DL N+LL K+SDFGLS AL + APE +N R +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192
Query: 195 ADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARILDPN 252
+D+WS GV ++ L+ G P+ + I + CPP L++
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252
Query: 253 P 253
Sbjct: 253 W 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 9e-60
Identities = 60/260 (23%), Positives = 112/260 (43%), Gaps = 8/260 (3%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y IGEG + V A ++ VA+K + + ++ RE+ + +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 71 PNVVRLYEVMGSKT----KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ + +++ + T K ++ + G +L+ ++ + D + Q++ + Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK-LLKTQHLSNDHICYFLYQILRGLKY 124
Query: 127 CHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT-CGTPNYVAPEVL 185
HS V HRDLKP NLLL+ +LK+ DFGL+ ++ D T T Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245
+ + D+WS G IL +L+ F + ++ I + L
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 246 ARILDPNPMTVSIYPFADIL 265
AR + + P+ +
Sbjct: 245 ARNYLLSLPHKNKVPWNRLF 264
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-59
Identities = 67/270 (24%), Positives = 103/270 (38%), Gaps = 32/270 (11%)
Query: 14 EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHK--MAEQIKREVATMKLVKHP 71
E +GEG FA V AR+ T + VA+K + + K + RE+ ++ + HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N++ L + G K+ I +V +F+ N + + Y + ++Y H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
+ HRDLKP NLLLD G LK++DFGL+ + T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLA--KSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----------------- 234
G D+W+ G IL LL + ++ +I T
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 235 -----------PWLSFTARKLIARILDPNP 253
LI + NP
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNP 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 7e-59
Identities = 50/274 (18%), Positives = 106/274 (38%), Gaps = 35/274 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATM- 65
E G+ +G G F KV A + VA+K+L ++ E + E+ M
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-------------------- 105
+L H N+V L I+++ E+ G+L + + +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 106 ---GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ ++ + Q+ +++ + HRDL N+L+ +K+ DFGL+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMN 221
+ + ++APE L + Y +D+WS G++L+ + + G P+ +
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 222 LYKKI--SAAEFTCPPWLSFTARKLIARILDPNP 253
+ K+ + + P + + ++ +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDS 308
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (474), Expect = 9e-59
Identities = 57/250 (22%), Positives = 99/250 (39%), Gaps = 12/250 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVK 69
++ + IG G F +V G+ VA+K L K E + M
Sbjct: 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFD 85
Query: 70 HPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCH 128
HPNV+ L V+ T + I+ EF+ G L N G+ + + + + Y
Sbjct: 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 145
Query: 129 SRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT---CGTPNYVAPEVL 185
HRDL N+L+++ KVSDFGLS + D + + APE +
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 186 NDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243
R + + +D+WS G++++ +++ G P+ D ++ I P +
Sbjct: 206 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQ 264
Query: 244 LIARILDPNP 253
L+ +
Sbjct: 265 LMLDCWQKDR 274
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-58
Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 14/260 (5%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
Y + +G G + V A + TG VA+K L + A++ RE+ +K ++H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHE 77
Query: 72 NVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVD 125
NV+ L +V + T ++V+ F+ G K++ H ++ ED + Q++ +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 126 YCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVL 185
Y H+ G+ HRDLKP NL ++ LK+ DFGL+ + D + T Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAPEVI 190
Query: 186 NDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLI 245
+ T D+WS G I+ ++ G F S+ ++ K+I T P +
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250
Query: 246 ARILDPNPMTVSIYPFADIL 265
A+ + FA IL
Sbjct: 251 AKNYMKGLPELEKKDFASIL 270
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-58
Identities = 53/244 (21%), Positives = 102/244 (41%), Gaps = 10/244 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ +G G F VK+ + VA+K++ + + + ++ E M + H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V+LY V + IFI+ E++ G L + + R + + + + A++Y S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
HRDL N L++ G +KVSDFGLS + + + PEVL +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 192 GSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIARIL 249
+D+W+ GV+++ + + G +P++ + I P S ++
Sbjct: 180 SK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 250 DPNP 253
Sbjct: 239 HEKA 242
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 4e-58
Identities = 53/245 (21%), Positives = 97/245 (39%), Gaps = 5/245 (2%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKE--KVLKHKMAEQIKREVATMKLVKH 70
++ + +G G F V GE V + + KE + K ++I E M V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 71 PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
P+V RL + + T I G L + + + Q+ ++Y R
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
+ HRDL N+L+ ++K++DFGL+ L + ++A E + R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 191 DGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARKLIARI 248
+D+WS GV ++ L+ G P+D + + E PP + ++ +
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249
Query: 249 LDPNP 253
+
Sbjct: 250 WMIDA 254
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 9e-58
Identities = 52/246 (21%), Positives = 101/246 (41%), Gaps = 12/246 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ +G G F +V VA+K L + + + E MK ++H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCHS 129
+VRLY V ++ I+I+ E++ G L D + +K ++ Q+ + +
Sbjct: 69 RLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
R HRDL+ N+L+ + K++DFGL+ L + + + APE +N
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPEAINYGT 186
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIAR 247
+ +D+WS G++L ++ G +P+ + + + P +L+
Sbjct: 187 FTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245
Query: 248 ILDPNP 253
P
Sbjct: 246 CWKERP 251
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (469), Expect = 1e-57
Identities = 71/258 (27%), Positives = 127/258 (49%), Gaps = 11/258 (4%)
Query: 7 KRRVG--KYEVGRTIGEGTFAKVKFAR---NSETGEPVALKILDKEKVL-KHKMAEQIKR 60
+VG +E+ + +G G + KV R +TG+ A+K+L K ++ K K E +
Sbjct: 18 AEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT 77
Query: 61 EVATMKLVKH-PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQ 119
E ++ ++ P +V L+ ++TK+ ++L+++ GGELF + R E E + Y +
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137
Query: 120 LINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNY 179
++ A+++ H G+ +RD+K EN+LLD+ G++ ++DFGLS +
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN----LMNLYKKISAAEFTCPP 235
V D WS GV+++ LL G PF + ++I +E P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 236 WLSFTARKLIARILDPNP 253
+S A+ LI R+L +P
Sbjct: 258 EMSALAKDLIQRLLMKDP 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-57
Identities = 57/246 (23%), Positives = 103/246 (41%), Gaps = 12/246 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G+G F +V + T VA+K L + E +E MK ++H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR--MKEDEARRYFQQLINAVDYCHS 129
+V+LY V+ S+ I+IV E+++ G L D + ++ + Q+ + + Y
Sbjct: 73 KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
HRDL+ N+L+ KV+DFGL+ L + + + APE
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190
Query: 190 YDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPWLSFTARKLIAR 247
+ +D+WS G++L L G +P+ + ++ CPP + L+ +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249
Query: 248 ILDPNP 253
P
Sbjct: 250 CWRKEP 255
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 182 bits (463), Expect = 3e-57
Identities = 77/271 (28%), Positives = 121/271 (44%), Gaps = 33/271 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KY IGEGT+ V A+N+ GE ALK + EK + RE++ +K +KH
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHS 60
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+V+LY+V+ +K ++ +V E + V G ++ A+ + QL+N + YCH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKP+NLL++ G LK++DFGL+ T Y AP+VL
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 192 GSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT------------------- 232
+T D+WS G I ++ G F + + +I T
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 233 ----------CPPWLSFTARKLIARILDPNP 253
L + L++++L +P
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 4e-57
Identities = 57/244 (23%), Positives = 97/244 (39%), Gaps = 10/244 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
+ IG G F V + VA+K + + + + E E M + HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 73 VVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
+V+LY V + I +V EF+ G L D G + + + Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDL N L+ +KVSDFG++ T + +PEV + Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 192 GSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARIL 249
S +D+WS GV+++ + + G +P+++ + + + IS P S +++
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 250 DPNP 253
P
Sbjct: 240 KERP 243
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 5e-57
Identities = 66/250 (26%), Positives = 112/250 (44%), Gaps = 15/250 (6%)
Query: 12 KYEVGRTIGEGTFAKVKFARN---SETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ E+GR IGEG F V VA+K + E+ +E TM+
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQF 65
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQLINAVDYC 127
HP++V+L V+ ++ ++I++E T GEL V + Y QL A+ Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTC--GTPNYVAPEVL 185
S+ HRD+ N+L+ + +K+ DFG LS+ + D + ++APE +
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFG---LSRYMEDSTYYKASKGKLPIKWMAPESI 181
Query: 186 NDRGYDGSTADLWSCGVILF-VLLAGYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243
N R + + +D+W GV ++ +L+ G PF ++ +I E PP T
Sbjct: 182 NFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240
Query: 244 LIARILDPNP 253
L+ + +P
Sbjct: 241 LMTKCWAYDP 250
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (460), Expect = 1e-56
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 10/246 (4%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+ +G G + +V + VA+K L ++ E+ +E A MK +KHP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHP 73
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMK--EDEARRYFQQLINAVDYCHS 129
N+V+L V + +I+ EF+T G L D + R + Q+ +A++Y
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRG 189
+ HRDL N L+ +KV+DFGLS L + APE L
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 190 YDGSTADLWSCGVILFVLL-AGYLPFDDSNLMNLYKKISA-AEFTCPPWLSFTARKLIAR 247
+ + W+ GV+L+ + G P+ +L +Y+ + P +L+
Sbjct: 193 FSIKSDV-WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251
Query: 248 ILDPNP 253
NP
Sbjct: 252 CWQWNP 257
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 1e-56
Identities = 54/260 (20%), Positives = 97/260 (37%), Gaps = 23/260 (8%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHP 71
+ IGEG F +V AR + G + I ++ E+ + KL HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARR 115
N++ L + +++ +E+ G L D + + +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 116 YFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCG 175
+ + +DY + HRDL N+L+ K++DFG LS+
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG---LSRGQEVYVKKTMGRL 188
Query: 176 TPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTC 233
++A E LN Y + +D+WS GV+L+ +++ G P+ LY+K+
Sbjct: 189 PVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 247
Query: 234 PPWLSFTARKLIARILDPNP 253
P L+ + P
Sbjct: 248 PLNCDDEVYDLMRQCWREKP 267
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-56
Identities = 73/272 (26%), Positives = 120/272 (44%), Gaps = 33/272 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
++ IGEGT+ V ARN TGE VALK + + + RE++ +K + HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFV-TGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR 130
N+V+L +V+ ++ K+++V EF+ + F + + Y QL+ + +CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 131 GVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGY 190
V HRDLKP+NLL++ G +K++DFGL+ T Y APE+L Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 191 DGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP---------------- 234
+ D+WS G I ++ F + ++ +I T
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 235 -------------PWLSFTARKLIARILDPNP 253
P L R L++++L +P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP 271
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 3e-56
Identities = 80/272 (29%), Positives = 121/272 (44%), Gaps = 33/272 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
KYE IGEGT+ V A+N ET E VALK + + + RE+ +K +KH
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHK 61
Query: 72 NVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG 131
N+VRL++V+ S K+ +V EF +G + + + + QL+ + +CHSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 132 VYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYD 191
V HRDLKP+NLL++ G LK+++FGL+ T Y P+VL
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 192 GSTADLWSCGVILFVLLAGYLP-FDDSNLMNLYKKISAAEFT------------------ 232
++ D+WS G I L P F +++ + K+I T
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 233 -----------CPPWLSFTARKLIARILDPNP 253
P L+ T R L+ +L NP
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNP 271
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 179 bits (454), Expect = 9e-56
Identities = 59/273 (21%), Positives = 98/273 (35%), Gaps = 34/273 (12%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
E R IGEG F +V AR E VA+K+L +E M +RE A M
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR------------------- 107
+PN+V+L V + ++ E++ G+L + + +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 108 -----MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162
+ E +Q+ + Y R HRDL N L+ +K++DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDSNLMN 221
++ PE + Y +D+W+ GV+L+ + + L P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 222 LYKKISAAEF-TCPPWLSFTARKLIARILDPNP 253
+ + CP L+ P
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLP 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 1e-55
Identities = 68/258 (26%), Positives = 114/258 (44%), Gaps = 10/258 (3%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP 71
+Y+ +G G + V A +++TG VA+K L + A++ RE+ +K +KH
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHE 77
Query: 72 NVVRLYEVMGSKTKIF----IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYC 127
NV+ L +V + + L G + IV ++ +D + Q++ + Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
HS + HRDLKP NL ++ LK+ DFGL+ D + T Y APE++ +
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIMLN 192
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247
+ T D+WS G I+ LL G F ++ ++ K I T L AR
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 248 ILDPNPMTVSIYPFADIL 265
+ + FA++
Sbjct: 253 NYIQSLTQMPKMNFANVF 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-55
Identities = 69/280 (24%), Positives = 112/280 (40%), Gaps = 49/280 (17%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPN 72
Y + IG G+F V A+ ++GE VA+K + ++K RE+ M+ + H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-------RFKNRELQIMRKLDHCN 74
Query: 73 VVRLYEVM------GSKTKIFIVLEFVTGG---ELFDKIVNHGRMKEDEARRYFQQLINA 123
+VRL + + +VL++V + + Y QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 124 VDYCHSRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAP 182
+ Y HS G+ HRD+KP+NLLLD LK+ DFG ++Q+ + + Y AP
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG---SAKQLVRGEPNVSYICSRYYRAP 191
Query: 183 EVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP-------- 234
E++ S+ D+WS G +L LL G F + ++ +I T
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 235 ---------------------PWLSFTARKLIARILDPNP 253
P A L +R+L+ P
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 9e-55
Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 42/283 (14%)
Query: 8 RRVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMK 66
R +YE IGEG + KV AR+ + G VALK + + + M REVA ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLR 62
Query: 67 L---VKHPNVVRLYEVM-----GSKTKIFIVLEFVTGGEL-FDKIVNHGRMKEDEARRYF 117
+HPNVVRL++V +TK+ +V E V + V + + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
QL+ +D+ HS V HRDLKP+N+L+ + G +K++DFGL+ + + T
Sbjct: 123 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTL 179
Query: 178 NYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----- 232
Y APEVL Y DLWS G I + F S+ ++ KI
Sbjct: 180 WYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 233 ----------------------CPPWLSFTARKLIARILDPNP 253
+ + L+ + L NP
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 281
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (439), Expect = 2e-53
Identities = 51/263 (19%), Positives = 85/263 (32%), Gaps = 24/263 (9%)
Query: 9 RVG-KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKL 67
RVG +Y +GR IG G+F + + GE VA+K+ + Q+ E K+
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKM 58
Query: 68 VKHPNVVRLYEVMGS-KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
++ + G+ +V+E + + Q+I+ ++Y
Sbjct: 59 MQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 127 CHSRGVYHRDLKPENLL---LDAYGNLKVSDFGLS-----ALSQQVRDDGLLHTTCGTPN 178
HS+ HRD+KP+N L + + DFGL+ A + Q GT
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF------- 231
Y + DL S G +L G LP+ +K
Sbjct: 179 YASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 232 -TCPPWLSFTARKLIARILDPNP 253
+
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRF 260
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 2e-53
Identities = 53/269 (19%), Positives = 102/269 (37%), Gaps = 30/269 (11%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATM- 65
+ G+T+G G F KV A S+ VA+K+L L + E + E+ +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTER--EALMSELKVLS 81
Query: 66 KLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKI------------------VNHGR 107
L H N+V L ++ E+ G+L + + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
+ ++ + Q+ + + S+ HRDL N+LL K+ DFGL+ + +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
+ ++APE + + +D+WS G+ L+ L + G P+ + + + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 227 --SAAEFTCPPWLSFTARKLIARILDPNP 253
P ++ D +P
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 8e-53
Identities = 55/268 (20%), Positives = 106/268 (39%), Gaps = 29/268 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGE-------PVALKILDKEKVLKHKMAEQIKREVAT 64
+ +G+ +GEG F +V A + VA+K+L + K + E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71
Query: 65 MK-LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHG----------------R 107
MK + KH N++ L +++++E+ + G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 108 MKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167
+ + Q+ ++Y S+ HRDL N+L+ +K++DFGL+ +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI 226
++APE L DR Y +D+WS GV+L+ + G P+ + L+K +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 227 SAAE-FTCPPWLSFTARKLIARILDPNP 253
P + ++ P
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVP 278
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 171 bits (433), Expect = 1e-52
Identities = 47/227 (20%), Positives = 83/227 (36%), Gaps = 17/227 (7%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
Y+VGR IGEG+F + N + VA+K + A Q++ E T KL+
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAG 59
Query: 71 -PNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS 129
+ +Y +V++ + + + +Q++ V H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 130 RGVYHRDLKPENLLLDAY-----GNLKVSDFGLSAL-----SQQVRDDGLLHTTCGTPNY 179
+ + +RD+KP+N L+ + V DFG+ ++Q GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 180 VAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
++ R DL + G + L G LP+ +K
Sbjct: 180 MSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKY 225
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 4e-52
Identities = 52/249 (20%), Positives = 98/249 (39%), Gaps = 11/249 (4%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLV 68
+ IG G F +V + PVA+K L K E M
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMGQF 66
Query: 69 KHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYC 127
H N++RL V+ + I+ E++ G L + G + + + + Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 128 HSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT-TCGTPNYVAPEVLN 186
+ HRDL N+L+++ KVSDFGLS + + + + + APE ++
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 187 DRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKL 244
R + + +D+WS G++++ ++ G P+ + + + K I+ P +L
Sbjct: 187 YRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 245 IARILDPNP 253
+ +
Sbjct: 246 MMQCWQQER 254
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 168 bits (427), Expect = 2e-51
Identities = 57/230 (24%), Positives = 106/230 (46%), Gaps = 17/230 (7%)
Query: 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKH 70
Y++ R +G G +++V A N E V +KIL K ++IKRE+ ++ L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89
Query: 71 PNVVRLYEVMGSKTK--IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCH 128
PN++ L +++ +V E V + + + + R Y +++ A+DYCH
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146
Query: 129 SRGVYHRDLKPENLLLDAYGN-LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLND 187
S G+ HRD+KP N+++D L++ D+GL+ + + + PE+L D
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVD 203
Query: 188 RGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAAEFTCPPW 236
+ D+WS G +L ++ PF + + +I+ T +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 7e-51
Identities = 57/257 (22%), Positives = 99/257 (38%), Gaps = 12/257 (4%)
Query: 6 IKRRVGKYEVGRTIGEGTFAKV---KFARNSETGEPVALKILDKEKVLKHKMAEQIKREV 62
I IG G F V N A+K L++ Q E
Sbjct: 22 IGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEG 79
Query: 63 ATMKLVKHPNVVRLYEV-MGSKTKIFIVLEFVTGGELFD-KIVNHGRMKEDEARRYFQQL 120
MK HPNV+ L + + S+ +VL ++ G+L + + + Q+
Sbjct: 80 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 139
Query: 121 INAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTT--CGTPN 178
+ + S+ HRDL N +LD +KV+DFGL+ D + + T
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 179 YVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKI-SAAEFTCPPW 236
++A E L + + +D+WS GV+L+ L+ G P+ D N ++ + P +
Sbjct: 200 WMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEY 258
Query: 237 LSFTARKLIARILDPNP 253
+++ + P
Sbjct: 259 CPDPLYEVMLKCWHPKA 275
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-49
Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 14/249 (5%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+Y+ + IG G V A ++ VA+K L + A++ RE+ MK V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNH 75
Query: 71 PNVVRLYEV------MGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAV 124
N++ L V + +++V+E + + + Q++ +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGI 132
Query: 125 DYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEV 184
+ HS G+ HRDLKP N+++ + LK+ DFG L++ ++ T Y APEV
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEV 189
Query: 185 LNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKL 244
+ GY + D+WS G I+ ++ + F + ++ + K+ T P +
Sbjct: 190 ILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 245 IARILDPNP 253
+ ++ P
Sbjct: 249 VRNYVENRP 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-49
Identities = 47/259 (18%), Positives = 99/259 (38%), Gaps = 20/259 (7%)
Query: 12 KYEVGRTIGEGTFAKV-----KFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
K + R +G+G+F V K E VA+K +++ ++ + + E + MK
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER--IEFLNEASVMK 78
Query: 67 LVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGR----------MKEDEARRY 116
+VVRL V+ +++E +T G+L + + + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 117 FQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGT 176
++ + + Y ++ HRDL N ++ +K+ DFG++ +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAAE-FTCP 234
+++PE L D + + WS GV+L+ + P+ + + + + P
Sbjct: 199 VRWMSPESLKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 235 PWLSFTARKLIARILDPNP 253
+L+ NP
Sbjct: 258 DNCPDMLFELMRMCWQYNP 276
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 7e-48
Identities = 53/262 (20%), Positives = 106/262 (40%), Gaps = 29/262 (11%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH 70
+ +IG+G F +V + GE VA+KI + + + + E+ +++H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 71 PNVVRLYEVM----GSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDY 126
N++ G+ T++++V ++ G LFD + N + + + + + +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115
Query: 127 CHS--------RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD--DGLLHTTCGT 176
H + HRDLK +N+L+ G ++D GL+ D D + GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 177 PNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF 231
Y+APEVL+D AD+++ G++ + + + Y+
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG---GIHEDYQLPYYDLV 232
Query: 232 TCPPWLSFTARKLIARILDPNP 253
P + + + + L PN
Sbjct: 233 PSDPSVEEMRKVVCEQKLRPNI 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 7e-48
Identities = 54/268 (20%), Positives = 102/268 (38%), Gaps = 29/268 (10%)
Query: 12 KYEVGRTIGEGTFAKVKFAR-----NSETGEPVALKILDKEKVLKHKMAEQIKREVATMK 66
+ ++G+ +G G F +V A + T VA+K+L + H + E+ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILI 71
Query: 67 LVKH-PNVVRLYEVMGSK-TKIFIVLEFVTGGELFDKIVNHGR----------------M 108
+ H NVV L + +++EF G L + + +
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 109 KEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168
+ Y Q+ +++ SR HRDL N+LL +K+ DFGL+ + D
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFDDSNLMNLYKKI- 226
++APE + DR Y +D+WS GV+L+ + + P+ + + +
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 250
Query: 227 -SAAEFTCPPWLSFTARKLIARILDPNP 253
P + + + + P
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEP 278
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (344), Expect = 8e-39
Identities = 49/230 (21%), Positives = 92/230 (40%), Gaps = 15/230 (6%)
Query: 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIK-------REVA 63
+Y + R +G G F+ V A++ VA+KI+ +KV ++IK +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 72
Query: 64 TMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT-----GGELFDKIVNHGRMKEDEARRYFQ 118
+ ++++L + K + + V K H + ++ +
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 119 QLINAVDYC-HSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQVRDDGLLHTTCGT 176
QL+ +DY G+ H D+KPEN+L++ + ++ L D + T
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 177 PNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI 226
Y +PEVL + AD+WS ++F L+ G F+ + K
Sbjct: 193 REYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 92.9 bits (230), Expect = 9e-24
Identities = 33/213 (15%), Positives = 69/213 (32%), Gaps = 42/213 (19%)
Query: 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMA---------------EQ 57
+G+ +GEG + V + E +K K+
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 58 IKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYF 117
+ E ++ ++ V ++Y G+ +++E + R++ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDEVL 109
Query: 118 QQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTP 177
++ V + RG+ H DL N+L+ G + + DF S + +L
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV--- 165
Query: 178 NYVAPEVLND---RGYDGSTADLWSCGVILFVL 207
+ R Y + D+ S I +L
Sbjct: 166 -----RNIITYFSRTY-RTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 269 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.95 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.48 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.38 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.63 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.47 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.36 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-62 Score=393.36 Aligned_cols=253 Identities=36% Similarity=0.688 Sum_probs=233.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||+|+||.||+|+++.+++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876655555567889999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||++||+|.+++...+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++..... ..
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~----~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SR 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC----CC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC----Cc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999864332 22
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhc
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (269)
.....|++.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+..+....+....+..+..+++++++||++||
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 344568999999999998776 4999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcCCCCccccccccC
Q 024347 250 DPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 250 ~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.||++|||+ .++|.|+|
T Consensus 240 ~~dp~~R~t~--~eil~hp~ 257 (263)
T d2j4za1 240 KHNPSQRPML--REVLEHPW 257 (263)
T ss_dssp CSSGGGSCCH--HHHHTCHH
T ss_pred cCCHhHCcCH--HHHHcCcC
Confidence 9999999999 78889987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-63 Score=398.62 Aligned_cols=261 Identities=30% Similarity=0.550 Sum_probs=232.1
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++.+.||+|+||.||+|+++.+|+.||+|++...........+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence 35678999999999999999999999999999999998766555555678999999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+||||++||+|.+++...+.+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||+++........
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999876544444
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 247 (269)
.......||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+......++..+++.++..+++++++||++
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 243 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred cccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence 444556789999999999887764 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCcCCCCccc----cccccC
Q 024347 248 ILDPNPMTVSIYPFAD----ILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~----~l~~~~ 269 (269)
||+.||++|||++++. ++.|+|
T Consensus 244 ~L~~dP~~R~t~~e~~~~~~i~~Hpf 269 (288)
T d1uu3a_ 244 LLVLDATKRLGCEEMEGYGPLKAHPF 269 (288)
T ss_dssp TSCSSGGGSTTSGGGTCHHHHHTSGG
T ss_pred HccCCHhHCcCHHHHcCCHHHHcCCc
Confidence 9999999999997653 456665
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-61 Score=388.66 Aligned_cols=257 Identities=38% Similarity=0.629 Sum_probs=219.3
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||+|+||+||+|+++.+|+.||+|++..... .+..+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEE
Confidence 45789999999999999999999999999999999876542 2234678899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
||||++|++|.+++...+.+++.++..++.|+++||.|||++||+|+||||+||+++.++.+||+|||+++.........
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~ 160 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 160 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred EEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999998665443333
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCccc--CCCCCCHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKISAAEFT--CPPWLSFTARKLI 245 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~--~~~~~~~~l~~li 245 (269)
......||+.|+|||++.+..+++.++||||||+++|+|++|+.||...... ............ ....+++++.+||
T Consensus 161 ~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 240 (271)
T d1nvra_ 161 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240 (271)
T ss_dssp CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHH
Confidence 4445678999999999988877668899999999999999999999765433 333333333322 2245899999999
Q ss_pred HHhcCCCCCCcCCCCccccccccC
Q 024347 246 ARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++||+.||++|||+ .+++.|+|
T Consensus 241 ~~~L~~dP~~R~t~--~eil~hpw 262 (271)
T d1nvra_ 241 HKILVENPSARITI--PDIKKDRW 262 (271)
T ss_dssp HHHSCSSTTTSCCH--HHHTTCTT
T ss_pred HHHcCCChhHCcCH--HHHhcCHh
Confidence 99999999999999 78899998
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-59 Score=381.08 Aligned_cols=251 Identities=29% Similarity=0.498 Sum_probs=220.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
-.+|++.+.||+|+||+||+|.++.+|+.||+|++....... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence 458999999999999999999999999999999997654332 46788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||++|++|.+++.. +.+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++.... ....
T Consensus 96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~ 172 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 172 (293)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCC
T ss_pred EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--cccc
Confidence 999999999887655 5799999999999999999999999999999999999999999999999999875432 2223
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---cccCCCCCCHHHHHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA---EFTCPPWLSFTARKLIA 246 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~ 246 (269)
.....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+... .+..++.+++++++||+
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence 344568999999999988776 48999999999999999999999988877766665443 23445678999999999
Q ss_pred HhcCCCCCCcCCCCccccccccC
Q 024347 247 RILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||+.||++|||+ .++|.|+|
T Consensus 252 ~~L~~dP~~R~s~--~eil~Hp~ 272 (293)
T d1yhwa1 252 RCLDMDVEKRGSA--KELLQHQF 272 (293)
T ss_dssp HHTCSSTTTSCCH--HHHTTCGG
T ss_pred HHccCChhHCcCH--HHHhcCHh
Confidence 9999999999999 78889987
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-59 Score=385.98 Aligned_cols=259 Identities=33% Similarity=0.586 Sum_probs=234.8
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
+..++|++++.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...++
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 45689999999999999999999999999999999998766554445678889999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+||||++||+|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.+|.++|+|||+++.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~ 159 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG 159 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999875332 22
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 247 (269)
.......||+.|+|||++.+..+ +.++|+|||||++|+|++|..||.+.+...+...+..+...+|..+++++++||++
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~ 238 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG 238 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred cccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence 23344678999999999998877 48999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCcCCCC---ccccccccC
Q 024347 248 ILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
||++||.+|++.. ..+++.|+|
T Consensus 239 ~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 239 LLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred hccCCchhhcccccccHHHHHcCcc
Confidence 9999999999743 256778876
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-60 Score=379.41 Aligned_cols=255 Identities=33% Similarity=0.542 Sum_probs=215.3
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee--CCeE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS--KTKI 86 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~ 86 (269)
+.++|++.+.||+|+||.||+|+++.+|+.||+|.+...... +...+.+.+|++++++++||||+++++++.+ .+.+
T Consensus 2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence 468999999999999999999999999999999999776543 3446789999999999999999999999864 4568
Q ss_pred EEEEeccCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----cEeecCCCCceEecCCCCEEEeeCCC
Q 024347 87 FIVLEFVTGGELFDKIVN----HGRMKEDEARRYFQQLINAVDYCHSRG-----VYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh~~~-----i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
++||||++||+|.+++.. .+.+++..++.++.|++.||.|||+.| |+|+||||+|||++.++.++|+|||+
T Consensus 81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence 999999999999998854 457999999999999999999999976 99999999999999999999999999
Q ss_pred ccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc-cCCCC
Q 024347 158 SALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF-TCPPW 236 (269)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 236 (269)
++.... .........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+..+.. ..+..
T Consensus 161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 237 (269)
T d2java1 161 ARILNH--DTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred eeeccc--CCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 876443 1222334568999999999988776 4999999999999999999999999999999988887765 45667
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+|+++.+||++||+.||++|||+ .+++.|+|
T Consensus 238 ~s~~l~~li~~~L~~dp~~Rps~--~ell~hp~ 268 (269)
T d2java1 238 YSDELNEIITRMLNLKDYHRPSV--EEILENPL 268 (269)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCH--HHHHTSTT
T ss_pred cCHHHHHHHHHHcCCChhHCcCH--HHHHhCCc
Confidence 99999999999999999999999 88999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.1e-59 Score=381.90 Aligned_cols=252 Identities=34% Similarity=0.682 Sum_probs=231.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++++.||+|+||+||+|+++.+|+.||+|++...........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999999999999999999876655555567889999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
|||++|+++...+.....+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++.... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----c
Confidence 99999999999999888999999999999999999999999999999999999999999999999999876443 2
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHhc
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARIL 249 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 249 (269)
.....|++.|+|||++.+..++ .++||||||+++|+|++|+.||.+.+..+...++..+....++.++++++++|++||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 2345689999999999887765 899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCcC-----CCCccccccccC
Q 024347 250 DPNPMTVS-----IYPFADILYMRF 269 (269)
Q Consensus 250 ~~dP~~Rp-----s~~~~~~l~~~~ 269 (269)
+.||.+|+ |+ .+++.|+|
T Consensus 237 ~~dp~~R~~~~r~t~--~~il~Hp~ 259 (316)
T d1fota_ 237 TRDLSQRLGNLQNGT--EDVKNHPW 259 (316)
T ss_dssp CSCTTTCTTSSTTTT--HHHHTSGG
T ss_pred hhCHHhccccchhhH--HHHHcCcc
Confidence 99999997 55 67788887
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.7e-59 Score=381.46 Aligned_cols=252 Identities=37% Similarity=0.662 Sum_probs=209.6
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
-++|++.+.||+|+||+||+|+++.+|+.||+|++....... ....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999999999999999997655432 235678999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec---CCCCEEEeeCCCccccccccC
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~---~~~~~~l~df~~~~~~~~~~~ 166 (269)
|||++|++|.+++...+.+++.++..++.|++.||.|||+.||+|+||||+||++. .++.++|+|||+++....
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~--- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence 99999999999999888999999999999999999999999999999999999995 578899999999875432
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCHHHH
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTAR 242 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~ 242 (269)
........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.........+.......+ +.+|+++.
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 241 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241 (307)
T ss_dssp ----------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence 222334568999999999988776 4999999999999999999999999999999998887765443 46899999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||+.||+.||++|||+ .+++.|+|
T Consensus 242 ~li~~~L~~dP~~R~s~--~eil~hp~ 266 (307)
T d1a06a_ 242 DFIRHLMEKDPEKRFTC--EQALQHPW 266 (307)
T ss_dssp HHHHHHSCSSGGGSCCH--HHHHHSTT
T ss_pred HHHHHHccCCHhHCcCH--HHHhcCHh
Confidence 99999999999999999 78888987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-59 Score=380.06 Aligned_cols=250 Identities=26% Similarity=0.377 Sum_probs=221.9
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEe
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLE 91 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~ 91 (269)
+|+.++.||+|+||+||+|++..+|+.||+|++...........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 49999999999999999999999999999999987665566667889999999999999999999999999999999999
Q ss_pred ccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCccc
Q 024347 92 FVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLH 171 (269)
Q Consensus 92 ~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~ 171 (269)
|+.++++...+..++.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~ 169 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------AN 169 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BC
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------CC
Confidence 999998877777778899999999999999999999999999999999999999999999999999875432 23
Q ss_pred ccccCccccCcccccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC--CCCCCHHHHHHHHH
Q 024347 172 TTCGTPNYVAPEVLNDR--GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC--PPWLSFTARKLIAR 247 (269)
Q Consensus 172 ~~~~~~~~~aPE~~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~ 247 (269)
...||+.|+|||++.+. ..++.++||||||+++|+|++|..||.+.........+..+..+. +..+|+++++||+.
T Consensus 170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~ 249 (309)
T d1u5ra_ 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249 (309)
T ss_dssp CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 35689999999998653 234689999999999999999999999888888777776665433 34589999999999
Q ss_pred hcCCCCCCcCCCCccccccccC
Q 024347 248 ILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||+.||++|||+ .++|.|+|
T Consensus 250 ~L~~dP~~Rpt~--~ell~Hp~ 269 (309)
T d1u5ra_ 250 CLQKIPQDRPTS--EVLLKHRF 269 (309)
T ss_dssp HTCSSGGGSCCH--HHHTTCHH
T ss_pred HCcCChhHCcCH--HHHHhCHH
Confidence 999999999999 77788876
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-58 Score=383.65 Aligned_cols=254 Identities=33% Similarity=0.612 Sum_probs=232.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
...++|++++.||+|+||.||+|+++.+|+.||+|++...........+.+.+|+++++.++||||+++++++.+....+
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 34689999999999999999999999999999999998766554455678899999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
+||+|+.|+++...+...+.+++.++..++.|++.||.|||++||+|+||||+|||++.++.++|+|||+++....
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---- 193 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---- 193 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS----
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc----
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999975432
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIAR 247 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 247 (269)
......|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+..+....+..+++++.+||+.
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 271 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN 271 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred -ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence 22345689999999999887764 8999999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCcC-----CCCccccccccC
Q 024347 248 ILDPNPMTVS-----IYPFADILYMRF 269 (269)
Q Consensus 248 ~l~~dP~~Rp-----s~~~~~~l~~~~ 269 (269)
||+.||.+|+ |+ .+++.|+|
T Consensus 272 ~L~~dP~kR~~~~r~t~--~ell~Hp~ 296 (350)
T d1rdqe_ 272 LLQVDLTKRFGNLKNGV--NDIKNHKW 296 (350)
T ss_dssp HSCSCTTTCTTSSTTTT--HHHHTSGG
T ss_pred HhhhCHHhccccccccH--HHHHcCcc
Confidence 9999999995 66 77888887
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-59 Score=377.08 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=218.9
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVL 90 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 90 (269)
+.|++++.||+|+||.||+|+++.+|+.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 469999999999999999999999999999999875432 22567889999999999999999999999999999999
Q ss_pred eccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 91 EFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 91 ~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
||++||+|.+++.+ .+.+++.++..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++....... ..
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~~ 166 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QR 166 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--HH
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc--cc
Confidence 99999999988765 4579999999999999999999999999999999999999999999999999986543211 12
Q ss_pred ccccccCccccCcccccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc---cCCCCCCHHHH
Q 024347 170 LHTTCGTPNYVAPEVLNDR----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---TCPPWLSFTAR 242 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 242 (269)
.....|++.|+|||++... ..++.++|||||||++|+|++|+.||.+.+..+...++..+.. ..+..++++++
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 246 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 246 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence 2235689999999998532 2335899999999999999999999999888888888777654 33456899999
Q ss_pred HHHHHhcCCCCCCcCCCCccccccccC
Q 024347 243 KLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+||++||+.||++|||+ .+++.|+|
T Consensus 247 ~li~~~L~~dp~~R~t~--~ell~hp~ 271 (288)
T d2jfla1 247 DFLKKCLEKNVDARWTT--SQLLQHPF 271 (288)
T ss_dssp HHHHHHSCSSTTTSCCH--HHHTTSGG
T ss_pred HHHHHHccCChhHCcCH--HHHhcCcc
Confidence 99999999999999999 77888887
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-58 Score=376.01 Aligned_cols=256 Identities=30% Similarity=0.538 Sum_probs=227.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHh-hhCCCCCceeeeEEEeeCCeEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATM-KLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l-~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
.++|++.+.||+|+||+||+|.++.+|+.||+|++...........+.+..|..++ +.++||||+++++++.+.+..++
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 36899999999999999999999999999999999876554444455666666665 47899999999999999999999
Q ss_pred EEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 89 VLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
||||++||+|.+++...+.+++.++..++.|++.||.|||++|++|+||||+|||++.++.++|+|||+++..... ..
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--DA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc--cc
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998754332 22
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHHHHHHh
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARKLIARI 248 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 248 (269)
......|++.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+.......+..+.+..+..+|+++.+||++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 33345689999999999988775 89999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCcCCCCccccccccC
Q 024347 249 LDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 249 l~~dP~~Rps~~~~~~l~~~~ 269 (269)
|+.||.+||+++ .+.+.|+|
T Consensus 238 L~~dP~~R~s~~-~~l~~hpf 257 (320)
T d1xjda_ 238 FVREPEKRLGVR-GDIRQHPL 257 (320)
T ss_dssp SCSSGGGSBTTB-SCGGGSGG
T ss_pred cccCCCCCcCHH-HHHHhCch
Confidence 999999999983 14667776
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-58 Score=374.44 Aligned_cols=253 Identities=36% Similarity=0.587 Sum_probs=224.6
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
++|++.+.||+|+||.||+|+++.+|+.||+|++........ ...+.+.+|+.++++++||||+++++++.+.+.++
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 679999999999999999999999999999999875433221 23577899999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC----CEEEeeCCCcccccc
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG----NLKVSDFGLSALSQQ 163 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~----~~~l~df~~~~~~~~ 163 (269)
+||||++|++|.+++...+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++ .++++|||++.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 9999999999999998888999999999999999999999999999999999999998776 499999999875432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 239 (269)
........+++.|+|||++.+..+ +.++||||+|+++|+|++|..||.+.+..+...++.......+ +.+|+
T Consensus 170 ---~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 245 (293)
T d1jksa_ 170 ---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245 (293)
T ss_dssp ---SCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCH
T ss_pred ---CccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCH
Confidence 223334567899999999988766 5999999999999999999999999999999999888766554 56899
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+++||++||+.||++|||+ .+++.|+|
T Consensus 246 ~~~~li~~~L~~dP~~R~s~--~eil~hp~ 273 (293)
T d1jksa_ 246 LAKDFIRRLLVKDPKKRMTI--QDSLQHPW 273 (293)
T ss_dssp HHHHHHHTTSCSSGGGSCCH--HHHHHSTT
T ss_pred HHHHHHHHHccCChhHCcCH--HHHhcCcc
Confidence 99999999999999999999 77888987
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-58 Score=379.94 Aligned_cols=254 Identities=26% Similarity=0.490 Sum_probs=224.8
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
+..+++|++++.||+|+||.||+|.++.+|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.+
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 4456789999999999999999999999999999999876442 2246788999999999999999999999999999
Q ss_pred EEEEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec--CCCCEEEeeCCCcccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD--AYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~--~~~~~~l~df~~~~~~~~ 163 (269)
++||||++|++|.+.+...+ .+++.++..++.|++.||.|||++||+|+||||+|||++ .++.++|+|||++.....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCC
Confidence 99999999999988776544 699999999999999999999999999999999999998 568899999999875443
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSF 239 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~ 239 (269)
........+++.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+.......+..+....+ +.+++
T Consensus 182 ---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 182 ---DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp ---TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred ---CCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2333445689999999999887764 999999999999999999999999999999888887765544 45899
Q ss_pred HHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 240 TARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++.+||+.||++||.+|||+ .++|.|+|
T Consensus 258 ~~~~li~~~L~~dp~~R~s~--~eil~Hp~ 285 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTV--HDALEHPW 285 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCH--HHHHTSTT
T ss_pred HHHHHHHHHccCChhHCcCH--HHHhcCHh
Confidence 99999999999999999999 77888887
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-57 Score=364.50 Aligned_cols=249 Identities=25% Similarity=0.479 Sum_probs=214.1
Q ss_pred Ce-EEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee----CCeE
Q 024347 12 KY-EVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS----KTKI 86 (269)
Q Consensus 12 ~~-~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~ 86 (269)
|| ++.+.||+|+||+||+|.++.+++.||+|.+...... ....+.+.+|++++++++||||+++++++.+ ...+
T Consensus 9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 45 6778999999999999999999999999999765543 3446789999999999999999999999865 3568
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--cEeecCCCCceEec-CCCCEEEeeCCCcccccc
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRG--VYHRDLKPENLLLD-AYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--i~h~di~~~nIl~~-~~~~~~l~df~~~~~~~~ 163 (269)
++||||+++++|.+++.+.+.+++.++..++.|++.||+|||+++ |+|+||||+||+++ .++.+||+|||+++....
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999999988889999999999999999999999998 99999999999996 578999999999874322
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcCcc--cCCCCCCHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS-NLMNLYKKISAAEF--TCPPWLSFT 240 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~-~~~~~~~~~~~~~~--~~~~~~~~~ 240 (269)
.......||+.|+|||++.+. + +.++||||||+++|+|++|+.||... +...+...+..+.. ..+...+++
T Consensus 168 ----~~~~~~~GT~~Y~aPE~~~~~-~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 241 (270)
T d1t4ha_ 168 ----SFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241 (270)
T ss_dssp ----TSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred ----CccCCcccCccccCHHHhCCC-C-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence 233445789999999998764 4 59999999999999999999999764 45556666665543 334558899
Q ss_pred HHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+++||++||++||++|||+ .++|.|+|
T Consensus 242 ~~~li~~~l~~dp~~R~s~--~ell~Hp~ 268 (270)
T d1t4ha_ 242 VKEIIEGCIRQNKDERYSI--KDLLNHAF 268 (270)
T ss_dssp HHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred HHHHHHHHccCCHhHCcCH--HHHhCCcc
Confidence 9999999999999999999 88899998
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.5e-57 Score=365.95 Aligned_cols=255 Identities=31% Similarity=0.514 Sum_probs=225.1
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh------hHHHHHHHHHHHHHhhhCC-CCCceeeeEEEee
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL------KHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS 82 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~------~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 82 (269)
.++|++.+.||+|+||+||+|+++.+|+.||+|++...... .....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57999999999999999999999999999999998754322 2334567889999999997 9999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
.+..++||||++|++|.+++..++.+++.++..++.|++.||+|||++||+||||+|+||+++.++.++|+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCcccccccCccccCcccccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC---
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDR-----GYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP--- 234 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--- 234 (269)
. ........+++.|+|||.+.+. ..++.++||||+|+++|+|++|+.||.+.+.......+..+....+
T Consensus 162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 3 2223445689999999998632 2236899999999999999999999999999998888887765433
Q ss_pred -CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 235 -PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 235 -~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
+.+|+++++||++||+.||++|||+ .++|.|+|
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~--~eil~h~~ 272 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTA--EEALAHPF 272 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCH--HHHTTSGG
T ss_pred cccCCHHHHHHHHHHccCChhHCcCH--HHHHcCHH
Confidence 3689999999999999999999999 88899987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.1e-58 Score=379.52 Aligned_cols=252 Identities=29% Similarity=0.544 Sum_probs=223.1
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
-.++|++.+.||+|+||.||+|+++.+|+.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 4578999999999999999999999999999999986543 2335778899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC--CCCEEEeeCCCcccccccc
Q 024347 89 VLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA--YGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~--~~~~~l~df~~~~~~~~~~ 165 (269)
||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+|+||||+||+++. ++.++|+|||++.....
T Consensus 101 vmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~-- 178 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-- 178 (350)
T ss_dssp EECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT--
T ss_pred EEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccc--
Confidence 9999999999998854 457999999999999999999999999999999999999964 57899999999875432
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCC----CCCCHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCP----PWLSFTA 241 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l 241 (269)
........+++.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+...++.......+ +.+++++
T Consensus 179 -~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 256 (350)
T d1koaa2 179 -KQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG 256 (350)
T ss_dssp -TSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHH
T ss_pred -ccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHH
Confidence 2333445689999999999887764 899999999999999999999999999999998887765444 3589999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++||++||+.||++|||+ .++|.|+|
T Consensus 257 ~~li~~~L~~dP~~R~t~--~eil~hp~ 282 (350)
T d1koaa2 257 KDFIRKLLLADPNTRMTI--HQALEHPW 282 (350)
T ss_dssp HHHHHHHCCSSGGGSCCH--HHHHHSTT
T ss_pred HHHHHHHccCChhHCcCH--HHHhcCcc
Confidence 999999999999999999 78889987
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-58 Score=376.12 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=213.5
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEE
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIF 87 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 87 (269)
..-++|++++.||+|+||+||+|+++.+|+.||+|+++.... ....+.+.+|+.++++++||||+++++++.+.+.++
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC--TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC--HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456899999999999999999999999999999999875432 233577899999999999999999999999999999
Q ss_pred EEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCCEEEeeCCCccccccccC
Q 024347 88 IVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRD 166 (269)
Q Consensus 88 ~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~ 166 (269)
+||||++|++|.+++.+.+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+|......
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999999888899999999999999999999997 59999999999999999999999999998754332
Q ss_pred CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH------------------------
Q 024347 167 DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL------------------------ 222 (269)
Q Consensus 167 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------------------------ 222 (269)
......|++.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..+.
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred --ccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 12335689999999999987764 999999999999999999999975433221
Q ss_pred ------------------HHHHhcCccc-CC-CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 223 ------------------YKKISAAEFT-CP-PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 223 ------------------~~~~~~~~~~-~~-~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+.....+ .+ ..++.++.+||++||+.||++|||+ .++|.|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta--~e~L~Hpf 300 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL--KQLMVHAF 300 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCH--HHHHTSHH
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCH--HHHhhCHh
Confidence 1111111111 11 1267899999999999999999999 88889987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.2e-57 Score=375.58 Aligned_cols=257 Identities=28% Similarity=0.417 Sum_probs=219.9
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHH---HHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAE---QIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~---~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
..++|++.+.||+|+||.||+|+++.+|+.||+|++............ ...+++++++.++||||+++++++.+.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 467999999999999999999999999999999999765543332222 33445778888899999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||++|++|.+++.....+++..+..++.|++.||.|||+.||+|+||||+|||++.++.+||+|||++.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999888999999999999999999999999999999999999999999999999999875433
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCcccCCCCCCHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSN---LMNLYKKISAAEFTCPPWLSFTAR 242 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~ 242 (269)
.......|++.|+|||++.+...++.++|||||||++|+|++|+.||.... ...............+..++++++
T Consensus 160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 223345689999999999766555699999999999999999999997643 334455555666777788999999
Q ss_pred HHHHHhcCCCCCCcCCCC---ccccccccC
Q 024347 243 KLIARILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 243 ~li~~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
+||+.||+.||++|||.. ..+++.|+|
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 999999999999999953 267778887
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-57 Score=370.81 Aligned_cols=251 Identities=24% Similarity=0.450 Sum_probs=222.9
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
-+++|++.+.||+|+||+||+|.++.+|+.||+|++...... ...+.+|+++++.++||||+++++++.+.+.+++
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 478999999999999999999999999999999999765422 3457889999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC--CCEEEeeCCCcccccccc
Q 024347 89 VLEFVTGGELFDKIVNHG-RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY--GNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~--~~~~l~df~~~~~~~~~~ 165 (269)
||||++|++|.+++...+ .+++.++..++.|++.||.|||+.||+|+||+|+||+++.+ ..++++|||++.....
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-- 156 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-- 156 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT--
T ss_pred EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhcccc--
Confidence 999999999999997765 79999999999999999999999999999999999999854 4799999999875432
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC----CCCHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP----WLSFTA 241 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~l 241 (269)
........+++.|+|||.+.+..+. .++|||||||++|+|++|..||...+..+....+.......+. .+++++
T Consensus 157 -~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 234 (321)
T d1tkia_ 157 -GDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234 (321)
T ss_dssp -TCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred -CCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence 2333445678999999999887764 8999999999999999999999999999999999888776653 589999
Q ss_pred HHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 242 RKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
++||+.||+.||++|||+ .+++.|+|
T Consensus 235 ~~li~~~L~~dp~~R~s~--~eil~hp~ 260 (321)
T d1tkia_ 235 MDFVDRLLVKERKSRMTA--SEALQHPW 260 (321)
T ss_dssp HHHHHTTSCSSGGGSCCH--HHHHHSHH
T ss_pred HHHHHHHccCChhHCcCH--HHHhcCHh
Confidence 999999999999999999 67788876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.5e-56 Score=360.01 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=213.3
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC----e
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----K 85 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~ 85 (269)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 468999999999999999999999999999999998776666667788999999999999999999999987643 4
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
.++||||++|++|...+...+.+++.++..++.|++.||.|||++||+|+||||+||+++.++..+++|||.+.......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999888899999999999999999999999999999999999999999999999999876543322
Q ss_pred C-CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCccc----CCCCCCHH
Q 024347 166 D-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFT----CPPWLSFT 240 (269)
Q Consensus 166 ~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 240 (269)
. ........|++.|+|||++.+..++ .++||||||+++|+|++|+.||.+.+..+...+....... ..+.+|++
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 244 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD 244 (277)
T ss_dssp -------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred ccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence 2 2233445689999999999887664 8999999999999999999999998888877776655432 23568999
Q ss_pred HHHHHHHhcCCCCCCcCCCCcccccc
Q 024347 241 ARKLIARILDPNPMTVSIYPFADILY 266 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~~~l~ 266 (269)
+.+||++||++||.+||+. ++.+.
T Consensus 245 l~~li~~~L~~dp~~R~~s--a~~l~ 268 (277)
T d1o6ya_ 245 LDAVVLKALAKNPENRYQT--AAEMR 268 (277)
T ss_dssp HHHHHHHHTCSSGGGSCSS--HHHHH
T ss_pred HHHHHHHHccCCHhHCHhH--HHHHH
Confidence 9999999999999999965 44443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-56 Score=362.17 Aligned_cols=251 Identities=24% Similarity=0.335 Sum_probs=215.8
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
++...++|++.+.||+|+||+||+|.+..+++.||+|++..+... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence 566778999999999999999999999999999999998754432 4578899999999999999999999999999
Q ss_pred EEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
.+++|||+++|++..++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCC
Confidence 99999999999999988764 4689999999999999999999999999999999999999999999999999876443
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCC-CCCCCCHHHHHHHHhcC-cccCCCCCCHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYL-PFDDSNLMNLYKKISAA-EFTCPPWLSFTA 241 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 241 (269)
.. ........+++.|+|||++.+..+ +.++||||||+++|+|++|.. ||...+.....+.+..+ .++.+..+++++
T Consensus 168 ~~-~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 245 (287)
T d1opja_ 168 DT-YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245 (287)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred CC-ceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHH
Confidence 21 112223346889999999988776 499999999999999999655 55666777776666554 456677899999
Q ss_pred HHHHHHhcCCCCCCcCCCCcc
Q 024347 242 RKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 242 ~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+||+.||+.||++|||++++
T Consensus 246 ~~li~~cl~~dP~~Rps~~ei 266 (287)
T d1opja_ 246 YELMRACWQWNPSDRPSFAEI 266 (287)
T ss_dssp HHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHcCCCHhHCcCHHHH
Confidence 999999999999999998655
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-55 Score=358.74 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=205.2
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCC---eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGE---PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~---~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
...++|++.+.||+|+||+||+|.++.+++ .||+|.+.... .....+.+.+|+.++++++||||+++++++...+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 345789999999999999999999876665 47788765432 3444678999999999999999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++||||+++|+|.+++... +.+++.++..++.|+++||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999999999888764 5799999999999999999999999999999999999999999999999999976543
Q ss_pred ccCCCc---ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCC
Q 024347 164 VRDDGL---LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLS 238 (269)
Q Consensus 164 ~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (269)
...... .....+++.|+|||++.+..++ .++||||||+++|+|+| |..||.+....+....+..+ +.+.+..++
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 259 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCP 259 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccch
Confidence 222111 1223468899999999887664 89999999999999998 89999999888888888665 456777899
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 239 FTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.+.+|+..||+.||++|||++++
T Consensus 260 ~~l~~li~~cl~~~P~~RPs~~ei 283 (299)
T d1jpaa_ 260 SALHQLMLDCWQKDRNHRPKFGQI 283 (299)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHH
Confidence 999999999999999999998553
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-56 Score=357.36 Aligned_cols=251 Identities=22% Similarity=0.371 Sum_probs=203.4
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
++...++|++.+.||+|+||+||+|++. ..||+|++...... ....+.+.+|+.++++++||||+++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4567789999999999999999999864 35999998754433 334678999999999999999999999874 456
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++||||+++|+|.+++... ..+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999999999998764 56999999999999999999999999999999999999999999999999999766544
Q ss_pred cCCCcccccccCccccCcccccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHhcCcc-----cCCCC
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRG--YDGSTADLWSCGVILFVLLAGYLPFDDSNLMNL-YKKISAAEF-----TCPPW 236 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~-----~~~~~ 236 (269)
..........+++.|+|||++.+.. .++.++||||||+++|+|++|+.||.+.+.... ...+..+.. ..+..
T Consensus 158 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 237 (276)
T d1uwha_ 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSN 237 (276)
T ss_dssp --------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTT
T ss_pred CCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhcccc
Confidence 4444444556899999999986543 346899999999999999999999987655443 333333321 23456
Q ss_pred CCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 237 LSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 237 ~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
+|+++.+|+.+||+.||.+|||+++
T Consensus 238 ~~~~l~~li~~cl~~dp~~RPt~~~ 262 (276)
T d1uwha_ 238 CPKAMKRLMAECLKKKRDERPLFPQ 262 (276)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHH
Confidence 8999999999999999999999844
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-56 Score=359.15 Aligned_cols=247 Identities=30% Similarity=0.532 Sum_probs=212.8
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhH---HHHHHHHHHHHHhhhCC--CCCceeeeEEEeeCCe
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKH---KMAEQIKREVATMKLVK--HPNVVRLYEVMGSKTK 85 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~---~~~~~~~~e~~~l~~l~--~~~i~~~~~~~~~~~~ 85 (269)
++|++.+.||+|+||+||+|.+..+|+.||+|++........ .....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 689999999999999999999999999999999876443221 11234567999999987 8999999999999999
Q ss_pred EEEEEeccCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCC-CCEEEeeCCCcccccc
Q 024347 86 IFIVLEFVTG-GELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAY-GNLKVSDFGLSALSQQ 163 (269)
Q Consensus 86 ~~~v~~~~~~-~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~-~~~~l~df~~~~~~~~ 163 (269)
.++||||+.+ +++.+++...+.+++.++..++.|++.||.|||++||+|+||||+||+++.+ +.++|+|||++.....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 9999999976 5777778778899999999999999999999999999999999999999854 6899999999875432
Q ss_pred ccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCCCCCHHHHH
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPPWLSFTARK 243 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 243 (269)
.......|++.|+|||++.+..+++.++|||||||++|+|++|+.||... +.+..+....++.+|+++++
T Consensus 164 ----~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i~~~~~~~~~~~s~~~~~ 233 (273)
T d1xwsa_ 164 ----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQH 233 (273)
T ss_dssp ----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHHHHCCCCCSSCCCHHHHH
T ss_pred ----ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hHHhhcccCCCCCCCHHHHH
Confidence 22334568999999999987776667899999999999999999999763 34556677788889999999
Q ss_pred HHHHhcCCCCCCcCCCCccccccccC
Q 024347 244 LIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
||++||+.||++|||+ .+++.|+|
T Consensus 234 li~~~L~~dp~~R~s~--~eil~hp~ 257 (273)
T d1xwsa_ 234 LIRWCLALRPSDRPTF--EEIQNHPW 257 (273)
T ss_dssp HHHHHTCSSGGGSCCH--HHHHTSGG
T ss_pred HHHHHccCCHhHCcCH--HHHhcCHh
Confidence 9999999999999999 77888887
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-56 Score=360.97 Aligned_cols=251 Identities=26% Similarity=0.346 Sum_probs=208.3
Q ss_pred EeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh--HHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEec
Q 024347 15 VGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK--HKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEF 92 (269)
Q Consensus 15 ~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~ 92 (269)
.++.||+|+||+||+|.++.+|+.||+|++....... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 4689999999999999999999999999986544322 12235688999999999999999999999999999999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCcccc
Q 024347 93 VTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHT 172 (269)
Q Consensus 93 ~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~ 172 (269)
+.++++.........+++.++..++.|++.||+|||++||+|+||||+||+++.++.+||+|||.+...... ......
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~~~~ 159 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTH 159 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--cccccc
Confidence 998877766666678999999999999999999999999999999999999999999999999998654332 222334
Q ss_pred cccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--c-------------------
Q 024347 173 TCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE--F------------------- 231 (269)
Q Consensus 173 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--~------------------- 231 (269)
..+++.|+|||++.+...++.++|||||||++|+|++|..||.+....+....+.... +
T Consensus 160 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ua2a_ 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239 (299)
T ss_dssp SCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCC
T ss_pred eecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhcc
Confidence 5689999999999877666799999999999999999999999988877766653210 0
Q ss_pred -------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 -------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 -------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+..++++.+||++||+.||++|||+ .++|.|+|
T Consensus 240 ~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa--~e~L~Hp~ 282 (299)
T d1ua2a_ 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITA--TQALKMKY 282 (299)
T ss_dssp CCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCH--HHHHTSGG
T ss_pred CCCCChHHhcccCCHHHHHHHHHHccCChhhCcCH--HHHhCCHh
Confidence 0012368899999999999999999999 77889987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-55 Score=363.71 Aligned_cols=253 Identities=20% Similarity=0.328 Sum_probs=210.6
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCC-----eEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEE
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGE-----PVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEV 79 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~-----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~ 79 (269)
++...++|++.+.||+|+||+||+|.+...++ .||+|.+.... .......+.+|+.++.++ +||||++++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 44566899999999999999999999876554 58999876543 233356788999999988 89999999999
Q ss_pred EeeCCeEEEEEeccCCCchhHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeec
Q 024347 80 MGSKTKIFIVLEFVTGGELFDKIVNHG-----------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRD 136 (269)
Q Consensus 80 ~~~~~~~~~v~~~~~~~~l~~~~~~~~-----------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~d 136 (269)
+.+.+..++||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+|||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 999999999999999999999986542 478899999999999999999999999999
Q ss_pred CCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 024347 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFD 215 (269)
Q Consensus 137 i~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~ 215 (269)
|||+||+++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCC
Confidence 999999999999999999999976554433333334557899999999987776 499999999999999997 899998
Q ss_pred CCCHHHHHHHHh-cC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 216 DSNLMNLYKKIS-AA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 216 ~~~~~~~~~~~~-~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
+.+......++. .+ +++.+..+|+++.+||+.||+.||++|||+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~e 316 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPN 316 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 766554444443 32 45667889999999999999999999999844
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=355.21 Aligned_cols=254 Identities=29% Similarity=0.433 Sum_probs=211.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++++.||+|+||+||+|.+..+|+.||+|++..... .+...+.+.+|++++++++||||+++++++.+.+.+++|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3789999999999999999999999999999999965442 233457888999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 90 LEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
|||+.++.+ ..+.. .+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||.++.... ..
T Consensus 80 ~e~~~~~~~-~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~ 156 (298)
T d1gz8a_ 80 FEFLHQDLK-KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV 156 (298)
T ss_dssp EECCSEEHH-HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred EeecCCchh-hhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Cc
Confidence 999976444 44432 35699999999999999999999999999999999999999999999999999875433 22
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcc----------------
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEF---------------- 231 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------- 231 (269)
.......+++.|+|||++......+.++|+||+|+++|+|++|+.||.+.+..+...++.....
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence 3334456899999999988877767999999999999999999999998877766555422100
Q ss_pred --c-----------CCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 232 --T-----------CPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 232 --~-----------~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ..+.+++++++||++||+.||++|||+ .++|.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~--~ell~H~f 285 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA--KAALAHPF 285 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH--HHHHTSGG
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH--HHHhCCHh
Confidence 0 012367899999999999999999999 78889987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=350.19 Aligned_cols=246 Identities=23% Similarity=0.378 Sum_probs=204.4
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEE
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 88 (269)
..++|++.+.||+|+||+||+|.+. +++.||||++...... .+.+.+|++++++++||||+++++++...+..++
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 3568999999999999999999986 5678999998754432 3568899999999999999999999999999999
Q ss_pred EEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC
Q 024347 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD 167 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~ 167 (269)
||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++........
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999999988764 56889999999999999999999999999999999999999999999999998765432221
Q ss_pred CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHHHH
Q 024347 168 GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLI 245 (269)
Q Consensus 168 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li 245 (269)
......+++.|+|||++.+..+ +.++||||||+++|+|++ |.+||......+..+.+..+ +...+..+++++.+|+
T Consensus 158 -~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 235 (263)
T d1sm2a_ 158 -SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235 (263)
T ss_dssp --------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred -eecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHH
Confidence 2233457889999999988776 499999999999999998 67888888888888888665 4555677899999999
Q ss_pred HHhcCCCCCCcCCCCc
Q 024347 246 ARILDPNPMTVSIYPF 261 (269)
Q Consensus 246 ~~~l~~dP~~Rps~~~ 261 (269)
..||+.||++|||+++
T Consensus 236 ~~cl~~~p~~Rps~~~ 251 (263)
T d1sm2a_ 236 NHCWKERPEDRPAFSR 251 (263)
T ss_dssp HHHTCSSGGGSCCHHH
T ss_pred HHHccCCHhHCcCHHH
Confidence 9999999999999843
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=354.79 Aligned_cols=253 Identities=20% Similarity=0.345 Sum_probs=213.9
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
+.+++...++|++.+.||+|+||.||+|.++ +++.||||++...... .+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 79 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ 79 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC----HHHHHHHHHHHHhCCCCCEeEEEeeecc
Confidence 4556677899999999999999999999986 5778999998754432 3578999999999999999999998754
Q ss_pred CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
+..++||||+++|+|.+.+... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~ 158 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEE
Confidence 5678999999999998876543 3699999999999999999999999999999999999999999999999999976
Q ss_pred cccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCC
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLS 238 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (269)
...... .......+++.|+|||++.+..+ +.++||||||+++|+|+| |.+||......+....+..+ +...+..++
T Consensus 159 ~~~~~~-~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~ 236 (272)
T d1qpca_ 159 IEDNEY-TAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCP 236 (272)
T ss_dssp CSSSCE-ECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCC
T ss_pred ccCCcc-ccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccCh
Confidence 543211 12223457889999999987666 489999999999999999 56677778888888888765 456677899
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 239 FTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
+++.+|++.||+.||++|||++++.
T Consensus 237 ~~l~~li~~cl~~~P~~Rpt~~ei~ 261 (272)
T d1qpca_ 237 EELYQLMRLCWKERPEDRPTFDYLR 261 (272)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 9999999999999999999986653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=348.49 Aligned_cols=245 Identities=22% Similarity=0.377 Sum_probs=215.2
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++.+.||+|+||+||+|+++ +++.||||+++..... .+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 478999999999999999999985 6788999999765433 35788999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCC
Q 024347 90 LEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDG 168 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~ 168 (269)
|||+++|++..++.. ...+++..+..++.|+++||.|||+.||+|+||+|+||+++.++.++|+|||+++....... .
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~ 156 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-T 156 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-C
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc-e
Confidence 999999999888655 45789999999999999999999999999999999999999999999999999876544222 2
Q ss_pred cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHHHHH
Q 024347 169 LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIA 246 (269)
Q Consensus 169 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~ 246 (269)
......+++.|+|||++.+..++ .++||||||+++|+|+| |+.||......+....+..+ +.+.|..+++++.+||+
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~ 235 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY 235 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred eecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence 22334578899999999887764 89999999999999998 89999999999998888775 45667789999999999
Q ss_pred HhcCCCCCCcCCCCc
Q 024347 247 RILDPNPMTVSIYPF 261 (269)
Q Consensus 247 ~~l~~dP~~Rps~~~ 261 (269)
.||+.||++|||+++
T Consensus 236 ~cl~~dP~~RPt~~e 250 (258)
T d1k2pa_ 236 SCWHEKADERPTFKI 250 (258)
T ss_dssp HTTCSSGGGSCCHHH
T ss_pred HHccCCHhHCcCHHH
Confidence 999999999999843
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=353.96 Aligned_cols=244 Identities=21% Similarity=0.340 Sum_probs=206.4
Q ss_pred eeeeccCCcEEEEEEEc--CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEEEeccC
Q 024347 17 RTIGEGTFAKVKFARNS--ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 17 ~~lg~g~~~~v~~~~~~--~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 94 (269)
+.||+|+||+||+|.+. .+++.||+|++..... +....+.+.+|++++++++||||+++++++.+. ..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 46999999999999764 3467899999865443 334467899999999999999999999998654 5689999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC-Cccccc
Q 024347 95 GGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD-GLLHTT 173 (269)
Q Consensus 95 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~ 173 (269)
+|+|.+++.....+++.++..++.|++.||.|||++||+|+||||+||+++.++.++++|||+++........ ......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999998889999999999999999999999999999999999999999999999999998765432221 122334
Q ss_pred ccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHHHHHHHHHhcCC
Q 024347 174 CGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFTARKLIARILDP 251 (269)
Q Consensus 174 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~ 251 (269)
.+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..+....+..+ +++.+..+|+++.+|+.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 57889999999987766 489999999999999997 89999999888888888765 4667788999999999999999
Q ss_pred CCCCcCCCCccc
Q 024347 252 NPMTVSIYPFAD 263 (269)
Q Consensus 252 dP~~Rps~~~~~ 263 (269)
||++|||++++.
T Consensus 250 dp~~RPs~~~i~ 261 (277)
T d1xbba_ 250 DVENRPGFAAVE 261 (277)
T ss_dssp STTTSCCHHHHH
T ss_pred CHhHCcCHHHHH
Confidence 999999986653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-55 Score=351.76 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=212.6
Q ss_pred cccCCeEEeee-eeccCCcEEEEEEEcC--CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC
Q 024347 8 RRVGKYEVGRT-IGEGTFAKVKFARNSE--TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT 84 (269)
Q Consensus 8 ~~~~~~~~~~~-lg~g~~~~v~~~~~~~--~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 84 (269)
..-++|.+.+. ||+|+||+||+|.+.. ++..||||++.... .....+.+.+|++++++++||||+++++++.+ +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 34468889885 9999999999998754 34579999986543 33446789999999999999999999999865 4
Q ss_pred eEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
..++||||+++|+|.+++... +.+++.++..++.|++.||.|||++||+|+||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 578999999999999987654 5799999999999999999999999999999999999999999999999999976544
Q ss_pred ccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHH
Q 024347 164 VRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFT 240 (269)
Q Consensus 164 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 240 (269)
.... .......+++.|+|||++.+..+ +.++||||||+++|+|++ |..||.+....+....+..+. ++.++.+|++
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~ 240 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE 240 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred cccccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHH
Confidence 2221 12223457889999999987766 489999999999999998 899999888888888887654 5677889999
Q ss_pred HHHHHHHhcCCCCCCcCCCCcc
Q 024347 241 ARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.+||..||+.||++|||+.++
T Consensus 241 l~~li~~cl~~~p~~RPs~~~i 262 (285)
T d1u59a_ 241 LYALMSDCWIYKWEDRPDFLTV 262 (285)
T ss_dssp HHHHHHHTTCSSGGGSCCHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHH
Confidence 9999999999999999998554
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.9e-54 Score=350.70 Aligned_cols=254 Identities=30% Similarity=0.424 Sum_probs=213.0
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++++.||+|+||+||+|+++ +|+.||+|++...... +...+.+.+|+.++++++||||+++++++.+.+..+++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 379999999999999999999986 7899999999765432 23357888999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
++++.++.+.......+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++++|||.+...... ...
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--VRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC--ccc
Confidence 999988777666666778999999999999999999999999999999999999999999999999998754332 222
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc-------------------
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------------- 230 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------------- 230 (269)
.....+++.|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+..+...++....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3334578899999999877766799999999999999999999999887776666542110
Q ss_pred ----------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ----------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
....+.+++.+.+||++||++||++|||+ .++|.|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~--~ell~Hp~ 283 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA--KQALEHAY 283 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCH--HHHHTSGG
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCH--HHHhcCcc
Confidence 01123468899999999999999999999 78899998
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-54 Score=349.05 Aligned_cols=257 Identities=21% Similarity=0.348 Sum_probs=211.4
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
..++.+..++|++.+.||+|+||+||+|.++. ++.||+|++...... .+.+.+|+.++++++||||+++++++.+
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~ 83 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCC----HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence 44567778999999999999999999999875 457999998755432 3678899999999999999999999854
Q ss_pred CCeEEEEEeccCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVN--HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
+..++||||+++|++..++.. .+.+++.++..++.|++.||+|||+.||+||||||+||+++.++.++|+|||+++.
T Consensus 84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~ 162 (285)
T d1fmka3 84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162 (285)
T ss_dssp -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhh
Confidence 567899999999999887754 35799999999999999999999999999999999999999999999999999876
Q ss_pred cccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcC-cccCCCCCC
Q 024347 161 SQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAA-EFTCPPWLS 238 (269)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (269)
...... .......+++.|+|||++.+...+ .++||||||+++|+|++| .+|+......+....+..+ +.+.++.++
T Consensus 163 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (285)
T d1fmka3 163 IEDNEY-TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 240 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred ccCCCc-eeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccC
Confidence 543221 222334578999999999887764 999999999999999995 5666777777777777654 457788899
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCccccccc
Q 024347 239 FTARKLIARILDPNPMTVSIYPFADILYM 267 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~~~l~~ 267 (269)
+++++||.+||+.||++|||++++....+
T Consensus 241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~ 269 (285)
T d1fmka3 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLE 269 (285)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHHHh
Confidence 99999999999999999999977654333
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-53 Score=344.52 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=206.4
Q ss_pred ccccCCeEEeeeeeccCCcEEEEEEEcCCC----CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 7 KRRVGKYEVGRTIGEGTFAKVKFARNSETG----EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 7 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~----~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
+...+.|+..+.||+|+||.||+|.++.++ ..||||.+.... .......+.+|++++++++||||+++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 455678999999999999999999987654 369999986543 23345678999999999999999999999999
Q ss_pred CCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
....+++|||+.++++.+.+... +.+++.++..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999998877654 57999999999999999999999999999999999999999999999999999765
Q ss_pred ccccCC-CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcC-cccCCCCCC
Q 024347 162 QQVRDD-GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISAA-EFTCPPWLS 238 (269)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 238 (269)
...... .......+++.|+|||++.+..++ .++||||||+++|+|+++ .+|+......+....+..+ +.+.+..++
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 239 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP 239 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhH
Confidence 443222 122334578899999999887764 899999999999999985 5566667777777777665 456677799
Q ss_pred HHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 239 FTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
..+.+||..||+.||++|||+.++
T Consensus 240 ~~l~~li~~cl~~~p~~RPt~~ei 263 (283)
T d1mqba_ 240 SAIYQLMMQCWQQERARRPKFADI 263 (283)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHHHHHHHCcCCHhHCcCHHHH
Confidence 999999999999999999998654
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-54 Score=356.12 Aligned_cols=248 Identities=33% Similarity=0.572 Sum_probs=205.1
Q ss_pred cccCCeEEee-eeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhh-hCCCCCceeeeEEEee---
Q 024347 8 RRVGKYEVGR-TIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMK-LVKHPNVVRLYEVMGS--- 82 (269)
Q Consensus 8 ~~~~~~~~~~-~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~--- 82 (269)
.-.++|.+.+ .||+|+||.||+|++..+++.||+|++... ..+.+|+.++. ..+||||+++++++.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 3468999875 599999999999999999999999998642 34567888865 4589999999999865
Q ss_pred -CCeEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC---CCCEEEeeCC
Q 024347 83 -KTKIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA---YGNLKVSDFG 156 (269)
Q Consensus 83 -~~~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~---~~~~~l~df~ 156 (269)
...+++||||++||+|.+++... ..+++.++..++.|++.||+|||+.||+||||||+||+++. ++.++|+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccc
Confidence 46689999999999999999774 36999999999999999999999999999999999999985 4569999999
Q ss_pred CccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHhcCccc
Q 024347 157 LSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLY----KKISAAEFT 232 (269)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~ 232 (269)
+++.... ........|++.|+|||++.+..++ .++|||||||++|+|++|..||.+....... ..+..+...
T Consensus 160 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 160 FAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235 (335)
T ss_dssp TCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSS
T ss_pred eeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 9875443 2233455689999999999887764 8999999999999999999999765543333 333444444
Q ss_pred CCC----CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 233 CPP----WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 233 ~~~----~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+. .+|+++.+||+.||+.||++|||+ .+++.|+|
T Consensus 236 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~--~eil~hp~ 274 (335)
T d2ozaa1 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTI--TEFMNHPW 274 (335)
T ss_dssp CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCH--HHHHHSHH
T ss_pred CCCcccccCCHHHHHHHHHHccCChhHCcCH--HHHHcCHH
Confidence 442 489999999999999999999999 67788776
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=343.25 Aligned_cols=252 Identities=26% Similarity=0.384 Sum_probs=204.5
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS 82 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 82 (269)
++...++|++.+.||+|+||.||+|.+..++ ..||+|.+... ......+.+.+|+.++++++||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4556789999999999999999999986543 35777776433 24455678999999999999999999999985
Q ss_pred CCeEEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccc
Q 024347 83 KTKIFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALS 161 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~ 161 (269)
.+..++||||++++++.+++... ..+++..+..++.|+++||.|||+.|++|+||||+||+++.++.+||+|||+++..
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 46789999999999998877654 57999999999999999999999999999999999999999999999999998754
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCH
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSF 239 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 239 (269)
.... ........+++.|+|||++.+..++ .++||||||+++|+|++ |..||......+....+..+. .+.++.+|+
T Consensus 159 ~~~~-~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~ 236 (273)
T d1mp8a_ 159 EDST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP 236 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred cCCc-ceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCH
Confidence 4322 1222334578899999999877764 89999999999999987 899999988888888887765 577888999
Q ss_pred HHHHHHHHhcCCCCCCcCCCCcc
Q 024347 240 TARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 240 ~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
++.+||+.||+.||++|||++++
T Consensus 237 ~~~~li~~cl~~dp~~Rps~~ei 259 (273)
T d1mp8a_ 237 TLYSLMTKCWAYDPSRRPRFTEL 259 (273)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHH
Confidence 99999999999999999998543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-53 Score=344.60 Aligned_cols=256 Identities=22% Similarity=0.397 Sum_probs=216.8
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEcCCC-------CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCcee
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNSETG-------EPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVR 75 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~ 75 (269)
+++....++|++.+.||+|+||.||+|++..++ ..||+|++..+. .......+.+|...+.++ +||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 455667799999999999999999999876554 479999986544 233456788888888888 7999999
Q ss_pred eeEEEeeCCeEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 024347 76 LYEVMGSKTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (269)
Q Consensus 76 ~~~~~~~~~~~~~v~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~ 139 (269)
+++++.+.+..++||||+++|++.+++... ..+++.+++.++.|++.||+|||+.||+||||||
T Consensus 84 ~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 84 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred cccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 999999999999999999999999998654 2489999999999999999999999999999999
Q ss_pred CceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 024347 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (269)
Q Consensus 140 ~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 218 (269)
+||+++.++.++|+|||.++...............+++.|+|||.+.+..+ +.++||||||+++|+|++ |+.||...+
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999999987766555555566678899999999988776 499999999999999998 799999999
Q ss_pred HHHHHHHHhcC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 219 LMNLYKKISAA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 219 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.......+..+ +++.+..+++++.+||++||+.||++|||+.++
T Consensus 243 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~ei 287 (299)
T d1fgka_ 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287 (299)
T ss_dssp HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHH
Confidence 88888887665 456677899999999999999999999998443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-53 Score=345.53 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=218.3
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEE
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVM 80 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~ 80 (269)
++...++|++.+.||+|+||+||+|+++. +++.||||++.... .....+.+.+|+.++++++||||+++++++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 34456789999999999999999998753 46789999986543 344467899999999999999999999999
Q ss_pred eeCCeEEEEEeccCCCchhHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeec
Q 024347 81 GSKTKIFIVLEFVTGGELFDKIVNHG------------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRD 136 (269)
Q Consensus 81 ~~~~~~~~v~~~~~~~~l~~~~~~~~------------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~d 136 (269)
......++++||+++++|.+++.... .++...+..++.|++.||+|||+.+++|||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999886422 378889999999999999999999999999
Q ss_pred CCCCceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCC-CCCC
Q 024347 137 LKPENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGY-LPFD 215 (269)
Q Consensus 137 i~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~p~~ 215 (269)
|||+||+++.++.+||+|||+++...............+++.|+|||.+.+..++ .++||||||+++|+|++|. .||.
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~ 244 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYY 244 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCC
Confidence 9999999999999999999999765544444444455678899999999887764 9999999999999999984 6899
Q ss_pred CCCHHHHHHHHhcCcc-cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 216 DSNLMNLYKKISAAEF-TCPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 216 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
..+..+....+..+.. +.+..+++++.+|+..||+.||++|||+.++.
T Consensus 245 ~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~ 293 (301)
T d1lufa_ 245 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293 (301)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999999888887764 45678999999999999999999999986653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-54 Score=343.87 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=203.3
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCC-C--CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCe
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSET-G--EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~--~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 85 (269)
..++|++.+.||+|+||+||+|++... + ..||+|++........+..+.+.+|+.++++++||||+++++++.+. .
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~ 84 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P 84 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-c
Confidence 357899999999999999999986533 3 36899998776665666678899999999999999999999999654 6
Q ss_pred EEEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.++||||++++++.+.+... +.++...+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus 85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~ 164 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 164 (273)
T ss_dssp CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence 78999999999998877654 57999999999999999999999999999999999999999999999999998865433
Q ss_pred cCCC-cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC--cccCCCCCCHH
Q 024347 165 RDDG-LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA--EFTCPPWLSFT 240 (269)
Q Consensus 165 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 240 (269)
.... ......++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..+....+... +++.++.+|+.
T Consensus 165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 243 (273)
T d1u46a_ 165 DDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD 243 (273)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred CCcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence 2222 2223346778999999988765 489999999999999998 89999999999988888655 34566789999
Q ss_pred HHHHHHHhcCCCCCCcCCCCcc
Q 024347 241 ARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+.+||..||+.||++|||++++
T Consensus 244 l~~li~~cl~~dp~~RPt~~ei 265 (273)
T d1u46a_ 244 IYNVMVQCWAHKPEDRPTFVAL 265 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHcCCChhHCcCHHHH
Confidence 9999999999999999998554
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=339.32 Aligned_cols=255 Identities=31% Similarity=0.445 Sum_probs=216.8
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeEEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKIFIV 89 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 89 (269)
.++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++.+....+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 3699999999999999999999999999999999976543 334568899999999999999999999999999999999
Q ss_pred EeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCCCc
Q 024347 90 LEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDDGL 169 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~~~ 169 (269)
++++.++++..+....+.+++..+..++.|++.||+|||++||+|+||||+||+++.++.++++|||.+....... ..
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--RC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC--SC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCC--cc
Confidence 9999999988888888899999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcC-------------------
Q 024347 170 LHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPF-DDSNLMNLYKKISAA------------------- 229 (269)
Q Consensus 170 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~-~~~~~~~~~~~~~~~------------------- 229 (269)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.|| .+.+..+....+...
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 233446788999999887776679999999999999999999885 555555555554211
Q ss_pred ----------cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ----------EFTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.......+++.+.+||++||++||.+|||+ .++|.|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa--~e~L~Hp~ 285 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA--EEALQHPY 285 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCH--HHHTTSGG
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCH--HHHhcChh
Confidence 011122368899999999999999999999 78899988
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-53 Score=346.62 Aligned_cols=258 Identities=29% Similarity=0.356 Sum_probs=209.5
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee------
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------ 82 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------ 82 (269)
..++|++++.||+|+||+||+|+++.+|+.||||++...... +...+.+.+|+.++++++|+|++++++++..
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 468999999999999999999999999999999998654432 2334677899999999999999999998854
Q ss_pred --CCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 83 --KTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 83 --~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
....+++|||+.++.+.........+++..++.++.|++.||.|||+.||+||||||+||+++.++.++++|||++..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 345899999998776655555556899999999999999999999999999999999999999999999999999875
Q ss_pred cccccC--CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccCCC---
Q 024347 161 SQQVRD--DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTCPP--- 235 (269)
Q Consensus 161 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 235 (269)
...... ........+++.|+|||++.+...++.++||||+|+++|+|++|+.||.+.+.......+.......++
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 543222 222333468999999999987655569999999999999999999999988877766665332111110
Q ss_pred -----------------------------CCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 236 -----------------------------WLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 236 -----------------------------~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..++.+.+||++||++||++|||+ .++|.|+|
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa--~elL~Hpf 307 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS--DDALNHDF 307 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCH--HHHHHSGG
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCH--HHHHcChh
Confidence 036778899999999999999999 78899987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=348.46 Aligned_cols=247 Identities=22% Similarity=0.361 Sum_probs=204.7
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCC----eEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCCeE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGE----PVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKTKI 86 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 86 (269)
++|++++.||+|+||+||+|.+..+|+ .||+|.+.... .....+.+.+|+.++++++||||+++++++.+. ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 579999999999999999999988776 47888775432 233457889999999999999999999999765 45
Q ss_pred EEEEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 87 FIVLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
+++++++.+++|.+.+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 6777888888998877664 579999999999999999999999999999999999999999999999999998665433
Q ss_pred CCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCc-ccCCCCCCHHHHH
Q 024347 166 DDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAAE-FTCPPWLSFTARK 243 (269)
Q Consensus 166 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~ 243 (269)
.........+++.|+|||++.+..+ +.++||||||+++|+|+| |..||.+.+..++...+..+. ++.++.+++.+.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 3333344457899999999988776 599999999999999998 899999888887777776654 6777889999999
Q ss_pred HHHHhcCCCCCCcCCCCc
Q 024347 244 LIARILDPNPMTVSIYPF 261 (269)
Q Consensus 244 li~~~l~~dP~~Rps~~~ 261 (269)
|+++||+.||++|||+++
T Consensus 245 li~~cl~~dP~~RPs~~e 262 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRE 262 (317)
T ss_dssp HHHHHTCSSGGGSCCHHH
T ss_pred HHHHhCCCChhhCcCHHH
Confidence 999999999999999854
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=339.61 Aligned_cols=243 Identities=23% Similarity=0.413 Sum_probs=205.1
Q ss_pred cccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-CC
Q 024347 6 IKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KT 84 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~ 84 (269)
+....++|++.+.||+|+||.||+|.++ |+.||+|+++.+. ..+.+.+|++++++++||||+++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4667889999999999999999999984 7789999986432 24678899999999999999999999854 56
Q ss_pred eEEEEEeccCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNH--GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++++|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 689999999999999998654 358999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-cccCCCCCCHH
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSNLMNLYKKISAA-EFTCPPWLSFT 240 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 240 (269)
.. .....++..|+|||++.+..+ +.++||||||+++|+|++ |..||...+..+....+..+ +++.+..++++
T Consensus 155 ~~-----~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 228 (262)
T d1byga_ 155 ST-----QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228 (262)
T ss_dssp ------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHH
T ss_pred CC-----CccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHH
Confidence 32 222346789999999987766 599999999999999998 79999988888888888664 56777889999
Q ss_pred HHHHHHHhcCCCCCCcCCCCc
Q 024347 241 ARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 241 l~~li~~~l~~dP~~Rps~~~ 261 (269)
+.+||++||+.||.+|||+.+
T Consensus 229 ~~~li~~cl~~dP~~Rps~~~ 249 (262)
T d1byga_ 229 VYEVMKNCWHLDAAMRPSFLQ 249 (262)
T ss_dssp HHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHcccCHhHCcCHHH
Confidence 999999999999999999843
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=348.83 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=206.6
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC----
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT---- 84 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---- 84 (269)
..++|++++.||+|+||+||+|.++.+|+.||+|++..... .....+.+.+|+++++.++||||+++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccc
Confidence 45799999999999999999999999999999999975433 4455688899999999999999999999997654
Q ss_pred --eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccc
Q 024347 85 --KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQ 162 (269)
Q Consensus 85 --~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~ 162 (269)
.+++||||+ +.++.... .++.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++++|||.++...
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 479999999 55666554 45689999999999999999999999999999999999999999999999999987543
Q ss_pred cccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc------------
Q 024347 163 QVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE------------ 230 (269)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~------------ 230 (269)
. ......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+............
T Consensus 173 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 173 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred C-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 2 22345688999999999877666799999999999999999999998877665544432110
Q ss_pred -------------------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 -------------------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 -------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
......+++++.+||++||+.||.+|||+ .++|.|+|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta--~eiL~Hp~ 303 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA--GEALAHPY 303 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH--HHHHHSGG
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH--HHHhcChh
Confidence 11224578999999999999999999999 88888887
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-53 Score=344.72 Aligned_cols=254 Identities=30% Similarity=0.392 Sum_probs=204.8
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCC-CCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC---CCCCceeeeEEEee--
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSET-GEPVALKILDKEKVLKHKMAEQIKREVATMKLV---KHPNVVRLYEVMGS-- 82 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l---~~~~i~~~~~~~~~-- 82 (269)
.-++|++++.||+|+||+||+|++..+ ++.||+|++....... .....+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 347999999999999999999999755 6679999986543221 1123344566666554 79999999999853
Q ss_pred ---CCeEEEEEeccCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCc
Q 024347 83 ---KTKIFIVLEFVTGGELFDKIVN-HGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (269)
Q Consensus 83 ---~~~~~~v~~~~~~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~ 158 (269)
....++++||++++.+...... ...+++..+..++.|++.||+|||++||+|+||||+|||++.++.++|+|||.+
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 3468999999988766444333 356899999999999999999999999999999999999999999999999988
Q ss_pred cccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------
Q 024347 159 ALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------- 229 (269)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------- 229 (269)
..... ........||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..+....+...
T Consensus 164 ~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 164 RIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp CCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 65432 2233445689999999999887774 9999999999999999999999998877766665321
Q ss_pred ------------------cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 ------------------EFTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 ------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.......+++.+++||++||++||++|||+ .++|.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa--~e~L~Hpf 295 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA--YSALSHPY 295 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH--HHHHTSGG
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH--HHHhcChh
Confidence 011233478899999999999999999999 78899987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-53 Score=344.13 Aligned_cols=249 Identities=21% Similarity=0.340 Sum_probs=210.4
Q ss_pred cccCCeEEeeeeeccCCcEEEEEEEcCCCCe--EEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeEEEeeCC
Q 024347 8 RRVGKYEVGRTIGEGTFAKVKFARNSETGEP--VALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYEVMGSKT 84 (269)
Q Consensus 8 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~--~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~ 84 (269)
+.+++|++.+.||+|+||.||+|.++.+|.. |++|.+.... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 4678999999999999999999999887775 5666654322 333467899999999999 6999999999999999
Q ss_pred eEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC
Q 024347 85 KIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG 148 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~ 148 (269)
..++||||+++|+|.+++... ..+++.++..++.|++.||.|+|+.+++||||+|+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998643 4689999999999999999999999999999999999999999
Q ss_pred CEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHh
Q 024347 149 NLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKIS 227 (269)
Q Consensus 149 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~ 227 (269)
.+||+|||+++....... .....++..|+|||.+.+..+ +.++||||||+++|+|++| ..||...+..++...+.
T Consensus 165 ~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~ 240 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240 (309)
T ss_dssp CEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred ceEEcccccccccccccc---ccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999875443222 223457889999999987776 4899999999999999996 56899999999998887
Q ss_pred cC-cccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 228 AA-EFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 228 ~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
.+ +++.+..+++++.+||..||+.||++|||++++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ei 276 (309)
T d1fvra_ 241 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 276 (309)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 65 466677899999999999999999999998554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-52 Score=343.22 Aligned_cols=253 Identities=25% Similarity=0.427 Sum_probs=205.8
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC-----e
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT-----K 85 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-----~ 85 (269)
++|++++.||+|+||+||+|.++.+|+.||||++.... .....+.+.+|+.++++++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999986543 3445678899999999999999999999986543 3
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~ 165 (269)
++++ +++.|++|.+++..+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 86 ~~l~-~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 86 VYLV-THLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp EEEE-EECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEE-EeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 4555 556688999888654 79999999999999999999999999999999999999999999999999987654432
Q ss_pred C-CCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCc--------------
Q 024347 166 D-DGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAE-------------- 230 (269)
Q Consensus 166 ~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------------- 230 (269)
. ........+++.|+|||++.....++.++||||+|+++|+|++|+.||.+....+.........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 2 2223445689999999998766666689999999999999999999998876654443331100
Q ss_pred --------c---------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 --------F---------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 --------~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
. ...+.+++++.+||++||+.||++|||+ .++|.|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta--~e~L~hpf 297 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV--EQALAHPY 297 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH--HHHHTSGG
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH--HHHhcCHh
Confidence 0 1123468899999999999999999999 77888887
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=345.51 Aligned_cols=246 Identities=28% Similarity=0.365 Sum_probs=202.2
Q ss_pred CeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC------Ce
Q 024347 12 KYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK------TK 85 (269)
Q Consensus 12 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~------~~ 85 (269)
+|+..+.||+|+||+||+|+++.+|+.||+|++..+.. ...+|++++++++|+||+++++++... ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 79999999999999999999999999999999875432 234699999999999999999998542 35
Q ss_pred EEEEEeccCCCchhHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-CEEEeeCCCcccc
Q 024347 86 IFIVLEFVTGGELFDK---IVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALS 161 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-~~~l~df~~~~~~ 161 (269)
+++||||++++.+... ......+++.++..++.|++.||+|||++||+||||||+|||++.++ .+||+|||++...
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 7899999976543222 23355799999999999999999999999999999999999999775 7999999998754
Q ss_pred ccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Q 024347 162 QQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA------------ 229 (269)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~------------ 229 (269)
.. ........+++.|+|||.+.+...++.++||||+||++|+|++|+.||......+....+...
T Consensus 174 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 250 (350)
T d1q5ka_ 174 VR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250 (350)
T ss_dssp CT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred cC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence 32 223334568999999999887665679999999999999999999999988776665554210
Q ss_pred -------cc----------cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 -------EF----------TCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 -------~~----------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
.+ ...+..++++.+||++||+.||++|||+ .++|.|+|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta--~e~L~Hp~ 305 (350)
T d1q5ka_ 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP--LEACAHSF 305 (350)
T ss_dssp CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCH--HHHhcCHh
Confidence 00 1123478899999999999999999999 77888887
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=343.11 Aligned_cols=260 Identities=29% Similarity=0.511 Sum_probs=217.9
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEc---CCCCeEEEEEeehhhhh-hHHHHHHHHHHHHHhhhCCC-CCceeeeEEEeeC
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNS---ETGEPVALKILDKEKVL-KHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSK 83 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~---~~~~~~~~K~~~~~~~~-~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 83 (269)
..++|++++.||+|+||+||+|.+. .+|+.||+|++...... .....+.+.+|+.++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 4588999999999999999999874 46899999998653321 12224567889999999976 8999999999999
Q ss_pred CeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCcccccc
Q 024347 84 TKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQ 163 (269)
Q Consensus 84 ~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~ 163 (269)
...++++||+.+++|...+...+.+++..+..++.|++.||.|+|+.||+|+||+|+||+++.++.++|+|||+++....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~ 181 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA 181 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999875543
Q ss_pred ccCCCcccccccCccccCcccccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCcccCCCCCC
Q 024347 164 VRDDGLLHTTCGTPNYVAPEVLNDRG-YDGSTADLWSCGVILFVLLAGYLPFDDSNL----MNLYKKISAAEFTCPPWLS 238 (269)
Q Consensus 164 ~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~ 238 (269)
.. ........+++.|+|||.+.+.. .++.++|||||||++|+|++|..||..... ..+.........+.+..++
T Consensus 182 ~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s 260 (322)
T d1vzoa_ 182 DE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260 (322)
T ss_dssp GG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred cc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCC
Confidence 22 22234456889999999997654 346899999999999999999999976433 3444445566677788899
Q ss_pred HHHHHHHHHhcCCCCCCcCCCC---ccccccccC
Q 024347 239 FTARKLIARILDPNPMTVSIYP---FADILYMRF 269 (269)
Q Consensus 239 ~~l~~li~~~l~~dP~~Rps~~---~~~~l~~~~ 269 (269)
+++.+||++||++||++|||+. ..+++.|+|
T Consensus 261 ~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 261 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred HHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 9999999999999999999853 256788887
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=339.36 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=199.2
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeeeE
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLYE 78 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~ 78 (269)
++....++|++.+.||+|+||.||+|.+.. +++.||+|.+..... ....+.+.+|...+.++ +|+||+.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 344556899999999999999999999754 346899999865432 23346677777777666 6899999999
Q ss_pred EEee-CCeEEEEEeccCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCc
Q 024347 79 VMGS-KTKIFIVLEFVTGGELFDKIVNH----------------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPEN 141 (269)
Q Consensus 79 ~~~~-~~~~~~v~~~~~~~~l~~~~~~~----------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~n 141 (269)
++.. ...++++|||+++|+|.+++... ..+++.++..++.|++.||.|||++||+||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 8755 45689999999999999998643 248899999999999999999999999999999999
Q ss_pred eEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHH
Q 024347 142 LLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLM 220 (269)
Q Consensus 142 Il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~ 220 (269)
|+++.++.+||+|||+++...............+++.|+|||++.+..+ +.++||||||+++|+|++| ..||.+....
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999976554444444445568999999999988766 4999999999999999986 5688765443
Q ss_pred -HHHHHHhc-CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCc
Q 024347 221 -NLYKKISA-AEFTCPPWLSFTARKLIARILDPNPMTVSIYPF 261 (269)
Q Consensus 221 -~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ 261 (269)
.....+.. ..++.+..+++++.+||..||+.||++|||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 286 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 286 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 33344433 345667789999999999999999999999843
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=336.73 Aligned_cols=255 Identities=18% Similarity=0.247 Sum_probs=220.3
Q ss_pred ccccccCCeEEeeeeeccCCcEEEEEEEcC-----CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEE
Q 024347 5 KIKRRVGKYEVGRTIGEGTFAKVKFARNSE-----TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEV 79 (269)
Q Consensus 5 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 79 (269)
+++...++|++.+.||+|+||+||+|.++. +++.||||+++... .......+.+|+.++++++||||++++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 456677999999999999999999998753 35789999987543 33445778999999999999999999999
Q ss_pred EeeCCeEEEEEeccCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCC
Q 024347 80 MGSKTKIFIVLEFVTGGELFDKIVNH----------GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGN 149 (269)
Q Consensus 80 ~~~~~~~~~v~~~~~~~~l~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~ 149 (269)
+......++||||+++|+|.+++... ..++...+..++.+++.||.|||+.+|+||||+|+||+++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999888643 24688999999999999999999999999999999999999999
Q ss_pred EEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhc
Q 024347 150 LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAG-YLPFDDSNLMNLYKKISA 228 (269)
Q Consensus 150 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~ 228 (269)
+||+|||+++...............+++.|+|||.+.+..+. .++||||||+++|+|++| ..||.+.+..+....+..
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~ 250 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 250 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 999999999866554444444445678999999999887764 899999999999999997 688999999888888876
Q ss_pred Cc-ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 229 AE-FTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 229 ~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
+. .+.++.+++.+.++|..||+.||++|||++++
T Consensus 251 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~i 285 (308)
T d1p4oa_ 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285 (308)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHH
Confidence 55 45677899999999999999999999998544
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=337.07 Aligned_cols=256 Identities=20% Similarity=0.332 Sum_probs=214.5
Q ss_pred cccccccCCeEEeeeeeccCCcEEEEEEEc-----CCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhC-CCCCceeee
Q 024347 4 PKIKRRVGKYEVGRTIGEGTFAKVKFARNS-----ETGEPVALKILDKEKVLKHKMAEQIKREVATMKLV-KHPNVVRLY 77 (269)
Q Consensus 4 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~ 77 (269)
+++....++|++.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+++.+ +||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 445667789999999999999999999863 4577899999876543 33456789999999999 699999999
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCC
Q 024347 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHG------------------RMKEDEARRYFQQLINAVDYCHSRGVYHRDLKP 139 (269)
Q Consensus 78 ~~~~~~~~~~~v~~~~~~~~l~~~~~~~~------------------~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~ 139 (269)
+++.+....+++|||++++++..++.... .+++..+..++.|++.||+|||+.|++|+||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 99999999999999999999999886532 588999999999999999999999999999999
Q ss_pred CceEecCCCCEEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 024347 140 ENLLLDAYGNLKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLA-GYLPFDDSN 218 (269)
Q Consensus 140 ~nIl~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~-g~~p~~~~~ 218 (269)
+||+++.++.++++|||.++...............+++.|+|||++.+..+ +.++||||||+++|+|++ |.+||...+
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999986654444444445578999999999987766 489999999999999998 677776655
Q ss_pred HHHHHHHH-hc-CcccCCCCCCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 219 LMNLYKKI-SA-AEFTCPPWLSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 219 ~~~~~~~~-~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
......++ .. .+...+..+++.+.+||..||+.||++|||++++
T Consensus 253 ~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~i 298 (311)
T d1t46a_ 253 VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298 (311)
T ss_dssp SSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred HHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHH
Confidence 54444443 33 3445566789999999999999999999998554
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=343.08 Aligned_cols=251 Identities=26% Similarity=0.343 Sum_probs=207.9
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeC-----C
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSK-----T 84 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 84 (269)
.+||++++.||+|+||+||+|+++.+|+.||+|++..... +....+.+.+|++++++++|||++++++++... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 4789999999999999999999999999999999976543 334457788999999999999999999998543 2
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
..+++++++.|++|.+++.. +.+++.++..++.|++.||+|||++||+||||||+||+++.++.++++|||.+.....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCc-
Confidence 34556677789999887754 5799999999999999999999999999999999999999999999999998864432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCcccC-----------
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAAEFTC----------- 233 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 233 (269)
......+++.|+|||++.+....+.++||||||+++|+|++|+.||.+.+.......+.......
T Consensus 174 ----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 174 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 23344578899999998887766799999999999999999999999887776666553221110
Q ss_pred --------------------CCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 234 --------------------PPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 234 --------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
...+++++++||++||+.||++|||+ .++|.|+|
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta--~elL~Hp~ 303 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA--AQALAHAY 303 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCH--HHHhcCHh
Confidence 12478899999999999999999999 78899987
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.9e-51 Score=335.17 Aligned_cols=247 Identities=23% Similarity=0.407 Sum_probs=202.7
Q ss_pred ccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEee--CCe
Q 024347 9 RVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMGS--KTK 85 (269)
Q Consensus 9 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--~~~ 85 (269)
..++|++++.||+|+||+||+|+++.+|+.||+|++.... .+.+.+|++++++++ ||||+++++++.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 4578999999999999999999999999999999986533 356788999999996 9999999999974 456
Q ss_pred EEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCC-CEEEeeCCCccccccc
Q 024347 86 IFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYG-NLKVSDFGLSALSQQV 164 (269)
Q Consensus 86 ~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~-~~~l~df~~~~~~~~~ 164 (269)
.++||||+.+++|... .+.+++..+..++.|++.||.|||++||+|+||||+|||++.++ .++|+|||.+......
T Consensus 107 ~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 107 PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 8999999999998665 34699999999999999999999999999999999999998655 5899999998754432
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHh-------------cCc
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLM-NLYKKIS-------------AAE 230 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~-------------~~~ 230 (269)
.......+++.|+|||.+.+...++.++|+||+|+++|++++|..||...... .....+. ...
T Consensus 184 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 ---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp ---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred ---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 22344567899999999988776679999999999999999999999754332 1111110 000
Q ss_pred ------------------------ccCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 231 ------------------------FTCPPWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 231 ------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
......+++++.+||++||+.||++|||+ .++|.|+|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta--~e~L~Hp~ 321 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA--REAMEHPY 321 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCH--HHHHTSGG
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCH--HHHhcCcc
Confidence 00112368899999999999999999999 78899987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=337.13 Aligned_cols=249 Identities=25% Similarity=0.406 Sum_probs=198.5
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee------CC
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS------KT 84 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~ 84 (269)
++|++++.||+|+||+||+|+++.+|+.||||++..... +....+.+.+|+.++++++||||+++++++.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 689999999999999999999999999999999976543 34446788999999999999999999999953 36
Q ss_pred eEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccc
Q 024347 85 KIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQV 164 (269)
Q Consensus 85 ~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~ 164 (269)
.+++||||+.++ +.+.+. ..+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++++|||.++....
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~- 171 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT- 171 (355)
T ss_dssp EEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchH-HHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc-
Confidence 789999999765 444443 4689999999999999999999999999999999999999999999999998765433
Q ss_pred cCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------
Q 024347 165 RDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKISAA--------------- 229 (269)
Q Consensus 165 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------- 229 (269)
........+++.|+|||++.+..+ +.++||||+||++++|++|+.||.+.+.......+...
T Consensus 172 --~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 248 (355)
T d2b1pa1 172 --SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248 (355)
T ss_dssp -----------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred --ccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence 223334467899999999988766 48999999999999999999999887766555443211
Q ss_pred -------cccCC--------------------CCCCHHHHHHHHHhcCCCCCCcCCCCccccccccC
Q 024347 230 -------EFTCP--------------------PWLSFTARKLIARILDPNPMTVSIYPFADILYMRF 269 (269)
Q Consensus 230 -------~~~~~--------------------~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l~~~~ 269 (269)
..... ...++++.+||++||+.||++|||+ .++|.|+|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta--~elL~Hpw 313 (355)
T d2b1pa1 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV--DDALQHPY 313 (355)
T ss_dssp HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH--HHHHTSTT
T ss_pred HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCH--HHHhcCcc
Confidence 00000 0135678999999999999999999 88899998
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=324.55 Aligned_cols=245 Identities=22% Similarity=0.274 Sum_probs=198.6
Q ss_pred EEeeeeeccCCcEEEEEEEcCCC---CeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEee-CCeEEEE
Q 024347 14 EVGRTIGEGTFAKVKFARNSETG---EPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGS-KTKIFIV 89 (269)
Q Consensus 14 ~~~~~lg~g~~~~v~~~~~~~~~---~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v 89 (269)
...+.||+|+||+||+|.+..++ ..||||.++.. ......+.+.+|++++++++||||+++++++.. ....++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34689999999999999986543 35889998642 245557889999999999999999999999865 5689999
Q ss_pred EeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCCccccccccCC-
Q 024347 90 LEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGLSALSQQVRDD- 167 (269)
Q Consensus 90 ~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~~~~~~~~- 167 (269)
|||++++++.+++... ..++...+..++.|++.||.|+|+.+|+||||||+||++++++.++|+|||+++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999999888754 35778889999999999999999999999999999999999999999999999765433222
Q ss_pred -CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC-cccCCCCCCHHHHHH
Q 024347 168 -GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDD-SNLMNLYKKISAA-EFTCPPWLSFTARKL 244 (269)
Q Consensus 168 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 244 (269)
.......+++.|+|||++.+..+ +.++||||||+++|+|++|..||.. ....+....+..+ ++..++.+++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 22233457899999999987766 5999999999999999997776654 3344455555444 455677899999999
Q ss_pred HHHhcCCCCCCcCCCCc
Q 024347 245 IARILDPNPMTVSIYPF 261 (269)
Q Consensus 245 i~~~l~~dP~~Rps~~~ 261 (269)
|..||+.||++|||+++
T Consensus 267 i~~cl~~dP~~RPs~~e 283 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSE 283 (311)
T ss_dssp HHHHTCSSGGGSCCHHH
T ss_pred HHHHcCCCHhHCcCHHH
Confidence 99999999999999843
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-49 Score=319.44 Aligned_cols=246 Identities=20% Similarity=0.246 Sum_probs=194.3
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEeeCCeEEEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGSKTKIFIV 89 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~~v 89 (269)
++|++.+.||+|+||.||+|++..+|+.||+|++..... .+.+..|+++++.++|+++ +.+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 579999999999999999999999999999999865432 2356789999999987665 5556666788889999
Q ss_pred EeccCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEec---CCCCEEEeeCCCcccccccc
Q 024347 90 LEFVTGGELFDKIV-NHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLD---AYGNLKVSDFGLSALSQQVR 165 (269)
Q Consensus 90 ~~~~~~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~---~~~~~~l~df~~~~~~~~~~ 165 (269)
|||+.+ ++...+. ..+.+++..+..++.|++.||+|||++||+|+||||+||+++ .+..++++|||+++......
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 999955 5555554 456899999999999999999999999999999999999986 34579999999998654432
Q ss_pred CCC-----cccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---hcCc-----cc
Q 024347 166 DDG-----LLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMNLYKKI---SAAE-----FT 232 (269)
Q Consensus 166 ~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~-----~~ 232 (269)
... ......|++.|+|||++.+..++ .++||||||+++|+|++|..||...........+ .... ..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 239 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhH
Confidence 221 22334689999999999887764 9999999999999999999999765544333222 1111 12
Q ss_pred CCCCCCHHHHHHHHHhcCCCCCCcCCCCccc
Q 024347 233 CPPWLSFTARKLIARILDPNPMTVSIYPFAD 263 (269)
Q Consensus 233 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~ 263 (269)
....+|+++.+|+..||+.||++||+++++.
T Consensus 240 ~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 240 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 2356899999999999999999999986553
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4e-48 Score=313.95 Aligned_cols=249 Identities=21% Similarity=0.278 Sum_probs=203.7
Q ss_pred cCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCC-CCceeeeEEEeeCCeEEE
Q 024347 10 VGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKH-PNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 10 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~ 88 (269)
-++|++.+.||+|+||+||+|++..+|+.||+|++..... ...+.+|++.++.+.| +|++.+++++......++
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 3689999999999999999999999999999998765432 2346678888988875 899999999999999999
Q ss_pred EEeccCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecC-----CCCEEEeeCCCccccc
Q 024347 89 VLEFVTGGELFDKIVNH-GRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDA-----YGNLKVSDFGLSALSQ 162 (269)
Q Consensus 89 v~~~~~~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~-----~~~~~l~df~~~~~~~ 162 (269)
||||+ +++|.+.+... ..++..++..++.|++.+|.+||+.||+|+||||+||+++. ++.++|+|||+++...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 67888888664 47999999999999999999999999999999999999974 5679999999998654
Q ss_pred cccCC-----CcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCcc---
Q 024347 163 QVRDD-----GLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDS---NLMNLYKKISAAEF--- 231 (269)
Q Consensus 163 ~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~~~--- 231 (269)
..... .......||+.|+|||++.+..++ .++||||||+++|+|++|..||.+. ........+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence 32221 122334689999999999887764 9999999999999999999999753 33333333332222
Q ss_pred --cCCCCCCHHHHHHHHHhcCCCCCCcCCCCccccc
Q 024347 232 --TCPPWLSFTARKLIARILDPNPMTVSIYPFADIL 265 (269)
Q Consensus 232 --~~~~~~~~~l~~li~~~l~~dP~~Rps~~~~~~l 265 (269)
..++.+|+++.+++..|++.+|++||+++++..+
T Consensus 237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~ 272 (293)
T d1csna_ 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 272 (293)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 2235689999999999999999999997665443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=309.74 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=189.9
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCceeeeEEEeeCC----eE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVVRLYEVMGSKT----KI 86 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~----~~ 86 (269)
.+|.+.+.||+|+||+||+|++ +|+.||+|++..+... ......|+..+..++||||+++++++.+.+ ..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh----HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4789999999999999999997 5889999998654321 123345677778899999999999997643 58
Q ss_pred EEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCcEeecCCCCceEecCCCCEEEeeCCCc
Q 024347 87 FIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHS--------RGVYHRDLKPENLLLDAYGNLKVSDFGLS 158 (269)
Q Consensus 87 ~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--------~~i~h~di~~~nIl~~~~~~~~l~df~~~ 158 (269)
++||||+++|+|..++.+. .++..++..++.+++.||.|+|+ .||+|+||||+||+++.++.+||+|||++
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 9999999999999999764 68999999999999999999996 59999999999999999999999999998
Q ss_pred cccccccCC--CcccccccCccccCcccccCCCC-----CCCchhHHHHHHHHHHHHcCCCCCCC---------------
Q 024347 159 ALSQQVRDD--GLLHTTCGTPNYVAPEVLNDRGY-----DGSTADLWSCGVILFVLLAGYLPFDD--------------- 216 (269)
Q Consensus 159 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~--------------- 216 (269)
+........ .......+++.|+|||++.+... .+.++||||||+++|+|++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 765443221 12334568999999999876532 24679999999999999999877632
Q ss_pred CCHHHHHHHHhcCcc--cCCCC-----CCHHHHHHHHHhcCCCCCCcCCCCcc
Q 024347 217 SNLMNLYKKISAAEF--TCPPW-----LSFTARKLIARILDPNPMTVSIYPFA 262 (269)
Q Consensus 217 ~~~~~~~~~~~~~~~--~~~~~-----~~~~l~~li~~~l~~dP~~Rps~~~~ 262 (269)
............... +.+.. .+..+.+|+++||+.||++|||+.++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei 288 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI 288 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHH
Confidence 122333333333222 22222 23458999999999999999998553
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-44 Score=299.59 Aligned_cols=247 Identities=23% Similarity=0.403 Sum_probs=186.3
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-----------CCCceeeeEE
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-----------HPNVVRLYEV 79 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------~~~i~~~~~~ 79 (269)
+||++++.||+|+||+||+|++..+|+.||||+++.+.. ..+.+.+|+++++.+. |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 379999999999999999999999999999999976542 2356677888887775 5789999988
Q ss_pred Eee--CCeEEEEEeccCCCch-hHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCcEeecCCCCceEecCCCC----
Q 024347 80 MGS--KTKIFIVLEFVTGGEL-FDKIV--NHGRMKEDEARRYFQQLINAVDYCHS-RGVYHRDLKPENLLLDAYGN---- 149 (269)
Q Consensus 80 ~~~--~~~~~~v~~~~~~~~l-~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lh~-~~i~h~di~~~nIl~~~~~~---- 149 (269)
+.. ....+.++.++..... ..... ....+++..+..++.|++.||.+||+ .||+|+||||+||+++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 754 4456666665544332 22222 23578999999999999999999998 89999999999999986554
Q ss_pred --EEEeeCCCccccccccCCCcccccccCccccCcccccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCHHH------
Q 024347 150 --LKVSDFGLSALSQQVRDDGLLHTTCGTPNYVAPEVLNDRGYDGSTADLWSCGVILFVLLAGYLPFDDSNLMN------ 221 (269)
Q Consensus 150 --~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------ 221 (269)
++++|||.+..... ......+++.|+|||++.+..++ .++|+||+|+++++|++|+.||.......
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 89999998764332 22345689999999999887774 89999999999999999999997543211
Q ss_pred -HHHHH--h---------------------------------------cCcccCCCCCCHHHHHHHHHhcCCCCCCcCCC
Q 024347 222 -LYKKI--S---------------------------------------AAEFTCPPWLSFTARKLIARILDPNPMTVSIY 259 (269)
Q Consensus 222 -~~~~~--~---------------------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~ 259 (269)
....+ . ......+...++++.+||..||++||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 10000 0 00011112246789999999999999999999
Q ss_pred CccccccccC
Q 024347 260 PFADILYMRF 269 (269)
Q Consensus 260 ~~~~~l~~~~ 269 (269)
.++|+|+|
T Consensus 323 --~e~L~Hp~ 330 (362)
T d1q8ya_ 323 --GGLVNHPW 330 (362)
T ss_dssp --HHHHTCGG
T ss_pred --HHHhcCcc
Confidence 77899987
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=9.9e-24 Score=159.36 Aligned_cols=135 Identities=19% Similarity=0.291 Sum_probs=106.2
Q ss_pred eEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhh---------------hHHHHHHHHHHHHHhhhCCCCCceeee
Q 024347 13 YEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVL---------------KHKMAEQIKREVATMKLVKHPNVVRLY 77 (269)
Q Consensus 13 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 77 (269)
+.+.+.||.|+||+||+|.+. +|+.||+|++...... ..........|...+.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999985 6899999987532111 112234556789999999999998887
Q ss_pred EEEeeCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcEeecCCCCceEecCCCCEEEeeCCC
Q 024347 78 EVMGSKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSRGVYHRDLKPENLLLDAYGNLKVSDFGL 157 (269)
Q Consensus 78 ~~~~~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~h~di~~~nIl~~~~~~~~l~df~~ 157 (269)
+... .+++|||+++..+.+ ++......++.|++.+|.+||+.||+|+||||+||++++++ ++|+|||.
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCC
Confidence 6532 268999998765533 34455668899999999999999999999999999999654 89999998
Q ss_pred ccc
Q 024347 158 SAL 160 (269)
Q Consensus 158 ~~~ 160 (269)
+..
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred ccc
Confidence 764
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.95 E-value=3.3e-09 Score=82.42 Aligned_cols=147 Identities=17% Similarity=0.163 Sum_probs=98.7
Q ss_pred ccccccccCCeEEeeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCC-CCCceeeeEEEe
Q 024347 3 QPKIKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVK-HPNVVRLYEVMG 81 (269)
Q Consensus 3 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~ 81 (269)
-+++....+.|+.++..+.++.+.||++.. +++.+++|......... ...+.+|...++.+. +-.+.+++.+..
T Consensus 6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~ 80 (263)
T d1j7la_ 6 SPELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFER 80 (263)
T ss_dssp CHHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEE
T ss_pred CHHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEe
Confidence 356677788999888877666789998863 56678899876443222 234566777777664 333567888888
Q ss_pred eCCeEEEEEeccCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------
Q 024347 82 SKTKIFIVLEFVTGGELFDKIVNHGRMKEDEARRYFQQLINAVDYCHSR------------------------------- 130 (269)
Q Consensus 82 ~~~~~~~v~~~~~~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~------------------------------- 130 (269)
+.+..++||++.+|.++....... .....++.++...+..||+.
T Consensus 81 ~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 81 HDGWSNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp ETTEEEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred cCCceEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence 888999999999987764432211 11112233333334444421
Q ss_pred ----------------------------CcEeecCCCCceEecCCCCEEEeeCCCcc
Q 024347 131 ----------------------------GVYHRDLKPENLLLDAYGNLKVSDFGLSA 159 (269)
Q Consensus 131 ----------------------------~i~h~di~~~nIl~~~~~~~~l~df~~~~ 159 (269)
.++|||++|.||++++++.+.++||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 25999999999999986666799999765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.48 E-value=5.1e-07 Score=69.31 Aligned_cols=85 Identities=15% Similarity=0.127 Sum_probs=56.1
Q ss_pred cccccCCeEEeeeeeccC-CcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCC--CceeeeEEEee
Q 024347 6 IKRRVGKYEVGRTIGEGT-FAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHP--NVVRLYEVMGS 82 (269)
Q Consensus 6 ~~~~~~~~~~~~~lg~g~-~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~--~i~~~~~~~~~ 82 (269)
+..+...+... .+..|. ...||+.... .+..+++|...... ...+..|...++.+... .+.+++.+..+
T Consensus 6 ~~~~l~g~~~~-~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~ 77 (255)
T d1nd4a_ 6 WVERLFGYDWA-QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTE 77 (255)
T ss_dssp GTTTTTTCEEE-ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEEC
T ss_pred HHHhccCCceE-EcCCcccCCeEEEEEeC-CCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeeccc
Confidence 44455556553 444454 4688988864 46668999865443 23455677777666432 35677888888
Q ss_pred CCeEEEEEeccCCCch
Q 024347 83 KTKIFIVLEFVTGGEL 98 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~l 98 (269)
.+..+++|++++|.++
T Consensus 78 ~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 78 AGRDWLLLGEVPGQDL 93 (255)
T ss_dssp SSCEEEEEECCSSEET
T ss_pred ccceEEEEEeeecccc
Confidence 8889999999988654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.38 E-value=8.7e-07 Score=72.61 Aligned_cols=81 Identities=15% Similarity=0.143 Sum_probs=48.1
Q ss_pred eeeeeccCCcEEEEEEEcCCCCeEEEEEeehhhhhh----HHHHHHHHHHHHHhhhCC-C--CCceeeeEEEeeCCeEEE
Q 024347 16 GRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLK----HKMAEQIKREVATMKLVK-H--PNVVRLYEVMGSKTKIFI 88 (269)
Q Consensus 16 ~~~lg~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~----~~~~~~~~~e~~~l~~l~-~--~~i~~~~~~~~~~~~~~~ 88 (269)
.+.+|.|....||++.....++.+++|.-....... +...++...|++.++.+. + ..+++++.+ +.....+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 457899999999999887778889999643211100 011234455777776663 2 335556554 4455678
Q ss_pred EEeccCCCch
Q 024347 89 VLEFVTGGEL 98 (269)
Q Consensus 89 v~~~~~~~~l 98 (269)
+||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.63 E-value=0.00014 Score=59.17 Aligned_cols=77 Identities=16% Similarity=0.246 Sum_probs=50.6
Q ss_pred CCeEEeeeeeccCCcEEEEEEEcC-------CCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCc-eeeeEEEee
Q 024347 11 GKYEVGRTIGEGTFAKVKFARNSE-------TGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNV-VRLYEVMGS 82 (269)
Q Consensus 11 ~~~~~~~~lg~g~~~~v~~~~~~~-------~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~ 82 (269)
+.+++ +.|+.|-.-.+|++.... ..+.++++++-... . ..+..+|..+++.+...++ .++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--h---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 44555 678878888999988653 34568888864211 1 2345678888888764444 467777643
Q ss_pred CCeEEEEEeccCCCc
Q 024347 83 KTKIFIVLEFVTGGE 97 (269)
Q Consensus 83 ~~~~~~v~~~~~~~~ 97 (269)
..|++|++|.+
T Consensus 117 ----g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 ----GRLEEYIPSRP 127 (395)
T ss_dssp ----EEEECCCCEEE
T ss_pred ----ceEEEEecccc
Confidence 57889998744
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.47 E-value=0.00023 Score=56.20 Aligned_cols=132 Identities=17% Similarity=0.119 Sum_probs=74.3
Q ss_pred cCCcEEEEEEEcCCCCeEEEEEeehhhhhhHHHHHHHHHHHHHhhhCCCCCce--eee-----EEEeeCCeEEEEEeccC
Q 024347 22 GTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIKREVATMKLVKHPNVV--RLY-----EVMGSKTKIFIVLEFVT 94 (269)
Q Consensus 22 g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~--~~~-----~~~~~~~~~~~v~~~~~ 94 (269)
+..-.||++.. .+|+.+++|+....... .+.+..|.+.+..|...++. ... ..+...+..+.++++.+
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 33468999886 46888999998654322 34566677777666532221 111 12244667788899887
Q ss_pred CCch--------------hHHHHh---c------CCCC-------------------HH---HHHHHHHHHHHHHHHHH-
Q 024347 95 GGEL--------------FDKIVN---H------GRMK-------------------ED---EARRYFQQLINAVDYCH- 128 (269)
Q Consensus 95 ~~~l--------------~~~~~~---~------~~l~-------------------~~---~~~~i~~~i~~~l~~lh- 128 (269)
|..+ ...++. . ...+ .. .....+.++...+...-
T Consensus 108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 6432 111111 0 0111 11 12222333333333221
Q ss_pred ---hCCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 129 ---SRGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 129 ---~~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
..++||||+++.||+++++ ..++||+.|..
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 1368999999999999743 56899997764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.36 E-value=0.00023 Score=55.91 Aligned_cols=31 Identities=26% Similarity=0.288 Sum_probs=27.1
Q ss_pred CCcEeecCCCCceEecCCCCEEEeeCCCccc
Q 024347 130 RGVYHRDLKPENLLLDAYGNLKVSDFGLSAL 160 (269)
Q Consensus 130 ~~i~h~di~~~nIl~~~~~~~~l~df~~~~~ 160 (269)
.|+||||+.++||+++.+...-++||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999877778999997753
|